data_2lqq_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lqq _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.778 0 CA-C-O 120.861 0.362 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.6 mt -111.54 129.23 56.12 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.975 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.2 m -103.56 107.95 19.01 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 173.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 57.8 mt -107.27 133.07 53.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 121.059 0.457 . . . . 0.0 109.775 -176.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.441 ' HD1' ' O ' ' A' ' 58' ' ' THR . 89.5 m-85 -87.16 128.18 35.13 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.458 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 21.1 p -140.29 163.93 31.45 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.581 0.229 . . . . 0.0 111.329 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.1 p -146.11 166.51 25.94 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 124.927 1.291 . . . . 0.0 107.795 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.0 t -74.78 -21.86 59.08 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 173.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -81.86 80.46 8.15 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 177.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.8 t -132.94 164.7 26.37 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.436 0.636 . . . . 0.0 112.439 -168.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -167.85 -81.34 0.05 OUTLIER Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 177.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.47 -31.75 68.11 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 123.891 0.876 . . . . 0.0 112.551 177.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.406 ' HA ' ' HB3' ' A' ' 57' ' ' PRO . 0.5 OUTLIER -64.49 -36.99 85.99 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.547 178.08 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 32.2 tp -68.04 -31.88 71.85 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.069 -176.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.9 mmp_? -58.28 -56.13 26.09 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.9 tp -65.09 -39.0 92.55 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.425 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -60.98 -35.94 78.13 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.76 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.9 m -70.51 -44.6 67.26 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.46 -46.33 89.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.898 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.7 mt -68.05 -37.48 81.38 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.4 m -67.12 -40.85 86.87 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 121.007 0.432 . . . . 0.0 110.179 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.65 -25.4 63.9 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.55 0.69 . . . . 0.0 110.94 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -88.25 6.9 34.69 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.983 178.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 72.9 mtm180 65.34 29.12 11.66 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.475 1.11 . . . . 0.0 111.924 176.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 80.2 mt -91.69 123.41 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.707 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.41 126.26 34.77 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.356 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -136.46 156.67 48.28 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.722 -177.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -118.6 114.85 23.42 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 16.4 pt-20 -91.12 144.82 25.23 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.217 0.532 . . . . 0.0 110.796 -177.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.6 t -89.53 152.86 3.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-O 122.07 0.938 . . . . 0.0 112.48 -172.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -82.76 2.27 34.75 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 127.944 2.498 . . . . 0.0 114.3 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.1 pt -41.56 -26.79 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.835 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 -167.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -61.83 -41.61 98.0 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.738 0.78 . . . . 0.0 109.131 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -100.66 -36.95 8.96 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.313 -178.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -90.92 99.85 12.81 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.26 -178.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -65.04 -38.37 90.64 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -171.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.56 -29.14 70.44 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -174.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.01 -23.42 25.0 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.382 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.67 -39.55 80.57 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.172 0.51 . . . . 0.0 110.117 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.444 ' CD ' HH22 ' A' ' 54' ' ' ARG . 19.2 mm-40 -67.02 -32.26 73.35 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.007 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -67.61 -30.14 69.66 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.756 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.7 t -62.38 -42.93 97.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 53' ' ' ASN . . . -60.55 -34.4 85.71 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.337 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.4 m -68.53 -48.13 65.13 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 122.872 0.469 . . . . 0.0 111.535 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.2 m -73.99 -27.6 22.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -176.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' ' 53' ' ' ASN . 15.4 m120 -87.95 -28.74 21.28 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.128 177.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.15 65.27 1.07 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.364 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.79 -12.43 68.81 Favored Glycine 0 C--N 1.315 -0.609 0 C-N-CA 121.234 -0.507 . . . . 0.0 112.485 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.47 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 93.2 m-20 -111.91 161.38 16.47 Favored 'General case' 0 CA--C 1.486 -1.504 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.444 HH22 ' CD ' ' A' ' 44' ' ' GLU . 84.4 mtt180 -127.64 84.09 2.22 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 173.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.4 m -85.64 132.49 34.15 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.439 ' CG1' ' HA ' ' A' ' 10' ' ' THR . 21.3 t -66.42 -67.12 1.02 Allowed Pre-proline 0 CA--C 1.472 -2.057 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -173.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.406 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . 91.7 Cg_endo -81.15 60.47 7.82 Favored 'Trans proline' 1 N--CA 1.399 -4.073 0 CA-C-N 121.115 1.434 . . . . 0.0 112.915 -164.599 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.441 ' O ' ' HD1' ' A' ' 9' ' ' TYR . 53.6 m -91.23 127.08 36.52 Favored 'General case' 1 N--CA 1.377 -4.075 0 C-N-CA 126.363 1.865 . . . . 0.0 106.731 177.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.0 p -115.19 132.73 63.62 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 CA-C-O 120.916 0.389 . . . . 0.0 110.172 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -115.01 126.91 55.29 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 174.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -88.94 173.81 8.28 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.389 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.09 -10.17 47.22 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.978 0.894 . . . . 0.0 109.727 174.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -78.63 -18.64 54.17 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.271 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.02 -22.12 41.33 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.778 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.8 t -75.2 149.79 38.84 Favored 'General case' 0 C--O 1.253 1.284 0 CA-C-O 120.868 0.366 . . . . 0.0 110.61 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.2 p -114.5 139.73 49.31 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.069 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 58.1 mt -119.83 113.91 21.31 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 174.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.8 m -87.22 112.83 22.39 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 58.04 65.43 3.26 Favored Pre-proline 0 N--CA 1.487 1.42 0 C-N-CA 123.939 0.896 . . . . 0.0 112.366 -177.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -86.22 172.93 6.99 Favored 'Trans proline' 0 C--O 1.249 1.073 0 C-N-CA 121.955 1.77 . . . . 0.0 112.003 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.3 m -93.78 153.3 18.38 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 174.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.71 -36.23 83.17 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.111 0.481 . . . . 0.0 110.708 -177.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -59.31 -45.72 90.54 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.974 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -60.02 -50.53 73.36 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.871 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.9 t -58.21 -45.82 88.79 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.519 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.982 -177.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -67.15 -38.13 84.95 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.335 -178.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.55 -31.02 61.96 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.247 0.546 . . . . 0.0 110.869 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -76.59 -37.64 56.14 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.894 175.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.6 tp -58.38 -51.05 71.46 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.6 m -60.49 -32.12 50.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.669 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -81.8 -40.8 22.03 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 119.869 -0.732 . . . . 0.0 112.016 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.3 pp -76.1 -24.43 16.4 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.426 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -176.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -0.99 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 176.77 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.46 0 CA-C-O 121.279 0.561 . . . . 0.0 110.737 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.6 tp -129.51 136.74 50.23 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 89.6 m -123.34 122.16 37.62 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 67.4 mt -111.85 133.49 57.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 121.298 0.571 . . . . 0.0 110.205 -177.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -87.95 129.39 35.26 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.047 176.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.5 p -134.03 166.04 23.64 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.607 -178.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.3 m -149.84 144.08 25.75 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.5 m -54.98 -44.42 74.43 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 123.435 0.459 . . . . 0.0 110.887 176.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 36.5 p90 -86.75 89.17 7.86 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 122.09 0.948 . . . . 0.0 109.459 175.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.1 t -163.57 154.68 16.47 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.072 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -135.89 -44.73 0.1 OUTLIER Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 177.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -63.6 -33.48 75.71 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.131 0.572 . . . . 0.0 111.38 -176.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.415 ' HA ' ' HB3' ' A' ' 57' ' ' PRO . 10.7 p -65.41 -34.48 78.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.28 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 87.9 mt -61.85 -41.94 98.43 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 115.872 -0.603 . . . . 0.0 112.019 -175.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.5 tpm_? -59.11 -44.81 92.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.968 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.9 tp -76.37 -38.64 55.51 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.648 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.461 ' HG2' ' OH ' ' A' ' 31' ' ' TYR . 16.4 ttpp -63.14 -43.46 98.29 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.548 -176.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.2 t -71.12 -28.18 64.11 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.34 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.35 -41.87 84.42 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.107 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.7 mt -69.6 -35.22 75.11 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.76 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.6 m -65.95 -42.93 89.37 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.0 -31.67 72.39 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-O 121.416 0.626 . . . . 0.0 110.458 176.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.42 0.44 29.31 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.274 176.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 69.02 28.26 5.15 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.071 1.349 . . . . 0.0 112.176 174.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 74.7 mt -87.64 123.05 40.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.326 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.92 117.36 22.71 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.681 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.461 ' OH ' ' HG2' ' A' ' 21' ' ' LYS . 46.4 p90 -136.53 164.0 29.2 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -119.85 138.85 53.14 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 171.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 6.7 pt-20 -101.7 137.97 39.31 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -177.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -94.43 138.57 20.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -169.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -60.9 2.13 0.12 Allowed 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 130.186 3.394 . . . . 0.0 116.074 176.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.2 pt -41.3 -27.86 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.519 3.001 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 -162.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -68.97 -24.29 64.22 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 119.552 1.069 . . . . 0.0 110.856 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -113.02 8.63 18.49 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -142.85 89.98 2.17 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-O 121.471 0.653 . . . . 0.0 109.837 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -65.82 -29.23 69.67 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.731 -1.122 . . . . 0.0 113.7 -173.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.81 -37.32 76.12 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.348 0.594 . . . . 0.0 111.303 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.53 ' O ' HG21 ' A' ' 46' ' ' VAL . . . -87.1 -30.38 21.15 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.129 177.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.67 -42.99 94.99 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.108 0.48 . . . . 0.0 111.508 -178.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -68.91 -29.34 67.59 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.182 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -68.04 -40.64 82.84 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.265 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.53 HG21 ' O ' ' A' ' 42' ' ' ALA . 73.8 t -52.85 -51.04 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.568 177.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.47 -32.23 83.46 Favored Glycine 0 N--CA 1.437 -1.288 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.319 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.8 t -65.48 -33.73 76.61 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 122.272 0.229 . . . . 0.0 110.996 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.3 m -95.1 -10.0 9.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -178.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -96.29 -51.35 4.42 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.004 0.431 . . . . 0.0 110.018 177.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 133.13 -138.66 10.3 Favored Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 -176.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.99 -21.65 62.73 Favored Glycine 0 C--N 1.306 -1.111 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -101.53 115.07 29.69 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -71.54 114.75 9.95 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 177.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.1 m -99.02 134.5 41.77 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.0 t -75.3 -64.52 0.58 Allowed Pre-proline 0 CA--C 1.463 -2.379 0 CA-C-O 117.23 -1.367 . . . . 0.0 113.98 -176.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.415 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . 82.9 Cg_endo -78.78 65.9 8.7 Favored 'Trans proline' 1 N--CA 1.399 -4.076 0 CA-C-N 121.261 1.486 . . . . 0.0 113.029 -167.067 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 96.3 m -92.32 121.37 33.75 Favored 'General case' 1 N--CA 1.376 -4.169 0 CA-C-N 113.146 -1.843 . . . . 0.0 106.051 178.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 66' ' ' THR . 12.7 p -105.61 137.85 33.48 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.998 -178.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -116.44 121.04 40.72 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -85.31 161.64 19.43 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.928 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -49.69 -32.52 13.56 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -175.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -90.58 -6.75 54.28 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.5 -176.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.6 1.88 30.78 Favored Glycine 0 C--O 1.241 0.551 0 C-N-CA 120.113 -1.041 . . . . 0.0 113.773 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.5 m -73.33 125.49 27.94 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 117.294 0.547 . . . . 0.0 109.651 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 49.5 p -114.2 138.36 50.56 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.9 mp -122.59 118.53 28.42 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 61.2 m -88.05 112.31 22.5 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.11 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 58.86 67.67 1.94 Allowed Pre-proline 0 N--CA 1.482 1.148 0 C-N-CA 124.057 0.943 . . . . 0.0 112.883 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -86.79 -174.73 1.47 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.006 1.804 . . . . 0.0 112.227 176.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.414 ' O ' HG22 ' A' ' 75' ' ' VAL . 50.5 m -116.87 150.41 38.47 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 176.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.78 -48.93 72.07 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -174.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -71.9 -24.2 61.61 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 120.639 0.257 . . . . 0.0 111.665 -176.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.552 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 38.1 mm-40 -71.77 -46.6 57.85 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 173.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 71' ' ' SER . 89.1 t -59.98 -44.12 93.95 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 O-C-N 123.842 0.714 . . . . 0.0 110.113 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -62.24 -44.46 96.51 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.652 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.72 -21.17 63.49 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.195 0.522 . . . . 0.0 111.538 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.591 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 46.8 mmtm -84.5 -38.92 19.49 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 175.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.9 tp -56.9 -49.01 76.86 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.767 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.1 m -61.33 -34.1 59.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.152 -177.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.591 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -81.76 -32.66 31.36 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.588 -179.079 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.2 pp -82.21 -12.52 12.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.136 0.493 . . . . 0.0 111.673 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.687 0 CA-C-O 121.394 0.616 . . . . 0.0 110.545 178.209 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 121.116 0.484 . . . . 0.0 110.775 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.9 mt -119.83 137.99 53.65 Favored 'General case' 0 CA--C 1.489 -1.377 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.951 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.4 m -106.91 113.95 27.74 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 174.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 51.9 mt -112.19 125.97 69.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-O 121.473 0.654 . . . . 0.0 110.094 -177.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -80.97 128.14 33.35 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.98 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.483 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 7.4 p -140.85 178.16 7.54 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.056 0.543 . . . . 0.0 111.747 -174.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.52 ' HB ' ' O ' ' A' ' 13' ' ' TRP . 27.4 m -156.42 158.81 37.96 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 177.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.7 m -64.8 -51.62 61.22 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 175.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.52 ' O ' ' HB ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -64.62 109.04 1.87 Allowed 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 168.068 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.0 t -159.44 130.6 6.04 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.465 -170.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -120.97 -78.56 0.51 Allowed Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -66.71 -33.88 76.63 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 120.915 0.388 . . . . 0.0 110.371 -177.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -57.56 -38.57 75.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.984 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -67.82 -35.09 77.99 Favored 'General case' 0 C--O 1.245 0.824 0 C-N-CA 123.675 0.79 . . . . 0.0 109.979 -175.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -62.29 -51.69 66.68 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.216 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.444 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 24.8 tp -68.26 -38.78 82.1 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.072 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -59.16 -43.91 92.09 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.616 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.2 m -68.7 -37.81 79.81 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.273 178.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.61 -42.17 98.25 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.875 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 78.6 mt -68.21 -39.53 82.37 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.623 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.5 m -65.35 -35.86 82.27 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-O 121.446 0.641 . . . . 0.0 109.987 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.2 -26.03 61.89 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-O 121.326 0.584 . . . . 0.0 111.19 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -93.25 11.52 27.76 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.877 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 64.93 25.2 12.75 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.275 1.03 . . . . 0.0 112.394 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 82.0 mt -89.95 116.13 30.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.47 128.82 36.01 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.003 -177.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -137.82 168.96 18.63 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.519 -177.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -119.71 121.54 39.45 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.483 ' HB2' ' OG1' ' A' ' 10' ' ' THR . 12.5 pt-20 -91.81 136.72 32.93 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-O 121.081 0.467 . . . . 0.0 110.408 -178.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.2 t -93.57 156.41 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 -168.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -77.09 -0.47 24.9 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 128.201 2.601 . . . . 0.0 113.866 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.3 pt -44.68 -21.37 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 N-CA-C 116.398 1.999 . . . . 0.0 116.398 -171.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -56.97 -52.65 64.38 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-N 118.834 0.743 . . . . 0.0 109.572 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -97.58 -36.86 10.16 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.136 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.416 ' ND2' ' H ' ' A' ' 42' ' ' ALA . 52.2 t30 -71.12 108.15 4.51 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 120.727 0.299 . . . . 0.0 111.013 -177.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.64 -22.14 57.07 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.316 -177.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.37 -44.95 67.03 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -177.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.416 ' H ' ' ND2' ' A' ' 39' ' ' ASN . . . -79.87 -24.85 40.94 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.01 177.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.68 -30.2 69.67 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.253 0.549 . . . . 0.0 109.756 177.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -68.77 -33.94 74.73 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.298 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -63.12 -44.1 96.57 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.6 t -60.76 -47.52 92.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.759 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.72 -21.61 69.32 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.545 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.6 m -83.21 -43.59 15.95 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 176.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.8 p -73.54 -33.14 38.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -176.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -118.63 154.75 32.16 Favored 'General case' 0 C--N 1.316 -0.849 0 O-C-N 121.893 -0.504 . . . . 0.0 109.948 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -113.25 156.09 15.85 Favored Glycine 0 N--CA 1.438 -1.212 0 C-N-CA 120.274 -0.965 . . . . 0.0 113.031 -175.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.14 -104.4 1.41 Allowed Glycine 0 N--CA 1.44 -1.085 0 O-C-N 123.866 0.392 . . . . 0.0 113.014 177.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -81.72 119.29 23.66 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -56.91 109.35 0.63 Allowed 'General case' 0 CA--C 1.516 -0.33 0 O-C-N 124.142 0.901 . . . . 0.0 109.348 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.6 m -81.27 123.65 28.67 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.6 t -75.19 -62.32 0.86 Allowed Pre-proline 0 CA--C 1.469 -2.154 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.087 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -79.16 73.41 6.04 Favored 'Trans proline' 1 N--CA 1.397 -4.176 0 CA-C-N 120.604 1.252 . . . . 0.0 112.609 -164.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.5 m -101.92 120.88 41.1 Favored 'General case' 1 N--CA 1.377 -4.116 0 CA-C-N 112.709 -2.041 . . . . 0.0 106.438 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.1 p -113.46 132.61 61.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-O 120.996 0.427 . . . . 0.0 110.882 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -110.22 126.1 53.78 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -92.08 174.07 7.51 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.432 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.25 -18.23 63.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.819 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -73.57 -18.03 61.12 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.19 0.519 . . . . 0.0 110.152 176.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.34 -12.85 64.95 Favored Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -176.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.2 p -75.28 145.71 41.64 Favored 'General case' 0 N--CA 1.421 -1.906 0 C-N-CA 123.211 0.605 . . . . 0.0 111.201 -178.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.6 p -114.1 139.16 49.55 Favored 'General case' 0 N--CA 1.419 -2.002 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.913 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.8 mp -117.05 123.87 47.88 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.2 m -100.82 112.62 25.08 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.894 -176.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 58.65 60.78 5.29 Favored Pre-proline 0 N--CA 1.492 1.668 0 C-N-CA 124.45 1.1 . . . . 0.0 112.906 -176.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -85.48 177.0 5.27 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.102 1.868 . . . . 0.0 111.696 176.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.7 m -110.99 151.42 27.98 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.79 -34.77 63.11 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -174.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -64.01 -37.25 86.73 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 122.287 0.235 . . . . 0.0 111.192 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -73.53 -42.16 62.1 Favored 'General case' 0 CA--C 1.489 -1.38 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.618 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.44 -40.8 85.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.807 -176.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -66.48 -45.13 80.67 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.866 0.365 . . . . 0.0 110.789 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.9 -35.82 74.9 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.541 0.686 . . . . 0.0 111.4 -177.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -78.13 -22.39 48.91 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 122.064 -0.397 . . . . 0.0 110.304 177.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.436 ' O ' HG13 ' A' ' 82' ' ' ILE . 26.0 tp -71.66 -46.5 58.74 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.7 m -64.94 -28.78 45.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -75.8 -29.46 58.73 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.869 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 79' ' ' LEU . 2.1 pp -85.69 -16.62 9.88 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 CA-C-O 121.443 0.64 . . . . 0.0 111.382 -176.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.672 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.443 178.023 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.548 0 CA-C-O 121.006 0.431 . . . . 0.0 110.617 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.1 tp -117.94 136.86 53.22 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.309 -176.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.468 ' HB ' ' HB3' ' A' ' 60' ' ' LYS . 22.4 m -110.65 117.82 34.54 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 53.1 mt -119.98 143.53 31.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -98.64 127.76 44.68 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.402 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 25.4 p -137.31 178.52 7.03 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 122.093 0.949 . . . . 0.0 113.459 -174.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.1 m -143.91 147.65 34.3 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 104.181 -2.526 . . . . 0.0 104.181 173.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.5 m -61.15 -43.2 99.25 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.352 0.596 . . . . 0.0 109.897 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 40.7 p90 -92.7 93.37 8.43 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-O 121.808 0.813 . . . . 0.0 111.177 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.9 t -163.3 117.31 1.61 Allowed 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.387 176.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.79 -32.16 13.64 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 111.219 -0.753 . . . . 0.0 111.219 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -68.96 -27.71 65.98 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.721 0.772 . . . . 0.0 109.666 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.448 ' SG ' ' HB ' ' A' ' 56' ' ' VAL . 70.5 m -71.77 -29.88 64.97 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.118 178.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 82.7 mt -70.43 -30.15 66.94 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.285 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -56.62 -44.16 80.94 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.247 177.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.409 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 28.7 tp -79.33 -41.09 28.71 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.623 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -56.76 -45.13 82.24 Favored 'General case' 0 C--O 1.247 0.941 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.6 m -64.04 -38.46 91.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.795 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.16 -44.08 80.65 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.421 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 57.3 mt -69.5 -42.31 74.93 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.445 -178.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.8 m -68.92 -23.51 64.18 Favored 'General case' 0 CA--C 1.56 1.352 0 CA-C-O 121.421 0.629 . . . . 0.0 110.651 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.87 -12.93 57.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.294 0.569 . . . . 0.0 110.482 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -109.39 14.17 23.78 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.27 -178.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.9 ttm180 55.14 62.07 2.65 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.403 1.081 . . . . 0.0 111.079 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.8 mt -122.78 115.88 47.18 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.046 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.17 111.97 22.21 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -116.38 144.59 44.08 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.577 -177.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -113.74 119.78 38.55 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 12.8 pt-20 -95.51 148.13 22.82 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.881 -176.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.417 ' CG1' HG21 ' A' ' 36' ' ' ILE . 25.1 t -96.69 144.88 9.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -172.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -58.63 -1.77 0.17 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 128.714 2.806 . . . . 0.0 114.05 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.417 HG21 ' CG1' ' A' ' 34' ' ' VAL . 2.0 pp -45.24 -20.96 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 -172.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -54.41 -48.84 71.16 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.137 0.494 . . . . 0.0 110.039 174.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -111.46 -29.67 7.69 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.795 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -77.67 103.25 7.5 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.552 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 8.7 ptm180 -71.88 -25.78 62.07 Favored 'General case' 0 C--O 1.21 -0.997 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.935 -178.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.56 -42.62 88.36 Favored 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 113.504 0.928 . . . . 0.0 113.504 -176.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.93 -21.0 26.54 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.694 -0.802 . . . . 0.0 109.956 177.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.4 -33.39 74.16 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.214 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.552 ' HG2' ' O ' ' A' ' 40' ' ' ARG . 61.4 mm-40 -61.56 -36.71 81.4 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.034 178.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -66.9 -37.11 83.76 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.119 0.485 . . . . 0.0 109.979 178.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.2 t -64.0 -42.6 96.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.607 0.718 . . . . 0.0 109.129 177.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.51 -18.96 72.33 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.348 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.3 m -81.42 -38.67 26.11 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.7 m -80.02 -35.11 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -83.65 137.1 33.95 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 176.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -98.89 139.15 14.29 Favored Glycine 0 C--N 1.301 -1.382 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.128 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.53 -87.37 1.03 Allowed Glycine 0 C--N 1.313 -0.731 0 C-N-CA 121.186 -0.53 . . . . 0.0 111.827 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -119.18 145.39 46.05 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -60.95 130.98 49.14 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.664 0.603 . . . . 0.0 111.064 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.7 m -108.55 127.68 54.16 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 177.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.448 ' HB ' ' SG ' ' A' ' 17' ' ' CYS . 8.1 t -73.75 -64.86 0.7 Allowed Pre-proline 0 CA--C 1.468 -2.178 0 CA-C-O 117.091 -1.433 . . . . 0.0 114.245 -171.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -73.75 80.57 2.03 Favored 'Trans proline' 1 N--CA 1.4 -4.018 0 CA-C-N 121.089 1.425 . . . . 0.0 112.65 -168.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 86.8 m -115.02 131.74 56.83 Favored 'General case' 0 N--CA 1.389 -3.503 0 CA-C-N 113.355 -1.748 . . . . 0.0 106.644 -177.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.69 142.91 29.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-O 120.844 0.354 . . . . 0.0 110.909 -175.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.468 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 77.5 tttt -116.28 130.7 56.91 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 177.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -104.58 177.86 4.73 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.02 -14.15 52.02 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.471 0.653 . . . . 0.0 110.543 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -67.32 -19.39 65.45 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.208 1.003 . . . . 0.0 110.33 176.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 92.71 -22.4 33.79 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.9 -0.591 . . . . 0.0 113.061 177.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.4 t -91.57 165.34 13.39 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.1 p -114.52 140.54 48.66 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.208 -177.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.9 mp -107.97 121.98 45.89 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 174.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.8 m -98.48 114.55 26.99 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.226 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.3 m120 61.21 61.82 2.83 Favored Pre-proline 0 N--CA 1.481 1.094 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -178.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -91.35 174.04 2.58 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.17 1.913 . . . . 0.0 110.369 176.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.432 ' O ' HG21 ' A' ' 75' ' ' VAL . 6.2 m -89.6 151.29 21.99 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 176.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.63 -37.95 80.01 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 123.186 0.304 . . . . 0.0 110.756 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -57.47 -43.62 84.17 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.108 177.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.516 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 47.3 mt-10 -68.38 -44.76 74.43 Favored 'General case' 0 C--O 1.207 -1.145 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.972 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.432 HG21 ' O ' ' A' ' 71' ' ' SER . 59.5 t -60.16 -43.14 92.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 O-C-N 123.252 0.345 . . . . 0.0 110.531 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -64.21 -44.71 91.09 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.27 -34.99 78.58 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.081 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 75.5 mmtt -75.07 -36.82 61.74 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 176.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 14.5 tp -61.62 -52.35 64.73 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.5 m -61.93 -35.54 68.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.7 ptpp? -72.87 -34.1 66.51 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.304 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.1 pp -83.89 -29.71 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.056 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.55 0 CA-C-O 120.803 0.335 . . . . 0.0 110.591 178.507 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.87 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.6 mp -109.48 141.23 42.2 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.558 0.694 . . . . 0.0 111.901 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.7 m -125.82 108.32 11.36 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 105.707 -1.961 . . . . 0.0 105.707 171.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.44 HG21 HG23 ' A' ' 10' ' ' THR . 62.4 mt -108.89 135.23 48.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 CA-C-O 121.943 0.878 . . . . 0.0 111.445 -173.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.419 ' CD1' HG22 ' A' ' 46' ' ' VAL . 98.9 m-85 -90.22 111.32 22.45 Favored 'General case' 0 C--N 1.28 -2.431 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.453 178.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.44 HG23 HG21 ' A' ' 8' ' ' ILE . 6.9 p -137.31 144.33 42.56 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.169 0.509 . . . . 0.0 112.215 -178.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.6 p -130.79 165.38 23.08 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 174.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.9 p -86.73 0.23 55.08 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 121.373 0.606 . . . . 0.0 110.723 176.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 10.6 m0 -83.0 12.84 4.47 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.518 -173.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.592 ' SG ' HG23 ' A' ' 56' ' ' VAL . 6.7 p -146.26 171.8 14.43 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 122.05 -0.406 . . . . 0.0 111.402 -177.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -116.39 -36.63 1.08 Allowed Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 176.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -64.69 -23.4 67.24 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 121.207 0.527 . . . . 0.0 112.068 -177.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.9 p -70.48 -43.1 70.45 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.154 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.1 mp -64.61 -31.43 72.64 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.924 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -61.06 -52.07 66.5 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.485 0.491 . . . . 0.0 110.673 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.4 tp -68.35 -41.92 80.01 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.987 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -56.78 -50.04 73.49 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.691 -177.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.5 p -68.1 -34.2 75.95 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.54 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.9 -48.77 78.99 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.215 178.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.6 mt -63.89 -37.0 85.77 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.325 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 58.0 m -59.53 -48.81 80.2 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.813 177.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.84 -34.66 77.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.883 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -81.93 5.15 19.96 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -177.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 70.07 24.55 4.99 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.046 0.938 . . . . 0.0 113.121 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.7 mt -93.94 115.49 32.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.68 144.87 37.0 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.95 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -159.71 145.09 15.54 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.837 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -102.39 133.4 47.39 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 175.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 12.7 pt-20 -94.13 142.37 27.48 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.406 HG21 ' CE1' ' A' ' 9' ' ' TYR . 13.6 t -87.83 144.69 8.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 121.717 0.77 . . . . 0.0 112.181 -175.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -65.17 -1.84 2.51 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 127.76 2.424 . . . . 0.0 113.91 -176.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.2 pt -44.3 -23.78 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.564 0 N-CA-C 116.334 1.975 . . . . 0.0 116.334 -172.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -65.51 -25.43 67.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.573 0.701 . . . . 0.0 109.262 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 43.4 m-70 -112.32 -46.74 3.15 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.199 -0.909 . . . . 0.0 108.906 175.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.496 ' ND2' ' H ' ' A' ' 42' ' ' ALA . 56.9 t30 -70.18 111.11 5.58 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.948 -176.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.1 ptp180 -73.53 -24.83 60.19 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.063 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.41 -54.6 13.56 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -175.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.496 ' H ' ' ND2' ' A' ' 39' ' ' ASN . . . -72.75 -20.97 61.09 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.647 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.03 93.45 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.182 0.515 . . . . 0.0 110.925 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -72.95 -29.97 63.49 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.162 0.506 . . . . 0.0 110.414 177.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -68.1 -33.07 73.83 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.752 177.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.496 HG21 ' O ' ' A' ' 42' ' ' ALA . 76.7 t -55.49 -56.2 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.498 175.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.41 -33.99 78.76 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.088 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.3 m -65.82 -42.83 90.09 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 122.862 0.465 . . . . 0.0 112.087 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.8 m -80.92 -19.54 11.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.873 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -77.82 -50.17 12.83 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 175.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.55 -104.91 0.28 Allowed Glycine 0 N--CA 1.431 -1.652 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -103.74 -37.02 3.09 Favored Glycine 0 C--N 1.307 -1.057 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -104.98 148.13 27.05 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -78.92 135.98 37.13 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.2 m -118.33 153.79 33.41 Favored 'General case' 0 C--N 1.268 -2.957 0 N-CA-C 103.73 -2.693 . . . . 0.0 103.73 174.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.592 HG23 ' SG ' ' A' ' 14' ' ' CYS 0.267 21.9 t -86.86 -72.35 0.07 OUTLIER Pre-proline 0 CA--C 1.456 -2.642 0 C-N-CA 116.136 -2.226 . . . . 0.0 114.506 -178.59 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.96 88.73 1.21 Allowed 'Trans proline' 1 N--CA 1.39 -4.575 0 CA-C-N 120.577 1.242 . . . . 0.0 112.498 -162.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.4 m -119.98 130.74 54.9 Favored 'General case' 0 N--CA 1.385 -3.698 0 CA-C-N 113.27 -1.786 . . . . 0.0 106.841 -174.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.1 p -116.45 132.67 65.38 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-O 121.15 0.5 . . . . 0.0 110.856 -176.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -107.04 116.79 32.55 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 174.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -87.66 155.18 20.06 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.189 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.16 -21.37 61.57 Favored 'General case' 0 C--O 1.22 -0.494 0 C-N-CA 123.481 0.712 . . . . 0.0 111.57 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -72.71 -14.33 61.54 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.507 0.67 . . . . 0.0 110.145 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.81 -20.43 26.88 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.901 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.8 m -71.36 140.1 50.07 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 122.687 0.395 . . . . 0.0 111.661 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.9 p -114.21 137.79 51.3 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 173.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mp -128.43 123.21 33.17 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 120.76 0.314 . . . . 0.0 110.4 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 87.6 m -97.15 119.14 35.1 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.231 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 57.77 67.78 2.2 Favored Pre-proline 0 N--CA 1.484 1.237 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -96.56 169.52 1.03 Allowed 'Trans proline' 0 CA--C 1.546 1.124 0 C-N-CA 122.324 2.016 . . . . 0.0 111.148 171.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.0 m -93.29 155.38 17.45 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 173.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.29 -36.43 71.04 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 122.91 0.484 . . . . 0.0 111.704 -178.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -69.18 -35.7 76.57 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.502 0.668 . . . . 0.0 110.839 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.03 -36.56 82.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.268 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.9 t -66.26 -46.75 86.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.038 177.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -53.72 -42.33 67.95 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.22 0.608 . . . . 0.0 112.027 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.34 -20.3 65.57 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.131 0.491 . . . . 0.0 111.394 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.587 ' O ' HG13 ' A' ' 82' ' ' ILE . 34.4 mmtp -84.59 -39.49 18.65 Favored 'General case' 0 N--CA 1.436 -1.168 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.116 175.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -56.82 -41.19 77.37 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.5 m -63.38 -40.5 89.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.304 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -83.03 -54.6 4.94 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.587 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.1 pp -68.52 -17.12 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -170.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -0.986 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.145 177.843 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.668 0 CA-C-O 121.086 0.469 . . . . 0.0 111.457 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.405 ' HB2' ' CG2' ' A' ' 59' ' ' VAL . 0.5 OUTLIER -130.56 123.96 30.75 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.542 0.687 . . . . 0.0 111.372 178.693 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.3 m -103.2 114.18 28.25 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 55.7 mt -103.58 136.98 33.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -177.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -91.5 118.21 30.38 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.547 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 29.3 p -128.19 -172.08 2.61 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 121.343 0.592 . . . . 0.0 111.894 -177.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.445 ' HB ' ' O ' ' A' ' 13' ' ' TRP . 38.7 m -155.81 146.12 21.72 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 177.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.1 m -56.36 -47.84 78.05 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . 0.445 ' O ' ' HB ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -65.94 111.78 3.48 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 164.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 11' ' ' THR . 42.8 t -150.71 120.14 6.89 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.788 -174.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -113.99 -70.24 0.52 Allowed Glycine 0 N--CA 1.427 -1.9 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.236 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -73.91 -30.23 62.47 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 123.029 0.531 . . . . 0.0 111.083 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -63.34 -27.78 69.55 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -63.08 -35.66 80.99 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.458 0.703 . . . . 0.0 109.678 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -51.87 -45.47 64.11 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 124.774 1.23 . . . . 0.0 111.301 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.421 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 12.4 tp -84.19 -42.37 16.03 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.86 -177.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -52.84 -48.91 66.68 Favored 'General case' 0 C--O 1.246 0.916 0 C-N-CA 124.397 1.079 . . . . 0.0 112.522 -176.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.9 t -74.15 -28.48 61.33 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.515 -178.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.16 -42.49 84.21 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.325 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 59.7 mt -65.26 -44.04 89.38 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.403 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 44.3 m -59.88 -43.59 94.65 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.963 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.12 -10.37 59.55 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.948 0.404 . . . . 0.0 111.928 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -109.31 16.03 22.68 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.964 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 67.77 17.39 9.77 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.27 1.028 . . . . 0.0 112.624 177.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.6 mt -91.06 118.15 35.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.59 138.14 33.68 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -136.3 171.01 15.11 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.044 -177.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -128.45 117.89 22.15 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 175.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.547 ' HB2' ' OG1' ' A' ' 10' ' ' THR . 13.8 pt-20 -95.03 135.2 36.86 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 120.866 0.365 . . . . 0.0 110.841 -178.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.7 t -85.05 140.09 16.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -171.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -58.67 0.39 0.08 Allowed 'General case' 0 CA--C 1.567 1.624 0 C-N-CA 129.508 3.123 . . . . 0.0 114.751 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.8 pt -43.59 -20.82 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 3.006 0 N-CA-C 116.971 2.212 . . . . 0.0 116.971 -168.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -73.18 -23.61 60.44 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 119.176 0.898 . . . . 0.0 110.276 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -105.39 -47.32 3.98 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 174.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -78.19 99.64 6.31 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.734 -177.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -67.26 -30.21 70.04 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.553 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.9 -44.89 82.81 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.422 ' O ' HG21 ' A' ' 46' ' ' VAL . . . -85.96 -23.34 26.96 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.419 178.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.36 -40.42 93.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.197 0.522 . . . . 0.0 110.222 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -65.46 -24.3 67.13 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.117 177.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -74.68 -38.16 62.48 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 176.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.422 HG21 ' O ' ' A' ' 42' ' ' ALA . 40.3 t -65.71 -41.88 91.37 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.447 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.826 178.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.78 -22.58 75.55 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.029 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -81.85 -41.86 20.43 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.6 p -76.55 -37.56 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 O-C-N 122.045 -0.409 . . . . 0.0 110.593 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -105.19 92.07 4.06 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 176.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -80.86 143.18 24.08 Favored Glycine 0 C--N 1.306 -1.12 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.494 -176.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.56 -62.88 2.68 Favored Glycine 0 N--CA 1.437 -1.29 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -126.11 145.92 50.15 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.6 ttp85 -88.31 89.06 7.84 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.0 m -65.58 133.46 51.23 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 176.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.4 t -77.01 -69.43 0.23 Allowed Pre-proline 0 CA--C 1.468 -2.187 0 C-N-CA 118.174 -1.411 . . . . 0.0 114.061 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.51 82.67 1.85 Allowed 'Trans proline' 0 N--CA 1.4 -3.992 0 CA-C-N 120.637 1.263 . . . . 0.0 112.969 -163.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 51.9 m -115.36 125.3 53.04 Favored 'General case' 0 N--CA 1.388 -3.53 0 CA-C-N 113.299 -1.773 . . . . 0.0 106.509 -176.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.405 ' CG2' ' HB2' ' A' ' 6' ' ' LEU . 7.2 p -118.3 137.17 53.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 CA-C-O 121.007 0.432 . . . . 0.0 111.181 -177.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -111.36 119.57 39.28 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 176.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -94.99 168.57 10.69 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.46 -10.98 20.0 Favored 'General case' 0 C--O 1.218 -0.57 0 O-C-N 123.738 0.649 . . . . 0.0 111.329 177.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -73.59 -18.31 61.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.794 0.807 . . . . 0.0 109.87 177.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.43 -15.12 63.88 Favored Glycine 0 CA--C 1.499 -0.917 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.236 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.5 m -83.41 151.69 25.37 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 p -113.6 139.31 49.12 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.6 tp -121.93 119.91 32.92 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -177.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.0 m -107.94 126.25 52.46 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 -174.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 54.03 60.04 11.48 Favored Pre-proline 0 N--CA 1.482 1.126 0 O-C-N 123.941 0.776 . . . . 0.0 112.315 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -90.08 178.44 2.23 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 121.856 1.704 . . . . 0.0 113.242 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.4 m -96.42 164.46 12.62 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 174.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.57 -39.34 94.14 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 120.958 0.409 . . . . 0.0 110.99 -178.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -64.42 -33.27 75.49 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.512 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -68.33 -39.09 82.05 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.048 0.451 . . . . 0.0 110.35 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.4 t -66.42 -44.91 90.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.899 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -60.49 -43.31 97.13 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.507 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.89 -36.8 84.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.714 0.293 . . . . 0.0 111.32 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.474 ' O ' HG13 ' A' ' 82' ' ' ILE . 14.4 mptt -70.96 -37.13 72.79 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.941 175.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 30.1 tp -62.06 -47.04 86.49 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.412 -178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.8 m -66.07 -32.69 59.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -177.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -77.29 -41.02 42.41 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.684 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.2 pp -74.41 -14.28 15.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.454 -0.498 . . . . 0.0 112.074 -177.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.881 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.66 176.083 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.705 0 CA-C-O 120.717 0.294 . . . . 0.0 111.386 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.536 ' H ' HD21 ' A' ' 6' ' ' LEU . 0.7 OUTLIER -68.58 120.65 14.95 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.849 0.833 . . . . 0.0 111.013 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.3 m -103.64 111.75 24.37 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 114.399 -1.273 . . . . 0.0 107.851 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 63.4 mt -102.79 139.04 24.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.303 0.573 . . . . 0.0 110.703 -174.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -92.04 122.8 34.88 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.511 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 27.3 p -138.57 177.22 8.04 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.533 0.682 . . . . 0.0 111.817 -177.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.5 m -148.08 156.16 42.29 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 174.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.5 m -69.22 -45.34 70.1 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -87.38 96.28 10.31 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-O 122.126 0.965 . . . . 0.0 109.906 175.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 32.7 t -163.56 152.17 13.84 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.415 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -119.93 -55.84 0.25 Allowed Glycine 0 N--CA 1.429 -1.831 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.226 178.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -68.39 -16.3 63.87 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -173.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.6 p -78.49 -24.88 45.68 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.211 0.529 . . . . 0.0 109.963 177.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 28.7 tp -69.01 -21.75 64.12 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.991 -175.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -60.18 -60.71 3.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.165 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.1 tp -66.3 -42.74 87.86 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.492 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -54.72 -47.23 74.01 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.35 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.5 p -71.12 -34.7 71.31 Favored 'General case' 0 C--O 1.244 0.778 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.654 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.38 -46.93 86.4 Favored 'General case' 0 CA--C 1.508 -0.657 0 C-N-CA 123.387 0.675 . . . . 0.0 110.66 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.9 mt -65.79 -37.88 87.49 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.902 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.3 m -65.24 -38.52 90.62 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.74 -26.94 62.67 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 111.02 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.17 2.8 48.81 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.308 178.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 61.67 30.52 18.55 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.54 1.136 . . . . 0.0 110.441 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 74.1 mt -86.86 115.41 27.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.666 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.48 100.65 3.31 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.509 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -113.61 163.94 14.31 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.412 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -130.5 130.1 43.74 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 175.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.511 ' HB2' ' OG1' ' A' ' 10' ' ' THR . 11.6 pt-20 -99.79 140.92 33.29 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.025 0.441 . . . . 0.0 111.14 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.2 t -78.07 146.79 7.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-O 121.86 0.838 . . . . 0.0 113.1 -172.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -66.85 -0.82 3.29 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 127.718 2.407 . . . . 0.0 114.371 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.5 pt -44.17 -22.58 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.514 2.737 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 -169.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -68.42 -31.43 70.75 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.796 0.808 . . . . 0.0 109.469 177.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 35.5 m-70 -103.17 -45.94 4.77 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.26 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -86.91 115.11 24.09 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.87 -175.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -72.7 -29.68 63.58 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.097 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.38 -41.16 93.22 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -173.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.35 -21.77 25.48 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.638 177.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.65 -39.59 84.58 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.309 0.576 . . . . 0.0 110.616 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -75.08 -21.38 59.0 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.334 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -69.45 -31.95 70.58 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 176.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.3 t -59.36 -42.73 88.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.38 -35.2 87.02 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.356 178.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.8 t -66.77 -50.07 63.87 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 122.503 0.321 . . . . 0.0 110.66 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.9 p -76.91 -28.12 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.181 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -174.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -98.66 1.89 46.67 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 121.698 -0.627 . . . . 0.0 112.266 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.52 60.22 4.82 Favored Glycine 0 C--N 1.322 -0.233 0 N-CA-C 114.395 0.518 . . . . 0.0 114.395 174.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.07 -46.63 3.43 Favored Glycine 0 C--N 1.31 -0.892 0 C-N-CA 121.769 -0.253 . . . . 0.0 112.615 176.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -77.42 122.34 25.04 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.9 mtm180 -93.75 79.95 4.22 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.774 0.797 . . . . 0.0 112.182 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.7 m -73.17 128.36 35.27 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 173.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.4 t -69.4 -66.71 0.87 Allowed Pre-proline 0 CA--C 1.473 -1.989 0 N-CA-C 114.703 1.372 . . . . 0.0 114.703 -173.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.62 76.77 4.13 Favored 'Trans proline' 0 N--CA 1.4 -3.985 0 CA-C-N 120.381 1.172 . . . . 0.0 112.578 -163.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 91.5 m -107.62 140.27 40.88 Favored 'General case' 0 N--CA 1.388 -3.565 0 CA-C-N 113.486 -1.688 . . . . 0.0 107.571 -176.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.2 p -122.68 132.83 70.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-O 121.318 0.58 . . . . 0.0 111.218 -176.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -110.21 120.31 42.04 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.498 176.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.446 ' CD1' HG12 ' A' ' 82' ' ' ILE . 90.1 m-85 -95.12 171.79 8.52 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.738 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.46 -24.0 61.13 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -173.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -89.87 -7.28 54.62 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 120.708 0.289 . . . . 0.0 111.34 -174.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.54 -5.72 31.41 Favored Glycine 0 N--CA 1.437 -1.237 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.268 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.3 m -75.98 125.91 30.01 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 121.18 0.514 . . . . 0.0 110.17 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.6 p -117.21 138.29 51.79 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.2 mp -130.91 146.31 52.29 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.1 m -116.0 112.64 22.1 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 64.2 t30 47.33 70.88 1.81 Allowed Pre-proline 0 N--CA 1.484 1.274 0 C-N-CA 124.713 1.205 . . . . 0.0 113.835 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -100.01 -175.52 0.15 Allowed 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.013 2.475 . . . . 0.0 111.968 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.6 t -82.31 154.1 25.48 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.48 -34.76 78.47 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 123.713 0.805 . . . . 0.0 109.958 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -63.5 -44.09 95.35 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.881 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.567 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 45.5 mm-40 -57.83 -47.36 82.89 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.392 176.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.6 t -57.73 -44.02 85.01 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.764 0 O-C-N 123.994 0.809 . . . . 0.0 111.502 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 66.1 tttp -62.87 -45.3 93.21 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.23 -21.84 59.61 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.054 0.454 . . . . 0.0 111.568 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.567 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 49.2 mmtm -81.93 -34.49 29.83 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 174.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.0 tp -57.39 -49.04 77.47 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.424 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.8 m -60.59 -33.6 55.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.505 -177.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 15.3 ptmm? -81.69 -38.71 25.41 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.476 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.446 HG12 ' CD1' ' A' ' 61' ' ' PHE . 2.4 pp -77.98 -32.15 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -175.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.852 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.7 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.399 0 CA-C-O 121.497 0.665 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.79 128.75 16.47 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.256 178.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.453 ' HB ' ' HB3' ' A' ' 60' ' ' LYS . 23.4 m -103.07 120.02 39.92 Favored 'General case' 0 C--N 1.277 -2.576 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 176.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.3 mt -109.88 128.44 66.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 CA-C-O 121.06 0.457 . . . . 0.0 109.915 -176.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.444 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 98.3 m-85 -81.05 129.0 34.34 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.636 177.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.8 p -136.83 145.98 45.1 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -174.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 69.4 p -140.22 161.72 36.98 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 172.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.5 p -85.98 -0.39 55.37 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.303 0.573 . . . . 0.0 110.799 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 11.2 m0 -78.91 -30.93 45.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.356 -176.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.8 p -105.65 132.2 52.09 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.265 -175.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.22 -27.99 26.51 Favored Glycine 0 N--CA 1.436 -1.352 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.675 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -65.86 -35.87 81.86 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.621 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 61.1 m -56.5 -46.71 80.37 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.287 176.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.2 tt -66.75 -39.39 87.89 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.751 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.6 mtp180 -58.23 -54.63 44.84 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.477 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 20.7 tp -62.05 -40.13 94.71 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.524 0.678 . . . . 0.0 109.716 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -57.2 -45.22 83.96 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.664 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.7 m -62.12 -43.59 98.49 Favored 'General case' 0 C--O 1.246 0.884 0 C-N-CA 123.719 0.808 . . . . 0.0 110.665 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.53 -48.21 82.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.04 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 72.4 mt -65.73 -35.64 81.32 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.995 -178.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.8 m -63.6 -45.99 87.83 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.83 -35.63 81.22 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.483 0.659 . . . . 0.0 110.843 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -84.46 21.03 1.54 Allowed 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.492 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 55.7 20.65 4.09 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 126.226 1.81 . . . . 0.0 113.782 175.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 71.4 mt -85.27 115.91 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.94 116.98 23.06 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.264 -177.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -127.75 159.54 34.47 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.215 -177.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -112.27 114.08 26.66 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 175.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -83.17 136.58 34.38 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.1 t -95.15 143.73 11.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 122.909 1.337 . . . . 0.0 113.233 -176.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.57 -0.57 6.92 Favored 'General case' 0 C--N 1.284 -2.283 0 C-N-CA 130.862 3.665 . . . . 0.0 115.118 177.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.453 HD12 HG21 ' A' ' 46' ' ' VAL . 12.7 pt -44.11 -26.42 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.843 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 -171.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -59.0 -36.3 74.68 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.12 0.486 . . . . 0.0 109.815 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 46.7 m-70 -93.15 -34.45 13.62 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.968 -175.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -116.36 113.58 23.12 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -176.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -62.86 -25.58 68.35 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 114.625 -1.171 . . . . 0.0 111.885 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.18 -41.49 71.96 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.238 0.542 . . . . 0.0 111.296 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.439 ' O ' HG22 ' A' ' 46' ' ' VAL . . . -86.96 -30.33 21.37 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.047 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.31 -33.89 77.05 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.996 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -67.53 -34.76 77.75 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.774 -0.194 . . . . 0.0 111.377 178.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -65.25 -37.69 88.0 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.453 HG21 HD12 ' A' ' 36' ' ' ILE . 60.1 t -59.99 -38.06 75.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.091 -0.958 . . . . 0.0 109.877 177.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.66 -49.22 44.82 Favored Glycine 0 N--CA 1.433 -1.55 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.9 m -60.31 -38.13 82.72 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.6 p -79.49 -9.37 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-O 121.531 0.682 . . . . 0.0 111.213 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -104.95 -67.82 0.89 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.145 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 137.67 -112.38 0.9 Allowed Glycine 0 N--CA 1.433 -1.554 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 -175.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.31 -48.33 5.11 Favored Glycine 0 C--N 1.306 -1.127 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.029 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -91.45 116.44 28.85 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -178.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -81.21 83.02 6.94 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.6 m -71.97 125.78 28.09 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.531 ' HB ' ' SG ' ' A' ' 17' ' ' CYS . 3.2 t -76.31 -56.16 1.59 Allowed Pre-proline 0 N--CA 1.435 -1.221 0 CA-C-O 117.323 -1.322 . . . . 0.0 113.55 -175.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.621 ' HD3' ' SG ' ' A' ' 17' ' ' CYS . 64.9 Cg_endo -73.64 44.24 0.89 Allowed 'Trans proline' 0 C--N 1.399 3.227 0 CA-C-N 121.472 1.562 . . . . 0.0 113.691 -170.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.435 ' H ' ' C ' ' A' ' 56' ' ' VAL . 84.1 m -80.57 117.66 21.47 Favored 'General case' 0 N--CA 1.387 -3.599 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 176.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.3 p -94.76 129.12 45.39 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.453 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 82.2 tttt -105.03 118.19 35.9 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -87.75 164.21 16.08 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 120.448 -0.501 . . . . 0.0 112.126 -177.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.04 -18.26 45.04 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 124.032 0.933 . . . . 0.0 112.956 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -78.31 -17.29 56.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.863 0.363 . . . . 0.0 110.286 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.02 -21.7 24.5 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 121.245 -0.502 . . . . 0.0 113.193 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.1 m -82.88 159.71 22.3 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.257 0.551 . . . . 0.0 110.522 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.3 p -114.0 171.39 7.62 Favored 'General case' 0 N--CA 1.418 -2.045 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.101 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.8 tp -145.0 109.7 5.0 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 176.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 89.1 m -86.11 122.7 30.49 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.965 -176.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 56.49 64.81 4.53 Favored Pre-proline 0 N--CA 1.482 1.15 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -90.71 -173.61 0.63 Allowed 'Trans proline' 0 N--CA 1.445 -1.38 0 C-N-CA 121.788 1.659 . . . . 0.0 112.653 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.6 m -127.26 165.86 18.86 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 174.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.69 -45.95 67.05 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -64.38 -36.54 84.48 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.431 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -63.71 -42.51 97.94 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.194 0.521 . . . . 0.0 110.88 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.1 t -67.21 -48.8 77.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.192 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -61.57 -31.05 71.08 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.118 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.2 -25.54 63.46 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.416 ' O ' HG13 ' A' ' 82' ' ' ILE . 10.1 mmmm -84.7 -37.22 21.2 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 172.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.8 tp -55.07 -49.63 71.17 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 124.165 0.916 . . . . 0.0 110.171 -177.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.3 m -58.6 -35.53 55.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -178.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.474 ' HZ2' ' HB3' ' A' ' 81' ' ' LYS . 0.3 OUTLIER -81.76 -42.53 19.65 Favored 'General case' 0 N--CA 1.427 -1.578 0 C-N-CA 119.071 -1.051 . . . . 0.0 111.804 -178.707 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.4 pp -76.41 -22.16 15.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -174.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.474 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.985 179.331 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.23 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 62.1 mt -113.97 122.53 47.23 Favored 'General case' 0 CA--C 1.496 -1.101 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.712 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.1 m -103.14 108.54 19.77 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 173.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.414 HG21 HG23 ' A' ' 10' ' ' THR . 55.4 mt -108.42 133.35 53.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-O 121.78 0.8 . . . . 0.0 111.605 -175.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -95.38 107.36 19.49 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.067 -0.969 . . . . 0.0 108.662 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.414 HG23 HG21 ' A' ' 8' ' ' ILE . 4.0 p -135.28 158.96 43.05 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 122.677 0.391 . . . . 0.0 111.897 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.6 p -134.77 174.61 10.39 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 176.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.1 t -86.72 -5.61 59.07 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 19.6 m0 -75.83 -32.61 59.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.093 -175.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.8 p -91.54 165.99 13.07 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 120.738 0.304 . . . . 0.0 111.628 -175.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -113.45 -42.83 0.86 Allowed Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 111.366 -0.693 . . . . 0.0 111.366 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -63.45 -25.77 68.42 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -178.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.485 ' SG ' HD13 ' A' ' 18' ' ' LEU . 1.6 p -56.32 -41.36 75.91 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.677 0.275 . . . . 0.0 111.04 176.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.485 HD13 ' SG ' ' A' ' 17' ' ' CYS . 6.3 mp -73.31 -24.96 60.47 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.65 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -71.76 -34.72 69.71 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.8 tp -75.74 -38.36 58.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.084 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.45 ' HD3' ' HA ' ' A' ' 18' ' ' LEU . 27.4 mtpp -55.75 -45.72 77.98 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.706 177.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 p -65.94 -40.2 91.14 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 111.541 0.2 . . . . 0.0 111.541 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.26 -49.53 76.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.674 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.5 mt -64.91 -41.68 95.37 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.754 0.311 . . . . 0.0 111.283 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 68.0 m -67.29 -38.29 84.78 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.198 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.84 -26.37 64.19 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.36 0.6 . . . . 0.0 110.66 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -94.07 10.77 32.33 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.066 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 59.15 30.86 20.73 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.04 1.336 . . . . 0.0 112.719 175.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.6 mt -89.26 123.87 41.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.73 129.93 34.68 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.071 0.463 . . . . 0.0 111.218 -176.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -144.08 157.62 44.21 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.651 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -127.96 124.03 36.28 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 11.7 pt-20 -95.25 146.82 24.07 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.271 0.557 . . . . 0.0 111.764 -175.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -81.07 153.05 4.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.457 -175.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -74.87 0.19 16.42 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 127.903 2.481 . . . . 0.0 114.042 -175.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.7 pt -43.36 -23.71 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.378 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 -172.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -52.85 -39.24 62.39 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.649 0.78 . . . . 0.0 109.709 176.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -119.42 20.28 12.52 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.081 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -139.42 106.89 5.55 Favored 'General case' 0 CA--C 1.492 -1.269 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.26 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -30.59 71.13 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.946 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.43 -38.57 84.76 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -173.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.79 -20.73 27.17 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.816 177.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.15 -41.44 86.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.463 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -69.92 -21.91 63.25 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.539 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -68.16 -33.53 74.64 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 175.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.616 ' O ' ' HB2' ' A' ' 50' ' ' ASN . 81.6 t -59.3 -40.22 80.83 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.925 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.631 177.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.92 -32.68 77.82 Favored Glycine 0 C--N 1.332 0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.09 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.0 t -65.8 -29.96 70.53 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 123.147 0.579 . . . . 0.0 110.265 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.4 m -108.1 17.2 6.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 120.887 0.375 . . . . 0.0 110.572 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.616 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 1.7 t-20 -116.49 -174.16 2.51 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -176.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -107.82 75.71 0.22 Allowed Glycine 0 N--CA 1.436 -1.343 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.064 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.01 -93.65 1.31 Allowed Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 -78.62 136.31 37.46 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -64.91 101.4 0.49 Allowed 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -178.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.9 m -83.0 153.35 25.01 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 102.984 -2.969 . . . . 0.0 102.984 169.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 0.442 3.8 t -86.95 -93.75 0.0 OUTLIER Pre-proline 0 CA--C 1.487 -1.472 0 C-N-CA 114.643 -2.823 . . . . 0.0 117.23 -174.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -47.51 93.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.386 2.538 0 N-CA-C 114.551 0.943 . . . . 0.0 114.551 -148.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.31 109.91 21.37 Favored 'General case' 0 N--CA 1.405 -2.705 0 CA-C-N 113.778 -1.555 . . . . 0.0 109.904 -173.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.3 p -102.58 126.46 56.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -104.8 127.41 52.59 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.477 ' HB3' HG23 ' A' ' 82' ' ' ILE . 95.8 m-85 -103.25 170.84 7.71 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.972 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.421 ' HB1' ' HB ' ' A' ' 82' ' ' ILE . . . -65.17 -13.89 59.27 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 -173.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -78.69 -13.09 60.0 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 121.478 0.656 . . . . 0.0 109.627 175.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.54 -1.54 64.15 Favored Glycine 0 N--CA 1.436 -1.319 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -174.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.3 m -67.62 133.5 49.49 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 123.787 0.835 . . . . 0.0 108.96 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.8 m -121.43 137.53 54.67 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 176.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.2 mp -120.06 119.38 33.19 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 120.687 0.28 . . . . 0.0 111.279 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.5 m -92.66 116.55 29.11 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 61.7 69.66 0.97 Allowed Pre-proline 0 CA--C 1.557 1.25 0 C-N-CA 123.643 0.777 . . . . 0.0 111.49 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -94.48 -167.02 0.14 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.444 2.096 . . . . 0.0 112.258 176.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.5 m -116.08 150.52 37.2 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.08 -40.43 76.94 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.775 0.43 . . . . 0.0 111.734 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -64.42 -37.76 88.64 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.947 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -62.18 -48.06 81.75 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.906 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.9 t -58.39 -42.3 83.73 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.922 0 O-C-N 124.013 0.821 . . . . 0.0 110.834 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -67.76 -40.38 84.09 Favored 'General case' 0 CA--C 1.559 1.315 0 CA-C-O 120.722 0.296 . . . . 0.0 110.52 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.45 -29.84 59.79 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.171 0.51 . . . . 0.0 111.024 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -77.21 -31.09 55.03 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 20.4 tp -58.92 -50.96 72.08 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.984 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.5 m -60.57 -39.42 81.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -176.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? -73.31 -32.33 64.54 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.481 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.477 HG23 ' HB3' ' A' ' 61' ' ' PHE . 2.0 pp -83.5 -11.91 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-O 121.39 0.614 . . . . 0.0 111.871 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.953 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.529 174.607 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 121.364 0.602 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.2 tp -142.19 114.71 8.45 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -178.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.9 m -107.06 127.74 53.75 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 71.4 mt -118.88 135.79 58.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-O 121.207 0.527 . . . . 0.0 110.389 -177.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -88.13 127.8 35.43 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.742 177.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.2 p -134.29 151.82 51.47 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -175.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.0 p -140.15 163.5 32.56 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 175.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.2 m -77.7 -8.21 57.61 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.238 0.542 . . . . 0.0 110.395 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 2.7 m0 -89.8 -25.88 20.86 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.922 0.868 . . . . 0.0 110.246 -176.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.6 t -91.98 118.42 30.75 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.876 -168.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -92.18 -32.54 8.27 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -68.98 -18.25 64.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.058 0.456 . . . . 0.0 112.161 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.631 ' SG ' ' HB ' ' A' ' 56' ' ' VAL . 72.4 m -68.85 -38.67 79.92 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.667 0.746 . . . . 0.0 109.178 174.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.3 tt -68.31 -30.0 68.89 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.775 -178.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -61.65 -41.5 97.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.77 176.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.467 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 17.6 tp -74.51 -39.91 62.12 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.494 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -56.36 -51.61 67.63 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.146 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.4 p -61.08 -42.44 98.51 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.999 0.428 . . . . 0.0 110.84 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.63 -49.54 77.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.993 178.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 51.8 mt -67.56 -36.77 81.58 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.392 -178.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.7 m -66.91 -41.8 86.5 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 121.207 0.527 . . . . 0.0 110.248 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.0 -7.42 53.61 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.195 0.521 . . . . 0.0 111.889 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -107.75 8.21 28.75 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 123.073 0.549 . . . . 0.0 110.867 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 57.61 62.85 1.99 Allowed 'General case' 0 C--O 1.243 0.724 0 C-N-CA 125.299 1.44 . . . . 0.0 112.219 -177.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 76.3 mt -121.58 117.41 52.5 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.689 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.82 121.88 30.78 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -135.23 156.01 49.7 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.853 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -116.2 132.79 56.56 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 175.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 8.8 pt-20 -96.01 151.05 19.8 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.417 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.6 t -94.76 145.36 8.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.875 0.845 . . . . 0.0 112.921 -173.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -62.51 -1.49 0.81 Allowed 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 128.352 2.661 . . . . 0.0 114.036 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.1 pt -45.2 -21.04 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 N-CA-C 115.759 1.762 . . . . 0.0 115.759 -173.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -56.38 -29.02 60.95 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.003 0.43 . . . . 0.0 110.862 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 46.4 t60 -127.94 -23.7 3.31 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.175 0.512 . . . . 0.0 110.285 173.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -87.71 87.11 7.28 Favored 'General case' 0 C--O 1.244 0.774 0 O-C-N 121.488 -0.758 . . . . 0.0 109.683 178.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -67.16 -23.87 65.83 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -174.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.75 -34.78 73.41 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.598 0.713 . . . . 0.0 110.963 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.09 -20.66 26.8 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.362 0.601 . . . . 0.0 109.871 176.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.01 -34.59 64.21 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.592 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.79 -32.82 74.68 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.52 173.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 94.2 t80 -63.02 -42.46 99.81 Favored 'General case' 0 N--CA 1.461 0.095 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.1 t -57.0 -45.15 83.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.01 177.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.69 -52.39 34.5 Favored Glycine 0 N--CA 1.432 -1.618 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.223 178.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.4 t -59.52 -39.36 83.6 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 123.472 0.709 . . . . 0.0 112.814 -175.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.0 p -70.1 -24.42 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 CA-C-O 121.132 0.492 . . . . 0.0 111.514 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -93.6 -27.58 16.52 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.146 0.498 . . . . 0.0 110.437 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 148.68 -63.1 0.42 Allowed Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 177.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -159.33 -34.19 0.02 OUTLIER Glycine 0 C--N 1.298 -1.565 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -76.56 145.97 38.66 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.224 0.535 . . . . 0.0 110.748 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -89.66 86.33 6.68 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.659 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.8 m -78.9 117.19 19.75 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 172.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.631 ' HB ' ' SG ' ' A' ' 17' ' ' CYS . 2.3 t -76.01 -60.82 0.94 Allowed Pre-proline 0 C--N 1.308 -1.206 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 -167.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.584 ' HD3' ' SG ' ' A' ' 17' ' ' CYS . 67.8 Cg_endo -73.14 70.67 3.73 Favored 'Trans proline' 0 C--N 1.399 3.219 0 CA-C-N 121.963 1.737 . . . . 0.0 112.952 -171.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 69.2 m -108.29 119.19 38.77 Favored 'General case' 1 N--CA 1.377 -4.096 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.7 p -101.33 139.96 21.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.672 -175.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -108.89 111.79 23.67 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -88.53 177.69 6.72 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.238 -177.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.29 -12.0 59.01 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.44 177.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -65.51 -19.88 66.11 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.953 174.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.18 -12.22 65.1 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -176.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 61.6 p -94.78 166.53 11.94 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.6 p -114.28 140.14 48.85 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.134 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.5 tp -119.25 110.56 17.16 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.8 m -79.16 120.96 24.42 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.044 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 53.89 75.75 0.59 Allowed Pre-proline 0 N--CA 1.481 1.115 0 C-N-CA 124.843 1.257 . . . . 0.0 111.981 176.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -97.88 165.62 0.8 Allowed 'Trans proline' 0 N--CA 1.442 -1.519 0 C-N-CA 122.401 2.068 . . . . 0.0 111.915 178.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.444 ' O ' HG23 ' A' ' 75' ' ' VAL . 13.4 m -84.34 149.82 25.79 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.62 -41.41 94.76 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.07 0.462 . . . . 0.0 111.918 -175.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -63.48 -37.66 88.14 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.723 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -64.92 -42.99 94.25 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.271 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 71' ' ' SER . 63.2 t -62.49 -43.91 98.78 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.75 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.922 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.416 ' O ' HG12 ' A' ' 80' ' ' VAL . 23.2 tptm -62.65 -47.11 85.15 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.551 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.68 -29.09 68.28 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -178.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.484 ' O ' HG13 ' A' ' 82' ' ' ILE . 3.5 tmtp? -82.49 -37.06 25.86 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 19.2 tp -57.69 -49.74 75.52 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.105 0.479 . . . . 0.0 110.068 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 76' ' ' LYS . 33.7 m -61.02 -34.99 62.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.99 -176.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.1 ptpp? -80.55 -32.61 36.64 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.685 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.1 pp -85.29 -12.45 11.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.289 0.566 . . . . 0.0 111.854 -178.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.532 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.236 174.66 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.416 0 CA-C-O 121.363 0.601 . . . . 0.0 109.758 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.1 tp -125.83 137.81 53.78 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -178.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.8 m -122.6 135.71 54.69 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 58.7 mt -126.03 131.33 71.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.264 0.554 . . . . 0.0 109.884 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -91.94 90.29 7.37 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.028 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.7 p -127.62 160.54 31.29 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 123.006 0.523 . . . . 0.0 111.159 -177.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.5 p -115.48 166.63 11.68 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 171.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.8 t -71.87 -13.65 61.72 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-O 121.678 0.751 . . . . 0.0 109.093 172.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 2.2 m0 -90.2 75.74 6.94 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -175.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.2 t -158.52 159.87 36.05 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.675 -178.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.47 -43.9 0.26 Allowed Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -72.24 -26.98 62.23 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 70.0 m -54.88 -32.41 60.84 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 122.652 0.381 . . . . 0.0 111.409 -177.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 38.4 tp -55.02 -33.72 62.88 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.146 0.978 . . . . 0.0 111.943 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -59.72 -42.58 93.4 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.3 0.64 . . . . 0.0 109.442 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.5 tp -84.32 -38.71 20.05 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.437 -178.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -55.44 -48.84 73.84 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.444 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.9 p -68.18 -40.22 82.32 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.876 -178.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.68 -45.83 90.9 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.481 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.0 mt -69.66 -42.67 73.91 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.723 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 59.6 m -64.71 -35.57 81.47 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-O 120.878 0.37 . . . . 0.0 111.175 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.93 -26.56 62.34 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-O 121.463 0.649 . . . . 0.0 110.425 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -91.89 10.64 27.89 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.48 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 65.58 23.87 11.74 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.144 1.377 . . . . 0.0 111.282 175.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 80.0 mt -90.11 130.76 38.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -102.29 150.39 23.37 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -147.86 138.27 22.99 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.3 112.43 22.83 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 176.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -83.38 126.83 33.13 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.4 t -75.51 154.81 6.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-O 121.864 0.84 . . . . 0.0 112.559 -173.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -68.79 -0.52 5.51 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 126.394 1.878 . . . . 0.0 114.418 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.2 pt -44.44 -24.92 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 N-CA-C 117.265 2.32 . . . . 0.0 117.265 -170.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -67.73 -25.77 65.81 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 119.561 -0.855 . . . . 0.0 111.109 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 14.6 t60 -108.93 -43.79 4.13 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 176.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -79.43 102.98 9.03 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.336 -178.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -71.47 -23.41 61.82 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.77 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.39 -38.38 89.82 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.34 -20.99 25.97 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.975 176.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.88 -33.82 76.45 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.402 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -70.81 -30.49 66.94 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.579 176.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -66.73 -32.96 74.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.172 0.51 . . . . 0.0 110.108 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 44.9 t -62.25 -32.51 55.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.392 177.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.55 -43.38 52.98 Favored Glycine 0 N--CA 1.44 -1.079 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 177.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.7 m -58.18 -40.42 81.44 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.497 0.719 . . . . 0.0 112.174 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.3 m -79.72 -7.58 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -107.75 -53.6 2.6 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.856 -0.337 . . . . 0.0 111.619 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 138.52 -87.51 0.21 Allowed Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.193 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -103.14 -42.7 2.02 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.339 -177.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -124.33 149.35 46.68 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.078 0.466 . . . . 0.0 110.72 -177.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.1 mtm180 -80.79 97.44 7.34 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.45 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.7 m -75.8 127.45 33.04 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 175.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 1.564 18.9 m -59.35 -71.02 0.34 Allowed Pre-proline 0 CA--C 1.45 -2.883 1 N-CA-C 124.52 5.007 . . . . 0.0 124.52 -177.329 . . . . . . . . 3 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.67 79.36 3.38 Favored 'Trans proline' 0 N--CA 1.401 -3.966 0 CA-C-N 122.617 1.97 . . . . 0.0 113.188 -170.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.4 m -108.14 120.97 43.85 Favored 'General case' 0 N--CA 1.417 -2.093 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.155 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.6 p -97.78 143.85 12.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.747 -177.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -121.08 128.17 52.35 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -103.79 149.08 25.36 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.27 -11.91 53.22 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.457 0.646 . . . . 0.0 111.562 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -74.92 -14.19 60.62 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 124.104 0.962 . . . . 0.0 110.064 178.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.03 -21.85 24.22 Favored Glycine 0 CA--C 1.501 -0.812 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.752 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 p -70.36 138.02 51.05 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 123.585 0.754 . . . . 0.0 111.889 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.98 138.09 54.51 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 174.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mp -129.58 119.6 23.9 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 120.87 0.366 . . . . 0.0 110.595 -178.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.9 m -90.3 112.72 24.39 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.732 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 36.4 t30 56.1 74.22 0.73 Allowed Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 177.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -103.59 172.2 0.19 Allowed 'Trans proline' 0 N--CA 1.444 -1.388 0 C-N-CA 122.478 2.119 . . . . 0.0 110.598 172.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.2 t -85.08 165.22 17.67 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 174.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.66 -32.45 71.64 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.958 0.409 . . . . 0.0 111.398 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -56.65 -40.62 75.8 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.598 1.159 . . . . 0.0 109.511 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -68.96 -53.12 22.48 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.653 -176.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 49.4 t -61.4 -40.84 87.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 114.997 -1.002 . . . . 0.0 111.126 -176.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -64.04 -37.8 88.74 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.572 -177.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.57 -22.58 34.83 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.897 0.38 . . . . 0.0 110.964 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.428 ' O ' HG21 ' A' ' 82' ' ' ILE . 74.8 mmtt -84.56 -35.99 22.42 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.493 177.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.9 tp -55.61 -46.48 77.32 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.467 0.651 . . . . 0.0 109.6 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.7 m -63.42 -40.88 90.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.864 -178.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.12 -24.18 51.73 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.71 -177.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.428 HG21 ' O ' ' A' ' 78' ' ' LYS . 1.9 pp -83.37 -25.45 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 120.004 -0.679 . . . . 0.0 110.426 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.57 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.462 175.991 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.691 0 CA-C-O 121.36 0.6 . . . . 0.0 109.665 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.4 HD21 ' CG1' ' A' ' 75' ' ' VAL . 8.5 mp -93.53 129.42 39.76 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.448 177.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.3 m -118.34 108.31 14.92 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 171.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 57.6 mt -108.5 134.09 51.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-O 121.147 0.498 . . . . 0.0 110.211 -174.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -86.14 123.65 31.66 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.556 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 31.5 p -138.79 -178.91 5.53 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.687 0.755 . . . . 0.0 111.103 -178.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.1 m -139.4 153.25 47.59 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 104.367 -2.457 . . . . 0.0 104.367 174.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.3 p -49.94 -42.6 48.85 Favored 'General case' 0 C--N 1.315 -0.928 0 O-C-N 123.605 0.565 . . . . 0.0 110.99 176.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 35.2 p90 -111.52 129.67 55.98 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 174.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.3 t -164.02 142.13 7.28 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 174.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.47 -49.2 2.04 Favored Glycine 0 N--CA 1.429 -1.792 0 C-N-CA 120.646 -0.787 . . . . 0.0 111.374 178.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -73.42 -34.02 65.26 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 122.548 0.339 . . . . 0.0 111.553 -175.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.4 m -62.69 -36.96 84.6 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.247 0.546 . . . . 0.0 110.216 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 24.2 tp -65.64 -27.79 68.63 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.831 -174.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.0 ttt180 -54.46 -53.26 56.68 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.865 0.866 . . . . 0.0 110.158 177.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.471 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 23.3 tp -79.99 -37.8 33.48 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.125 -177.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.6 tttm -58.13 -43.56 87.34 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 123.747 0.819 . . . . 0.0 111.069 -175.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.6 m -72.4 -32.06 66.06 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.351 -178.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.97 -46.19 78.95 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.275 0.56 . . . . 0.0 110.042 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 68.9 mt -63.61 -44.46 93.88 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.599 -178.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.5 m -61.57 -37.42 83.78 Favored 'General case' 0 CA--C 1.555 1.167 0 CA-C-O 121.217 0.532 . . . . 0.0 110.68 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.18 -19.82 59.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.107 0.48 . . . . 0.0 111.134 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -97.31 10.96 38.18 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.519 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 63.99 26.2 14.05 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.792 0.837 . . . . 0.0 111.978 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 77.0 mt -91.52 120.19 40.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.04 146.48 26.08 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -153.01 147.91 26.46 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -176.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -109.46 116.27 31.49 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 177.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.556 ' HB2' ' OG1' ' A' ' 10' ' ' THR . 14.0 pt-20 -87.98 146.91 25.28 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.617 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.7 t -91.07 151.73 3.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -171.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -77.91 1.55 20.23 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 128.724 2.81 . . . . 0.0 113.103 -178.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.1 pt -42.92 -22.48 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.526 3.341 0 N-CA-C 116.978 2.214 . . . . 0.0 116.978 -168.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -74.37 -21.81 59.5 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 119.403 1.001 . . . . 0.0 109.732 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -111.01 -34.86 6.09 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.573 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.477 ' ND2' ' H ' ' A' ' 42' ' ' ALA . 49.6 t30 -90.98 113.46 25.71 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.819 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -72.03 -29.85 64.6 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.625 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.65 -46.94 74.1 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -174.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.477 ' H ' ' ND2' ' A' ' 39' ' ' ASN . . . -76.03 -25.18 55.43 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.522 179.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.48 -42.61 87.2 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.65 -39.55 84.76 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.617 176.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -65.08 -32.85 74.77 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.082 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 42' ' ' ALA . 64.9 t -59.68 -34.47 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 121.195 0.522 . . . . 0.0 109.674 178.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.24 -18.38 65.02 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.834 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.5 t -81.54 -26.85 34.72 Favored 'General case' 0 N--CA 1.433 -1.285 0 O-C-N 122.228 -0.572 . . . . 0.0 110.391 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.4 m -99.42 -23.01 4.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 119.831 -0.748 . . . . 0.0 112.729 -178.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -147.76 154.09 40.07 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 175.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -144.32 170.04 26.18 Favored Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -178.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.51 -82.79 1.66 Allowed Glycine 0 CA--C 1.501 -0.834 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -177.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -104.85 123.59 47.97 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 174.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -67.13 106.25 1.93 Allowed 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.127 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.5 m -78.48 110.72 13.82 Favored 'General case' 0 N--CA 1.409 -2.476 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.4 t -76.89 -57.71 1.15 Allowed Pre-proline 0 N--CA 1.426 -1.632 0 CA-C-O 117.119 -1.42 . . . . 0.0 113.087 -174.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -73.39 45.49 1.02 Allowed 'Trans proline' 0 C--N 1.402 3.374 0 C-N-CA 121.393 1.395 . . . . 0.0 114.014 -168.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 95.5 m -80.49 138.21 36.53 Favored 'General case' 0 N--CA 1.39 -3.473 0 C-N-CA 126.063 1.745 . . . . 0.0 107.29 177.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.67 136.48 59.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-O 121.13 0.49 . . . . 0.0 110.569 -178.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -114.58 130.59 56.79 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 175.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -100.35 151.99 20.86 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.919 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.4 -10.08 15.29 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 124.234 1.013 . . . . 0.0 113.569 -177.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -89.76 -13.98 35.57 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.181 0.515 . . . . 0.0 109.663 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.72 3.13 30.49 Favored Glycine 0 N--CA 1.436 -1.312 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.6 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.0 m -82.86 131.01 35.21 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.796 177.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.0 p -113.93 137.65 51.4 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 171.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.3 mp -128.08 116.56 20.17 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.9 m -96.91 112.42 24.18 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -178.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 54.08 69.88 1.97 Allowed Pre-proline 0 N--CA 1.488 1.466 0 C-N-CA 124.213 1.005 . . . . 0.0 113.141 -174.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -95.55 172.88 1.16 Allowed 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 122.058 1.839 . . . . 0.0 111.567 175.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.0 t -93.55 161.49 14.34 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 172.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.81 -28.9 67.86 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.16 0.505 . . . . 0.0 110.243 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -56.55 -49.97 73.25 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.191 177.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -65.25 -42.56 93.18 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-N 114.805 -1.088 . . . . 0.0 110.653 -177.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.4 ' CG1' HD21 ' A' ' 6' ' ' LEU . 96.9 t -62.05 -49.38 84.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.29 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -61.36 -43.91 98.06 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.379 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.81 -38.79 87.16 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.575 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.409 ' O ' HG13 ' A' ' 82' ' ' ILE . 18.1 tppt? -66.6 -45.08 80.36 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 177.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.9 tp -59.98 -49.45 77.61 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.923 -177.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.8 m -66.61 -30.17 48.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -79.72 -33.44 40.92 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.543 -0.863 . . . . 0.0 111.221 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.5 pp -83.4 -23.8 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.768 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.829 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.997 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.386 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.2 tp -110.29 151.55 27.25 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.779 -174.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.2 m -121.44 119.64 32.65 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 176.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 52.3 mt -120.34 131.87 71.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.394 0.616 . . . . 0.0 110.886 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -95.0 127.3 40.96 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 174.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.418 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 7.3 p -151.27 176.54 11.13 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.06 0.457 . . . . 0.0 111.723 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 29.0 m -132.02 149.45 52.42 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 174.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.2 p -68.68 -30.05 68.64 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.957 0.884 . . . . 0.0 108.85 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -84.92 101.78 12.61 Favored 'General case' 0 N--CA 1.412 -2.343 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 171.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.514 ' SG ' HG22 ' A' ' 56' ' ' VAL . 10.0 m -164.22 158.93 19.54 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.954 -1.475 . . . . 0.0 109.471 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -116.75 -62.66 0.33 Allowed Glycine 0 C--N 1.305 -1.193 0 N-CA-C 108.296 -1.921 . . . . 0.0 108.296 167.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.62 -30.67 63.52 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 124.696 1.198 . . . . 0.0 113.197 176.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.446 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 36.1 m -66.04 -44.63 84.09 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 70.3 mt -62.53 -43.26 99.26 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.196 -176.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -59.01 -39.23 81.24 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.335 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.579 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 25.8 tp -77.7 -45.61 24.33 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.074 0.464 . . . . 0.0 109.826 177.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -56.9 -44.47 82.39 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 123.887 0.875 . . . . 0.0 111.971 -177.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.5 t -71.91 -31.07 66.01 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.47 177.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.64 -45.0 88.68 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.579 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 42.5 mt -63.79 -39.98 95.57 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.27 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.0 m -69.09 -33.14 73.04 Favored 'General case' 0 CA--C 1.562 1.426 0 CA-C-O 121.268 0.556 . . . . 0.0 110.504 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.03 -40.47 65.1 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.563 0.697 . . . . 0.0 111.583 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -91.23 18.32 7.14 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 114.959 -1.018 . . . . 0.0 111.902 -174.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 54.66 64.08 1.93 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.612 1.165 . . . . 0.0 113.479 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.423 HD11 ' HB2' ' A' ' 76' ' ' LYS . 89.7 mt -119.68 123.56 71.24 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.706 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 174.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.32 135.19 34.78 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.164 -177.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -155.8 150.7 26.37 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 123.208 0.317 . . . . 0.0 111.564 -176.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -109.44 136.07 49.45 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 172.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 10.0 pt-20 -102.77 142.48 33.85 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.819 178.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -84.07 154.85 3.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-O 121.259 0.552 . . . . 0.0 111.979 -173.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -71.59 -2.21 16.26 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 126.707 2.003 . . . . 0.0 113.245 -174.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.433 HD13 HG21 ' A' ' 46' ' ' VAL . 3.3 pt -44.12 -24.38 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 117.166 2.284 . . . . 0.0 117.166 -167.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -63.52 -41.48 98.5 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.853 0.835 . . . . 0.0 109.058 176.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 56.7 t60 -94.85 -41.76 9.05 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.581 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.467 ' ND2' ' H ' ' A' ' 42' ' ' ALA . 42.1 t30 -85.47 109.94 18.83 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.124 0.487 . . . . 0.0 111.574 -178.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -75.88 -16.68 60.01 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.683 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.11 -43.85 41.34 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -175.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.467 ' H ' ' ND2' ' A' ' 39' ' ' ASN . . . -81.32 -22.79 38.26 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.377 0.608 . . . . 0.0 109.881 177.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.37 -27.13 68.35 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.617 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -64.61 -33.25 75.49 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.942 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -67.54 -36.8 81.67 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.433 HG21 HD13 ' A' ' 36' ' ' ILE . 57.3 t -64.87 -45.68 94.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.999 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.64 -21.02 76.2 Favored Glycine 0 C--O 1.218 -0.881 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.862 178.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.6 t -81.87 -41.62 20.73 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 122.798 0.439 . . . . 0.0 110.798 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.2 p -82.22 -31.43 10.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -96.19 137.02 35.87 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.807 0.337 . . . . 0.0 110.156 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.85 136.14 12.9 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.78 -174.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.32 -88.17 1.58 Allowed Glycine 0 N--CA 1.43 -1.702 0 CA-C-N 115.436 -0.382 . . . . 0.0 112.501 177.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -93.29 162.21 14.09 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -85.48 83.43 7.93 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 173.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.6 m -60.96 127.76 33.15 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.498 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.514 HG22 ' SG ' ' A' ' 14' ' ' CYS 1.539 12.0 m -68.47 -75.05 0.14 Allowed Pre-proline 0 CA--C 1.433 -3.548 1 N-CA-C 123.902 4.778 . . . . 0.0 123.902 179.509 . . . . . . . . 4 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.446 ' HD3' ' SG ' ' A' ' 17' ' ' CYS . 98.3 Cg_endo -74.15 89.69 1.03 Allowed 'Trans proline' 0 N--CA 1.403 -3.812 0 CA-C-N 121.218 1.471 . . . . 0.0 112.004 -167.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.7 m -114.42 116.81 29.49 Favored 'General case' 0 N--CA 1.397 -3.1 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 -177.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.13 139.68 23.41 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.137 -176.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -115.2 121.14 42.03 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 78' ' ' LYS . 97.0 m-85 -101.58 155.89 17.81 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.27 -9.87 27.6 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.696 0.76 . . . . 0.0 110.583 176.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -64.92 -18.77 65.51 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.893 1.277 . . . . 0.0 109.906 176.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.43 18.18 36.79 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.501 177.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 27.8 t -133.94 153.73 51.57 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -178.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.2 p -114.33 139.52 49.38 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.578 177.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.9 mp -119.33 123.88 45.26 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 18.2 m -97.67 112.69 24.47 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 54.03 68.81 2.51 Favored Pre-proline 0 N--CA 1.489 1.483 0 C-N-CA 124.437 1.095 . . . . 0.0 112.885 -171.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -85.56 165.26 10.67 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.759 1.639 . . . . 0.0 109.855 172.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.3 m -84.49 159.75 20.68 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 177.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.52 -43.28 79.65 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 122.971 0.508 . . . . 0.0 111.807 -177.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -58.92 -42.37 89.55 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.976 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.481 ' O ' ' HE2' ' A' ' 78' ' ' LYS . 56.2 mm-40 -61.15 -44.39 97.39 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.243 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.8 t -65.83 -48.0 83.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.413 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.423 ' HB2' HD11 ' A' ' 29' ' ' ILE . 57.5 tttp -61.43 -43.81 98.21 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.998 -177.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.1 -35.31 69.15 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.029 0.442 . . . . 0.0 111.369 -178.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.481 ' HE2' ' O ' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -74.22 -31.43 62.61 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 119.994 -0.683 . . . . 0.0 110.13 177.377 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.5 tp -63.21 -48.4 78.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.188 0.518 . . . . 0.0 109.761 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.7 m -65.21 -30.29 49.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.66 -176.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -80.94 -25.81 37.14 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.123 -0.631 . . . . 0.0 111.21 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.4 pp -85.24 -32.03 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.202 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.611 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.709 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.59 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.0 mt -119.28 117.93 29.89 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.675 -1.148 . . . . 0.0 107.933 175.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.9 m -102.36 108.04 19.25 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 59.4 mt -108.06 134.49 49.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-O 121.629 0.728 . . . . 0.0 110.26 -176.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -91.19 120.12 31.85 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.031 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.528 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 24.9 p -139.67 162.13 35.85 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.375 0.27 . . . . 0.0 111.193 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.5 p -155.69 -175.1 5.26 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 125.316 1.446 . . . . 0.0 107.684 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.7 t -76.72 -11.03 59.78 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.984 0.421 . . . . 0.0 109.871 172.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 4.1 m0 -83.98 44.96 1.04 Allowed 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 41.3 t -133.97 126.46 30.34 Favored 'General case' 0 N--CA 1.416 -2.143 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -166.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -128.72 -69.91 0.13 Allowed Glycine 0 N--CA 1.437 -1.24 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 170.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -61.66 -18.34 59.13 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.37 -33.98 70.02 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.218 0.532 . . . . 0.0 110.516 177.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 84.1 mt -65.38 -37.28 86.53 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.348 -178.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 -52.58 -48.59 66.13 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 124.274 0.984 . . . . 0.0 110.099 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.4 tp -74.12 -45.8 46.67 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.658 -177.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.7 pttp -70.86 -26.91 63.47 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 119.285 -0.966 . . . . 0.0 112.123 -173.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.9 p -74.98 -28.49 60.57 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.848 -0.532 . . . . 0.0 110.311 175.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.46 -42.06 88.14 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 175.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.1 mt -63.32 -47.54 81.8 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.991 177.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.3 m -57.73 -47.06 83.48 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.811 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.69 -25.61 68.28 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.301 0.572 . . . . 0.0 111.936 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -95.5 6.88 47.82 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.027 -178.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 67.53 24.0 8.78 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.78 0.832 . . . . 0.0 112.551 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 73.2 mt -83.89 120.76 35.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 176.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.52 127.7 34.9 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.4 -176.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -140.27 169.27 18.0 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -136.52 142.52 43.47 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.528 ' HB2' ' OG1' ' A' ' 10' ' ' THR . 10.3 pt-20 -105.32 131.58 52.59 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 123.659 0.599 . . . . 0.0 110.939 -176.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.4 t -78.84 143.61 12.35 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -172.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -59.65 -1.3 0.24 Allowed 'General case' 0 N--CA 1.503 2.215 0 C-N-CA 128.826 2.85 . . . . 0.0 114.878 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.2 pt -44.22 -25.19 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 117.092 2.256 . . . . 0.0 117.092 -168.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -70.91 -25.49 62.79 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 118.967 0.803 . . . . 0.0 109.096 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -97.97 -35.48 10.44 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.257 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . 0.254 0.2 OUTLIER -112.62 118.69 35.77 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.959 0.885 . . . . 0.0 112.667 179.448 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.563 ' HD3' ' H ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -75.85 -18.9 59.27 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.655 -174.88 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.87 -53.52 56.34 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.789 0.328 . . . . 0.0 111.496 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.412 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -72.82 -21.1 61.02 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.913 177.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.88 -35.46 76.9 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.126 0.489 . . . . 0.0 110.714 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -73.9 -29.28 61.98 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.951 0.405 . . . . 0.0 110.269 177.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -65.21 -29.8 70.64 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.788 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 42' ' ' ALA . 48.0 t -63.03 -30.83 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.834 176.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.75 -43.13 60.27 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 178.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.2 m -65.22 -28.82 69.63 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.222 0.609 . . . . 0.0 112.359 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.8 m -84.61 -5.03 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 O-C-N 121.655 -0.653 . . . . 0.0 111.594 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -104.83 -52.94 2.77 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.638 176.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 143.64 -37.9 1.41 Allowed Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -167.24 -47.73 0.03 OUTLIER Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -88.64 177.31 6.79 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.0 mtm180 -126.19 116.85 21.95 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.407 HG23 ' HD2' ' A' ' 57' ' ' PRO . 16.3 m -98.02 151.16 20.62 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 174.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.43 ' CG1' ' HA ' ' A' ' 10' ' ' THR . 34.5 t -79.38 -69.13 0.21 Allowed Pre-proline 0 CA--C 1.475 -1.926 0 CA-C-O 117.509 -1.234 . . . . 0.0 113.988 -178.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.407 ' HD2' HG23 ' A' ' 55' ' ' THR . 72.8 Cg_endo -76.07 86.68 1.5 Allowed 'Trans proline' 1 N--CA 1.393 -4.387 0 CA-C-N 120.867 1.345 . . . . 0.0 111.797 -163.121 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 64.0 m -121.64 124.88 45.37 Favored 'General case' 1 N--CA 1.373 -4.299 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 -175.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 66' ' ' THR . 4.6 p -115.53 136.1 53.44 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.956 -175.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.7 ttpp -111.74 123.19 49.72 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 174.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.402 ' HB3' HG21 ' A' ' 82' ' ' ILE . 88.2 m-85 -92.03 175.61 6.81 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.015 -178.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.423 ' HB2' ' HB ' ' A' ' 82' ' ' ILE . . . -66.44 -22.84 66.22 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.538 ' OD2' HG23 ' A' ' 82' ' ' ILE . 48.9 m-20 -82.17 0.07 42.65 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.198 0.523 . . . . 0.0 111.046 177.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.57 -0.8 87.02 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.939 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.1 m -68.27 130.45 42.94 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 6.4 p -114.13 137.8 51.27 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 176.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.9 mt -134.61 121.67 21.23 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.926 0.393 . . . . 0.0 110.432 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 91.8 m -90.92 121.83 33.09 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 174.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 58.33 65.64 3.01 Favored Pre-proline 0 N--CA 1.472 0.629 0 C-N-CA 124.284 1.033 . . . . 0.0 113.055 -177.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -84.0 -178.88 3.72 Favored 'Trans proline' 0 C--O 1.25 1.117 0 C-N-CA 121.694 1.596 . . . . 0.0 110.463 171.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.461 ' O ' HG21 ' A' ' 75' ' ' VAL . 3.4 m -112.09 150.83 30.16 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.41 -41.92 66.48 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -174.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -78.27 -34.83 48.71 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.948 0.404 . . . . 0.0 109.953 -178.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -65.06 -37.53 87.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.273 178.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.461 HG21 ' O ' ' A' ' 71' ' ' SER . 91.7 t -61.44 -42.17 92.81 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.626 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -62.52 -41.1 98.63 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.984 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 80' ' ' VAL . . . -69.42 -31.58 70.01 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.504 0.669 . . . . 0.0 111.289 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -78.11 -29.71 49.11 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 176.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 31.1 tp -65.94 -41.57 91.12 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.445 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 77' ' ' ALA . 27.4 m -66.12 -36.19 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -72.99 -34.37 66.37 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.943 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.538 HG23 ' OD2' ' A' ' 63' ' ' ASP . 2.1 pp -77.02 -31.53 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 120.344 -0.543 . . . . 0.0 111.246 -177.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.588 0 CA-C-O 121.062 0.458 . . . . 0.0 110.145 177.596 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.503 0 CA-C-O 120.891 0.376 . . . . 0.0 111.357 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.84 123.12 41.01 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 121.397 0.618 . . . . 0.0 109.679 175.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.1 m -110.16 112.3 24.2 Favored 'General case' 0 C--N 1.276 -2.605 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 177.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.499 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 57.5 mt -97.88 137.17 26.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.049 -174.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -92.72 117.91 30.5 Favored 'General case' 0 C--N 1.279 -2.459 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.512 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 14.0 p -128.68 155.92 44.29 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 122.511 0.324 . . . . 0.0 110.589 -178.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.47 ' HA ' ' HG2' ' A' ' 37' ' ' GLU . 46.9 p -140.2 175.41 9.62 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.8 m -86.03 -11.41 52.95 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 175.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 8.5 m0 -82.18 -20.23 38.28 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.312 -169.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.473 ' SG ' HG11 ' A' ' 56' ' ' VAL . 9.0 p -109.39 148.33 31.28 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -172.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -101.99 -42.37 2.27 Favored Glycine 0 N--CA 1.432 -1.586 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 172.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -59.75 -24.7 64.25 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -177.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.9 p -68.52 -39.14 81.33 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.448 0.642 . . . . 0.0 109.931 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 37.2 tp -69.29 -28.93 66.72 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.549 -175.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -63.39 -50.82 68.37 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.013 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.438 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 41.4 tp -68.5 -36.84 79.47 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.101 0.477 . . . . 0.0 109.908 178.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -56.56 -37.29 70.34 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.479 177.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.9 m -75.15 -40.11 59.85 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.117 178.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.83 -41.03 94.95 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.818 0.447 . . . . 0.0 111.123 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 81.9 mt -66.13 -33.77 76.53 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.76 178.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.7 m -65.55 -44.25 87.4 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.002 177.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.44 -26.89 65.74 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.561 0.696 . . . . 0.0 110.963 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -84.53 4.35 32.37 Favored 'General case' 0 C--O 1.254 1.3 0 C-N-CA 123.907 0.883 . . . . 0.0 111.858 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 60.3 37.12 20.51 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.931 1.293 . . . . 0.0 110.252 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 85.2 mt -95.61 122.74 47.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.625 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.04 125.2 31.18 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 176.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -135.69 148.67 48.99 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 120.707 0.289 . . . . 0.0 110.671 -178.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -111.04 123.73 50.78 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 174.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.512 ' HB2' ' OG1' ' A' ' 10' ' ' THR . 15.7 pt-20 -96.91 151.04 20.08 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.9 t -90.92 143.63 10.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-O 122.163 0.982 . . . . 0.0 113.497 -171.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -63.59 -2.1 1.52 Allowed 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 128.305 2.642 . . . . 0.0 114.822 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.4 pt -45.28 -24.84 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -175.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.47 ' HG2' ' HA ' ' A' ' 11' ' ' THR . 45.3 mt-10 -55.8 -31.7 62.87 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.355 0.662 . . . . 0.0 111.427 178.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -128.08 20.56 6.37 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.22 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.429 ' ND2' ' H ' ' A' ' 42' ' ' ALA . 28.7 t30 -143.52 122.18 12.57 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.957 0.408 . . . . 0.0 111.26 -178.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -77.15 -28.21 54.1 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.421 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.04 -37.48 81.38 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 -172.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.429 ' H ' ' ND2' ' A' ' 39' ' ' ASN . . . -84.19 -24.75 29.98 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 120.113 -0.635 . . . . 0.0 109.466 176.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.79 -30.28 68.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.288 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -64.4 -36.6 84.68 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 114.97 -1.013 . . . . 0.0 108.737 178.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -67.53 -31.78 72.11 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.123 0.487 . . . . 0.0 110.463 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 43.6 t -66.49 -31.42 53.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.33 -23.65 67.68 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.321 176.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 42.3 t -67.94 -43.72 78.47 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 176.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 31.5 m -81.06 -39.52 17.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.923 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.417 ' HB3' ' O ' ' A' ' 53' ' ' ASN . 54.5 m-80 -106.97 109.22 21.06 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 120.862 0.363 . . . . 0.0 110.701 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -81.93 128.17 8.33 Favored Glycine 0 N--CA 1.439 -1.116 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.798 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.31 -84.25 1.37 Allowed Glycine 0 N--CA 1.438 -1.204 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.417 ' O ' ' HB3' ' A' ' 50' ' ' ASN . 93.0 m-20 -88.64 122.61 32.27 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -80.63 94.03 6.24 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.821 177.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.8 m -67.0 123.71 20.99 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 175.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.473 HG11 ' SG ' ' A' ' 14' ' ' CYS . 16.5 t -72.89 -60.56 1.85 Allowed Pre-proline 0 CA--C 1.462 -2.412 0 CA-C-O 117.149 -1.405 . . . . 0.0 114.746 -172.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -77.74 72.17 6.21 Favored 'Trans proline' 1 N--CA 1.394 -4.343 0 CA-C-N 121.185 1.459 . . . . 0.0 112.782 -167.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 88.2 m -106.35 142.12 36.54 Favored 'General case' 0 N--CA 1.38 -3.96 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.6 p -136.81 139.16 45.24 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.862 -174.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -104.54 128.59 52.53 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -112.4 166.43 11.3 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.102 0.477 . . . . 0.0 110.489 177.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.34 -8.84 53.65 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.142 171.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -62.91 -17.07 61.29 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.111 1.764 . . . . 0.0 110.997 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.68 8.67 55.69 Favored Glycine 0 CA--C 1.506 -0.517 0 C-N-CA 120.743 -0.741 . . . . 0.0 113.78 173.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.0 t -150.71 173.75 13.81 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.8 p -114.13 139.68 49.14 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -178.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mp -106.09 151.79 24.23 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 177.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 18.2 m -131.48 113.79 14.13 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -177.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.7 m120 61.05 44.96 0.84 Allowed Pre-proline 0 N--CA 1.485 1.322 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -175.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.28 160.33 32.69 Favored 'Trans proline' 0 C--N 1.366 1.464 0 C-N-CA 121.305 1.337 . . . . 0.0 111.098 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.1 m -84.27 155.25 22.52 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.42 -42.12 70.12 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.717 0.807 . . . . 0.0 112.172 -177.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -61.46 -40.39 94.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.593 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -67.11 -40.81 86.92 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-O 121.075 0.464 . . . . 0.0 110.089 -178.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.3 t -61.22 -43.82 97.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.619 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -68.61 -41.28 79.73 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.452 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.11 -38.88 89.28 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 122.703 0.401 . . . . 0.0 111.033 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.648 ' O ' HG13 ' A' ' 82' ' ' ILE . 28.7 mmtp -69.48 -39.78 77.48 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.366 174.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.9 tp -60.53 -51.07 70.99 Favored 'General case' 0 C--N 1.318 -0.781 0 O-C-N 123.475 0.485 . . . . 0.0 110.729 -178.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.6 m -61.67 -31.41 50.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -177.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.44 ' HB3' ' HZ3' ' A' ' 81' ' ' LYS . 0.4 OUTLIER -81.09 -44.32 18.16 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 119.801 -0.76 . . . . 0.0 111.575 -179.8 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.648 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.2 pp -82.1 -20.37 10.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -175.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.63 0 CA-C-O 121.208 0.527 . . . . 0.0 111.504 -179.006 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.5 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.74 130.71 21.76 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-N 113.561 -1.654 . . . . 0.0 108.922 174.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.5 m -102.94 117.32 34.34 Favored 'General case' 0 C--N 1.274 -2.679 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 68.9 mt -108.86 133.61 53.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 121.446 0.641 . . . . 0.0 110.93 -175.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -85.12 127.42 34.24 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.598 177.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 39.0 p -133.63 163.17 30.03 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.0 0.429 . . . . 0.0 111.215 -178.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.3 m -147.87 151.6 36.19 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 175.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.4 p -58.41 -42.91 88.27 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 118.534 0.606 . . . . 0.0 109.736 174.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.11 94.36 1.51 Allowed 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 167.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 m -163.82 117.46 1.49 Allowed 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.098 -1.41 . . . . 0.0 111.568 178.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -106.83 -56.93 0.62 Allowed Glycine 0 N--CA 1.428 -1.898 0 N-CA-C 108.681 -1.768 . . . . 0.0 108.681 172.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -69.97 -20.96 63.28 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -179.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.507 ' SG ' ' HB ' ' A' ' 56' ' ' VAL . 3.6 m -72.5 -34.99 68.02 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 177.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 18.3 tp -72.29 -29.39 63.83 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.092 -173.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.432 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 2.2 mmp_? -59.34 -37.59 78.23 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.81 177.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.7 tp -82.58 -41.33 19.69 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.564 178.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -58.61 -45.54 88.96 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.635 -176.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -66.34 -36.73 83.66 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.62 -45.42 86.93 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.947 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.4 mt -67.54 -37.87 83.34 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.359 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.0 m -67.09 -42.72 84.13 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.998 0.428 . . . . 0.0 110.41 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.47 -23.86 65.54 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-O 121.233 0.54 . . . . 0.0 110.801 177.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -93.35 6.63 47.47 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.073 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 64.28 24.21 13.26 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.601 0.76 . . . . 0.0 112.494 176.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 78.1 mt -86.49 120.58 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.4 127.24 33.89 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.634 -178.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -142.47 167.19 22.68 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -129.43 135.59 48.87 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 177.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 17.0 pt-20 -100.44 141.69 32.94 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.079 0.466 . . . . 0.0 111.408 -177.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.4 t -83.57 146.72 6.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -171.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -63.68 -2.36 1.69 Allowed 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 129.187 2.995 . . . . 0.0 115.923 178.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.7 pt -45.7 -24.34 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 -173.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -70.19 -23.56 62.98 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 121.724 0.773 . . . . 0.0 110.327 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 -111.42 -36.62 5.49 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.926 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.405 ' ND2' ' H ' ' A' ' 42' ' ' ALA . 26.5 t30 -100.85 122.43 43.43 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.095 -175.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.421 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 9.7 ptp85 -75.76 -25.6 56.64 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.379 177.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.95 -36.21 79.72 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -172.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.405 ' H ' ' ND2' ' A' ' 39' ' ' ASN . . . -87.0 -22.23 25.64 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.554 175.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.29 -41.25 81.26 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.766 -178.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 40' ' ' ARG . 19.0 mm-40 -70.13 -24.66 63.22 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.787 178.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -67.35 -32.6 73.66 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.71 177.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 38.9 t -65.54 -39.87 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.82 -18.06 78.67 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.956 178.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.8 t -80.54 -42.63 22.07 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 31.7 m -84.07 -32.62 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -103.52 160.0 15.11 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -178.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -128.74 152.12 19.21 Favored Glycine 0 N--CA 1.432 -1.571 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.065 -178.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.63 -111.91 3.62 Favored Glycine 0 N--CA 1.438 -1.189 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -91.62 147.69 22.82 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 175.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -71.49 96.7 1.54 Allowed 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.515 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.8 m -61.98 114.81 3.59 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 174.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.507 ' HB ' ' SG ' ' A' ' 17' ' ' CYS . 5.2 t -75.1 -55.33 2.3 Favored Pre-proline 0 N--CA 1.428 -1.541 0 CA-C-O 117.435 -1.269 . . . . 0.0 113.424 -175.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.55 75.6 3.44 Favored 'Trans proline' 0 N--CA 1.41 -3.42 0 CA-C-N 121.155 1.448 . . . . 0.0 112.706 -170.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 58.5 m -106.5 125.66 51.29 Favored 'General case' 0 N--CA 1.381 -3.909 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.73 121.0 60.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-O 121.505 0.669 . . . . 0.0 110.872 -175.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -105.2 110.11 22.35 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -79.34 159.97 26.94 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.585 -178.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.56 -24.27 31.49 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.239 1.016 . . . . 0.0 113.588 -177.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -80.58 -17.1 52.43 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.014 0.435 . . . . 0.0 110.694 -178.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.2 -8.26 30.99 Favored Glycine 0 C--O 1.246 0.885 0 C-N-CA 121.009 -0.615 . . . . 0.0 113.169 178.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.9 t -79.31 135.87 36.86 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.3 m -116.7 138.6 51.34 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.0 mp -121.83 142.16 50.51 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 120.881 0.372 . . . . 0.0 110.748 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.8 m -98.73 116.32 30.69 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 115.503 -0.772 . . . . 0.0 108.982 -178.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . 0.324 25.9 p-10 34.88 74.66 0.53 Allowed Pre-proline 0 N--CA 1.494 1.755 0 N-CA-C 116.825 2.157 . . . . 0.0 116.825 179.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -92.04 -165.43 0.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.405 2.07 . . . . 0.0 110.248 175.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.4 m -115.02 169.99 8.68 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.73 -41.68 87.01 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -177.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . 0.41 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 5.2 m-20 -64.92 -33.76 76.79 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.691 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -64.21 -51.16 65.07 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.8 t -61.0 -44.76 98.88 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.167 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.779 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . 0.41 ' HE2' ' HA ' ' A' ' 73' ' ' ASP . 37.1 ttpt -58.46 -46.68 86.1 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 123.421 0.688 . . . . 0.0 111.991 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.36 -22.19 61.19 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 120.874 0.369 . . . . 0.0 111.538 -178.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.441 ' O ' HG13 ' A' ' 82' ' ' ILE . 45.3 mmtm -81.55 -40.75 22.63 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 173.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 27.1 tp -55.68 -47.66 76.38 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 123.721 0.808 . . . . 0.0 109.603 -178.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.8 m -60.53 -36.77 72.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.728 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -82.11 -36.35 27.6 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.4 pp -84.6 -29.53 6.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 113.477 0.918 . . . . 0.0 113.477 -176.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -1.0 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.505 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.312 0 CA-C-O 121.103 0.477 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.6 mp -98.52 104.82 16.89 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.163 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.4 m -102.56 107.3 18.19 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 173.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.0 mt -106.83 129.85 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 CA-C-O 121.687 0.755 . . . . 0.0 111.555 -173.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -94.09 106.67 18.64 Favored 'General case' 0 N--CA 1.406 -2.654 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.408 176.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.1 p -140.23 142.29 35.82 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.817 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.4 m -84.37 154.41 22.88 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 175.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 p -62.07 -51.98 65.77 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 46.3 p90 -83.28 92.67 7.54 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-O 121.914 0.864 . . . . 0.0 110.917 176.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.4 t -163.84 117.13 1.47 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.483 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.44 -36.13 15.24 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -62.96 -39.18 93.89 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.462 0.648 . . . . 0.0 109.683 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 55.7 m -68.09 -39.21 82.91 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.252 177.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.83 -38.63 82.6 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 123.832 0.853 . . . . 0.0 110.112 -177.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -57.12 -38.78 73.93 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.581 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.442 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 19.5 tp -78.89 -44.08 23.54 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.174 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -54.42 -49.49 69.85 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.908 -178.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.9 p -65.49 -33.68 76.51 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.963 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.21 -42.33 88.9 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.246 178.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 80.3 mt -64.34 -48.52 75.26 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.486 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 87.1 m -54.91 -42.57 72.37 Favored 'General case' 0 CA--C 1.553 1.088 0 CA-C-O 121.058 0.456 . . . . 0.0 110.768 177.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.15 -13.29 60.2 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -177.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -109.4 14.34 23.69 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 65.99 17.33 10.77 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.84 1.256 . . . . 0.0 112.256 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 63.3 mt -87.37 117.32 31.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.99 144.55 28.22 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.4 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -152.3 150.97 30.33 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 120.678 0.275 . . . . 0.0 111.059 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -114.11 113.01 24.13 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 176.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -91.37 145.02 24.98 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.0 t -90.73 151.8 3.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -171.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.67 -4.23 0.06 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 129.641 3.177 . . . . 0.0 114.91 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.8 pt -49.51 -22.48 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 116.49 2.033 . . . . 0.0 116.49 -168.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -72.73 -13.41 61.33 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 121.458 0.647 . . . . 0.0 111.808 -178.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 34.4 p-80 -128.59 -34.87 1.97 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.615 170.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.432 ' ND2' ' H ' ' A' ' 42' ' ' ALA . 44.3 t30 -80.23 107.23 12.85 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 120.692 0.282 . . . . 0.0 110.77 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -70.77 -23.68 62.45 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.313 -179.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.52 -42.1 71.7 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -176.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.432 ' H ' ' ND2' ' A' ' 39' ' ' ASN . . . -80.02 -23.47 41.45 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.361 177.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.72 -35.42 77.12 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.283 177.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -61.28 -39.66 91.23 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.085 175.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -66.06 -30.96 71.58 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.633 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 88.1 t -64.31 -36.83 78.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.5 -19.01 77.0 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.602 177.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.0 m -76.52 -30.65 57.24 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 177.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.5 m -98.79 -11.38 8.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -125.48 105.13 8.82 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 175.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.99 135.06 23.96 Favored Glycine 0 C--N 1.298 -1.534 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.926 -175.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.25 -59.31 4.99 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.383 -0.409 . . . . 0.0 113.574 176.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -125.75 133.34 52.11 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 -176.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.4 mtm180 -70.63 95.69 1.12 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.307 0.575 . . . . 0.0 110.788 176.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.0 m -77.04 131.02 38.2 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 1.716 15.3 m -58.46 -89.78 0.0 OUTLIER Pre-proline 0 CA--C 1.438 -3.338 1 N-CA-C 123.659 4.689 . . . . 0.0 123.659 -178.891 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -69.9 94.02 0.54 Allowed 'Trans proline' 0 N--CA 1.409 -3.48 0 CA-C-N 120.799 1.321 . . . . 0.0 112.508 -165.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.5 m -119.69 112.42 19.26 Favored 'General case' 0 N--CA 1.407 -2.609 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 -177.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.4 p -103.41 134.85 43.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-O 121.405 0.622 . . . . 0.0 111.211 -176.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -109.03 116.93 32.91 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -100.32 178.81 4.65 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.57 -9.16 24.23 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 122.346 1.07 . . . . 0.0 110.153 174.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -63.01 -19.33 64.25 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.876 1.67 . . . . 0.0 110.152 175.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.51 -22.81 14.63 Favored Glycine 0 C--O 1.238 0.353 0 CA-C-N 116.137 -0.483 . . . . 0.0 113.396 176.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.1 t -100.78 171.57 7.6 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.7 p -113.81 141.13 47.68 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 46.7 tp -115.11 125.25 53.26 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 178.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.9 m -105.24 144.76 31.59 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -175.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.6 p30 50.04 48.41 5.98 Favored Pre-proline 0 N--CA 1.491 1.59 0 C-N-CA 124.78 1.232 . . . . 0.0 113.043 -179.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -80.94 160.66 21.06 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 121.991 1.794 . . . . 0.0 112.703 -174.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.3 m -97.4 153.8 17.86 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 174.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.84 -35.54 73.08 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.044 0.45 . . . . 0.0 111.664 -176.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -62.44 -44.18 97.04 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.218 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -64.38 -41.19 96.82 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.581 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.9 t -57.82 -51.72 66.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.068 178.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -60.96 -44.11 97.77 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.379 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.05 -37.91 84.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.674 -178.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -68.81 -41.24 78.91 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 177.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.17 -49.74 74.62 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 123.796 0.685 . . . . 0.0 110.121 -175.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.5 m -61.88 -35.93 70.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.485 ' HZ2' ' HB2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -81.14 -31.24 34.25 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 119.771 -0.772 . . . . 0.0 111.731 -178.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.4 pp -75.02 -21.52 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.51 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.939 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.682 176.42 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.574 0 CA-C-O 121.069 0.462 . . . . 0.0 111.466 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.3 tp -132.68 133.27 43.34 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -178.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.0 m -114.86 124.34 51.47 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.551 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 67.0 mt -119.03 144.94 25.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.438 ' HD1' ' O ' ' A' ' 58' ' ' THR . 92.7 m-85 -98.75 133.01 43.68 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.423 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . 17.1 p -140.49 153.85 46.38 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -176.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.3 p -144.69 164.74 30.07 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 175.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.6 p -86.14 -0.82 56.57 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.34 0.591 . . . . 0.0 111.529 177.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -94.68 27.96 2.84 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -174.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.1 t -148.08 151.49 35.76 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -168.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.71 -28.21 0.98 Allowed Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.771 176.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -65.09 -36.46 84.37 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.262 0.553 . . . . 0.0 110.793 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.421 ' HA ' ' HB3' ' A' ' 57' ' ' PRO . 1.7 p -61.0 -32.59 72.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.165 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 81.9 mt -66.73 -28.85 68.75 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.906 -177.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -60.78 -56.08 25.47 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.292 0.568 . . . . 0.0 109.5 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.508 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 16.4 tp -66.79 -39.93 87.97 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.994 -177.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.419 ' HG2' ' OH ' ' A' ' 31' ' ' TYR . 51.1 tttm -58.34 -45.66 87.71 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.847 -177.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.7 p -71.41 -37.47 71.5 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.597 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.47 -42.9 97.18 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 123.066 0.546 . . . . 0.0 110.997 178.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 76.4 mt -69.26 -42.62 75.32 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.01 -178.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.4 m -62.52 -42.13 99.31 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 120.712 0.291 . . . . 0.0 110.273 177.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.79 -19.0 65.04 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.479 0.657 . . . . 0.0 111.196 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -98.25 9.4 43.07 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.932 178.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.464 ' HA ' ' NE ' ' A' ' 28' ' ' ARG . 4.2 mmp_? 65.96 23.14 11.24 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.54 0.736 . . . . 0.0 112.127 177.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.7 mt -87.15 119.95 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.35 127.16 35.78 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.165 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.419 ' OH ' ' HG2' ' A' ' 21' ' ' LYS . 51.6 p90 -136.52 151.92 49.96 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.878 -178.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -111.38 136.25 50.78 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 173.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.551 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 12.8 pt-20 -102.64 146.23 28.49 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.641 -177.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.3 t -96.04 134.69 32.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -173.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -54.57 -0.59 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 129.529 3.132 . . . . 0.0 115.986 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.6 pt -43.85 -25.46 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.514 2.753 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 -168.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -59.63 -45.55 91.63 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -100.54 -31.27 11.35 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.321 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.426 ' ND2' ' H ' ' A' ' 42' ' ' ALA . 50.1 t30 -88.8 104.45 16.93 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -72.86 -17.69 61.51 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.572 -177.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.31 -46.94 53.52 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -176.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.463 ' O ' HG21 ' A' ' 46' ' ' VAL . . . -75.29 -25.2 57.74 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.268 0.556 . . . . 0.0 110.001 177.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.16 -32.77 74.1 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.41 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -66.29 -39.89 89.67 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -61.18 -46.17 91.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.796 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.463 HG21 ' O ' ' A' ' 42' ' ' ALA . 80.9 t -57.08 -42.34 79.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.492 178.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.95 -32.95 76.78 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.299 178.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.3 m -81.87 -25.85 34.71 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 120.925 0.393 . . . . 0.0 111.304 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.6 t -79.41 -39.09 20.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.098 0.475 . . . . 0.0 110.516 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -84.97 -174.61 5.37 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.094 -178.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -90.23 -93.14 1.22 Allowed Glycine 0 N--CA 1.438 -1.201 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.181 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.25 -47.15 3.37 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.705 -174.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -126.22 151.82 46.88 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.3 mtm180 -57.88 111.18 1.07 Allowed 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.73 0.776 . . . . 0.0 111.826 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.5 m -87.95 133.82 33.85 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 178.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.423 ' CG1' ' HA ' ' A' ' 10' ' ' THR . 21.9 t -74.77 -64.46 0.64 Allowed Pre-proline 0 CA--C 1.459 -2.528 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -171.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.421 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . 33.0 Cg_endo -79.36 50.48 3.52 Favored 'Trans proline' 0 N--CA 1.415 -3.136 0 CA-C-N 121.092 1.426 . . . . 0.0 113.349 -164.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.438 ' O ' ' HD1' ' A' ' 9' ' ' TYR . 98.8 m -80.02 136.31 36.56 Favored 'General case' 0 N--CA 1.38 -3.938 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 176.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.3 p -125.74 148.69 30.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.325 -174.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -127.22 119.58 26.73 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -87.91 161.13 17.64 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.408 -178.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.56 -10.5 8.2 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.687 0.795 . . . . 0.0 111.735 176.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -77.68 -18.7 56.39 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.845 176.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.44 -13.35 58.31 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.176 -179.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.2 m -82.12 143.88 31.16 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -178.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.8 p -114.35 148.07 38.17 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.346 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.5 mt -130.16 136.3 49.12 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 175.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 82.9 m -100.63 118.03 35.95 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 176.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 58.18 67.44 2.22 Favored Pre-proline 0 N--CA 1.485 1.318 0 C-N-CA 124.395 1.078 . . . . 0.0 112.282 -178.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -88.24 157.54 6.88 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.776 1.651 . . . . 0.0 112.029 176.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.4 ' O ' HG22 ' A' ' 75' ' ' VAL . 56.5 p -84.79 149.77 25.5 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 175.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.93 -32.83 72.32 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 120.913 0.387 . . . . 0.0 110.318 -178.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -62.11 -49.76 74.6 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.584 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.424 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 19.6 mt-10 -64.89 -42.04 95.12 Favored 'General case' 0 C--O 1.203 -1.386 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.573 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 71' ' ' SER . 89.3 t -57.72 -44.64 86.13 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.633 -179.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -65.86 -44.94 83.92 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.21 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.94 -32.13 72.36 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.214 0.531 . . . . 0.0 111.617 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.435 ' O ' HG13 ' A' ' 82' ' ' ILE . 31.4 mmtp -77.15 -38.14 52.51 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 177.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.6 tp -57.59 -48.26 79.87 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 122.734 0.414 . . . . 0.0 110.061 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.6 m -60.62 -35.64 65.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.724 -176.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -81.86 -39.89 23.24 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.2 pp -75.31 -12.44 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -176.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.069 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.775 177.105 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.45 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -116.57 115.66 26.16 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 176.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.445 ' HB ' ' HB3' ' A' ' 60' ' ' LYS . 6.2 m -102.26 108.36 19.71 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 177.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.3 mt -104.54 132.35 51.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-O 121.285 0.564 . . . . 0.0 110.697 -175.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -93.92 119.96 33.53 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.425 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.8 p -139.06 156.33 47.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.702 -0.226 . . . . 0.0 110.405 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 14' ' ' CYS . 37.5 p -142.57 -178.21 5.66 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.1 p -74.39 -0.79 18.42 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 121.337 0.589 . . . . 0.0 110.646 173.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 4.2 m0 -93.26 6.42 48.14 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 177.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 11' ' ' THR . 6.9 m -91.41 117.1 29.39 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -176.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -122.51 -56.91 0.2 Allowed Glycine 0 N--CA 1.417 -2.583 0 N-CA-C 107.653 -2.179 . . . . 0.0 107.653 170.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -68.48 -18.76 64.47 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 179.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 28.7 m -64.86 -30.46 71.46 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.182 0.515 . . . . 0.0 109.818 178.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 89.2 mt -68.97 -28.37 66.56 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.579 -173.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -63.85 -32.87 74.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.03 0.443 . . . . 0.0 110.836 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.472 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 13.0 tp -84.19 -43.57 14.81 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.374 177.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -55.9 -54.06 49.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.28 -176.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.3 m -63.72 -30.03 71.18 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-O 121.106 0.479 . . . . 0.0 110.973 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.17 -38.68 82.34 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.047 178.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 70.8 mt -69.94 -39.49 76.07 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.788 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 60.5 m -58.55 -43.26 89.27 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-O 121.329 0.585 . . . . 0.0 110.069 174.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.35 -37.77 83.76 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.05 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -79.32 5.8 11.56 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 123.729 0.812 . . . . 0.0 112.712 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 61.84 26.34 15.95 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.81 0.844 . . . . 0.0 111.344 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 76.9 mt -84.89 125.0 40.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 -178.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.29 115.99 26.19 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.488 -176.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -138.35 164.23 29.83 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.328 0.585 . . . . 0.0 111.266 -174.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -127.92 125.94 40.53 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . 0.254 0.0 OUTLIER -100.01 132.78 45.16 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.506 0.67 . . . . 0.0 111.121 178.45 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.0 t -82.7 134.89 25.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -168.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -56.59 -0.69 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 130.544 3.538 . . . . 0.0 114.748 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.5 pt -41.98 -27.87 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 N-CA-C 117.862 2.541 . . . . 0.0 117.862 -163.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -67.92 -13.49 62.2 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 119.529 1.059 . . . . 0.0 113.336 -173.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 -116.17 -4.65 11.92 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 119.916 -0.714 . . . . 0.0 110.479 177.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -128.96 108.77 10.68 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -176.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -52.05 -38.25 56.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 113.577 -1.647 . . . . 0.0 113.818 -176.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.34 -52.38 61.76 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -174.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.426 ' O ' HG22 ' A' ' 46' ' ' VAL . . . -87.0 -26.61 23.69 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.876 -177.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.09 -38.09 87.38 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.351 0.596 . . . . 0.0 110.639 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -72.66 -29.18 63.22 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.152 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -68.39 -29.4 68.08 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.516 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 42' ' ' ALA . 44.9 t -63.66 -32.04 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 121.463 0.649 . . . . 0.0 109.658 177.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.81 -39.93 46.25 Favored Glycine 0 N--CA 1.439 -1.115 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 177.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.2 m -63.79 -29.67 70.85 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.503 0.721 . . . . 0.0 112.331 -178.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.9 m -91.56 -4.86 10.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -116.03 -32.33 5.43 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.55 65.37 0.53 Allowed Glycine 0 N--CA 1.431 -1.651 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.741 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.33 -46.25 2.81 Favored Glycine 0 C--N 1.316 -0.536 0 C-N-CA 121.287 -0.482 . . . . 0.0 112.846 175.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -90.66 154.21 19.74 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -176.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -105.12 82.74 1.88 Allowed 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.48 0.657 . . . . 0.0 109.301 178.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.1 m -74.98 128.08 34.74 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.727 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 1.704 15.3 m -55.23 -88.0 0.0 OUTLIER Pre-proline 0 CA--C 1.447 -2.989 1 N-CA-C 124.219 4.896 . . . . 0.0 124.219 -176.946 . . . . . . . . 3 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -75.88 77.63 3.36 Favored 'Trans proline' 0 N--CA 1.406 -3.672 0 CA-C-N 121.303 1.501 . . . . 0.0 113.251 -167.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.9 m -103.87 130.68 51.48 Favored 'General case' 0 N--CA 1.399 -2.976 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.1 p -114.74 131.96 65.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-O 121.228 0.537 . . . . 0.0 110.095 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.445 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 26.1 ttpp -104.95 119.97 40.3 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 174.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -89.98 168.06 12.31 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.257 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.46 -10.3 57.45 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.329 175.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -71.06 -19.26 62.5 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.252 178.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.53 -22.21 41.68 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -178.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.2 m -82.09 149.96 27.77 Favored 'General case' 0 C--O 1.255 1.383 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.3 p -114.15 139.32 49.44 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.3 mp -117.67 115.89 25.96 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 51.4 m -87.75 112.01 21.95 Favored 'General case' 0 N--CA 1.411 -2.41 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.207 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 54.89 70.88 1.46 Allowed Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 124.673 1.189 . . . . 0.0 112.548 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -94.21 -175.94 0.46 Allowed 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.501 2.134 . . . . 0.0 110.337 173.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.418 ' O ' HG21 ' A' ' 75' ' ' VAL . 10.3 t -100.16 163.4 12.43 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.31 97.36 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 123.199 0.599 . . . . 0.0 112.125 -175.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -60.82 -37.13 80.96 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.927 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -69.91 -41.11 75.11 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.833 -179.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.418 HG21 ' O ' ' A' ' 71' ' ' SER . 98.0 t -59.54 -42.3 87.59 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.562 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 177.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -61.25 -44.0 97.96 Favored 'General case' 0 CA--C 1.556 1.196 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.922 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.02 -24.28 58.34 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.141 0.496 . . . . 0.0 112.227 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -84.86 -25.15 28.22 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 174.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.4 tp -68.87 -40.73 79.14 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.3 m -61.78 -32.98 55.58 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.83 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.325 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -81.04 -30.34 34.87 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.651 -0.82 . . . . 0.0 111.077 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.9 pp -85.46 -32.06 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.204 -175.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.229 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.378 178.928 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.371 0 CA-C-O 121.156 0.503 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -131.82 135.48 46.76 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.939 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.7 m -108.27 124.98 51.14 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 177.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 62.0 mt -113.33 134.56 55.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-O 121.348 0.594 . . . . 0.0 110.556 -176.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.434 ' CD1' HG23 ' A' ' 46' ' ' VAL . 97.3 m-85 -85.83 128.07 34.72 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.43 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 13.7 p -139.19 147.94 42.49 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -176.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 50.9 m -148.88 142.84 25.8 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 171.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.7 p -70.81 -4.39 23.85 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -172.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -39.23 94.1 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 122.553 1.168 . . . . 0.0 111.493 178.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.1 t -93.98 132.65 38.23 Favored 'General case' 0 N--CA 1.42 -1.942 0 CA-C-N 113.491 -1.686 . . . . 0.0 112.754 -169.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -92.74 -35.81 6.33 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.041 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -63.18 -36.35 83.33 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.442 0.639 . . . . 0.0 110.833 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.735 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 62.2 m -57.12 -42.05 80.16 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.257 177.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.3 tt -72.12 -30.21 64.84 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.189 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.3 tpp180 -62.9 -47.27 84.01 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.063 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.43 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 29.7 tp -73.48 -39.04 65.18 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.008 178.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -55.34 -47.45 75.68 Favored 'General case' 0 C--O 1.245 0.861 0 C-N-CA 124.05 0.94 . . . . 0.0 110.639 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 p -69.88 -35.06 74.36 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.573 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.32 -44.94 96.36 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 177.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 87.9 mt -63.71 -39.4 94.21 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.425 178.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.6 m -64.93 -43.55 92.4 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.222 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.2 -22.95 66.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.28 0.562 . . . . 0.0 110.91 178.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -95.34 11.41 32.76 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.34 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 65.97 16.09 10.33 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.834 1.254 . . . . 0.0 111.016 175.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 77.5 mt -78.81 122.64 34.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.654 -0.654 . . . . 0.0 109.262 -179.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.86 129.56 38.74 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.867 -178.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -142.89 161.13 38.91 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.527 -175.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -119.77 124.07 45.27 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 176.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 13.0 pt-20 -91.94 146.08 24.03 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -178.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 t -85.57 156.23 3.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.867 -175.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -83.0 0.3 45.36 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 127.101 2.16 . . . . 0.0 113.683 -176.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.6 pt -42.95 -29.91 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 -168.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -61.14 -33.76 73.92 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.509 0.671 . . . . 0.0 110.186 -179.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -123.74 24.0 8.56 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.026 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -148.91 100.88 3.12 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.244 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -67.66 -21.03 65.38 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.73 -43.31 84.57 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -176.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.47 -20.74 31.24 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.932 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.9 -38.16 90.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.175 178.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -58.06 -39.84 79.48 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.364 174.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -68.83 -29.19 67.47 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.027 -175.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.434 HG23 ' CD1' ' A' ' 9' ' ' TYR . 58.2 t -63.2 -43.59 98.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 177.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.97 -18.88 77.99 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.469 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.7 t -82.43 -30.42 30.11 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 120.6 0.238 . . . . 0.0 110.398 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.7 m -81.75 -37.0 14.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.963 178.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -119.17 87.0 2.65 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 122.439 1.114 . . . . 0.0 109.075 172.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -49.51 118.37 5.37 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 113.293 -1.776 . . . . 0.0 115.566 -170.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.4 -20.72 49.34 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 121.366 -0.445 . . . . 0.0 114.117 175.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -126.74 171.44 11.19 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 117.71 0.755 . . . . 0.0 109.344 -177.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -122.32 70.28 0.98 Allowed 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 170.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.1 m -72.08 122.88 21.69 Favored 'General case' 0 C--O 1.248 1.02 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.69 ' HB ' ' SG ' ' A' ' 17' ' ' CYS . 9.4 t -69.36 -65.85 1.11 Allowed Pre-proline 0 CA--C 1.47 -2.126 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -170.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.735 ' HD3' ' SG ' ' A' ' 17' ' ' CYS . 43.9 Cg_endo -77.04 72.31 5.91 Favored 'Trans proline' 0 N--CA 1.403 -3.827 0 CA-C-N 121.755 1.662 . . . . 0.0 112.744 -167.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.429 ' O ' ' HD2' ' A' ' 9' ' ' TYR . 81.6 m -107.72 131.45 54.41 Favored 'General case' 1 N--CA 1.366 -4.637 0 CA-C-N 112.97 -1.923 . . . . 0.0 106.422 179.819 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.2 p -115.43 134.52 58.34 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.366 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.745 -178.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -112.65 119.28 37.56 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 175.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -88.66 159.44 17.84 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.95 -20.5 38.16 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.525 0.679 . . . . 0.0 111.289 177.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -67.68 -18.55 64.97 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.573 1.149 . . . . 0.0 111.22 177.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.95 -9.17 59.82 Favored Glycine 0 CA--C 1.503 -0.695 0 N-CA-C 111.466 -0.653 . . . . 0.0 111.466 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.8 p -81.07 136.03 35.9 Favored 'General case' 0 N--CA 1.412 -2.338 0 CA-C-N 114.948 -0.626 . . . . 0.0 111.088 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.2 p -114.04 137.93 51.06 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 177.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.3 mp -127.43 128.18 45.35 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 61.5 m -105.35 123.88 48.61 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 55.41 54.23 9.43 Favored Pre-proline 0 N--CA 1.477 0.917 0 C-N-CA 124.258 1.023 . . . . 0.0 113.117 -177.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -83.27 166.48 14.23 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.629 1.553 . . . . 0.0 111.235 178.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.4 m -87.38 155.55 19.98 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 175.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.29 -37.01 83.89 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.924 0.392 . . . . 0.0 111.328 -177.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -64.71 -34.88 79.36 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.885 178.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -67.04 -44.37 80.38 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.1 t -61.01 -45.48 98.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.835 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -58.37 -48.87 79.23 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.185 178.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.33 -22.35 62.81 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.89 0.376 . . . . 0.0 111.92 -178.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.474 ' O ' HG13 ' A' ' 82' ' ' ILE . 47.6 mmtm -80.89 -43.31 20.05 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 39.9 tp -54.3 -48.49 71.24 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.82 0.7 . . . . 0.0 110.475 -176.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.0 m -59.4 -41.31 84.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.135 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -81.36 -38.28 26.88 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -176.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 78' ' ' LYS 0.255 2.5 pp -81.44 -37.4 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -176.886 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.454 ' N ' HD11 ' A' ' 82' ' ' ILE . . . . . . . . 0 C--N 1.321 -0.671 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.892 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 N--CA 1.451 -0.399 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.3 p -78.93 100.15 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 122.0 0.905 . . . . 0.0 109.495 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.6 m -73.87 105.9 5.35 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.091 -0.958 . . . . 0.0 112.086 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -84.98 99.94 11.32 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.595 177.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.02 -0.87 57.33 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.963 -176.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.6 mt -111.54 129.23 56.12 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.975 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.2 m -103.56 107.95 19.01 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 173.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 57.8 mt -107.27 133.07 53.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 121.059 0.457 . . . . 0.0 109.775 -176.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.441 ' HD1' ' O ' ' A' ' 58' ' ' THR . 89.5 m-85 -87.16 128.18 35.13 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.458 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 21.1 p -140.29 163.93 31.45 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.581 0.229 . . . . 0.0 111.329 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.1 p -146.11 166.51 25.94 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 124.927 1.291 . . . . 0.0 107.795 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.0 t -74.78 -21.86 59.08 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 173.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -81.86 80.46 8.15 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 177.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.8 t -132.94 164.7 26.37 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.436 0.636 . . . . 0.0 112.439 -168.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -167.85 -81.34 0.05 OUTLIER Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 177.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.47 -31.75 68.11 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 123.891 0.876 . . . . 0.0 112.551 177.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.406 ' HA ' ' HB3' ' A' ' 57' ' ' PRO . 0.5 OUTLIER -64.49 -36.99 85.99 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.547 178.08 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 32.2 tp -68.04 -31.88 71.85 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.069 -176.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.9 mmp_? -58.28 -56.13 26.09 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.9 tp -65.09 -39.0 92.55 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.425 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -60.98 -35.94 78.13 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.76 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.9 m -70.51 -44.6 67.26 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.46 -46.33 89.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.898 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.7 mt -68.05 -37.48 81.38 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.4 m -67.12 -40.85 86.87 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 121.007 0.432 . . . . 0.0 110.179 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.65 -25.4 63.9 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.55 0.69 . . . . 0.0 110.94 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -88.25 6.9 34.69 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.983 178.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 72.9 mtm180 65.34 29.12 11.66 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.475 1.11 . . . . 0.0 111.924 176.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 80.2 mt -91.69 123.41 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.707 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.41 126.26 34.77 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.356 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -136.46 156.67 48.28 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.722 -177.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -118.6 114.85 23.42 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.503 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 16.4 pt-20 -91.12 144.82 25.23 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.217 0.532 . . . . 0.0 110.796 -177.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.6 t -89.53 152.86 3.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-O 122.07 0.938 . . . . 0.0 112.48 -172.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -82.76 2.27 34.75 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 127.944 2.498 . . . . 0.0 114.3 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.1 pt -41.56 -26.79 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.835 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 -167.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -61.83 -41.61 98.0 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.738 0.78 . . . . 0.0 109.131 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -100.66 -36.95 8.96 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.313 -178.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -90.92 99.85 12.81 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.26 -178.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -65.04 -38.37 90.64 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -171.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.56 -29.14 70.44 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -174.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.01 -23.42 25.0 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.382 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.67 -39.55 80.57 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.172 0.51 . . . . 0.0 110.117 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.444 ' CD ' HH22 ' A' ' 54' ' ' ARG . 19.2 mm-40 -67.02 -32.26 73.35 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.007 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -67.61 -30.14 69.66 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.756 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.7 t -62.38 -42.93 97.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 53' ' ' ASN . . . -60.55 -34.4 85.71 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.337 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.4 m -68.53 -48.13 65.13 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 122.872 0.469 . . . . 0.0 111.535 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.2 m -73.99 -27.6 22.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -176.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.41 ' HB2' ' O ' ' A' ' 53' ' ' ASN . 15.4 m120 -87.95 -28.74 21.28 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.128 177.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.15 65.27 1.07 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.364 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.79 -12.43 68.81 Favored Glycine 0 C--N 1.315 -0.609 0 C-N-CA 121.234 -0.507 . . . . 0.0 112.485 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.47 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 93.2 m-20 -111.91 161.38 16.47 Favored 'General case' 0 CA--C 1.486 -1.504 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.444 HH22 ' CD ' ' A' ' 44' ' ' GLU . 84.4 mtt180 -127.64 84.09 2.22 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 173.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.4 m -85.64 132.49 34.15 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.439 ' CG1' ' HA ' ' A' ' 10' ' ' THR . 21.3 t -66.42 -67.12 1.02 Allowed Pre-proline 0 CA--C 1.472 -2.057 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -173.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.406 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . 91.7 Cg_endo -81.15 60.47 7.82 Favored 'Trans proline' 1 N--CA 1.399 -4.073 0 CA-C-N 121.115 1.434 . . . . 0.0 112.915 -164.599 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.441 ' O ' ' HD1' ' A' ' 9' ' ' TYR . 53.6 m -91.23 127.08 36.52 Favored 'General case' 1 N--CA 1.377 -4.075 0 C-N-CA 126.363 1.865 . . . . 0.0 106.731 177.922 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.0 p -115.19 132.73 63.62 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 CA-C-O 120.916 0.389 . . . . 0.0 110.172 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -115.01 126.91 55.29 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 174.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -88.94 173.81 8.28 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.389 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.09 -10.17 47.22 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.978 0.894 . . . . 0.0 109.727 174.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -78.63 -18.64 54.17 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.271 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.02 -22.12 41.33 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.778 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.8 t -75.2 149.79 38.84 Favored 'General case' 0 C--O 1.253 1.284 0 CA-C-O 120.868 0.366 . . . . 0.0 110.61 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.2 p -114.5 139.73 49.31 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.069 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 58.1 mt -119.83 113.91 21.31 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 174.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.8 m -87.22 112.83 22.39 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 58.04 65.43 3.26 Favored Pre-proline 0 N--CA 1.487 1.42 0 C-N-CA 123.939 0.896 . . . . 0.0 112.366 -177.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -86.22 172.93 6.99 Favored 'Trans proline' 0 C--O 1.249 1.073 0 C-N-CA 121.955 1.77 . . . . 0.0 112.003 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.3 m -93.78 153.3 18.38 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 174.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.71 -36.23 83.17 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.111 0.481 . . . . 0.0 110.708 -177.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -59.31 -45.72 90.54 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.974 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -60.02 -50.53 73.36 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.871 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.9 t -58.21 -45.82 88.79 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.519 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.982 -177.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -67.15 -38.13 84.95 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.335 -178.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.55 -31.02 61.96 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.247 0.546 . . . . 0.0 110.869 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -76.59 -37.64 56.14 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.894 175.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.6 tp -58.38 -51.05 71.46 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.6 m -60.49 -32.12 50.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.669 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -81.8 -40.8 22.03 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 119.869 -0.732 . . . . 0.0 112.016 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.3 pp -76.1 -24.43 16.4 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.426 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -176.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.77 -32.73 16.01 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 176.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.49 29.35 69.97 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.3 tp -146.2 153.65 40.86 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 64.03 21.72 12.69 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-O 122.095 0.95 . . . . 0.0 109.736 -176.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -90.2 -33.03 16.35 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.343 -174.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 66.9 t60 . . . . . 0 N--CA 1.428 -1.557 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 -177.73 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mmm . . . . . 0 CA--C 1.515 -0.396 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.9 m -74.28 -12.16 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.2 m 65.1 44.61 3.3 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-O 122.282 1.039 . . . . 0.0 109.475 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -81.39 92.62 6.45 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.774 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.5 1.1 54.46 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.737 -177.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.6 tp -129.51 136.74 50.23 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 89.6 m -123.34 122.16 37.62 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 67.4 mt -111.85 133.49 57.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 121.298 0.571 . . . . 0.0 110.205 -177.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -87.95 129.39 35.26 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.047 176.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.5 p -134.03 166.04 23.64 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.607 -178.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.3 m -149.84 144.08 25.75 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.5 m -54.98 -44.42 74.43 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 123.435 0.459 . . . . 0.0 110.887 176.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 36.5 p90 -86.75 89.17 7.86 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 122.09 0.948 . . . . 0.0 109.459 175.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.1 t -163.57 154.68 16.47 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.072 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -135.89 -44.73 0.1 OUTLIER Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 177.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -63.6 -33.48 75.71 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.131 0.572 . . . . 0.0 111.38 -176.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.415 ' HA ' ' HB3' ' A' ' 57' ' ' PRO . 10.7 p -65.41 -34.48 78.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.28 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 87.9 mt -61.85 -41.94 98.43 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 115.872 -0.603 . . . . 0.0 112.019 -175.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.5 tpm_? -59.11 -44.81 92.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.968 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.9 tp -76.37 -38.64 55.51 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.648 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.461 ' HG2' ' OH ' ' A' ' 31' ' ' TYR . 16.4 ttpp -63.14 -43.46 98.29 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.548 -176.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.2 t -71.12 -28.18 64.11 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.34 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.35 -41.87 84.42 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.107 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.7 mt -69.6 -35.22 75.11 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.76 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.6 m -65.95 -42.93 89.37 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.0 -31.67 72.39 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-O 121.416 0.626 . . . . 0.0 110.458 176.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.42 0.44 29.31 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.274 176.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 69.02 28.26 5.15 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.071 1.349 . . . . 0.0 112.176 174.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 74.7 mt -87.64 123.05 40.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.326 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.92 117.36 22.71 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.681 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.461 ' OH ' ' HG2' ' A' ' 21' ' ' LYS . 46.4 p90 -136.53 164.0 29.2 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -119.85 138.85 53.14 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 171.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 6.7 pt-20 -101.7 137.97 39.31 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -177.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -94.43 138.57 20.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -169.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -60.9 2.13 0.12 Allowed 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 130.186 3.394 . . . . 0.0 116.074 176.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.2 pt -41.3 -27.86 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.519 3.001 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 -162.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -68.97 -24.29 64.22 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 119.552 1.069 . . . . 0.0 110.856 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -113.02 8.63 18.49 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -142.85 89.98 2.17 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-O 121.471 0.653 . . . . 0.0 109.837 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -65.82 -29.23 69.67 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.731 -1.122 . . . . 0.0 113.7 -173.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.81 -37.32 76.12 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.348 0.594 . . . . 0.0 111.303 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.53 ' O ' HG21 ' A' ' 46' ' ' VAL . . . -87.1 -30.38 21.15 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.129 177.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.67 -42.99 94.99 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.108 0.48 . . . . 0.0 111.508 -178.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -68.91 -29.34 67.59 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.182 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -68.04 -40.64 82.84 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.265 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.53 HG21 ' O ' ' A' ' 42' ' ' ALA . 73.8 t -52.85 -51.04 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.568 177.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.47 -32.23 83.46 Favored Glycine 0 N--CA 1.437 -1.288 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.319 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.8 t -65.48 -33.73 76.61 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 122.272 0.229 . . . . 0.0 110.996 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.3 m -95.1 -10.0 9.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -178.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -96.29 -51.35 4.42 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.004 0.431 . . . . 0.0 110.018 177.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 133.13 -138.66 10.3 Favored Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 -176.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.99 -21.65 62.73 Favored Glycine 0 C--N 1.306 -1.111 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -101.53 115.07 29.69 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -71.54 114.75 9.95 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 177.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.1 m -99.02 134.5 41.77 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.0 t -75.3 -64.52 0.58 Allowed Pre-proline 0 CA--C 1.463 -2.379 0 CA-C-O 117.23 -1.367 . . . . 0.0 113.98 -176.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.415 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . 82.9 Cg_endo -78.78 65.9 8.7 Favored 'Trans proline' 1 N--CA 1.399 -4.076 0 CA-C-N 121.261 1.486 . . . . 0.0 113.029 -167.067 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 96.3 m -92.32 121.37 33.75 Favored 'General case' 1 N--CA 1.376 -4.169 0 CA-C-N 113.146 -1.843 . . . . 0.0 106.051 178.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 66' ' ' THR . 12.7 p -105.61 137.85 33.48 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.998 -178.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -116.44 121.04 40.72 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -85.31 161.64 19.43 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.928 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -49.69 -32.52 13.56 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -175.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -90.58 -6.75 54.28 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.5 -176.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.6 1.88 30.78 Favored Glycine 0 C--O 1.241 0.551 0 C-N-CA 120.113 -1.041 . . . . 0.0 113.773 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.5 m -73.33 125.49 27.94 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 117.294 0.547 . . . . 0.0 109.651 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 49.5 p -114.2 138.36 50.56 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.9 mp -122.59 118.53 28.42 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 61.2 m -88.05 112.31 22.5 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.11 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 58.86 67.67 1.94 Allowed Pre-proline 0 N--CA 1.482 1.148 0 C-N-CA 124.057 0.943 . . . . 0.0 112.883 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -86.79 -174.73 1.47 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.006 1.804 . . . . 0.0 112.227 176.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.414 ' O ' HG22 ' A' ' 75' ' ' VAL . 50.5 m -116.87 150.41 38.47 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 176.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.78 -48.93 72.07 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -174.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -71.9 -24.2 61.61 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 120.639 0.257 . . . . 0.0 111.665 -176.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.552 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 38.1 mm-40 -71.77 -46.6 57.85 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 173.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 71' ' ' SER . 89.1 t -59.98 -44.12 93.95 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 O-C-N 123.842 0.714 . . . . 0.0 110.113 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -62.24 -44.46 96.51 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.652 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.72 -21.17 63.49 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.195 0.522 . . . . 0.0 111.538 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.591 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 46.8 mmtm -84.5 -38.92 19.49 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 175.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.9 tp -56.9 -49.01 76.86 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.767 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.1 m -61.33 -34.1 59.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.152 -177.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.591 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -81.76 -32.66 31.36 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.588 -179.079 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.2 pp -82.21 -12.52 12.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.136 0.493 . . . . 0.0 111.673 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -91.57 4.08 53.47 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.394 0.616 . . . . 0.0 110.545 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 85.14 -120.06 5.21 Favored Glycine 0 N--CA 1.431 -1.669 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.565 178.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 24.5 tp -106.03 0.77 25.89 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.348 0.594 . . . . 0.0 109.557 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -85.2 94.85 8.99 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.38 0.609 . . . . 0.0 111.05 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -95.55 -29.46 14.34 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.126 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 . . . . . 0 C--N 1.313 -0.979 0 CA-C-O 118.951 -0.547 . . . . 0.0 110.494 -171.517 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mpp? . . . . . 0 CA--C 1.518 -0.255 0 CA-C-O 120.583 0.23 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p -116.51 98.53 6.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 122.166 0.984 . . . . 0.0 111.218 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.7 t -109.31 173.66 6.22 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.123 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.51 89.31 2.7 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.567 0.699 . . . . 0.0 110.355 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -96.32 0.68 51.09 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.775 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.9 mt -119.83 137.99 53.65 Favored 'General case' 0 CA--C 1.489 -1.377 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.951 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.4 m -106.91 113.95 27.74 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 174.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 51.9 mt -112.19 125.97 69.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-O 121.473 0.654 . . . . 0.0 110.094 -177.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -80.97 128.14 33.35 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.98 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.483 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 7.4 p -140.85 178.16 7.54 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.056 0.543 . . . . 0.0 111.747 -174.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.52 ' HB ' ' O ' ' A' ' 13' ' ' TRP . 27.4 m -156.42 158.81 37.96 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 177.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.7 m -64.8 -51.62 61.22 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 175.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.52 ' O ' ' HB ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -64.62 109.04 1.87 Allowed 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 168.068 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.0 t -159.44 130.6 6.04 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.465 -170.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -120.97 -78.56 0.51 Allowed Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -66.71 -33.88 76.63 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 120.915 0.388 . . . . 0.0 110.371 -177.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -57.56 -38.57 75.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.984 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -67.82 -35.09 77.99 Favored 'General case' 0 C--O 1.245 0.824 0 C-N-CA 123.675 0.79 . . . . 0.0 109.979 -175.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -62.29 -51.69 66.68 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.216 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.444 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 24.8 tp -68.26 -38.78 82.1 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.072 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -59.16 -43.91 92.09 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.616 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.2 m -68.7 -37.81 79.81 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.273 178.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.61 -42.17 98.25 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.875 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 78.6 mt -68.21 -39.53 82.37 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.623 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.5 m -65.35 -35.86 82.27 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-O 121.446 0.641 . . . . 0.0 109.987 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.2 -26.03 61.89 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-O 121.326 0.584 . . . . 0.0 111.19 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -93.25 11.52 27.76 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.877 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 64.93 25.2 12.75 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.275 1.03 . . . . 0.0 112.394 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 82.0 mt -89.95 116.13 30.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.47 128.82 36.01 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.003 -177.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -137.82 168.96 18.63 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.519 -177.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -119.71 121.54 39.45 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.483 ' HB2' ' OG1' ' A' ' 10' ' ' THR . 12.5 pt-20 -91.81 136.72 32.93 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-O 121.081 0.467 . . . . 0.0 110.408 -178.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.2 t -93.57 156.41 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 -168.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -77.09 -0.47 24.9 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 128.201 2.601 . . . . 0.0 113.866 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.3 pt -44.68 -21.37 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 N-CA-C 116.398 1.999 . . . . 0.0 116.398 -171.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -56.97 -52.65 64.38 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-N 118.834 0.743 . . . . 0.0 109.572 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -97.58 -36.86 10.16 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.136 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.416 ' ND2' ' H ' ' A' ' 42' ' ' ALA . 52.2 t30 -71.12 108.15 4.51 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 120.727 0.299 . . . . 0.0 111.013 -177.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.64 -22.14 57.07 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.316 -177.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.37 -44.95 67.03 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -177.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.416 ' H ' ' ND2' ' A' ' 39' ' ' ASN . . . -79.87 -24.85 40.94 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.01 177.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.68 -30.2 69.67 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.253 0.549 . . . . 0.0 109.756 177.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -68.77 -33.94 74.73 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.298 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -63.12 -44.1 96.57 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.6 t -60.76 -47.52 92.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.759 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.72 -21.61 69.32 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.545 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.6 m -83.21 -43.59 15.95 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 176.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.8 p -73.54 -33.14 38.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -176.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -118.63 154.75 32.16 Favored 'General case' 0 C--N 1.316 -0.849 0 O-C-N 121.893 -0.504 . . . . 0.0 109.948 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -113.25 156.09 15.85 Favored Glycine 0 N--CA 1.438 -1.212 0 C-N-CA 120.274 -0.965 . . . . 0.0 113.031 -175.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.14 -104.4 1.41 Allowed Glycine 0 N--CA 1.44 -1.085 0 O-C-N 123.866 0.392 . . . . 0.0 113.014 177.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -81.72 119.29 23.66 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -56.91 109.35 0.63 Allowed 'General case' 0 CA--C 1.516 -0.33 0 O-C-N 124.142 0.901 . . . . 0.0 109.348 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.6 m -81.27 123.65 28.67 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.6 t -75.19 -62.32 0.86 Allowed Pre-proline 0 CA--C 1.469 -2.154 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.087 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -79.16 73.41 6.04 Favored 'Trans proline' 1 N--CA 1.397 -4.176 0 CA-C-N 120.604 1.252 . . . . 0.0 112.609 -164.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.5 m -101.92 120.88 41.1 Favored 'General case' 1 N--CA 1.377 -4.116 0 CA-C-N 112.709 -2.041 . . . . 0.0 106.438 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.1 p -113.46 132.61 61.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-O 120.996 0.427 . . . . 0.0 110.882 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -110.22 126.1 53.78 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -92.08 174.07 7.51 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.432 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.25 -18.23 63.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.819 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -73.57 -18.03 61.12 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.19 0.519 . . . . 0.0 110.152 176.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.34 -12.85 64.95 Favored Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -176.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.2 p -75.28 145.71 41.64 Favored 'General case' 0 N--CA 1.421 -1.906 0 C-N-CA 123.211 0.605 . . . . 0.0 111.201 -178.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.6 p -114.1 139.16 49.55 Favored 'General case' 0 N--CA 1.419 -2.002 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.913 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.8 mp -117.05 123.87 47.88 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.2 m -100.82 112.62 25.08 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.894 -176.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 58.65 60.78 5.29 Favored Pre-proline 0 N--CA 1.492 1.668 0 C-N-CA 124.45 1.1 . . . . 0.0 112.906 -176.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -85.48 177.0 5.27 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.102 1.868 . . . . 0.0 111.696 176.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 41.7 m -110.99 151.42 27.98 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.79 -34.77 63.11 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -174.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -64.01 -37.25 86.73 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 122.287 0.235 . . . . 0.0 111.192 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -73.53 -42.16 62.1 Favored 'General case' 0 CA--C 1.489 -1.38 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.618 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 54.5 t -60.44 -40.8 85.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.807 -176.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -66.48 -45.13 80.67 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.866 0.365 . . . . 0.0 110.789 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.9 -35.82 74.9 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.541 0.686 . . . . 0.0 111.4 -177.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -78.13 -22.39 48.91 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 122.064 -0.397 . . . . 0.0 110.304 177.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.436 ' O ' HG13 ' A' ' 82' ' ' ILE . 26.0 tp -71.66 -46.5 58.74 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.7 m -64.94 -28.78 45.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -75.8 -29.46 58.73 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.869 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 79' ' ' LEU . 2.1 pp -85.69 -16.62 9.88 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 CA-C-O 121.443 0.64 . . . . 0.0 111.382 -176.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.11 -25.02 43.01 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.443 178.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 113.29 -156.92 15.29 Favored Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.3 mt -94.3 79.37 3.95 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.648 0.737 . . . . 0.0 110.756 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -102.94 -52.12 3.12 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 177.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 -91.66 78.24 5.55 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.446 175.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 . . . . . 0 C--N 1.296 -1.737 0 CA-C-O 118.1 -0.952 . . . . 0.0 108.462 -177.626 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.4 mtm . . . . . 0 CA--C 1.509 -0.633 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.7 p -141.82 147.29 21.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.5 p -70.05 94.39 0.87 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.263 0.554 . . . . 0.0 110.535 178.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -120.13 124.42 45.73 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.853 -177.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -103.55 1.43 32.2 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.617 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.1 tp -117.94 136.86 53.22 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.309 -176.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.468 ' HB ' ' HB3' ' A' ' 60' ' ' LYS . 22.4 m -110.65 117.82 34.54 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 53.1 mt -119.98 143.53 31.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -98.64 127.76 44.68 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.402 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 25.4 p -137.31 178.52 7.03 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 122.093 0.949 . . . . 0.0 113.459 -174.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.1 m -143.91 147.65 34.3 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 104.181 -2.526 . . . . 0.0 104.181 173.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.5 m -61.15 -43.2 99.25 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.352 0.596 . . . . 0.0 109.897 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 40.7 p90 -92.7 93.37 8.43 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-O 121.808 0.813 . . . . 0.0 111.177 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.9 t -163.3 117.31 1.61 Allowed 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.387 176.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.79 -32.16 13.64 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 111.219 -0.753 . . . . 0.0 111.219 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -68.96 -27.71 65.98 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.721 0.772 . . . . 0.0 109.666 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.448 ' SG ' ' HB ' ' A' ' 56' ' ' VAL . 70.5 m -71.77 -29.88 64.97 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.118 178.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 82.7 mt -70.43 -30.15 66.94 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.285 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -56.62 -44.16 80.94 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.247 177.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.409 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 28.7 tp -79.33 -41.09 28.71 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.623 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -56.76 -45.13 82.24 Favored 'General case' 0 C--O 1.247 0.941 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.6 m -64.04 -38.46 91.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.795 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.16 -44.08 80.65 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.421 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 57.3 mt -69.5 -42.31 74.93 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.445 -178.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.8 m -68.92 -23.51 64.18 Favored 'General case' 0 CA--C 1.56 1.352 0 CA-C-O 121.421 0.629 . . . . 0.0 110.651 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.87 -12.93 57.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.294 0.569 . . . . 0.0 110.482 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -109.39 14.17 23.78 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.27 -178.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.9 ttm180 55.14 62.07 2.65 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.403 1.081 . . . . 0.0 111.079 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 75.8 mt -122.78 115.88 47.18 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.046 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.17 111.97 22.21 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -116.38 144.59 44.08 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.577 -177.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -113.74 119.78 38.55 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.501 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 12.8 pt-20 -95.51 148.13 22.82 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.881 -176.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.417 ' CG1' HG21 ' A' ' 36' ' ' ILE . 25.1 t -96.69 144.88 9.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -172.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -58.63 -1.77 0.17 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 128.714 2.806 . . . . 0.0 114.05 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.417 HG21 ' CG1' ' A' ' 34' ' ' VAL . 2.0 pp -45.24 -20.96 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 -172.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -54.41 -48.84 71.16 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.137 0.494 . . . . 0.0 110.039 174.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -111.46 -29.67 7.69 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.795 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -77.67 103.25 7.5 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.552 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 8.7 ptm180 -71.88 -25.78 62.07 Favored 'General case' 0 C--O 1.21 -0.997 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.935 -178.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.56 -42.62 88.36 Favored 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 113.504 0.928 . . . . 0.0 113.504 -176.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.93 -21.0 26.54 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.694 -0.802 . . . . 0.0 109.956 177.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.4 -33.39 74.16 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.214 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.552 ' HG2' ' O ' ' A' ' 40' ' ' ARG . 61.4 mm-40 -61.56 -36.71 81.4 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.034 178.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -66.9 -37.11 83.76 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.119 0.485 . . . . 0.0 109.979 178.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.2 t -64.0 -42.6 96.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.607 0.718 . . . . 0.0 109.129 177.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.51 -18.96 72.33 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.348 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.3 m -81.42 -38.67 26.11 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.7 m -80.02 -35.11 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -83.65 137.1 33.95 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 176.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -98.89 139.15 14.29 Favored Glycine 0 C--N 1.301 -1.382 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.128 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.53 -87.37 1.03 Allowed Glycine 0 C--N 1.313 -0.731 0 C-N-CA 121.186 -0.53 . . . . 0.0 111.827 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -119.18 145.39 46.05 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -60.95 130.98 49.14 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.664 0.603 . . . . 0.0 111.064 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.7 m -108.55 127.68 54.16 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 177.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.448 ' HB ' ' SG ' ' A' ' 17' ' ' CYS . 8.1 t -73.75 -64.86 0.7 Allowed Pre-proline 0 CA--C 1.468 -2.178 0 CA-C-O 117.091 -1.433 . . . . 0.0 114.245 -171.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -73.75 80.57 2.03 Favored 'Trans proline' 1 N--CA 1.4 -4.018 0 CA-C-N 121.089 1.425 . . . . 0.0 112.65 -168.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 86.8 m -115.02 131.74 56.83 Favored 'General case' 0 N--CA 1.389 -3.503 0 CA-C-N 113.355 -1.748 . . . . 0.0 106.644 -177.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.69 142.91 29.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-O 120.844 0.354 . . . . 0.0 110.909 -175.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.468 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 77.5 tttt -116.28 130.7 56.91 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 177.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -104.58 177.86 4.73 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.02 -14.15 52.02 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.471 0.653 . . . . 0.0 110.543 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -67.32 -19.39 65.45 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.208 1.003 . . . . 0.0 110.33 176.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 92.71 -22.4 33.79 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.9 -0.591 . . . . 0.0 113.061 177.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.4 t -91.57 165.34 13.39 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.1 p -114.52 140.54 48.66 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.208 -177.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.9 mp -107.97 121.98 45.89 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 174.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.8 m -98.48 114.55 26.99 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.226 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.3 m120 61.21 61.82 2.83 Favored Pre-proline 0 N--CA 1.481 1.094 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -178.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -91.35 174.04 2.58 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.17 1.913 . . . . 0.0 110.369 176.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.432 ' O ' HG21 ' A' ' 75' ' ' VAL . 6.2 m -89.6 151.29 21.99 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 176.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.63 -37.95 80.01 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 123.186 0.304 . . . . 0.0 110.756 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -57.47 -43.62 84.17 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.108 177.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.516 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 47.3 mt-10 -68.38 -44.76 74.43 Favored 'General case' 0 C--O 1.207 -1.145 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.972 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.432 HG21 ' O ' ' A' ' 71' ' ' SER . 59.5 t -60.16 -43.14 92.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 O-C-N 123.252 0.345 . . . . 0.0 110.531 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -64.21 -44.71 91.09 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.27 -34.99 78.58 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.081 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 75.5 mmtt -75.07 -36.82 61.74 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 176.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 14.5 tp -61.62 -52.35 64.73 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.543 ' HB ' ' O ' ' A' ' 86' ' ' GLU . 35.5 m -61.93 -35.54 68.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.7 ptpp? -72.87 -34.1 66.51 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.304 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.1 pp -83.89 -29.71 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.056 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.77 -42.76 27.14 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 120.803 0.335 . . . . 0.0 110.591 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.91 -44.98 3.16 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 114.55 0.58 . . . . 0.0 114.55 175.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -73.5 -4.13 31.92 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -173.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.543 ' O ' ' HB ' ' A' ' 80' ' ' VAL . 40.4 tt0 -143.07 154.32 43.83 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.431 ' HA ' ' HB ' ' A' ' 80' ' ' VAL . 44.6 t-80 -139.19 -68.91 0.43 Allowed 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 172.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 . . . . . 0 C--O 1.243 0.759 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.767 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.7 ttp . . . . . 0 N--CA 1.471 0.607 0 CA-C-O 120.745 0.307 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.6 p -117.02 97.43 5.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-O 121.581 0.705 . . . . 0.0 109.543 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.8 m 74.07 -35.78 0.32 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.569 1.147 . . . . 0.0 111.683 -177.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.32 133.76 38.69 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 176.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.09 -18.78 63.27 Favored 'General case' 0 C--O 1.246 0.87 0 C-N-CA 123.212 0.605 . . . . 0.0 112.109 -176.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.6 mp -109.48 141.23 42.2 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.558 0.694 . . . . 0.0 111.901 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.7 m -125.82 108.32 11.36 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 105.707 -1.961 . . . . 0.0 105.707 171.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.44 HG21 HG23 ' A' ' 10' ' ' THR . 62.4 mt -108.89 135.23 48.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 CA-C-O 121.943 0.878 . . . . 0.0 111.445 -173.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.419 ' CD1' HG22 ' A' ' 46' ' ' VAL . 98.9 m-85 -90.22 111.32 22.45 Favored 'General case' 0 C--N 1.28 -2.431 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.453 178.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.44 HG23 HG21 ' A' ' 8' ' ' ILE . 6.9 p -137.31 144.33 42.56 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.169 0.509 . . . . 0.0 112.215 -178.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.6 p -130.79 165.38 23.08 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 174.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.9 p -86.73 0.23 55.08 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 121.373 0.606 . . . . 0.0 110.723 176.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 10.6 m0 -83.0 12.84 4.47 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.518 -173.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.592 ' SG ' HG23 ' A' ' 56' ' ' VAL . 6.7 p -146.26 171.8 14.43 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 122.05 -0.406 . . . . 0.0 111.402 -177.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -116.39 -36.63 1.08 Allowed Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 176.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -64.69 -23.4 67.24 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 121.207 0.527 . . . . 0.0 112.068 -177.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.9 p -70.48 -43.1 70.45 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.154 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.1 mp -64.61 -31.43 72.64 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.924 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -61.06 -52.07 66.5 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.485 0.491 . . . . 0.0 110.673 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.4 tp -68.35 -41.92 80.01 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.987 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -56.78 -50.04 73.49 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.691 -177.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.5 p -68.1 -34.2 75.95 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.54 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.9 -48.77 78.99 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.215 178.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.6 mt -63.89 -37.0 85.77 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.325 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 58.0 m -59.53 -48.81 80.2 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.813 177.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.84 -34.66 77.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.883 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -81.93 5.15 19.96 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -177.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 70.07 24.55 4.99 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.046 0.938 . . . . 0.0 113.121 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.7 mt -93.94 115.49 32.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.68 144.87 37.0 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.95 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -159.71 145.09 15.54 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.837 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -102.39 133.4 47.39 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 175.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 12.7 pt-20 -94.13 142.37 27.48 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.406 HG21 ' CE1' ' A' ' 9' ' ' TYR . 13.6 t -87.83 144.69 8.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 121.717 0.77 . . . . 0.0 112.181 -175.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -65.17 -1.84 2.51 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 127.76 2.424 . . . . 0.0 113.91 -176.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.2 pt -44.3 -23.78 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.564 0 N-CA-C 116.334 1.975 . . . . 0.0 116.334 -172.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -65.51 -25.43 67.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.573 0.701 . . . . 0.0 109.262 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 43.4 m-70 -112.32 -46.74 3.15 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.199 -0.909 . . . . 0.0 108.906 175.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.496 ' ND2' ' H ' ' A' ' 42' ' ' ALA . 56.9 t30 -70.18 111.11 5.58 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.948 -176.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.1 ptp180 -73.53 -24.83 60.19 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.063 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.41 -54.6 13.56 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -175.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.496 ' H ' ' ND2' ' A' ' 39' ' ' ASN . . . -72.75 -20.97 61.09 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.647 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.03 93.45 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.182 0.515 . . . . 0.0 110.925 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -72.95 -29.97 63.49 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.162 0.506 . . . . 0.0 110.414 177.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -68.1 -33.07 73.83 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.752 177.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.496 HG21 ' O ' ' A' ' 42' ' ' ALA . 76.7 t -55.49 -56.2 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.498 175.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.41 -33.99 78.76 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.088 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.3 m -65.82 -42.83 90.09 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 122.862 0.465 . . . . 0.0 112.087 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.8 m -80.92 -19.54 11.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.873 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -77.82 -50.17 12.83 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 175.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.55 -104.91 0.28 Allowed Glycine 0 N--CA 1.431 -1.652 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -103.74 -37.02 3.09 Favored Glycine 0 C--N 1.307 -1.057 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -104.98 148.13 27.05 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -78.92 135.98 37.13 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.2 m -118.33 153.79 33.41 Favored 'General case' 0 C--N 1.268 -2.957 0 N-CA-C 103.73 -2.693 . . . . 0.0 103.73 174.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.592 HG23 ' SG ' ' A' ' 14' ' ' CYS 0.267 21.9 t -86.86 -72.35 0.07 OUTLIER Pre-proline 0 CA--C 1.456 -2.642 0 C-N-CA 116.136 -2.226 . . . . 0.0 114.506 -178.59 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.96 88.73 1.21 Allowed 'Trans proline' 1 N--CA 1.39 -4.575 0 CA-C-N 120.577 1.242 . . . . 0.0 112.498 -162.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.4 m -119.98 130.74 54.9 Favored 'General case' 0 N--CA 1.385 -3.698 0 CA-C-N 113.27 -1.786 . . . . 0.0 106.841 -174.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.1 p -116.45 132.67 65.38 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-O 121.15 0.5 . . . . 0.0 110.856 -176.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -107.04 116.79 32.55 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 174.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -87.66 155.18 20.06 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.189 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.16 -21.37 61.57 Favored 'General case' 0 C--O 1.22 -0.494 0 C-N-CA 123.481 0.712 . . . . 0.0 111.57 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -72.71 -14.33 61.54 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.507 0.67 . . . . 0.0 110.145 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.81 -20.43 26.88 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.901 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.8 m -71.36 140.1 50.07 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 122.687 0.395 . . . . 0.0 111.661 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.9 p -114.21 137.79 51.3 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 173.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mp -128.43 123.21 33.17 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 120.76 0.314 . . . . 0.0 110.4 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 87.6 m -97.15 119.14 35.1 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.231 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 57.77 67.78 2.2 Favored Pre-proline 0 N--CA 1.484 1.237 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -96.56 169.52 1.03 Allowed 'Trans proline' 0 CA--C 1.546 1.124 0 C-N-CA 122.324 2.016 . . . . 0.0 111.148 171.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.0 m -93.29 155.38 17.45 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 173.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.29 -36.43 71.04 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 122.91 0.484 . . . . 0.0 111.704 -178.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -69.18 -35.7 76.57 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.502 0.668 . . . . 0.0 110.839 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.03 -36.56 82.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.268 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.9 t -66.26 -46.75 86.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.038 177.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -53.72 -42.33 67.95 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.22 0.608 . . . . 0.0 112.027 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.34 -20.3 65.57 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.131 0.491 . . . . 0.0 111.394 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.587 ' O ' HG13 ' A' ' 82' ' ' ILE . 34.4 mmtp -84.59 -39.49 18.65 Favored 'General case' 0 N--CA 1.436 -1.168 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.116 175.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -56.82 -41.19 77.37 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.5 m -63.38 -40.5 89.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.304 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.46 ' HA ' ' HB3' ' A' ' 87' ' ' HIS . 22.2 ptmt -83.03 -54.6 4.94 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.587 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.1 pp -68.52 -17.12 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -170.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.37 -11.64 59.68 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.145 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 62.79 57.43 16.14 Favored Glycine 0 CA--C 1.494 -1.26 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -177.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -134.5 -70.08 0.51 Allowed 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -176.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -90.44 4.63 50.44 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 122.362 1.077 . . . . 0.0 109.911 -174.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.46 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 58.6 t-80 -167.93 131.52 1.65 Allowed 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 175.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 . . . . . 0 C--N 1.292 -1.934 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.577 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 mmt . . . . . 0 CA--C 1.502 -0.871 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.8 t -75.83 84.1 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.768 0.795 . . . . 0.0 110.428 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.5 t -109.88 6.48 23.35 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.07 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -133.7 141.39 47.54 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.61 -12.26 51.92 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 123.752 0.657 . . . . 0.0 111.457 -177.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.405 ' HB2' ' CG2' ' A' ' 59' ' ' VAL . 0.5 OUTLIER -130.56 123.96 30.75 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.542 0.687 . . . . 0.0 111.372 178.693 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.3 m -103.2 114.18 28.25 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 55.7 mt -103.58 136.98 33.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -177.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -91.5 118.21 30.38 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.547 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 29.3 p -128.19 -172.08 2.61 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 121.343 0.592 . . . . 0.0 111.894 -177.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.445 ' HB ' ' O ' ' A' ' 13' ' ' TRP . 38.7 m -155.81 146.12 21.72 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 177.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.1 m -56.36 -47.84 78.05 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . 0.445 ' O ' ' HB ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -65.94 111.78 3.48 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 164.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 11' ' ' THR . 42.8 t -150.71 120.14 6.89 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.788 -174.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -113.99 -70.24 0.52 Allowed Glycine 0 N--CA 1.427 -1.9 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.236 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -73.91 -30.23 62.47 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 123.029 0.531 . . . . 0.0 111.083 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -63.34 -27.78 69.55 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -63.08 -35.66 80.99 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.458 0.703 . . . . 0.0 109.678 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -51.87 -45.47 64.11 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 124.774 1.23 . . . . 0.0 111.301 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.421 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 12.4 tp -84.19 -42.37 16.03 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.86 -177.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -52.84 -48.91 66.68 Favored 'General case' 0 C--O 1.246 0.916 0 C-N-CA 124.397 1.079 . . . . 0.0 112.522 -176.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.9 t -74.15 -28.48 61.33 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.515 -178.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.16 -42.49 84.21 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.325 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 59.7 mt -65.26 -44.04 89.38 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.403 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 44.3 m -59.88 -43.59 94.65 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.963 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.12 -10.37 59.55 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.948 0.404 . . . . 0.0 111.928 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -109.31 16.03 22.68 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.964 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 67.77 17.39 9.77 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.27 1.028 . . . . 0.0 112.624 177.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.6 mt -91.06 118.15 35.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.59 138.14 33.68 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -136.3 171.01 15.11 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.044 -177.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -128.45 117.89 22.15 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 175.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.547 ' HB2' ' OG1' ' A' ' 10' ' ' THR . 13.8 pt-20 -95.03 135.2 36.86 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 120.866 0.365 . . . . 0.0 110.841 -178.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.7 t -85.05 140.09 16.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -171.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -58.67 0.39 0.08 Allowed 'General case' 0 CA--C 1.567 1.624 0 C-N-CA 129.508 3.123 . . . . 0.0 114.751 178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.8 pt -43.59 -20.82 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 3.006 0 N-CA-C 116.971 2.212 . . . . 0.0 116.971 -168.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -73.18 -23.61 60.44 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 119.176 0.898 . . . . 0.0 110.276 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -105.39 -47.32 3.98 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 174.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -78.19 99.64 6.31 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.734 -177.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -67.26 -30.21 70.04 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.553 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.9 -44.89 82.81 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.422 ' O ' HG21 ' A' ' 46' ' ' VAL . . . -85.96 -23.34 26.96 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.419 178.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.36 -40.42 93.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.197 0.522 . . . . 0.0 110.222 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -65.46 -24.3 67.13 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.117 177.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -74.68 -38.16 62.48 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 176.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.422 HG21 ' O ' ' A' ' 42' ' ' ALA . 40.3 t -65.71 -41.88 91.37 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.447 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.826 178.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.78 -22.58 75.55 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.029 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -81.85 -41.86 20.43 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.6 p -76.55 -37.56 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 O-C-N 122.045 -0.409 . . . . 0.0 110.593 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -105.19 92.07 4.06 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 176.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -80.86 143.18 24.08 Favored Glycine 0 C--N 1.306 -1.12 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.494 -176.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.56 -62.88 2.68 Favored Glycine 0 N--CA 1.437 -1.29 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -126.11 145.92 50.15 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.6 ttp85 -88.31 89.06 7.84 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.0 m -65.58 133.46 51.23 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 176.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.4 t -77.01 -69.43 0.23 Allowed Pre-proline 0 CA--C 1.468 -2.187 0 C-N-CA 118.174 -1.411 . . . . 0.0 114.061 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.51 82.67 1.85 Allowed 'Trans proline' 0 N--CA 1.4 -3.992 0 CA-C-N 120.637 1.263 . . . . 0.0 112.969 -163.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 51.9 m -115.36 125.3 53.04 Favored 'General case' 0 N--CA 1.388 -3.53 0 CA-C-N 113.299 -1.773 . . . . 0.0 106.509 -176.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.405 ' CG2' ' HB2' ' A' ' 6' ' ' LEU . 7.2 p -118.3 137.17 53.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 CA-C-O 121.007 0.432 . . . . 0.0 111.181 -177.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -111.36 119.57 39.28 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 176.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -94.99 168.57 10.69 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.46 -10.98 20.0 Favored 'General case' 0 C--O 1.218 -0.57 0 O-C-N 123.738 0.649 . . . . 0.0 111.329 177.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -73.59 -18.31 61.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.794 0.807 . . . . 0.0 109.87 177.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.43 -15.12 63.88 Favored Glycine 0 CA--C 1.499 -0.917 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.236 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.5 m -83.41 151.69 25.37 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 p -113.6 139.31 49.12 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.6 tp -121.93 119.91 32.92 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -177.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.0 m -107.94 126.25 52.46 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 -174.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 54.03 60.04 11.48 Favored Pre-proline 0 N--CA 1.482 1.126 0 O-C-N 123.941 0.776 . . . . 0.0 112.315 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -90.08 178.44 2.23 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 121.856 1.704 . . . . 0.0 113.242 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.4 m -96.42 164.46 12.62 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 174.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.57 -39.34 94.14 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 120.958 0.409 . . . . 0.0 110.99 -178.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -64.42 -33.27 75.49 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.512 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -68.33 -39.09 82.05 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.048 0.451 . . . . 0.0 110.35 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.4 t -66.42 -44.91 90.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.899 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -60.49 -43.31 97.13 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.507 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.89 -36.8 84.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.714 0.293 . . . . 0.0 111.32 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.474 ' O ' HG13 ' A' ' 82' ' ' ILE . 14.4 mptt -70.96 -37.13 72.79 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.941 175.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 30.1 tp -62.06 -47.04 86.49 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.412 -178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.8 m -66.07 -32.69 59.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -177.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.413 ' HA ' ' HB3' ' A' ' 87' ' ' HIS . 19.6 ptmt -77.29 -41.02 42.41 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.684 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.2 pp -74.41 -14.28 15.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.454 -0.498 . . . . 0.0 112.074 -177.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.81 -26.18 59.54 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.66 176.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 58.46 49.0 80.88 Favored Glycine 0 C--N 1.344 0.973 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 62.2 tp -154.08 -49.2 0.09 Allowed 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.324 0.583 . . . . 0.0 110.044 -174.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -94.79 -7.24 40.97 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 122.009 0.909 . . . . 0.0 110.077 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.413 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 55.5 t-80 -167.59 143.63 4.1 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 176.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 . . . . . 0 C--N 1.292 -1.916 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.586 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.441 ' SD ' ' HE3' ' A' ' 60' ' ' LYS . 83.1 mtp . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.427 HG22 ' H ' ' A' ' 3' ' ' THR . 5.1 m -111.98 -100.51 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 O-C-N 121.739 -0.601 . . . . 0.0 112.425 176.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.427 ' H ' HG22 ' A' ' 2' ' ' VAL . 14.0 p -80.63 -34.99 34.6 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 173.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.18 102.1 14.39 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 105.577 -2.008 . . . . 0.0 105.577 169.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -68.92 -58.51 4.03 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.386 -175.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.536 ' H ' HD21 ' A' ' 6' ' ' LEU . 0.7 OUTLIER -68.58 120.65 14.95 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.849 0.833 . . . . 0.0 111.013 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.3 m -103.64 111.75 24.37 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 114.399 -1.273 . . . . 0.0 107.851 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 63.4 mt -102.79 139.04 24.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.303 0.573 . . . . 0.0 110.703 -174.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -92.04 122.8 34.88 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.511 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 27.3 p -138.57 177.22 8.04 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.533 0.682 . . . . 0.0 111.817 -177.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.5 m -148.08 156.16 42.29 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 174.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.5 m -69.22 -45.34 70.1 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -87.38 96.28 10.31 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-O 122.126 0.965 . . . . 0.0 109.906 175.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 32.7 t -163.56 152.17 13.84 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.415 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -119.93 -55.84 0.25 Allowed Glycine 0 N--CA 1.429 -1.831 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.226 178.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -68.39 -16.3 63.87 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -173.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.6 p -78.49 -24.88 45.68 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.211 0.529 . . . . 0.0 109.963 177.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 28.7 tp -69.01 -21.75 64.12 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.991 -175.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -60.18 -60.71 3.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.165 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.1 tp -66.3 -42.74 87.86 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.492 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -54.72 -47.23 74.01 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.35 -178.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.5 p -71.12 -34.7 71.31 Favored 'General case' 0 C--O 1.244 0.778 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.654 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.38 -46.93 86.4 Favored 'General case' 0 CA--C 1.508 -0.657 0 C-N-CA 123.387 0.675 . . . . 0.0 110.66 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.9 mt -65.79 -37.88 87.49 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.902 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.3 m -65.24 -38.52 90.62 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.74 -26.94 62.67 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 111.02 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.17 2.8 48.81 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.308 178.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 61.67 30.52 18.55 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.54 1.136 . . . . 0.0 110.441 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 74.1 mt -86.86 115.41 27.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.666 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.48 100.65 3.31 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.509 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -113.61 163.94 14.31 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.412 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -130.5 130.1 43.74 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 175.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.511 ' HB2' ' OG1' ' A' ' 10' ' ' THR . 11.6 pt-20 -99.79 140.92 33.29 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.025 0.441 . . . . 0.0 111.14 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.2 t -78.07 146.79 7.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-O 121.86 0.838 . . . . 0.0 113.1 -172.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -66.85 -0.82 3.29 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 127.718 2.407 . . . . 0.0 114.371 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.5 pt -44.17 -22.58 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.514 2.737 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 -169.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -68.42 -31.43 70.75 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.796 0.808 . . . . 0.0 109.469 177.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 35.5 m-70 -103.17 -45.94 4.77 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.26 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -86.91 115.11 24.09 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.87 -175.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -72.7 -29.68 63.58 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.097 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.38 -41.16 93.22 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -173.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.35 -21.77 25.48 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.638 177.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.65 -39.59 84.58 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.309 0.576 . . . . 0.0 110.616 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -75.08 -21.38 59.0 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.334 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -69.45 -31.95 70.58 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 176.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.3 t -59.36 -42.73 88.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.38 -35.2 87.02 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.356 178.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.8 t -66.77 -50.07 63.87 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 122.503 0.321 . . . . 0.0 110.66 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.9 p -76.91 -28.12 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.181 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -174.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -98.66 1.89 46.67 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 121.698 -0.627 . . . . 0.0 112.266 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.52 60.22 4.82 Favored Glycine 0 C--N 1.322 -0.233 0 N-CA-C 114.395 0.518 . . . . 0.0 114.395 174.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.07 -46.63 3.43 Favored Glycine 0 C--N 1.31 -0.892 0 C-N-CA 121.769 -0.253 . . . . 0.0 112.615 176.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -77.42 122.34 25.04 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.9 mtm180 -93.75 79.95 4.22 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.774 0.797 . . . . 0.0 112.182 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.7 m -73.17 128.36 35.27 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 173.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.4 t -69.4 -66.71 0.87 Allowed Pre-proline 0 CA--C 1.473 -1.989 0 N-CA-C 114.703 1.372 . . . . 0.0 114.703 -173.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.62 76.77 4.13 Favored 'Trans proline' 0 N--CA 1.4 -3.985 0 CA-C-N 120.381 1.172 . . . . 0.0 112.578 -163.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 91.5 m -107.62 140.27 40.88 Favored 'General case' 0 N--CA 1.388 -3.565 0 CA-C-N 113.486 -1.688 . . . . 0.0 107.571 -176.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.2 p -122.68 132.83 70.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-O 121.318 0.58 . . . . 0.0 111.218 -176.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.441 ' HE3' ' SD ' ' A' ' 1' ' ' MET . 63.5 tttp -110.21 120.31 42.04 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.498 176.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.446 ' CD1' HG12 ' A' ' 82' ' ' ILE . 90.1 m-85 -95.12 171.79 8.52 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.738 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.46 -24.0 61.13 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -173.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -89.87 -7.28 54.62 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 120.708 0.289 . . . . 0.0 111.34 -174.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.54 -5.72 31.41 Favored Glycine 0 N--CA 1.437 -1.237 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.268 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.3 m -75.98 125.91 30.01 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 121.18 0.514 . . . . 0.0 110.17 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.6 p -117.21 138.29 51.79 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.2 mp -130.91 146.31 52.29 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.1 m -116.0 112.64 22.1 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 64.2 t30 47.33 70.88 1.81 Allowed Pre-proline 0 N--CA 1.484 1.274 0 C-N-CA 124.713 1.205 . . . . 0.0 113.835 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -100.01 -175.52 0.15 Allowed 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.013 2.475 . . . . 0.0 111.968 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.6 t -82.31 154.1 25.48 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.48 -34.76 78.47 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 123.713 0.805 . . . . 0.0 109.958 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -63.5 -44.09 95.35 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.881 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.567 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 45.5 mm-40 -57.83 -47.36 82.89 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.392 176.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.6 t -57.73 -44.02 85.01 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.764 0 O-C-N 123.994 0.809 . . . . 0.0 111.502 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 66.1 tttp -62.87 -45.3 93.21 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.23 -21.84 59.61 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.054 0.454 . . . . 0.0 111.568 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.567 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 49.2 mmtm -81.93 -34.49 29.83 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 174.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.0 tp -57.39 -49.04 77.47 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.424 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.8 m -60.59 -33.6 55.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.505 -177.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 15.3 ptmm? -81.69 -38.71 25.41 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.476 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.446 HG12 ' CD1' ' A' ' 61' ' ' PHE . 2.4 pp -77.98 -32.15 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -175.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.44 -42.31 59.35 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 82.82 -49.68 4.25 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.399 177.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.5 pp -84.47 167.12 16.69 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 61.37 32.48 19.09 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 126.179 1.792 . . . . 0.0 112.717 174.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 46.1 t60 -107.42 78.39 1.21 Allowed 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 174.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 34.7 m80 . . . . . 0 C--O 1.262 1.749 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.918 -176.186 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 ptp . . . . . 0 CA--C 1.513 -0.462 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.1 m -128.37 143.28 41.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 171.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.2 t -130.95 114.29 15.05 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-O 122.05 0.929 . . . . 0.0 110.993 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -113.37 113.47 25.27 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.94 1.16 53.57 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.497 0.665 . . . . 0.0 110.334 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.79 128.75 16.47 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.256 178.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.453 ' HB ' ' HB3' ' A' ' 60' ' ' LYS . 23.4 m -103.07 120.02 39.92 Favored 'General case' 0 C--N 1.277 -2.576 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 176.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.3 mt -109.88 128.44 66.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 CA-C-O 121.06 0.457 . . . . 0.0 109.915 -176.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.444 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 98.3 m-85 -81.05 129.0 34.34 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.636 177.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.8 p -136.83 145.98 45.1 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -174.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 69.4 p -140.22 161.72 36.98 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 172.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.5 p -85.98 -0.39 55.37 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.303 0.573 . . . . 0.0 110.799 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 11.2 m0 -78.91 -30.93 45.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.356 -176.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.8 p -105.65 132.2 52.09 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.265 -175.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.22 -27.99 26.51 Favored Glycine 0 N--CA 1.436 -1.352 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.675 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -65.86 -35.87 81.86 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.621 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 61.1 m -56.5 -46.71 80.37 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.287 176.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.2 tt -66.75 -39.39 87.89 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.751 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.6 mtp180 -58.23 -54.63 44.84 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.477 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 20.7 tp -62.05 -40.13 94.71 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.524 0.678 . . . . 0.0 109.716 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -57.2 -45.22 83.96 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.664 179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.7 m -62.12 -43.59 98.49 Favored 'General case' 0 C--O 1.246 0.884 0 C-N-CA 123.719 0.808 . . . . 0.0 110.665 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.53 -48.21 82.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.04 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 72.4 mt -65.73 -35.64 81.32 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.995 -178.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.8 m -63.6 -45.99 87.83 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.83 -35.63 81.22 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.483 0.659 . . . . 0.0 110.843 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -84.46 21.03 1.54 Allowed 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.492 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 55.7 20.65 4.09 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 126.226 1.81 . . . . 0.0 113.782 175.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 71.4 mt -85.27 115.91 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.94 116.98 23.06 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.264 -177.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -127.75 159.54 34.47 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.215 -177.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -112.27 114.08 26.66 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 175.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -83.17 136.58 34.38 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.1 t -95.15 143.73 11.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 122.909 1.337 . . . . 0.0 113.233 -176.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.57 -0.57 6.92 Favored 'General case' 0 C--N 1.284 -2.283 0 C-N-CA 130.862 3.665 . . . . 0.0 115.118 177.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.453 HD12 HG21 ' A' ' 46' ' ' VAL . 12.7 pt -44.11 -26.42 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.843 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 -171.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -59.0 -36.3 74.68 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.12 0.486 . . . . 0.0 109.815 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 46.7 m-70 -93.15 -34.45 13.62 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.968 -175.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -116.36 113.58 23.12 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -176.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -62.86 -25.58 68.35 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 114.625 -1.171 . . . . 0.0 111.885 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.18 -41.49 71.96 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.238 0.542 . . . . 0.0 111.296 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.439 ' O ' HG22 ' A' ' 46' ' ' VAL . . . -86.96 -30.33 21.37 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.047 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.31 -33.89 77.05 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.996 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -67.53 -34.76 77.75 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.774 -0.194 . . . . 0.0 111.377 178.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -65.25 -37.69 88.0 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.453 HG21 HD12 ' A' ' 36' ' ' ILE . 60.1 t -59.99 -38.06 75.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.091 -0.958 . . . . 0.0 109.877 177.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.66 -49.22 44.82 Favored Glycine 0 N--CA 1.433 -1.55 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.9 m -60.31 -38.13 82.72 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.6 p -79.49 -9.37 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-O 121.531 0.682 . . . . 0.0 111.213 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -104.95 -67.82 0.89 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.145 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 137.67 -112.38 0.9 Allowed Glycine 0 N--CA 1.433 -1.554 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 -175.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.31 -48.33 5.11 Favored Glycine 0 C--N 1.306 -1.127 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.029 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -91.45 116.44 28.85 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -178.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -81.21 83.02 6.94 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.6 m -71.97 125.78 28.09 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.531 ' HB ' ' SG ' ' A' ' 17' ' ' CYS . 3.2 t -76.31 -56.16 1.59 Allowed Pre-proline 0 N--CA 1.435 -1.221 0 CA-C-O 117.323 -1.322 . . . . 0.0 113.55 -175.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.621 ' HD3' ' SG ' ' A' ' 17' ' ' CYS . 64.9 Cg_endo -73.64 44.24 0.89 Allowed 'Trans proline' 0 C--N 1.399 3.227 0 CA-C-N 121.472 1.562 . . . . 0.0 113.691 -170.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.435 ' H ' ' C ' ' A' ' 56' ' ' VAL . 84.1 m -80.57 117.66 21.47 Favored 'General case' 0 N--CA 1.387 -3.599 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 176.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.3 p -94.76 129.12 45.39 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.453 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 82.2 tttt -105.03 118.19 35.9 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -87.75 164.21 16.08 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 120.448 -0.501 . . . . 0.0 112.126 -177.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.04 -18.26 45.04 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 124.032 0.933 . . . . 0.0 112.956 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -78.31 -17.29 56.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.863 0.363 . . . . 0.0 110.286 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.02 -21.7 24.5 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 121.245 -0.502 . . . . 0.0 113.193 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.1 m -82.88 159.71 22.3 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.257 0.551 . . . . 0.0 110.522 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.3 p -114.0 171.39 7.62 Favored 'General case' 0 N--CA 1.418 -2.045 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.101 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.8 tp -145.0 109.7 5.0 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 176.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 89.1 m -86.11 122.7 30.49 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.965 -176.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 56.49 64.81 4.53 Favored Pre-proline 0 N--CA 1.482 1.15 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -90.71 -173.61 0.63 Allowed 'Trans proline' 0 N--CA 1.445 -1.38 0 C-N-CA 121.788 1.659 . . . . 0.0 112.653 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.6 m -127.26 165.86 18.86 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 174.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.69 -45.95 67.05 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -64.38 -36.54 84.48 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.431 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -63.71 -42.51 97.94 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.194 0.521 . . . . 0.0 110.88 177.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.1 t -67.21 -48.8 77.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.192 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -61.57 -31.05 71.08 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.118 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.2 -25.54 63.46 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.416 ' O ' HG13 ' A' ' 82' ' ' ILE . 10.1 mmmm -84.7 -37.22 21.2 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 172.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.8 tp -55.07 -49.63 71.17 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 124.165 0.916 . . . . 0.0 110.171 -177.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.3 m -58.6 -35.53 55.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -178.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.474 ' HZ2' ' HB3' ' A' ' 81' ' ' LYS . 0.3 OUTLIER -81.76 -42.53 19.65 Favored 'General case' 0 N--CA 1.427 -1.578 0 C-N-CA 119.071 -1.051 . . . . 0.0 111.804 -178.707 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.4 pp -76.41 -22.16 15.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -174.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -87.35 4.42 43.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.985 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.39 -102.89 1.65 Allowed Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 116.259 -0.428 . . . . 0.0 112.13 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -127.56 0.69 6.2 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.152 0.501 . . . . 0.0 110.504 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.9 88.62 5.8 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 35.3 p80 -163.58 174.83 11.29 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -177.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 . . . . . 0 C--N 1.305 -1.33 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 176.776 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 tmt? . . . . . 0 N--CA 1.473 0.676 0 N-CA-C 110.818 -0.068 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 65.5 t -65.2 113.83 2.3 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.463 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 175.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.6 m -76.91 94.08 3.87 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-O 121.805 0.812 . . . . 0.0 111.703 -172.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.74 173.82 9.22 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.486 175.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -68.58 -22.85 64.44 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 62.1 mt -113.97 122.53 47.23 Favored 'General case' 0 CA--C 1.496 -1.101 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.712 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.1 m -103.14 108.54 19.77 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 173.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.414 HG21 HG23 ' A' ' 10' ' ' THR . 55.4 mt -108.42 133.35 53.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-O 121.78 0.8 . . . . 0.0 111.605 -175.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -95.38 107.36 19.49 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.067 -0.969 . . . . 0.0 108.662 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.414 HG23 HG21 ' A' ' 8' ' ' ILE . 4.0 p -135.28 158.96 43.05 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 122.677 0.391 . . . . 0.0 111.897 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.6 p -134.77 174.61 10.39 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 176.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.1 t -86.72 -5.61 59.07 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 19.6 m0 -75.83 -32.61 59.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.093 -175.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.8 p -91.54 165.99 13.07 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 120.738 0.304 . . . . 0.0 111.628 -175.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -113.45 -42.83 0.86 Allowed Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 111.366 -0.693 . . . . 0.0 111.366 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -63.45 -25.77 68.42 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -178.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.485 ' SG ' HD13 ' A' ' 18' ' ' LEU . 1.6 p -56.32 -41.36 75.91 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.677 0.275 . . . . 0.0 111.04 176.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.485 HD13 ' SG ' ' A' ' 17' ' ' CYS . 6.3 mp -73.31 -24.96 60.47 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.65 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -71.76 -34.72 69.71 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.8 tp -75.74 -38.36 58.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.084 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.45 ' HD3' ' HA ' ' A' ' 18' ' ' LEU . 27.4 mtpp -55.75 -45.72 77.98 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.706 177.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 p -65.94 -40.2 91.14 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 111.541 0.2 . . . . 0.0 111.541 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.26 -49.53 76.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.674 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.5 mt -64.91 -41.68 95.37 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.754 0.311 . . . . 0.0 111.283 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 68.0 m -67.29 -38.29 84.78 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.198 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.84 -26.37 64.19 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.36 0.6 . . . . 0.0 110.66 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -94.07 10.77 32.33 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.066 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 59.15 30.86 20.73 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.04 1.336 . . . . 0.0 112.719 175.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.6 mt -89.26 123.87 41.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.73 129.93 34.68 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.071 0.463 . . . . 0.0 111.218 -176.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -144.08 157.62 44.21 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.651 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -127.96 124.03 36.28 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 11.7 pt-20 -95.25 146.82 24.07 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.271 0.557 . . . . 0.0 111.764 -175.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -81.07 153.05 4.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.457 -175.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -74.87 0.19 16.42 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 127.903 2.481 . . . . 0.0 114.042 -175.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.7 pt -43.36 -23.71 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.378 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 -172.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -52.85 -39.24 62.39 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.649 0.78 . . . . 0.0 109.709 176.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -119.42 20.28 12.52 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.081 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -139.42 106.89 5.55 Favored 'General case' 0 CA--C 1.492 -1.269 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.26 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -30.59 71.13 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.946 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.43 -38.57 84.76 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -173.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.79 -20.73 27.17 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.816 177.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.15 -41.44 86.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.463 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -69.92 -21.91 63.25 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.539 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -68.16 -33.53 74.64 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 175.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.616 ' O ' ' HB2' ' A' ' 50' ' ' ASN . 81.6 t -59.3 -40.22 80.83 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.925 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.631 177.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.92 -32.68 77.82 Favored Glycine 0 C--N 1.332 0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.09 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.0 t -65.8 -29.96 70.53 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 123.147 0.579 . . . . 0.0 110.265 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.4 m -108.1 17.2 6.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 120.887 0.375 . . . . 0.0 110.572 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.616 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 1.7 t-20 -116.49 -174.16 2.51 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -176.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -107.82 75.71 0.22 Allowed Glycine 0 N--CA 1.436 -1.343 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.064 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.01 -93.65 1.31 Allowed Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 -78.62 136.31 37.46 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -64.91 101.4 0.49 Allowed 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -178.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.9 m -83.0 153.35 25.01 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 102.984 -2.969 . . . . 0.0 102.984 169.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 0.442 3.8 t -86.95 -93.75 0.0 OUTLIER Pre-proline 0 CA--C 1.487 -1.472 0 C-N-CA 114.643 -2.823 . . . . 0.0 117.23 -174.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -47.51 93.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.386 2.538 0 N-CA-C 114.551 0.943 . . . . 0.0 114.551 -148.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.31 109.91 21.37 Favored 'General case' 0 N--CA 1.405 -2.705 0 CA-C-N 113.778 -1.555 . . . . 0.0 109.904 -173.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.3 p -102.58 126.46 56.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -104.8 127.41 52.59 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.477 ' HB3' HG23 ' A' ' 82' ' ' ILE . 95.8 m-85 -103.25 170.84 7.71 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.972 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.421 ' HB1' ' HB ' ' A' ' 82' ' ' ILE . . . -65.17 -13.89 59.27 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 -173.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -78.69 -13.09 60.0 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 121.478 0.656 . . . . 0.0 109.627 175.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.54 -1.54 64.15 Favored Glycine 0 N--CA 1.436 -1.319 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -174.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.3 m -67.62 133.5 49.49 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 123.787 0.835 . . . . 0.0 108.96 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.8 m -121.43 137.53 54.67 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 176.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.2 mp -120.06 119.38 33.19 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 120.687 0.28 . . . . 0.0 111.279 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.5 m -92.66 116.55 29.11 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 61.7 69.66 0.97 Allowed Pre-proline 0 CA--C 1.557 1.25 0 C-N-CA 123.643 0.777 . . . . 0.0 111.49 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -94.48 -167.02 0.14 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.444 2.096 . . . . 0.0 112.258 176.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.5 m -116.08 150.52 37.2 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 176.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.08 -40.43 76.94 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.775 0.43 . . . . 0.0 111.734 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -64.42 -37.76 88.64 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.947 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -62.18 -48.06 81.75 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.906 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.9 t -58.39 -42.3 83.73 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.922 0 O-C-N 124.013 0.821 . . . . 0.0 110.834 -178.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -67.76 -40.38 84.09 Favored 'General case' 0 CA--C 1.559 1.315 0 CA-C-O 120.722 0.296 . . . . 0.0 110.52 -178.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.45 -29.84 59.79 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.171 0.51 . . . . 0.0 111.024 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -77.21 -31.09 55.03 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 20.4 tp -58.92 -50.96 72.08 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.984 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.558 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 27.5 m -60.57 -39.42 81.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -176.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? -73.31 -32.33 64.54 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.481 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.477 HG23 ' HB3' ' A' ' 61' ' ' PHE . 2.0 pp -83.5 -11.91 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-O 121.39 0.614 . . . . 0.0 111.871 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.85 -7.2 57.68 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.529 174.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 81.17 -71.83 2.84 Favored Glycine 0 N--CA 1.44 -1.045 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.896 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 80.5 mt -92.69 15.0 15.44 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 123.158 0.583 . . . . 0.0 110.376 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.558 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 41.8 mt-10 61.1 -84.66 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 125.634 1.574 . . . . 0.0 113.621 177.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 162.06 -24.03 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 103.364 -2.828 . . . . 0.0 103.364 -171.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 34.8 m80 . . . . . 0 C--O 1.245 0.836 0 CA-C-N 113.558 -1.656 . . . . 0.0 108.447 176.705 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.5 ttt . . . . . 0 CA--C 1.517 -0.297 0 N-CA-C 110.613 -0.143 . . . . 0.0 110.613 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 53.0 t 65.04 92.19 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.08 0.952 . . . . 0.0 110.588 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 35.5 m -136.61 123.56 21.44 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.847 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -127.51 173.3 9.96 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.28 1.1 57.36 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.364 0.602 . . . . 0.0 109.61 177.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.2 tp -142.19 114.71 8.45 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -178.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.9 m -107.06 127.74 53.75 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 71.4 mt -118.88 135.79 58.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-O 121.207 0.527 . . . . 0.0 110.389 -177.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 92.8 m-85 -88.13 127.8 35.43 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.742 177.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.2 p -134.29 151.82 51.47 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -175.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.0 p -140.15 163.5 32.56 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 175.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.2 m -77.7 -8.21 57.61 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.238 0.542 . . . . 0.0 110.395 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 2.7 m0 -89.8 -25.88 20.86 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.922 0.868 . . . . 0.0 110.246 -176.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.6 t -91.98 118.42 30.75 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.876 -168.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -92.18 -32.54 8.27 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -68.98 -18.25 64.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.058 0.456 . . . . 0.0 112.161 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.631 ' SG ' ' HB ' ' A' ' 56' ' ' VAL . 72.4 m -68.85 -38.67 79.92 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.667 0.746 . . . . 0.0 109.178 174.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.3 tt -68.31 -30.0 68.89 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.775 -178.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -61.65 -41.5 97.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.77 176.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.467 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 17.6 tp -74.51 -39.91 62.12 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.494 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -56.36 -51.61 67.63 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.146 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.4 p -61.08 -42.44 98.51 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.999 0.428 . . . . 0.0 110.84 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.63 -49.54 77.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.993 178.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 51.8 mt -67.56 -36.77 81.58 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.392 -178.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.7 m -66.91 -41.8 86.5 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 121.207 0.527 . . . . 0.0 110.248 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.0 -7.42 53.61 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.195 0.521 . . . . 0.0 111.889 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -107.75 8.21 28.75 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 123.073 0.549 . . . . 0.0 110.867 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 57.61 62.85 1.99 Allowed 'General case' 0 C--O 1.243 0.724 0 C-N-CA 125.299 1.44 . . . . 0.0 112.219 -177.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 76.3 mt -121.58 117.41 52.5 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.689 176.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.82 121.88 30.78 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -135.23 156.01 49.7 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.853 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -116.2 132.79 56.56 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 175.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.498 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 8.8 pt-20 -96.01 151.05 19.8 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.417 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.6 t -94.76 145.36 8.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.875 0.845 . . . . 0.0 112.921 -173.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -62.51 -1.49 0.81 Allowed 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 128.352 2.661 . . . . 0.0 114.036 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 26.1 pt -45.2 -21.04 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 N-CA-C 115.759 1.762 . . . . 0.0 115.759 -173.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -56.38 -29.02 60.95 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.003 0.43 . . . . 0.0 110.862 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 46.4 t60 -127.94 -23.7 3.31 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.175 0.512 . . . . 0.0 110.285 173.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.4 t30 -87.71 87.11 7.28 Favored 'General case' 0 C--O 1.244 0.774 0 O-C-N 121.488 -0.758 . . . . 0.0 109.683 178.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -67.16 -23.87 65.83 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -174.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.75 -34.78 73.41 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.598 0.713 . . . . 0.0 110.963 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.09 -20.66 26.8 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.362 0.601 . . . . 0.0 109.871 176.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.01 -34.59 64.21 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.592 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.79 -32.82 74.68 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.52 173.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 94.2 t80 -63.02 -42.46 99.81 Favored 'General case' 0 N--CA 1.461 0.095 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.1 t -57.0 -45.15 83.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.01 177.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.69 -52.39 34.5 Favored Glycine 0 N--CA 1.432 -1.618 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.223 178.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.4 t -59.52 -39.36 83.6 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 123.472 0.709 . . . . 0.0 112.814 -175.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.0 p -70.1 -24.42 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 CA-C-O 121.132 0.492 . . . . 0.0 111.514 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -93.6 -27.58 16.52 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.146 0.498 . . . . 0.0 110.437 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 148.68 -63.1 0.42 Allowed Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 177.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -159.33 -34.19 0.02 OUTLIER Glycine 0 C--N 1.298 -1.565 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.3 p-10 -76.56 145.97 38.66 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.224 0.535 . . . . 0.0 110.748 178.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -89.66 86.33 6.68 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.659 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.8 m -78.9 117.19 19.75 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 172.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.631 ' HB ' ' SG ' ' A' ' 17' ' ' CYS . 2.3 t -76.01 -60.82 0.94 Allowed Pre-proline 0 C--N 1.308 -1.206 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 -167.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.584 ' HD3' ' SG ' ' A' ' 17' ' ' CYS . 67.8 Cg_endo -73.14 70.67 3.73 Favored 'Trans proline' 0 C--N 1.399 3.219 0 CA-C-N 121.963 1.737 . . . . 0.0 112.952 -171.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 69.2 m -108.29 119.19 38.77 Favored 'General case' 1 N--CA 1.377 -4.096 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.7 p -101.33 139.96 21.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.672 -175.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -108.89 111.79 23.67 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -88.53 177.69 6.72 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.238 -177.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.29 -12.0 59.01 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.44 177.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -65.51 -19.88 66.11 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.953 174.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.18 -12.22 65.1 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -176.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 61.6 p -94.78 166.53 11.94 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.6 p -114.28 140.14 48.85 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.134 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.5 tp -119.25 110.56 17.16 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.8 m -79.16 120.96 24.42 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.044 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 53.89 75.75 0.59 Allowed Pre-proline 0 N--CA 1.481 1.115 0 C-N-CA 124.843 1.257 . . . . 0.0 111.981 176.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -97.88 165.62 0.8 Allowed 'Trans proline' 0 N--CA 1.442 -1.519 0 C-N-CA 122.401 2.068 . . . . 0.0 111.915 178.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.444 ' O ' HG23 ' A' ' 75' ' ' VAL . 13.4 m -84.34 149.82 25.79 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.62 -41.41 94.76 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.07 0.462 . . . . 0.0 111.918 -175.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -63.48 -37.66 88.14 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.723 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -64.92 -42.99 94.25 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.271 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 71' ' ' SER . 63.2 t -62.49 -43.91 98.78 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.75 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.922 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.416 ' O ' HG12 ' A' ' 80' ' ' VAL . 23.2 tptm -62.65 -47.11 85.15 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.551 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.68 -29.09 68.28 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -178.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.484 ' O ' HG13 ' A' ' 82' ' ' ILE . 3.5 tmtp? -82.49 -37.06 25.86 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 19.2 tp -57.69 -49.74 75.52 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.105 0.479 . . . . 0.0 110.068 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.416 HG12 ' O ' ' A' ' 76' ' ' LYS . 33.7 m -61.02 -34.99 62.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.99 -176.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.1 ptpp? -80.55 -32.61 36.64 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.685 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.1 pp -85.29 -12.45 11.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.289 0.566 . . . . 0.0 111.854 -178.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.14 -6.83 58.93 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.236 174.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.21 -128.15 9.19 Favored Glycine 0 N--CA 1.421 -2.327 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.963 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 42.5 tp -97.82 -9.01 27.2 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 120.98 0.419 . . . . 0.0 109.947 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -72.66 90.93 1.41 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.505 -177.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -129.86 -7.03 4.5 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.485 0.659 . . . . 0.0 110.071 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 65.2 m80 . . . . . 0 C--N 1.312 -1.045 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -176.076 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ptm . . . . . 0 CA--C 1.539 0.543 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.3 p -105.33 -53.73 6.74 Favored 'Isoleucine or valine' 0 C--N 1.345 0.376 0 C-N-CA 118.625 -1.23 . . . . 0.0 111.707 -178.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.8 p -133.98 -19.61 2.0 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.155 0.502 . . . . 0.0 111.505 177.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -101.0 158.37 16.06 Favored 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 177.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -88.16 -2.19 58.46 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.363 0.601 . . . . 0.0 109.758 178.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.1 tp -125.83 137.81 53.78 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -178.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.8 m -122.6 135.71 54.69 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 58.7 mt -126.03 131.33 71.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.264 0.554 . . . . 0.0 109.884 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -91.94 90.29 7.37 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.028 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.7 p -127.62 160.54 31.29 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 123.006 0.523 . . . . 0.0 111.159 -177.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.5 p -115.48 166.63 11.68 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 171.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.8 t -71.87 -13.65 61.72 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-O 121.678 0.751 . . . . 0.0 109.093 172.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 2.2 m0 -90.2 75.74 6.94 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -175.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.2 t -158.52 159.87 36.05 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.675 -178.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.47 -43.9 0.26 Allowed Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -72.24 -26.98 62.23 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 70.0 m -54.88 -32.41 60.84 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 122.652 0.381 . . . . 0.0 111.409 -177.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 38.4 tp -55.02 -33.72 62.88 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.146 0.978 . . . . 0.0 111.943 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -59.72 -42.58 93.4 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.3 0.64 . . . . 0.0 109.442 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.5 tp -84.32 -38.71 20.05 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.437 -178.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -55.44 -48.84 73.84 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.444 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.9 p -68.18 -40.22 82.32 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.876 -178.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.68 -45.83 90.9 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.481 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.0 mt -69.66 -42.67 73.91 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.723 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 59.6 m -64.71 -35.57 81.47 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-O 120.878 0.37 . . . . 0.0 111.175 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.93 -26.56 62.34 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-O 121.463 0.649 . . . . 0.0 110.425 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -91.89 10.64 27.89 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.48 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 65.58 23.87 11.74 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.144 1.377 . . . . 0.0 111.282 175.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 80.0 mt -90.11 130.76 38.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -102.29 150.39 23.37 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -147.86 138.27 22.99 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.3 112.43 22.83 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 176.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -83.38 126.83 33.13 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.4 t -75.51 154.81 6.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-O 121.864 0.84 . . . . 0.0 112.559 -173.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -68.79 -0.52 5.51 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 126.394 1.878 . . . . 0.0 114.418 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.2 pt -44.44 -24.92 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 N-CA-C 117.265 2.32 . . . . 0.0 117.265 -170.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -67.73 -25.77 65.81 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 119.561 -0.855 . . . . 0.0 111.109 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 14.6 t60 -108.93 -43.79 4.13 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 176.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -79.43 102.98 9.03 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.336 -178.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.9 ptp180 -71.47 -23.41 61.82 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.77 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.39 -38.38 89.82 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.34 -20.99 25.97 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.975 176.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.88 -33.82 76.45 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.402 -178.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -70.81 -30.49 66.94 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.579 176.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -66.73 -32.96 74.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.172 0.51 . . . . 0.0 110.108 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 44.9 t -62.25 -32.51 55.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.392 177.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.55 -43.38 52.98 Favored Glycine 0 N--CA 1.44 -1.079 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 177.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.7 m -58.18 -40.42 81.44 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.497 0.719 . . . . 0.0 112.174 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.3 m -79.72 -7.58 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -107.75 -53.6 2.6 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.856 -0.337 . . . . 0.0 111.619 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 138.52 -87.51 0.21 Allowed Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.193 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -103.14 -42.7 2.02 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.339 -177.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -124.33 149.35 46.68 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.078 0.466 . . . . 0.0 110.72 -177.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.1 mtm180 -80.79 97.44 7.34 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.45 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.7 m -75.8 127.45 33.04 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 175.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 1.564 18.9 m -59.35 -71.02 0.34 Allowed Pre-proline 0 CA--C 1.45 -2.883 1 N-CA-C 124.52 5.007 . . . . 0.0 124.52 -177.329 . . . . . . . . 3 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.67 79.36 3.38 Favored 'Trans proline' 0 N--CA 1.401 -3.966 0 CA-C-N 122.617 1.97 . . . . 0.0 113.188 -170.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.4 m -108.14 120.97 43.85 Favored 'General case' 0 N--CA 1.417 -2.093 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.155 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.6 p -97.78 143.85 12.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.747 -177.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -121.08 128.17 52.35 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -103.79 149.08 25.36 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.27 -11.91 53.22 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.457 0.646 . . . . 0.0 111.562 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -74.92 -14.19 60.62 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 124.104 0.962 . . . . 0.0 110.064 178.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.03 -21.85 24.22 Favored Glycine 0 CA--C 1.501 -0.812 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.752 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 p -70.36 138.02 51.05 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 123.585 0.754 . . . . 0.0 111.889 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.98 138.09 54.51 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 174.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mp -129.58 119.6 23.9 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 120.87 0.366 . . . . 0.0 110.595 -178.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.9 m -90.3 112.72 24.39 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.732 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 36.4 t30 56.1 74.22 0.73 Allowed Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 177.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -103.59 172.2 0.19 Allowed 'Trans proline' 0 N--CA 1.444 -1.388 0 C-N-CA 122.478 2.119 . . . . 0.0 110.598 172.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.2 t -85.08 165.22 17.67 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 174.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.66 -32.45 71.64 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.958 0.409 . . . . 0.0 111.398 -179.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -56.65 -40.62 75.8 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.598 1.159 . . . . 0.0 109.511 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -68.96 -53.12 22.48 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.653 -176.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 49.4 t -61.4 -40.84 87.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 114.997 -1.002 . . . . 0.0 111.126 -176.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -64.04 -37.8 88.74 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.572 -177.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.57 -22.58 34.83 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.897 0.38 . . . . 0.0 110.964 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.428 ' O ' HG21 ' A' ' 82' ' ' ILE . 74.8 mmtt -84.56 -35.99 22.42 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.493 177.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.9 tp -55.61 -46.48 77.32 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.467 0.651 . . . . 0.0 109.6 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.7 m -63.42 -40.88 90.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.864 -178.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.12 -24.18 51.73 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.71 -177.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.428 HG21 ' O ' ' A' ' 78' ' ' LYS . 1.9 pp -83.37 -25.45 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 120.004 -0.679 . . . . 0.0 110.426 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.5 -28.37 59.13 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.462 175.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 143.57 -122.5 1.87 Allowed Glycine 0 N--CA 1.428 -1.842 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 178.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.6 mt -127.81 30.01 5.36 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 -178.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.407 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 4.5 mm-40 -78.9 -57.15 3.9 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 112.987 -1.915 . . . . 0.0 109.735 -172.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.0 t60 58.09 80.17 0.18 Allowed 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.798 1.239 . . . . 0.0 111.53 -178.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.407 ' CE1' ' HB3' ' A' ' 86' ' ' GLU . 37.0 m80 . . . . . 0 C--N 1.308 -1.213 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.504 -0.814 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.8 t 68.15 -70.55 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.921 0 C-N-CA 124.227 1.011 . . . . 0.0 109.891 -174.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 29.4 m 71.59 -47.79 0.67 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.602 1.561 . . . . 0.0 113.996 174.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.46 146.51 26.28 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 121.93 -0.481 . . . . 0.0 110.726 -178.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.13 -22.78 20.51 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.36 0.6 . . . . 0.0 109.665 177.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.4 HD21 ' CG1' ' A' ' 75' ' ' VAL . 8.5 mp -93.53 129.42 39.76 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.448 177.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.3 m -118.34 108.31 14.92 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 171.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 57.6 mt -108.5 134.09 51.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-O 121.147 0.498 . . . . 0.0 110.211 -174.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -86.14 123.65 31.66 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.556 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 31.5 p -138.79 -178.91 5.53 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.687 0.755 . . . . 0.0 111.103 -178.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.1 m -139.4 153.25 47.59 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 104.367 -2.457 . . . . 0.0 104.367 174.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.3 p -49.94 -42.6 48.85 Favored 'General case' 0 C--N 1.315 -0.928 0 O-C-N 123.605 0.565 . . . . 0.0 110.99 176.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 35.2 p90 -111.52 129.67 55.98 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 174.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.3 t -164.02 142.13 7.28 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 174.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.47 -49.2 2.04 Favored Glycine 0 N--CA 1.429 -1.792 0 C-N-CA 120.646 -0.787 . . . . 0.0 111.374 178.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -73.42 -34.02 65.26 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 122.548 0.339 . . . . 0.0 111.553 -175.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.4 m -62.69 -36.96 84.6 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.247 0.546 . . . . 0.0 110.216 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 24.2 tp -65.64 -27.79 68.63 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.831 -174.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.0 ttt180 -54.46 -53.26 56.68 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.865 0.866 . . . . 0.0 110.158 177.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.471 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 23.3 tp -79.99 -37.8 33.48 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.125 -177.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.6 tttm -58.13 -43.56 87.34 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 123.747 0.819 . . . . 0.0 111.069 -175.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.6 m -72.4 -32.06 66.06 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.351 -178.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.97 -46.19 78.95 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.275 0.56 . . . . 0.0 110.042 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 68.9 mt -63.61 -44.46 93.88 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.599 -178.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.5 m -61.57 -37.42 83.78 Favored 'General case' 0 CA--C 1.555 1.167 0 CA-C-O 121.217 0.532 . . . . 0.0 110.68 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.18 -19.82 59.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.107 0.48 . . . . 0.0 111.134 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -97.31 10.96 38.18 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.519 -179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 63.99 26.2 14.05 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.792 0.837 . . . . 0.0 111.978 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 77.0 mt -91.52 120.19 40.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.04 146.48 26.08 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -153.01 147.91 26.46 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -176.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -109.46 116.27 31.49 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 177.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.556 ' HB2' ' OG1' ' A' ' 10' ' ' THR . 14.0 pt-20 -87.98 146.91 25.28 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.617 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.7 t -91.07 151.73 3.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -171.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -77.91 1.55 20.23 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 128.724 2.81 . . . . 0.0 113.103 -178.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.1 pt -42.92 -22.48 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.526 3.341 0 N-CA-C 116.978 2.214 . . . . 0.0 116.978 -168.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -74.37 -21.81 59.5 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 119.403 1.001 . . . . 0.0 109.732 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -111.01 -34.86 6.09 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.573 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.477 ' ND2' ' H ' ' A' ' 42' ' ' ALA . 49.6 t30 -90.98 113.46 25.71 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.819 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -72.03 -29.85 64.6 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.625 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.65 -46.94 74.1 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -174.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.477 ' H ' ' ND2' ' A' ' 39' ' ' ASN . . . -76.03 -25.18 55.43 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.522 179.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.48 -42.61 87.2 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.65 -39.55 84.76 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.617 176.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -65.08 -32.85 74.77 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.082 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 42' ' ' ALA . 64.9 t -59.68 -34.47 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 121.195 0.522 . . . . 0.0 109.674 178.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.24 -18.38 65.02 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.834 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.5 t -81.54 -26.85 34.72 Favored 'General case' 0 N--CA 1.433 -1.285 0 O-C-N 122.228 -0.572 . . . . 0.0 110.391 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.4 m -99.42 -23.01 4.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 119.831 -0.748 . . . . 0.0 112.729 -178.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -147.76 154.09 40.07 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 175.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -144.32 170.04 26.18 Favored Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -178.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.51 -82.79 1.66 Allowed Glycine 0 CA--C 1.501 -0.834 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -177.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -104.85 123.59 47.97 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 174.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -67.13 106.25 1.93 Allowed 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.127 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.5 m -78.48 110.72 13.82 Favored 'General case' 0 N--CA 1.409 -2.476 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.4 t -76.89 -57.71 1.15 Allowed Pre-proline 0 N--CA 1.426 -1.632 0 CA-C-O 117.119 -1.42 . . . . 0.0 113.087 -174.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -73.39 45.49 1.02 Allowed 'Trans proline' 0 C--N 1.402 3.374 0 C-N-CA 121.393 1.395 . . . . 0.0 114.014 -168.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 95.5 m -80.49 138.21 36.53 Favored 'General case' 0 N--CA 1.39 -3.473 0 C-N-CA 126.063 1.745 . . . . 0.0 107.29 177.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.67 136.48 59.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-O 121.13 0.49 . . . . 0.0 110.569 -178.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -114.58 130.59 56.79 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 175.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -100.35 151.99 20.86 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.919 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.4 -10.08 15.29 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 124.234 1.013 . . . . 0.0 113.569 -177.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -89.76 -13.98 35.57 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.181 0.515 . . . . 0.0 109.663 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.72 3.13 30.49 Favored Glycine 0 N--CA 1.436 -1.312 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.6 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.0 m -82.86 131.01 35.21 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.796 177.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.0 p -113.93 137.65 51.4 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 171.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.3 mp -128.08 116.56 20.17 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.9 m -96.91 112.42 24.18 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -178.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 54.08 69.88 1.97 Allowed Pre-proline 0 N--CA 1.488 1.466 0 C-N-CA 124.213 1.005 . . . . 0.0 113.141 -174.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -95.55 172.88 1.16 Allowed 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 122.058 1.839 . . . . 0.0 111.567 175.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.0 t -93.55 161.49 14.34 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 172.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.81 -28.9 67.86 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.16 0.505 . . . . 0.0 110.243 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -56.55 -49.97 73.25 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.191 177.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -65.25 -42.56 93.18 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-N 114.805 -1.088 . . . . 0.0 110.653 -177.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.4 ' CG1' HD21 ' A' ' 6' ' ' LEU . 96.9 t -62.05 -49.38 84.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.29 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -61.36 -43.91 98.06 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.379 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.81 -38.79 87.16 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.575 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.409 ' O ' HG13 ' A' ' 82' ' ' ILE . 18.1 tppt? -66.6 -45.08 80.36 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 177.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.9 tp -59.98 -49.45 77.61 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.923 -177.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.8 m -66.61 -30.17 48.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -79.72 -33.44 40.92 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.543 -0.863 . . . . 0.0 111.221 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.5 pp -83.4 -23.8 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.768 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.81 -31.91 23.61 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.27 -60.88 4.79 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.2 mt -134.48 -152.6 0.48 Allowed 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 69.63 -74.48 0.08 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.818 1.247 . . . . 0.0 111.257 177.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -80.08 -26.07 39.77 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 . . . . . 0 N--CA 1.427 -1.58 0 CA-C-N 113.804 -1.544 . . . . 0.0 107.199 177.349 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.551 ' HG3' ' H ' ' A' ' 2' ' ' VAL . 17.8 ptm . . . . . 0 N--CA 1.466 0.34 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.551 ' H ' ' HG3' ' A' ' 1' ' ' MET . 67.7 t -125.67 -43.39 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -177.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.91 -42.46 76.07 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.994 177.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -122.9 148.1 45.84 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 167.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.14 -20.91 65.81 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -174.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.2 tp -110.29 151.55 27.25 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.779 -174.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.2 m -121.44 119.64 32.65 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 176.023 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 52.3 mt -120.34 131.87 71.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.394 0.616 . . . . 0.0 110.886 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -95.0 127.3 40.96 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 174.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.418 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 7.3 p -151.27 176.54 11.13 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.06 0.457 . . . . 0.0 111.723 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 29.0 m -132.02 149.45 52.42 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 174.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.2 p -68.68 -30.05 68.64 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.957 0.884 . . . . 0.0 108.85 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -84.92 101.78 12.61 Favored 'General case' 0 N--CA 1.412 -2.343 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 171.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.514 ' SG ' HG22 ' A' ' 56' ' ' VAL . 10.0 m -164.22 158.93 19.54 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.954 -1.475 . . . . 0.0 109.471 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -116.75 -62.66 0.33 Allowed Glycine 0 C--N 1.305 -1.193 0 N-CA-C 108.296 -1.921 . . . . 0.0 108.296 167.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.62 -30.67 63.52 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 124.696 1.198 . . . . 0.0 113.197 176.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.446 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 36.1 m -66.04 -44.63 84.09 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 70.3 mt -62.53 -43.26 99.26 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.196 -176.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -59.01 -39.23 81.24 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.335 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.579 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 25.8 tp -77.7 -45.61 24.33 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.074 0.464 . . . . 0.0 109.826 177.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -56.9 -44.47 82.39 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 123.887 0.875 . . . . 0.0 111.971 -177.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.5 t -71.91 -31.07 66.01 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.47 177.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.64 -45.0 88.68 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.579 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 42.5 mt -63.79 -39.98 95.57 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.27 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.0 m -69.09 -33.14 73.04 Favored 'General case' 0 CA--C 1.562 1.426 0 CA-C-O 121.268 0.556 . . . . 0.0 110.504 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.03 -40.47 65.1 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.563 0.697 . . . . 0.0 111.583 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -91.23 18.32 7.14 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 114.959 -1.018 . . . . 0.0 111.902 -174.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.546 ' NH1' ' HA ' ' A' ' 88' ' ' HIS . 35.5 ttt180 54.66 64.08 1.93 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.612 1.165 . . . . 0.0 113.479 179.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.423 HD11 ' HB2' ' A' ' 76' ' ' LYS . 89.7 mt -119.68 123.56 71.24 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.706 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 174.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.32 135.19 34.78 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.164 -177.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -155.8 150.7 26.37 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 123.208 0.317 . . . . 0.0 111.564 -176.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -109.44 136.07 49.45 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 172.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 10.0 pt-20 -102.77 142.48 33.85 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.819 178.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -84.07 154.85 3.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-O 121.259 0.552 . . . . 0.0 111.979 -173.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -71.59 -2.21 16.26 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 126.707 2.003 . . . . 0.0 113.245 -174.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.433 HD13 HG21 ' A' ' 46' ' ' VAL . 3.3 pt -44.12 -24.38 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 117.166 2.284 . . . . 0.0 117.166 -167.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -63.52 -41.48 98.5 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.853 0.835 . . . . 0.0 109.058 176.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 56.7 t60 -94.85 -41.76 9.05 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.581 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.467 ' ND2' ' H ' ' A' ' 42' ' ' ALA . 42.1 t30 -85.47 109.94 18.83 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.124 0.487 . . . . 0.0 111.574 -178.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -75.88 -16.68 60.01 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.683 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.11 -43.85 41.34 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -175.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.467 ' H ' ' ND2' ' A' ' 39' ' ' ASN . . . -81.32 -22.79 38.26 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.377 0.608 . . . . 0.0 109.881 177.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.37 -27.13 68.35 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.617 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -64.61 -33.25 75.49 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.942 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -67.54 -36.8 81.67 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.433 HG21 HD13 ' A' ' 36' ' ' ILE . 57.3 t -64.87 -45.68 94.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.999 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.64 -21.02 76.2 Favored Glycine 0 C--O 1.218 -0.881 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.862 178.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.6 t -81.87 -41.62 20.73 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 122.798 0.439 . . . . 0.0 110.798 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.2 p -82.22 -31.43 10.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -96.19 137.02 35.87 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.807 0.337 . . . . 0.0 110.156 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.85 136.14 12.9 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.78 -174.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.32 -88.17 1.58 Allowed Glycine 0 N--CA 1.43 -1.702 0 CA-C-N 115.436 -0.382 . . . . 0.0 112.501 177.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -93.29 162.21 14.09 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -85.48 83.43 7.93 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 173.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.6 m -60.96 127.76 33.15 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.498 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.514 HG22 ' SG ' ' A' ' 14' ' ' CYS 1.539 12.0 m -68.47 -75.05 0.14 Allowed Pre-proline 0 CA--C 1.433 -3.548 1 N-CA-C 123.902 4.778 . . . . 0.0 123.902 179.509 . . . . . . . . 4 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.446 ' HD3' ' SG ' ' A' ' 17' ' ' CYS . 98.3 Cg_endo -74.15 89.69 1.03 Allowed 'Trans proline' 0 N--CA 1.403 -3.812 0 CA-C-N 121.218 1.471 . . . . 0.0 112.004 -167.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.7 m -114.42 116.81 29.49 Favored 'General case' 0 N--CA 1.397 -3.1 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 -177.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.13 139.68 23.41 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.137 -176.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -115.2 121.14 42.03 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.435 ' CE2' ' HB3' ' A' ' 78' ' ' LYS . 97.0 m-85 -101.58 155.89 17.81 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.27 -9.87 27.6 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.696 0.76 . . . . 0.0 110.583 176.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -64.92 -18.77 65.51 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.893 1.277 . . . . 0.0 109.906 176.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.43 18.18 36.79 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.501 177.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 27.8 t -133.94 153.73 51.57 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -178.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.2 p -114.33 139.52 49.38 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.578 177.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.9 mp -119.33 123.88 45.26 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 18.2 m -97.67 112.69 24.47 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 54.03 68.81 2.51 Favored Pre-proline 0 N--CA 1.489 1.483 0 C-N-CA 124.437 1.095 . . . . 0.0 112.885 -171.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -85.56 165.26 10.67 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.759 1.639 . . . . 0.0 109.855 172.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.3 m -84.49 159.75 20.68 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 177.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.52 -43.28 79.65 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 122.971 0.508 . . . . 0.0 111.807 -177.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -58.92 -42.37 89.55 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.976 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.481 ' O ' ' HE2' ' A' ' 78' ' ' LYS . 56.2 mm-40 -61.15 -44.39 97.39 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.243 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.8 t -65.83 -48.0 83.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.413 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.423 ' HB2' HD11 ' A' ' 29' ' ' ILE . 57.5 tttp -61.43 -43.81 98.21 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.998 -177.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.1 -35.31 69.15 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.029 0.442 . . . . 0.0 111.369 -178.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.481 ' HE2' ' O ' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -74.22 -31.43 62.61 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 119.994 -0.683 . . . . 0.0 110.13 177.377 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 16.5 tp -63.21 -48.4 78.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.188 0.518 . . . . 0.0 109.761 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.7 m -65.21 -30.29 49.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.66 -176.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.415 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -80.94 -25.81 37.14 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.123 -0.631 . . . . 0.0 111.21 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.4 pp -85.24 -32.03 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.202 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.23 -62.06 1.81 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.78 -109.37 1.63 Allowed Glycine 0 N--CA 1.429 -1.784 0 C-N-CA 120.475 -0.869 . . . . 0.0 113.001 177.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -67.62 -44.53 77.81 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 123.069 0.548 . . . . 0.0 110.342 -176.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -76.6 98.1 4.59 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.661 0.743 . . . . 0.0 111.516 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 21.6 p-80 -97.31 128.83 44.49 Favored 'General case' 0 N--CA 1.423 -1.794 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.802 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.546 ' HA ' ' NH1' ' A' ' 28' ' ' ARG . 82.3 m-70 . . . . . 0 C--N 1.293 -1.881 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtm . . . . . 0 CA--C 1.509 -0.617 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.5 p -98.7 -11.83 8.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 174.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.5 p -70.08 123.79 22.46 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.343 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.37 117.18 22.24 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.337 -177.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.72 -33.63 62.42 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 172.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.0 mt -119.28 117.93 29.89 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.675 -1.148 . . . . 0.0 107.933 175.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.9 m -102.36 108.04 19.25 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 59.4 mt -108.06 134.49 49.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-O 121.629 0.728 . . . . 0.0 110.26 -176.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -91.19 120.12 31.85 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.031 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.528 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 24.9 p -139.67 162.13 35.85 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.375 0.27 . . . . 0.0 111.193 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.5 p -155.69 -175.1 5.26 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 125.316 1.446 . . . . 0.0 107.684 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.7 t -76.72 -11.03 59.78 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.984 0.421 . . . . 0.0 109.871 172.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 4.1 m0 -83.98 44.96 1.04 Allowed 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 41.3 t -133.97 126.46 30.34 Favored 'General case' 0 N--CA 1.416 -2.143 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -166.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -128.72 -69.91 0.13 Allowed Glycine 0 N--CA 1.437 -1.24 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 170.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -61.66 -18.34 59.13 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.37 -33.98 70.02 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.218 0.532 . . . . 0.0 110.516 177.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 84.1 mt -65.38 -37.28 86.53 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.348 -178.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 -52.58 -48.59 66.13 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 124.274 0.984 . . . . 0.0 110.099 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.4 tp -74.12 -45.8 46.67 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.658 -177.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.7 pttp -70.86 -26.91 63.47 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 119.285 -0.966 . . . . 0.0 112.123 -173.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.9 p -74.98 -28.49 60.57 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.848 -0.532 . . . . 0.0 110.311 175.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.46 -42.06 88.14 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 175.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.1 mt -63.32 -47.54 81.8 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.991 177.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.3 m -57.73 -47.06 83.48 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.811 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.69 -25.61 68.28 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.301 0.572 . . . . 0.0 111.936 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -95.5 6.88 47.82 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.027 -178.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 16.3 mmm180 67.53 24.0 8.78 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.78 0.832 . . . . 0.0 112.551 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 73.2 mt -83.89 120.76 35.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 176.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.52 127.7 34.9 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.4 -176.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -140.27 169.27 18.0 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -136.52 142.52 43.47 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.528 ' HB2' ' OG1' ' A' ' 10' ' ' THR . 10.3 pt-20 -105.32 131.58 52.59 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 123.659 0.599 . . . . 0.0 110.939 -176.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.4 t -78.84 143.61 12.35 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -172.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -59.65 -1.3 0.24 Allowed 'General case' 0 N--CA 1.503 2.215 0 C-N-CA 128.826 2.85 . . . . 0.0 114.878 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.2 pt -44.22 -25.19 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 117.092 2.256 . . . . 0.0 117.092 -168.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -70.91 -25.49 62.79 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 118.967 0.803 . . . . 0.0 109.096 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -97.97 -35.48 10.44 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.257 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . 0.254 0.2 OUTLIER -112.62 118.69 35.77 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.959 0.885 . . . . 0.0 112.667 179.448 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.563 ' HD3' ' H ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -75.85 -18.9 59.27 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.655 -174.88 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.87 -53.52 56.34 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.789 0.328 . . . . 0.0 111.496 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.412 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -72.82 -21.1 61.02 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.913 177.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.88 -35.46 76.9 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.126 0.489 . . . . 0.0 110.714 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -73.9 -29.28 61.98 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.951 0.405 . . . . 0.0 110.269 177.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -65.21 -29.8 70.64 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.788 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 42' ' ' ALA . 48.0 t -63.03 -30.83 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.834 176.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.75 -43.13 60.27 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 178.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.2 m -65.22 -28.82 69.63 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.222 0.609 . . . . 0.0 112.359 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.8 m -84.61 -5.03 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 O-C-N 121.655 -0.653 . . . . 0.0 111.594 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -104.83 -52.94 2.77 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.638 176.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 143.64 -37.9 1.41 Allowed Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -167.24 -47.73 0.03 OUTLIER Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -88.64 177.31 6.79 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.0 mtm180 -126.19 116.85 21.95 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.407 HG23 ' HD2' ' A' ' 57' ' ' PRO . 16.3 m -98.02 151.16 20.62 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 174.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.43 ' CG1' ' HA ' ' A' ' 10' ' ' THR . 34.5 t -79.38 -69.13 0.21 Allowed Pre-proline 0 CA--C 1.475 -1.926 0 CA-C-O 117.509 -1.234 . . . . 0.0 113.988 -178.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.407 ' HD2' HG23 ' A' ' 55' ' ' THR . 72.8 Cg_endo -76.07 86.68 1.5 Allowed 'Trans proline' 1 N--CA 1.393 -4.387 0 CA-C-N 120.867 1.345 . . . . 0.0 111.797 -163.121 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 64.0 m -121.64 124.88 45.37 Favored 'General case' 1 N--CA 1.373 -4.299 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 -175.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 66' ' ' THR . 4.6 p -115.53 136.1 53.44 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.956 -175.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 29.7 ttpp -111.74 123.19 49.72 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 174.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.402 ' HB3' HG21 ' A' ' 82' ' ' ILE . 88.2 m-85 -92.03 175.61 6.81 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.015 -178.22 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.423 ' HB2' ' HB ' ' A' ' 82' ' ' ILE . . . -66.44 -22.84 66.22 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.538 ' OD2' HG23 ' A' ' 82' ' ' ILE . 48.9 m-20 -82.17 0.07 42.65 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.198 0.523 . . . . 0.0 111.046 177.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.57 -0.8 87.02 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.939 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.1 m -68.27 130.45 42.94 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.42 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 6.4 p -114.13 137.8 51.27 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 176.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.9 mt -134.61 121.67 21.23 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.926 0.393 . . . . 0.0 110.432 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 91.8 m -90.92 121.83 33.09 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 174.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 58.33 65.64 3.01 Favored Pre-proline 0 N--CA 1.472 0.629 0 C-N-CA 124.284 1.033 . . . . 0.0 113.055 -177.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -84.0 -178.88 3.72 Favored 'Trans proline' 0 C--O 1.25 1.117 0 C-N-CA 121.694 1.596 . . . . 0.0 110.463 171.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.461 ' O ' HG21 ' A' ' 75' ' ' VAL . 3.4 m -112.09 150.83 30.16 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.41 -41.92 66.48 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -174.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -78.27 -34.83 48.71 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.948 0.404 . . . . 0.0 109.953 -178.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -65.06 -37.53 87.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.273 178.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.461 HG21 ' O ' ' A' ' 71' ' ' SER . 91.7 t -61.44 -42.17 92.81 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.626 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -62.52 -41.1 98.63 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.984 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.437 ' O ' HG23 ' A' ' 80' ' ' VAL . . . -69.42 -31.58 70.01 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.504 0.669 . . . . 0.0 111.289 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -78.11 -29.71 49.11 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 176.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 31.1 tp -65.94 -41.57 91.12 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.445 179.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 77' ' ' ALA . 27.4 m -66.12 -36.19 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -72.99 -34.37 66.37 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.943 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.538 HG23 ' OD2' ' A' ' 63' ' ' ASP . 2.1 pp -77.02 -31.53 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 120.344 -0.543 . . . . 0.0 111.246 -177.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.63 -46.92 18.14 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.062 0.458 . . . . 0.0 110.145 177.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 82.48 -65.28 4.13 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.654 -0.578 . . . . 0.0 111.654 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.6 mt -99.65 -178.28 3.83 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 74.24 -53.77 0.68 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.078 1.351 . . . . 0.0 112.202 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 -72.02 -23.86 61.46 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 121.522 0.677 . . . . 0.0 110.09 176.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 . . . . . 0 N--CA 1.421 -1.909 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 177.526 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.3 mmt . . . . . 0 CA--C 1.506 -0.719 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 97.6 t -80.93 -32.58 12.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -178.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 82.3 p 63.92 142.08 0.02 OUTLIER 'General case' 0 C--O 1.239 0.507 0 C-N-CA 126.445 1.898 . . . . 0.0 112.066 -174.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -78.3 150.64 33.28 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-O 120.902 0.382 . . . . 0.0 110.066 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.88 -5.27 47.77 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.357 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.84 123.12 41.01 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 121.397 0.618 . . . . 0.0 109.679 175.13 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.1 m -110.16 112.3 24.2 Favored 'General case' 0 C--N 1.276 -2.605 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 177.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.499 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 57.5 mt -97.88 137.17 26.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.049 -174.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -92.72 117.91 30.5 Favored 'General case' 0 C--N 1.279 -2.459 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.512 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 14.0 p -128.68 155.92 44.29 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 122.511 0.324 . . . . 0.0 110.589 -178.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.47 ' HA ' ' HG2' ' A' ' 37' ' ' GLU . 46.9 p -140.2 175.41 9.62 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.8 m -86.03 -11.41 52.95 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 175.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 8.5 m0 -82.18 -20.23 38.28 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.312 -169.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.473 ' SG ' HG11 ' A' ' 56' ' ' VAL . 9.0 p -109.39 148.33 31.28 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -172.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -101.99 -42.37 2.27 Favored Glycine 0 N--CA 1.432 -1.586 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 172.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -59.75 -24.7 64.25 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -177.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.9 p -68.52 -39.14 81.33 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.448 0.642 . . . . 0.0 109.931 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 37.2 tp -69.29 -28.93 66.72 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.549 -175.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -63.39 -50.82 68.37 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.013 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.438 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 41.4 tp -68.5 -36.84 79.47 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.101 0.477 . . . . 0.0 109.908 178.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -56.56 -37.29 70.34 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.479 177.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.9 m -75.15 -40.11 59.85 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.117 178.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.83 -41.03 94.95 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.818 0.447 . . . . 0.0 111.123 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 81.9 mt -66.13 -33.77 76.53 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.76 178.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.7 m -65.55 -44.25 87.4 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.002 177.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.44 -26.89 65.74 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.561 0.696 . . . . 0.0 110.963 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -84.53 4.35 32.37 Favored 'General case' 0 C--O 1.254 1.3 0 C-N-CA 123.907 0.883 . . . . 0.0 111.858 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 60.3 37.12 20.51 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.931 1.293 . . . . 0.0 110.252 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 85.2 mt -95.61 122.74 47.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.625 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.04 125.2 31.18 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 176.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -135.69 148.67 48.99 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 120.707 0.289 . . . . 0.0 110.671 -178.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -111.04 123.73 50.78 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 174.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.512 ' HB2' ' OG1' ' A' ' 10' ' ' THR . 15.7 pt-20 -96.91 151.04 20.08 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.9 t -90.92 143.63 10.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-O 122.163 0.982 . . . . 0.0 113.497 -171.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -63.59 -2.1 1.52 Allowed 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 128.305 2.642 . . . . 0.0 114.822 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.4 pt -45.28 -24.84 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -175.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.47 ' HG2' ' HA ' ' A' ' 11' ' ' THR . 45.3 mt-10 -55.8 -31.7 62.87 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.355 0.662 . . . . 0.0 111.427 178.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -128.08 20.56 6.37 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.22 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.429 ' ND2' ' H ' ' A' ' 42' ' ' ALA . 28.7 t30 -143.52 122.18 12.57 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.957 0.408 . . . . 0.0 111.26 -178.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -77.15 -28.21 54.1 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.421 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.04 -37.48 81.38 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 -172.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.429 ' H ' ' ND2' ' A' ' 39' ' ' ASN . . . -84.19 -24.75 29.98 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 120.113 -0.635 . . . . 0.0 109.466 176.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.79 -30.28 68.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.288 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -64.4 -36.6 84.68 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 114.97 -1.013 . . . . 0.0 108.737 178.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -67.53 -31.78 72.11 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.123 0.487 . . . . 0.0 110.463 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 43.6 t -66.49 -31.42 53.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.33 -23.65 67.68 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.321 176.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 42.3 t -67.94 -43.72 78.47 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 176.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 31.5 m -81.06 -39.52 17.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.923 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.417 ' HB3' ' O ' ' A' ' 53' ' ' ASN . 54.5 m-80 -106.97 109.22 21.06 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 120.862 0.363 . . . . 0.0 110.701 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -81.93 128.17 8.33 Favored Glycine 0 N--CA 1.439 -1.116 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.798 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.31 -84.25 1.37 Allowed Glycine 0 N--CA 1.438 -1.204 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.417 ' O ' ' HB3' ' A' ' 50' ' ' ASN . 93.0 m-20 -88.64 122.61 32.27 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -80.63 94.03 6.24 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.821 177.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.8 m -67.0 123.71 20.99 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 175.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.473 HG11 ' SG ' ' A' ' 14' ' ' CYS . 16.5 t -72.89 -60.56 1.85 Allowed Pre-proline 0 CA--C 1.462 -2.412 0 CA-C-O 117.149 -1.405 . . . . 0.0 114.746 -172.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -77.74 72.17 6.21 Favored 'Trans proline' 1 N--CA 1.394 -4.343 0 CA-C-N 121.185 1.459 . . . . 0.0 112.782 -167.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 88.2 m -106.35 142.12 36.54 Favored 'General case' 0 N--CA 1.38 -3.96 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.6 p -136.81 139.16 45.24 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.862 -174.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -104.54 128.59 52.53 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -112.4 166.43 11.3 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.102 0.477 . . . . 0.0 110.489 177.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.34 -8.84 53.65 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.142 171.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -62.91 -17.07 61.29 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.111 1.764 . . . . 0.0 110.997 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.68 8.67 55.69 Favored Glycine 0 CA--C 1.506 -0.517 0 C-N-CA 120.743 -0.741 . . . . 0.0 113.78 173.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.0 t -150.71 173.75 13.81 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.8 p -114.13 139.68 49.14 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -178.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mp -106.09 151.79 24.23 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 177.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 18.2 m -131.48 113.79 14.13 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -177.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.7 m120 61.05 44.96 0.84 Allowed Pre-proline 0 N--CA 1.485 1.322 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -175.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.28 160.33 32.69 Favored 'Trans proline' 0 C--N 1.366 1.464 0 C-N-CA 121.305 1.337 . . . . 0.0 111.098 179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.1 m -84.27 155.25 22.52 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.42 -42.12 70.12 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.717 0.807 . . . . 0.0 112.172 -177.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -61.46 -40.39 94.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.593 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -67.11 -40.81 86.92 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-O 121.075 0.464 . . . . 0.0 110.089 -178.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.3 t -61.22 -43.82 97.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.619 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -68.61 -41.28 79.73 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.452 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.11 -38.88 89.28 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 122.703 0.401 . . . . 0.0 111.033 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.648 ' O ' HG13 ' A' ' 82' ' ' ILE . 28.7 mmtp -69.48 -39.78 77.48 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.366 174.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.9 tp -60.53 -51.07 70.99 Favored 'General case' 0 C--N 1.318 -0.781 0 O-C-N 123.475 0.485 . . . . 0.0 110.729 -178.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.6 m -61.67 -31.41 50.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -177.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.44 ' HB3' ' HZ3' ' A' ' 81' ' ' LYS . 0.4 OUTLIER -81.09 -44.32 18.16 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 119.801 -0.76 . . . . 0.0 111.575 -179.8 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.648 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.2 pp -82.1 -20.37 10.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -175.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.38 4.14 43.7 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.208 0.527 . . . . 0.0 111.504 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.14 179.1 51.71 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.875 -0.679 . . . . 0.0 114.511 173.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.6 tp -63.4 -26.79 68.9 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 124.609 1.164 . . . . 0.0 110.8 -177.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -66.71 -26.35 66.97 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.651 -1.159 . . . . 0.0 112.013 -175.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -101.3 112.82 25.44 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.634 0.73 . . . . 0.0 111.161 -177.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 7.0 p80 . . . . . 0 C--N 1.306 -1.308 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -176.902 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.1 mtp . . . . . 0 CA--C 1.497 -1.058 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.3 t -76.76 96.72 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 29.0 m -83.08 -47.59 11.5 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.28 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -97.87 76.57 2.45 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 121.381 0.61 . . . . 0.0 111.518 -177.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -82.6 -24.52 33.85 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 173.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.74 130.71 21.76 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-N 113.561 -1.654 . . . . 0.0 108.922 174.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.5 m -102.94 117.32 34.34 Favored 'General case' 0 C--N 1.274 -2.679 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 68.9 mt -108.86 133.61 53.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 121.446 0.641 . . . . 0.0 110.93 -175.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -85.12 127.42 34.24 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.598 177.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 39.0 p -133.63 163.17 30.03 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.0 0.429 . . . . 0.0 111.215 -178.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.3 m -147.87 151.6 36.19 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 175.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.4 p -58.41 -42.91 88.27 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 118.534 0.606 . . . . 0.0 109.736 174.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.11 94.36 1.51 Allowed 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 167.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 m -163.82 117.46 1.49 Allowed 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.098 -1.41 . . . . 0.0 111.568 178.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -106.83 -56.93 0.62 Allowed Glycine 0 N--CA 1.428 -1.898 0 N-CA-C 108.681 -1.768 . . . . 0.0 108.681 172.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -69.97 -20.96 63.28 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -179.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.507 ' SG ' ' HB ' ' A' ' 56' ' ' VAL . 3.6 m -72.5 -34.99 68.02 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 177.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 18.3 tp -72.29 -29.39 63.83 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.092 -173.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.432 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 2.2 mmp_? -59.34 -37.59 78.23 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.81 177.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.7 tp -82.58 -41.33 19.69 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.564 178.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -58.61 -45.54 88.96 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.635 -176.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -66.34 -36.73 83.66 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.62 -45.42 86.93 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.947 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.4 mt -67.54 -37.87 83.34 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.359 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.0 m -67.09 -42.72 84.13 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.998 0.428 . . . . 0.0 110.41 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.47 -23.86 65.54 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-O 121.233 0.54 . . . . 0.0 110.801 177.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -93.35 6.63 47.47 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.073 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 64.28 24.21 13.26 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.601 0.76 . . . . 0.0 112.494 176.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 78.1 mt -86.49 120.58 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.4 127.24 33.89 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.634 -178.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -142.47 167.19 22.68 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -129.43 135.59 48.87 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 177.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.475 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 17.0 pt-20 -100.44 141.69 32.94 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.079 0.466 . . . . 0.0 111.408 -177.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.4 t -83.57 146.72 6.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -171.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -63.68 -2.36 1.69 Allowed 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 129.187 2.995 . . . . 0.0 115.923 178.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.7 pt -45.7 -24.34 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 -173.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -70.19 -23.56 62.98 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 121.724 0.773 . . . . 0.0 110.327 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 -111.42 -36.62 5.49 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.926 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.405 ' ND2' ' H ' ' A' ' 42' ' ' ALA . 26.5 t30 -100.85 122.43 43.43 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.095 -175.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.421 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 9.7 ptp85 -75.76 -25.6 56.64 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.379 177.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.95 -36.21 79.72 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -172.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.405 ' H ' ' ND2' ' A' ' 39' ' ' ASN . . . -87.0 -22.23 25.64 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.554 175.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.29 -41.25 81.26 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.766 -178.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 40' ' ' ARG . 19.0 mm-40 -70.13 -24.66 63.22 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.787 178.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -67.35 -32.6 73.66 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.71 177.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 38.9 t -65.54 -39.87 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.82 -18.06 78.67 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.956 178.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.8 t -80.54 -42.63 22.07 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 31.7 m -84.07 -32.62 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -103.52 160.0 15.11 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -178.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -128.74 152.12 19.21 Favored Glycine 0 N--CA 1.432 -1.571 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.065 -178.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.63 -111.91 3.62 Favored Glycine 0 N--CA 1.438 -1.189 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -91.62 147.69 22.82 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 175.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -71.49 96.7 1.54 Allowed 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.515 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.8 m -61.98 114.81 3.59 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 174.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.507 ' HB ' ' SG ' ' A' ' 17' ' ' CYS . 5.2 t -75.1 -55.33 2.3 Favored Pre-proline 0 N--CA 1.428 -1.541 0 CA-C-O 117.435 -1.269 . . . . 0.0 113.424 -175.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.55 75.6 3.44 Favored 'Trans proline' 0 N--CA 1.41 -3.42 0 CA-C-N 121.155 1.448 . . . . 0.0 112.706 -170.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 58.5 m -106.5 125.66 51.29 Favored 'General case' 0 N--CA 1.381 -3.909 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.73 121.0 60.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-O 121.505 0.669 . . . . 0.0 110.872 -175.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -105.2 110.11 22.35 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -79.34 159.97 26.94 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.585 -178.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.56 -24.27 31.49 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.239 1.016 . . . . 0.0 113.588 -177.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -80.58 -17.1 52.43 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.014 0.435 . . . . 0.0 110.694 -178.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.2 -8.26 30.99 Favored Glycine 0 C--O 1.246 0.885 0 C-N-CA 121.009 -0.615 . . . . 0.0 113.169 178.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.9 t -79.31 135.87 36.86 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.3 m -116.7 138.6 51.34 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.0 mp -121.83 142.16 50.51 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 120.881 0.372 . . . . 0.0 110.748 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.8 m -98.73 116.32 30.69 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 115.503 -0.772 . . . . 0.0 108.982 -178.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . 0.324 25.9 p-10 34.88 74.66 0.53 Allowed Pre-proline 0 N--CA 1.494 1.755 0 N-CA-C 116.825 2.157 . . . . 0.0 116.825 179.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -92.04 -165.43 0.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.405 2.07 . . . . 0.0 110.248 175.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.4 m -115.02 169.99 8.68 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.73 -41.68 87.01 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -177.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . 0.41 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 5.2 m-20 -64.92 -33.76 76.79 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.691 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -64.21 -51.16 65.07 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.8 t -61.0 -44.76 98.88 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.167 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.779 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . 0.41 ' HE2' ' HA ' ' A' ' 73' ' ' ASP . 37.1 ttpt -58.46 -46.68 86.1 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 123.421 0.688 . . . . 0.0 111.991 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.36 -22.19 61.19 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 120.874 0.369 . . . . 0.0 111.538 -178.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.441 ' O ' HG13 ' A' ' 82' ' ' ILE . 45.3 mmtm -81.55 -40.75 22.63 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 173.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 27.1 tp -55.68 -47.66 76.38 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 123.721 0.808 . . . . 0.0 109.603 -178.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.8 m -60.53 -36.77 72.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.728 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -82.11 -36.35 27.6 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.4 pp -84.6 -29.53 6.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 113.477 0.918 . . . . 0.0 113.477 -176.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.22 -30.83 15.7 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 97.31 -144.39 17.3 Favored Glycine 0 N--CA 1.427 -1.955 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.27 -30.82 67.94 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 120.661 0.267 . . . . 0.0 110.772 -178.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -98.14 93.91 6.52 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-O 121.31 0.576 . . . . 0.0 109.915 178.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 12.6 p-80 -118.62 -0.92 11.24 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.597 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 . . . . . 0 C--O 1.251 1.178 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 172.806 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 ptp . . . . . 0 CA--C 1.507 -0.681 0 N-CA-C 110.499 -0.186 . . . . 0.0 110.499 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.9 m -96.1 177.16 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -172.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 61.0 m -146.32 116.64 7.46 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 105.159 -2.164 . . . . 0.0 105.159 173.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -130.35 173.65 10.61 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.174 -0.61 . . . . 0.0 112.36 -177.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.58 1.0 27.63 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.866 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.6 mp -98.52 104.82 16.89 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.163 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.4 m -102.56 107.3 18.19 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 173.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.0 mt -106.83 129.85 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 CA-C-O 121.687 0.755 . . . . 0.0 111.555 -173.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -94.09 106.67 18.64 Favored 'General case' 0 N--CA 1.406 -2.654 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.408 176.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 2.1 p -140.23 142.29 35.82 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.817 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.4 m -84.37 154.41 22.88 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 175.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 p -62.07 -51.98 65.77 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 46.3 p90 -83.28 92.67 7.54 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-O 121.914 0.864 . . . . 0.0 110.917 176.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.4 t -163.84 117.13 1.47 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.483 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.44 -36.13 15.24 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -62.96 -39.18 93.89 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.462 0.648 . . . . 0.0 109.683 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 55.7 m -68.09 -39.21 82.91 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.252 177.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.83 -38.63 82.6 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 123.832 0.853 . . . . 0.0 110.112 -177.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -57.12 -38.78 73.93 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.581 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.442 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 19.5 tp -78.89 -44.08 23.54 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.174 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -54.42 -49.49 69.85 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.908 -178.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.9 p -65.49 -33.68 76.51 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.963 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.21 -42.33 88.9 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.246 178.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.442 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 80.3 mt -64.34 -48.52 75.26 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.486 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 87.1 m -54.91 -42.57 72.37 Favored 'General case' 0 CA--C 1.553 1.088 0 CA-C-O 121.058 0.456 . . . . 0.0 110.768 177.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.15 -13.29 60.2 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -177.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -109.4 14.34 23.69 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 65.99 17.33 10.77 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.84 1.256 . . . . 0.0 112.256 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 63.3 mt -87.37 117.32 31.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.99 144.55 28.22 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.4 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -152.3 150.97 30.33 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 120.678 0.275 . . . . 0.0 111.059 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -114.11 113.01 24.13 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 176.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -91.37 145.02 24.98 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.0 t -90.73 151.8 3.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -171.076 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.67 -4.23 0.06 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 129.641 3.177 . . . . 0.0 114.91 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.8 pt -49.51 -22.48 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 116.49 2.033 . . . . 0.0 116.49 -168.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -72.73 -13.41 61.33 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 121.458 0.647 . . . . 0.0 111.808 -178.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 34.4 p-80 -128.59 -34.87 1.97 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.615 170.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.432 ' ND2' ' H ' ' A' ' 42' ' ' ALA . 44.3 t30 -80.23 107.23 12.85 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 120.692 0.282 . . . . 0.0 110.77 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -70.77 -23.68 62.45 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.313 -179.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.52 -42.1 71.7 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -176.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.432 ' H ' ' ND2' ' A' ' 39' ' ' ASN . . . -80.02 -23.47 41.45 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.361 177.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.72 -35.42 77.12 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.283 177.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -61.28 -39.66 91.23 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.085 175.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -66.06 -30.96 71.58 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.633 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 88.1 t -64.31 -36.83 78.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.5 -19.01 77.0 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.602 177.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.0 m -76.52 -30.65 57.24 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 177.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.5 m -98.79 -11.38 8.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -125.48 105.13 8.82 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 175.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.99 135.06 23.96 Favored Glycine 0 C--N 1.298 -1.534 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.926 -175.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.25 -59.31 4.99 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.383 -0.409 . . . . 0.0 113.574 176.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -125.75 133.34 52.11 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 -176.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.4 mtm180 -70.63 95.69 1.12 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.307 0.575 . . . . 0.0 110.788 176.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.0 m -77.04 131.02 38.2 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 1.716 15.3 m -58.46 -89.78 0.0 OUTLIER Pre-proline 0 CA--C 1.438 -3.338 1 N-CA-C 123.659 4.689 . . . . 0.0 123.659 -178.891 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -69.9 94.02 0.54 Allowed 'Trans proline' 0 N--CA 1.409 -3.48 0 CA-C-N 120.799 1.321 . . . . 0.0 112.508 -165.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.5 m -119.69 112.42 19.26 Favored 'General case' 0 N--CA 1.407 -2.609 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 -177.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.4 p -103.41 134.85 43.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-O 121.405 0.622 . . . . 0.0 111.211 -176.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -109.03 116.93 32.91 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -100.32 178.81 4.65 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.57 -9.16 24.23 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 122.346 1.07 . . . . 0.0 110.153 174.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -63.01 -19.33 64.25 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.876 1.67 . . . . 0.0 110.152 175.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.51 -22.81 14.63 Favored Glycine 0 C--O 1.238 0.353 0 CA-C-N 116.137 -0.483 . . . . 0.0 113.396 176.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.1 t -100.78 171.57 7.6 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.7 p -113.81 141.13 47.68 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 46.7 tp -115.11 125.25 53.26 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 178.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.9 m -105.24 144.76 31.59 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -175.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.6 p30 50.04 48.41 5.98 Favored Pre-proline 0 N--CA 1.491 1.59 0 C-N-CA 124.78 1.232 . . . . 0.0 113.043 -179.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -80.94 160.66 21.06 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 121.991 1.794 . . . . 0.0 112.703 -174.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.3 m -97.4 153.8 17.86 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 174.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.84 -35.54 73.08 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.044 0.45 . . . . 0.0 111.664 -176.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -62.44 -44.18 97.04 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.218 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -64.38 -41.19 96.82 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.581 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.9 t -57.82 -51.72 66.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.068 178.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -60.96 -44.11 97.77 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.379 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.05 -37.91 84.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.674 -178.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -68.81 -41.24 78.91 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 177.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.17 -49.74 74.62 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 123.796 0.685 . . . . 0.0 110.121 -175.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.5 m -61.88 -35.93 70.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.485 ' HZ2' ' HB2' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -81.14 -31.24 34.25 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 119.771 -0.772 . . . . 0.0 111.731 -178.985 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.4 pp -75.02 -21.52 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.51 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.87 4.75 35.91 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.682 176.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 96.46 -105.56 3.24 Favored Glycine 0 N--CA 1.424 -2.161 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.1 mt -138.85 19.57 2.66 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 173.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -97.78 142.75 29.17 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 15.7 m170 75.69 9.71 3.49 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.125 0.97 . . . . 0.0 110.739 -172.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 . . . . . 0 N--CA 1.426 -1.63 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 177.4 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.355 0 CA-C-O 120.269 0.08 . . . . 0.0 111.182 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.7 t -80.55 72.47 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-O 121.839 0.828 . . . . 0.0 108.999 -178.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.7 m -83.87 -21.74 31.87 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.99 -178.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -134.88 163.14 30.5 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.329 -178.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -95.89 1.18 52.83 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.069 0.462 . . . . 0.0 111.466 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.3 tp -132.68 133.27 43.34 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -178.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.0 m -114.86 124.34 51.47 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.551 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 67.0 mt -119.03 144.94 25.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.438 ' HD1' ' O ' ' A' ' 58' ' ' THR . 92.7 m-85 -98.75 133.01 43.68 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.423 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . 17.1 p -140.49 153.85 46.38 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -176.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.3 p -144.69 164.74 30.07 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 175.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.6 p -86.14 -0.82 56.57 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.34 0.591 . . . . 0.0 111.529 177.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -94.68 27.96 2.84 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -174.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.1 t -148.08 151.49 35.76 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -168.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.71 -28.21 0.98 Allowed Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.771 176.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -65.09 -36.46 84.37 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.262 0.553 . . . . 0.0 110.793 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.421 ' HA ' ' HB3' ' A' ' 57' ' ' PRO . 1.7 p -61.0 -32.59 72.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.165 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 81.9 mt -66.73 -28.85 68.75 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.906 -177.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -60.78 -56.08 25.47 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.292 0.568 . . . . 0.0 109.5 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.508 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 16.4 tp -66.79 -39.93 87.97 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.994 -177.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.419 ' HG2' ' OH ' ' A' ' 31' ' ' TYR . 51.1 tttm -58.34 -45.66 87.71 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.847 -177.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.7 p -71.41 -37.47 71.5 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.597 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.47 -42.9 97.18 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 123.066 0.546 . . . . 0.0 110.997 178.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.508 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 76.4 mt -69.26 -42.62 75.32 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.01 -178.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.4 m -62.52 -42.13 99.31 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 120.712 0.291 . . . . 0.0 110.273 177.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.79 -19.0 65.04 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.479 0.657 . . . . 0.0 111.196 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -98.25 9.4 43.07 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.932 178.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.464 ' HA ' ' NE ' ' A' ' 28' ' ' ARG . 4.2 mmp_? 65.96 23.14 11.24 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.54 0.736 . . . . 0.0 112.127 177.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.7 mt -87.15 119.95 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.35 127.16 35.78 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.165 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.419 ' OH ' ' HG2' ' A' ' 21' ' ' LYS . 51.6 p90 -136.52 151.92 49.96 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.878 -178.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -111.38 136.25 50.78 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 173.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.551 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 12.8 pt-20 -102.64 146.23 28.49 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.641 -177.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.3 t -96.04 134.69 32.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -173.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -54.57 -0.59 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 129.529 3.132 . . . . 0.0 115.986 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.6 pt -43.85 -25.46 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.514 2.753 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 -168.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -59.63 -45.55 91.63 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -100.54 -31.27 11.35 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.321 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.426 ' ND2' ' H ' ' A' ' 42' ' ' ALA . 50.1 t30 -88.8 104.45 16.93 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -72.86 -17.69 61.51 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.572 -177.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.31 -46.94 53.52 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -176.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.463 ' O ' HG21 ' A' ' 46' ' ' VAL . . . -75.29 -25.2 57.74 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.268 0.556 . . . . 0.0 110.001 177.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.16 -32.77 74.1 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.41 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -66.29 -39.89 89.67 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -61.18 -46.17 91.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.796 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.463 HG21 ' O ' ' A' ' 42' ' ' ALA . 80.9 t -57.08 -42.34 79.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.492 178.222 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.95 -32.95 76.78 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.299 178.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.3 m -81.87 -25.85 34.71 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 120.925 0.393 . . . . 0.0 111.304 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.6 t -79.41 -39.09 20.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.098 0.475 . . . . 0.0 110.516 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -84.97 -174.61 5.37 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.094 -178.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -90.23 -93.14 1.22 Allowed Glycine 0 N--CA 1.438 -1.201 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.181 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.25 -47.15 3.37 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.705 -174.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -126.22 151.82 46.88 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.3 mtm180 -57.88 111.18 1.07 Allowed 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.73 0.776 . . . . 0.0 111.826 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.5 m -87.95 133.82 33.85 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 178.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.423 ' CG1' ' HA ' ' A' ' 10' ' ' THR . 21.9 t -74.77 -64.46 0.64 Allowed Pre-proline 0 CA--C 1.459 -2.528 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -171.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.421 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . 33.0 Cg_endo -79.36 50.48 3.52 Favored 'Trans proline' 0 N--CA 1.415 -3.136 0 CA-C-N 121.092 1.426 . . . . 0.0 113.349 -164.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.438 ' O ' ' HD1' ' A' ' 9' ' ' TYR . 98.8 m -80.02 136.31 36.56 Favored 'General case' 0 N--CA 1.38 -3.938 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 176.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.3 p -125.74 148.69 30.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.325 -174.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -127.22 119.58 26.73 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -87.91 161.13 17.64 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.408 -178.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.56 -10.5 8.2 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.687 0.795 . . . . 0.0 111.735 176.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -77.68 -18.7 56.39 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.845 176.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.44 -13.35 58.31 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.176 -179.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.2 m -82.12 143.88 31.16 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -178.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.8 p -114.35 148.07 38.17 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.346 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.5 mt -130.16 136.3 49.12 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 175.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 82.9 m -100.63 118.03 35.95 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 176.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 58.18 67.44 2.22 Favored Pre-proline 0 N--CA 1.485 1.318 0 C-N-CA 124.395 1.078 . . . . 0.0 112.282 -178.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -88.24 157.54 6.88 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.776 1.651 . . . . 0.0 112.029 176.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.4 ' O ' HG22 ' A' ' 75' ' ' VAL . 56.5 p -84.79 149.77 25.5 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 175.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.93 -32.83 72.32 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 120.913 0.387 . . . . 0.0 110.318 -178.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -62.11 -49.76 74.6 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.584 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.424 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 19.6 mt-10 -64.89 -42.04 95.12 Favored 'General case' 0 C--O 1.203 -1.386 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.573 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 71' ' ' SER . 89.3 t -57.72 -44.64 86.13 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.633 -179.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -65.86 -44.94 83.92 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.21 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.94 -32.13 72.36 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.214 0.531 . . . . 0.0 111.617 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.435 ' O ' HG13 ' A' ' 82' ' ' ILE . 31.4 mmtp -77.15 -38.14 52.51 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 177.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.6 tp -57.59 -48.26 79.87 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 122.734 0.414 . . . . 0.0 110.061 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.455 ' HA ' ' CE1' ' A' ' 87' ' ' HIS . 34.6 m -60.62 -35.64 65.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.724 -176.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -81.86 -39.89 23.24 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.2 pp -75.31 -12.44 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -176.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.22 3.98 28.77 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.775 177.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 79.39 -146.22 28.7 Favored Glycine 0 CA--C 1.496 -1.14 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.2 tt -94.63 103.99 15.92 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 176.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -150.75 -49.58 0.12 Allowed 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.569 0.7 . . . . 0.0 110.115 -175.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . 0.455 ' CE1' ' HA ' ' A' ' 80' ' ' VAL . 65.3 m80 -78.89 -48.66 14.22 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.838 -178.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 33.8 t60 . . . . . 0 C--N 1.299 -1.62 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -178.911 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 CA--C 1.513 -0.472 0 CA-C-O 120.866 0.365 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.6 m -99.66 -176.48 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -174.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.0 m -54.29 134.81 45.15 Favored 'General case' 0 C--O 1.248 1.0 0 O-C-N 123.957 0.786 . . . . 0.0 110.342 178.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.5 89.14 0.35 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.052 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.25 -31.52 67.63 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 175.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -116.57 115.66 26.16 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 176.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.445 ' HB ' ' HB3' ' A' ' 60' ' ' LYS . 6.2 m -102.26 108.36 19.71 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 177.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.3 mt -104.54 132.35 51.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-O 121.285 0.564 . . . . 0.0 110.697 -175.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -93.92 119.96 33.53 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.425 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.8 p -139.06 156.33 47.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.702 -0.226 . . . . 0.0 110.405 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . 0.408 ' O ' ' HB2' ' A' ' 14' ' ' CYS . 37.5 p -142.57 -178.21 5.66 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.1 p -74.39 -0.79 18.42 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 121.337 0.589 . . . . 0.0 110.646 173.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 4.2 m0 -93.26 6.42 48.14 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 177.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 11' ' ' THR . 6.9 m -91.41 117.1 29.39 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -176.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -122.51 -56.91 0.2 Allowed Glycine 0 N--CA 1.417 -2.583 0 N-CA-C 107.653 -2.179 . . . . 0.0 107.653 170.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -68.48 -18.76 64.47 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 179.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 28.7 m -64.86 -30.46 71.46 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.182 0.515 . . . . 0.0 109.818 178.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 89.2 mt -68.97 -28.37 66.56 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.579 -173.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -63.85 -32.87 74.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.03 0.443 . . . . 0.0 110.836 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.472 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 13.0 tp -84.19 -43.57 14.81 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.374 177.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -55.9 -54.06 49.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.28 -176.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.3 m -63.72 -30.03 71.18 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-O 121.106 0.479 . . . . 0.0 110.973 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.17 -38.68 82.34 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.047 178.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 70.8 mt -69.94 -39.49 76.07 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.788 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 60.5 m -58.55 -43.26 89.27 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-O 121.329 0.585 . . . . 0.0 110.069 174.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.35 -37.77 83.76 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.05 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -79.32 5.8 11.56 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 123.729 0.812 . . . . 0.0 112.712 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 61.84 26.34 15.95 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.81 0.844 . . . . 0.0 111.344 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 76.9 mt -84.89 125.0 40.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 -178.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.29 115.99 26.19 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.488 -176.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -138.35 164.23 29.83 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.328 0.585 . . . . 0.0 111.266 -174.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -127.92 125.94 40.53 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . 0.254 0.0 OUTLIER -100.01 132.78 45.16 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.506 0.67 . . . . 0.0 111.121 178.45 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.0 t -82.7 134.89 25.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -168.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -56.59 -0.69 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 130.544 3.538 . . . . 0.0 114.748 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.5 pt -41.98 -27.87 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 N-CA-C 117.862 2.541 . . . . 0.0 117.862 -163.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -67.92 -13.49 62.2 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 119.529 1.059 . . . . 0.0 113.336 -173.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 -116.17 -4.65 11.92 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 119.916 -0.714 . . . . 0.0 110.479 177.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -128.96 108.77 10.68 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -176.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -52.05 -38.25 56.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 113.577 -1.647 . . . . 0.0 113.818 -176.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.34 -52.38 61.76 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -174.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.426 ' O ' HG22 ' A' ' 46' ' ' VAL . . . -87.0 -26.61 23.69 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.876 -177.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.09 -38.09 87.38 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.351 0.596 . . . . 0.0 110.639 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -72.66 -29.18 63.22 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.152 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -68.39 -29.4 68.08 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.516 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 42' ' ' ALA . 44.9 t -63.66 -32.04 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 121.463 0.649 . . . . 0.0 109.658 177.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.81 -39.93 46.25 Favored Glycine 0 N--CA 1.439 -1.115 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 177.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.2 m -63.79 -29.67 70.85 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.503 0.721 . . . . 0.0 112.331 -178.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.9 m -91.56 -4.86 10.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -116.03 -32.33 5.43 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.55 65.37 0.53 Allowed Glycine 0 N--CA 1.431 -1.651 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.741 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.33 -46.25 2.81 Favored Glycine 0 C--N 1.316 -0.536 0 C-N-CA 121.287 -0.482 . . . . 0.0 112.846 175.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -90.66 154.21 19.74 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -176.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -105.12 82.74 1.88 Allowed 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.48 0.657 . . . . 0.0 109.301 178.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.1 m -74.98 128.08 34.74 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.727 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 1.704 15.3 m -55.23 -88.0 0.0 OUTLIER Pre-proline 0 CA--C 1.447 -2.989 1 N-CA-C 124.219 4.896 . . . . 0.0 124.219 -176.946 . . . . . . . . 3 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -75.88 77.63 3.36 Favored 'Trans proline' 0 N--CA 1.406 -3.672 0 CA-C-N 121.303 1.501 . . . . 0.0 113.251 -167.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.9 m -103.87 130.68 51.48 Favored 'General case' 0 N--CA 1.399 -2.976 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.1 p -114.74 131.96 65.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-O 121.228 0.537 . . . . 0.0 110.095 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.445 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 26.1 ttpp -104.95 119.97 40.3 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 174.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -89.98 168.06 12.31 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.257 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.46 -10.3 57.45 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.329 175.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -71.06 -19.26 62.5 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.252 178.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.53 -22.21 41.68 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -178.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.2 m -82.09 149.96 27.77 Favored 'General case' 0 C--O 1.255 1.383 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.3 p -114.15 139.32 49.44 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.3 mp -117.67 115.89 25.96 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 51.4 m -87.75 112.01 21.95 Favored 'General case' 0 N--CA 1.411 -2.41 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.207 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 54.89 70.88 1.46 Allowed Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 124.673 1.189 . . . . 0.0 112.548 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -94.21 -175.94 0.46 Allowed 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.501 2.134 . . . . 0.0 110.337 173.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.418 ' O ' HG21 ' A' ' 75' ' ' VAL . 10.3 t -100.16 163.4 12.43 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.31 97.36 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 123.199 0.599 . . . . 0.0 112.125 -175.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -60.82 -37.13 80.96 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.927 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -69.91 -41.11 75.11 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.833 -179.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.418 HG21 ' O ' ' A' ' 71' ' ' SER . 98.0 t -59.54 -42.3 87.59 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.562 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 177.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -61.25 -44.0 97.96 Favored 'General case' 0 CA--C 1.556 1.196 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.922 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.02 -24.28 58.34 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.141 0.496 . . . . 0.0 112.227 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -84.86 -25.15 28.22 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 174.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 24.4 tp -68.87 -40.73 79.14 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.3 m -61.78 -32.98 55.58 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.83 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.325 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -81.04 -30.34 34.87 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.651 -0.82 . . . . 0.0 111.077 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.9 pp -85.46 -32.06 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.204 -175.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.21 -61.86 1.32 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.378 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 83.06 21.5 58.97 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 -176.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 32.6 tp -99.99 -46.33 5.38 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 122.348 -0.501 . . . . 0.0 110.616 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -70.77 -43.66 68.32 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.7 m170 -167.23 178.95 5.32 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 126.362 1.865 . . . . 0.0 106.175 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 15.1 p80 . . . . . 0 C--N 1.302 -1.493 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 174.616 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.8 ttm . . . . . 0 N--CA 1.467 0.423 0 CA-C-O 121.248 0.546 . . . . 0.0 110.075 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.3 m -120.62 171.85 8.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 26.2 m -82.31 75.77 9.21 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.865 0.841 . . . . 0.0 110.536 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.54 86.56 5.25 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.89 1.19 57.34 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.848 -177.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -131.82 135.48 46.76 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.939 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.7 m -108.27 124.98 51.14 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 177.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 62.0 mt -113.33 134.56 55.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-O 121.348 0.594 . . . . 0.0 110.556 -176.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.434 ' CD1' HG23 ' A' ' 46' ' ' VAL . 97.3 m-85 -85.83 128.07 34.72 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.43 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 13.7 p -139.19 147.94 42.49 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -176.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 50.9 m -148.88 142.84 25.8 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 171.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.7 p -70.81 -4.39 23.85 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -172.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -39.23 94.1 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 122.553 1.168 . . . . 0.0 111.493 178.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.1 t -93.98 132.65 38.23 Favored 'General case' 0 N--CA 1.42 -1.942 0 CA-C-N 113.491 -1.686 . . . . 0.0 112.754 -169.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -92.74 -35.81 6.33 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.041 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -63.18 -36.35 83.33 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.442 0.639 . . . . 0.0 110.833 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.735 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 62.2 m -57.12 -42.05 80.16 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.257 177.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.3 tt -72.12 -30.21 64.84 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.189 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.3 tpp180 -62.9 -47.27 84.01 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.063 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.43 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 29.7 tp -73.48 -39.04 65.18 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.008 178.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -55.34 -47.45 75.68 Favored 'General case' 0 C--O 1.245 0.861 0 C-N-CA 124.05 0.94 . . . . 0.0 110.639 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 p -69.88 -35.06 74.36 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.573 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.32 -44.94 96.36 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 177.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 87.9 mt -63.71 -39.4 94.21 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.425 178.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.6 m -64.93 -43.55 92.4 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.222 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.2 -22.95 66.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.28 0.562 . . . . 0.0 110.91 178.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -95.34 11.41 32.76 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.34 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 65.97 16.09 10.33 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.834 1.254 . . . . 0.0 111.016 175.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 77.5 mt -78.81 122.64 34.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.654 -0.654 . . . . 0.0 109.262 -179.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.86 129.56 38.74 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.867 -178.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -142.89 161.13 38.91 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.527 -175.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -119.77 124.07 45.27 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 176.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 13.0 pt-20 -91.94 146.08 24.03 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -178.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 t -85.57 156.23 3.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.867 -175.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -83.0 0.3 45.36 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 127.101 2.16 . . . . 0.0 113.683 -176.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.6 pt -42.95 -29.91 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 -168.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -61.14 -33.76 73.92 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.509 0.671 . . . . 0.0 110.186 -179.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -123.74 24.0 8.56 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.026 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -148.91 100.88 3.12 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.244 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -67.66 -21.03 65.38 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.73 -43.31 84.57 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -176.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.47 -20.74 31.24 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.932 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.9 -38.16 90.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.175 178.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -58.06 -39.84 79.48 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.364 174.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -68.83 -29.19 67.47 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.027 -175.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.434 HG23 ' CD1' ' A' ' 9' ' ' TYR . 58.2 t -63.2 -43.59 98.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 177.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.97 -18.88 77.99 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.469 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.7 t -82.43 -30.42 30.11 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 120.6 0.238 . . . . 0.0 110.398 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.7 m -81.75 -37.0 14.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.963 178.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -119.17 87.0 2.65 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 122.439 1.114 . . . . 0.0 109.075 172.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -49.51 118.37 5.37 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 113.293 -1.776 . . . . 0.0 115.566 -170.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.4 -20.72 49.34 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 121.366 -0.445 . . . . 0.0 114.117 175.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -126.74 171.44 11.19 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 117.71 0.755 . . . . 0.0 109.344 -177.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -122.32 70.28 0.98 Allowed 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 170.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.1 m -72.08 122.88 21.69 Favored 'General case' 0 C--O 1.248 1.02 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.69 ' HB ' ' SG ' ' A' ' 17' ' ' CYS . 9.4 t -69.36 -65.85 1.11 Allowed Pre-proline 0 CA--C 1.47 -2.126 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -170.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.735 ' HD3' ' SG ' ' A' ' 17' ' ' CYS . 43.9 Cg_endo -77.04 72.31 5.91 Favored 'Trans proline' 0 N--CA 1.403 -3.827 0 CA-C-N 121.755 1.662 . . . . 0.0 112.744 -167.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.429 ' O ' ' HD2' ' A' ' 9' ' ' TYR . 81.6 m -107.72 131.45 54.41 Favored 'General case' 1 N--CA 1.366 -4.637 0 CA-C-N 112.97 -1.923 . . . . 0.0 106.422 179.819 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.2 p -115.43 134.52 58.34 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.366 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.745 -178.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -112.65 119.28 37.56 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 175.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -88.66 159.44 17.84 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.95 -20.5 38.16 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.525 0.679 . . . . 0.0 111.289 177.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -67.68 -18.55 64.97 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.573 1.149 . . . . 0.0 111.22 177.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.95 -9.17 59.82 Favored Glycine 0 CA--C 1.503 -0.695 0 N-CA-C 111.466 -0.653 . . . . 0.0 111.466 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.8 p -81.07 136.03 35.9 Favored 'General case' 0 N--CA 1.412 -2.338 0 CA-C-N 114.948 -0.626 . . . . 0.0 111.088 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.2 p -114.04 137.93 51.06 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 177.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.3 mp -127.43 128.18 45.35 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 61.5 m -105.35 123.88 48.61 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 55.41 54.23 9.43 Favored Pre-proline 0 N--CA 1.477 0.917 0 C-N-CA 124.258 1.023 . . . . 0.0 113.117 -177.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -83.27 166.48 14.23 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.629 1.553 . . . . 0.0 111.235 178.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.4 m -87.38 155.55 19.98 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 175.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.29 -37.01 83.89 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.924 0.392 . . . . 0.0 111.328 -177.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -64.71 -34.88 79.36 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.885 178.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -67.04 -44.37 80.38 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.1 t -61.01 -45.48 98.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.835 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -58.37 -48.87 79.23 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.185 178.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.33 -22.35 62.81 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.89 0.376 . . . . 0.0 111.92 -178.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.474 ' O ' HG13 ' A' ' 82' ' ' ILE . 47.6 mmtm -80.89 -43.31 20.05 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 39.9 tp -54.3 -48.49 71.24 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.82 0.7 . . . . 0.0 110.475 -176.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.0 m -59.4 -41.31 84.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.135 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -81.36 -38.28 26.88 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -176.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 78' ' ' LYS 0.255 2.5 pp -81.44 -37.4 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -176.886 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.454 ' N ' HD11 ' A' ' 82' ' ' ILE . . . -83.81 -31.17 26.0 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.892 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.2 -50.38 3.96 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 116.287 -0.415 . . . . 0.0 113.929 174.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.406 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 35.6 tp -84.73 27.32 0.75 Allowed 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.452 0.644 . . . . 0.0 111.848 -175.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.79 98.84 7.88 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 175.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 55.88 71.17 0.57 Allowed 'General case' 0 C--O 1.239 0.537 0 O-C-N 124.423 1.077 . . . . 0.0 108.806 -175.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 29.9 t60 . . . . . 0 C--N 1.305 -1.339 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.539 -173.438 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.778 0 CA-C-O 120.861 0.362 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.6 mt -111.54 129.23 56.12 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.975 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.2 m -103.56 107.95 19.01 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 173.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.53 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 57.8 mt -107.27 133.07 53.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 121.059 0.457 . . . . 0.0 109.775 -176.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.44 ' HD1' ' O ' ' A' ' 58' ' ' THR . 89.5 m-85 -87.16 128.18 35.13 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.464 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 21.1 p -140.29 163.93 31.45 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.581 0.229 . . . . 0.0 111.329 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.1 p -146.11 166.51 25.94 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 124.927 1.291 . . . . 0.0 107.795 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.0 t -74.78 -21.86 59.08 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 173.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -81.86 80.46 8.15 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 177.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.8 t -132.94 164.7 26.37 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.436 0.636 . . . . 0.0 112.439 -168.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -167.85 -81.34 0.05 OUTLIER Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 177.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.47 -31.75 68.11 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 123.891 0.876 . . . . 0.0 112.551 177.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.447 ' HA ' ' HB3' ' A' ' 57' ' ' PRO . 0.5 OUTLIER -64.49 -36.99 85.99 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.547 178.08 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 32.2 tp -68.04 -31.88 71.85 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.069 -176.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.9 mmp_? -58.28 -56.13 26.09 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.9 tp -65.09 -39.0 92.55 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.425 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -60.98 -35.94 78.13 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.76 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.9 m -70.51 -44.6 67.26 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.46 -46.33 89.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.898 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.7 mt -68.05 -37.48 81.38 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.4 m -67.12 -40.85 86.87 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 121.007 0.432 . . . . 0.0 110.179 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.65 -25.4 63.9 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.55 0.69 . . . . 0.0 110.94 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -88.25 6.9 34.69 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.983 178.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 72.9 mtm180 65.34 29.12 11.66 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.475 1.11 . . . . 0.0 111.924 176.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.457 HG23 HD22 ' A' ' 79' ' ' LEU . 80.2 mt -91.69 123.41 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.707 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.41 126.26 34.77 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.356 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -136.46 156.67 48.28 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.722 -177.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -118.6 114.85 23.42 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.53 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 16.4 pt-20 -91.12 144.82 25.23 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.217 0.532 . . . . 0.0 110.796 -177.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.6 t -89.53 152.86 3.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-O 122.07 0.938 . . . . 0.0 112.48 -172.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -82.76 2.27 34.75 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 127.944 2.498 . . . . 0.0 114.3 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.1 pt -41.56 -26.79 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.835 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 -167.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -61.83 -41.61 98.0 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.738 0.78 . . . . 0.0 109.131 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -100.66 -36.95 8.96 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.313 -178.009 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -90.92 99.85 12.81 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.26 -178.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -65.04 -38.37 90.64 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -171.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.56 -29.14 70.44 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -174.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.01 -23.42 25.0 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.382 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.67 -39.55 80.57 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.172 0.51 . . . . 0.0 110.117 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.468 ' CD ' HH22 ' A' ' 54' ' ' ARG . 19.2 mm-40 -67.02 -32.26 73.35 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.007 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -67.61 -30.14 69.66 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.756 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.7 t -62.38 -42.93 97.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 53' ' ' ASN . . . -60.55 -34.4 85.71 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.337 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.4 m -68.53 -48.13 65.13 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 122.872 0.469 . . . . 0.0 111.535 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.2 m -73.99 -27.6 22.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -176.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 53' ' ' ASN . 15.4 m120 -87.95 -28.74 21.28 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.128 177.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.15 65.27 1.07 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.364 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.79 -12.43 68.81 Favored Glycine 0 C--N 1.315 -0.609 0 C-N-CA 121.234 -0.507 . . . . 0.0 112.485 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.475 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 93.2 m-20 -111.91 161.38 16.47 Favored 'General case' 0 CA--C 1.486 -1.504 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.468 HH22 ' CD ' ' A' ' 44' ' ' GLU . 84.4 mtt180 -127.64 84.09 2.22 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 173.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.4 m -85.64 132.49 34.15 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.451 ' CG1' ' HA ' ' A' ' 10' ' ' THR . 21.3 t -66.42 -67.12 1.02 Allowed Pre-proline 0 CA--C 1.472 -2.057 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -173.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.447 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . 91.7 Cg_endo -81.15 60.47 7.82 Favored 'Trans proline' 1 N--CA 1.399 -4.073 0 CA-C-N 121.115 1.434 . . . . 0.0 112.915 -164.599 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.44 ' O ' ' HD1' ' A' ' 9' ' ' TYR . 53.6 m -91.23 127.08 36.52 Favored 'General case' 1 N--CA 1.377 -4.075 0 C-N-CA 126.363 1.865 . . . . 0.0 106.731 177.922 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.0 p -115.19 132.73 63.62 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 CA-C-O 120.916 0.389 . . . . 0.0 110.172 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -115.01 126.91 55.29 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 174.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -88.94 173.81 8.28 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.389 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.09 -10.17 47.22 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.978 0.894 . . . . 0.0 109.727 174.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -78.63 -18.64 54.17 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.271 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.02 -22.12 41.33 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.778 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.8 t -75.2 149.79 38.84 Favored 'General case' 0 C--O 1.253 1.284 0 CA-C-O 120.868 0.366 . . . . 0.0 110.61 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.2 p -114.5 139.73 49.31 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.069 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 58.1 mt -119.83 113.91 21.31 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 174.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.8 m -87.22 112.83 22.39 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 58.04 65.43 3.26 Favored Pre-proline 0 N--CA 1.487 1.42 0 C-N-CA 123.939 0.896 . . . . 0.0 112.366 -177.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -86.22 172.93 6.99 Favored 'Trans proline' 0 C--O 1.249 1.073 0 C-N-CA 121.955 1.77 . . . . 0.0 112.003 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.3 m -93.78 153.3 18.38 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 174.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.71 -36.23 83.17 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.111 0.481 . . . . 0.0 110.708 -177.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -59.31 -45.72 90.54 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.974 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -60.02 -50.53 73.36 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.871 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.9 t -58.21 -45.82 88.79 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.519 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.982 -177.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -67.15 -38.13 84.95 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.335 -178.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.55 -31.02 61.96 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.247 0.546 . . . . 0.0 110.869 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -76.59 -37.64 56.14 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.894 175.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.457 HD22 HG23 ' A' ' 29' ' ' ILE . 21.6 tp -58.38 -51.05 71.46 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.6 m -60.49 -32.12 50.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.669 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -81.8 -40.8 22.03 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 119.869 -0.732 . . . . 0.0 112.016 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.3 pp -76.1 -24.43 16.4 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.426 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -176.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -0.99 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 176.77 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.46 0 CA-C-O 121.279 0.561 . . . . 0.0 110.737 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.6 tp -129.51 136.74 50.23 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 89.6 m -123.34 122.16 37.62 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 67.4 mt -111.85 133.49 57.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 121.298 0.571 . . . . 0.0 110.205 -177.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -87.95 129.39 35.26 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.047 176.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.5 p -134.03 166.04 23.64 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.607 -178.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.3 m -149.84 144.08 25.75 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.5 m -54.98 -44.42 74.43 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 123.435 0.459 . . . . 0.0 110.887 176.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 36.5 p90 -86.75 89.17 7.86 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 122.09 0.948 . . . . 0.0 109.459 175.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.1 t -163.57 154.68 16.47 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.072 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -135.89 -44.73 0.1 OUTLIER Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 177.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -63.6 -33.48 75.71 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.131 0.572 . . . . 0.0 111.38 -176.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.445 ' HA ' ' HB3' ' A' ' 57' ' ' PRO . 10.7 p -65.41 -34.48 78.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.28 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 87.9 mt -61.85 -41.94 98.43 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 115.872 -0.603 . . . . 0.0 112.019 -175.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.5 tpm_? -59.11 -44.81 92.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.968 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.9 tp -76.37 -38.64 55.51 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.648 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.471 ' HG2' ' OH ' ' A' ' 31' ' ' TYR . 16.4 ttpp -63.14 -43.46 98.29 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.548 -176.277 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.2 t -71.12 -28.18 64.11 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.34 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.35 -41.87 84.42 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.107 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.446 HD22 HD12 ' A' ' 29' ' ' ILE . 92.7 mt -69.6 -35.22 75.11 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.76 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.6 m -65.95 -42.93 89.37 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.0 -31.67 72.39 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-O 121.416 0.626 . . . . 0.0 110.458 176.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.42 0.44 29.31 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.274 176.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 69.02 28.26 5.15 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.071 1.349 . . . . 0.0 112.176 174.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.446 HD12 HD22 ' A' ' 24' ' ' LEU . 74.7 mt -87.64 123.05 40.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.326 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.92 117.36 22.71 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.681 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.471 ' OH ' ' HG2' ' A' ' 21' ' ' LYS . 46.4 p90 -136.53 164.0 29.2 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -119.85 138.85 53.14 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 171.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 6.7 pt-20 -101.7 137.97 39.31 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -177.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -94.43 138.57 20.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -169.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -60.9 2.13 0.12 Allowed 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 130.186 3.394 . . . . 0.0 116.074 176.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.2 pt -41.3 -27.86 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.519 3.001 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 -162.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -68.97 -24.29 64.22 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 119.552 1.069 . . . . 0.0 110.856 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -113.02 8.63 18.49 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -142.85 89.98 2.17 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-O 121.471 0.653 . . . . 0.0 109.837 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.4 ' HA ' ' HB3' ' A' ' 43' ' ' ALA . 16.3 ptm180 -65.82 -29.23 69.67 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.731 -1.122 . . . . 0.0 113.7 -173.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.81 -37.32 76.12 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.348 0.594 . . . . 0.0 111.303 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.541 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -87.1 -30.38 21.15 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.129 177.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.4 ' HB3' ' HA ' ' A' ' 40' ' ' ARG . . . -64.67 -42.99 94.99 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.108 0.48 . . . . 0.0 111.508 -178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -68.91 -29.34 67.59 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.182 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -68.04 -40.64 82.84 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.265 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 42' ' ' ALA . 73.8 t -52.85 -51.04 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.568 177.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.47 -32.23 83.46 Favored Glycine 0 N--CA 1.437 -1.288 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.319 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.8 t -65.48 -33.73 76.61 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 122.272 0.229 . . . . 0.0 110.996 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.3 m -95.1 -10.0 9.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -178.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -96.29 -51.35 4.42 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.004 0.431 . . . . 0.0 110.018 177.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 133.13 -138.66 10.3 Favored Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 -176.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.99 -21.65 62.73 Favored Glycine 0 C--N 1.306 -1.111 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -101.53 115.07 29.69 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -71.54 114.75 9.95 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 177.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.1 m -99.02 134.5 41.77 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.0 t -75.3 -64.52 0.58 Allowed Pre-proline 0 CA--C 1.463 -2.379 0 CA-C-O 117.23 -1.367 . . . . 0.0 113.98 -176.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.445 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . 82.9 Cg_endo -78.78 65.9 8.7 Favored 'Trans proline' 1 N--CA 1.399 -4.076 0 CA-C-N 121.261 1.486 . . . . 0.0 113.029 -167.067 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 96.3 m -92.32 121.37 33.75 Favored 'General case' 1 N--CA 1.376 -4.169 0 CA-C-N 113.146 -1.843 . . . . 0.0 106.051 178.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 66' ' ' THR . 12.7 p -105.61 137.85 33.48 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.998 -178.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -116.44 121.04 40.72 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -85.31 161.64 19.43 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.928 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -49.69 -32.52 13.56 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -175.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -90.58 -6.75 54.28 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.5 -176.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.6 1.88 30.78 Favored Glycine 0 C--O 1.241 0.551 0 C-N-CA 120.113 -1.041 . . . . 0.0 113.773 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.5 m -73.33 125.49 27.94 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 117.294 0.547 . . . . 0.0 109.651 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 49.5 p -114.2 138.36 50.56 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.9 mp -122.59 118.53 28.42 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 61.2 m -88.05 112.31 22.5 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.11 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 58.86 67.67 1.94 Allowed Pre-proline 0 N--CA 1.482 1.148 0 C-N-CA 124.057 0.943 . . . . 0.0 112.883 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -86.79 -174.73 1.47 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.006 1.804 . . . . 0.0 112.227 176.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.424 ' O ' HG23 ' A' ' 75' ' ' VAL . 50.5 m -116.87 150.41 38.47 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 176.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.78 -48.93 72.07 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -174.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -71.9 -24.2 61.61 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 120.639 0.257 . . . . 0.0 111.665 -176.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.56 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 38.1 mm-40 -71.77 -46.6 57.85 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 173.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 71' ' ' SER . 89.1 t -59.98 -44.12 93.95 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 O-C-N 123.842 0.714 . . . . 0.0 110.113 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.421 ' HB3' ' HE2' ' A' ' 76' ' ' LYS . 33.1 ttpt -62.24 -44.46 96.51 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.652 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.72 -21.17 63.49 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.195 0.522 . . . . 0.0 111.538 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.606 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 46.8 mmtm -84.5 -38.92 19.49 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 175.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.9 tp -56.9 -49.01 76.86 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.767 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.1 m -61.33 -34.1 59.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.152 -177.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.606 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -81.76 -32.66 31.36 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.588 -179.079 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.2 pp -82.21 -12.52 12.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.136 0.493 . . . . 0.0 111.673 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.687 0 CA-C-O 121.394 0.616 . . . . 0.0 110.545 178.209 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 121.116 0.484 . . . . 0.0 110.775 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.9 mt -119.83 137.99 53.65 Favored 'General case' 0 CA--C 1.489 -1.377 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.951 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.4 m -106.91 113.95 27.74 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 174.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.408 HG22 HG23 ' A' ' 10' ' ' THR . 51.9 mt -112.19 125.97 69.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-O 121.473 0.654 . . . . 0.0 110.094 -177.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -80.97 128.14 33.35 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.98 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.489 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 7.4 p -140.85 178.16 7.54 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.056 0.543 . . . . 0.0 111.747 -174.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.523 ' HB ' ' O ' ' A' ' 13' ' ' TRP . 27.4 m -156.42 158.81 37.96 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 177.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.7 m -64.8 -51.62 61.22 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 175.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.523 ' O ' ' HB ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -64.62 109.04 1.87 Allowed 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 168.068 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.0 t -159.44 130.6 6.04 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.465 -170.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -120.97 -78.56 0.51 Allowed Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -66.71 -33.88 76.63 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 120.915 0.388 . . . . 0.0 110.371 -177.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -57.56 -38.57 75.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.984 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -67.82 -35.09 77.99 Favored 'General case' 0 C--O 1.245 0.824 0 C-N-CA 123.675 0.79 . . . . 0.0 109.979 -175.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -62.29 -51.69 66.68 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.216 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.459 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 24.8 tp -68.26 -38.78 82.1 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.072 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -59.16 -43.91 92.09 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.616 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.2 m -68.7 -37.81 79.81 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.273 178.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.61 -42.17 98.25 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.875 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 78.6 mt -68.21 -39.53 82.37 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.623 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.5 m -65.35 -35.86 82.27 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-O 121.446 0.641 . . . . 0.0 109.987 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.2 -26.03 61.89 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-O 121.326 0.584 . . . . 0.0 111.19 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -93.25 11.52 27.76 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.877 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 64.93 25.2 12.75 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.275 1.03 . . . . 0.0 112.394 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 82.0 mt -89.95 116.13 30.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.47 128.82 36.01 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.003 -177.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -137.82 168.96 18.63 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.519 -177.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -119.71 121.54 39.45 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.489 ' HB2' ' OG1' ' A' ' 10' ' ' THR . 12.5 pt-20 -91.81 136.72 32.93 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-O 121.081 0.467 . . . . 0.0 110.408 -178.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.2 t -93.57 156.41 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 -168.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -77.09 -0.47 24.9 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 128.201 2.601 . . . . 0.0 113.866 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.3 pt -44.68 -21.37 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 N-CA-C 116.398 1.999 . . . . 0.0 116.398 -171.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -56.97 -52.65 64.38 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-N 118.834 0.743 . . . . 0.0 109.572 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -97.58 -36.86 10.16 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.136 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -71.12 108.15 4.51 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 120.727 0.299 . . . . 0.0 111.013 -177.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.64 -22.14 57.07 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.316 -177.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.37 -44.95 67.03 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -177.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.87 -24.85 40.94 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.01 177.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.68 -30.2 69.67 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.253 0.549 . . . . 0.0 109.756 177.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -68.77 -33.94 74.73 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.298 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -63.12 -44.1 96.57 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.6 t -60.76 -47.52 92.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.759 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.72 -21.61 69.32 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.545 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.6 m -83.21 -43.59 15.95 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 176.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.8 p -73.54 -33.14 38.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -176.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -118.63 154.75 32.16 Favored 'General case' 0 C--N 1.316 -0.849 0 O-C-N 121.893 -0.504 . . . . 0.0 109.948 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -113.25 156.09 15.85 Favored Glycine 0 N--CA 1.438 -1.212 0 C-N-CA 120.274 -0.965 . . . . 0.0 113.031 -175.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.14 -104.4 1.41 Allowed Glycine 0 N--CA 1.44 -1.085 0 O-C-N 123.866 0.392 . . . . 0.0 113.014 177.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -81.72 119.29 23.66 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -56.91 109.35 0.63 Allowed 'General case' 0 CA--C 1.516 -0.33 0 O-C-N 124.142 0.901 . . . . 0.0 109.348 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.6 m -81.27 123.65 28.67 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.6 t -75.19 -62.32 0.86 Allowed Pre-proline 0 CA--C 1.469 -2.154 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.087 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -79.16 73.41 6.04 Favored 'Trans proline' 1 N--CA 1.397 -4.176 0 CA-C-N 120.604 1.252 . . . . 0.0 112.609 -164.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.5 m -101.92 120.88 41.1 Favored 'General case' 1 N--CA 1.377 -4.116 0 CA-C-N 112.709 -2.041 . . . . 0.0 106.438 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.1 p -113.46 132.61 61.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-O 120.996 0.427 . . . . 0.0 110.882 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -110.22 126.1 53.78 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -92.08 174.07 7.51 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.432 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.25 -18.23 63.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.819 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -73.57 -18.03 61.12 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.19 0.519 . . . . 0.0 110.152 176.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.34 -12.85 64.95 Favored Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -176.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.2 p -75.28 145.71 41.64 Favored 'General case' 0 N--CA 1.421 -1.906 0 C-N-CA 123.211 0.605 . . . . 0.0 111.201 -178.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.6 p -114.1 139.16 49.55 Favored 'General case' 0 N--CA 1.419 -2.002 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.913 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.8 mp -117.05 123.87 47.88 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.2 m -100.82 112.62 25.08 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.894 -176.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 58.65 60.78 5.29 Favored Pre-proline 0 N--CA 1.492 1.668 0 C-N-CA 124.45 1.1 . . . . 0.0 112.906 -176.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -85.48 177.0 5.27 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.102 1.868 . . . . 0.0 111.696 176.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.402 ' O ' HG23 ' A' ' 75' ' ' VAL . 41.7 m -110.99 151.42 27.98 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 175.222 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.79 -34.77 63.11 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -174.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -64.01 -37.25 86.73 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 122.287 0.235 . . . . 0.0 111.192 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -73.53 -42.16 62.1 Favored 'General case' 0 CA--C 1.489 -1.38 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.618 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 71' ' ' SER . 54.5 t -60.44 -40.8 85.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.807 -176.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -66.48 -45.13 80.67 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.866 0.365 . . . . 0.0 110.789 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.9 -35.82 74.9 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.541 0.686 . . . . 0.0 111.4 -177.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -78.13 -22.39 48.91 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 122.064 -0.397 . . . . 0.0 110.304 177.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.436 ' O ' HG13 ' A' ' 82' ' ' ILE . 26.0 tp -71.66 -46.5 58.74 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.7 m -64.94 -28.78 45.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -75.8 -29.46 58.73 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.869 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 79' ' ' LEU . 2.1 pp -85.69 -16.62 9.88 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 CA-C-O 121.443 0.64 . . . . 0.0 111.382 -176.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.672 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.443 178.023 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.548 0 CA-C-O 121.006 0.431 . . . . 0.0 110.617 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.1 tp -117.94 136.86 53.22 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.309 -176.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.496 ' HB ' ' HB3' ' A' ' 60' ' ' LYS . 22.4 m -110.65 117.82 34.54 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 53.1 mt -119.98 143.53 31.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -98.64 127.76 44.68 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.43 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . 25.4 p -137.31 178.52 7.03 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 122.093 0.949 . . . . 0.0 113.459 -174.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.1 m -143.91 147.65 34.3 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 104.181 -2.526 . . . . 0.0 104.181 173.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.5 m -61.15 -43.2 99.25 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.352 0.596 . . . . 0.0 109.897 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 40.7 p90 -92.7 93.37 8.43 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-O 121.808 0.813 . . . . 0.0 111.177 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.9 t -163.3 117.31 1.61 Allowed 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.387 176.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.79 -32.16 13.64 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 111.219 -0.753 . . . . 0.0 111.219 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -68.96 -27.71 65.98 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.721 0.772 . . . . 0.0 109.666 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.435 ' SG ' ' HB ' ' A' ' 56' ' ' VAL . 70.5 m -71.77 -29.88 64.97 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.118 178.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 82.7 mt -70.43 -30.15 66.94 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.285 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -56.62 -44.16 80.94 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.247 177.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.422 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 28.7 tp -79.33 -41.09 28.71 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.623 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -56.76 -45.13 82.24 Favored 'General case' 0 C--O 1.247 0.941 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.6 m -64.04 -38.46 91.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.795 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.16 -44.08 80.65 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.421 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 57.3 mt -69.5 -42.31 74.93 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.445 -178.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.8 m -68.92 -23.51 64.18 Favored 'General case' 0 CA--C 1.56 1.352 0 CA-C-O 121.421 0.629 . . . . 0.0 110.651 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.87 -12.93 57.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.294 0.569 . . . . 0.0 110.482 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -109.39 14.17 23.78 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.27 -178.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.9 ttm180 55.14 62.07 2.65 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.403 1.081 . . . . 0.0 111.079 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.41 ' HB ' ' HB3' ' A' ' 24' ' ' LEU . 75.8 mt -122.78 115.88 47.18 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.046 178.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.17 111.97 22.21 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -116.38 144.59 44.08 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.577 -177.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -113.74 119.78 38.55 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 12.8 pt-20 -95.51 148.13 22.82 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.881 -176.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.434 ' CG1' HG23 ' A' ' 36' ' ' ILE . 25.1 t -96.69 144.88 9.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -172.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -58.63 -1.77 0.17 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 128.714 2.806 . . . . 0.0 114.05 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.434 HG23 ' CG1' ' A' ' 34' ' ' VAL . 2.0 pp -45.24 -20.96 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 -172.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -54.41 -48.84 71.16 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.137 0.494 . . . . 0.0 110.039 174.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -111.46 -29.67 7.69 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.795 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -77.67 103.25 7.5 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.55 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 8.7 ptm180 -71.88 -25.78 62.07 Favored 'General case' 0 C--O 1.21 -0.997 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.935 -178.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.56 -42.62 88.36 Favored 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 113.504 0.928 . . . . 0.0 113.504 -176.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.93 -21.0 26.54 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.694 -0.802 . . . . 0.0 109.956 177.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.429 ' HB3' ' HA ' ' A' ' 40' ' ' ARG . . . -68.4 -33.39 74.16 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.214 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.55 ' HG2' ' O ' ' A' ' 40' ' ' ARG . 61.4 mm-40 -61.56 -36.71 81.4 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.034 178.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -66.9 -37.11 83.76 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.119 0.485 . . . . 0.0 109.979 178.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.2 t -64.0 -42.6 96.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.607 0.718 . . . . 0.0 109.129 177.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.51 -18.96 72.33 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.348 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.3 m -81.42 -38.67 26.11 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.7 m -80.02 -35.11 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -83.65 137.1 33.95 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 176.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -98.89 139.15 14.29 Favored Glycine 0 C--N 1.301 -1.382 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.128 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.53 -87.37 1.03 Allowed Glycine 0 C--N 1.313 -0.731 0 C-N-CA 121.186 -0.53 . . . . 0.0 111.827 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -119.18 145.39 46.05 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -60.95 130.98 49.14 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.664 0.603 . . . . 0.0 111.064 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.7 m -108.55 127.68 54.16 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 177.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.435 ' HB ' ' SG ' ' A' ' 17' ' ' CYS . 8.1 t -73.75 -64.86 0.7 Allowed Pre-proline 0 CA--C 1.468 -2.178 0 CA-C-O 117.091 -1.433 . . . . 0.0 114.245 -171.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -73.75 80.57 2.03 Favored 'Trans proline' 1 N--CA 1.4 -4.018 0 CA-C-N 121.089 1.425 . . . . 0.0 112.65 -168.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 86.8 m -115.02 131.74 56.83 Favored 'General case' 0 N--CA 1.389 -3.503 0 CA-C-N 113.355 -1.748 . . . . 0.0 106.644 -177.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.69 142.91 29.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-O 120.844 0.354 . . . . 0.0 110.909 -175.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.496 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 77.5 tttt -116.28 130.7 56.91 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 177.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -104.58 177.86 4.73 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.02 -14.15 52.02 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.471 0.653 . . . . 0.0 110.543 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -67.32 -19.39 65.45 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.208 1.003 . . . . 0.0 110.33 176.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 92.71 -22.4 33.79 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.9 -0.591 . . . . 0.0 113.061 177.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.4 t -91.57 165.34 13.39 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.1 p -114.52 140.54 48.66 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.208 -177.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.9 mp -107.97 121.98 45.89 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 174.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.8 m -98.48 114.55 26.99 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.226 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 61.21 61.82 2.83 Favored Pre-proline 0 N--CA 1.481 1.094 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -178.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -91.35 174.04 2.58 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.17 1.913 . . . . 0.0 110.369 176.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.441 ' O ' HG23 ' A' ' 75' ' ' VAL . 6.2 m -89.6 151.29 21.99 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 176.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.63 -37.95 80.01 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 123.186 0.304 . . . . 0.0 110.756 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -57.47 -43.62 84.17 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.108 177.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.53 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 47.3 mt-10 -68.38 -44.76 74.43 Favored 'General case' 0 C--O 1.207 -1.145 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.972 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 71' ' ' SER . 59.5 t -60.16 -43.14 92.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 O-C-N 123.252 0.345 . . . . 0.0 110.531 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -64.21 -44.71 91.09 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.27 -34.99 78.58 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.081 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.53 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 75.5 mmtt -75.07 -36.82 61.74 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 176.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 14.5 tp -61.62 -52.35 64.73 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.5 m -61.93 -35.54 68.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.7 ptpp? -72.87 -34.1 66.51 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.304 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.1 pp -83.89 -29.71 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.056 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.55 0 CA-C-O 120.803 0.335 . . . . 0.0 110.591 178.507 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.87 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.537 HD11 HD21 ' A' ' 79' ' ' LEU . 8.6 mp -109.48 141.23 42.2 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.558 0.694 . . . . 0.0 111.901 -177.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.4 ' HB ' ' HB3' ' A' ' 60' ' ' LYS . 28.7 m -125.82 108.32 11.36 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 105.707 -1.961 . . . . 0.0 105.707 171.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.559 HG22 HG23 ' A' ' 10' ' ' THR . 62.4 mt -108.89 135.23 48.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 CA-C-O 121.943 0.878 . . . . 0.0 111.445 -173.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.43 ' CD1' HG22 ' A' ' 46' ' ' VAL . 98.9 m-85 -90.22 111.32 22.45 Favored 'General case' 0 C--N 1.28 -2.431 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.453 178.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.559 HG23 HG22 ' A' ' 8' ' ' ILE . 6.9 p -137.31 144.33 42.56 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.169 0.509 . . . . 0.0 112.215 -178.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.6 p -130.79 165.38 23.08 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 174.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.9 p -86.73 0.23 55.08 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 121.373 0.606 . . . . 0.0 110.723 176.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 10.6 m0 -83.0 12.84 4.47 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.518 -173.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.583 ' SG ' HG21 ' A' ' 56' ' ' VAL . 6.7 p -146.26 171.8 14.43 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 122.05 -0.406 . . . . 0.0 111.402 -177.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -116.39 -36.63 1.08 Allowed Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 176.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -64.69 -23.4 67.24 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 121.207 0.527 . . . . 0.0 112.068 -177.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.9 p -70.48 -43.1 70.45 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.154 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.1 mp -64.61 -31.43 72.64 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.924 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -61.06 -52.07 66.5 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.485 0.491 . . . . 0.0 110.673 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.4 tp -68.35 -41.92 80.01 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.987 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -56.78 -50.04 73.49 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.691 -177.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.5 p -68.1 -34.2 75.95 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.54 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.9 -48.77 78.99 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.215 178.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.6 mt -63.89 -37.0 85.77 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.325 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 58.0 m -59.53 -48.81 80.2 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.813 177.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.84 -34.66 77.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.883 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -81.93 5.15 19.96 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -177.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 70.07 24.55 4.99 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.046 0.938 . . . . 0.0 113.121 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.7 mt -93.94 115.49 32.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.68 144.87 37.0 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.95 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -159.71 145.09 15.54 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.837 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -102.39 133.4 47.39 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 175.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 12.7 pt-20 -94.13 142.37 27.48 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.415 HG21 ' CE1' ' A' ' 9' ' ' TYR . 13.6 t -87.83 144.69 8.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 121.717 0.77 . . . . 0.0 112.181 -175.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -65.17 -1.84 2.51 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 127.76 2.424 . . . . 0.0 113.91 -176.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.2 pt -44.3 -23.78 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.564 0 N-CA-C 116.334 1.975 . . . . 0.0 116.334 -172.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -65.51 -25.43 67.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.573 0.701 . . . . 0.0 109.262 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 43.4 m-70 -112.32 -46.74 3.15 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.199 -0.909 . . . . 0.0 108.906 175.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -70.18 111.11 5.58 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.948 -176.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.1 ptp180 -73.53 -24.83 60.19 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.063 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.41 -54.6 13.56 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -175.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.505 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -72.75 -20.97 61.09 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.647 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.03 93.45 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.182 0.515 . . . . 0.0 110.925 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -72.95 -29.97 63.49 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.162 0.506 . . . . 0.0 110.414 177.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -68.1 -33.07 73.83 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.752 177.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 42' ' ' ALA . 76.7 t -55.49 -56.2 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.498 175.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.41 -33.99 78.76 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.088 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.3 m -65.82 -42.83 90.09 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 122.862 0.465 . . . . 0.0 112.087 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.8 m -80.92 -19.54 11.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.873 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -77.82 -50.17 12.83 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 175.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.55 -104.91 0.28 Allowed Glycine 0 N--CA 1.431 -1.652 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -103.74 -37.02 3.09 Favored Glycine 0 C--N 1.307 -1.057 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -104.98 148.13 27.05 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -78.92 135.98 37.13 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.2 m -118.33 153.79 33.41 Favored 'General case' 0 C--N 1.268 -2.957 0 N-CA-C 103.73 -2.693 . . . . 0.0 103.73 174.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.583 HG21 ' SG ' ' A' ' 14' ' ' CYS 0.267 21.9 t -86.86 -72.35 0.07 OUTLIER Pre-proline 0 CA--C 1.456 -2.642 0 C-N-CA 116.136 -2.226 . . . . 0.0 114.506 -178.59 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.96 88.73 1.21 Allowed 'Trans proline' 1 N--CA 1.39 -4.575 0 CA-C-N 120.577 1.242 . . . . 0.0 112.498 -162.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.4 m -119.98 130.74 54.9 Favored 'General case' 0 N--CA 1.385 -3.698 0 CA-C-N 113.27 -1.786 . . . . 0.0 106.841 -174.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.1 p -116.45 132.67 65.38 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-O 121.15 0.5 . . . . 0.0 110.856 -176.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.4 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 62.9 tttm -107.04 116.79 32.55 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 174.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -87.66 155.18 20.06 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.189 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.16 -21.37 61.57 Favored 'General case' 0 C--O 1.22 -0.494 0 C-N-CA 123.481 0.712 . . . . 0.0 111.57 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -72.71 -14.33 61.54 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.507 0.67 . . . . 0.0 110.145 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.81 -20.43 26.88 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.901 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.8 m -71.36 140.1 50.07 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 122.687 0.395 . . . . 0.0 111.661 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.9 p -114.21 137.79 51.3 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 173.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mp -128.43 123.21 33.17 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 120.76 0.314 . . . . 0.0 110.4 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 87.6 m -97.15 119.14 35.1 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.231 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 57.77 67.78 2.2 Favored Pre-proline 0 N--CA 1.484 1.237 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -96.56 169.52 1.03 Allowed 'Trans proline' 0 CA--C 1.546 1.124 0 C-N-CA 122.324 2.016 . . . . 0.0 111.148 171.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.0 m -93.29 155.38 17.45 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 173.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.29 -36.43 71.04 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 122.91 0.484 . . . . 0.0 111.704 -178.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -69.18 -35.7 76.57 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.502 0.668 . . . . 0.0 110.839 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.03 -36.56 82.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.268 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.9 t -66.26 -46.75 86.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.038 177.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -53.72 -42.33 67.95 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.22 0.608 . . . . 0.0 112.027 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.34 -20.3 65.57 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.131 0.491 . . . . 0.0 111.394 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.597 ' O ' HG13 ' A' ' 82' ' ' ILE . 34.4 mmtp -84.59 -39.49 18.65 Favored 'General case' 0 N--CA 1.436 -1.168 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.116 175.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.537 HD21 HD11 ' A' ' 6' ' ' LEU . 4.5 mm? -56.82 -41.19 77.37 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.5 m -63.38 -40.5 89.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.304 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -83.03 -54.6 4.94 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.597 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.1 pp -68.52 -17.12 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -170.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -0.986 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.145 177.843 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.668 0 CA-C-O 121.086 0.469 . . . . 0.0 111.457 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.444 ' HB2' ' CG2' ' A' ' 59' ' ' VAL . 0.5 OUTLIER -130.56 123.96 30.75 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.542 0.687 . . . . 0.0 111.372 178.693 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.3 m -103.2 114.18 28.25 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.576 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 55.7 mt -103.58 136.98 33.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -177.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -91.5 118.21 30.38 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.556 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 29.3 p -128.19 -172.08 2.61 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 121.343 0.592 . . . . 0.0 111.894 -177.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 13' ' ' TRP . 38.7 m -155.81 146.12 21.72 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 177.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.1 m -56.36 -47.84 78.05 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.474 ' O ' ' HB ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -65.94 111.78 3.48 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 164.903 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 11' ' ' THR . 42.8 t -150.71 120.14 6.89 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.788 -174.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -113.99 -70.24 0.52 Allowed Glycine 0 N--CA 1.427 -1.9 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.236 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -73.91 -30.23 62.47 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 123.029 0.531 . . . . 0.0 111.083 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -63.34 -27.78 69.55 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -63.08 -35.66 80.99 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.458 0.703 . . . . 0.0 109.678 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -51.87 -45.47 64.11 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 124.774 1.23 . . . . 0.0 111.301 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.428 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 12.4 tp -84.19 -42.37 16.03 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.86 -177.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -52.84 -48.91 66.68 Favored 'General case' 0 C--O 1.246 0.916 0 C-N-CA 124.397 1.079 . . . . 0.0 112.522 -176.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.9 t -74.15 -28.48 61.33 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.515 -178.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.16 -42.49 84.21 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.325 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 59.7 mt -65.26 -44.04 89.38 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.403 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 44.3 m -59.88 -43.59 94.65 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.963 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.12 -10.37 59.55 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.948 0.404 . . . . 0.0 111.928 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -109.31 16.03 22.68 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.964 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 67.77 17.39 9.77 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.27 1.028 . . . . 0.0 112.624 177.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.6 mt -91.06 118.15 35.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.59 138.14 33.68 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -136.3 171.01 15.11 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.044 -177.19 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -128.45 117.89 22.15 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 175.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.576 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 13.8 pt-20 -95.03 135.2 36.86 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 120.866 0.365 . . . . 0.0 110.841 -178.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.7 t -85.05 140.09 16.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -171.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.418 ' OD2' ' HB2' ' A' ' 38' ' ' HIS . 14.5 t70 -58.67 0.39 0.08 Allowed 'General case' 0 CA--C 1.567 1.624 0 C-N-CA 129.508 3.123 . . . . 0.0 114.751 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.8 pt -43.59 -20.82 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 3.006 0 N-CA-C 116.971 2.212 . . . . 0.0 116.971 -168.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -73.18 -23.61 60.44 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 119.176 0.898 . . . . 0.0 110.276 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' HIS . . . . . 0.418 ' HB2' ' OD2' ' A' ' 35' ' ' ASP . 78.6 m80 -105.39 -47.32 3.98 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 174.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -78.19 99.64 6.31 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.734 -177.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -67.26 -30.21 70.04 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.553 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.9 -44.89 82.81 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.43 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -85.96 -23.34 26.96 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.419 178.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.36 -40.42 93.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.197 0.522 . . . . 0.0 110.222 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -65.46 -24.3 67.13 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.117 177.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -74.68 -38.16 62.48 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 176.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 42' ' ' ALA . 40.3 t -65.71 -41.88 91.37 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.447 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.826 178.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.78 -22.58 75.55 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.029 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -81.85 -41.86 20.43 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.6 p -76.55 -37.56 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 O-C-N 122.045 -0.409 . . . . 0.0 110.593 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -105.19 92.07 4.06 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 176.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -80.86 143.18 24.08 Favored Glycine 0 C--N 1.306 -1.12 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.494 -176.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.56 -62.88 2.68 Favored Glycine 0 N--CA 1.437 -1.29 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -126.11 145.92 50.15 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.6 ttp85 -88.31 89.06 7.84 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.0 m -65.58 133.46 51.23 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 176.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.4 t -77.01 -69.43 0.23 Allowed Pre-proline 0 CA--C 1.468 -2.187 0 C-N-CA 118.174 -1.411 . . . . 0.0 114.061 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.51 82.67 1.85 Allowed 'Trans proline' 0 N--CA 1.4 -3.992 0 CA-C-N 120.637 1.263 . . . . 0.0 112.969 -163.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 51.9 m -115.36 125.3 53.04 Favored 'General case' 0 N--CA 1.388 -3.53 0 CA-C-N 113.299 -1.773 . . . . 0.0 106.509 -176.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.444 ' CG2' ' HB2' ' A' ' 6' ' ' LEU . 7.2 p -118.3 137.17 53.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 CA-C-O 121.007 0.432 . . . . 0.0 111.181 -177.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -111.36 119.57 39.28 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 176.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -94.99 168.57 10.69 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.46 -10.98 20.0 Favored 'General case' 0 C--O 1.218 -0.57 0 O-C-N 123.738 0.649 . . . . 0.0 111.329 177.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -73.59 -18.31 61.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.794 0.807 . . . . 0.0 109.87 177.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.43 -15.12 63.88 Favored Glycine 0 CA--C 1.499 -0.917 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.236 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.5 m -83.41 151.69 25.37 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 p -113.6 139.31 49.12 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.6 tp -121.93 119.91 32.92 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -177.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.0 m -107.94 126.25 52.46 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 -174.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 54.03 60.04 11.48 Favored Pre-proline 0 N--CA 1.482 1.126 0 O-C-N 123.941 0.776 . . . . 0.0 112.315 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -90.08 178.44 2.23 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 121.856 1.704 . . . . 0.0 113.242 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.4 m -96.42 164.46 12.62 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 174.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.57 -39.34 94.14 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 120.958 0.409 . . . . 0.0 110.99 -178.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -64.42 -33.27 75.49 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.512 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -68.33 -39.09 82.05 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.048 0.451 . . . . 0.0 110.35 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.4 t -66.42 -44.91 90.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.899 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -60.49 -43.31 97.13 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.507 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.89 -36.8 84.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.714 0.293 . . . . 0.0 111.32 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.487 ' O ' HG13 ' A' ' 82' ' ' ILE . 14.4 mptt -70.96 -37.13 72.79 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.941 175.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 30.1 tp -62.06 -47.04 86.49 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.412 -178.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.8 m -66.07 -32.69 59.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -177.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -77.29 -41.02 42.41 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.684 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.2 pp -74.41 -14.28 15.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.454 -0.498 . . . . 0.0 112.074 -177.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.881 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.66 176.083 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.705 0 CA-C-O 120.717 0.294 . . . . 0.0 111.386 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.635 HD23 ' H ' ' A' ' 6' ' ' LEU . 0.7 OUTLIER -68.58 120.65 14.95 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.849 0.833 . . . . 0.0 111.013 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.3 m -103.64 111.75 24.37 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 114.399 -1.273 . . . . 0.0 107.851 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 63.4 mt -102.79 139.04 24.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.303 0.573 . . . . 0.0 110.703 -174.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -92.04 122.8 34.88 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.523 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 27.3 p -138.57 177.22 8.04 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.533 0.682 . . . . 0.0 111.817 -177.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.5 m -148.08 156.16 42.29 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 174.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.5 m -69.22 -45.34 70.1 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -87.38 96.28 10.31 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-O 122.126 0.965 . . . . 0.0 109.906 175.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 32.7 t -163.56 152.17 13.84 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.415 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -119.93 -55.84 0.25 Allowed Glycine 0 N--CA 1.429 -1.831 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.226 178.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -68.39 -16.3 63.87 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -173.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.6 p -78.49 -24.88 45.68 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.211 0.529 . . . . 0.0 109.963 177.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 21' ' ' LYS . 28.7 tp -69.01 -21.75 64.12 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.991 -175.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -60.18 -60.71 3.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.165 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.1 tp -66.3 -42.74 87.86 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.492 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.423 ' HB3' ' HA ' ' A' ' 18' ' ' LEU . 63.8 tttp -54.72 -47.23 74.01 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.35 -178.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.5 p -71.12 -34.7 71.31 Favored 'General case' 0 C--O 1.244 0.778 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.654 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.38 -46.93 86.4 Favored 'General case' 0 CA--C 1.508 -0.657 0 C-N-CA 123.387 0.675 . . . . 0.0 110.66 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.9 mt -65.79 -37.88 87.49 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.902 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.3 m -65.24 -38.52 90.62 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.74 -26.94 62.67 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 111.02 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.17 2.8 48.81 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.308 178.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 61.67 30.52 18.55 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.54 1.136 . . . . 0.0 110.441 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 74.1 mt -86.86 115.41 27.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.666 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.48 100.65 3.31 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.509 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -113.61 163.94 14.31 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.412 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -130.5 130.1 43.74 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 175.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.523 ' HB2' ' OG1' ' A' ' 10' ' ' THR . 11.6 pt-20 -99.79 140.92 33.29 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.025 0.441 . . . . 0.0 111.14 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.2 t -78.07 146.79 7.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-O 121.86 0.838 . . . . 0.0 113.1 -172.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -66.85 -0.82 3.29 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 127.718 2.407 . . . . 0.0 114.371 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.5 pt -44.17 -22.58 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.514 2.737 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 -169.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -68.42 -31.43 70.75 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.796 0.808 . . . . 0.0 109.469 177.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 35.5 m-70 -103.17 -45.94 4.77 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.26 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.431 ' ND2' ' H ' ' A' ' 42' ' ' ALA . 37.8 t30 -86.91 115.11 24.09 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.87 -175.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -72.7 -29.68 63.58 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.097 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.38 -41.16 93.22 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -173.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.431 ' H ' ' ND2' ' A' ' 39' ' ' ASN . . . -87.35 -21.77 25.48 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.638 177.058 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.65 -39.59 84.58 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.309 0.576 . . . . 0.0 110.616 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -75.08 -21.38 59.0 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.334 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -69.45 -31.95 70.58 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 176.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.3 t -59.36 -42.73 88.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.38 -35.2 87.02 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.356 178.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.8 t -66.77 -50.07 63.87 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 122.503 0.321 . . . . 0.0 110.66 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.9 p -76.91 -28.12 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.181 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -174.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -98.66 1.89 46.67 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 121.698 -0.627 . . . . 0.0 112.266 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.52 60.22 4.82 Favored Glycine 0 C--N 1.322 -0.233 0 N-CA-C 114.395 0.518 . . . . 0.0 114.395 174.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.07 -46.63 3.43 Favored Glycine 0 C--N 1.31 -0.892 0 C-N-CA 121.769 -0.253 . . . . 0.0 112.615 176.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -77.42 122.34 25.04 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.9 mtm180 -93.75 79.95 4.22 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.774 0.797 . . . . 0.0 112.182 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.7 m -73.17 128.36 35.27 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 173.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.4 t -69.4 -66.71 0.87 Allowed Pre-proline 0 CA--C 1.473 -1.989 0 N-CA-C 114.703 1.372 . . . . 0.0 114.703 -173.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.62 76.77 4.13 Favored 'Trans proline' 0 N--CA 1.4 -3.985 0 CA-C-N 120.381 1.172 . . . . 0.0 112.578 -163.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 91.5 m -107.62 140.27 40.88 Favored 'General case' 0 N--CA 1.388 -3.565 0 CA-C-N 113.486 -1.688 . . . . 0.0 107.571 -176.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.2 p -122.68 132.83 70.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-O 121.318 0.58 . . . . 0.0 111.218 -176.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -110.21 120.31 42.04 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.498 176.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.453 ' CD1' HG12 ' A' ' 82' ' ' ILE . 90.1 m-85 -95.12 171.79 8.52 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.738 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.46 -24.0 61.13 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -173.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -89.87 -7.28 54.62 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 120.708 0.289 . . . . 0.0 111.34 -174.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.54 -5.72 31.41 Favored Glycine 0 N--CA 1.437 -1.237 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.268 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.3 m -75.98 125.91 30.01 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 121.18 0.514 . . . . 0.0 110.17 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.6 p -117.21 138.29 51.79 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.2 mp -130.91 146.31 52.29 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.1 m -116.0 112.64 22.1 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 64.2 t30 47.33 70.88 1.81 Allowed Pre-proline 0 N--CA 1.484 1.274 0 C-N-CA 124.713 1.205 . . . . 0.0 113.835 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -100.01 -175.52 0.15 Allowed 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.013 2.475 . . . . 0.0 111.968 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.6 t -82.31 154.1 25.48 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.48 -34.76 78.47 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 123.713 0.805 . . . . 0.0 109.958 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -63.5 -44.09 95.35 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.881 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.585 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 45.5 mm-40 -57.83 -47.36 82.89 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.392 176.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.6 t -57.73 -44.02 85.01 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.764 0 O-C-N 123.994 0.809 . . . . 0.0 111.502 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 66.1 tttp -62.87 -45.3 93.21 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.23 -21.84 59.61 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.054 0.454 . . . . 0.0 111.568 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.585 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 49.2 mmtm -81.93 -34.49 29.83 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 174.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.0 tp -57.39 -49.04 77.47 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.424 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.8 m -60.59 -33.6 55.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.505 -177.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 15.3 ptmm? -81.69 -38.71 25.41 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.476 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.453 HG12 ' CD1' ' A' ' 61' ' ' PHE . 2.4 pp -77.98 -32.15 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -175.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.852 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.7 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.399 0 CA-C-O 121.497 0.665 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.79 128.75 16.47 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.256 178.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 60' ' ' LYS . 23.4 m -103.07 120.02 39.92 Favored 'General case' 0 C--N 1.277 -2.576 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 176.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.3 mt -109.88 128.44 66.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 CA-C-O 121.06 0.457 . . . . 0.0 109.915 -176.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.463 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 98.3 m-85 -81.05 129.0 34.34 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.636 177.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.8 p -136.83 145.98 45.1 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -174.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 69.4 p -140.22 161.72 36.98 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 172.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.5 p -85.98 -0.39 55.37 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.303 0.573 . . . . 0.0 110.799 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 11.2 m0 -78.91 -30.93 45.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.356 -176.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.8 p -105.65 132.2 52.09 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.265 -175.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.22 -27.99 26.51 Favored Glycine 0 N--CA 1.436 -1.352 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.675 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -65.86 -35.87 81.86 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.592 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 61.1 m -56.5 -46.71 80.37 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.287 176.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.2 tt -66.75 -39.39 87.89 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.751 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.6 mtp180 -58.23 -54.63 44.84 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.484 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 20.7 tp -62.05 -40.13 94.71 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.524 0.678 . . . . 0.0 109.716 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 17' ' ' CYS . 60.5 tttm -57.2 -45.22 83.96 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.664 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.7 m -62.12 -43.59 98.49 Favored 'General case' 0 C--O 1.246 0.884 0 C-N-CA 123.719 0.808 . . . . 0.0 110.665 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.53 -48.21 82.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.04 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 72.4 mt -65.73 -35.64 81.32 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.995 -178.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.8 m -63.6 -45.99 87.83 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.83 -35.63 81.22 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.483 0.659 . . . . 0.0 110.843 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -84.46 21.03 1.54 Allowed 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.492 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 55.7 20.65 4.09 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 126.226 1.81 . . . . 0.0 113.782 175.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 71.4 mt -85.27 115.91 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.94 116.98 23.06 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.264 -177.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -127.75 159.54 34.47 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.215 -177.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -112.27 114.08 26.66 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 175.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -83.17 136.58 34.38 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.1 t -95.15 143.73 11.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 122.909 1.337 . . . . 0.0 113.233 -176.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.57 -0.57 6.92 Favored 'General case' 0 C--N 1.284 -2.283 0 C-N-CA 130.862 3.665 . . . . 0.0 115.118 177.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.471 HD13 HG21 ' A' ' 46' ' ' VAL . 12.7 pt -44.11 -26.42 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.843 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 -171.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -59.0 -36.3 74.68 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.12 0.486 . . . . 0.0 109.815 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 46.7 m-70 -93.15 -34.45 13.62 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.968 -175.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -116.36 113.58 23.12 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -176.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.482 ' HA ' ' HB3' ' A' ' 43' ' ' ALA . 3.8 ptp180 -62.86 -25.58 68.35 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 114.625 -1.171 . . . . 0.0 111.885 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.18 -41.49 71.96 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.238 0.542 . . . . 0.0 111.296 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.451 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -86.96 -30.33 21.37 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.047 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.482 ' HB3' ' HA ' ' A' ' 40' ' ' ARG . . . -65.31 -33.89 77.05 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.996 -178.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -67.53 -34.76 77.75 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.774 -0.194 . . . . 0.0 111.377 178.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -65.25 -37.69 88.0 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.471 HG21 HD13 ' A' ' 36' ' ' ILE . 60.1 t -59.99 -38.06 75.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.091 -0.958 . . . . 0.0 109.877 177.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.66 -49.22 44.82 Favored Glycine 0 N--CA 1.433 -1.55 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.9 m -60.31 -38.13 82.72 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.6 p -79.49 -9.37 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-O 121.531 0.682 . . . . 0.0 111.213 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -104.95 -67.82 0.89 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.145 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 137.67 -112.38 0.9 Allowed Glycine 0 N--CA 1.433 -1.554 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 -175.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.31 -48.33 5.11 Favored Glycine 0 C--N 1.306 -1.127 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.029 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -91.45 116.44 28.85 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -178.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -81.21 83.02 6.94 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.6 m -71.97 125.78 28.09 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.538 ' HB ' ' SG ' ' A' ' 17' ' ' CYS . 3.2 t -76.31 -56.16 1.59 Allowed Pre-proline 0 N--CA 1.435 -1.221 0 CA-C-O 117.323 -1.322 . . . . 0.0 113.55 -175.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.592 ' HD3' ' SG ' ' A' ' 17' ' ' CYS . 64.9 Cg_endo -73.64 44.24 0.89 Allowed 'Trans proline' 0 C--N 1.399 3.227 0 CA-C-N 121.472 1.562 . . . . 0.0 113.691 -170.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 84.1 m -80.57 117.66 21.47 Favored 'General case' 0 N--CA 1.387 -3.599 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.3 p -94.76 129.12 45.39 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.479 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 82.2 tttt -105.03 118.19 35.9 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -87.75 164.21 16.08 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 120.448 -0.501 . . . . 0.0 112.126 -177.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.04 -18.26 45.04 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 124.032 0.933 . . . . 0.0 112.956 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -78.31 -17.29 56.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.863 0.363 . . . . 0.0 110.286 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.02 -21.7 24.5 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 121.245 -0.502 . . . . 0.0 113.193 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.1 m -82.88 159.71 22.3 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.257 0.551 . . . . 0.0 110.522 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.3 p -114.0 171.39 7.62 Favored 'General case' 0 N--CA 1.418 -2.045 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.101 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.8 tp -145.0 109.7 5.0 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 176.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 89.1 m -86.11 122.7 30.49 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.965 -176.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 56.49 64.81 4.53 Favored Pre-proline 0 N--CA 1.482 1.15 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -90.71 -173.61 0.63 Allowed 'Trans proline' 0 N--CA 1.445 -1.38 0 C-N-CA 121.788 1.659 . . . . 0.0 112.653 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.414 ' H ' ' HB2' ' A' ' 74' ' ' GLU . 16.6 m -127.26 165.86 18.86 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 174.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.69 -45.95 67.05 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -64.38 -36.54 84.48 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.431 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.414 ' HB2' ' H ' ' A' ' 71' ' ' SER . 67.0 mm-40 -63.71 -42.51 97.94 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.194 0.521 . . . . 0.0 110.88 177.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.1 t -67.21 -48.8 77.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.192 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -61.57 -31.05 71.08 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.118 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.2 -25.54 63.46 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.431 ' O ' HG13 ' A' ' 82' ' ' ILE . 10.1 mmmm -84.7 -37.22 21.2 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 172.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.8 tp -55.07 -49.63 71.17 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 124.165 0.916 . . . . 0.0 110.171 -177.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.3 m -58.6 -35.53 55.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -178.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.76 -42.53 19.65 Favored 'General case' 0 N--CA 1.427 -1.578 0 C-N-CA 119.071 -1.051 . . . . 0.0 111.804 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.4 pp -76.41 -22.16 15.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -174.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.474 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.985 179.331 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.23 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 62.1 mt -113.97 122.53 47.23 Favored 'General case' 0 CA--C 1.496 -1.101 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.712 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.1 m -103.14 108.54 19.77 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 173.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.476 HG22 HG23 ' A' ' 10' ' ' THR . 55.4 mt -108.42 133.35 53.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-O 121.78 0.8 . . . . 0.0 111.605 -175.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -95.38 107.36 19.49 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.067 -0.969 . . . . 0.0 108.662 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.476 HG23 HG22 ' A' ' 8' ' ' ILE . 4.0 p -135.28 158.96 43.05 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 122.677 0.391 . . . . 0.0 111.897 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.6 p -134.77 174.61 10.39 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 176.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.1 t -86.72 -5.61 59.07 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 19.6 m0 -75.83 -32.61 59.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.093 -175.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.8 p -91.54 165.99 13.07 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 120.738 0.304 . . . . 0.0 111.628 -175.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -113.45 -42.83 0.86 Allowed Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 111.366 -0.693 . . . . 0.0 111.366 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -63.45 -25.77 68.42 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -178.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.493 ' SG ' HD12 ' A' ' 18' ' ' LEU . 1.6 p -56.32 -41.36 75.91 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.677 0.275 . . . . 0.0 111.04 176.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.511 ' HA ' ' HD3' ' A' ' 21' ' ' LYS . 6.3 mp -73.31 -24.96 60.47 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.65 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -71.76 -34.72 69.71 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.8 tp -75.74 -38.36 58.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.084 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.511 ' HD3' ' HA ' ' A' ' 18' ' ' LEU . 27.4 mtpp -55.75 -45.72 77.98 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.706 177.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 p -65.94 -40.2 91.14 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 111.541 0.2 . . . . 0.0 111.541 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.26 -49.53 76.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.674 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.5 mt -64.91 -41.68 95.37 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.754 0.311 . . . . 0.0 111.283 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 68.0 m -67.29 -38.29 84.78 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.198 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.84 -26.37 64.19 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.36 0.6 . . . . 0.0 110.66 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -94.07 10.77 32.33 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.066 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 59.15 30.86 20.73 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.04 1.336 . . . . 0.0 112.719 175.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.6 mt -89.26 123.87 41.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.73 129.93 34.68 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.071 0.463 . . . . 0.0 111.218 -176.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -144.08 157.62 44.21 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.651 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -127.96 124.03 36.28 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 11.7 pt-20 -95.25 146.82 24.07 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.271 0.557 . . . . 0.0 111.764 -175.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -81.07 153.05 4.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.457 -175.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -74.87 0.19 16.42 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 127.903 2.481 . . . . 0.0 114.042 -175.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.7 pt -43.36 -23.71 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.378 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 -172.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -52.85 -39.24 62.39 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.649 0.78 . . . . 0.0 109.709 176.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -119.42 20.28 12.52 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.081 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.413 ' ND2' ' H ' ' A' ' 42' ' ' ALA . 49.5 t30 -139.42 106.89 5.55 Favored 'General case' 0 CA--C 1.492 -1.269 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.26 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -30.59 71.13 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.946 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.43 -38.57 84.76 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -173.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.413 ' H ' ' ND2' ' A' ' 39' ' ' ASN . . . -86.79 -20.73 27.17 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.816 177.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.15 -41.44 86.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.463 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -69.92 -21.91 63.25 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.539 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -68.16 -33.53 74.64 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 175.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.626 ' O ' ' HB2' ' A' ' 50' ' ' ASN . 81.6 t -59.3 -40.22 80.83 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.925 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.631 177.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.92 -32.68 77.82 Favored Glycine 0 C--N 1.332 0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.09 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.0 t -65.8 -29.96 70.53 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 123.147 0.579 . . . . 0.0 110.265 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.4 m -108.1 17.2 6.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 120.887 0.375 . . . . 0.0 110.572 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.626 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 1.7 t-20 -116.49 -174.16 2.51 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -176.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -107.82 75.71 0.22 Allowed Glycine 0 N--CA 1.436 -1.343 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.064 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.01 -93.65 1.31 Allowed Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 -78.62 136.31 37.46 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -64.91 101.4 0.49 Allowed 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -178.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.9 m -83.0 153.35 25.01 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 102.984 -2.969 . . . . 0.0 102.984 169.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 0.442 3.8 t -86.95 -93.75 0.0 OUTLIER Pre-proline 0 CA--C 1.487 -1.472 0 C-N-CA 114.643 -2.823 . . . . 0.0 117.23 -174.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -47.51 93.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.386 2.538 0 N-CA-C 114.551 0.943 . . . . 0.0 114.551 -148.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.31 109.91 21.37 Favored 'General case' 0 N--CA 1.405 -2.705 0 CA-C-N 113.778 -1.555 . . . . 0.0 109.904 -173.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.3 p -102.58 126.46 56.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -104.8 127.41 52.59 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.626 ' HB3' HG21 ' A' ' 82' ' ' ILE . 95.8 m-85 -103.25 170.84 7.71 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.972 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.664 ' HB3' ' HB ' ' A' ' 82' ' ' ILE . . . -65.17 -13.89 59.27 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 -173.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -78.69 -13.09 60.0 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 121.478 0.656 . . . . 0.0 109.627 175.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.54 -1.54 64.15 Favored Glycine 0 N--CA 1.436 -1.319 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -174.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.3 m -67.62 133.5 49.49 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 123.787 0.835 . . . . 0.0 108.96 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.8 m -121.43 137.53 54.67 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 176.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.2 mp -120.06 119.38 33.19 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 120.687 0.28 . . . . 0.0 111.279 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.5 m -92.66 116.55 29.11 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 61.7 69.66 0.97 Allowed Pre-proline 0 CA--C 1.557 1.25 0 C-N-CA 123.643 0.777 . . . . 0.0 111.49 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -94.48 -167.02 0.14 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.444 2.096 . . . . 0.0 112.258 176.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.403 ' O ' HG23 ' A' ' 75' ' ' VAL . 13.5 m -116.08 150.52 37.2 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 176.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.08 -40.43 76.94 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.775 0.43 . . . . 0.0 111.734 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -64.42 -37.76 88.64 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.947 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -62.18 -48.06 81.75 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.906 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 71' ' ' SER . 95.9 t -58.39 -42.3 83.73 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.922 0 O-C-N 124.013 0.821 . . . . 0.0 110.834 -178.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.408 ' O ' ' HD3' ' A' ' 76' ' ' LYS . 2.7 tmtp? -67.76 -40.38 84.09 Favored 'General case' 0 CA--C 1.559 1.315 0 CA-C-O 120.722 0.296 . . . . 0.0 110.52 -178.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.45 -29.84 59.79 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.171 0.51 . . . . 0.0 111.024 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -77.21 -31.09 55.03 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 20.4 tp -58.92 -50.96 72.08 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.984 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.5 m -60.57 -39.42 81.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -176.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? -73.31 -32.33 64.54 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.481 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.664 ' HB ' ' HB3' ' A' ' 62' ' ' ALA . 2.0 pp -83.5 -11.91 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-O 121.39 0.614 . . . . 0.0 111.871 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.953 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.529 174.607 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 121.364 0.602 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.2 tp -142.19 114.71 8.45 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -178.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' A' ' 60' ' ' LYS . 40.9 m -107.06 127.74 53.75 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 71.4 mt -118.88 135.79 58.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-O 121.207 0.527 . . . . 0.0 110.389 -177.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.407 ' O ' HG12 ' A' ' 56' ' ' VAL . 92.8 m-85 -88.13 127.8 35.43 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.742 177.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.2 p -134.29 151.82 51.47 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -175.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.0 p -140.15 163.5 32.56 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 175.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.2 m -77.7 -8.21 57.61 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.238 0.542 . . . . 0.0 110.395 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 2.7 m0 -89.8 -25.88 20.86 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.922 0.868 . . . . 0.0 110.246 -176.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.6 t -91.98 118.42 30.75 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.876 -168.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -92.18 -32.54 8.27 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -68.98 -18.25 64.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.058 0.456 . . . . 0.0 112.161 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.632 ' SG ' ' HB ' ' A' ' 56' ' ' VAL . 72.4 m -68.85 -38.67 79.92 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.667 0.746 . . . . 0.0 109.178 174.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.3 tt -68.31 -30.0 68.89 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.775 -178.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -61.65 -41.5 97.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.77 176.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.477 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 17.6 tp -74.51 -39.91 62.12 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.494 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -56.36 -51.61 67.63 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.146 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.4 p -61.08 -42.44 98.51 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.999 0.428 . . . . 0.0 110.84 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.63 -49.54 77.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.993 178.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.484 HD22 HD12 ' A' ' 29' ' ' ILE . 51.8 mt -67.56 -36.77 81.58 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.392 -178.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.7 m -66.91 -41.8 86.5 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 121.207 0.527 . . . . 0.0 110.248 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.0 -7.42 53.61 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.195 0.521 . . . . 0.0 111.889 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -107.75 8.21 28.75 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 123.073 0.549 . . . . 0.0 110.867 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 57.61 62.85 1.99 Allowed 'General case' 0 C--O 1.243 0.724 0 C-N-CA 125.299 1.44 . . . . 0.0 112.219 -177.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.484 HD12 HD22 ' A' ' 24' ' ' LEU . 76.3 mt -121.58 117.41 52.5 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.689 176.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.82 121.88 30.78 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -135.23 156.01 49.7 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.853 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -116.2 132.79 56.56 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 175.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 8.8 pt-20 -96.01 151.05 19.8 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.417 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.6 t -94.76 145.36 8.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.875 0.845 . . . . 0.0 112.921 -173.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.411 ' OD2' ' HB2' ' A' ' 39' ' ' ASN . 28.6 t70 -62.51 -1.49 0.81 Allowed 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 128.352 2.661 . . . . 0.0 114.036 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.423 HG22 ' HB3' ' A' ' 42' ' ' ALA . 26.1 pt -45.2 -21.04 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 N-CA-C 115.759 1.762 . . . . 0.0 115.759 -173.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -56.38 -29.02 60.95 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.003 0.43 . . . . 0.0 110.862 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 46.4 t60 -127.94 -23.7 3.31 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.175 0.512 . . . . 0.0 110.285 173.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.411 ' HB2' ' OD2' ' A' ' 35' ' ' ASP . 25.2 t-20 -87.71 87.11 7.28 Favored 'General case' 0 C--O 1.244 0.774 0 O-C-N 121.488 -0.758 . . . . 0.0 109.683 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -67.16 -23.87 65.83 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -174.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.75 -34.78 73.41 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.598 0.713 . . . . 0.0 110.963 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.423 ' HB3' HG22 ' A' ' 36' ' ' ILE . . . -87.09 -20.66 26.8 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.362 0.601 . . . . 0.0 109.871 176.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.01 -34.59 64.21 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.592 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.79 -32.82 74.68 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.52 173.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 94.2 t80 -63.02 -42.46 99.81 Favored 'General case' 0 N--CA 1.461 0.095 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.1 t -57.0 -45.15 83.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.01 177.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 53' ' ' ASN . . . -66.69 -52.39 34.5 Favored Glycine 0 N--CA 1.432 -1.618 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.223 178.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.4 t -59.52 -39.36 83.6 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 123.472 0.709 . . . . 0.0 112.814 -175.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.0 p -70.1 -24.42 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 CA-C-O 121.132 0.492 . . . . 0.0 111.514 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -93.6 -27.58 16.52 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.146 0.498 . . . . 0.0 110.437 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 148.68 -63.1 0.42 Allowed Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 177.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -159.33 -34.19 0.02 OUTLIER Glycine 0 C--N 1.298 -1.565 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.402 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 29.3 p-10 -76.56 145.97 38.66 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.224 0.535 . . . . 0.0 110.748 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -89.66 86.33 6.68 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.659 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.8 m -78.9 117.19 19.75 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 172.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.632 ' HB ' ' SG ' ' A' ' 17' ' ' CYS . 2.3 t -76.01 -60.82 0.94 Allowed Pre-proline 0 C--N 1.308 -1.206 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 -167.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.53 ' HD3' ' SG ' ' A' ' 17' ' ' CYS . 67.8 Cg_endo -73.14 70.67 3.73 Favored 'Trans proline' 0 C--N 1.399 3.219 0 CA-C-N 121.963 1.737 . . . . 0.0 112.952 -171.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 69.2 m -108.29 119.19 38.77 Favored 'General case' 1 N--CA 1.377 -4.096 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.7 p -101.33 139.96 21.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.672 -175.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.417 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 66.2 tttm -108.89 111.79 23.67 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -88.53 177.69 6.72 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.238 -177.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.29 -12.0 59.01 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.44 177.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -65.51 -19.88 66.11 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.953 174.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.18 -12.22 65.1 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -176.504 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 61.6 p -94.78 166.53 11.94 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.6 p -114.28 140.14 48.85 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.134 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.5 tp -119.25 110.56 17.16 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.8 m -79.16 120.96 24.42 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.044 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 53.89 75.75 0.59 Allowed Pre-proline 0 N--CA 1.481 1.115 0 C-N-CA 124.843 1.257 . . . . 0.0 111.981 176.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -97.88 165.62 0.8 Allowed 'Trans proline' 0 N--CA 1.442 -1.519 0 C-N-CA 122.401 2.068 . . . . 0.0 111.915 178.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.456 ' O ' HG23 ' A' ' 75' ' ' VAL . 13.4 m -84.34 149.82 25.79 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.62 -41.41 94.76 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.07 0.462 . . . . 0.0 111.918 -175.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -63.48 -37.66 88.14 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.723 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -64.92 -42.99 94.25 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.271 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 71' ' ' SER . 63.2 t -62.49 -43.91 98.78 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.75 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.922 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.404 ' O ' HG13 ' A' ' 80' ' ' VAL . 23.2 tptm -62.65 -47.11 85.15 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.551 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.68 -29.09 68.28 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -178.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.496 ' O ' HG13 ' A' ' 82' ' ' ILE . 3.5 tmtp? -82.49 -37.06 25.86 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 19.2 tp -57.69 -49.74 75.52 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.105 0.479 . . . . 0.0 110.068 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 76' ' ' LYS . 33.7 m -61.02 -34.99 62.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.99 -176.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.1 ptpp? -80.55 -32.61 36.64 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.685 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.1 pp -85.29 -12.45 11.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.289 0.566 . . . . 0.0 111.854 -178.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.532 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.236 174.66 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.416 0 CA-C-O 121.363 0.601 . . . . 0.0 109.758 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.1 tp -125.83 137.81 53.78 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -178.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.8 m -122.6 135.71 54.69 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.632 HG22 HG23 ' A' ' 10' ' ' THR . 58.7 mt -126.03 131.33 71.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.264 0.554 . . . . 0.0 109.884 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -91.94 90.29 7.37 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.028 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.632 HG23 HG22 ' A' ' 8' ' ' ILE . 3.7 p -127.62 160.54 31.29 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 123.006 0.523 . . . . 0.0 111.159 -177.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.5 p -115.48 166.63 11.68 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 171.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.8 t -71.87 -13.65 61.72 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-O 121.678 0.751 . . . . 0.0 109.093 172.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 2.2 m0 -90.2 75.74 6.94 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -175.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.2 t -158.52 159.87 36.05 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.675 -178.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.47 -43.9 0.26 Allowed Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -72.24 -26.98 62.23 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 70.0 m -54.88 -32.41 60.84 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 122.652 0.381 . . . . 0.0 111.409 -177.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 38.4 tp -55.02 -33.72 62.88 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.146 0.978 . . . . 0.0 111.943 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -59.72 -42.58 93.4 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.3 0.64 . . . . 0.0 109.442 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.5 tp -84.32 -38.71 20.05 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.437 -178.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -55.44 -48.84 73.84 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.444 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.9 p -68.18 -40.22 82.32 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.876 -178.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.529 ' HB1' ' HB2' ' A' ' 72' ' ' ALA . . . -59.68 -45.83 90.9 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.481 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.0 mt -69.66 -42.67 73.91 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.723 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 59.6 m -64.71 -35.57 81.47 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-O 120.878 0.37 . . . . 0.0 111.175 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.93 -26.56 62.34 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-O 121.463 0.649 . . . . 0.0 110.425 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -91.89 10.64 27.89 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.48 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 65.58 23.87 11.74 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.144 1.377 . . . . 0.0 111.282 175.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 80.0 mt -90.11 130.76 38.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -102.29 150.39 23.37 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -147.86 138.27 22.99 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.3 112.43 22.83 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 176.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -83.38 126.83 33.13 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.4 t -75.51 154.81 6.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-O 121.864 0.84 . . . . 0.0 112.559 -173.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -68.79 -0.52 5.51 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 126.394 1.878 . . . . 0.0 114.418 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.2 pt -44.44 -24.92 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 N-CA-C 117.265 2.32 . . . . 0.0 117.265 -170.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -67.73 -25.77 65.81 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 119.561 -0.855 . . . . 0.0 111.109 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 14.6 t60 -108.93 -43.79 4.13 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 176.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -79.43 102.98 9.03 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.336 -178.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.406 ' HA ' ' HB3' ' A' ' 43' ' ' ALA . 16.9 ptp180 -71.47 -23.41 61.82 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.77 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.39 -38.38 89.82 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.34 -20.99 25.97 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.975 176.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.406 ' HB3' ' HA ' ' A' ' 40' ' ' ARG . . . -66.88 -33.82 76.45 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.402 -178.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -70.81 -30.49 66.94 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.579 176.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -66.73 -32.96 74.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.172 0.51 . . . . 0.0 110.108 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 44.9 t -62.25 -32.51 55.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.392 177.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.55 -43.38 52.98 Favored Glycine 0 N--CA 1.44 -1.079 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 177.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.7 m -58.18 -40.42 81.44 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.497 0.719 . . . . 0.0 112.174 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.3 m -79.72 -7.58 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -107.75 -53.6 2.6 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.856 -0.337 . . . . 0.0 111.619 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 138.52 -87.51 0.21 Allowed Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.193 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -103.14 -42.7 2.02 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.339 -177.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -124.33 149.35 46.68 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.078 0.466 . . . . 0.0 110.72 -177.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.1 mtm180 -80.79 97.44 7.34 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.45 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.7 m -75.8 127.45 33.04 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 175.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 1.564 18.9 m -59.35 -71.02 0.34 Allowed Pre-proline 0 CA--C 1.45 -2.883 1 N-CA-C 124.52 5.007 . . . . 0.0 124.52 -177.329 . . . . . . . . 3 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.67 79.36 3.38 Favored 'Trans proline' 0 N--CA 1.401 -3.966 0 CA-C-N 122.617 1.97 . . . . 0.0 113.188 -170.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.4 m -108.14 120.97 43.85 Favored 'General case' 0 N--CA 1.417 -2.093 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.155 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.6 p -97.78 143.85 12.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.747 -177.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -121.08 128.17 52.35 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -103.79 149.08 25.36 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.27 -11.91 53.22 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.457 0.646 . . . . 0.0 111.562 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.4 ' HB2' HG22 ' A' ' 82' ' ' ILE . 36.9 t70 -74.92 -14.19 60.62 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 124.104 0.962 . . . . 0.0 110.064 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.03 -21.85 24.22 Favored Glycine 0 CA--C 1.501 -0.812 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.752 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 p -70.36 138.02 51.05 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 123.585 0.754 . . . . 0.0 111.889 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.98 138.09 54.51 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 174.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mp -129.58 119.6 23.9 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 120.87 0.366 . . . . 0.0 110.595 -178.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.9 m -90.3 112.72 24.39 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.732 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 36.4 t30 56.1 74.22 0.73 Allowed Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 177.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -103.59 172.2 0.19 Allowed 'Trans proline' 0 N--CA 1.444 -1.388 0 C-N-CA 122.478 2.119 . . . . 0.0 110.598 172.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.2 t -85.08 165.22 17.67 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 174.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.529 ' HB2' ' HB1' ' A' ' 23' ' ' ALA . . . -60.66 -32.45 71.64 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.958 0.409 . . . . 0.0 111.398 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -56.65 -40.62 75.8 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.598 1.159 . . . . 0.0 109.511 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 11.7 mm-40 -68.96 -53.12 22.48 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.653 -176.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 49.4 t -61.4 -40.84 87.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 114.997 -1.002 . . . . 0.0 111.126 -176.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -64.04 -37.8 88.74 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.572 -177.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.57 -22.58 34.83 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.897 0.38 . . . . 0.0 110.964 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.423 ' O ' HG23 ' A' ' 82' ' ' ILE . 74.8 mmtt -84.56 -35.99 22.42 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.493 177.252 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.9 tp -55.61 -46.48 77.32 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.467 0.651 . . . . 0.0 109.6 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.7 m -63.42 -40.88 90.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.864 -178.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.12 -24.18 51.73 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.71 -177.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 78' ' ' LYS . 1.9 pp -83.37 -25.45 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 120.004 -0.679 . . . . 0.0 110.426 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.57 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.462 175.991 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.691 0 CA-C-O 121.36 0.6 . . . . 0.0 109.665 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.437 ' CD1' HD13 ' A' ' 79' ' ' LEU . 8.5 mp -93.53 129.42 39.76 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.448 177.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.3 m -118.34 108.31 14.92 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 171.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 57.6 mt -108.5 134.09 51.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-O 121.147 0.498 . . . . 0.0 110.211 -174.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -86.14 123.65 31.66 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.565 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 31.5 p -138.79 -178.91 5.53 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.687 0.755 . . . . 0.0 111.103 -178.032 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.1 m -139.4 153.25 47.59 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 104.367 -2.457 . . . . 0.0 104.367 174.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.3 p -49.94 -42.6 48.85 Favored 'General case' 0 C--N 1.315 -0.928 0 O-C-N 123.605 0.565 . . . . 0.0 110.99 176.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 35.2 p90 -111.52 129.67 55.98 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 174.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.3 t -164.02 142.13 7.28 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 174.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.47 -49.2 2.04 Favored Glycine 0 N--CA 1.429 -1.792 0 C-N-CA 120.646 -0.787 . . . . 0.0 111.374 178.272 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -73.42 -34.02 65.26 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 122.548 0.339 . . . . 0.0 111.553 -175.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.414 ' HA ' ' HB3' ' A' ' 57' ' ' PRO . 21.4 m -62.69 -36.96 84.6 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.247 0.546 . . . . 0.0 110.216 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 24.2 tp -65.64 -27.79 68.63 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.831 -174.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.0 ttt180 -54.46 -53.26 56.68 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.865 0.866 . . . . 0.0 110.158 177.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.48 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 23.3 tp -79.99 -37.8 33.48 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.125 -177.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.6 tttm -58.13 -43.56 87.34 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 123.747 0.819 . . . . 0.0 111.069 -175.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.6 m -72.4 -32.06 66.06 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.351 -178.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.97 -46.19 78.95 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.275 0.56 . . . . 0.0 110.042 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 68.9 mt -63.61 -44.46 93.88 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.599 -178.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.5 m -61.57 -37.42 83.78 Favored 'General case' 0 CA--C 1.555 1.167 0 CA-C-O 121.217 0.532 . . . . 0.0 110.68 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.18 -19.82 59.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.107 0.48 . . . . 0.0 111.134 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.422 ' HB3' HG13 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -97.31 10.96 38.18 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.519 -179.284 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 63.99 26.2 14.05 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.792 0.837 . . . . 0.0 111.978 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.422 HG13 ' HB3' ' A' ' 27' ' ' ASN . 77.0 mt -91.52 120.19 40.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.04 146.48 26.08 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -153.01 147.91 26.46 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -176.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -109.46 116.27 31.49 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 177.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.565 ' HB2' ' OG1' ' A' ' 10' ' ' THR . 14.0 pt-20 -87.98 146.91 25.28 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.617 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.7 t -91.07 151.73 3.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -171.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -77.91 1.55 20.23 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 128.724 2.81 . . . . 0.0 113.103 -178.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.1 pt -42.92 -22.48 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.526 3.341 0 N-CA-C 116.978 2.214 . . . . 0.0 116.978 -168.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -74.37 -21.81 59.5 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 119.403 1.001 . . . . 0.0 109.732 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -111.01 -34.86 6.09 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.573 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -90.98 113.46 25.71 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.819 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -72.03 -29.85 64.6 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.625 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.65 -46.94 74.1 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -174.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.441 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -76.03 -25.18 55.43 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.522 179.228 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.48 -42.61 87.2 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.65 -39.55 84.76 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.617 176.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -65.08 -32.85 74.77 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.082 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 42' ' ' ALA . 64.9 t -59.68 -34.47 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 121.195 0.522 . . . . 0.0 109.674 178.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.24 -18.38 65.02 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.834 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.5 t -81.54 -26.85 34.72 Favored 'General case' 0 N--CA 1.433 -1.285 0 O-C-N 122.228 -0.572 . . . . 0.0 110.391 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.4 m -99.42 -23.01 4.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 119.831 -0.748 . . . . 0.0 112.729 -178.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -147.76 154.09 40.07 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 175.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -144.32 170.04 26.18 Favored Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -178.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.51 -82.79 1.66 Allowed Glycine 0 CA--C 1.501 -0.834 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -177.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -104.85 123.59 47.97 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 174.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -67.13 106.25 1.93 Allowed 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.127 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.5 m -78.48 110.72 13.82 Favored 'General case' 0 N--CA 1.409 -2.476 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.4 t -76.89 -57.71 1.15 Allowed Pre-proline 0 N--CA 1.426 -1.632 0 CA-C-O 117.119 -1.42 . . . . 0.0 113.087 -174.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.414 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . 81.1 Cg_endo -73.39 45.49 1.02 Allowed 'Trans proline' 0 C--N 1.402 3.374 0 C-N-CA 121.393 1.395 . . . . 0.0 114.014 -168.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 95.5 m -80.49 138.21 36.53 Favored 'General case' 0 N--CA 1.39 -3.473 0 C-N-CA 126.063 1.745 . . . . 0.0 107.29 177.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.67 136.48 59.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-O 121.13 0.49 . . . . 0.0 110.569 -178.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -114.58 130.59 56.79 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 175.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -100.35 151.99 20.86 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.919 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.4 -10.08 15.29 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 124.234 1.013 . . . . 0.0 113.569 -177.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -89.76 -13.98 35.57 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.181 0.515 . . . . 0.0 109.663 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.72 3.13 30.49 Favored Glycine 0 N--CA 1.436 -1.312 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.6 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.0 m -82.86 131.01 35.21 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.796 177.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.0 p -113.93 137.65 51.4 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 171.383 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.3 mp -128.08 116.56 20.17 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.9 m -96.91 112.42 24.18 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -178.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 54.08 69.88 1.97 Allowed Pre-proline 0 N--CA 1.488 1.466 0 C-N-CA 124.213 1.005 . . . . 0.0 113.141 -174.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -95.55 172.88 1.16 Allowed 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 122.058 1.839 . . . . 0.0 111.567 175.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.0 t -93.55 161.49 14.34 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 172.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.81 -28.9 67.86 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.16 0.505 . . . . 0.0 110.243 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -56.55 -49.97 73.25 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.191 177.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -65.25 -42.56 93.18 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-N 114.805 -1.088 . . . . 0.0 110.653 -177.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.414 ' CG1' HD21 ' A' ' 6' ' ' LEU . 96.9 t -62.05 -49.38 84.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.29 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -61.36 -43.91 98.06 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.379 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.81 -38.79 87.16 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.575 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.421 ' O ' HG13 ' A' ' 82' ' ' ILE . 18.1 tppt? -66.6 -45.08 80.36 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 177.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.437 HD13 ' CD1' ' A' ' 6' ' ' LEU . 33.9 tp -59.98 -49.45 77.61 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.923 -177.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.8 m -66.61 -30.17 48.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -79.72 -33.44 40.92 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.543 -0.863 . . . . 0.0 111.221 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.5 pp -83.4 -23.8 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.768 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.829 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.997 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.386 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.2 tp -110.29 151.55 27.25 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.779 -174.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.2 m -121.44 119.64 32.65 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 176.023 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 52.3 mt -120.34 131.87 71.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.394 0.616 . . . . 0.0 110.886 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -95.0 127.3 40.96 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 174.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.436 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 7.3 p -151.27 176.54 11.13 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.06 0.457 . . . . 0.0 111.723 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 29.0 m -132.02 149.45 52.42 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 174.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.2 p -68.68 -30.05 68.64 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.957 0.884 . . . . 0.0 108.85 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -84.92 101.78 12.61 Favored 'General case' 0 N--CA 1.412 -2.343 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 171.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.458 ' SG ' HG23 ' A' ' 56' ' ' VAL . 10.0 m -164.22 158.93 19.54 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.954 -1.475 . . . . 0.0 109.471 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -116.75 -62.66 0.33 Allowed Glycine 0 C--N 1.305 -1.193 0 N-CA-C 108.296 -1.921 . . . . 0.0 108.296 167.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.471 ' HD1' ' H ' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -56.62 -30.67 63.52 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 124.696 1.198 . . . . 0.0 113.197 176.842 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.425 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 36.1 m -66.04 -44.63 84.09 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 70.3 mt -62.53 -43.26 99.26 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.196 -176.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -59.01 -39.23 81.24 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.335 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.597 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 25.8 tp -77.7 -45.61 24.33 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.074 0.464 . . . . 0.0 109.826 177.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -56.9 -44.47 82.39 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 123.887 0.875 . . . . 0.0 111.971 -177.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.5 t -71.91 -31.07 66.01 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.47 177.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.64 -45.0 88.68 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 42.5 mt -63.79 -39.98 95.57 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.27 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.0 m -69.09 -33.14 73.04 Favored 'General case' 0 CA--C 1.562 1.426 0 CA-C-O 121.268 0.556 . . . . 0.0 110.504 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.03 -40.47 65.1 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.563 0.697 . . . . 0.0 111.583 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -91.23 18.32 7.14 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 114.959 -1.018 . . . . 0.0 111.902 -174.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 54.66 64.08 1.93 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.612 1.165 . . . . 0.0 113.479 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.489 HD11 ' HB2' ' A' ' 76' ' ' LYS . 89.7 mt -119.68 123.56 71.24 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.706 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 174.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.32 135.19 34.78 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.164 -177.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -155.8 150.7 26.37 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 123.208 0.317 . . . . 0.0 111.564 -176.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -109.44 136.07 49.45 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 172.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 10.0 pt-20 -102.77 142.48 33.85 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.819 178.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -84.07 154.85 3.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-O 121.259 0.552 . . . . 0.0 111.979 -173.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -71.59 -2.21 16.26 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 126.707 2.003 . . . . 0.0 113.245 -174.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.443 HD13 HG21 ' A' ' 46' ' ' VAL . 3.3 pt -44.12 -24.38 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 117.166 2.284 . . . . 0.0 117.166 -167.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -63.52 -41.48 98.5 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.853 0.835 . . . . 0.0 109.058 176.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 56.7 t60 -94.85 -41.76 9.05 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.581 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.502 ' ND2' ' H ' ' A' ' 42' ' ' ALA . 42.1 t30 -85.47 109.94 18.83 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.124 0.487 . . . . 0.0 111.574 -178.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -75.88 -16.68 60.01 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.683 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.11 -43.85 41.34 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -175.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.502 ' H ' ' ND2' ' A' ' 39' ' ' ASN . . . -81.32 -22.79 38.26 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.377 0.608 . . . . 0.0 109.881 177.162 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.37 -27.13 68.35 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.617 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -64.61 -33.25 75.49 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.942 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -67.54 -36.8 81.67 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.443 HG21 HD13 ' A' ' 36' ' ' ILE . 57.3 t -64.87 -45.68 94.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.999 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.64 -21.02 76.2 Favored Glycine 0 C--O 1.218 -0.881 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.862 178.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.6 t -81.87 -41.62 20.73 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 122.798 0.439 . . . . 0.0 110.798 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.2 p -82.22 -31.43 10.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -96.19 137.02 35.87 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.807 0.337 . . . . 0.0 110.156 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.85 136.14 12.9 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.78 -174.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.32 -88.17 1.58 Allowed Glycine 0 N--CA 1.43 -1.702 0 CA-C-N 115.436 -0.382 . . . . 0.0 112.501 177.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -93.29 162.21 14.09 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -178.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -85.48 83.43 7.93 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 173.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.6 m -60.96 127.76 33.15 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.498 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.458 HG23 ' SG ' ' A' ' 14' ' ' CYS 1.539 12.0 m -68.47 -75.05 0.14 Allowed Pre-proline 0 CA--C 1.433 -3.548 1 N-CA-C 123.902 4.778 . . . . 0.0 123.902 179.509 . . . . . . . . 4 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.425 ' HD3' ' SG ' ' A' ' 17' ' ' CYS . 98.3 Cg_endo -74.15 89.69 1.03 Allowed 'Trans proline' 0 N--CA 1.403 -3.812 0 CA-C-N 121.218 1.471 . . . . 0.0 112.004 -167.235 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.7 m -114.42 116.81 29.49 Favored 'General case' 0 N--CA 1.397 -3.1 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 -177.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.13 139.68 23.41 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.137 -176.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -115.2 121.14 42.03 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.454 ' CE2' ' HB3' ' A' ' 78' ' ' LYS . 97.0 m-85 -101.58 155.89 17.81 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.27 -9.87 27.6 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.696 0.76 . . . . 0.0 110.583 176.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -64.92 -18.77 65.51 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.893 1.277 . . . . 0.0 109.906 176.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.43 18.18 36.79 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.501 177.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 27.8 t -133.94 153.73 51.57 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -178.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.2 p -114.33 139.52 49.38 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.578 177.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.9 mp -119.33 123.88 45.26 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 18.2 m -97.67 112.69 24.47 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 54.03 68.81 2.51 Favored Pre-proline 0 N--CA 1.489 1.483 0 C-N-CA 124.437 1.095 . . . . 0.0 112.885 -171.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -85.56 165.26 10.67 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.759 1.639 . . . . 0.0 109.855 172.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.3 m -84.49 159.75 20.68 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 177.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.52 -43.28 79.65 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 122.971 0.508 . . . . 0.0 111.807 -177.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -58.92 -42.37 89.55 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.976 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.494 ' O ' ' HE2' ' A' ' 78' ' ' LYS . 56.2 mm-40 -61.15 -44.39 97.39 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.243 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.8 t -65.83 -48.0 83.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.413 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.489 ' HB2' HD11 ' A' ' 29' ' ' ILE . 57.5 tttp -61.43 -43.81 98.21 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.998 -177.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.1 -35.31 69.15 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.029 0.442 . . . . 0.0 111.369 -178.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.494 ' HE2' ' O ' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -74.22 -31.43 62.61 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 119.994 -0.683 . . . . 0.0 110.13 177.377 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.414 HD22 HG23 ' A' ' 29' ' ' ILE . 16.5 tp -63.21 -48.4 78.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.188 0.518 . . . . 0.0 109.761 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.7 m -65.21 -30.29 49.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.66 -176.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -80.94 -25.81 37.14 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.123 -0.631 . . . . 0.0 111.21 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.4 pp -85.24 -32.03 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.202 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.611 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.709 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.59 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.0 mt -119.28 117.93 29.89 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.675 -1.148 . . . . 0.0 107.933 175.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 60' ' ' LYS . 11.9 m -102.36 108.04 19.25 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 177.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 59.4 mt -108.06 134.49 49.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-O 121.629 0.728 . . . . 0.0 110.26 -176.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -91.19 120.12 31.85 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.031 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.528 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 24.9 p -139.67 162.13 35.85 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.375 0.27 . . . . 0.0 111.193 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.5 p -155.69 -175.1 5.26 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 125.316 1.446 . . . . 0.0 107.684 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.7 t -76.72 -11.03 59.78 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.984 0.421 . . . . 0.0 109.871 172.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 4.1 m0 -83.98 44.96 1.04 Allowed 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 41.3 t -133.97 126.46 30.34 Favored 'General case' 0 N--CA 1.416 -2.143 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -166.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -128.72 -69.91 0.13 Allowed Glycine 0 N--CA 1.437 -1.24 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 170.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -61.66 -18.34 59.13 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.37 -33.98 70.02 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.218 0.532 . . . . 0.0 110.516 177.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 84.1 mt -65.38 -37.28 86.53 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.348 -178.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 -52.58 -48.59 66.13 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 124.274 0.984 . . . . 0.0 110.099 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.4 tp -74.12 -45.8 46.67 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.658 -177.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.7 pttp -70.86 -26.91 63.47 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 119.285 -0.966 . . . . 0.0 112.123 -173.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.9 p -74.98 -28.49 60.57 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.848 -0.532 . . . . 0.0 110.311 175.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.46 -42.06 88.14 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 175.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.1 mt -63.32 -47.54 81.8 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.991 177.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.3 m -57.73 -47.06 83.48 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.811 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.69 -25.61 68.28 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.301 0.572 . . . . 0.0 111.936 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -95.5 6.88 47.82 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.027 -178.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.405 ' HD2' ' HA ' ' A' ' 28' ' ' ARG . 16.3 mmm180 67.53 24.0 8.78 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.78 0.832 . . . . 0.0 112.551 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.438 HG23 HD22 ' A' ' 79' ' ' LEU . 73.2 mt -83.89 120.76 35.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 176.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.52 127.7 34.9 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.4 -176.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -140.27 169.27 18.0 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -136.52 142.52 43.47 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.528 ' HB2' ' OG1' ' A' ' 10' ' ' THR . 10.3 pt-20 -105.32 131.58 52.59 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 123.659 0.599 . . . . 0.0 110.939 -176.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.4 t -78.84 143.61 12.35 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -172.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -59.65 -1.3 0.24 Allowed 'General case' 0 N--CA 1.503 2.215 0 C-N-CA 128.826 2.85 . . . . 0.0 114.878 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.2 pt -44.22 -25.19 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 117.092 2.256 . . . . 0.0 117.092 -168.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -70.91 -25.49 62.79 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 118.967 0.803 . . . . 0.0 109.096 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -97.97 -35.48 10.44 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.257 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . 0.254 0.2 OUTLIER -112.62 118.69 35.77 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.959 0.885 . . . . 0.0 112.667 179.448 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.695 ' HD3' ' H ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -75.85 -18.9 59.27 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.655 -174.88 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.87 -53.52 56.34 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.789 0.328 . . . . 0.0 111.496 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.417 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -72.82 -21.1 61.02 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.913 177.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.88 -35.46 76.9 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.126 0.489 . . . . 0.0 110.714 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -73.9 -29.28 61.98 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.951 0.405 . . . . 0.0 110.269 177.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -65.21 -29.8 70.64 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.788 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 42' ' ' ALA . 48.0 t -63.03 -30.83 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.834 176.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.75 -43.13 60.27 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 178.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.2 m -65.22 -28.82 69.63 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.222 0.609 . . . . 0.0 112.359 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.8 m -84.61 -5.03 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 O-C-N 121.655 -0.653 . . . . 0.0 111.594 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -104.83 -52.94 2.77 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.638 176.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 143.64 -37.9 1.41 Allowed Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -167.24 -47.73 0.03 OUTLIER Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -88.64 177.31 6.79 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.0 mtm180 -126.19 116.85 21.95 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.529 HG22 ' HD2' ' A' ' 57' ' ' PRO . 16.3 m -98.02 151.16 20.62 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 174.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.44 ' CG1' ' HA ' ' A' ' 10' ' ' THR . 34.5 t -79.38 -69.13 0.21 Allowed Pre-proline 0 CA--C 1.475 -1.926 0 CA-C-O 117.509 -1.234 . . . . 0.0 113.988 -178.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.529 ' HD2' HG22 ' A' ' 55' ' ' THR . 72.8 Cg_endo -76.07 86.68 1.5 Allowed 'Trans proline' 1 N--CA 1.393 -4.387 0 CA-C-N 120.867 1.345 . . . . 0.0 111.797 -163.121 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 64.0 m -121.64 124.88 45.37 Favored 'General case' 1 N--CA 1.373 -4.299 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 -175.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 66' ' ' THR . 4.6 p -115.53 136.1 53.44 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.956 -175.118 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.413 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 29.7 ttpp -111.74 123.19 49.72 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 174.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.443 ' HB3' HG21 ' A' ' 82' ' ' ILE . 88.2 m-85 -92.03 175.61 6.81 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.015 -178.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.524 ' HB3' ' HB ' ' A' ' 82' ' ' ILE . . . -66.44 -22.84 66.22 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.146 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.543 ' OD2' HG22 ' A' ' 82' ' ' ILE . 48.9 m-20 -82.17 0.07 42.65 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.198 0.523 . . . . 0.0 111.046 177.19 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.57 -0.8 87.02 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.939 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.1 m -68.27 130.45 42.94 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 6.4 p -114.13 137.8 51.27 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 176.329 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.9 mt -134.61 121.67 21.23 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.926 0.393 . . . . 0.0 110.432 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 91.8 m -90.92 121.83 33.09 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 174.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 58.33 65.64 3.01 Favored Pre-proline 0 N--CA 1.472 0.629 0 C-N-CA 124.284 1.033 . . . . 0.0 113.055 -177.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -84.0 -178.88 3.72 Favored 'Trans proline' 0 C--O 1.25 1.117 0 C-N-CA 121.694 1.596 . . . . 0.0 110.463 171.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.47 ' O ' HG23 ' A' ' 75' ' ' VAL . 3.4 m -112.09 150.83 30.16 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.165 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.41 -41.92 66.48 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -174.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -78.27 -34.83 48.71 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.948 0.404 . . . . 0.0 109.953 -178.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -65.06 -37.53 87.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.273 178.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 71' ' ' SER . 91.7 t -61.44 -42.17 92.81 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.626 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.203 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -62.52 -41.1 98.63 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.984 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.412 ' O ' HG22 ' A' ' 80' ' ' VAL . . . -69.42 -31.58 70.01 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.504 0.669 . . . . 0.0 111.289 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -78.11 -29.71 49.11 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 176.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.438 HD22 HG23 ' A' ' 29' ' ' ILE . 31.1 tp -65.94 -41.57 91.12 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.445 179.223 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 77' ' ' ALA . 27.4 m -66.12 -36.19 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -72.99 -34.37 66.37 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.943 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.543 HG22 ' OD2' ' A' ' 63' ' ' ASP . 2.1 pp -77.02 -31.53 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 120.344 -0.543 . . . . 0.0 111.246 -177.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.588 0 CA-C-O 121.062 0.458 . . . . 0.0 110.145 177.596 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.503 0 CA-C-O 120.891 0.376 . . . . 0.0 111.357 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.84 123.12 41.01 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 121.397 0.618 . . . . 0.0 109.679 175.13 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.1 m -110.16 112.3 24.2 Favored 'General case' 0 C--N 1.276 -2.605 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 177.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.539 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 57.5 mt -97.88 137.17 26.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.049 -174.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -92.72 117.91 30.5 Favored 'General case' 0 C--N 1.279 -2.459 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.52 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 14.0 p -128.68 155.92 44.29 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 122.511 0.324 . . . . 0.0 110.589 -178.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.573 ' HA ' ' HG2' ' A' ' 37' ' ' GLU . 46.9 p -140.2 175.41 9.62 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.8 m -86.03 -11.41 52.95 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 175.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 8.5 m0 -82.18 -20.23 38.28 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.312 -169.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.492 ' SG ' HG11 ' A' ' 56' ' ' VAL . 9.0 p -109.39 148.33 31.28 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -172.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -101.99 -42.37 2.27 Favored Glycine 0 N--CA 1.432 -1.586 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 172.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -59.75 -24.7 64.25 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -177.545 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.9 p -68.52 -39.14 81.33 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.448 0.642 . . . . 0.0 109.931 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 37.2 tp -69.29 -28.93 66.72 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.549 -175.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -63.39 -50.82 68.37 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.013 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.448 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 41.4 tp -68.5 -36.84 79.47 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.101 0.477 . . . . 0.0 109.908 178.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -56.56 -37.29 70.34 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.479 177.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.9 m -75.15 -40.11 59.85 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.117 178.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.83 -41.03 94.95 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.818 0.447 . . . . 0.0 111.123 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 81.9 mt -66.13 -33.77 76.53 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.76 178.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.7 m -65.55 -44.25 87.4 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.002 177.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.44 -26.89 65.74 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.561 0.696 . . . . 0.0 110.963 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -84.53 4.35 32.37 Favored 'General case' 0 C--O 1.254 1.3 0 C-N-CA 123.907 0.883 . . . . 0.0 111.858 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 60.3 37.12 20.51 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.931 1.293 . . . . 0.0 110.252 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 85.2 mt -95.61 122.74 47.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.625 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.04 125.2 31.18 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 176.705 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -135.69 148.67 48.99 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 120.707 0.289 . . . . 0.0 110.671 -178.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -111.04 123.73 50.78 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 174.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 15.7 pt-20 -96.91 151.04 20.08 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.9 t -90.92 143.63 10.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-O 122.163 0.982 . . . . 0.0 113.497 -171.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -63.59 -2.1 1.52 Allowed 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 128.305 2.642 . . . . 0.0 114.822 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.4 pt -45.28 -24.84 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -175.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.573 ' HG2' ' HA ' ' A' ' 11' ' ' THR . 45.3 mt-10 -55.8 -31.7 62.87 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.355 0.662 . . . . 0.0 111.427 178.085 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -128.08 20.56 6.37 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.22 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.462 ' ND2' ' H ' ' A' ' 42' ' ' ALA . 28.7 t30 -143.52 122.18 12.57 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.957 0.408 . . . . 0.0 111.26 -178.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -77.15 -28.21 54.1 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.421 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.04 -37.48 81.38 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 -172.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.462 ' H ' ' ND2' ' A' ' 39' ' ' ASN . . . -84.19 -24.75 29.98 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 120.113 -0.635 . . . . 0.0 109.466 176.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.79 -30.28 68.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.288 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -64.4 -36.6 84.68 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 114.97 -1.013 . . . . 0.0 108.737 178.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -67.53 -31.78 72.11 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.123 0.487 . . . . 0.0 110.463 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 43.6 t -66.49 -31.42 53.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.33 -23.65 67.68 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.321 176.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 42.3 t -67.94 -43.72 78.47 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 176.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 31.5 m -81.06 -39.52 17.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.923 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' A' ' 53' ' ' ASN . 54.5 m-80 -106.97 109.22 21.06 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 120.862 0.363 . . . . 0.0 110.701 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -81.93 128.17 8.33 Favored Glycine 0 N--CA 1.439 -1.116 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.798 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.31 -84.25 1.37 Allowed Glycine 0 N--CA 1.438 -1.204 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.429 ' O ' ' HB3' ' A' ' 50' ' ' ASN . 93.0 m-20 -88.64 122.61 32.27 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -80.63 94.03 6.24 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.821 177.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.8 m -67.0 123.71 20.99 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 175.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.492 HG11 ' SG ' ' A' ' 14' ' ' CYS . 16.5 t -72.89 -60.56 1.85 Allowed Pre-proline 0 CA--C 1.462 -2.412 0 CA-C-O 117.149 -1.405 . . . . 0.0 114.746 -172.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -77.74 72.17 6.21 Favored 'Trans proline' 1 N--CA 1.394 -4.343 0 CA-C-N 121.185 1.459 . . . . 0.0 112.782 -167.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 88.2 m -106.35 142.12 36.54 Favored 'General case' 0 N--CA 1.38 -3.96 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.6 p -136.81 139.16 45.24 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.862 -174.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -104.54 128.59 52.53 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -112.4 166.43 11.3 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.102 0.477 . . . . 0.0 110.489 177.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.34 -8.84 53.65 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.142 171.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -62.91 -17.07 61.29 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.111 1.764 . . . . 0.0 110.997 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.68 8.67 55.69 Favored Glycine 0 CA--C 1.506 -0.517 0 C-N-CA 120.743 -0.741 . . . . 0.0 113.78 173.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.0 t -150.71 173.75 13.81 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.8 p -114.13 139.68 49.14 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -178.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.403 HD23 ' HB3' ' A' ' 70' ' ' PRO . 9.7 mp -106.09 151.79 24.23 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 177.1 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 18.2 m -131.48 113.79 14.13 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -177.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.7 m120 61.05 44.96 0.84 Allowed Pre-proline 0 N--CA 1.485 1.322 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -175.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.403 ' HB3' HD23 ' A' ' 67' ' ' LEU . 74.5 Cg_endo -77.28 160.33 32.69 Favored 'Trans proline' 0 C--N 1.366 1.464 0 C-N-CA 121.305 1.337 . . . . 0.0 111.098 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.1 m -84.27 155.25 22.52 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.42 -42.12 70.12 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.717 0.807 . . . . 0.0 112.172 -177.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -61.46 -40.39 94.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.593 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -67.11 -40.81 86.92 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-O 121.075 0.464 . . . . 0.0 110.089 -178.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.3 t -61.22 -43.82 97.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.619 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -68.61 -41.28 79.73 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.452 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.11 -38.88 89.28 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 122.703 0.401 . . . . 0.0 111.033 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.658 ' O ' HG13 ' A' ' 82' ' ' ILE . 28.7 mmtp -69.48 -39.78 77.48 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.366 174.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.9 tp -60.53 -51.07 70.99 Favored 'General case' 0 C--N 1.318 -0.781 0 O-C-N 123.475 0.485 . . . . 0.0 110.729 -178.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.6 m -61.67 -31.41 50.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -177.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.09 -44.32 18.16 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 119.801 -0.76 . . . . 0.0 111.575 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.658 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.2 pp -82.1 -20.37 10.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -175.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.63 0 CA-C-O 121.208 0.527 . . . . 0.0 111.504 -179.006 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.5 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.74 130.71 21.76 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-N 113.561 -1.654 . . . . 0.0 108.922 174.226 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.5 m -102.94 117.32 34.34 Favored 'General case' 0 C--N 1.274 -2.679 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.504 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 68.9 mt -108.86 133.61 53.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 121.446 0.641 . . . . 0.0 110.93 -175.161 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -85.12 127.42 34.24 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.598 177.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 39.0 p -133.63 163.17 30.03 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.0 0.429 . . . . 0.0 111.215 -178.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.3 m -147.87 151.6 36.19 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 175.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.4 p -58.41 -42.91 88.27 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 118.534 0.606 . . . . 0.0 109.736 174.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.11 94.36 1.51 Allowed 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 167.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 m -163.82 117.46 1.49 Allowed 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.098 -1.41 . . . . 0.0 111.568 178.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -106.83 -56.93 0.62 Allowed Glycine 0 N--CA 1.428 -1.898 0 N-CA-C 108.681 -1.768 . . . . 0.0 108.681 172.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -69.97 -20.96 63.28 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -179.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.519 ' SG ' ' HB ' ' A' ' 56' ' ' VAL . 3.6 m -72.5 -34.99 68.02 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 177.115 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 18.3 tp -72.29 -29.39 63.83 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.092 -173.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.419 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 2.2 mmp_? -59.34 -37.59 78.23 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.81 177.415 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.7 tp -82.58 -41.33 19.69 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.564 178.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -58.61 -45.54 88.96 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.635 -176.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -66.34 -36.73 83.66 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.62 -45.42 86.93 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.947 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.4 mt -67.54 -37.87 83.34 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.359 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.0 m -67.09 -42.72 84.13 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.998 0.428 . . . . 0.0 110.41 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.47 -23.86 65.54 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-O 121.233 0.54 . . . . 0.0 110.801 177.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -93.35 6.63 47.47 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.073 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 64.28 24.21 13.26 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.601 0.76 . . . . 0.0 112.494 176.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 78.1 mt -86.49 120.58 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.4 127.24 33.89 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.634 -178.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -142.47 167.19 22.68 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -129.43 135.59 48.87 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 177.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 17.0 pt-20 -100.44 141.69 32.94 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.079 0.466 . . . . 0.0 111.408 -177.063 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.4 t -83.57 146.72 6.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -171.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -63.68 -2.36 1.69 Allowed 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 129.187 2.995 . . . . 0.0 115.923 178.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.7 pt -45.7 -24.34 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 -173.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -70.19 -23.56 62.98 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 121.724 0.773 . . . . 0.0 110.327 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 -111.42 -36.62 5.49 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.926 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.426 ' ND2' ' H ' ' A' ' 42' ' ' ALA . 26.5 t30 -100.85 122.43 43.43 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.095 -175.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.426 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 9.7 ptp85 -75.76 -25.6 56.64 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.379 177.498 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.95 -36.21 79.72 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -172.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.426 ' H ' ' ND2' ' A' ' 39' ' ' ASN . . . -87.0 -22.23 25.64 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.554 175.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.29 -41.25 81.26 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.766 -178.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 40' ' ' ARG . 19.0 mm-40 -70.13 -24.66 63.22 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.787 178.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -67.35 -32.6 73.66 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.71 177.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 38.9 t -65.54 -39.87 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.82 -18.06 78.67 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.956 178.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.8 t -80.54 -42.63 22.07 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 31.7 m -84.07 -32.62 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -103.52 160.0 15.11 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -178.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -128.74 152.12 19.21 Favored Glycine 0 N--CA 1.432 -1.571 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.065 -178.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.63 -111.91 3.62 Favored Glycine 0 N--CA 1.438 -1.189 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -91.62 147.69 22.82 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 175.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -71.49 96.7 1.54 Allowed 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.515 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.8 m -61.98 114.81 3.59 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 174.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.519 ' HB ' ' SG ' ' A' ' 17' ' ' CYS . 5.2 t -75.1 -55.33 2.3 Favored Pre-proline 0 N--CA 1.428 -1.541 0 CA-C-O 117.435 -1.269 . . . . 0.0 113.424 -175.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.55 75.6 3.44 Favored 'Trans proline' 0 N--CA 1.41 -3.42 0 CA-C-N 121.155 1.448 . . . . 0.0 112.706 -170.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 58.5 m -106.5 125.66 51.29 Favored 'General case' 0 N--CA 1.381 -3.909 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.73 121.0 60.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-O 121.505 0.669 . . . . 0.0 110.872 -175.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -105.2 110.11 22.35 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -79.34 159.97 26.94 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.585 -178.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.56 -24.27 31.49 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.239 1.016 . . . . 0.0 113.588 -177.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -80.58 -17.1 52.43 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.014 0.435 . . . . 0.0 110.694 -178.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.2 -8.26 30.99 Favored Glycine 0 C--O 1.246 0.885 0 C-N-CA 121.009 -0.615 . . . . 0.0 113.169 178.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.9 t -79.31 135.87 36.86 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.3 m -116.7 138.6 51.34 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.0 mp -121.83 142.16 50.51 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 120.881 0.372 . . . . 0.0 110.748 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.8 m -98.73 116.32 30.69 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 115.503 -0.772 . . . . 0.0 108.982 -178.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . 0.324 25.9 p-10 34.88 74.66 0.53 Allowed Pre-proline 0 N--CA 1.494 1.755 0 N-CA-C 116.825 2.157 . . . . 0.0 116.825 179.032 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -92.04 -165.43 0.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.405 2.07 . . . . 0.0 110.248 175.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.4 m -115.02 169.99 8.68 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.73 -41.68 87.01 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -177.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASP . . . . . 0.425 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 5.2 m-20 -64.92 -33.76 76.79 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.691 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -64.21 -51.16 65.07 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.8 t -61.0 -44.76 98.88 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.167 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.779 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . 0.425 ' HE2' ' HA ' ' A' ' 73' ' ' ASP . 37.1 ttpt -58.46 -46.68 86.1 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 123.421 0.688 . . . . 0.0 111.991 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.36 -22.19 61.19 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 120.874 0.369 . . . . 0.0 111.538 -178.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.455 ' O ' HG13 ' A' ' 82' ' ' ILE . 45.3 mmtm -81.55 -40.75 22.63 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 173.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 27.1 tp -55.68 -47.66 76.38 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 123.721 0.808 . . . . 0.0 109.603 -178.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.8 m -60.53 -36.77 72.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.728 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -82.11 -36.35 27.6 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.4 pp -84.6 -29.53 6.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 113.477 0.918 . . . . 0.0 113.477 -176.044 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -1.0 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.505 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.312 0 CA-C-O 121.103 0.477 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.6 mp -98.52 104.82 16.89 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.163 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.4 m -102.56 107.3 18.19 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 173.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.454 HG22 HG23 ' A' ' 10' ' ' THR . 31.0 mt -106.83 129.85 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 CA-C-O 121.687 0.755 . . . . 0.0 111.555 -173.024 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -94.09 106.67 18.64 Favored 'General case' 0 N--CA 1.406 -2.654 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.408 176.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.454 HG23 HG22 ' A' ' 8' ' ' ILE . 2.1 p -140.23 142.29 35.82 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.817 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.4 m -84.37 154.41 22.88 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 175.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 p -62.07 -51.98 65.77 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 46.3 p90 -83.28 92.67 7.54 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-O 121.914 0.864 . . . . 0.0 110.917 176.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.4 t -163.84 117.13 1.47 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.483 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.44 -36.13 15.24 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -62.96 -39.18 93.89 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.462 0.648 . . . . 0.0 109.683 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 55.7 m -68.09 -39.21 82.91 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.252 177.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.83 -38.63 82.6 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 123.832 0.853 . . . . 0.0 110.112 -177.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -57.12 -38.78 73.93 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.581 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.453 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 19.5 tp -78.89 -44.08 23.54 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.174 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -54.42 -49.49 69.85 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.908 -178.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.9 p -65.49 -33.68 76.51 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.963 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.21 -42.33 88.9 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.246 178.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 80.3 mt -64.34 -48.52 75.26 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.486 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 87.1 m -54.91 -42.57 72.37 Favored 'General case' 0 CA--C 1.553 1.088 0 CA-C-O 121.058 0.456 . . . . 0.0 110.768 177.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.15 -13.29 60.2 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -177.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -109.4 14.34 23.69 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 65.99 17.33 10.77 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.84 1.256 . . . . 0.0 112.256 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 63.3 mt -87.37 117.32 31.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.99 144.55 28.22 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.4 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -152.3 150.97 30.33 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 120.678 0.275 . . . . 0.0 111.059 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -114.11 113.01 24.13 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 176.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 15.4 pt-20 -91.37 145.02 24.98 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.0 t -90.73 151.8 3.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -171.076 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.67 -4.23 0.06 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 129.641 3.177 . . . . 0.0 114.91 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.8 pt -49.51 -22.48 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 116.49 2.033 . . . . 0.0 116.49 -168.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -72.73 -13.41 61.33 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 121.458 0.647 . . . . 0.0 111.808 -178.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 34.4 p-80 -128.59 -34.87 1.97 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.615 170.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -80.23 107.23 12.85 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 120.692 0.282 . . . . 0.0 110.77 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -70.77 -23.68 62.45 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.313 -179.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.52 -42.1 71.7 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -176.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.02 -23.47 41.45 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.361 177.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.72 -35.42 77.12 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.283 177.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -61.28 -39.66 91.23 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.085 175.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -66.06 -30.96 71.58 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.633 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 88.1 t -64.31 -36.83 78.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.5 -19.01 77.0 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.602 177.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.0 m -76.52 -30.65 57.24 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 177.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.5 m -98.79 -11.38 8.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -125.48 105.13 8.82 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 175.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.99 135.06 23.96 Favored Glycine 0 C--N 1.298 -1.534 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.926 -175.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.25 -59.31 4.99 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.383 -0.409 . . . . 0.0 113.574 176.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -125.75 133.34 52.11 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 -176.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.4 mtm180 -70.63 95.69 1.12 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.307 0.575 . . . . 0.0 110.788 176.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.0 m -77.04 131.02 38.2 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 1.716 15.3 m -58.46 -89.78 0.0 OUTLIER Pre-proline 0 CA--C 1.438 -3.338 1 N-CA-C 123.659 4.689 . . . . 0.0 123.659 -178.891 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -69.9 94.02 0.54 Allowed 'Trans proline' 0 N--CA 1.409 -3.48 0 CA-C-N 120.799 1.321 . . . . 0.0 112.508 -165.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.5 m -119.69 112.42 19.26 Favored 'General case' 0 N--CA 1.407 -2.609 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 -177.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.4 p -103.41 134.85 43.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-O 121.405 0.622 . . . . 0.0 111.211 -176.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -109.03 116.93 32.91 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -100.32 178.81 4.65 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.57 -9.16 24.23 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 122.346 1.07 . . . . 0.0 110.153 174.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -63.01 -19.33 64.25 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.876 1.67 . . . . 0.0 110.152 175.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.51 -22.81 14.63 Favored Glycine 0 C--O 1.238 0.353 0 CA-C-N 116.137 -0.483 . . . . 0.0 113.396 176.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.1 t -100.78 171.57 7.6 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.7 p -113.81 141.13 47.68 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 46.7 tp -115.11 125.25 53.26 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 178.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.9 m -105.24 144.76 31.59 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -175.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.6 p30 50.04 48.41 5.98 Favored Pre-proline 0 N--CA 1.491 1.59 0 C-N-CA 124.78 1.232 . . . . 0.0 113.043 -179.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -80.94 160.66 21.06 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 121.991 1.794 . . . . 0.0 112.703 -174.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.3 m -97.4 153.8 17.86 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 174.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.84 -35.54 73.08 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.044 0.45 . . . . 0.0 111.664 -176.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -62.44 -44.18 97.04 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.218 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -64.38 -41.19 96.82 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.581 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.9 t -57.82 -51.72 66.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.068 178.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -60.96 -44.11 97.77 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.379 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.05 -37.91 84.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.674 -178.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -68.81 -41.24 78.91 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 177.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.17 -49.74 74.62 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 123.796 0.685 . . . . 0.0 110.121 -175.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.5 m -61.88 -35.93 70.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.14 -31.24 34.25 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 119.771 -0.772 . . . . 0.0 111.731 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.4 pp -75.02 -21.52 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.51 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.939 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.682 176.42 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.574 0 CA-C-O 121.069 0.462 . . . . 0.0 111.466 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.3 tp -132.68 133.27 43.34 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -178.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.0 m -114.86 124.34 51.47 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.573 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 67.0 mt -119.03 144.94 25.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.436 ' HD1' ' O ' ' A' ' 58' ' ' THR . 92.7 m-85 -98.75 133.01 43.68 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.452 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . 17.1 p -140.49 153.85 46.38 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -176.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.3 p -144.69 164.74 30.07 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 175.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.6 p -86.14 -0.82 56.57 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.34 0.591 . . . . 0.0 111.529 177.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -94.68 27.96 2.84 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -174.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.442 ' HB2' HG21 ' A' ' 56' ' ' VAL . 6.1 t -148.08 151.49 35.76 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -168.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.71 -28.21 0.98 Allowed Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.771 176.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -65.09 -36.46 84.37 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.262 0.553 . . . . 0.0 110.793 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.443 ' HA ' ' HB3' ' A' ' 57' ' ' PRO . 1.7 p -61.0 -32.59 72.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.165 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 81.9 mt -66.73 -28.85 68.75 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.906 -177.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -60.78 -56.08 25.47 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.292 0.568 . . . . 0.0 109.5 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.522 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 16.4 tp -66.79 -39.93 87.97 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.994 -177.366 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.438 ' HG2' ' OH ' ' A' ' 31' ' ' TYR . 51.1 tttm -58.34 -45.66 87.71 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.847 -177.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.7 p -71.41 -37.47 71.5 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.597 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.47 -42.9 97.18 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 123.066 0.546 . . . . 0.0 110.997 178.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 76.4 mt -69.26 -42.62 75.32 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.01 -178.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.4 m -62.52 -42.13 99.31 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 120.712 0.291 . . . . 0.0 110.273 177.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.79 -19.0 65.04 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.479 0.657 . . . . 0.0 111.196 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -98.25 9.4 43.07 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.932 178.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.475 ' HA ' ' NE ' ' A' ' 28' ' ' ARG . 4.2 mmp_? 65.96 23.14 11.24 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.54 0.736 . . . . 0.0 112.127 177.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.7 mt -87.15 119.95 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.35 127.16 35.78 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.165 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.438 ' OH ' ' HG2' ' A' ' 21' ' ' LYS . 51.6 p90 -136.52 151.92 49.96 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.878 -178.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -111.38 136.25 50.78 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 173.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.573 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 12.8 pt-20 -102.64 146.23 28.49 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.641 -177.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.3 t -96.04 134.69 32.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -173.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -54.57 -0.59 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 129.529 3.132 . . . . 0.0 115.986 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.6 pt -43.85 -25.46 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.514 2.753 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 -168.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -59.63 -45.55 91.63 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -100.54 -31.27 11.35 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.321 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -88.8 104.45 16.93 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -72.86 -17.69 61.51 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.572 -177.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.31 -46.94 53.52 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -176.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -75.29 -25.2 57.74 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.268 0.556 . . . . 0.0 110.001 177.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.16 -32.77 74.1 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.41 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -66.29 -39.89 89.67 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -61.18 -46.17 91.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.796 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 42' ' ' ALA . 80.9 t -57.08 -42.34 79.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.492 178.222 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.95 -32.95 76.78 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.299 178.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.3 m -81.87 -25.85 34.71 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 120.925 0.393 . . . . 0.0 111.304 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.6 t -79.41 -39.09 20.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.098 0.475 . . . . 0.0 110.516 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -84.97 -174.61 5.37 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.094 -178.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -90.23 -93.14 1.22 Allowed Glycine 0 N--CA 1.438 -1.201 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.181 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.25 -47.15 3.37 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.705 -174.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -126.22 151.82 46.88 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.3 mtm180 -57.88 111.18 1.07 Allowed 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.73 0.776 . . . . 0.0 111.826 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.5 m -87.95 133.82 33.85 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 178.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.452 ' CG1' ' HA ' ' A' ' 10' ' ' THR . 21.9 t -74.77 -64.46 0.64 Allowed Pre-proline 0 CA--C 1.459 -2.528 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -171.103 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.443 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . 33.0 Cg_endo -79.36 50.48 3.52 Favored 'Trans proline' 0 N--CA 1.415 -3.136 0 CA-C-N 121.092 1.426 . . . . 0.0 113.349 -164.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.436 ' O ' ' HD1' ' A' ' 9' ' ' TYR . 98.8 m -80.02 136.31 36.56 Favored 'General case' 0 N--CA 1.38 -3.938 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 176.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.3 p -125.74 148.69 30.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.325 -174.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -127.22 119.58 26.73 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -87.91 161.13 17.64 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.408 -178.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.56 -10.5 8.2 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.687 0.795 . . . . 0.0 111.735 176.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -77.68 -18.7 56.39 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.845 176.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.44 -13.35 58.31 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.176 -179.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.2 m -82.12 143.88 31.16 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -178.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.8 p -114.35 148.07 38.17 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.346 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.5 mt -130.16 136.3 49.12 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 175.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 82.9 m -100.63 118.03 35.95 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 176.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 58.18 67.44 2.22 Favored Pre-proline 0 N--CA 1.485 1.318 0 C-N-CA 124.395 1.078 . . . . 0.0 112.282 -178.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -88.24 157.54 6.88 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.776 1.651 . . . . 0.0 112.029 176.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 56.5 p -84.79 149.77 25.5 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 175.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.93 -32.83 72.32 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 120.913 0.387 . . . . 0.0 110.318 -178.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -62.11 -49.76 74.6 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.584 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 19.6 mt-10 -64.89 -42.04 95.12 Favored 'General case' 0 C--O 1.203 -1.386 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.573 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.3 t -57.72 -44.64 86.13 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.633 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -65.86 -44.94 83.92 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.21 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.94 -32.13 72.36 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.214 0.531 . . . . 0.0 111.617 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.449 ' O ' HG13 ' A' ' 82' ' ' ILE . 31.4 mmtp -77.15 -38.14 52.51 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 177.241 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.6 tp -57.59 -48.26 79.87 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 122.734 0.414 . . . . 0.0 110.061 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.6 m -60.62 -35.64 65.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.724 -176.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -81.86 -39.89 23.24 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.2 pp -75.31 -12.44 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -176.039 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.069 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.775 177.105 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.45 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.538 HD21 HD13 ' A' ' 79' ' ' LEU . 1.6 mm? -116.57 115.66 26.16 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 176.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.465 ' HB ' ' HB3' ' A' ' 60' ' ' LYS . 6.2 m -102.26 108.36 19.71 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 177.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 59.3 mt -104.54 132.35 51.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-O 121.285 0.564 . . . . 0.0 110.697 -175.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -93.92 119.96 33.53 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.425 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.8 p -139.06 156.33 47.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.702 -0.226 . . . . 0.0 110.405 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 37.5 p -142.57 -178.21 5.66 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.1 p -74.39 -0.79 18.42 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 121.337 0.589 . . . . 0.0 110.646 173.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 4.2 m0 -93.26 6.42 48.14 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 177.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.9 m -91.41 117.1 29.39 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -176.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -122.51 -56.91 0.2 Allowed Glycine 0 N--CA 1.417 -2.583 0 N-CA-C 107.653 -2.179 . . . . 0.0 107.653 170.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -68.48 -18.76 64.47 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 179.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 28.7 m -64.86 -30.46 71.46 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.182 0.515 . . . . 0.0 109.818 178.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 89.2 mt -68.97 -28.37 66.56 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.579 -173.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -63.85 -32.87 74.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.03 0.443 . . . . 0.0 110.836 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.483 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 13.0 tp -84.19 -43.57 14.81 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.374 177.22 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -55.9 -54.06 49.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.28 -176.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.3 m -63.72 -30.03 71.18 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-O 121.106 0.479 . . . . 0.0 110.973 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.17 -38.68 82.34 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.047 178.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 70.8 mt -69.94 -39.49 76.07 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.788 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 60.5 m -58.55 -43.26 89.27 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-O 121.329 0.585 . . . . 0.0 110.069 174.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.35 -37.77 83.76 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.05 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -79.32 5.8 11.56 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 123.729 0.812 . . . . 0.0 112.712 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 61.84 26.34 15.95 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.81 0.844 . . . . 0.0 111.344 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 76.9 mt -84.89 125.0 40.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 -178.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.29 115.99 26.19 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.488 -176.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -138.35 164.23 29.83 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.328 0.585 . . . . 0.0 111.266 -174.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -127.92 125.94 40.53 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 8' ' ' ILE 0.254 0.0 OUTLIER -100.01 132.78 45.16 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.506 0.67 . . . . 0.0 111.121 178.45 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.401 ' CG1' HG23 ' A' ' 36' ' ' ILE . 13.0 t -82.7 134.89 25.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -168.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -56.59 -0.69 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 130.544 3.538 . . . . 0.0 114.748 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.401 HG23 ' CG1' ' A' ' 34' ' ' VAL . 31.5 pt -41.98 -27.87 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 N-CA-C 117.862 2.541 . . . . 0.0 117.862 -163.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -67.92 -13.49 62.2 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 119.529 1.059 . . . . 0.0 113.336 -173.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 -116.17 -4.65 11.92 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 119.916 -0.714 . . . . 0.0 110.479 177.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -128.96 108.77 10.68 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -176.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -52.05 -38.25 56.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 113.577 -1.647 . . . . 0.0 113.818 -176.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.34 -52.38 61.76 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -174.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.431 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -87.0 -26.61 23.69 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.876 -177.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' A' ' 36' ' ' ILE . . . -66.09 -38.09 87.38 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.351 0.596 . . . . 0.0 110.639 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -72.66 -29.18 63.22 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.152 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -68.39 -29.4 68.08 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.516 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 42' ' ' ALA . 44.9 t -63.66 -32.04 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 121.463 0.649 . . . . 0.0 109.658 177.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.81 -39.93 46.25 Favored Glycine 0 N--CA 1.439 -1.115 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 177.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.2 m -63.79 -29.67 70.85 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.503 0.721 . . . . 0.0 112.331 -178.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.9 m -91.56 -4.86 10.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -116.03 -32.33 5.43 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.55 65.37 0.53 Allowed Glycine 0 N--CA 1.431 -1.651 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.741 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.33 -46.25 2.81 Favored Glycine 0 C--N 1.316 -0.536 0 C-N-CA 121.287 -0.482 . . . . 0.0 112.846 175.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -90.66 154.21 19.74 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -176.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -105.12 82.74 1.88 Allowed 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.48 0.657 . . . . 0.0 109.301 178.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.1 m -74.98 128.08 34.74 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.727 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 1.704 15.3 m -55.23 -88.0 0.0 OUTLIER Pre-proline 0 CA--C 1.447 -2.989 1 N-CA-C 124.219 4.896 . . . . 0.0 124.219 -176.946 . . . . . . . . 3 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -75.88 77.63 3.36 Favored 'Trans proline' 0 N--CA 1.406 -3.672 0 CA-C-N 121.303 1.501 . . . . 0.0 113.251 -167.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.9 m -103.87 130.68 51.48 Favored 'General case' 0 N--CA 1.399 -2.976 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.1 p -114.74 131.96 65.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-O 121.228 0.537 . . . . 0.0 110.095 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.465 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 26.1 ttpp -104.95 119.97 40.3 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 174.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -89.98 168.06 12.31 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.257 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.46 -10.3 57.45 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.329 175.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -71.06 -19.26 62.5 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.252 178.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.53 -22.21 41.68 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -178.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.2 m -82.09 149.96 27.77 Favored 'General case' 0 C--O 1.255 1.383 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.3 p -114.15 139.32 49.44 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.3 mp -117.67 115.89 25.96 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 51.4 m -87.75 112.01 21.95 Favored 'General case' 0 N--CA 1.411 -2.41 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.207 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 54.89 70.88 1.46 Allowed Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 124.673 1.189 . . . . 0.0 112.548 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -94.21 -175.94 0.46 Allowed 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.501 2.134 . . . . 0.0 110.337 173.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.426 ' O ' HG23 ' A' ' 75' ' ' VAL . 10.3 t -100.16 163.4 12.43 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.31 97.36 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 123.199 0.599 . . . . 0.0 112.125 -175.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -60.82 -37.13 80.96 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.927 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -69.91 -41.11 75.11 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.833 -179.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 71' ' ' SER . 98.0 t -59.54 -42.3 87.59 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.562 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 177.479 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -61.25 -44.0 97.96 Favored 'General case' 0 CA--C 1.556 1.196 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.922 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.02 -24.28 58.34 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.141 0.496 . . . . 0.0 112.227 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.4 ' O ' ' HG2' ' A' ' 81' ' ' LYS . 74.1 mmtt -84.86 -25.15 28.22 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 174.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.538 HD13 HD21 ' A' ' 6' ' ' LEU . 24.4 tp -68.87 -40.73 79.14 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.3 m -61.78 -32.98 55.58 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.83 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.325 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 14.6 ptmm? -81.04 -30.34 34.87 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.651 -0.82 . . . . 0.0 111.077 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.9 pp -85.46 -32.06 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.204 -175.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.229 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.378 178.928 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.371 0 CA-C-O 121.156 0.503 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -131.82 135.48 46.76 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.939 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.7 m -108.27 124.98 51.14 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 177.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 62.0 mt -113.33 134.56 55.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-O 121.348 0.594 . . . . 0.0 110.556 -176.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.449 ' CD1' HG22 ' A' ' 46' ' ' VAL . 97.3 m-85 -85.83 128.07 34.72 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.131 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.434 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 13.7 p -139.19 147.94 42.49 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -176.139 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.418 HG23 ' HG3' ' A' ' 37' ' ' GLU . 50.9 m -148.88 142.84 25.8 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 171.186 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.7 p -70.81 -4.39 23.85 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -172.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -39.23 94.1 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 122.553 1.168 . . . . 0.0 111.493 178.254 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.1 t -93.98 132.65 38.23 Favored 'General case' 0 N--CA 1.42 -1.942 0 CA-C-N 113.491 -1.686 . . . . 0.0 112.754 -169.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -92.74 -35.81 6.33 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.041 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -63.18 -36.35 83.33 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.442 0.639 . . . . 0.0 110.833 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.676 ' SG ' ' HB ' ' A' ' 56' ' ' VAL . 62.2 m -57.12 -42.05 80.16 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.257 177.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.3 tt -72.12 -30.21 64.84 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.189 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.3 tpp180 -62.9 -47.27 84.01 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.063 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.439 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 29.7 tp -73.48 -39.04 65.18 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.008 178.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -55.34 -47.45 75.68 Favored 'General case' 0 C--O 1.245 0.861 0 C-N-CA 124.05 0.94 . . . . 0.0 110.639 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 p -69.88 -35.06 74.36 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.573 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.32 -44.94 96.36 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 177.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 87.9 mt -63.71 -39.4 94.21 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.425 178.342 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.6 m -64.93 -43.55 92.4 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.222 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.2 -22.95 66.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.28 0.562 . . . . 0.0 110.91 178.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -95.34 11.41 32.76 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.34 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 65.97 16.09 10.33 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.834 1.254 . . . . 0.0 111.016 175.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 77.5 mt -78.81 122.64 34.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.654 -0.654 . . . . 0.0 109.262 -179.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.86 129.56 38.74 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.867 -178.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -142.89 161.13 38.91 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.527 -175.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -119.77 124.07 45.27 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 176.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 13.0 pt-20 -91.94 146.08 24.03 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -178.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 t -85.57 156.23 3.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.867 -175.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -83.0 0.3 45.36 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 127.101 2.16 . . . . 0.0 113.683 -176.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.6 pt -42.95 -29.91 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 -168.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.418 ' HG3' HG23 ' A' ' 11' ' ' THR . 40.8 tt0 -61.14 -33.76 73.92 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.509 0.671 . . . . 0.0 110.186 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -123.74 24.0 8.56 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.026 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -148.91 100.88 3.12 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.244 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -67.66 -21.03 65.38 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.73 -43.31 84.57 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -176.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.47 -20.74 31.24 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.932 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.9 -38.16 90.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.175 178.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -58.06 -39.84 79.48 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.364 174.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -68.83 -29.19 67.47 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.027 -175.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.449 HG22 ' CD1' ' A' ' 9' ' ' TYR . 58.2 t -63.2 -43.59 98.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 177.063 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.97 -18.88 77.99 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.469 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.7 t -82.43 -30.42 30.11 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 120.6 0.238 . . . . 0.0 110.398 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.7 m -81.75 -37.0 14.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.963 178.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -119.17 87.0 2.65 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 122.439 1.114 . . . . 0.0 109.075 172.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -49.51 118.37 5.37 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 113.293 -1.776 . . . . 0.0 115.566 -170.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.4 -20.72 49.34 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 121.366 -0.445 . . . . 0.0 114.117 175.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -126.74 171.44 11.19 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 117.71 0.755 . . . . 0.0 109.344 -177.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -122.32 70.28 0.98 Allowed 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 170.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.1 m -72.08 122.88 21.69 Favored 'General case' 0 C--O 1.248 1.02 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.676 ' HB ' ' SG ' ' A' ' 17' ' ' CYS . 9.4 t -69.36 -65.85 1.11 Allowed Pre-proline 0 CA--C 1.47 -2.126 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -170.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.652 ' HD3' ' SG ' ' A' ' 17' ' ' CYS . 43.9 Cg_endo -77.04 72.31 5.91 Favored 'Trans proline' 0 N--CA 1.403 -3.827 0 CA-C-N 121.755 1.662 . . . . 0.0 112.744 -167.142 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.424 ' O ' ' HD2' ' A' ' 9' ' ' TYR . 81.6 m -107.72 131.45 54.41 Favored 'General case' 1 N--CA 1.366 -4.637 0 CA-C-N 112.97 -1.923 . . . . 0.0 106.422 179.819 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.2 p -115.43 134.52 58.34 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.366 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.745 -178.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -112.65 119.28 37.56 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 175.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -88.66 159.44 17.84 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.95 -20.5 38.16 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.525 0.679 . . . . 0.0 111.289 177.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -67.68 -18.55 64.97 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.573 1.149 . . . . 0.0 111.22 177.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.95 -9.17 59.82 Favored Glycine 0 CA--C 1.503 -0.695 0 N-CA-C 111.466 -0.653 . . . . 0.0 111.466 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.8 p -81.07 136.03 35.9 Favored 'General case' 0 N--CA 1.412 -2.338 0 CA-C-N 114.948 -0.626 . . . . 0.0 111.088 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.2 p -114.04 137.93 51.06 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 177.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.3 mp -127.43 128.18 45.35 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 61.5 m -105.35 123.88 48.61 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 55.41 54.23 9.43 Favored Pre-proline 0 N--CA 1.477 0.917 0 C-N-CA 124.258 1.023 . . . . 0.0 113.117 -177.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -83.27 166.48 14.23 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.629 1.553 . . . . 0.0 111.235 178.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.4 m -87.38 155.55 19.98 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 175.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.29 -37.01 83.89 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.924 0.392 . . . . 0.0 111.328 -177.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -64.71 -34.88 79.36 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.885 178.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -67.04 -44.37 80.38 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.1 t -61.01 -45.48 98.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.835 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -58.37 -48.87 79.23 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.185 178.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.33 -22.35 62.81 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.89 0.376 . . . . 0.0 111.92 -178.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.486 ' O ' HG13 ' A' ' 82' ' ' ILE . 47.6 mmtm -80.89 -43.31 20.05 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.11 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 39.9 tp -54.3 -48.49 71.24 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.82 0.7 . . . . 0.0 110.475 -176.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.0 m -59.4 -41.31 84.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.135 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -81.36 -38.28 26.88 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -176.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 78' ' ' LYS 0.255 2.5 pp -81.44 -37.4 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -176.886 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.459 ' N ' HD12 ' A' ' 82' ' ' ILE . . . . . . . . 0 C--N 1.321 -0.671 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.892 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 N--CA 1.451 -0.399 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.3 p -78.93 100.15 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 122.0 0.905 . . . . 0.0 109.495 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.6 m -73.87 105.9 5.35 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.091 -0.958 . . . . 0.0 112.086 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -84.98 99.94 11.32 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.595 177.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.02 -0.87 57.33 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.963 -176.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.6 mt -111.54 129.23 56.12 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.975 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.2 m -103.56 107.95 19.01 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 173.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.53 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 57.8 mt -107.27 133.07 53.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 121.059 0.457 . . . . 0.0 109.775 -176.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.44 ' HD1' ' O ' ' A' ' 58' ' ' THR . 89.5 m-85 -87.16 128.18 35.13 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.464 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 21.1 p -140.29 163.93 31.45 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.581 0.229 . . . . 0.0 111.329 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.1 p -146.11 166.51 25.94 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 124.927 1.291 . . . . 0.0 107.795 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.0 t -74.78 -21.86 59.08 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 173.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -81.86 80.46 8.15 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 177.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.8 t -132.94 164.7 26.37 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.436 0.636 . . . . 0.0 112.439 -168.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -167.85 -81.34 0.05 OUTLIER Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 177.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.47 -31.75 68.11 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 123.891 0.876 . . . . 0.0 112.551 177.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.447 ' HA ' ' HB3' ' A' ' 57' ' ' PRO . 0.5 OUTLIER -64.49 -36.99 85.99 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.547 178.08 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 32.2 tp -68.04 -31.88 71.85 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.069 -176.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.9 mmp_? -58.28 -56.13 26.09 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.9 tp -65.09 -39.0 92.55 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.425 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -60.98 -35.94 78.13 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.76 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.9 m -70.51 -44.6 67.26 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.46 -46.33 89.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.898 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.7 mt -68.05 -37.48 81.38 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.4 m -67.12 -40.85 86.87 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 121.007 0.432 . . . . 0.0 110.179 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.65 -25.4 63.9 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.55 0.69 . . . . 0.0 110.94 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -88.25 6.9 34.69 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.983 178.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 72.9 mtm180 65.34 29.12 11.66 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.475 1.11 . . . . 0.0 111.924 176.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.457 HG23 HD22 ' A' ' 79' ' ' LEU . 80.2 mt -91.69 123.41 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.707 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.41 126.26 34.77 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.356 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -136.46 156.67 48.28 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.722 -177.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -118.6 114.85 23.42 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.53 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 16.4 pt-20 -91.12 144.82 25.23 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.217 0.532 . . . . 0.0 110.796 -177.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.6 t -89.53 152.86 3.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-O 122.07 0.938 . . . . 0.0 112.48 -172.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -82.76 2.27 34.75 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 127.944 2.498 . . . . 0.0 114.3 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.1 pt -41.56 -26.79 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.835 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 -167.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -61.83 -41.61 98.0 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.738 0.78 . . . . 0.0 109.131 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -100.66 -36.95 8.96 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.313 -178.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -90.92 99.85 12.81 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.26 -178.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -65.04 -38.37 90.64 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -171.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.56 -29.14 70.44 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -174.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.01 -23.42 25.0 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.382 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.67 -39.55 80.57 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.172 0.51 . . . . 0.0 110.117 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.468 ' CD ' HH22 ' A' ' 54' ' ' ARG . 19.2 mm-40 -67.02 -32.26 73.35 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.007 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -67.61 -30.14 69.66 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.756 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.7 t -62.38 -42.93 97.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 53' ' ' ASN . . . -60.55 -34.4 85.71 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.337 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.4 m -68.53 -48.13 65.13 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 122.872 0.469 . . . . 0.0 111.535 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.2 m -73.99 -27.6 22.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -176.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 53' ' ' ASN . 15.4 m120 -87.95 -28.74 21.28 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.128 177.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.15 65.27 1.07 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.364 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.79 -12.43 68.81 Favored Glycine 0 C--N 1.315 -0.609 0 C-N-CA 121.234 -0.507 . . . . 0.0 112.485 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.475 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 93.2 m-20 -111.91 161.38 16.47 Favored 'General case' 0 CA--C 1.486 -1.504 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.468 HH22 ' CD ' ' A' ' 44' ' ' GLU . 84.4 mtt180 -127.64 84.09 2.22 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 173.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.4 m -85.64 132.49 34.15 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.451 ' CG1' ' HA ' ' A' ' 10' ' ' THR . 21.3 t -66.42 -67.12 1.02 Allowed Pre-proline 0 CA--C 1.472 -2.057 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -173.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.447 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . 91.7 Cg_endo -81.15 60.47 7.82 Favored 'Trans proline' 1 N--CA 1.399 -4.073 0 CA-C-N 121.115 1.434 . . . . 0.0 112.915 -164.599 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.44 ' O ' ' HD1' ' A' ' 9' ' ' TYR . 53.6 m -91.23 127.08 36.52 Favored 'General case' 1 N--CA 1.377 -4.075 0 C-N-CA 126.363 1.865 . . . . 0.0 106.731 177.922 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.0 p -115.19 132.73 63.62 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 CA-C-O 120.916 0.389 . . . . 0.0 110.172 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -115.01 126.91 55.29 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 174.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -88.94 173.81 8.28 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.389 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.09 -10.17 47.22 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.978 0.894 . . . . 0.0 109.727 174.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -78.63 -18.64 54.17 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.271 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.02 -22.12 41.33 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.778 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.8 t -75.2 149.79 38.84 Favored 'General case' 0 C--O 1.253 1.284 0 CA-C-O 120.868 0.366 . . . . 0.0 110.61 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.2 p -114.5 139.73 49.31 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.069 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 58.1 mt -119.83 113.91 21.31 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 174.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.8 m -87.22 112.83 22.39 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 58.04 65.43 3.26 Favored Pre-proline 0 N--CA 1.487 1.42 0 C-N-CA 123.939 0.896 . . . . 0.0 112.366 -177.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -86.22 172.93 6.99 Favored 'Trans proline' 0 C--O 1.249 1.073 0 C-N-CA 121.955 1.77 . . . . 0.0 112.003 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.3 m -93.78 153.3 18.38 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 174.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.71 -36.23 83.17 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.111 0.481 . . . . 0.0 110.708 -177.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -59.31 -45.72 90.54 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.974 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -60.02 -50.53 73.36 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.871 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.9 t -58.21 -45.82 88.79 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.519 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.982 -177.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -67.15 -38.13 84.95 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.335 -178.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.55 -31.02 61.96 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.247 0.546 . . . . 0.0 110.869 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -76.59 -37.64 56.14 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.894 175.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.457 HD22 HG23 ' A' ' 29' ' ' ILE . 21.6 tp -58.38 -51.05 71.46 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.6 m -60.49 -32.12 50.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.669 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -81.8 -40.8 22.03 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 119.869 -0.732 . . . . 0.0 112.016 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.3 pp -76.1 -24.43 16.4 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.426 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -176.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.77 -32.73 16.01 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 176.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.49 29.35 69.97 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.3 tp -146.2 153.65 40.86 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 64.03 21.72 12.69 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-O 122.095 0.95 . . . . 0.0 109.736 -176.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -90.2 -33.03 16.35 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.343 -174.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 66.9 t60 . . . . . 0 N--CA 1.428 -1.557 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 -177.73 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mmm . . . . . 0 CA--C 1.515 -0.396 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.9 m -74.28 -12.16 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.2 m 65.1 44.61 3.3 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-O 122.282 1.039 . . . . 0.0 109.475 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -81.39 92.62 6.45 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.774 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.5 1.1 54.46 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.737 -177.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.6 tp -129.51 136.74 50.23 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 89.6 m -123.34 122.16 37.62 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 67.4 mt -111.85 133.49 57.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 121.298 0.571 . . . . 0.0 110.205 -177.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -87.95 129.39 35.26 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.047 176.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.5 p -134.03 166.04 23.64 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.607 -178.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.3 m -149.84 144.08 25.75 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.5 m -54.98 -44.42 74.43 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 123.435 0.459 . . . . 0.0 110.887 176.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 36.5 p90 -86.75 89.17 7.86 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 122.09 0.948 . . . . 0.0 109.459 175.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.1 t -163.57 154.68 16.47 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.072 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -135.89 -44.73 0.1 OUTLIER Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 177.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -63.6 -33.48 75.71 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.131 0.572 . . . . 0.0 111.38 -176.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.445 ' HA ' ' HB3' ' A' ' 57' ' ' PRO . 10.7 p -65.41 -34.48 78.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.28 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 87.9 mt -61.85 -41.94 98.43 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 115.872 -0.603 . . . . 0.0 112.019 -175.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.5 tpm_? -59.11 -44.81 92.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.968 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.9 tp -76.37 -38.64 55.51 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.648 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.471 ' HG2' ' OH ' ' A' ' 31' ' ' TYR . 16.4 ttpp -63.14 -43.46 98.29 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.548 -176.277 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.2 t -71.12 -28.18 64.11 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.34 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.35 -41.87 84.42 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.107 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.446 HD22 HD12 ' A' ' 29' ' ' ILE . 92.7 mt -69.6 -35.22 75.11 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.76 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.6 m -65.95 -42.93 89.37 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.0 -31.67 72.39 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-O 121.416 0.626 . . . . 0.0 110.458 176.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.42 0.44 29.31 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.274 176.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 69.02 28.26 5.15 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.071 1.349 . . . . 0.0 112.176 174.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.446 HD12 HD22 ' A' ' 24' ' ' LEU . 74.7 mt -87.64 123.05 40.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.326 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.92 117.36 22.71 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.681 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.471 ' OH ' ' HG2' ' A' ' 21' ' ' LYS . 46.4 p90 -136.53 164.0 29.2 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -119.85 138.85 53.14 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 171.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 6.7 pt-20 -101.7 137.97 39.31 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -177.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -94.43 138.57 20.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -169.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -60.9 2.13 0.12 Allowed 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 130.186 3.394 . . . . 0.0 116.074 176.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.2 pt -41.3 -27.86 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.519 3.001 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 -162.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -68.97 -24.29 64.22 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 119.552 1.069 . . . . 0.0 110.856 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -113.02 8.63 18.49 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -142.85 89.98 2.17 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-O 121.471 0.653 . . . . 0.0 109.837 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.4 ' HA ' ' HB3' ' A' ' 43' ' ' ALA . 16.3 ptm180 -65.82 -29.23 69.67 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.731 -1.122 . . . . 0.0 113.7 -173.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.81 -37.32 76.12 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.348 0.594 . . . . 0.0 111.303 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.541 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -87.1 -30.38 21.15 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.129 177.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.4 ' HB3' ' HA ' ' A' ' 40' ' ' ARG . . . -64.67 -42.99 94.99 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.108 0.48 . . . . 0.0 111.508 -178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -68.91 -29.34 67.59 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.182 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -68.04 -40.64 82.84 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.265 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 42' ' ' ALA . 73.8 t -52.85 -51.04 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.568 177.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.47 -32.23 83.46 Favored Glycine 0 N--CA 1.437 -1.288 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.319 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.8 t -65.48 -33.73 76.61 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 122.272 0.229 . . . . 0.0 110.996 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.3 m -95.1 -10.0 9.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -178.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -96.29 -51.35 4.42 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.004 0.431 . . . . 0.0 110.018 177.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 133.13 -138.66 10.3 Favored Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 -176.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.99 -21.65 62.73 Favored Glycine 0 C--N 1.306 -1.111 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -101.53 115.07 29.69 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -71.54 114.75 9.95 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 177.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.1 m -99.02 134.5 41.77 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.0 t -75.3 -64.52 0.58 Allowed Pre-proline 0 CA--C 1.463 -2.379 0 CA-C-O 117.23 -1.367 . . . . 0.0 113.98 -176.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.445 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . 82.9 Cg_endo -78.78 65.9 8.7 Favored 'Trans proline' 1 N--CA 1.399 -4.076 0 CA-C-N 121.261 1.486 . . . . 0.0 113.029 -167.067 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 96.3 m -92.32 121.37 33.75 Favored 'General case' 1 N--CA 1.376 -4.169 0 CA-C-N 113.146 -1.843 . . . . 0.0 106.051 178.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 66' ' ' THR . 12.7 p -105.61 137.85 33.48 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.998 -178.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -116.44 121.04 40.72 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -85.31 161.64 19.43 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.928 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -49.69 -32.52 13.56 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -175.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -90.58 -6.75 54.28 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.5 -176.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.6 1.88 30.78 Favored Glycine 0 C--O 1.241 0.551 0 C-N-CA 120.113 -1.041 . . . . 0.0 113.773 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.5 m -73.33 125.49 27.94 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 117.294 0.547 . . . . 0.0 109.651 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 49.5 p -114.2 138.36 50.56 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.9 mp -122.59 118.53 28.42 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 61.2 m -88.05 112.31 22.5 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.11 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 58.86 67.67 1.94 Allowed Pre-proline 0 N--CA 1.482 1.148 0 C-N-CA 124.057 0.943 . . . . 0.0 112.883 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -86.79 -174.73 1.47 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.006 1.804 . . . . 0.0 112.227 176.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.424 ' O ' HG23 ' A' ' 75' ' ' VAL . 50.5 m -116.87 150.41 38.47 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 176.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.78 -48.93 72.07 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -174.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -71.9 -24.2 61.61 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 120.639 0.257 . . . . 0.0 111.665 -176.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.56 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 38.1 mm-40 -71.77 -46.6 57.85 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 173.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 71' ' ' SER . 89.1 t -59.98 -44.12 93.95 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 O-C-N 123.842 0.714 . . . . 0.0 110.113 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.421 ' HB3' ' HE2' ' A' ' 76' ' ' LYS . 33.1 ttpt -62.24 -44.46 96.51 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.652 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.72 -21.17 63.49 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.195 0.522 . . . . 0.0 111.538 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.606 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 46.8 mmtm -84.5 -38.92 19.49 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 175.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.9 tp -56.9 -49.01 76.86 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.767 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.1 m -61.33 -34.1 59.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.152 -177.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.606 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -81.76 -32.66 31.36 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.588 -179.079 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.2 pp -82.21 -12.52 12.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.136 0.493 . . . . 0.0 111.673 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -91.57 4.08 53.47 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.394 0.616 . . . . 0.0 110.545 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 85.14 -120.06 5.21 Favored Glycine 0 N--CA 1.431 -1.669 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.565 178.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 24.5 tp -106.03 0.77 25.89 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.348 0.594 . . . . 0.0 109.557 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -85.2 94.85 8.99 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.38 0.609 . . . . 0.0 111.05 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -95.55 -29.46 14.34 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.126 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 . . . . . 0 C--N 1.313 -0.979 0 CA-C-O 118.951 -0.547 . . . . 0.0 110.494 -171.517 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mpp? . . . . . 0 CA--C 1.518 -0.255 0 CA-C-O 120.583 0.23 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p -116.51 98.53 6.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 122.166 0.984 . . . . 0.0 111.218 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.7 t -109.31 173.66 6.22 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.123 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.51 89.31 2.7 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.567 0.699 . . . . 0.0 110.355 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -96.32 0.68 51.09 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.775 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.9 mt -119.83 137.99 53.65 Favored 'General case' 0 CA--C 1.489 -1.377 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.951 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.4 m -106.91 113.95 27.74 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 174.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.408 HG22 HG23 ' A' ' 10' ' ' THR . 51.9 mt -112.19 125.97 69.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-O 121.473 0.654 . . . . 0.0 110.094 -177.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -80.97 128.14 33.35 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.98 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.489 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 7.4 p -140.85 178.16 7.54 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.056 0.543 . . . . 0.0 111.747 -174.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.523 ' HB ' ' O ' ' A' ' 13' ' ' TRP . 27.4 m -156.42 158.81 37.96 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 177.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.7 m -64.8 -51.62 61.22 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 175.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.523 ' O ' ' HB ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -64.62 109.04 1.87 Allowed 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 168.068 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.0 t -159.44 130.6 6.04 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.465 -170.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -120.97 -78.56 0.51 Allowed Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -66.71 -33.88 76.63 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 120.915 0.388 . . . . 0.0 110.371 -177.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -57.56 -38.57 75.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.984 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -67.82 -35.09 77.99 Favored 'General case' 0 C--O 1.245 0.824 0 C-N-CA 123.675 0.79 . . . . 0.0 109.979 -175.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -62.29 -51.69 66.68 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.216 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.459 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 24.8 tp -68.26 -38.78 82.1 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.072 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -59.16 -43.91 92.09 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.616 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.2 m -68.7 -37.81 79.81 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.273 178.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.61 -42.17 98.25 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.875 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 78.6 mt -68.21 -39.53 82.37 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.623 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.5 m -65.35 -35.86 82.27 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-O 121.446 0.641 . . . . 0.0 109.987 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.2 -26.03 61.89 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-O 121.326 0.584 . . . . 0.0 111.19 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -93.25 11.52 27.76 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.877 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 64.93 25.2 12.75 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.275 1.03 . . . . 0.0 112.394 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 82.0 mt -89.95 116.13 30.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.47 128.82 36.01 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.003 -177.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -137.82 168.96 18.63 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.519 -177.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -119.71 121.54 39.45 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.489 ' HB2' ' OG1' ' A' ' 10' ' ' THR . 12.5 pt-20 -91.81 136.72 32.93 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-O 121.081 0.467 . . . . 0.0 110.408 -178.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.2 t -93.57 156.41 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 -168.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -77.09 -0.47 24.9 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 128.201 2.601 . . . . 0.0 113.866 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.3 pt -44.68 -21.37 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 N-CA-C 116.398 1.999 . . . . 0.0 116.398 -171.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -56.97 -52.65 64.38 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-N 118.834 0.743 . . . . 0.0 109.572 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -97.58 -36.86 10.16 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.136 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -71.12 108.15 4.51 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 120.727 0.299 . . . . 0.0 111.013 -177.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.64 -22.14 57.07 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.316 -177.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.37 -44.95 67.03 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -177.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -79.87 -24.85 40.94 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.01 177.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.68 -30.2 69.67 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.253 0.549 . . . . 0.0 109.756 177.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -68.77 -33.94 74.73 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.298 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -63.12 -44.1 96.57 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.6 t -60.76 -47.52 92.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.759 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.72 -21.61 69.32 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.545 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.6 m -83.21 -43.59 15.95 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 176.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.8 p -73.54 -33.14 38.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -176.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -118.63 154.75 32.16 Favored 'General case' 0 C--N 1.316 -0.849 0 O-C-N 121.893 -0.504 . . . . 0.0 109.948 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -113.25 156.09 15.85 Favored Glycine 0 N--CA 1.438 -1.212 0 C-N-CA 120.274 -0.965 . . . . 0.0 113.031 -175.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.14 -104.4 1.41 Allowed Glycine 0 N--CA 1.44 -1.085 0 O-C-N 123.866 0.392 . . . . 0.0 113.014 177.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -81.72 119.29 23.66 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -56.91 109.35 0.63 Allowed 'General case' 0 CA--C 1.516 -0.33 0 O-C-N 124.142 0.901 . . . . 0.0 109.348 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.6 m -81.27 123.65 28.67 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.6 t -75.19 -62.32 0.86 Allowed Pre-proline 0 CA--C 1.469 -2.154 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.087 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -79.16 73.41 6.04 Favored 'Trans proline' 1 N--CA 1.397 -4.176 0 CA-C-N 120.604 1.252 . . . . 0.0 112.609 -164.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.5 m -101.92 120.88 41.1 Favored 'General case' 1 N--CA 1.377 -4.116 0 CA-C-N 112.709 -2.041 . . . . 0.0 106.438 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.1 p -113.46 132.61 61.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-O 120.996 0.427 . . . . 0.0 110.882 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -110.22 126.1 53.78 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -92.08 174.07 7.51 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.432 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.25 -18.23 63.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.819 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -73.57 -18.03 61.12 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.19 0.519 . . . . 0.0 110.152 176.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.34 -12.85 64.95 Favored Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -176.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.2 p -75.28 145.71 41.64 Favored 'General case' 0 N--CA 1.421 -1.906 0 C-N-CA 123.211 0.605 . . . . 0.0 111.201 -178.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.6 p -114.1 139.16 49.55 Favored 'General case' 0 N--CA 1.419 -2.002 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.913 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.8 mp -117.05 123.87 47.88 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.2 m -100.82 112.62 25.08 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.894 -176.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 58.65 60.78 5.29 Favored Pre-proline 0 N--CA 1.492 1.668 0 C-N-CA 124.45 1.1 . . . . 0.0 112.906 -176.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -85.48 177.0 5.27 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.102 1.868 . . . . 0.0 111.696 176.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.402 ' O ' HG23 ' A' ' 75' ' ' VAL . 41.7 m -110.99 151.42 27.98 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 175.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.79 -34.77 63.11 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -174.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -64.01 -37.25 86.73 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 122.287 0.235 . . . . 0.0 111.192 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -73.53 -42.16 62.1 Favored 'General case' 0 CA--C 1.489 -1.38 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.618 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 71' ' ' SER . 54.5 t -60.44 -40.8 85.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.807 -176.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -66.48 -45.13 80.67 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.866 0.365 . . . . 0.0 110.789 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.9 -35.82 74.9 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.541 0.686 . . . . 0.0 111.4 -177.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -78.13 -22.39 48.91 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 122.064 -0.397 . . . . 0.0 110.304 177.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.436 ' O ' HG13 ' A' ' 82' ' ' ILE . 26.0 tp -71.66 -46.5 58.74 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.7 m -64.94 -28.78 45.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -75.8 -29.46 58.73 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.869 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 79' ' ' LEU . 2.1 pp -85.69 -16.62 9.88 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 CA-C-O 121.443 0.64 . . . . 0.0 111.382 -176.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.11 -25.02 43.01 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.443 178.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 113.29 -156.92 15.29 Favored Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.3 mt -94.3 79.37 3.95 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.648 0.737 . . . . 0.0 110.756 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -102.94 -52.12 3.12 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 177.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 -91.66 78.24 5.55 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.446 175.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 . . . . . 0 C--N 1.296 -1.737 0 CA-C-O 118.1 -0.952 . . . . 0.0 108.462 -177.626 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.4 mtm . . . . . 0 CA--C 1.509 -0.633 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.7 p -141.82 147.29 21.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.5 p -70.05 94.39 0.87 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.263 0.554 . . . . 0.0 110.535 178.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -120.13 124.42 45.73 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.853 -177.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -103.55 1.43 32.2 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.617 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.1 tp -117.94 136.86 53.22 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.309 -176.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.496 ' HB ' ' HB3' ' A' ' 60' ' ' LYS . 22.4 m -110.65 117.82 34.54 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 53.1 mt -119.98 143.53 31.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -98.64 127.76 44.68 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.43 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . 25.4 p -137.31 178.52 7.03 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 122.093 0.949 . . . . 0.0 113.459 -174.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.1 m -143.91 147.65 34.3 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 104.181 -2.526 . . . . 0.0 104.181 173.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.5 m -61.15 -43.2 99.25 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.352 0.596 . . . . 0.0 109.897 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 40.7 p90 -92.7 93.37 8.43 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-O 121.808 0.813 . . . . 0.0 111.177 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.9 t -163.3 117.31 1.61 Allowed 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.387 176.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.79 -32.16 13.64 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 111.219 -0.753 . . . . 0.0 111.219 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -68.96 -27.71 65.98 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.721 0.772 . . . . 0.0 109.666 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.435 ' SG ' ' HB ' ' A' ' 56' ' ' VAL . 70.5 m -71.77 -29.88 64.97 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.118 178.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 82.7 mt -70.43 -30.15 66.94 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.285 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -56.62 -44.16 80.94 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.247 177.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.422 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 28.7 tp -79.33 -41.09 28.71 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.623 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -56.76 -45.13 82.24 Favored 'General case' 0 C--O 1.247 0.941 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.6 m -64.04 -38.46 91.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.795 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.16 -44.08 80.65 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.421 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 57.3 mt -69.5 -42.31 74.93 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.445 -178.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.8 m -68.92 -23.51 64.18 Favored 'General case' 0 CA--C 1.56 1.352 0 CA-C-O 121.421 0.629 . . . . 0.0 110.651 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.87 -12.93 57.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.294 0.569 . . . . 0.0 110.482 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -109.39 14.17 23.78 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.27 -178.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.9 ttm180 55.14 62.07 2.65 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.403 1.081 . . . . 0.0 111.079 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.41 ' HB ' ' HB3' ' A' ' 24' ' ' LEU . 75.8 mt -122.78 115.88 47.18 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.046 178.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.17 111.97 22.21 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -116.38 144.59 44.08 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.577 -177.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -113.74 119.78 38.55 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 12.8 pt-20 -95.51 148.13 22.82 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.881 -176.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.434 ' CG1' HG23 ' A' ' 36' ' ' ILE . 25.1 t -96.69 144.88 9.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -172.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -58.63 -1.77 0.17 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 128.714 2.806 . . . . 0.0 114.05 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.434 HG23 ' CG1' ' A' ' 34' ' ' VAL . 2.0 pp -45.24 -20.96 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 -172.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -54.41 -48.84 71.16 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.137 0.494 . . . . 0.0 110.039 174.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -111.46 -29.67 7.69 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.795 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -77.67 103.25 7.5 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.55 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 8.7 ptm180 -71.88 -25.78 62.07 Favored 'General case' 0 C--O 1.21 -0.997 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.935 -178.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.56 -42.62 88.36 Favored 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 113.504 0.928 . . . . 0.0 113.504 -176.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.93 -21.0 26.54 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.694 -0.802 . . . . 0.0 109.956 177.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.429 ' HB3' ' HA ' ' A' ' 40' ' ' ARG . . . -68.4 -33.39 74.16 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.214 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.55 ' HG2' ' O ' ' A' ' 40' ' ' ARG . 61.4 mm-40 -61.56 -36.71 81.4 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.034 178.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -66.9 -37.11 83.76 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.119 0.485 . . . . 0.0 109.979 178.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.2 t -64.0 -42.6 96.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.607 0.718 . . . . 0.0 109.129 177.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.51 -18.96 72.33 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.348 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.3 m -81.42 -38.67 26.11 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.7 m -80.02 -35.11 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -83.65 137.1 33.95 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 176.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -98.89 139.15 14.29 Favored Glycine 0 C--N 1.301 -1.382 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.128 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.53 -87.37 1.03 Allowed Glycine 0 C--N 1.313 -0.731 0 C-N-CA 121.186 -0.53 . . . . 0.0 111.827 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -119.18 145.39 46.05 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -60.95 130.98 49.14 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.664 0.603 . . . . 0.0 111.064 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.7 m -108.55 127.68 54.16 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 177.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.435 ' HB ' ' SG ' ' A' ' 17' ' ' CYS . 8.1 t -73.75 -64.86 0.7 Allowed Pre-proline 0 CA--C 1.468 -2.178 0 CA-C-O 117.091 -1.433 . . . . 0.0 114.245 -171.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -73.75 80.57 2.03 Favored 'Trans proline' 1 N--CA 1.4 -4.018 0 CA-C-N 121.089 1.425 . . . . 0.0 112.65 -168.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 86.8 m -115.02 131.74 56.83 Favored 'General case' 0 N--CA 1.389 -3.503 0 CA-C-N 113.355 -1.748 . . . . 0.0 106.644 -177.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.69 142.91 29.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-O 120.844 0.354 . . . . 0.0 110.909 -175.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.496 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 77.5 tttt -116.28 130.7 56.91 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 177.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -104.58 177.86 4.73 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.02 -14.15 52.02 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.471 0.653 . . . . 0.0 110.543 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -67.32 -19.39 65.45 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.208 1.003 . . . . 0.0 110.33 176.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 92.71 -22.4 33.79 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.9 -0.591 . . . . 0.0 113.061 177.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.4 t -91.57 165.34 13.39 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.1 p -114.52 140.54 48.66 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.208 -177.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.9 mp -107.97 121.98 45.89 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 174.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.8 m -98.48 114.55 26.99 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.226 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 61.21 61.82 2.83 Favored Pre-proline 0 N--CA 1.481 1.094 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -178.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -91.35 174.04 2.58 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.17 1.913 . . . . 0.0 110.369 176.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.441 ' O ' HG23 ' A' ' 75' ' ' VAL . 6.2 m -89.6 151.29 21.99 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 176.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.63 -37.95 80.01 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 123.186 0.304 . . . . 0.0 110.756 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -57.47 -43.62 84.17 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.108 177.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.53 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 47.3 mt-10 -68.38 -44.76 74.43 Favored 'General case' 0 C--O 1.207 -1.145 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.972 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 71' ' ' SER . 59.5 t -60.16 -43.14 92.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 O-C-N 123.252 0.345 . . . . 0.0 110.531 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -64.21 -44.71 91.09 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.27 -34.99 78.58 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.081 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.53 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 75.5 mmtt -75.07 -36.82 61.74 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 176.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 14.5 tp -61.62 -52.35 64.73 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.545 ' HB ' ' O ' ' A' ' 86' ' ' GLU . 35.5 m -61.93 -35.54 68.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.7 ptpp? -72.87 -34.1 66.51 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.304 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.1 pp -83.89 -29.71 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.056 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.77 -42.76 27.14 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 120.803 0.335 . . . . 0.0 110.591 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.91 -44.98 3.16 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 114.55 0.58 . . . . 0.0 114.55 175.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.442 ' H ' HD23 ' A' ' 85' ' ' LEU . 2.6 pt? -73.5 -4.13 31.92 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -173.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.545 ' O ' ' HB ' ' A' ' 80' ' ' VAL . 40.4 tt0 -143.07 154.32 43.83 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.45 ' HA ' ' HB ' ' A' ' 80' ' ' VAL . 44.6 t-80 -139.19 -68.91 0.43 Allowed 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 172.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 . . . . . 0 C--O 1.243 0.759 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.767 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.7 ttp . . . . . 0 N--CA 1.471 0.607 0 CA-C-O 120.745 0.307 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.6 p -117.02 97.43 5.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-O 121.581 0.705 . . . . 0.0 109.543 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.8 m 74.07 -35.78 0.32 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.569 1.147 . . . . 0.0 111.683 -177.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.32 133.76 38.69 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 176.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.09 -18.78 63.27 Favored 'General case' 0 C--O 1.246 0.87 0 C-N-CA 123.212 0.605 . . . . 0.0 112.109 -176.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.537 HD11 HD21 ' A' ' 79' ' ' LEU . 8.6 mp -109.48 141.23 42.2 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.558 0.694 . . . . 0.0 111.901 -177.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.4 ' HB ' ' HB3' ' A' ' 60' ' ' LYS . 28.7 m -125.82 108.32 11.36 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 105.707 -1.961 . . . . 0.0 105.707 171.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.559 HG22 HG23 ' A' ' 10' ' ' THR . 62.4 mt -108.89 135.23 48.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 CA-C-O 121.943 0.878 . . . . 0.0 111.445 -173.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.43 ' CD1' HG22 ' A' ' 46' ' ' VAL . 98.9 m-85 -90.22 111.32 22.45 Favored 'General case' 0 C--N 1.28 -2.431 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.453 178.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.559 HG23 HG22 ' A' ' 8' ' ' ILE . 6.9 p -137.31 144.33 42.56 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.169 0.509 . . . . 0.0 112.215 -178.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.6 p -130.79 165.38 23.08 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 174.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.9 p -86.73 0.23 55.08 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 121.373 0.606 . . . . 0.0 110.723 176.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 10.6 m0 -83.0 12.84 4.47 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.518 -173.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.583 ' SG ' HG21 ' A' ' 56' ' ' VAL . 6.7 p -146.26 171.8 14.43 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 122.05 -0.406 . . . . 0.0 111.402 -177.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -116.39 -36.63 1.08 Allowed Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 176.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -64.69 -23.4 67.24 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 121.207 0.527 . . . . 0.0 112.068 -177.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.9 p -70.48 -43.1 70.45 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.154 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.1 mp -64.61 -31.43 72.64 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.924 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -61.06 -52.07 66.5 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.485 0.491 . . . . 0.0 110.673 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.4 tp -68.35 -41.92 80.01 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.987 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -56.78 -50.04 73.49 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.691 -177.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.5 p -68.1 -34.2 75.95 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.54 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.9 -48.77 78.99 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.215 178.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.6 mt -63.89 -37.0 85.77 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.325 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 58.0 m -59.53 -48.81 80.2 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.813 177.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.84 -34.66 77.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.883 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -81.93 5.15 19.96 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -177.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 70.07 24.55 4.99 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.046 0.938 . . . . 0.0 113.121 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.7 mt -93.94 115.49 32.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.68 144.87 37.0 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.95 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -159.71 145.09 15.54 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.837 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -102.39 133.4 47.39 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 175.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 12.7 pt-20 -94.13 142.37 27.48 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.415 HG21 ' CE1' ' A' ' 9' ' ' TYR . 13.6 t -87.83 144.69 8.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 121.717 0.77 . . . . 0.0 112.181 -175.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -65.17 -1.84 2.51 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 127.76 2.424 . . . . 0.0 113.91 -176.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.2 pt -44.3 -23.78 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.564 0 N-CA-C 116.334 1.975 . . . . 0.0 116.334 -172.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -65.51 -25.43 67.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.573 0.701 . . . . 0.0 109.262 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 43.4 m-70 -112.32 -46.74 3.15 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.199 -0.909 . . . . 0.0 108.906 175.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -70.18 111.11 5.58 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.948 -176.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.1 ptp180 -73.53 -24.83 60.19 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.063 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.41 -54.6 13.56 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -175.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.505 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -72.75 -20.97 61.09 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.647 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.03 93.45 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.182 0.515 . . . . 0.0 110.925 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -72.95 -29.97 63.49 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.162 0.506 . . . . 0.0 110.414 177.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -68.1 -33.07 73.83 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.752 177.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 42' ' ' ALA . 76.7 t -55.49 -56.2 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.498 175.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.41 -33.99 78.76 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.088 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.3 m -65.82 -42.83 90.09 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 122.862 0.465 . . . . 0.0 112.087 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.8 m -80.92 -19.54 11.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.873 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -77.82 -50.17 12.83 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 175.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.55 -104.91 0.28 Allowed Glycine 0 N--CA 1.431 -1.652 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -103.74 -37.02 3.09 Favored Glycine 0 C--N 1.307 -1.057 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -104.98 148.13 27.05 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -78.92 135.98 37.13 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.2 m -118.33 153.79 33.41 Favored 'General case' 0 C--N 1.268 -2.957 0 N-CA-C 103.73 -2.693 . . . . 0.0 103.73 174.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.583 HG21 ' SG ' ' A' ' 14' ' ' CYS 0.267 21.9 t -86.86 -72.35 0.07 OUTLIER Pre-proline 0 CA--C 1.456 -2.642 0 C-N-CA 116.136 -2.226 . . . . 0.0 114.506 -178.59 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.96 88.73 1.21 Allowed 'Trans proline' 1 N--CA 1.39 -4.575 0 CA-C-N 120.577 1.242 . . . . 0.0 112.498 -162.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.4 m -119.98 130.74 54.9 Favored 'General case' 0 N--CA 1.385 -3.698 0 CA-C-N 113.27 -1.786 . . . . 0.0 106.841 -174.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.1 p -116.45 132.67 65.38 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-O 121.15 0.5 . . . . 0.0 110.856 -176.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.4 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 62.9 tttm -107.04 116.79 32.55 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 174.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -87.66 155.18 20.06 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.189 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.16 -21.37 61.57 Favored 'General case' 0 C--O 1.22 -0.494 0 C-N-CA 123.481 0.712 . . . . 0.0 111.57 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -72.71 -14.33 61.54 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.507 0.67 . . . . 0.0 110.145 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.81 -20.43 26.88 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.901 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.8 m -71.36 140.1 50.07 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 122.687 0.395 . . . . 0.0 111.661 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.9 p -114.21 137.79 51.3 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 173.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mp -128.43 123.21 33.17 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 120.76 0.314 . . . . 0.0 110.4 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 87.6 m -97.15 119.14 35.1 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.231 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 57.77 67.78 2.2 Favored Pre-proline 0 N--CA 1.484 1.237 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -96.56 169.52 1.03 Allowed 'Trans proline' 0 CA--C 1.546 1.124 0 C-N-CA 122.324 2.016 . . . . 0.0 111.148 171.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.0 m -93.29 155.38 17.45 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 173.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.29 -36.43 71.04 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 122.91 0.484 . . . . 0.0 111.704 -178.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -69.18 -35.7 76.57 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.502 0.668 . . . . 0.0 110.839 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.03 -36.56 82.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.268 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.9 t -66.26 -46.75 86.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.038 177.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -53.72 -42.33 67.95 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.22 0.608 . . . . 0.0 112.027 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.34 -20.3 65.57 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.131 0.491 . . . . 0.0 111.394 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.597 ' O ' HG13 ' A' ' 82' ' ' ILE . 34.4 mmtp -84.59 -39.49 18.65 Favored 'General case' 0 N--CA 1.436 -1.168 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.116 175.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.537 HD21 HD11 ' A' ' 6' ' ' LEU . 4.5 mm? -56.82 -41.19 77.37 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.5 m -63.38 -40.5 89.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.304 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.497 ' HA ' ' HB3' ' A' ' 87' ' ' HIS . 22.2 ptmt -83.03 -54.6 4.94 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.597 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.1 pp -68.52 -17.12 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -170.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.37 -11.64 59.68 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.145 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 62.79 57.43 16.14 Favored Glycine 0 CA--C 1.494 -1.26 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -177.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -134.5 -70.08 0.51 Allowed 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -176.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -90.44 4.63 50.44 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 122.362 1.077 . . . . 0.0 109.911 -174.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.497 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 58.6 t-80 -167.93 131.52 1.65 Allowed 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 175.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 . . . . . 0 C--N 1.292 -1.934 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.577 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 mmt . . . . . 0 CA--C 1.502 -0.871 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.8 t -75.83 84.1 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.768 0.795 . . . . 0.0 110.428 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.5 t -109.88 6.48 23.35 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.07 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -133.7 141.39 47.54 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.61 -12.26 51.92 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 123.752 0.657 . . . . 0.0 111.457 -177.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.444 ' HB2' ' CG2' ' A' ' 59' ' ' VAL . 0.5 OUTLIER -130.56 123.96 30.75 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.542 0.687 . . . . 0.0 111.372 178.693 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.3 m -103.2 114.18 28.25 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.576 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 55.7 mt -103.58 136.98 33.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -177.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -91.5 118.21 30.38 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.556 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 29.3 p -128.19 -172.08 2.61 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 121.343 0.592 . . . . 0.0 111.894 -177.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 13' ' ' TRP . 38.7 m -155.81 146.12 21.72 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 177.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.1 m -56.36 -47.84 78.05 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.474 ' O ' ' HB ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -65.94 111.78 3.48 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 164.903 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 11' ' ' THR . 42.8 t -150.71 120.14 6.89 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.788 -174.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -113.99 -70.24 0.52 Allowed Glycine 0 N--CA 1.427 -1.9 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.236 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -73.91 -30.23 62.47 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 123.029 0.531 . . . . 0.0 111.083 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -63.34 -27.78 69.55 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -63.08 -35.66 80.99 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.458 0.703 . . . . 0.0 109.678 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -51.87 -45.47 64.11 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 124.774 1.23 . . . . 0.0 111.301 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.428 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 12.4 tp -84.19 -42.37 16.03 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.86 -177.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -52.84 -48.91 66.68 Favored 'General case' 0 C--O 1.246 0.916 0 C-N-CA 124.397 1.079 . . . . 0.0 112.522 -176.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.9 t -74.15 -28.48 61.33 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.515 -178.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.16 -42.49 84.21 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.325 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 59.7 mt -65.26 -44.04 89.38 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.403 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 44.3 m -59.88 -43.59 94.65 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.963 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.12 -10.37 59.55 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.948 0.404 . . . . 0.0 111.928 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -109.31 16.03 22.68 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.964 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 67.77 17.39 9.77 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.27 1.028 . . . . 0.0 112.624 177.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.6 mt -91.06 118.15 35.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.59 138.14 33.68 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -136.3 171.01 15.11 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.044 -177.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -128.45 117.89 22.15 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 175.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.576 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 13.8 pt-20 -95.03 135.2 36.86 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 120.866 0.365 . . . . 0.0 110.841 -178.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.7 t -85.05 140.09 16.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -171.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.418 ' OD2' ' HB2' ' A' ' 38' ' ' HIS . 14.5 t70 -58.67 0.39 0.08 Allowed 'General case' 0 CA--C 1.567 1.624 0 C-N-CA 129.508 3.123 . . . . 0.0 114.751 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.8 pt -43.59 -20.82 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 3.006 0 N-CA-C 116.971 2.212 . . . . 0.0 116.971 -168.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -73.18 -23.61 60.44 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 119.176 0.898 . . . . 0.0 110.276 178.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' HIS . . . . . 0.418 ' HB2' ' OD2' ' A' ' 35' ' ' ASP . 78.6 m80 -105.39 -47.32 3.98 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 174.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 9.3 t-20 -78.19 99.64 6.31 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.734 -177.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -67.26 -30.21 70.04 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.553 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.9 -44.89 82.81 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.43 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -85.96 -23.34 26.96 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.419 178.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.36 -40.42 93.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.197 0.522 . . . . 0.0 110.222 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -65.46 -24.3 67.13 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.117 177.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -74.68 -38.16 62.48 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 176.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 42' ' ' ALA . 40.3 t -65.71 -41.88 91.37 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.447 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.826 178.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.78 -22.58 75.55 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.029 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -81.85 -41.86 20.43 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.6 p -76.55 -37.56 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 O-C-N 122.045 -0.409 . . . . 0.0 110.593 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -105.19 92.07 4.06 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 176.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -80.86 143.18 24.08 Favored Glycine 0 C--N 1.306 -1.12 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.494 -176.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.56 -62.88 2.68 Favored Glycine 0 N--CA 1.437 -1.29 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -126.11 145.92 50.15 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.6 ttp85 -88.31 89.06 7.84 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.0 m -65.58 133.46 51.23 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 176.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.4 t -77.01 -69.43 0.23 Allowed Pre-proline 0 CA--C 1.468 -2.187 0 C-N-CA 118.174 -1.411 . . . . 0.0 114.061 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.51 82.67 1.85 Allowed 'Trans proline' 0 N--CA 1.4 -3.992 0 CA-C-N 120.637 1.263 . . . . 0.0 112.969 -163.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 51.9 m -115.36 125.3 53.04 Favored 'General case' 0 N--CA 1.388 -3.53 0 CA-C-N 113.299 -1.773 . . . . 0.0 106.509 -176.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.444 ' CG2' ' HB2' ' A' ' 6' ' ' LEU . 7.2 p -118.3 137.17 53.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 CA-C-O 121.007 0.432 . . . . 0.0 111.181 -177.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -111.36 119.57 39.28 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 176.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -94.99 168.57 10.69 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.46 -10.98 20.0 Favored 'General case' 0 C--O 1.218 -0.57 0 O-C-N 123.738 0.649 . . . . 0.0 111.329 177.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -73.59 -18.31 61.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.794 0.807 . . . . 0.0 109.87 177.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.43 -15.12 63.88 Favored Glycine 0 CA--C 1.499 -0.917 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.236 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.5 m -83.41 151.69 25.37 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 p -113.6 139.31 49.12 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.6 tp -121.93 119.91 32.92 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -177.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.0 m -107.94 126.25 52.46 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 -174.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 54.03 60.04 11.48 Favored Pre-proline 0 N--CA 1.482 1.126 0 O-C-N 123.941 0.776 . . . . 0.0 112.315 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -90.08 178.44 2.23 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 121.856 1.704 . . . . 0.0 113.242 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.4 m -96.42 164.46 12.62 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 174.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.57 -39.34 94.14 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 120.958 0.409 . . . . 0.0 110.99 -178.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -64.42 -33.27 75.49 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.512 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -68.33 -39.09 82.05 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.048 0.451 . . . . 0.0 110.35 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.4 t -66.42 -44.91 90.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.899 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -60.49 -43.31 97.13 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.507 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.89 -36.8 84.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.714 0.293 . . . . 0.0 111.32 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.487 ' O ' HG13 ' A' ' 82' ' ' ILE . 14.4 mptt -70.96 -37.13 72.79 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.941 175.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 30.1 tp -62.06 -47.04 86.49 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.412 -178.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.8 m -66.07 -32.69 59.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -177.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.484 ' HA ' ' HB3' ' A' ' 87' ' ' HIS . 19.6 ptmt -77.29 -41.02 42.41 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.684 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.2 pp -74.41 -14.28 15.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.454 -0.498 . . . . 0.0 112.074 -177.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.81 -26.18 59.54 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.66 176.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 58.46 49.0 80.88 Favored Glycine 0 C--N 1.344 0.973 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 62.2 tp -154.08 -49.2 0.09 Allowed 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.324 0.583 . . . . 0.0 110.044 -174.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -94.79 -7.24 40.97 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 122.009 0.909 . . . . 0.0 110.077 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.484 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 55.5 t-80 -167.59 143.63 4.1 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 176.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 . . . . . 0 C--N 1.292 -1.916 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.586 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.451 ' SD ' ' HE3' ' A' ' 60' ' ' LYS . 83.1 mtp . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.489 HG23 ' H ' ' A' ' 3' ' ' THR . 5.1 m -111.98 -100.51 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 O-C-N 121.739 -0.601 . . . . 0.0 112.425 176.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.489 ' H ' HG23 ' A' ' 2' ' ' VAL . 14.0 p -80.63 -34.99 34.6 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 173.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.18 102.1 14.39 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 105.577 -2.008 . . . . 0.0 105.577 169.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -68.92 -58.51 4.03 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.386 -175.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.635 HD23 ' H ' ' A' ' 6' ' ' LEU . 0.7 OUTLIER -68.58 120.65 14.95 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.849 0.833 . . . . 0.0 111.013 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.3 m -103.64 111.75 24.37 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 114.399 -1.273 . . . . 0.0 107.851 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 63.4 mt -102.79 139.04 24.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.303 0.573 . . . . 0.0 110.703 -174.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -92.04 122.8 34.88 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.523 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 27.3 p -138.57 177.22 8.04 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.533 0.682 . . . . 0.0 111.817 -177.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.5 m -148.08 156.16 42.29 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 174.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.5 m -69.22 -45.34 70.1 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -87.38 96.28 10.31 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-O 122.126 0.965 . . . . 0.0 109.906 175.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 32.7 t -163.56 152.17 13.84 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.415 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -119.93 -55.84 0.25 Allowed Glycine 0 N--CA 1.429 -1.831 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.226 178.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -68.39 -16.3 63.87 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -173.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.6 p -78.49 -24.88 45.68 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.211 0.529 . . . . 0.0 109.963 177.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 21' ' ' LYS . 28.7 tp -69.01 -21.75 64.12 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.991 -175.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -60.18 -60.71 3.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.165 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.1 tp -66.3 -42.74 87.86 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.492 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.423 ' HB3' ' HA ' ' A' ' 18' ' ' LEU . 63.8 tttp -54.72 -47.23 74.01 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.35 -178.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.5 p -71.12 -34.7 71.31 Favored 'General case' 0 C--O 1.244 0.778 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.654 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.38 -46.93 86.4 Favored 'General case' 0 CA--C 1.508 -0.657 0 C-N-CA 123.387 0.675 . . . . 0.0 110.66 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.9 mt -65.79 -37.88 87.49 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.902 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.3 m -65.24 -38.52 90.62 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.74 -26.94 62.67 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 111.02 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.17 2.8 48.81 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.308 178.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 61.67 30.52 18.55 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.54 1.136 . . . . 0.0 110.441 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 74.1 mt -86.86 115.41 27.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.666 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.48 100.65 3.31 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.509 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -113.61 163.94 14.31 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.412 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -130.5 130.1 43.74 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 175.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.523 ' HB2' ' OG1' ' A' ' 10' ' ' THR . 11.6 pt-20 -99.79 140.92 33.29 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.025 0.441 . . . . 0.0 111.14 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.2 t -78.07 146.79 7.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-O 121.86 0.838 . . . . 0.0 113.1 -172.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -66.85 -0.82 3.29 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 127.718 2.407 . . . . 0.0 114.371 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.5 pt -44.17 -22.58 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.514 2.737 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 -169.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -68.42 -31.43 70.75 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.796 0.808 . . . . 0.0 109.469 177.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 35.5 m-70 -103.17 -45.94 4.77 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.26 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.431 ' ND2' ' H ' ' A' ' 42' ' ' ALA . 37.8 t30 -86.91 115.11 24.09 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.87 -175.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -72.7 -29.68 63.58 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.097 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.38 -41.16 93.22 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -173.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.431 ' H ' ' ND2' ' A' ' 39' ' ' ASN . . . -87.35 -21.77 25.48 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.638 177.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.65 -39.59 84.58 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.309 0.576 . . . . 0.0 110.616 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -75.08 -21.38 59.0 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.334 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -69.45 -31.95 70.58 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 176.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.3 t -59.36 -42.73 88.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.38 -35.2 87.02 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.356 178.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.8 t -66.77 -50.07 63.87 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 122.503 0.321 . . . . 0.0 110.66 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.9 p -76.91 -28.12 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.181 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -174.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -98.66 1.89 46.67 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 121.698 -0.627 . . . . 0.0 112.266 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.52 60.22 4.82 Favored Glycine 0 C--N 1.322 -0.233 0 N-CA-C 114.395 0.518 . . . . 0.0 114.395 174.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.07 -46.63 3.43 Favored Glycine 0 C--N 1.31 -0.892 0 C-N-CA 121.769 -0.253 . . . . 0.0 112.615 176.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -77.42 122.34 25.04 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.9 mtm180 -93.75 79.95 4.22 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.774 0.797 . . . . 0.0 112.182 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.7 m -73.17 128.36 35.27 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 173.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.4 t -69.4 -66.71 0.87 Allowed Pre-proline 0 CA--C 1.473 -1.989 0 N-CA-C 114.703 1.372 . . . . 0.0 114.703 -173.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.62 76.77 4.13 Favored 'Trans proline' 0 N--CA 1.4 -3.985 0 CA-C-N 120.381 1.172 . . . . 0.0 112.578 -163.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 91.5 m -107.62 140.27 40.88 Favored 'General case' 0 N--CA 1.388 -3.565 0 CA-C-N 113.486 -1.688 . . . . 0.0 107.571 -176.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.2 p -122.68 132.83 70.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-O 121.318 0.58 . . . . 0.0 111.218 -176.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.451 ' HE3' ' SD ' ' A' ' 1' ' ' MET . 63.5 tttp -110.21 120.31 42.04 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.498 176.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.453 ' CD1' HG12 ' A' ' 82' ' ' ILE . 90.1 m-85 -95.12 171.79 8.52 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.738 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.46 -24.0 61.13 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -173.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -89.87 -7.28 54.62 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 120.708 0.289 . . . . 0.0 111.34 -174.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.54 -5.72 31.41 Favored Glycine 0 N--CA 1.437 -1.237 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.268 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.3 m -75.98 125.91 30.01 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 121.18 0.514 . . . . 0.0 110.17 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.6 p -117.21 138.29 51.79 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.2 mp -130.91 146.31 52.29 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.1 m -116.0 112.64 22.1 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 64.2 t30 47.33 70.88 1.81 Allowed Pre-proline 0 N--CA 1.484 1.274 0 C-N-CA 124.713 1.205 . . . . 0.0 113.835 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -100.01 -175.52 0.15 Allowed 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.013 2.475 . . . . 0.0 111.968 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.6 t -82.31 154.1 25.48 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.48 -34.76 78.47 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 123.713 0.805 . . . . 0.0 109.958 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -63.5 -44.09 95.35 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.881 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.585 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 45.5 mm-40 -57.83 -47.36 82.89 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.392 176.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.6 t -57.73 -44.02 85.01 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.764 0 O-C-N 123.994 0.809 . . . . 0.0 111.502 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 66.1 tttp -62.87 -45.3 93.21 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.23 -21.84 59.61 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.054 0.454 . . . . 0.0 111.568 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.585 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 49.2 mmtm -81.93 -34.49 29.83 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 174.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.0 tp -57.39 -49.04 77.47 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.424 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.8 m -60.59 -33.6 55.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.505 -177.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 15.3 ptmm? -81.69 -38.71 25.41 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.476 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.453 HG12 ' CD1' ' A' ' 61' ' ' PHE . 2.4 pp -77.98 -32.15 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -175.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.44 -42.31 59.35 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 82.82 -49.68 4.25 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.399 177.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.5 pp -84.47 167.12 16.69 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 61.37 32.48 19.09 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 126.179 1.792 . . . . 0.0 112.717 174.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 46.1 t60 -107.42 78.39 1.21 Allowed 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 174.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 34.7 m80 . . . . . 0 C--O 1.262 1.749 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.918 -176.186 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 ptp . . . . . 0 CA--C 1.513 -0.462 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.1 m -128.37 143.28 41.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 171.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.2 t -130.95 114.29 15.05 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-O 122.05 0.929 . . . . 0.0 110.993 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -113.37 113.47 25.27 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.94 1.16 53.57 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.497 0.665 . . . . 0.0 110.334 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.79 128.75 16.47 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.256 178.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 60' ' ' LYS . 23.4 m -103.07 120.02 39.92 Favored 'General case' 0 C--N 1.277 -2.576 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 176.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.3 mt -109.88 128.44 66.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 CA-C-O 121.06 0.457 . . . . 0.0 109.915 -176.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.463 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 98.3 m-85 -81.05 129.0 34.34 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.636 177.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.8 p -136.83 145.98 45.1 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -174.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 69.4 p -140.22 161.72 36.98 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 172.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.5 p -85.98 -0.39 55.37 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.303 0.573 . . . . 0.0 110.799 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 11.2 m0 -78.91 -30.93 45.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.356 -176.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.8 p -105.65 132.2 52.09 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.265 -175.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.22 -27.99 26.51 Favored Glycine 0 N--CA 1.436 -1.352 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.675 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -65.86 -35.87 81.86 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.592 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 61.1 m -56.5 -46.71 80.37 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.287 176.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.2 tt -66.75 -39.39 87.89 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.751 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.6 mtp180 -58.23 -54.63 44.84 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.484 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 20.7 tp -62.05 -40.13 94.71 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.524 0.678 . . . . 0.0 109.716 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 17' ' ' CYS . 60.5 tttm -57.2 -45.22 83.96 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.664 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.7 m -62.12 -43.59 98.49 Favored 'General case' 0 C--O 1.246 0.884 0 C-N-CA 123.719 0.808 . . . . 0.0 110.665 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.53 -48.21 82.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.04 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 72.4 mt -65.73 -35.64 81.32 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.995 -178.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.8 m -63.6 -45.99 87.83 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.83 -35.63 81.22 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.483 0.659 . . . . 0.0 110.843 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -84.46 21.03 1.54 Allowed 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.492 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 55.7 20.65 4.09 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 126.226 1.81 . . . . 0.0 113.782 175.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 71.4 mt -85.27 115.91 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.94 116.98 23.06 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.264 -177.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -127.75 159.54 34.47 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.215 -177.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -112.27 114.08 26.66 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 175.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -83.17 136.58 34.38 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.1 t -95.15 143.73 11.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 122.909 1.337 . . . . 0.0 113.233 -176.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.57 -0.57 6.92 Favored 'General case' 0 C--N 1.284 -2.283 0 C-N-CA 130.862 3.665 . . . . 0.0 115.118 177.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.471 HD13 HG21 ' A' ' 46' ' ' VAL . 12.7 pt -44.11 -26.42 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.843 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 -171.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -59.0 -36.3 74.68 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.12 0.486 . . . . 0.0 109.815 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 46.7 m-70 -93.15 -34.45 13.62 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.968 -175.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -116.36 113.58 23.12 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -176.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.482 ' HA ' ' HB3' ' A' ' 43' ' ' ALA . 3.8 ptp180 -62.86 -25.58 68.35 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 114.625 -1.171 . . . . 0.0 111.885 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.18 -41.49 71.96 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.238 0.542 . . . . 0.0 111.296 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.451 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -86.96 -30.33 21.37 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.047 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.482 ' HB3' ' HA ' ' A' ' 40' ' ' ARG . . . -65.31 -33.89 77.05 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.996 -178.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -67.53 -34.76 77.75 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.774 -0.194 . . . . 0.0 111.377 178.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -65.25 -37.69 88.0 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.471 HG21 HD13 ' A' ' 36' ' ' ILE . 60.1 t -59.99 -38.06 75.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.091 -0.958 . . . . 0.0 109.877 177.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.66 -49.22 44.82 Favored Glycine 0 N--CA 1.433 -1.55 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.9 m -60.31 -38.13 82.72 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.6 p -79.49 -9.37 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-O 121.531 0.682 . . . . 0.0 111.213 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -104.95 -67.82 0.89 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.145 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 137.67 -112.38 0.9 Allowed Glycine 0 N--CA 1.433 -1.554 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 -175.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.31 -48.33 5.11 Favored Glycine 0 C--N 1.306 -1.127 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.029 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -91.45 116.44 28.85 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -178.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -81.21 83.02 6.94 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.6 m -71.97 125.78 28.09 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.538 ' HB ' ' SG ' ' A' ' 17' ' ' CYS . 3.2 t -76.31 -56.16 1.59 Allowed Pre-proline 0 N--CA 1.435 -1.221 0 CA-C-O 117.323 -1.322 . . . . 0.0 113.55 -175.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.592 ' HD3' ' SG ' ' A' ' 17' ' ' CYS . 64.9 Cg_endo -73.64 44.24 0.89 Allowed 'Trans proline' 0 C--N 1.399 3.227 0 CA-C-N 121.472 1.562 . . . . 0.0 113.691 -170.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 84.1 m -80.57 117.66 21.47 Favored 'General case' 0 N--CA 1.387 -3.599 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.3 p -94.76 129.12 45.39 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.479 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 82.2 tttt -105.03 118.19 35.9 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -87.75 164.21 16.08 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 120.448 -0.501 . . . . 0.0 112.126 -177.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.04 -18.26 45.04 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 124.032 0.933 . . . . 0.0 112.956 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -78.31 -17.29 56.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.863 0.363 . . . . 0.0 110.286 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.02 -21.7 24.5 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 121.245 -0.502 . . . . 0.0 113.193 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.1 m -82.88 159.71 22.3 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.257 0.551 . . . . 0.0 110.522 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.3 p -114.0 171.39 7.62 Favored 'General case' 0 N--CA 1.418 -2.045 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.101 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.8 tp -145.0 109.7 5.0 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 176.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 89.1 m -86.11 122.7 30.49 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.965 -176.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 56.49 64.81 4.53 Favored Pre-proline 0 N--CA 1.482 1.15 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -90.71 -173.61 0.63 Allowed 'Trans proline' 0 N--CA 1.445 -1.38 0 C-N-CA 121.788 1.659 . . . . 0.0 112.653 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.414 ' H ' ' HB2' ' A' ' 74' ' ' GLU . 16.6 m -127.26 165.86 18.86 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 174.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.69 -45.95 67.05 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -64.38 -36.54 84.48 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.431 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.414 ' HB2' ' H ' ' A' ' 71' ' ' SER . 67.0 mm-40 -63.71 -42.51 97.94 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.194 0.521 . . . . 0.0 110.88 177.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.1 t -67.21 -48.8 77.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.192 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -61.57 -31.05 71.08 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.118 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.2 -25.54 63.46 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.431 ' O ' HG13 ' A' ' 82' ' ' ILE . 10.1 mmmm -84.7 -37.22 21.2 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 172.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.8 tp -55.07 -49.63 71.17 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 124.165 0.916 . . . . 0.0 110.171 -177.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.3 m -58.6 -35.53 55.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -178.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.76 -42.53 19.65 Favored 'General case' 0 N--CA 1.427 -1.578 0 C-N-CA 119.071 -1.051 . . . . 0.0 111.804 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.4 pp -76.41 -22.16 15.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -174.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -87.35 4.42 43.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.985 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.39 -102.89 1.65 Allowed Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 116.259 -0.428 . . . . 0.0 112.13 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.421 ' H ' HD23 ' A' ' 85' ' ' LEU . 2.1 pt? -127.56 0.69 6.2 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.152 0.501 . . . . 0.0 110.504 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.9 88.62 5.8 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 35.3 p80 -163.58 174.83 11.29 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -177.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 . . . . . 0 C--N 1.305 -1.33 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 176.776 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 tmt? . . . . . 0 N--CA 1.473 0.676 0 N-CA-C 110.818 -0.068 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 65.5 t -65.2 113.83 2.3 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.463 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 175.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.6 m -76.91 94.08 3.87 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-O 121.805 0.812 . . . . 0.0 111.703 -172.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.74 173.82 9.22 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.486 175.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -68.58 -22.85 64.44 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 62.1 mt -113.97 122.53 47.23 Favored 'General case' 0 CA--C 1.496 -1.101 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.712 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.1 m -103.14 108.54 19.77 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 173.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.476 HG22 HG23 ' A' ' 10' ' ' THR . 55.4 mt -108.42 133.35 53.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-O 121.78 0.8 . . . . 0.0 111.605 -175.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -95.38 107.36 19.49 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.067 -0.969 . . . . 0.0 108.662 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.476 HG23 HG22 ' A' ' 8' ' ' ILE . 4.0 p -135.28 158.96 43.05 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 122.677 0.391 . . . . 0.0 111.897 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.6 p -134.77 174.61 10.39 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 176.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.1 t -86.72 -5.61 59.07 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 19.6 m0 -75.83 -32.61 59.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.093 -175.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.8 p -91.54 165.99 13.07 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 120.738 0.304 . . . . 0.0 111.628 -175.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -113.45 -42.83 0.86 Allowed Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 111.366 -0.693 . . . . 0.0 111.366 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -63.45 -25.77 68.42 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -178.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.493 ' SG ' HD12 ' A' ' 18' ' ' LEU . 1.6 p -56.32 -41.36 75.91 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.677 0.275 . . . . 0.0 111.04 176.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.511 ' HA ' ' HD3' ' A' ' 21' ' ' LYS . 6.3 mp -73.31 -24.96 60.47 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.65 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -71.76 -34.72 69.71 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.8 tp -75.74 -38.36 58.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.084 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.511 ' HD3' ' HA ' ' A' ' 18' ' ' LEU . 27.4 mtpp -55.75 -45.72 77.98 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.706 177.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 p -65.94 -40.2 91.14 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 111.541 0.2 . . . . 0.0 111.541 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.26 -49.53 76.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.674 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.5 mt -64.91 -41.68 95.37 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.754 0.311 . . . . 0.0 111.283 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 68.0 m -67.29 -38.29 84.78 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.198 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.84 -26.37 64.19 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.36 0.6 . . . . 0.0 110.66 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -94.07 10.77 32.33 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.066 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 59.15 30.86 20.73 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.04 1.336 . . . . 0.0 112.719 175.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.6 mt -89.26 123.87 41.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.73 129.93 34.68 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.071 0.463 . . . . 0.0 111.218 -176.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -144.08 157.62 44.21 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.651 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -127.96 124.03 36.28 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 11.7 pt-20 -95.25 146.82 24.07 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.271 0.557 . . . . 0.0 111.764 -175.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -81.07 153.05 4.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.457 -175.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -74.87 0.19 16.42 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 127.903 2.481 . . . . 0.0 114.042 -175.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.7 pt -43.36 -23.71 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.378 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 -172.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -52.85 -39.24 62.39 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.649 0.78 . . . . 0.0 109.709 176.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -119.42 20.28 12.52 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.081 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.413 ' ND2' ' H ' ' A' ' 42' ' ' ALA . 49.5 t30 -139.42 106.89 5.55 Favored 'General case' 0 CA--C 1.492 -1.269 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.26 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -30.59 71.13 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.946 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.43 -38.57 84.76 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -173.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.413 ' H ' ' ND2' ' A' ' 39' ' ' ASN . . . -86.79 -20.73 27.17 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.816 177.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.15 -41.44 86.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.463 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -69.92 -21.91 63.25 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.539 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -68.16 -33.53 74.64 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 175.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.626 ' O ' ' HB2' ' A' ' 50' ' ' ASN . 81.6 t -59.3 -40.22 80.83 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.925 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.631 177.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.92 -32.68 77.82 Favored Glycine 0 C--N 1.332 0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.09 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.0 t -65.8 -29.96 70.53 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 123.147 0.579 . . . . 0.0 110.265 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.4 m -108.1 17.2 6.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 120.887 0.375 . . . . 0.0 110.572 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.626 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 1.7 t-20 -116.49 -174.16 2.51 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -176.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -107.82 75.71 0.22 Allowed Glycine 0 N--CA 1.436 -1.343 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.064 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.01 -93.65 1.31 Allowed Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 -78.62 136.31 37.46 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -64.91 101.4 0.49 Allowed 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -178.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.9 m -83.0 153.35 25.01 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 102.984 -2.969 . . . . 0.0 102.984 169.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 0.442 3.8 t -86.95 -93.75 0.0 OUTLIER Pre-proline 0 CA--C 1.487 -1.472 0 C-N-CA 114.643 -2.823 . . . . 0.0 117.23 -174.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -47.51 93.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.386 2.538 0 N-CA-C 114.551 0.943 . . . . 0.0 114.551 -148.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.31 109.91 21.37 Favored 'General case' 0 N--CA 1.405 -2.705 0 CA-C-N 113.778 -1.555 . . . . 0.0 109.904 -173.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.3 p -102.58 126.46 56.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -104.8 127.41 52.59 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.626 ' HB3' HG21 ' A' ' 82' ' ' ILE . 95.8 m-85 -103.25 170.84 7.71 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.972 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.664 ' HB3' ' HB ' ' A' ' 82' ' ' ILE . . . -65.17 -13.89 59.27 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 -173.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -78.69 -13.09 60.0 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 121.478 0.656 . . . . 0.0 109.627 175.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.54 -1.54 64.15 Favored Glycine 0 N--CA 1.436 -1.319 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -174.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.3 m -67.62 133.5 49.49 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 123.787 0.835 . . . . 0.0 108.96 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.8 m -121.43 137.53 54.67 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 176.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.2 mp -120.06 119.38 33.19 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 120.687 0.28 . . . . 0.0 111.279 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.5 m -92.66 116.55 29.11 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 61.7 69.66 0.97 Allowed Pre-proline 0 CA--C 1.557 1.25 0 C-N-CA 123.643 0.777 . . . . 0.0 111.49 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -94.48 -167.02 0.14 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.444 2.096 . . . . 0.0 112.258 176.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.403 ' O ' HG23 ' A' ' 75' ' ' VAL . 13.5 m -116.08 150.52 37.2 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 176.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.08 -40.43 76.94 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.775 0.43 . . . . 0.0 111.734 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -64.42 -37.76 88.64 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.947 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -62.18 -48.06 81.75 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.906 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 71' ' ' SER . 95.9 t -58.39 -42.3 83.73 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.922 0 O-C-N 124.013 0.821 . . . . 0.0 110.834 -178.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.408 ' O ' ' HD3' ' A' ' 76' ' ' LYS . 2.7 tmtp? -67.76 -40.38 84.09 Favored 'General case' 0 CA--C 1.559 1.315 0 CA-C-O 120.722 0.296 . . . . 0.0 110.52 -178.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.45 -29.84 59.79 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.171 0.51 . . . . 0.0 111.024 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -77.21 -31.09 55.03 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 20.4 tp -58.92 -50.96 72.08 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.984 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 27.5 m -60.57 -39.42 81.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -176.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? -73.31 -32.33 64.54 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.481 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.664 ' HB ' ' HB3' ' A' ' 62' ' ' ALA . 2.0 pp -83.5 -11.91 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-O 121.39 0.614 . . . . 0.0 111.871 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.85 -7.2 57.68 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.529 174.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 81.17 -71.83 2.84 Favored Glycine 0 N--CA 1.44 -1.045 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.896 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 80.5 mt -92.69 15.0 15.44 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 123.158 0.583 . . . . 0.0 110.376 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.566 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 41.8 mt-10 61.1 -84.66 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 125.634 1.574 . . . . 0.0 113.621 177.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 162.06 -24.03 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 103.364 -2.828 . . . . 0.0 103.364 -171.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 34.8 m80 . . . . . 0 C--O 1.245 0.836 0 CA-C-N 113.558 -1.656 . . . . 0.0 108.447 176.705 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.43 ' HG2' HG23 ' A' ' 2' ' ' VAL . 27.5 ttt . . . . . 0 CA--C 1.517 -0.297 0 N-CA-C 110.613 -0.143 . . . . 0.0 110.613 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.43 HG23 ' HG2' ' A' ' 1' ' ' MET . 53.0 t 65.04 92.19 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.08 0.952 . . . . 0.0 110.588 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 35.5 m -136.61 123.56 21.44 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.847 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -127.51 173.3 9.96 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.28 1.1 57.36 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.364 0.602 . . . . 0.0 109.61 177.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.2 tp -142.19 114.71 8.45 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -178.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' A' ' 60' ' ' LYS . 40.9 m -107.06 127.74 53.75 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 71.4 mt -118.88 135.79 58.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-O 121.207 0.527 . . . . 0.0 110.389 -177.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.407 ' O ' HG12 ' A' ' 56' ' ' VAL . 92.8 m-85 -88.13 127.8 35.43 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.742 177.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.2 p -134.29 151.82 51.47 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -175.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.0 p -140.15 163.5 32.56 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 175.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.2 m -77.7 -8.21 57.61 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.238 0.542 . . . . 0.0 110.395 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 2.7 m0 -89.8 -25.88 20.86 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.922 0.868 . . . . 0.0 110.246 -176.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.6 t -91.98 118.42 30.75 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.876 -168.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -92.18 -32.54 8.27 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -68.98 -18.25 64.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.058 0.456 . . . . 0.0 112.161 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.632 ' SG ' ' HB ' ' A' ' 56' ' ' VAL . 72.4 m -68.85 -38.67 79.92 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.667 0.746 . . . . 0.0 109.178 174.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.3 tt -68.31 -30.0 68.89 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.775 -178.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -61.65 -41.5 97.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.77 176.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.477 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 17.6 tp -74.51 -39.91 62.12 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.494 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -56.36 -51.61 67.63 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.146 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.4 p -61.08 -42.44 98.51 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.999 0.428 . . . . 0.0 110.84 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.63 -49.54 77.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.993 178.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.484 HD22 HD12 ' A' ' 29' ' ' ILE . 51.8 mt -67.56 -36.77 81.58 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.392 -178.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.7 m -66.91 -41.8 86.5 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 121.207 0.527 . . . . 0.0 110.248 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.0 -7.42 53.61 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.195 0.521 . . . . 0.0 111.889 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -107.75 8.21 28.75 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 123.073 0.549 . . . . 0.0 110.867 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 57.61 62.85 1.99 Allowed 'General case' 0 C--O 1.243 0.724 0 C-N-CA 125.299 1.44 . . . . 0.0 112.219 -177.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.484 HD12 HD22 ' A' ' 24' ' ' LEU . 76.3 mt -121.58 117.41 52.5 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.689 176.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.82 121.88 30.78 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -135.23 156.01 49.7 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.853 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -116.2 132.79 56.56 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 175.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 8.8 pt-20 -96.01 151.05 19.8 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.417 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.6 t -94.76 145.36 8.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.875 0.845 . . . . 0.0 112.921 -173.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.411 ' OD2' ' HB2' ' A' ' 39' ' ' ASN . 28.6 t70 -62.51 -1.49 0.81 Allowed 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 128.352 2.661 . . . . 0.0 114.036 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.423 HG22 ' HB3' ' A' ' 42' ' ' ALA . 26.1 pt -45.2 -21.04 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 N-CA-C 115.759 1.762 . . . . 0.0 115.759 -173.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -56.38 -29.02 60.95 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.003 0.43 . . . . 0.0 110.862 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 46.4 t60 -127.94 -23.7 3.31 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.175 0.512 . . . . 0.0 110.285 173.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.411 ' HB2' ' OD2' ' A' ' 35' ' ' ASP . 25.2 t-20 -87.71 87.11 7.28 Favored 'General case' 0 C--O 1.244 0.774 0 O-C-N 121.488 -0.758 . . . . 0.0 109.683 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -67.16 -23.87 65.83 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -174.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.75 -34.78 73.41 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.598 0.713 . . . . 0.0 110.963 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.423 ' HB3' HG22 ' A' ' 36' ' ' ILE . . . -87.09 -20.66 26.8 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.362 0.601 . . . . 0.0 109.871 176.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.01 -34.59 64.21 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.592 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.79 -32.82 74.68 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.52 173.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 94.2 t80 -63.02 -42.46 99.81 Favored 'General case' 0 N--CA 1.461 0.095 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.1 t -57.0 -45.15 83.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.01 177.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 53' ' ' ASN . . . -66.69 -52.39 34.5 Favored Glycine 0 N--CA 1.432 -1.618 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.223 178.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.4 t -59.52 -39.36 83.6 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 123.472 0.709 . . . . 0.0 112.814 -175.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.0 p -70.1 -24.42 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 CA-C-O 121.132 0.492 . . . . 0.0 111.514 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -93.6 -27.58 16.52 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.146 0.498 . . . . 0.0 110.437 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 148.68 -63.1 0.42 Allowed Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 177.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -159.33 -34.19 0.02 OUTLIER Glycine 0 C--N 1.298 -1.565 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.402 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 29.3 p-10 -76.56 145.97 38.66 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.224 0.535 . . . . 0.0 110.748 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -89.66 86.33 6.68 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.659 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.8 m -78.9 117.19 19.75 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 172.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.632 ' HB ' ' SG ' ' A' ' 17' ' ' CYS . 2.3 t -76.01 -60.82 0.94 Allowed Pre-proline 0 C--N 1.308 -1.206 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 -167.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.53 ' HD3' ' SG ' ' A' ' 17' ' ' CYS . 67.8 Cg_endo -73.14 70.67 3.73 Favored 'Trans proline' 0 C--N 1.399 3.219 0 CA-C-N 121.963 1.737 . . . . 0.0 112.952 -171.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 69.2 m -108.29 119.19 38.77 Favored 'General case' 1 N--CA 1.377 -4.096 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.7 p -101.33 139.96 21.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.672 -175.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.417 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 66.2 tttm -108.89 111.79 23.67 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -88.53 177.69 6.72 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.238 -177.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.29 -12.0 59.01 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.44 177.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -65.51 -19.88 66.11 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.953 174.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.18 -12.22 65.1 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -176.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 61.6 p -94.78 166.53 11.94 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.6 p -114.28 140.14 48.85 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.134 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.5 tp -119.25 110.56 17.16 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.8 m -79.16 120.96 24.42 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.044 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 53.89 75.75 0.59 Allowed Pre-proline 0 N--CA 1.481 1.115 0 C-N-CA 124.843 1.257 . . . . 0.0 111.981 176.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -97.88 165.62 0.8 Allowed 'Trans proline' 0 N--CA 1.442 -1.519 0 C-N-CA 122.401 2.068 . . . . 0.0 111.915 178.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.456 ' O ' HG23 ' A' ' 75' ' ' VAL . 13.4 m -84.34 149.82 25.79 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.62 -41.41 94.76 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.07 0.462 . . . . 0.0 111.918 -175.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -63.48 -37.66 88.14 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.723 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -64.92 -42.99 94.25 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.271 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 71' ' ' SER . 63.2 t -62.49 -43.91 98.78 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.75 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.922 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.404 ' O ' HG13 ' A' ' 80' ' ' VAL . 23.2 tptm -62.65 -47.11 85.15 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.551 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.68 -29.09 68.28 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -178.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.496 ' O ' HG13 ' A' ' 82' ' ' ILE . 3.5 tmtp? -82.49 -37.06 25.86 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 19.2 tp -57.69 -49.74 75.52 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.105 0.479 . . . . 0.0 110.068 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 76' ' ' LYS . 33.7 m -61.02 -34.99 62.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.99 -176.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.1 ptpp? -80.55 -32.61 36.64 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.685 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.1 pp -85.29 -12.45 11.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.289 0.566 . . . . 0.0 111.854 -178.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.14 -6.83 58.93 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.236 174.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.21 -128.15 9.19 Favored Glycine 0 N--CA 1.421 -2.327 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.963 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 42.5 tp -97.82 -9.01 27.2 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 120.98 0.419 . . . . 0.0 109.947 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -72.66 90.93 1.41 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.505 -177.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -129.86 -7.03 4.5 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.485 0.659 . . . . 0.0 110.071 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 65.2 m80 . . . . . 0 C--N 1.312 -1.045 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -176.076 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ptm . . . . . 0 CA--C 1.539 0.543 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.3 p -105.33 -53.73 6.74 Favored 'Isoleucine or valine' 0 C--N 1.345 0.376 0 C-N-CA 118.625 -1.23 . . . . 0.0 111.707 -178.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.8 p -133.98 -19.61 2.0 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.155 0.502 . . . . 0.0 111.505 177.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -101.0 158.37 16.06 Favored 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 177.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -88.16 -2.19 58.46 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.363 0.601 . . . . 0.0 109.758 178.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.1 tp -125.83 137.81 53.78 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -178.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.8 m -122.6 135.71 54.69 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.632 HG22 HG23 ' A' ' 10' ' ' THR . 58.7 mt -126.03 131.33 71.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.264 0.554 . . . . 0.0 109.884 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -91.94 90.29 7.37 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.028 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.632 HG23 HG22 ' A' ' 8' ' ' ILE . 3.7 p -127.62 160.54 31.29 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 123.006 0.523 . . . . 0.0 111.159 -177.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.5 p -115.48 166.63 11.68 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 171.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.8 t -71.87 -13.65 61.72 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-O 121.678 0.751 . . . . 0.0 109.093 172.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 2.2 m0 -90.2 75.74 6.94 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -175.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.2 t -158.52 159.87 36.05 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.675 -178.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.47 -43.9 0.26 Allowed Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -72.24 -26.98 62.23 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 70.0 m -54.88 -32.41 60.84 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 122.652 0.381 . . . . 0.0 111.409 -177.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 38.4 tp -55.02 -33.72 62.88 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.146 0.978 . . . . 0.0 111.943 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -59.72 -42.58 93.4 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.3 0.64 . . . . 0.0 109.442 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.5 tp -84.32 -38.71 20.05 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.437 -178.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -55.44 -48.84 73.84 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.444 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.9 p -68.18 -40.22 82.32 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.876 -178.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.529 ' HB1' ' HB2' ' A' ' 72' ' ' ALA . . . -59.68 -45.83 90.9 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.481 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.0 mt -69.66 -42.67 73.91 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.723 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 59.6 m -64.71 -35.57 81.47 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-O 120.878 0.37 . . . . 0.0 111.175 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.93 -26.56 62.34 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-O 121.463 0.649 . . . . 0.0 110.425 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -91.89 10.64 27.89 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.48 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 65.58 23.87 11.74 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.144 1.377 . . . . 0.0 111.282 175.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 80.0 mt -90.11 130.76 38.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -102.29 150.39 23.37 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -147.86 138.27 22.99 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.3 112.43 22.83 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 176.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -83.38 126.83 33.13 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.4 t -75.51 154.81 6.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-O 121.864 0.84 . . . . 0.0 112.559 -173.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -68.79 -0.52 5.51 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 126.394 1.878 . . . . 0.0 114.418 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.2 pt -44.44 -24.92 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 N-CA-C 117.265 2.32 . . . . 0.0 117.265 -170.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -67.73 -25.77 65.81 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 119.561 -0.855 . . . . 0.0 111.109 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 14.6 t60 -108.93 -43.79 4.13 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 176.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -79.43 102.98 9.03 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.336 -178.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.406 ' HA ' ' HB3' ' A' ' 43' ' ' ALA . 16.9 ptp180 -71.47 -23.41 61.82 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.77 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.39 -38.38 89.82 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.34 -20.99 25.97 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.975 176.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.406 ' HB3' ' HA ' ' A' ' 40' ' ' ARG . . . -66.88 -33.82 76.45 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.402 -178.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -70.81 -30.49 66.94 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.579 176.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -66.73 -32.96 74.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.172 0.51 . . . . 0.0 110.108 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 44.9 t -62.25 -32.51 55.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.392 177.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.55 -43.38 52.98 Favored Glycine 0 N--CA 1.44 -1.079 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 177.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.7 m -58.18 -40.42 81.44 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.497 0.719 . . . . 0.0 112.174 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.3 m -79.72 -7.58 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -107.75 -53.6 2.6 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.856 -0.337 . . . . 0.0 111.619 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 138.52 -87.51 0.21 Allowed Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.193 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -103.14 -42.7 2.02 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.339 -177.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 -124.33 149.35 46.68 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.078 0.466 . . . . 0.0 110.72 -177.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.1 mtm180 -80.79 97.44 7.34 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.45 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.7 m -75.8 127.45 33.04 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 175.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 1.564 18.9 m -59.35 -71.02 0.34 Allowed Pre-proline 0 CA--C 1.45 -2.883 1 N-CA-C 124.52 5.007 . . . . 0.0 124.52 -177.329 . . . . . . . . 3 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.67 79.36 3.38 Favored 'Trans proline' 0 N--CA 1.401 -3.966 0 CA-C-N 122.617 1.97 . . . . 0.0 113.188 -170.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.4 m -108.14 120.97 43.85 Favored 'General case' 0 N--CA 1.417 -2.093 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.155 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.6 p -97.78 143.85 12.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.747 -177.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -121.08 128.17 52.35 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -103.79 149.08 25.36 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.27 -11.91 53.22 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.457 0.646 . . . . 0.0 111.562 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.4 ' HB2' HG22 ' A' ' 82' ' ' ILE . 36.9 t70 -74.92 -14.19 60.62 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 124.104 0.962 . . . . 0.0 110.064 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.03 -21.85 24.22 Favored Glycine 0 CA--C 1.501 -0.812 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.752 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 p -70.36 138.02 51.05 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 123.585 0.754 . . . . 0.0 111.889 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.98 138.09 54.51 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 174.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mp -129.58 119.6 23.9 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 120.87 0.366 . . . . 0.0 110.595 -178.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.9 m -90.3 112.72 24.39 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.732 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 36.4 t30 56.1 74.22 0.73 Allowed Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 177.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -103.59 172.2 0.19 Allowed 'Trans proline' 0 N--CA 1.444 -1.388 0 C-N-CA 122.478 2.119 . . . . 0.0 110.598 172.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.2 t -85.08 165.22 17.67 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 174.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.529 ' HB2' ' HB1' ' A' ' 23' ' ' ALA . . . -60.66 -32.45 71.64 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.958 0.409 . . . . 0.0 111.398 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -56.65 -40.62 75.8 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.598 1.159 . . . . 0.0 109.511 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 11.7 mm-40 -68.96 -53.12 22.48 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.653 -176.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 49.4 t -61.4 -40.84 87.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 114.997 -1.002 . . . . 0.0 111.126 -176.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -64.04 -37.8 88.74 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.572 -177.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.57 -22.58 34.83 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.897 0.38 . . . . 0.0 110.964 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.423 ' O ' HG23 ' A' ' 82' ' ' ILE . 74.8 mmtt -84.56 -35.99 22.42 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.493 177.252 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.9 tp -55.61 -46.48 77.32 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.467 0.651 . . . . 0.0 109.6 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.7 m -63.42 -40.88 90.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.864 -178.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.12 -24.18 51.73 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.71 -177.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 78' ' ' LYS . 1.9 pp -83.37 -25.45 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 120.004 -0.679 . . . . 0.0 110.426 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.5 -28.37 59.13 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.462 175.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 143.57 -122.5 1.87 Allowed Glycine 0 N--CA 1.428 -1.842 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 178.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.6 mt -127.81 30.01 5.36 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 -178.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -78.9 -57.15 3.9 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 112.987 -1.915 . . . . 0.0 109.735 -172.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.0 t60 58.09 80.17 0.18 Allowed 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.798 1.239 . . . . 0.0 111.53 -178.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 . . . . . 0 C--N 1.308 -1.213 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.803 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.504 -0.814 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.8 t 68.15 -70.55 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.921 0 C-N-CA 124.227 1.011 . . . . 0.0 109.891 -174.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 29.4 m 71.59 -47.79 0.67 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.602 1.561 . . . . 0.0 113.996 174.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.46 146.51 26.28 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 121.93 -0.481 . . . . 0.0 110.726 -178.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.13 -22.78 20.51 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.36 0.6 . . . . 0.0 109.665 177.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.437 ' CD1' HD13 ' A' ' 79' ' ' LEU . 8.5 mp -93.53 129.42 39.76 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.448 177.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.3 m -118.34 108.31 14.92 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 171.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 57.6 mt -108.5 134.09 51.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-O 121.147 0.498 . . . . 0.0 110.211 -174.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -86.14 123.65 31.66 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.565 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 31.5 p -138.79 -178.91 5.53 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.687 0.755 . . . . 0.0 111.103 -178.032 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.1 m -139.4 153.25 47.59 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 104.367 -2.457 . . . . 0.0 104.367 174.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.3 p -49.94 -42.6 48.85 Favored 'General case' 0 C--N 1.315 -0.928 0 O-C-N 123.605 0.565 . . . . 0.0 110.99 176.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 35.2 p90 -111.52 129.67 55.98 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 174.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.3 t -164.02 142.13 7.28 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 174.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.47 -49.2 2.04 Favored Glycine 0 N--CA 1.429 -1.792 0 C-N-CA 120.646 -0.787 . . . . 0.0 111.374 178.272 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -73.42 -34.02 65.26 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 122.548 0.339 . . . . 0.0 111.553 -175.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.414 ' HA ' ' HB3' ' A' ' 57' ' ' PRO . 21.4 m -62.69 -36.96 84.6 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.247 0.546 . . . . 0.0 110.216 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 24.2 tp -65.64 -27.79 68.63 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.831 -174.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.0 ttt180 -54.46 -53.26 56.68 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.865 0.866 . . . . 0.0 110.158 177.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.48 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 23.3 tp -79.99 -37.8 33.48 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.125 -177.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.6 tttm -58.13 -43.56 87.34 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 123.747 0.819 . . . . 0.0 111.069 -175.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.6 m -72.4 -32.06 66.06 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.351 -178.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.97 -46.19 78.95 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.275 0.56 . . . . 0.0 110.042 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 68.9 mt -63.61 -44.46 93.88 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.599 -178.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.5 m -61.57 -37.42 83.78 Favored 'General case' 0 CA--C 1.555 1.167 0 CA-C-O 121.217 0.532 . . . . 0.0 110.68 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.18 -19.82 59.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.107 0.48 . . . . 0.0 111.134 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.422 ' HB3' HG13 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -97.31 10.96 38.18 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.519 -179.284 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 63.99 26.2 14.05 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.792 0.837 . . . . 0.0 111.978 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.422 HG13 ' HB3' ' A' ' 27' ' ' ASN . 77.0 mt -91.52 120.19 40.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.04 146.48 26.08 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -153.01 147.91 26.46 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -176.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -109.46 116.27 31.49 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 177.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.565 ' HB2' ' OG1' ' A' ' 10' ' ' THR . 14.0 pt-20 -87.98 146.91 25.28 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.617 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.7 t -91.07 151.73 3.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -171.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -77.91 1.55 20.23 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 128.724 2.81 . . . . 0.0 113.103 -178.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.1 pt -42.92 -22.48 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.526 3.341 0 N-CA-C 116.978 2.214 . . . . 0.0 116.978 -168.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -74.37 -21.81 59.5 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 119.403 1.001 . . . . 0.0 109.732 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -111.01 -34.86 6.09 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.573 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -90.98 113.46 25.71 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.819 179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -72.03 -29.85 64.6 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.625 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.65 -46.94 74.1 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -174.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.441 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -76.03 -25.18 55.43 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.522 179.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.48 -42.61 87.2 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.65 -39.55 84.76 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.617 176.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -65.08 -32.85 74.77 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.082 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 42' ' ' ALA . 64.9 t -59.68 -34.47 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 121.195 0.522 . . . . 0.0 109.674 178.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.24 -18.38 65.02 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.834 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.5 t -81.54 -26.85 34.72 Favored 'General case' 0 N--CA 1.433 -1.285 0 O-C-N 122.228 -0.572 . . . . 0.0 110.391 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.4 m -99.42 -23.01 4.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 119.831 -0.748 . . . . 0.0 112.729 -178.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -147.76 154.09 40.07 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 175.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -144.32 170.04 26.18 Favored Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -178.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.51 -82.79 1.66 Allowed Glycine 0 CA--C 1.501 -0.834 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -177.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -104.85 123.59 47.97 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 174.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -67.13 106.25 1.93 Allowed 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.127 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.5 m -78.48 110.72 13.82 Favored 'General case' 0 N--CA 1.409 -2.476 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.4 t -76.89 -57.71 1.15 Allowed Pre-proline 0 N--CA 1.426 -1.632 0 CA-C-O 117.119 -1.42 . . . . 0.0 113.087 -174.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.414 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . 81.1 Cg_endo -73.39 45.49 1.02 Allowed 'Trans proline' 0 C--N 1.402 3.374 0 C-N-CA 121.393 1.395 . . . . 0.0 114.014 -168.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 95.5 m -80.49 138.21 36.53 Favored 'General case' 0 N--CA 1.39 -3.473 0 C-N-CA 126.063 1.745 . . . . 0.0 107.29 177.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.67 136.48 59.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-O 121.13 0.49 . . . . 0.0 110.569 -178.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -114.58 130.59 56.79 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 175.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -100.35 151.99 20.86 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.919 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.4 -10.08 15.29 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 124.234 1.013 . . . . 0.0 113.569 -177.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -89.76 -13.98 35.57 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.181 0.515 . . . . 0.0 109.663 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.72 3.13 30.49 Favored Glycine 0 N--CA 1.436 -1.312 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.6 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.0 m -82.86 131.01 35.21 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.796 177.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.0 p -113.93 137.65 51.4 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 171.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.3 mp -128.08 116.56 20.17 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.9 m -96.91 112.42 24.18 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -178.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 54.08 69.88 1.97 Allowed Pre-proline 0 N--CA 1.488 1.466 0 C-N-CA 124.213 1.005 . . . . 0.0 113.141 -174.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -95.55 172.88 1.16 Allowed 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 122.058 1.839 . . . . 0.0 111.567 175.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.0 t -93.55 161.49 14.34 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 172.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.81 -28.9 67.86 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.16 0.505 . . . . 0.0 110.243 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -56.55 -49.97 73.25 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.191 177.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -65.25 -42.56 93.18 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-N 114.805 -1.088 . . . . 0.0 110.653 -177.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.414 ' CG1' HD21 ' A' ' 6' ' ' LEU . 96.9 t -62.05 -49.38 84.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.29 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -61.36 -43.91 98.06 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.379 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.81 -38.79 87.16 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.575 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.421 ' O ' HG13 ' A' ' 82' ' ' ILE . 18.1 tppt? -66.6 -45.08 80.36 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 177.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.437 HD13 ' CD1' ' A' ' 6' ' ' LEU . 33.9 tp -59.98 -49.45 77.61 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.923 -177.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.8 m -66.61 -30.17 48.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -79.72 -33.44 40.92 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.543 -0.863 . . . . 0.0 111.221 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.5 pp -83.4 -23.8 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.768 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.81 -31.91 23.61 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.27 -60.88 4.79 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.2 mt -134.48 -152.6 0.48 Allowed 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 69.63 -74.48 0.08 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.818 1.247 . . . . 0.0 111.257 177.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 62.1 t-80 -80.08 -26.07 39.77 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 . . . . . 0 N--CA 1.427 -1.58 0 CA-C-N 113.804 -1.544 . . . . 0.0 107.199 177.349 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.6 ' HG3' ' H ' ' A' ' 2' ' ' VAL . 17.8 ptm . . . . . 0 N--CA 1.466 0.34 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.6 ' H ' ' HG3' ' A' ' 1' ' ' MET . 67.7 t -125.67 -43.39 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -177.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.91 -42.46 76.07 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.994 177.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -122.9 148.1 45.84 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 167.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.14 -20.91 65.81 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -174.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.2 tp -110.29 151.55 27.25 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.779 -174.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.2 m -121.44 119.64 32.65 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 176.023 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 52.3 mt -120.34 131.87 71.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.394 0.616 . . . . 0.0 110.886 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -95.0 127.3 40.96 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 174.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.436 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 7.3 p -151.27 176.54 11.13 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.06 0.457 . . . . 0.0 111.723 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 29.0 m -132.02 149.45 52.42 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 174.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.2 p -68.68 -30.05 68.64 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.957 0.884 . . . . 0.0 108.85 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -84.92 101.78 12.61 Favored 'General case' 0 N--CA 1.412 -2.343 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 171.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.458 ' SG ' HG23 ' A' ' 56' ' ' VAL . 10.0 m -164.22 158.93 19.54 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.954 -1.475 . . . . 0.0 109.471 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -116.75 -62.66 0.33 Allowed Glycine 0 C--N 1.305 -1.193 0 N-CA-C 108.296 -1.921 . . . . 0.0 108.296 167.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.471 ' HD1' ' H ' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -56.62 -30.67 63.52 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 124.696 1.198 . . . . 0.0 113.197 176.842 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.425 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 36.1 m -66.04 -44.63 84.09 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 70.3 mt -62.53 -43.26 99.26 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.196 -176.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -59.01 -39.23 81.24 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.335 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.597 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 25.8 tp -77.7 -45.61 24.33 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.074 0.464 . . . . 0.0 109.826 177.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -56.9 -44.47 82.39 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 123.887 0.875 . . . . 0.0 111.971 -177.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.5 t -71.91 -31.07 66.01 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.47 177.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.64 -45.0 88.68 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 42.5 mt -63.79 -39.98 95.57 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.27 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.0 m -69.09 -33.14 73.04 Favored 'General case' 0 CA--C 1.562 1.426 0 CA-C-O 121.268 0.556 . . . . 0.0 110.504 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.03 -40.47 65.1 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.563 0.697 . . . . 0.0 111.583 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -91.23 18.32 7.14 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 114.959 -1.018 . . . . 0.0 111.902 -174.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.535 ' NH1' ' HA ' ' A' ' 88' ' ' HIS . 35.5 ttt180 54.66 64.08 1.93 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.612 1.165 . . . . 0.0 113.479 179.118 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.489 HD11 ' HB2' ' A' ' 76' ' ' LYS . 89.7 mt -119.68 123.56 71.24 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.706 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 174.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.32 135.19 34.78 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.164 -177.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -155.8 150.7 26.37 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 123.208 0.317 . . . . 0.0 111.564 -176.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -109.44 136.07 49.45 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 172.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 10.0 pt-20 -102.77 142.48 33.85 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.819 178.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -84.07 154.85 3.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-O 121.259 0.552 . . . . 0.0 111.979 -173.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -71.59 -2.21 16.26 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 126.707 2.003 . . . . 0.0 113.245 -174.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.443 HD13 HG21 ' A' ' 46' ' ' VAL . 3.3 pt -44.12 -24.38 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 117.166 2.284 . . . . 0.0 117.166 -167.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -63.52 -41.48 98.5 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.853 0.835 . . . . 0.0 109.058 176.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 56.7 t60 -94.85 -41.76 9.05 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.581 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.502 ' ND2' ' H ' ' A' ' 42' ' ' ALA . 42.1 t30 -85.47 109.94 18.83 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.124 0.487 . . . . 0.0 111.574 -178.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -75.88 -16.68 60.01 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.683 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.11 -43.85 41.34 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -175.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.502 ' H ' ' ND2' ' A' ' 39' ' ' ASN . . . -81.32 -22.79 38.26 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.377 0.608 . . . . 0.0 109.881 177.162 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.37 -27.13 68.35 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.617 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -64.61 -33.25 75.49 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.942 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -67.54 -36.8 81.67 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.443 HG21 HD13 ' A' ' 36' ' ' ILE . 57.3 t -64.87 -45.68 94.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.999 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.64 -21.02 76.2 Favored Glycine 0 C--O 1.218 -0.881 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.862 178.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.6 t -81.87 -41.62 20.73 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 122.798 0.439 . . . . 0.0 110.798 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.2 p -82.22 -31.43 10.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -96.19 137.02 35.87 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.807 0.337 . . . . 0.0 110.156 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.85 136.14 12.9 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.78 -174.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.32 -88.17 1.58 Allowed Glycine 0 N--CA 1.43 -1.702 0 CA-C-N 115.436 -0.382 . . . . 0.0 112.501 177.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -93.29 162.21 14.09 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -178.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -85.48 83.43 7.93 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 173.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.6 m -60.96 127.76 33.15 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.498 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.458 HG23 ' SG ' ' A' ' 14' ' ' CYS 1.539 12.0 m -68.47 -75.05 0.14 Allowed Pre-proline 0 CA--C 1.433 -3.548 1 N-CA-C 123.902 4.778 . . . . 0.0 123.902 179.509 . . . . . . . . 4 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.425 ' HD3' ' SG ' ' A' ' 17' ' ' CYS . 98.3 Cg_endo -74.15 89.69 1.03 Allowed 'Trans proline' 0 N--CA 1.403 -3.812 0 CA-C-N 121.218 1.471 . . . . 0.0 112.004 -167.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.7 m -114.42 116.81 29.49 Favored 'General case' 0 N--CA 1.397 -3.1 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 -177.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.13 139.68 23.41 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.137 -176.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -115.2 121.14 42.03 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.454 ' CE2' ' HB3' ' A' ' 78' ' ' LYS . 97.0 m-85 -101.58 155.89 17.81 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.27 -9.87 27.6 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.696 0.76 . . . . 0.0 110.583 176.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -64.92 -18.77 65.51 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.893 1.277 . . . . 0.0 109.906 176.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.43 18.18 36.79 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.501 177.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 27.8 t -133.94 153.73 51.57 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -178.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.2 p -114.33 139.52 49.38 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.578 177.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.9 mp -119.33 123.88 45.26 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 18.2 m -97.67 112.69 24.47 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 54.03 68.81 2.51 Favored Pre-proline 0 N--CA 1.489 1.483 0 C-N-CA 124.437 1.095 . . . . 0.0 112.885 -171.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -85.56 165.26 10.67 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.759 1.639 . . . . 0.0 109.855 172.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.3 m -84.49 159.75 20.68 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 177.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.52 -43.28 79.65 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 122.971 0.508 . . . . 0.0 111.807 -177.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -58.92 -42.37 89.55 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.976 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.494 ' O ' ' HE2' ' A' ' 78' ' ' LYS . 56.2 mm-40 -61.15 -44.39 97.39 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.243 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.8 t -65.83 -48.0 83.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.413 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.489 ' HB2' HD11 ' A' ' 29' ' ' ILE . 57.5 tttp -61.43 -43.81 98.21 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.998 -177.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.1 -35.31 69.15 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.029 0.442 . . . . 0.0 111.369 -178.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.494 ' HE2' ' O ' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -74.22 -31.43 62.61 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 119.994 -0.683 . . . . 0.0 110.13 177.377 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.414 HD22 HG23 ' A' ' 29' ' ' ILE . 16.5 tp -63.21 -48.4 78.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.188 0.518 . . . . 0.0 109.761 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.7 m -65.21 -30.29 49.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.66 -176.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -80.94 -25.81 37.14 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.123 -0.631 . . . . 0.0 111.21 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.4 pp -85.24 -32.03 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.202 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.23 -62.06 1.81 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.78 -109.37 1.63 Allowed Glycine 0 N--CA 1.429 -1.784 0 C-N-CA 120.475 -0.869 . . . . 0.0 113.001 177.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -67.62 -44.53 77.81 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 123.069 0.548 . . . . 0.0 110.342 -176.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -76.6 98.1 4.59 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.661 0.743 . . . . 0.0 111.516 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 21.6 p-80 -97.31 128.83 44.49 Favored 'General case' 0 N--CA 1.423 -1.794 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.802 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.535 ' HA ' ' NH1' ' A' ' 28' ' ' ARG . 82.3 m-70 . . . . . 0 C--N 1.293 -1.881 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtm . . . . . 0 CA--C 1.509 -0.617 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.5 p -98.7 -11.83 8.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 174.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.5 p -70.08 123.79 22.46 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.343 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.401 ' HB2' ' HB3' ' A' ' 32' ' ' ASP . . . -82.37 117.18 22.24 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.337 -177.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.72 -33.63 62.42 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 172.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.0 mt -119.28 117.93 29.89 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.675 -1.148 . . . . 0.0 107.933 175.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 60' ' ' LYS . 11.9 m -102.36 108.04 19.25 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 177.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 59.4 mt -108.06 134.49 49.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-O 121.629 0.728 . . . . 0.0 110.26 -176.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -91.19 120.12 31.85 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.031 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.528 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 24.9 p -139.67 162.13 35.85 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.375 0.27 . . . . 0.0 111.193 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.5 p -155.69 -175.1 5.26 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 125.316 1.446 . . . . 0.0 107.684 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.7 t -76.72 -11.03 59.78 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.984 0.421 . . . . 0.0 109.871 172.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 4.1 m0 -83.98 44.96 1.04 Allowed 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 41.3 t -133.97 126.46 30.34 Favored 'General case' 0 N--CA 1.416 -2.143 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -166.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -128.72 -69.91 0.13 Allowed Glycine 0 N--CA 1.437 -1.24 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 170.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -61.66 -18.34 59.13 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.37 -33.98 70.02 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.218 0.532 . . . . 0.0 110.516 177.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 84.1 mt -65.38 -37.28 86.53 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.348 -178.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 -52.58 -48.59 66.13 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 124.274 0.984 . . . . 0.0 110.099 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.4 tp -74.12 -45.8 46.67 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.658 -177.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.7 pttp -70.86 -26.91 63.47 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 119.285 -0.966 . . . . 0.0 112.123 -173.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.9 p -74.98 -28.49 60.57 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.848 -0.532 . . . . 0.0 110.311 175.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.46 -42.06 88.14 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 175.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.1 mt -63.32 -47.54 81.8 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.991 177.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.3 m -57.73 -47.06 83.48 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.811 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.69 -25.61 68.28 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.301 0.572 . . . . 0.0 111.936 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -95.5 6.88 47.82 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.027 -178.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.405 ' HD2' ' HA ' ' A' ' 28' ' ' ARG . 16.3 mmm180 67.53 24.0 8.78 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.78 0.832 . . . . 0.0 112.551 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.438 HG23 HD22 ' A' ' 79' ' ' LEU . 73.2 mt -83.89 120.76 35.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 176.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.52 127.7 34.9 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.4 -176.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -140.27 169.27 18.0 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.401 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 21.7 t0 -136.52 142.52 43.47 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.528 ' HB2' ' OG1' ' A' ' 10' ' ' THR . 10.3 pt-20 -105.32 131.58 52.59 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 123.659 0.599 . . . . 0.0 110.939 -176.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.4 t -78.84 143.61 12.35 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -172.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -59.65 -1.3 0.24 Allowed 'General case' 0 N--CA 1.503 2.215 0 C-N-CA 128.826 2.85 . . . . 0.0 114.878 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.2 pt -44.22 -25.19 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 117.092 2.256 . . . . 0.0 117.092 -168.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -70.91 -25.49 62.79 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 118.967 0.803 . . . . 0.0 109.096 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -97.97 -35.48 10.44 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.257 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . 0.254 0.2 OUTLIER -112.62 118.69 35.77 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.959 0.885 . . . . 0.0 112.667 179.448 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.695 ' HD3' ' H ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -75.85 -18.9 59.27 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.655 -174.88 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.87 -53.52 56.34 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.789 0.328 . . . . 0.0 111.496 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.417 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -72.82 -21.1 61.02 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.913 177.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.88 -35.46 76.9 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.126 0.489 . . . . 0.0 110.714 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -73.9 -29.28 61.98 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.951 0.405 . . . . 0.0 110.269 177.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -65.21 -29.8 70.64 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.788 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 42' ' ' ALA . 48.0 t -63.03 -30.83 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.834 176.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.75 -43.13 60.27 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 178.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.2 m -65.22 -28.82 69.63 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.222 0.609 . . . . 0.0 112.359 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.8 m -84.61 -5.03 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 O-C-N 121.655 -0.653 . . . . 0.0 111.594 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -104.83 -52.94 2.77 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.638 176.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 143.64 -37.9 1.41 Allowed Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -167.24 -47.73 0.03 OUTLIER Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -88.64 177.31 6.79 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.0 mtm180 -126.19 116.85 21.95 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.529 HG22 ' HD2' ' A' ' 57' ' ' PRO . 16.3 m -98.02 151.16 20.62 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 174.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.44 ' CG1' ' HA ' ' A' ' 10' ' ' THR . 34.5 t -79.38 -69.13 0.21 Allowed Pre-proline 0 CA--C 1.475 -1.926 0 CA-C-O 117.509 -1.234 . . . . 0.0 113.988 -178.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.529 ' HD2' HG22 ' A' ' 55' ' ' THR . 72.8 Cg_endo -76.07 86.68 1.5 Allowed 'Trans proline' 1 N--CA 1.393 -4.387 0 CA-C-N 120.867 1.345 . . . . 0.0 111.797 -163.121 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 64.0 m -121.64 124.88 45.37 Favored 'General case' 1 N--CA 1.373 -4.299 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 -175.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 66' ' ' THR . 4.6 p -115.53 136.1 53.44 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.956 -175.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.413 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 29.7 ttpp -111.74 123.19 49.72 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 174.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.443 ' HB3' HG21 ' A' ' 82' ' ' ILE . 88.2 m-85 -92.03 175.61 6.81 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.015 -178.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.524 ' HB3' ' HB ' ' A' ' 82' ' ' ILE . . . -66.44 -22.84 66.22 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.146 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.543 ' OD2' HG22 ' A' ' 82' ' ' ILE . 48.9 m-20 -82.17 0.07 42.65 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.198 0.523 . . . . 0.0 111.046 177.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.57 -0.8 87.02 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.939 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.1 m -68.27 130.45 42.94 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 6.4 p -114.13 137.8 51.27 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 176.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.9 mt -134.61 121.67 21.23 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.926 0.393 . . . . 0.0 110.432 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 91.8 m -90.92 121.83 33.09 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 174.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 58.33 65.64 3.01 Favored Pre-proline 0 N--CA 1.472 0.629 0 C-N-CA 124.284 1.033 . . . . 0.0 113.055 -177.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -84.0 -178.88 3.72 Favored 'Trans proline' 0 C--O 1.25 1.117 0 C-N-CA 121.694 1.596 . . . . 0.0 110.463 171.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.47 ' O ' HG23 ' A' ' 75' ' ' VAL . 3.4 m -112.09 150.83 30.16 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.41 -41.92 66.48 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -174.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -78.27 -34.83 48.71 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.948 0.404 . . . . 0.0 109.953 -178.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -65.06 -37.53 87.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.273 178.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 71' ' ' SER . 91.7 t -61.44 -42.17 92.81 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.626 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.203 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -62.52 -41.1 98.63 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.984 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.412 ' O ' HG22 ' A' ' 80' ' ' VAL . . . -69.42 -31.58 70.01 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.504 0.669 . . . . 0.0 111.289 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -78.11 -29.71 49.11 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 176.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.438 HD22 HG23 ' A' ' 29' ' ' ILE . 31.1 tp -65.94 -41.57 91.12 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.445 179.223 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 77' ' ' ALA . 27.4 m -66.12 -36.19 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -72.99 -34.37 66.37 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.943 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.543 HG22 ' OD2' ' A' ' 63' ' ' ASP . 2.1 pp -77.02 -31.53 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 120.344 -0.543 . . . . 0.0 111.246 -177.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.63 -46.92 18.14 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.062 0.458 . . . . 0.0 110.145 177.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 82.48 -65.28 4.13 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.654 -0.578 . . . . 0.0 111.654 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.6 mt -99.65 -178.28 3.83 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 74.24 -53.77 0.68 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.078 1.351 . . . . 0.0 112.202 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 -72.02 -23.86 61.46 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 121.522 0.677 . . . . 0.0 110.09 176.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' HIS . . . . . 0.411 ' NE2' ' HB ' ' A' ' 80' ' ' VAL . 92.0 m-70 . . . . . 0 N--CA 1.421 -1.909 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 177.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.3 mmt . . . . . 0 CA--C 1.506 -0.719 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 97.6 t -80.93 -32.58 12.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -178.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 82.3 p 63.92 142.08 0.02 OUTLIER 'General case' 0 C--O 1.239 0.507 0 C-N-CA 126.445 1.898 . . . . 0.0 112.066 -174.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -78.3 150.64 33.28 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-O 120.902 0.382 . . . . 0.0 110.066 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.88 -5.27 47.77 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.357 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.84 123.12 41.01 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 121.397 0.618 . . . . 0.0 109.679 175.13 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.1 m -110.16 112.3 24.2 Favored 'General case' 0 C--N 1.276 -2.605 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 177.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.539 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 57.5 mt -97.88 137.17 26.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.049 -174.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -92.72 117.91 30.5 Favored 'General case' 0 C--N 1.279 -2.459 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.52 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 14.0 p -128.68 155.92 44.29 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 122.511 0.324 . . . . 0.0 110.589 -178.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.573 ' HA ' ' HG2' ' A' ' 37' ' ' GLU . 46.9 p -140.2 175.41 9.62 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.8 m -86.03 -11.41 52.95 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 175.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 8.5 m0 -82.18 -20.23 38.28 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.312 -169.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.492 ' SG ' HG11 ' A' ' 56' ' ' VAL . 9.0 p -109.39 148.33 31.28 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -172.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -101.99 -42.37 2.27 Favored Glycine 0 N--CA 1.432 -1.586 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 172.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -59.75 -24.7 64.25 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -177.545 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.9 p -68.52 -39.14 81.33 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.448 0.642 . . . . 0.0 109.931 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 37.2 tp -69.29 -28.93 66.72 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.549 -175.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -63.39 -50.82 68.37 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.013 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.448 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 41.4 tp -68.5 -36.84 79.47 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.101 0.477 . . . . 0.0 109.908 178.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -56.56 -37.29 70.34 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.479 177.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.9 m -75.15 -40.11 59.85 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.117 178.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.83 -41.03 94.95 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.818 0.447 . . . . 0.0 111.123 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 81.9 mt -66.13 -33.77 76.53 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.76 178.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.7 m -65.55 -44.25 87.4 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.002 177.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.44 -26.89 65.74 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.561 0.696 . . . . 0.0 110.963 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -84.53 4.35 32.37 Favored 'General case' 0 C--O 1.254 1.3 0 C-N-CA 123.907 0.883 . . . . 0.0 111.858 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 60.3 37.12 20.51 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.931 1.293 . . . . 0.0 110.252 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 85.2 mt -95.61 122.74 47.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.625 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.04 125.2 31.18 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 176.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -135.69 148.67 48.99 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 120.707 0.289 . . . . 0.0 110.671 -178.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -111.04 123.73 50.78 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 174.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 15.7 pt-20 -96.91 151.04 20.08 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.9 t -90.92 143.63 10.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-O 122.163 0.982 . . . . 0.0 113.497 -171.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -63.59 -2.1 1.52 Allowed 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 128.305 2.642 . . . . 0.0 114.822 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.4 pt -45.28 -24.84 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -175.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.573 ' HG2' ' HA ' ' A' ' 11' ' ' THR . 45.3 mt-10 -55.8 -31.7 62.87 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.355 0.662 . . . . 0.0 111.427 178.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -128.08 20.56 6.37 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.22 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.462 ' ND2' ' H ' ' A' ' 42' ' ' ALA . 28.7 t30 -143.52 122.18 12.57 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.957 0.408 . . . . 0.0 111.26 -178.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -77.15 -28.21 54.1 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.421 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.04 -37.48 81.38 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 -172.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.462 ' H ' ' ND2' ' A' ' 39' ' ' ASN . . . -84.19 -24.75 29.98 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 120.113 -0.635 . . . . 0.0 109.466 176.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.79 -30.28 68.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.288 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -64.4 -36.6 84.68 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 114.97 -1.013 . . . . 0.0 108.737 178.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -67.53 -31.78 72.11 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.123 0.487 . . . . 0.0 110.463 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 43.6 t -66.49 -31.42 53.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.33 -23.65 67.68 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.321 176.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 42.3 t -67.94 -43.72 78.47 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 176.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 31.5 m -81.06 -39.52 17.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.923 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' A' ' 53' ' ' ASN . 54.5 m-80 -106.97 109.22 21.06 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 120.862 0.363 . . . . 0.0 110.701 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -81.93 128.17 8.33 Favored Glycine 0 N--CA 1.439 -1.116 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.798 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.31 -84.25 1.37 Allowed Glycine 0 N--CA 1.438 -1.204 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.429 ' O ' ' HB3' ' A' ' 50' ' ' ASN . 93.0 m-20 -88.64 122.61 32.27 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -80.63 94.03 6.24 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.821 177.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.8 m -67.0 123.71 20.99 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 175.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.492 HG11 ' SG ' ' A' ' 14' ' ' CYS . 16.5 t -72.89 -60.56 1.85 Allowed Pre-proline 0 CA--C 1.462 -2.412 0 CA-C-O 117.149 -1.405 . . . . 0.0 114.746 -172.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -77.74 72.17 6.21 Favored 'Trans proline' 1 N--CA 1.394 -4.343 0 CA-C-N 121.185 1.459 . . . . 0.0 112.782 -167.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 88.2 m -106.35 142.12 36.54 Favored 'General case' 0 N--CA 1.38 -3.96 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.6 p -136.81 139.16 45.24 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.862 -174.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -104.54 128.59 52.53 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -112.4 166.43 11.3 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.102 0.477 . . . . 0.0 110.489 177.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.34 -8.84 53.65 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.142 171.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -62.91 -17.07 61.29 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.111 1.764 . . . . 0.0 110.997 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.68 8.67 55.69 Favored Glycine 0 CA--C 1.506 -0.517 0 C-N-CA 120.743 -0.741 . . . . 0.0 113.78 173.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.0 t -150.71 173.75 13.81 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.8 p -114.13 139.68 49.14 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -178.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.403 HD23 ' HB3' ' A' ' 70' ' ' PRO . 9.7 mp -106.09 151.79 24.23 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 177.1 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 18.2 m -131.48 113.79 14.13 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -177.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.7 m120 61.05 44.96 0.84 Allowed Pre-proline 0 N--CA 1.485 1.322 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -175.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.403 ' HB3' HD23 ' A' ' 67' ' ' LEU . 74.5 Cg_endo -77.28 160.33 32.69 Favored 'Trans proline' 0 C--N 1.366 1.464 0 C-N-CA 121.305 1.337 . . . . 0.0 111.098 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.1 m -84.27 155.25 22.52 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.42 -42.12 70.12 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.717 0.807 . . . . 0.0 112.172 -177.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -61.46 -40.39 94.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.593 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -67.11 -40.81 86.92 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-O 121.075 0.464 . . . . 0.0 110.089 -178.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.3 t -61.22 -43.82 97.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.619 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -68.61 -41.28 79.73 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.452 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.11 -38.88 89.28 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 122.703 0.401 . . . . 0.0 111.033 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.658 ' O ' HG13 ' A' ' 82' ' ' ILE . 28.7 mmtp -69.48 -39.78 77.48 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.366 174.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.9 tp -60.53 -51.07 70.99 Favored 'General case' 0 C--N 1.318 -0.781 0 O-C-N 123.475 0.485 . . . . 0.0 110.729 -178.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.6 m -61.67 -31.41 50.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -177.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.09 -44.32 18.16 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 119.801 -0.76 . . . . 0.0 111.575 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.658 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.2 pp -82.1 -20.37 10.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -175.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.38 4.14 43.7 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.208 0.527 . . . . 0.0 111.504 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.14 179.1 51.71 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.875 -0.679 . . . . 0.0 114.511 173.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.6 tp -63.4 -26.79 68.9 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 124.609 1.164 . . . . 0.0 110.8 -177.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -66.71 -26.35 66.97 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.651 -1.159 . . . . 0.0 112.013 -175.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -101.3 112.82 25.44 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.634 0.73 . . . . 0.0 111.161 -177.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 7.0 p80 . . . . . 0 C--N 1.306 -1.308 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -176.902 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.1 mtp . . . . . 0 CA--C 1.497 -1.058 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.3 t -76.76 96.72 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 29.0 m -83.08 -47.59 11.5 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.28 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -97.87 76.57 2.45 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 121.381 0.61 . . . . 0.0 111.518 -177.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -82.6 -24.52 33.85 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 173.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.74 130.71 21.76 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-N 113.561 -1.654 . . . . 0.0 108.922 174.226 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.5 m -102.94 117.32 34.34 Favored 'General case' 0 C--N 1.274 -2.679 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.504 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 68.9 mt -108.86 133.61 53.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 121.446 0.641 . . . . 0.0 110.93 -175.161 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -85.12 127.42 34.24 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.598 177.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 39.0 p -133.63 163.17 30.03 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.0 0.429 . . . . 0.0 111.215 -178.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.3 m -147.87 151.6 36.19 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 175.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.4 p -58.41 -42.91 88.27 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 118.534 0.606 . . . . 0.0 109.736 174.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.11 94.36 1.51 Allowed 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 167.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 m -163.82 117.46 1.49 Allowed 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.098 -1.41 . . . . 0.0 111.568 178.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -106.83 -56.93 0.62 Allowed Glycine 0 N--CA 1.428 -1.898 0 N-CA-C 108.681 -1.768 . . . . 0.0 108.681 172.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -69.97 -20.96 63.28 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -179.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.519 ' SG ' ' HB ' ' A' ' 56' ' ' VAL . 3.6 m -72.5 -34.99 68.02 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 177.115 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 18.3 tp -72.29 -29.39 63.83 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.092 -173.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.419 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 2.2 mmp_? -59.34 -37.59 78.23 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.81 177.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.7 tp -82.58 -41.33 19.69 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.564 178.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -58.61 -45.54 88.96 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.635 -176.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -66.34 -36.73 83.66 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.62 -45.42 86.93 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.947 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.4 mt -67.54 -37.87 83.34 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.359 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.0 m -67.09 -42.72 84.13 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.998 0.428 . . . . 0.0 110.41 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.47 -23.86 65.54 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-O 121.233 0.54 . . . . 0.0 110.801 177.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -93.35 6.63 47.47 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.073 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 64.28 24.21 13.26 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.601 0.76 . . . . 0.0 112.494 176.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 78.1 mt -86.49 120.58 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.4 127.24 33.89 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.634 -178.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -142.47 167.19 22.68 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -129.43 135.59 48.87 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 177.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 17.0 pt-20 -100.44 141.69 32.94 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.079 0.466 . . . . 0.0 111.408 -177.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.4 t -83.57 146.72 6.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -171.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -63.68 -2.36 1.69 Allowed 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 129.187 2.995 . . . . 0.0 115.923 178.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.7 pt -45.7 -24.34 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 -173.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -70.19 -23.56 62.98 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 121.724 0.773 . . . . 0.0 110.327 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 -111.42 -36.62 5.49 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.926 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.426 ' ND2' ' H ' ' A' ' 42' ' ' ALA . 26.5 t30 -100.85 122.43 43.43 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.095 -175.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.426 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 9.7 ptp85 -75.76 -25.6 56.64 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.379 177.498 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.95 -36.21 79.72 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -172.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.426 ' H ' ' ND2' ' A' ' 39' ' ' ASN . . . -87.0 -22.23 25.64 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.554 175.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.29 -41.25 81.26 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.766 -178.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 40' ' ' ARG . 19.0 mm-40 -70.13 -24.66 63.22 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.787 178.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -67.35 -32.6 73.66 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.71 177.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 38.9 t -65.54 -39.87 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.82 -18.06 78.67 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.956 178.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.8 t -80.54 -42.63 22.07 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 31.7 m -84.07 -32.62 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -103.52 160.0 15.11 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -178.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -128.74 152.12 19.21 Favored Glycine 0 N--CA 1.432 -1.571 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.065 -178.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.63 -111.91 3.62 Favored Glycine 0 N--CA 1.438 -1.189 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -91.62 147.69 22.82 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 175.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -71.49 96.7 1.54 Allowed 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.515 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.8 m -61.98 114.81 3.59 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 174.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.519 ' HB ' ' SG ' ' A' ' 17' ' ' CYS . 5.2 t -75.1 -55.33 2.3 Favored Pre-proline 0 N--CA 1.428 -1.541 0 CA-C-O 117.435 -1.269 . . . . 0.0 113.424 -175.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.55 75.6 3.44 Favored 'Trans proline' 0 N--CA 1.41 -3.42 0 CA-C-N 121.155 1.448 . . . . 0.0 112.706 -170.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 58.5 m -106.5 125.66 51.29 Favored 'General case' 0 N--CA 1.381 -3.909 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.73 121.0 60.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-O 121.505 0.669 . . . . 0.0 110.872 -175.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -105.2 110.11 22.35 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -79.34 159.97 26.94 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.585 -178.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.56 -24.27 31.49 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.239 1.016 . . . . 0.0 113.588 -177.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -80.58 -17.1 52.43 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.014 0.435 . . . . 0.0 110.694 -178.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.2 -8.26 30.99 Favored Glycine 0 C--O 1.246 0.885 0 C-N-CA 121.009 -0.615 . . . . 0.0 113.169 178.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.9 t -79.31 135.87 36.86 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.3 m -116.7 138.6 51.34 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.0 mp -121.83 142.16 50.51 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 120.881 0.372 . . . . 0.0 110.748 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.8 m -98.73 116.32 30.69 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 115.503 -0.772 . . . . 0.0 108.982 -178.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . 0.324 25.9 p-10 34.88 74.66 0.53 Allowed Pre-proline 0 N--CA 1.494 1.755 0 N-CA-C 116.825 2.157 . . . . 0.0 116.825 179.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -92.04 -165.43 0.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.405 2.07 . . . . 0.0 110.248 175.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.4 m -115.02 169.99 8.68 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.73 -41.68 87.01 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -177.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASP . . . . . 0.425 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 5.2 m-20 -64.92 -33.76 76.79 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.691 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -64.21 -51.16 65.07 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.8 t -61.0 -44.76 98.88 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.167 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.779 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . 0.425 ' HE2' ' HA ' ' A' ' 73' ' ' ASP . 37.1 ttpt -58.46 -46.68 86.1 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 123.421 0.688 . . . . 0.0 111.991 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.36 -22.19 61.19 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 120.874 0.369 . . . . 0.0 111.538 -178.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.455 ' O ' HG13 ' A' ' 82' ' ' ILE . 45.3 mmtm -81.55 -40.75 22.63 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 173.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 27.1 tp -55.68 -47.66 76.38 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 123.721 0.808 . . . . 0.0 109.603 -178.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.8 m -60.53 -36.77 72.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.728 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -82.11 -36.35 27.6 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.4 pp -84.6 -29.53 6.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 113.477 0.918 . . . . 0.0 113.477 -176.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.22 -30.83 15.7 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 97.31 -144.39 17.3 Favored Glycine 0 N--CA 1.427 -1.955 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.27 -30.82 67.94 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 120.661 0.267 . . . . 0.0 110.772 -178.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -98.14 93.91 6.52 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-O 121.31 0.576 . . . . 0.0 109.915 178.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 12.6 p-80 -118.62 -0.92 11.24 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.597 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 . . . . . 0 C--O 1.251 1.178 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 172.806 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 ptp . . . . . 0 CA--C 1.507 -0.681 0 N-CA-C 110.499 -0.186 . . . . 0.0 110.499 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.9 m -96.1 177.16 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -172.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 61.0 m -146.32 116.64 7.46 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 105.159 -2.164 . . . . 0.0 105.159 173.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -130.35 173.65 10.61 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.174 -0.61 . . . . 0.0 112.36 -177.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.58 1.0 27.63 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.866 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.6 mp -98.52 104.82 16.89 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.163 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.4 m -102.56 107.3 18.19 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 173.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.454 HG22 HG23 ' A' ' 10' ' ' THR . 31.0 mt -106.83 129.85 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 CA-C-O 121.687 0.755 . . . . 0.0 111.555 -173.024 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -94.09 106.67 18.64 Favored 'General case' 0 N--CA 1.406 -2.654 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.408 176.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.454 HG23 HG22 ' A' ' 8' ' ' ILE . 2.1 p -140.23 142.29 35.82 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.817 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.4 m -84.37 154.41 22.88 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 175.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 p -62.07 -51.98 65.77 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 46.3 p90 -83.28 92.67 7.54 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-O 121.914 0.864 . . . . 0.0 110.917 176.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.4 t -163.84 117.13 1.47 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.483 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.44 -36.13 15.24 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -62.96 -39.18 93.89 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.462 0.648 . . . . 0.0 109.683 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 55.7 m -68.09 -39.21 82.91 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.252 177.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.83 -38.63 82.6 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 123.832 0.853 . . . . 0.0 110.112 -177.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -57.12 -38.78 73.93 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.581 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.453 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 19.5 tp -78.89 -44.08 23.54 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.174 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -54.42 -49.49 69.85 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.908 -178.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.9 p -65.49 -33.68 76.51 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.963 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.21 -42.33 88.9 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.246 178.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 80.3 mt -64.34 -48.52 75.26 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.486 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 87.1 m -54.91 -42.57 72.37 Favored 'General case' 0 CA--C 1.553 1.088 0 CA-C-O 121.058 0.456 . . . . 0.0 110.768 177.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.15 -13.29 60.2 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -177.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -109.4 14.34 23.69 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 65.99 17.33 10.77 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.84 1.256 . . . . 0.0 112.256 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 63.3 mt -87.37 117.32 31.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.99 144.55 28.22 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.4 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -152.3 150.97 30.33 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 120.678 0.275 . . . . 0.0 111.059 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -114.11 113.01 24.13 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 176.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 15.4 pt-20 -91.37 145.02 24.98 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.0 t -90.73 151.8 3.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -171.076 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.67 -4.23 0.06 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 129.641 3.177 . . . . 0.0 114.91 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.8 pt -49.51 -22.48 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 116.49 2.033 . . . . 0.0 116.49 -168.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -72.73 -13.41 61.33 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 121.458 0.647 . . . . 0.0 111.808 -178.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 34.4 p-80 -128.59 -34.87 1.97 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.615 170.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -80.23 107.23 12.85 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 120.692 0.282 . . . . 0.0 110.77 -179.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -70.77 -23.68 62.45 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.313 -179.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.52 -42.1 71.7 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -176.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -80.02 -23.47 41.45 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.361 177.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.72 -35.42 77.12 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.283 177.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -61.28 -39.66 91.23 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.085 175.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -66.06 -30.96 71.58 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.633 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 88.1 t -64.31 -36.83 78.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.5 -19.01 77.0 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.602 177.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.0 m -76.52 -30.65 57.24 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 177.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.5 m -98.79 -11.38 8.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -125.48 105.13 8.82 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 175.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.99 135.06 23.96 Favored Glycine 0 C--N 1.298 -1.534 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.926 -175.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.25 -59.31 4.99 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.383 -0.409 . . . . 0.0 113.574 176.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -125.75 133.34 52.11 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 -176.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.4 mtm180 -70.63 95.69 1.12 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.307 0.575 . . . . 0.0 110.788 176.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.0 m -77.04 131.02 38.2 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 1.716 15.3 m -58.46 -89.78 0.0 OUTLIER Pre-proline 0 CA--C 1.438 -3.338 1 N-CA-C 123.659 4.689 . . . . 0.0 123.659 -178.891 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -69.9 94.02 0.54 Allowed 'Trans proline' 0 N--CA 1.409 -3.48 0 CA-C-N 120.799 1.321 . . . . 0.0 112.508 -165.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.5 m -119.69 112.42 19.26 Favored 'General case' 0 N--CA 1.407 -2.609 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 -177.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.4 p -103.41 134.85 43.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-O 121.405 0.622 . . . . 0.0 111.211 -176.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -109.03 116.93 32.91 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -100.32 178.81 4.65 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.57 -9.16 24.23 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 122.346 1.07 . . . . 0.0 110.153 174.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -63.01 -19.33 64.25 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.876 1.67 . . . . 0.0 110.152 175.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.51 -22.81 14.63 Favored Glycine 0 C--O 1.238 0.353 0 CA-C-N 116.137 -0.483 . . . . 0.0 113.396 176.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.1 t -100.78 171.57 7.6 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.7 p -113.81 141.13 47.68 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 46.7 tp -115.11 125.25 53.26 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 178.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.9 m -105.24 144.76 31.59 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -175.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.6 p30 50.04 48.41 5.98 Favored Pre-proline 0 N--CA 1.491 1.59 0 C-N-CA 124.78 1.232 . . . . 0.0 113.043 -179.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -80.94 160.66 21.06 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 121.991 1.794 . . . . 0.0 112.703 -174.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.3 m -97.4 153.8 17.86 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 174.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.84 -35.54 73.08 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.044 0.45 . . . . 0.0 111.664 -176.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -62.44 -44.18 97.04 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.218 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -64.38 -41.19 96.82 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.581 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.9 t -57.82 -51.72 66.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.068 178.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -60.96 -44.11 97.77 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.379 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.05 -37.91 84.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.674 -178.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -68.81 -41.24 78.91 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 177.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.17 -49.74 74.62 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 123.796 0.685 . . . . 0.0 110.121 -175.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.5 m -61.88 -35.93 70.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.14 -31.24 34.25 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 119.771 -0.772 . . . . 0.0 111.731 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.4 pp -75.02 -21.52 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.51 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.87 4.75 35.91 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.682 176.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 96.46 -105.56 3.24 Favored Glycine 0 N--CA 1.424 -2.161 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.1 mt -138.85 19.57 2.66 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 173.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -97.78 142.75 29.17 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 15.7 m170 75.69 9.71 3.49 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.125 0.97 . . . . 0.0 110.739 -172.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 . . . . . 0 N--CA 1.426 -1.63 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 177.4 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.355 0 CA-C-O 120.269 0.08 . . . . 0.0 111.182 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.7 t -80.55 72.47 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-O 121.839 0.828 . . . . 0.0 108.999 -178.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.7 m -83.87 -21.74 31.87 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.99 -178.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -134.88 163.14 30.5 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.329 -178.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -95.89 1.18 52.83 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.069 0.462 . . . . 0.0 111.466 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.3 tp -132.68 133.27 43.34 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -178.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.0 m -114.86 124.34 51.47 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.573 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 67.0 mt -119.03 144.94 25.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.436 ' HD1' ' O ' ' A' ' 58' ' ' THR . 92.7 m-85 -98.75 133.01 43.68 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.452 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . 17.1 p -140.49 153.85 46.38 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -176.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.3 p -144.69 164.74 30.07 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 175.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.6 p -86.14 -0.82 56.57 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.34 0.591 . . . . 0.0 111.529 177.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -94.68 27.96 2.84 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -174.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.442 ' HB2' HG21 ' A' ' 56' ' ' VAL . 6.1 t -148.08 151.49 35.76 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -168.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.71 -28.21 0.98 Allowed Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.771 176.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -65.09 -36.46 84.37 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.262 0.553 . . . . 0.0 110.793 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.443 ' HA ' ' HB3' ' A' ' 57' ' ' PRO . 1.7 p -61.0 -32.59 72.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.165 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 81.9 mt -66.73 -28.85 68.75 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.906 -177.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -60.78 -56.08 25.47 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.292 0.568 . . . . 0.0 109.5 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.522 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 16.4 tp -66.79 -39.93 87.97 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.994 -177.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.438 ' HG2' ' OH ' ' A' ' 31' ' ' TYR . 51.1 tttm -58.34 -45.66 87.71 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.847 -177.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.7 p -71.41 -37.47 71.5 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.597 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.47 -42.9 97.18 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 123.066 0.546 . . . . 0.0 110.997 178.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 76.4 mt -69.26 -42.62 75.32 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.01 -178.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.4 m -62.52 -42.13 99.31 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 120.712 0.291 . . . . 0.0 110.273 177.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.79 -19.0 65.04 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.479 0.657 . . . . 0.0 111.196 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -98.25 9.4 43.07 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.932 178.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.475 ' HA ' ' NE ' ' A' ' 28' ' ' ARG . 4.2 mmp_? 65.96 23.14 11.24 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.54 0.736 . . . . 0.0 112.127 177.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.7 mt -87.15 119.95 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.35 127.16 35.78 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.165 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.438 ' OH ' ' HG2' ' A' ' 21' ' ' LYS . 51.6 p90 -136.52 151.92 49.96 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.878 -178.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -111.38 136.25 50.78 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 173.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.573 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 12.8 pt-20 -102.64 146.23 28.49 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.641 -177.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.3 t -96.04 134.69 32.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -173.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -54.57 -0.59 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 129.529 3.132 . . . . 0.0 115.986 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.6 pt -43.85 -25.46 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.514 2.753 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 -168.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -59.63 -45.55 91.63 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -100.54 -31.27 11.35 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.321 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -88.8 104.45 16.93 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -72.86 -17.69 61.51 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.572 -177.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.31 -46.94 53.52 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -176.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -75.29 -25.2 57.74 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.268 0.556 . . . . 0.0 110.001 177.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.16 -32.77 74.1 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.41 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -66.29 -39.89 89.67 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -61.18 -46.17 91.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.796 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 42' ' ' ALA . 80.9 t -57.08 -42.34 79.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.492 178.222 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.95 -32.95 76.78 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.299 178.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.3 m -81.87 -25.85 34.71 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 120.925 0.393 . . . . 0.0 111.304 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.6 t -79.41 -39.09 20.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.098 0.475 . . . . 0.0 110.516 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -84.97 -174.61 5.37 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.094 -178.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -90.23 -93.14 1.22 Allowed Glycine 0 N--CA 1.438 -1.201 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.181 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.25 -47.15 3.37 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.705 -174.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -126.22 151.82 46.88 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.3 mtm180 -57.88 111.18 1.07 Allowed 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.73 0.776 . . . . 0.0 111.826 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.5 m -87.95 133.82 33.85 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 178.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.452 ' CG1' ' HA ' ' A' ' 10' ' ' THR . 21.9 t -74.77 -64.46 0.64 Allowed Pre-proline 0 CA--C 1.459 -2.528 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -171.103 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.443 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . 33.0 Cg_endo -79.36 50.48 3.52 Favored 'Trans proline' 0 N--CA 1.415 -3.136 0 CA-C-N 121.092 1.426 . . . . 0.0 113.349 -164.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.436 ' O ' ' HD1' ' A' ' 9' ' ' TYR . 98.8 m -80.02 136.31 36.56 Favored 'General case' 0 N--CA 1.38 -3.938 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 176.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.3 p -125.74 148.69 30.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.325 -174.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -127.22 119.58 26.73 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -87.91 161.13 17.64 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.408 -178.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.56 -10.5 8.2 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.687 0.795 . . . . 0.0 111.735 176.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -77.68 -18.7 56.39 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.845 176.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.44 -13.35 58.31 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.176 -179.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.2 m -82.12 143.88 31.16 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -178.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.8 p -114.35 148.07 38.17 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.346 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.5 mt -130.16 136.3 49.12 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 175.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 82.9 m -100.63 118.03 35.95 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 176.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 58.18 67.44 2.22 Favored Pre-proline 0 N--CA 1.485 1.318 0 C-N-CA 124.395 1.078 . . . . 0.0 112.282 -178.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -88.24 157.54 6.88 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.776 1.651 . . . . 0.0 112.029 176.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 56.5 p -84.79 149.77 25.5 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 175.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.93 -32.83 72.32 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 120.913 0.387 . . . . 0.0 110.318 -178.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -62.11 -49.76 74.6 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.584 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 19.6 mt-10 -64.89 -42.04 95.12 Favored 'General case' 0 C--O 1.203 -1.386 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.573 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.3 t -57.72 -44.64 86.13 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.633 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -65.86 -44.94 83.92 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.21 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.94 -32.13 72.36 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.214 0.531 . . . . 0.0 111.617 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.449 ' O ' HG13 ' A' ' 82' ' ' ILE . 31.4 mmtp -77.15 -38.14 52.51 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 177.241 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.6 tp -57.59 -48.26 79.87 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 122.734 0.414 . . . . 0.0 110.061 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.469 ' HA ' ' CE1' ' A' ' 87' ' ' HIS . 34.6 m -60.62 -35.64 65.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.724 -176.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -81.86 -39.89 23.24 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.2 pp -75.31 -12.44 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -176.039 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.22 3.98 28.77 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.775 177.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 79.39 -146.22 28.7 Favored Glycine 0 CA--C 1.496 -1.14 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.2 tt -94.63 103.99 15.92 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 176.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -150.75 -49.58 0.12 Allowed 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.569 0.7 . . . . 0.0 110.115 -175.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' HIS . . . . . 0.469 ' CE1' ' HA ' ' A' ' 80' ' ' VAL . 65.3 m80 -78.89 -48.66 14.22 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.838 -178.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 33.8 t60 . . . . . 0 C--N 1.299 -1.62 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -178.911 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 CA--C 1.513 -0.472 0 CA-C-O 120.866 0.365 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.6 m -99.66 -176.48 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -174.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.0 m -54.29 134.81 45.15 Favored 'General case' 0 C--O 1.248 1.0 0 O-C-N 123.957 0.786 . . . . 0.0 110.342 178.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.5 89.14 0.35 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.052 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.25 -31.52 67.63 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 175.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.538 HD21 HD13 ' A' ' 79' ' ' LEU . 1.6 mm? -116.57 115.66 26.16 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 176.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.465 ' HB ' ' HB3' ' A' ' 60' ' ' LYS . 6.2 m -102.26 108.36 19.71 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 177.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 59.3 mt -104.54 132.35 51.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-O 121.285 0.564 . . . . 0.0 110.697 -175.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -93.92 119.96 33.53 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.425 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.8 p -139.06 156.33 47.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.702 -0.226 . . . . 0.0 110.405 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 37.5 p -142.57 -178.21 5.66 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.1 p -74.39 -0.79 18.42 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 121.337 0.589 . . . . 0.0 110.646 173.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 4.2 m0 -93.26 6.42 48.14 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 177.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.9 m -91.41 117.1 29.39 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -176.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -122.51 -56.91 0.2 Allowed Glycine 0 N--CA 1.417 -2.583 0 N-CA-C 107.653 -2.179 . . . . 0.0 107.653 170.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -68.48 -18.76 64.47 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 179.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 28.7 m -64.86 -30.46 71.46 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.182 0.515 . . . . 0.0 109.818 178.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 89.2 mt -68.97 -28.37 66.56 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.579 -173.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -63.85 -32.87 74.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.03 0.443 . . . . 0.0 110.836 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.483 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 13.0 tp -84.19 -43.57 14.81 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.374 177.22 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -55.9 -54.06 49.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.28 -176.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.3 m -63.72 -30.03 71.18 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-O 121.106 0.479 . . . . 0.0 110.973 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.17 -38.68 82.34 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.047 178.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 70.8 mt -69.94 -39.49 76.07 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.788 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 60.5 m -58.55 -43.26 89.27 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-O 121.329 0.585 . . . . 0.0 110.069 174.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.35 -37.77 83.76 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.05 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -79.32 5.8 11.56 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 123.729 0.812 . . . . 0.0 112.712 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 61.84 26.34 15.95 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.81 0.844 . . . . 0.0 111.344 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 76.9 mt -84.89 125.0 40.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 -178.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.29 115.99 26.19 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.488 -176.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -138.35 164.23 29.83 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.328 0.585 . . . . 0.0 111.266 -174.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -127.92 125.94 40.53 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 8' ' ' ILE 0.254 0.0 OUTLIER -100.01 132.78 45.16 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.506 0.67 . . . . 0.0 111.121 178.45 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.401 ' CG1' HG23 ' A' ' 36' ' ' ILE . 13.0 t -82.7 134.89 25.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -168.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -56.59 -0.69 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 130.544 3.538 . . . . 0.0 114.748 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.401 HG23 ' CG1' ' A' ' 34' ' ' VAL . 31.5 pt -41.98 -27.87 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 N-CA-C 117.862 2.541 . . . . 0.0 117.862 -163.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -67.92 -13.49 62.2 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 119.529 1.059 . . . . 0.0 113.336 -173.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 -116.17 -4.65 11.92 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 119.916 -0.714 . . . . 0.0 110.479 177.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -128.96 108.77 10.68 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -176.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -52.05 -38.25 56.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 113.577 -1.647 . . . . 0.0 113.818 -176.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.34 -52.38 61.76 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -174.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.431 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -87.0 -26.61 23.69 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.876 -177.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' A' ' 36' ' ' ILE . . . -66.09 -38.09 87.38 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.351 0.596 . . . . 0.0 110.639 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -72.66 -29.18 63.22 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.152 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -68.39 -29.4 68.08 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.516 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 42' ' ' ALA . 44.9 t -63.66 -32.04 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 121.463 0.649 . . . . 0.0 109.658 177.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.81 -39.93 46.25 Favored Glycine 0 N--CA 1.439 -1.115 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 177.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.2 m -63.79 -29.67 70.85 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.503 0.721 . . . . 0.0 112.331 -178.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.9 m -91.56 -4.86 10.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -116.03 -32.33 5.43 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.55 65.37 0.53 Allowed Glycine 0 N--CA 1.431 -1.651 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.741 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.33 -46.25 2.81 Favored Glycine 0 C--N 1.316 -0.536 0 C-N-CA 121.287 -0.482 . . . . 0.0 112.846 175.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -90.66 154.21 19.74 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -176.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -105.12 82.74 1.88 Allowed 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.48 0.657 . . . . 0.0 109.301 178.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.1 m -74.98 128.08 34.74 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.727 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 1.704 15.3 m -55.23 -88.0 0.0 OUTLIER Pre-proline 0 CA--C 1.447 -2.989 1 N-CA-C 124.219 4.896 . . . . 0.0 124.219 -176.946 . . . . . . . . 3 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -75.88 77.63 3.36 Favored 'Trans proline' 0 N--CA 1.406 -3.672 0 CA-C-N 121.303 1.501 . . . . 0.0 113.251 -167.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.9 m -103.87 130.68 51.48 Favored 'General case' 0 N--CA 1.399 -2.976 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.1 p -114.74 131.96 65.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-O 121.228 0.537 . . . . 0.0 110.095 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.465 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 26.1 ttpp -104.95 119.97 40.3 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 174.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -89.98 168.06 12.31 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.257 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.46 -10.3 57.45 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.329 175.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -71.06 -19.26 62.5 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.252 178.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.53 -22.21 41.68 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -178.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.2 m -82.09 149.96 27.77 Favored 'General case' 0 C--O 1.255 1.383 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.3 p -114.15 139.32 49.44 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.3 mp -117.67 115.89 25.96 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 51.4 m -87.75 112.01 21.95 Favored 'General case' 0 N--CA 1.411 -2.41 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.207 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 54.89 70.88 1.46 Allowed Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 124.673 1.189 . . . . 0.0 112.548 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -94.21 -175.94 0.46 Allowed 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.501 2.134 . . . . 0.0 110.337 173.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.426 ' O ' HG23 ' A' ' 75' ' ' VAL . 10.3 t -100.16 163.4 12.43 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.31 97.36 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 123.199 0.599 . . . . 0.0 112.125 -175.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -60.82 -37.13 80.96 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.927 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -69.91 -41.11 75.11 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.833 -179.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 71' ' ' SER . 98.0 t -59.54 -42.3 87.59 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.562 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 177.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -61.25 -44.0 97.96 Favored 'General case' 0 CA--C 1.556 1.196 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.922 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.02 -24.28 58.34 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.141 0.496 . . . . 0.0 112.227 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.4 ' O ' ' HG2' ' A' ' 81' ' ' LYS . 74.1 mmtt -84.86 -25.15 28.22 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 174.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.538 HD13 HD21 ' A' ' 6' ' ' LEU . 24.4 tp -68.87 -40.73 79.14 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.3 m -61.78 -32.98 55.58 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.83 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.325 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 14.6 ptmm? -81.04 -30.34 34.87 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.651 -0.82 . . . . 0.0 111.077 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.9 pp -85.46 -32.06 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.204 -175.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.21 -61.86 1.32 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.378 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 83.06 21.5 58.97 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 -176.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 32.6 tp -99.99 -46.33 5.38 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 122.348 -0.501 . . . . 0.0 110.616 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -70.77 -43.66 68.32 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.7 m170 -167.23 178.95 5.32 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 126.362 1.865 . . . . 0.0 106.175 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 15.1 p80 . . . . . 0 C--N 1.302 -1.493 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 174.616 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.8 ttm . . . . . 0 N--CA 1.467 0.423 0 CA-C-O 121.248 0.546 . . . . 0.0 110.075 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.3 m -120.62 171.85 8.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 26.2 m -82.31 75.77 9.21 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.865 0.841 . . . . 0.0 110.536 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.54 86.56 5.25 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.89 1.19 57.34 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.848 -177.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -131.82 135.48 46.76 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.939 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.7 m -108.27 124.98 51.14 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 177.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 62.0 mt -113.33 134.56 55.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-O 121.348 0.594 . . . . 0.0 110.556 -176.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.449 ' CD1' HG22 ' A' ' 46' ' ' VAL . 97.3 m-85 -85.83 128.07 34.72 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.131 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.434 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 13.7 p -139.19 147.94 42.49 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -176.139 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.418 HG23 ' HG3' ' A' ' 37' ' ' GLU . 50.9 m -148.88 142.84 25.8 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 171.186 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.7 p -70.81 -4.39 23.85 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -172.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -39.23 94.1 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 122.553 1.168 . . . . 0.0 111.493 178.254 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.1 t -93.98 132.65 38.23 Favored 'General case' 0 N--CA 1.42 -1.942 0 CA-C-N 113.491 -1.686 . . . . 0.0 112.754 -169.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -92.74 -35.81 6.33 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.041 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -63.18 -36.35 83.33 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.442 0.639 . . . . 0.0 110.833 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.676 ' SG ' ' HB ' ' A' ' 56' ' ' VAL . 62.2 m -57.12 -42.05 80.16 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.257 177.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.3 tt -72.12 -30.21 64.84 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.189 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.3 tpp180 -62.9 -47.27 84.01 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.063 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.439 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 29.7 tp -73.48 -39.04 65.18 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.008 178.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -55.34 -47.45 75.68 Favored 'General case' 0 C--O 1.245 0.861 0 C-N-CA 124.05 0.94 . . . . 0.0 110.639 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 p -69.88 -35.06 74.36 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.573 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.32 -44.94 96.36 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 177.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 87.9 mt -63.71 -39.4 94.21 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.425 178.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.6 m -64.93 -43.55 92.4 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.222 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.2 -22.95 66.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.28 0.562 . . . . 0.0 110.91 178.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -95.34 11.41 32.76 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.34 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 65.97 16.09 10.33 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.834 1.254 . . . . 0.0 111.016 175.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 77.5 mt -78.81 122.64 34.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.654 -0.654 . . . . 0.0 109.262 -179.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.86 129.56 38.74 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.867 -178.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -142.89 161.13 38.91 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.527 -175.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -119.77 124.07 45.27 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 176.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 13.0 pt-20 -91.94 146.08 24.03 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -178.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 t -85.57 156.23 3.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.867 -175.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -83.0 0.3 45.36 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 127.101 2.16 . . . . 0.0 113.683 -176.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.6 pt -42.95 -29.91 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 -168.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.418 ' HG3' HG23 ' A' ' 11' ' ' THR . 40.8 tt0 -61.14 -33.76 73.92 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.509 0.671 . . . . 0.0 110.186 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -123.74 24.0 8.56 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.026 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -148.91 100.88 3.12 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.244 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -67.66 -21.03 65.38 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.73 -43.31 84.57 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -176.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.47 -20.74 31.24 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.932 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.9 -38.16 90.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.175 178.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -58.06 -39.84 79.48 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.364 174.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -68.83 -29.19 67.47 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.027 -175.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.449 HG22 ' CD1' ' A' ' 9' ' ' TYR . 58.2 t -63.2 -43.59 98.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 177.063 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.97 -18.88 77.99 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.469 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.7 t -82.43 -30.42 30.11 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 120.6 0.238 . . . . 0.0 110.398 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.7 m -81.75 -37.0 14.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.963 178.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -119.17 87.0 2.65 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 122.439 1.114 . . . . 0.0 109.075 172.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -49.51 118.37 5.37 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 113.293 -1.776 . . . . 0.0 115.566 -170.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.4 -20.72 49.34 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 121.366 -0.445 . . . . 0.0 114.117 175.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -126.74 171.44 11.19 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 117.71 0.755 . . . . 0.0 109.344 -177.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -122.32 70.28 0.98 Allowed 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 170.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.1 m -72.08 122.88 21.69 Favored 'General case' 0 C--O 1.248 1.02 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.676 ' HB ' ' SG ' ' A' ' 17' ' ' CYS . 9.4 t -69.36 -65.85 1.11 Allowed Pre-proline 0 CA--C 1.47 -2.126 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -170.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.652 ' HD3' ' SG ' ' A' ' 17' ' ' CYS . 43.9 Cg_endo -77.04 72.31 5.91 Favored 'Trans proline' 0 N--CA 1.403 -3.827 0 CA-C-N 121.755 1.662 . . . . 0.0 112.744 -167.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.424 ' O ' ' HD2' ' A' ' 9' ' ' TYR . 81.6 m -107.72 131.45 54.41 Favored 'General case' 1 N--CA 1.366 -4.637 0 CA-C-N 112.97 -1.923 . . . . 0.0 106.422 179.819 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.2 p -115.43 134.52 58.34 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.366 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.745 -178.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -112.65 119.28 37.56 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 175.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -88.66 159.44 17.84 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.95 -20.5 38.16 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.525 0.679 . . . . 0.0 111.289 177.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -67.68 -18.55 64.97 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.573 1.149 . . . . 0.0 111.22 177.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.95 -9.17 59.82 Favored Glycine 0 CA--C 1.503 -0.695 0 N-CA-C 111.466 -0.653 . . . . 0.0 111.466 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.8 p -81.07 136.03 35.9 Favored 'General case' 0 N--CA 1.412 -2.338 0 CA-C-N 114.948 -0.626 . . . . 0.0 111.088 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.2 p -114.04 137.93 51.06 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 177.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.3 mp -127.43 128.18 45.35 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 61.5 m -105.35 123.88 48.61 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 55.41 54.23 9.43 Favored Pre-proline 0 N--CA 1.477 0.917 0 C-N-CA 124.258 1.023 . . . . 0.0 113.117 -177.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -83.27 166.48 14.23 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.629 1.553 . . . . 0.0 111.235 178.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.4 m -87.38 155.55 19.98 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 175.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.29 -37.01 83.89 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.924 0.392 . . . . 0.0 111.328 -177.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -64.71 -34.88 79.36 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.885 178.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -67.04 -44.37 80.38 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.1 t -61.01 -45.48 98.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.835 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -58.37 -48.87 79.23 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.185 178.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.33 -22.35 62.81 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.89 0.376 . . . . 0.0 111.92 -178.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.486 ' O ' HG13 ' A' ' 82' ' ' ILE . 47.6 mmtm -80.89 -43.31 20.05 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 39.9 tp -54.3 -48.49 71.24 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.82 0.7 . . . . 0.0 110.475 -176.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.0 m -59.4 -41.31 84.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.135 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -81.36 -38.28 26.88 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -176.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 78' ' ' LYS 0.255 2.5 pp -81.44 -37.4 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -176.886 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.459 ' N ' HD12 ' A' ' 82' ' ' ILE . . . -83.81 -31.17 26.0 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.892 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.2 -50.38 3.96 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 116.287 -0.415 . . . . 0.0 113.929 174.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.414 ' O ' ' HG ' ' A' ' 85' ' ' LEU . 35.6 tp -84.73 27.32 0.75 Allowed 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.452 0.644 . . . . 0.0 111.848 -175.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.79 98.84 7.88 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 175.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 55.88 71.17 0.57 Allowed 'General case' 0 C--O 1.239 0.537 0 O-C-N 124.423 1.077 . . . . 0.0 108.806 -175.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 29.9 t60 . . . . . 0 C--N 1.305 -1.339 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.539 -173.438 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.778 0 CA-C-O 120.861 0.362 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.6 mt -111.54 129.23 56.12 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.975 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.2 m -103.56 107.95 19.01 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 173.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.53 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 57.8 mt -107.27 133.07 53.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 121.059 0.457 . . . . 0.0 109.775 -176.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.44 ' HD1' ' O ' ' A' ' 58' ' ' THR . 89.5 m-85 -87.16 128.18 35.13 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.464 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 21.1 p -140.29 163.93 31.45 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.581 0.229 . . . . 0.0 111.329 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.1 p -146.11 166.51 25.94 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 124.927 1.291 . . . . 0.0 107.795 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.0 t -74.78 -21.86 59.08 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 173.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -81.86 80.46 8.15 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 177.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.8 t -132.94 164.7 26.37 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.436 0.636 . . . . 0.0 112.439 -168.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -167.85 -81.34 0.05 OUTLIER Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 177.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.47 -31.75 68.11 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 123.891 0.876 . . . . 0.0 112.551 177.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.447 ' HA ' ' HB3' ' A' ' 57' ' ' PRO . 0.5 OUTLIER -64.49 -36.99 85.99 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.547 178.08 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 32.2 tp -68.04 -31.88 71.85 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.069 -176.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.9 mmp_? -58.28 -56.13 26.09 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.9 tp -65.09 -39.0 92.55 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.425 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -60.98 -35.94 78.13 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.76 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.9 m -70.51 -44.6 67.26 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.46 -46.33 89.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.898 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.7 mt -68.05 -37.48 81.38 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.4 m -67.12 -40.85 86.87 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 121.007 0.432 . . . . 0.0 110.179 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.65 -25.4 63.9 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.55 0.69 . . . . 0.0 110.94 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -88.25 6.9 34.69 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.983 178.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 72.9 mtm180 65.34 29.12 11.66 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.475 1.11 . . . . 0.0 111.924 176.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.457 HG23 HD22 ' A' ' 79' ' ' LEU . 80.2 mt -91.69 123.41 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.707 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.41 126.26 34.77 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.356 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -136.46 156.67 48.28 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.722 -177.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -118.6 114.85 23.42 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.53 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 16.4 pt-20 -91.12 144.82 25.23 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.217 0.532 . . . . 0.0 110.796 -177.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.6 t -89.53 152.86 3.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-O 122.07 0.938 . . . . 0.0 112.48 -172.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -82.76 2.27 34.75 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 127.944 2.498 . . . . 0.0 114.3 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.1 pt -41.56 -26.79 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.835 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 -167.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -61.83 -41.61 98.0 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.738 0.78 . . . . 0.0 109.131 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -100.66 -36.95 8.96 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.313 -178.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -90.92 99.85 12.81 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.26 -178.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -65.04 -38.37 90.64 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -171.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.56 -29.14 70.44 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -174.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.01 -23.42 25.0 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.382 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.67 -39.55 80.57 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.172 0.51 . . . . 0.0 110.117 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.468 ' CD ' HH22 ' A' ' 54' ' ' ARG . 19.2 mm-40 -67.02 -32.26 73.35 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.007 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -67.61 -30.14 69.66 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.756 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.7 t -62.38 -42.93 97.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 53' ' ' ASN . . . -60.55 -34.4 85.71 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.337 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.4 m -68.53 -48.13 65.13 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 122.872 0.469 . . . . 0.0 111.535 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.2 m -73.99 -27.6 22.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -176.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 53' ' ' ASN . 15.4 m120 -87.95 -28.74 21.28 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.128 177.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.15 65.27 1.07 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.364 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.79 -12.43 68.81 Favored Glycine 0 C--N 1.315 -0.609 0 C-N-CA 121.234 -0.507 . . . . 0.0 112.485 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.475 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 93.2 m-20 -111.91 161.38 16.47 Favored 'General case' 0 CA--C 1.486 -1.504 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.468 HH22 ' CD ' ' A' ' 44' ' ' GLU . 84.4 mtt180 -127.64 84.09 2.22 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 173.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.4 m -85.64 132.49 34.15 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.451 ' CG1' ' HA ' ' A' ' 10' ' ' THR . 21.3 t -66.42 -67.12 1.02 Allowed Pre-proline 0 CA--C 1.472 -2.057 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -173.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.447 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . 91.7 Cg_endo -81.15 60.47 7.82 Favored 'Trans proline' 1 N--CA 1.399 -4.073 0 CA-C-N 121.115 1.434 . . . . 0.0 112.915 -164.599 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.44 ' O ' ' HD1' ' A' ' 9' ' ' TYR . 53.6 m -91.23 127.08 36.52 Favored 'General case' 1 N--CA 1.377 -4.075 0 C-N-CA 126.363 1.865 . . . . 0.0 106.731 177.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.0 p -115.19 132.73 63.62 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 CA-C-O 120.916 0.389 . . . . 0.0 110.172 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -115.01 126.91 55.29 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 174.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -88.94 173.81 8.28 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.389 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.09 -10.17 47.22 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.978 0.894 . . . . 0.0 109.727 174.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -78.63 -18.64 54.17 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.271 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.02 -22.12 41.33 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.778 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.8 t -75.2 149.79 38.84 Favored 'General case' 0 C--O 1.253 1.284 0 CA-C-O 120.868 0.366 . . . . 0.0 110.61 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.2 p -114.5 139.73 49.31 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.069 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 58.1 mt -119.83 113.91 21.31 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 174.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.8 m -87.22 112.83 22.39 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 58.04 65.43 3.26 Favored Pre-proline 0 N--CA 1.487 1.42 0 C-N-CA 123.939 0.896 . . . . 0.0 112.366 -177.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -86.22 172.93 6.99 Favored 'Trans proline' 0 C--O 1.249 1.073 0 C-N-CA 121.955 1.77 . . . . 0.0 112.003 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.3 m -93.78 153.3 18.38 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 174.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.71 -36.23 83.17 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.111 0.481 . . . . 0.0 110.708 -177.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -59.31 -45.72 90.54 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.974 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -60.02 -50.53 73.36 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.871 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.9 t -58.21 -45.82 88.79 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.519 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.982 -177.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -67.15 -38.13 84.95 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.335 -178.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.55 -31.02 61.96 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.247 0.546 . . . . 0.0 110.869 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -76.59 -37.64 56.14 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.894 175.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.457 HD22 HG23 ' A' ' 29' ' ' ILE . 21.6 tp -58.38 -51.05 71.46 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.6 m -60.49 -32.12 50.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.669 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -81.8 -40.8 22.03 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 119.869 -0.732 . . . . 0.0 112.016 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.3 pp -76.1 -24.43 16.4 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.426 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -176.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -0.99 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 176.77 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.46 0 CA-C-O 121.279 0.561 . . . . 0.0 110.737 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.6 tp -129.51 136.74 50.23 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 89.6 m -123.34 122.16 37.62 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 67.4 mt -111.85 133.49 57.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 121.298 0.571 . . . . 0.0 110.205 -177.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -87.95 129.39 35.26 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.047 176.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.5 p -134.03 166.04 23.64 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.607 -178.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.3 m -149.84 144.08 25.75 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.5 m -54.98 -44.42 74.43 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 123.435 0.459 . . . . 0.0 110.887 176.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 36.5 p90 -86.75 89.17 7.86 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 122.09 0.948 . . . . 0.0 109.459 175.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.1 t -163.57 154.68 16.47 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.072 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -135.89 -44.73 0.1 OUTLIER Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 177.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -63.6 -33.48 75.71 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.131 0.572 . . . . 0.0 111.38 -176.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.445 ' HA ' ' HB3' ' A' ' 57' ' ' PRO . 10.7 p -65.41 -34.48 78.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.28 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 87.9 mt -61.85 -41.94 98.43 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 115.872 -0.603 . . . . 0.0 112.019 -175.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.5 tpm_? -59.11 -44.81 92.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.968 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.9 tp -76.37 -38.64 55.51 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.648 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.471 ' HG2' ' OH ' ' A' ' 31' ' ' TYR . 16.4 ttpp -63.14 -43.46 98.29 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.548 -176.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.2 t -71.12 -28.18 64.11 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.34 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.35 -41.87 84.42 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.107 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.446 HD22 HD12 ' A' ' 29' ' ' ILE . 92.7 mt -69.6 -35.22 75.11 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.76 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.6 m -65.95 -42.93 89.37 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.0 -31.67 72.39 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-O 121.416 0.626 . . . . 0.0 110.458 176.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.42 0.44 29.31 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.274 176.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 69.02 28.26 5.15 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.071 1.349 . . . . 0.0 112.176 174.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.446 HD12 HD22 ' A' ' 24' ' ' LEU . 74.7 mt -87.64 123.05 40.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.326 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.92 117.36 22.71 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.681 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.471 ' OH ' ' HG2' ' A' ' 21' ' ' LYS . 46.4 p90 -136.53 164.0 29.2 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -119.85 138.85 53.14 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 171.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 6.7 pt-20 -101.7 137.97 39.31 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -177.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -94.43 138.57 20.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -169.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -60.9 2.13 0.12 Allowed 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 130.186 3.394 . . . . 0.0 116.074 176.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.2 pt -41.3 -27.86 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.519 3.001 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 -162.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -68.97 -24.29 64.22 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 119.552 1.069 . . . . 0.0 110.856 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -113.02 8.63 18.49 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -142.85 89.98 2.17 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-O 121.471 0.653 . . . . 0.0 109.837 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.4 ' HA ' ' HB3' ' A' ' 43' ' ' ALA . 16.3 ptm180 -65.82 -29.23 69.67 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.731 -1.122 . . . . 0.0 113.7 -173.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.81 -37.32 76.12 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.348 0.594 . . . . 0.0 111.303 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.541 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -87.1 -30.38 21.15 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.129 177.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.4 ' HB3' ' HA ' ' A' ' 40' ' ' ARG . . . -64.67 -42.99 94.99 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.108 0.48 . . . . 0.0 111.508 -178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -68.91 -29.34 67.59 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.182 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -68.04 -40.64 82.84 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.265 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 42' ' ' ALA . 73.8 t -52.85 -51.04 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.568 177.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.47 -32.23 83.46 Favored Glycine 0 N--CA 1.437 -1.288 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.319 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.8 t -65.48 -33.73 76.61 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 122.272 0.229 . . . . 0.0 110.996 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.3 m -95.1 -10.0 9.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -178.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -96.29 -51.35 4.42 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.004 0.431 . . . . 0.0 110.018 177.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 133.13 -138.66 10.3 Favored Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 -176.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.99 -21.65 62.73 Favored Glycine 0 C--N 1.306 -1.111 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -101.53 115.07 29.69 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -71.54 114.75 9.95 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 177.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.1 m -99.02 134.5 41.77 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.0 t -75.3 -64.52 0.58 Allowed Pre-proline 0 CA--C 1.463 -2.379 0 CA-C-O 117.23 -1.367 . . . . 0.0 113.98 -176.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.445 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . 82.9 Cg_endo -78.78 65.9 8.7 Favored 'Trans proline' 1 N--CA 1.399 -4.076 0 CA-C-N 121.261 1.486 . . . . 0.0 113.029 -167.067 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 96.3 m -92.32 121.37 33.75 Favored 'General case' 1 N--CA 1.376 -4.169 0 CA-C-N 113.146 -1.843 . . . . 0.0 106.051 178.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 66' ' ' THR . 12.7 p -105.61 137.85 33.48 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.998 -178.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -116.44 121.04 40.72 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -85.31 161.64 19.43 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.928 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -49.69 -32.52 13.56 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -175.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -90.58 -6.75 54.28 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.5 -176.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.6 1.88 30.78 Favored Glycine 0 C--O 1.241 0.551 0 C-N-CA 120.113 -1.041 . . . . 0.0 113.773 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.5 m -73.33 125.49 27.94 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 117.294 0.547 . . . . 0.0 109.651 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 49.5 p -114.2 138.36 50.56 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.9 mp -122.59 118.53 28.42 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 61.2 m -88.05 112.31 22.5 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.11 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 58.86 67.67 1.94 Allowed Pre-proline 0 N--CA 1.482 1.148 0 C-N-CA 124.057 0.943 . . . . 0.0 112.883 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -86.79 -174.73 1.47 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.006 1.804 . . . . 0.0 112.227 176.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.424 ' O ' HG23 ' A' ' 75' ' ' VAL . 50.5 m -116.87 150.41 38.47 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 176.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.78 -48.93 72.07 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -174.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -71.9 -24.2 61.61 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 120.639 0.257 . . . . 0.0 111.665 -176.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.56 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 38.1 mm-40 -71.77 -46.6 57.85 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 173.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 71' ' ' SER . 89.1 t -59.98 -44.12 93.95 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 O-C-N 123.842 0.714 . . . . 0.0 110.113 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.421 ' HB3' ' HE2' ' A' ' 76' ' ' LYS . 33.1 ttpt -62.24 -44.46 96.51 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.652 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.72 -21.17 63.49 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.195 0.522 . . . . 0.0 111.538 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.606 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 46.8 mmtm -84.5 -38.92 19.49 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 175.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.9 tp -56.9 -49.01 76.86 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.767 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.1 m -61.33 -34.1 59.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.152 -177.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.606 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -81.76 -32.66 31.36 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.588 -179.079 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.2 pp -82.21 -12.52 12.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.136 0.493 . . . . 0.0 111.673 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.687 0 CA-C-O 121.394 0.616 . . . . 0.0 110.545 178.209 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.537 0 CA-C-O 121.116 0.484 . . . . 0.0 110.775 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.9 mt -119.83 137.99 53.65 Favored 'General case' 0 CA--C 1.489 -1.377 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.951 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.4 m -106.91 113.95 27.74 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 174.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.408 HG22 HG23 ' A' ' 10' ' ' THR . 51.9 mt -112.19 125.97 69.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-O 121.473 0.654 . . . . 0.0 110.094 -177.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -80.97 128.14 33.35 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.98 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.489 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 7.4 p -140.85 178.16 7.54 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.056 0.543 . . . . 0.0 111.747 -174.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.523 ' HB ' ' O ' ' A' ' 13' ' ' TRP . 27.4 m -156.42 158.81 37.96 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 177.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.7 m -64.8 -51.62 61.22 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 175.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.523 ' O ' ' HB ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -64.62 109.04 1.87 Allowed 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 168.068 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.0 t -159.44 130.6 6.04 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.465 -170.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -120.97 -78.56 0.51 Allowed Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -66.71 -33.88 76.63 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 120.915 0.388 . . . . 0.0 110.371 -177.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -57.56 -38.57 75.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.984 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -67.82 -35.09 77.99 Favored 'General case' 0 C--O 1.245 0.824 0 C-N-CA 123.675 0.79 . . . . 0.0 109.979 -175.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -62.29 -51.69 66.68 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.216 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.459 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 24.8 tp -68.26 -38.78 82.1 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.072 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -59.16 -43.91 92.09 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.616 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.2 m -68.7 -37.81 79.81 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.273 178.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.61 -42.17 98.25 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.875 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 78.6 mt -68.21 -39.53 82.37 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.623 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.5 m -65.35 -35.86 82.27 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-O 121.446 0.641 . . . . 0.0 109.987 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.2 -26.03 61.89 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-O 121.326 0.584 . . . . 0.0 111.19 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -93.25 11.52 27.76 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.877 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 64.93 25.2 12.75 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.275 1.03 . . . . 0.0 112.394 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 82.0 mt -89.95 116.13 30.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.47 128.82 36.01 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.003 -177.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -137.82 168.96 18.63 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.519 -177.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -119.71 121.54 39.45 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.489 ' HB2' ' OG1' ' A' ' 10' ' ' THR . 12.5 pt-20 -91.81 136.72 32.93 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-O 121.081 0.467 . . . . 0.0 110.408 -178.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.2 t -93.57 156.41 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 -168.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -77.09 -0.47 24.9 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 128.201 2.601 . . . . 0.0 113.866 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.3 pt -44.68 -21.37 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 N-CA-C 116.398 1.999 . . . . 0.0 116.398 -171.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -56.97 -52.65 64.38 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-N 118.834 0.743 . . . . 0.0 109.572 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -97.58 -36.86 10.16 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.136 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.452 ' ND2' ' H ' ' A' ' 42' ' ' ALA . 52.2 t30 -71.12 108.15 4.51 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 120.727 0.299 . . . . 0.0 111.013 -177.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.64 -22.14 57.07 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.316 -177.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.37 -44.95 67.03 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -177.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.452 ' H ' ' ND2' ' A' ' 39' ' ' ASN . . . -79.87 -24.85 40.94 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.01 177.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.68 -30.2 69.67 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.253 0.549 . . . . 0.0 109.756 177.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -68.77 -33.94 74.73 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.298 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -63.12 -44.1 96.57 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.6 t -60.76 -47.52 92.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.759 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.72 -21.61 69.32 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.545 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.6 m -83.21 -43.59 15.95 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 176.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.8 p -73.54 -33.14 38.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -176.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -118.63 154.75 32.16 Favored 'General case' 0 C--N 1.316 -0.849 0 O-C-N 121.893 -0.504 . . . . 0.0 109.948 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -113.25 156.09 15.85 Favored Glycine 0 N--CA 1.438 -1.212 0 C-N-CA 120.274 -0.965 . . . . 0.0 113.031 -175.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.14 -104.4 1.41 Allowed Glycine 0 N--CA 1.44 -1.085 0 O-C-N 123.866 0.392 . . . . 0.0 113.014 177.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -81.72 119.29 23.66 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -56.91 109.35 0.63 Allowed 'General case' 0 CA--C 1.516 -0.33 0 O-C-N 124.142 0.901 . . . . 0.0 109.348 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.6 m -81.27 123.65 28.67 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.6 t -75.19 -62.32 0.86 Allowed Pre-proline 0 CA--C 1.469 -2.154 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.087 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -79.16 73.41 6.04 Favored 'Trans proline' 1 N--CA 1.397 -4.176 0 CA-C-N 120.604 1.252 . . . . 0.0 112.609 -164.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.5 m -101.92 120.88 41.1 Favored 'General case' 1 N--CA 1.377 -4.116 0 CA-C-N 112.709 -2.041 . . . . 0.0 106.438 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.1 p -113.46 132.61 61.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-O 120.996 0.427 . . . . 0.0 110.882 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -110.22 126.1 53.78 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -92.08 174.07 7.51 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.432 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.25 -18.23 63.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.819 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -73.57 -18.03 61.12 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.19 0.519 . . . . 0.0 110.152 176.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.34 -12.85 64.95 Favored Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -176.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.2 p -75.28 145.71 41.64 Favored 'General case' 0 N--CA 1.421 -1.906 0 C-N-CA 123.211 0.605 . . . . 0.0 111.201 -178.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.6 p -114.1 139.16 49.55 Favored 'General case' 0 N--CA 1.419 -2.002 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.913 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.8 mp -117.05 123.87 47.88 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.2 m -100.82 112.62 25.08 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.894 -176.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 58.65 60.78 5.29 Favored Pre-proline 0 N--CA 1.492 1.668 0 C-N-CA 124.45 1.1 . . . . 0.0 112.906 -176.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -85.48 177.0 5.27 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.102 1.868 . . . . 0.0 111.696 176.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.402 ' O ' HG23 ' A' ' 75' ' ' VAL . 41.7 m -110.99 151.42 27.98 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 175.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.79 -34.77 63.11 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -174.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -64.01 -37.25 86.73 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 122.287 0.235 . . . . 0.0 111.192 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -73.53 -42.16 62.1 Favored 'General case' 0 CA--C 1.489 -1.38 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.618 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 71' ' ' SER . 54.5 t -60.44 -40.8 85.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.807 -176.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -66.48 -45.13 80.67 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.866 0.365 . . . . 0.0 110.789 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.9 -35.82 74.9 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.541 0.686 . . . . 0.0 111.4 -177.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -78.13 -22.39 48.91 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 122.064 -0.397 . . . . 0.0 110.304 177.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.436 ' O ' HG13 ' A' ' 82' ' ' ILE . 26.0 tp -71.66 -46.5 58.74 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.7 m -64.94 -28.78 45.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -75.8 -29.46 58.73 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.869 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 79' ' ' LEU . 2.1 pp -85.69 -16.62 9.88 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 CA-C-O 121.443 0.64 . . . . 0.0 111.382 -176.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.672 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.443 178.023 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.548 0 CA-C-O 121.006 0.431 . . . . 0.0 110.617 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.1 tp -117.94 136.86 53.22 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.309 -176.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.496 ' HB ' ' HB3' ' A' ' 60' ' ' LYS . 22.4 m -110.65 117.82 34.54 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 53.1 mt -119.98 143.53 31.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -98.64 127.76 44.68 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.43 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . 25.4 p -137.31 178.52 7.03 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 122.093 0.949 . . . . 0.0 113.459 -174.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.1 m -143.91 147.65 34.3 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 104.181 -2.526 . . . . 0.0 104.181 173.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.5 m -61.15 -43.2 99.25 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.352 0.596 . . . . 0.0 109.897 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 40.7 p90 -92.7 93.37 8.43 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-O 121.808 0.813 . . . . 0.0 111.177 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.9 t -163.3 117.31 1.61 Allowed 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.387 176.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.79 -32.16 13.64 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 111.219 -0.753 . . . . 0.0 111.219 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -68.96 -27.71 65.98 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.721 0.772 . . . . 0.0 109.666 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.435 ' SG ' ' HB ' ' A' ' 56' ' ' VAL . 70.5 m -71.77 -29.88 64.97 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.118 178.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 82.7 mt -70.43 -30.15 66.94 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.285 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -56.62 -44.16 80.94 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.247 177.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.422 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 28.7 tp -79.33 -41.09 28.71 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.623 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -56.76 -45.13 82.24 Favored 'General case' 0 C--O 1.247 0.941 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.6 m -64.04 -38.46 91.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.795 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.16 -44.08 80.65 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.421 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 57.3 mt -69.5 -42.31 74.93 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.445 -178.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.8 m -68.92 -23.51 64.18 Favored 'General case' 0 CA--C 1.56 1.352 0 CA-C-O 121.421 0.629 . . . . 0.0 110.651 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.87 -12.93 57.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.294 0.569 . . . . 0.0 110.482 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -109.39 14.17 23.78 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.27 -178.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.9 ttm180 55.14 62.07 2.65 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.403 1.081 . . . . 0.0 111.079 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.41 ' HB ' ' HB3' ' A' ' 24' ' ' LEU . 75.8 mt -122.78 115.88 47.18 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.046 178.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.17 111.97 22.21 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -116.38 144.59 44.08 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.577 -177.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -113.74 119.78 38.55 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 12.8 pt-20 -95.51 148.13 22.82 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.881 -176.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.434 ' CG1' HG23 ' A' ' 36' ' ' ILE . 25.1 t -96.69 144.88 9.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -172.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -58.63 -1.77 0.17 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 128.714 2.806 . . . . 0.0 114.05 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.434 HG23 ' CG1' ' A' ' 34' ' ' VAL . 2.0 pp -45.24 -20.96 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 -172.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -54.41 -48.84 71.16 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.137 0.494 . . . . 0.0 110.039 174.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -111.46 -29.67 7.69 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.795 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -77.67 103.25 7.5 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.55 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 8.7 ptm180 -71.88 -25.78 62.07 Favored 'General case' 0 C--O 1.21 -0.997 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.935 -178.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.56 -42.62 88.36 Favored 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 113.504 0.928 . . . . 0.0 113.504 -176.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.93 -21.0 26.54 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.694 -0.802 . . . . 0.0 109.956 177.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.429 ' HB3' ' HA ' ' A' ' 40' ' ' ARG . . . -68.4 -33.39 74.16 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.214 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.55 ' HG2' ' O ' ' A' ' 40' ' ' ARG . 61.4 mm-40 -61.56 -36.71 81.4 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.034 178.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -66.9 -37.11 83.76 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.119 0.485 . . . . 0.0 109.979 178.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.2 t -64.0 -42.6 96.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.607 0.718 . . . . 0.0 109.129 177.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.51 -18.96 72.33 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.348 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.3 m -81.42 -38.67 26.11 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.7 m -80.02 -35.11 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -83.65 137.1 33.95 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 176.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -98.89 139.15 14.29 Favored Glycine 0 C--N 1.301 -1.382 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.128 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.53 -87.37 1.03 Allowed Glycine 0 C--N 1.313 -0.731 0 C-N-CA 121.186 -0.53 . . . . 0.0 111.827 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -119.18 145.39 46.05 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -60.95 130.98 49.14 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.664 0.603 . . . . 0.0 111.064 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.7 m -108.55 127.68 54.16 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 177.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.435 ' HB ' ' SG ' ' A' ' 17' ' ' CYS . 8.1 t -73.75 -64.86 0.7 Allowed Pre-proline 0 CA--C 1.468 -2.178 0 CA-C-O 117.091 -1.433 . . . . 0.0 114.245 -171.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -73.75 80.57 2.03 Favored 'Trans proline' 1 N--CA 1.4 -4.018 0 CA-C-N 121.089 1.425 . . . . 0.0 112.65 -168.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 86.8 m -115.02 131.74 56.83 Favored 'General case' 0 N--CA 1.389 -3.503 0 CA-C-N 113.355 -1.748 . . . . 0.0 106.644 -177.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.69 142.91 29.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-O 120.844 0.354 . . . . 0.0 110.909 -175.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.496 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 77.5 tttt -116.28 130.7 56.91 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 177.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -104.58 177.86 4.73 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.02 -14.15 52.02 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.471 0.653 . . . . 0.0 110.543 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -67.32 -19.39 65.45 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.208 1.003 . . . . 0.0 110.33 176.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 92.71 -22.4 33.79 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.9 -0.591 . . . . 0.0 113.061 177.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.4 t -91.57 165.34 13.39 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.1 p -114.52 140.54 48.66 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.208 -177.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.9 mp -107.97 121.98 45.89 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 174.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.8 m -98.48 114.55 26.99 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.226 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.3 m120 61.21 61.82 2.83 Favored Pre-proline 0 N--CA 1.481 1.094 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -178.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -91.35 174.04 2.58 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.17 1.913 . . . . 0.0 110.369 176.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.441 ' O ' HG23 ' A' ' 75' ' ' VAL . 6.2 m -89.6 151.29 21.99 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 176.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.63 -37.95 80.01 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 123.186 0.304 . . . . 0.0 110.756 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -57.47 -43.62 84.17 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.108 177.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.53 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 47.3 mt-10 -68.38 -44.76 74.43 Favored 'General case' 0 C--O 1.207 -1.145 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.972 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 71' ' ' SER . 59.5 t -60.16 -43.14 92.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 O-C-N 123.252 0.345 . . . . 0.0 110.531 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -64.21 -44.71 91.09 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.27 -34.99 78.58 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.081 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.53 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 75.5 mmtt -75.07 -36.82 61.74 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 176.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 14.5 tp -61.62 -52.35 64.73 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.5 m -61.93 -35.54 68.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.7 ptpp? -72.87 -34.1 66.51 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.304 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.1 pp -83.89 -29.71 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.056 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.55 0 CA-C-O 120.803 0.335 . . . . 0.0 110.591 178.507 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.87 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.537 HD11 HD21 ' A' ' 79' ' ' LEU . 8.6 mp -109.48 141.23 42.2 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.558 0.694 . . . . 0.0 111.901 -177.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.4 ' HB ' ' HB3' ' A' ' 60' ' ' LYS . 28.7 m -125.82 108.32 11.36 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 105.707 -1.961 . . . . 0.0 105.707 171.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.559 HG22 HG23 ' A' ' 10' ' ' THR . 62.4 mt -108.89 135.23 48.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 CA-C-O 121.943 0.878 . . . . 0.0 111.445 -173.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.43 ' CD1' HG22 ' A' ' 46' ' ' VAL . 98.9 m-85 -90.22 111.32 22.45 Favored 'General case' 0 C--N 1.28 -2.431 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.453 178.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.559 HG23 HG22 ' A' ' 8' ' ' ILE . 6.9 p -137.31 144.33 42.56 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.169 0.509 . . . . 0.0 112.215 -178.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.6 p -130.79 165.38 23.08 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 174.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.9 p -86.73 0.23 55.08 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 121.373 0.606 . . . . 0.0 110.723 176.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 10.6 m0 -83.0 12.84 4.47 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.518 -173.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.583 ' SG ' HG21 ' A' ' 56' ' ' VAL . 6.7 p -146.26 171.8 14.43 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 122.05 -0.406 . . . . 0.0 111.402 -177.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -116.39 -36.63 1.08 Allowed Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 176.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -64.69 -23.4 67.24 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 121.207 0.527 . . . . 0.0 112.068 -177.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.9 p -70.48 -43.1 70.45 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.154 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.1 mp -64.61 -31.43 72.64 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.924 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -61.06 -52.07 66.5 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.485 0.491 . . . . 0.0 110.673 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.4 tp -68.35 -41.92 80.01 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.987 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -56.78 -50.04 73.49 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.691 -177.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.5 p -68.1 -34.2 75.95 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.54 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.9 -48.77 78.99 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.215 178.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.6 mt -63.89 -37.0 85.77 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.325 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 58.0 m -59.53 -48.81 80.2 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.813 177.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.84 -34.66 77.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.883 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -81.93 5.15 19.96 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -177.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 70.07 24.55 4.99 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.046 0.938 . . . . 0.0 113.121 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.7 mt -93.94 115.49 32.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.68 144.87 37.0 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.95 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -159.71 145.09 15.54 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.837 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -102.39 133.4 47.39 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 175.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 12.7 pt-20 -94.13 142.37 27.48 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.415 HG21 ' CE1' ' A' ' 9' ' ' TYR . 13.6 t -87.83 144.69 8.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 121.717 0.77 . . . . 0.0 112.181 -175.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -65.17 -1.84 2.51 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 127.76 2.424 . . . . 0.0 113.91 -176.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.2 pt -44.3 -23.78 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.564 0 N-CA-C 116.334 1.975 . . . . 0.0 116.334 -172.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -65.51 -25.43 67.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.573 0.701 . . . . 0.0 109.262 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 43.4 m-70 -112.32 -46.74 3.15 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.199 -0.909 . . . . 0.0 108.906 175.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.538 ' ND2' ' H ' ' A' ' 42' ' ' ALA . 56.9 t30 -70.18 111.11 5.58 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.948 -176.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.1 ptp180 -73.53 -24.83 60.19 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.063 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.41 -54.6 13.56 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -175.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.538 ' H ' ' ND2' ' A' ' 39' ' ' ASN . . . -72.75 -20.97 61.09 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.647 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.03 93.45 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.182 0.515 . . . . 0.0 110.925 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -72.95 -29.97 63.49 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.162 0.506 . . . . 0.0 110.414 177.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -68.1 -33.07 73.83 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.752 177.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 42' ' ' ALA . 76.7 t -55.49 -56.2 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.498 175.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.41 -33.99 78.76 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.088 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.3 m -65.82 -42.83 90.09 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 122.862 0.465 . . . . 0.0 112.087 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.8 m -80.92 -19.54 11.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.873 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -77.82 -50.17 12.83 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 175.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.55 -104.91 0.28 Allowed Glycine 0 N--CA 1.431 -1.652 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -103.74 -37.02 3.09 Favored Glycine 0 C--N 1.307 -1.057 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -104.98 148.13 27.05 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -78.92 135.98 37.13 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.2 m -118.33 153.79 33.41 Favored 'General case' 0 C--N 1.268 -2.957 0 N-CA-C 103.73 -2.693 . . . . 0.0 103.73 174.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.583 HG21 ' SG ' ' A' ' 14' ' ' CYS 0.267 21.9 t -86.86 -72.35 0.07 OUTLIER Pre-proline 0 CA--C 1.456 -2.642 0 C-N-CA 116.136 -2.226 . . . . 0.0 114.506 -178.59 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.96 88.73 1.21 Allowed 'Trans proline' 1 N--CA 1.39 -4.575 0 CA-C-N 120.577 1.242 . . . . 0.0 112.498 -162.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.4 m -119.98 130.74 54.9 Favored 'General case' 0 N--CA 1.385 -3.698 0 CA-C-N 113.27 -1.786 . . . . 0.0 106.841 -174.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.1 p -116.45 132.67 65.38 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-O 121.15 0.5 . . . . 0.0 110.856 -176.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.4 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 62.9 tttm -107.04 116.79 32.55 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 174.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -87.66 155.18 20.06 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.189 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.16 -21.37 61.57 Favored 'General case' 0 C--O 1.22 -0.494 0 C-N-CA 123.481 0.712 . . . . 0.0 111.57 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -72.71 -14.33 61.54 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.507 0.67 . . . . 0.0 110.145 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.81 -20.43 26.88 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.901 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.8 m -71.36 140.1 50.07 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 122.687 0.395 . . . . 0.0 111.661 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.9 p -114.21 137.79 51.3 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 173.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mp -128.43 123.21 33.17 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 120.76 0.314 . . . . 0.0 110.4 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 87.6 m -97.15 119.14 35.1 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.231 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 57.77 67.78 2.2 Favored Pre-proline 0 N--CA 1.484 1.237 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -96.56 169.52 1.03 Allowed 'Trans proline' 0 CA--C 1.546 1.124 0 C-N-CA 122.324 2.016 . . . . 0.0 111.148 171.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.0 m -93.29 155.38 17.45 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 173.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.29 -36.43 71.04 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 122.91 0.484 . . . . 0.0 111.704 -178.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -69.18 -35.7 76.57 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.502 0.668 . . . . 0.0 110.839 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.03 -36.56 82.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.268 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.9 t -66.26 -46.75 86.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.038 177.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -53.72 -42.33 67.95 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.22 0.608 . . . . 0.0 112.027 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.34 -20.3 65.57 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.131 0.491 . . . . 0.0 111.394 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.597 ' O ' HG13 ' A' ' 82' ' ' ILE . 34.4 mmtp -84.59 -39.49 18.65 Favored 'General case' 0 N--CA 1.436 -1.168 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.116 175.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.537 HD21 HD11 ' A' ' 6' ' ' LEU . 4.5 mm? -56.82 -41.19 77.37 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.5 m -63.38 -40.5 89.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.304 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 22.2 ptmt -83.03 -54.6 4.94 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.597 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.1 pp -68.52 -17.12 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -170.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -0.986 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.145 177.843 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.668 0 CA-C-O 121.086 0.469 . . . . 0.0 111.457 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.444 ' HB2' ' CG2' ' A' ' 59' ' ' VAL . 0.5 OUTLIER -130.56 123.96 30.75 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.542 0.687 . . . . 0.0 111.372 178.693 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.3 m -103.2 114.18 28.25 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.576 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 55.7 mt -103.58 136.98 33.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -177.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -91.5 118.21 30.38 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.556 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 29.3 p -128.19 -172.08 2.61 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 121.343 0.592 . . . . 0.0 111.894 -177.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 13' ' ' TRP . 38.7 m -155.81 146.12 21.72 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 177.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.1 m -56.36 -47.84 78.05 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.474 ' O ' ' HB ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -65.94 111.78 3.48 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 164.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 11' ' ' THR . 42.8 t -150.71 120.14 6.89 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.788 -174.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -113.99 -70.24 0.52 Allowed Glycine 0 N--CA 1.427 -1.9 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.236 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -73.91 -30.23 62.47 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 123.029 0.531 . . . . 0.0 111.083 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -63.34 -27.78 69.55 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -63.08 -35.66 80.99 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.458 0.703 . . . . 0.0 109.678 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -51.87 -45.47 64.11 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 124.774 1.23 . . . . 0.0 111.301 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.428 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 12.4 tp -84.19 -42.37 16.03 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.86 -177.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -52.84 -48.91 66.68 Favored 'General case' 0 C--O 1.246 0.916 0 C-N-CA 124.397 1.079 . . . . 0.0 112.522 -176.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.9 t -74.15 -28.48 61.33 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.515 -178.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.16 -42.49 84.21 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.325 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 59.7 mt -65.26 -44.04 89.38 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.403 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 44.3 m -59.88 -43.59 94.65 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.963 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.12 -10.37 59.55 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.948 0.404 . . . . 0.0 111.928 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -109.31 16.03 22.68 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.964 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 67.77 17.39 9.77 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.27 1.028 . . . . 0.0 112.624 177.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.6 mt -91.06 118.15 35.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.59 138.14 33.68 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -136.3 171.01 15.11 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.044 -177.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -128.45 117.89 22.15 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 175.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.576 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 13.8 pt-20 -95.03 135.2 36.86 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 120.866 0.365 . . . . 0.0 110.841 -178.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.7 t -85.05 140.09 16.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -171.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.418 ' OD2' ' HB2' ' A' ' 38' ' ' HIS . 14.5 t70 -58.67 0.39 0.08 Allowed 'General case' 0 CA--C 1.567 1.624 0 C-N-CA 129.508 3.123 . . . . 0.0 114.751 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.8 pt -43.59 -20.82 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 3.006 0 N-CA-C 116.971 2.212 . . . . 0.0 116.971 -168.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.42 ' HG3' ' CD2' ' A' ' 38' ' ' HIS . 13.2 pt-20 -73.18 -23.61 60.44 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 119.176 0.898 . . . . 0.0 110.276 178.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . 0.42 ' CD2' ' HG3' ' A' ' 37' ' ' GLU . 67.2 m-70 -105.39 -47.32 3.98 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 174.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -78.19 99.64 6.31 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.734 -177.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -67.26 -30.21 70.04 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.553 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.9 -44.89 82.81 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.43 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -85.96 -23.34 26.96 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.419 178.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.36 -40.42 93.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.197 0.522 . . . . 0.0 110.222 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -65.46 -24.3 67.13 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.117 177.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -74.68 -38.16 62.48 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 176.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 42' ' ' ALA . 40.3 t -65.71 -41.88 91.37 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.447 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.826 178.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.78 -22.58 75.55 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.029 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -81.85 -41.86 20.43 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.6 p -76.55 -37.56 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 O-C-N 122.045 -0.409 . . . . 0.0 110.593 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -105.19 92.07 4.06 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 176.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -80.86 143.18 24.08 Favored Glycine 0 C--N 1.306 -1.12 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.494 -176.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.56 -62.88 2.68 Favored Glycine 0 N--CA 1.437 -1.29 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -126.11 145.92 50.15 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.6 ttp85 -88.31 89.06 7.84 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.0 m -65.58 133.46 51.23 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 176.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.4 t -77.01 -69.43 0.23 Allowed Pre-proline 0 CA--C 1.468 -2.187 0 C-N-CA 118.174 -1.411 . . . . 0.0 114.061 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.51 82.67 1.85 Allowed 'Trans proline' 0 N--CA 1.4 -3.992 0 CA-C-N 120.637 1.263 . . . . 0.0 112.969 -163.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 51.9 m -115.36 125.3 53.04 Favored 'General case' 0 N--CA 1.388 -3.53 0 CA-C-N 113.299 -1.773 . . . . 0.0 106.509 -176.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.444 ' CG2' ' HB2' ' A' ' 6' ' ' LEU . 7.2 p -118.3 137.17 53.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 CA-C-O 121.007 0.432 . . . . 0.0 111.181 -177.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -111.36 119.57 39.28 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 176.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -94.99 168.57 10.69 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.46 -10.98 20.0 Favored 'General case' 0 C--O 1.218 -0.57 0 O-C-N 123.738 0.649 . . . . 0.0 111.329 177.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -73.59 -18.31 61.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.794 0.807 . . . . 0.0 109.87 177.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.43 -15.12 63.88 Favored Glycine 0 CA--C 1.499 -0.917 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.236 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.5 m -83.41 151.69 25.37 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 p -113.6 139.31 49.12 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.6 tp -121.93 119.91 32.92 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -177.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.0 m -107.94 126.25 52.46 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 -174.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 54.03 60.04 11.48 Favored Pre-proline 0 N--CA 1.482 1.126 0 O-C-N 123.941 0.776 . . . . 0.0 112.315 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -90.08 178.44 2.23 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 121.856 1.704 . . . . 0.0 113.242 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.4 m -96.42 164.46 12.62 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 174.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.57 -39.34 94.14 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 120.958 0.409 . . . . 0.0 110.99 -178.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -64.42 -33.27 75.49 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.512 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -68.33 -39.09 82.05 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.048 0.451 . . . . 0.0 110.35 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.4 t -66.42 -44.91 90.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.899 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -60.49 -43.31 97.13 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.507 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.89 -36.8 84.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.714 0.293 . . . . 0.0 111.32 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.487 ' O ' HG13 ' A' ' 82' ' ' ILE . 14.4 mptt -70.96 -37.13 72.79 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.941 175.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 30.1 tp -62.06 -47.04 86.49 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.412 -178.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.8 m -66.07 -32.69 59.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -177.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.6 ptmt -77.29 -41.02 42.41 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.684 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.2 pp -74.41 -14.28 15.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.454 -0.498 . . . . 0.0 112.074 -177.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.881 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.66 176.083 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.705 0 CA-C-O 120.717 0.294 . . . . 0.0 111.386 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.635 HD23 ' H ' ' A' ' 6' ' ' LEU . 0.7 OUTLIER -68.58 120.65 14.95 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.849 0.833 . . . . 0.0 111.013 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.3 m -103.64 111.75 24.37 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 114.399 -1.273 . . . . 0.0 107.851 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 63.4 mt -102.79 139.04 24.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.303 0.573 . . . . 0.0 110.703 -174.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -92.04 122.8 34.88 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.523 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 27.3 p -138.57 177.22 8.04 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.533 0.682 . . . . 0.0 111.817 -177.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.5 m -148.08 156.16 42.29 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 174.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.5 m -69.22 -45.34 70.1 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -87.38 96.28 10.31 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-O 122.126 0.965 . . . . 0.0 109.906 175.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 32.7 t -163.56 152.17 13.84 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.415 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -119.93 -55.84 0.25 Allowed Glycine 0 N--CA 1.429 -1.831 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.226 178.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -68.39 -16.3 63.87 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -173.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.6 p -78.49 -24.88 45.68 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.211 0.529 . . . . 0.0 109.963 177.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 21' ' ' LYS . 28.7 tp -69.01 -21.75 64.12 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.991 -175.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -60.18 -60.71 3.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.165 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.1 tp -66.3 -42.74 87.86 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.492 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.423 ' HB3' ' HA ' ' A' ' 18' ' ' LEU . 63.8 tttp -54.72 -47.23 74.01 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.35 -178.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.5 p -71.12 -34.7 71.31 Favored 'General case' 0 C--O 1.244 0.778 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.654 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.38 -46.93 86.4 Favored 'General case' 0 CA--C 1.508 -0.657 0 C-N-CA 123.387 0.675 . . . . 0.0 110.66 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.9 mt -65.79 -37.88 87.49 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.902 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.3 m -65.24 -38.52 90.62 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.74 -26.94 62.67 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 111.02 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.17 2.8 48.81 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.308 178.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 61.67 30.52 18.55 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.54 1.136 . . . . 0.0 110.441 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 74.1 mt -86.86 115.41 27.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.666 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.48 100.65 3.31 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.509 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -113.61 163.94 14.31 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.412 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -130.5 130.1 43.74 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 175.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.523 ' HB2' ' OG1' ' A' ' 10' ' ' THR . 11.6 pt-20 -99.79 140.92 33.29 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.025 0.441 . . . . 0.0 111.14 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.2 t -78.07 146.79 7.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-O 121.86 0.838 . . . . 0.0 113.1 -172.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -66.85 -0.82 3.29 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 127.718 2.407 . . . . 0.0 114.371 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.5 pt -44.17 -22.58 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.514 2.737 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 -169.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -68.42 -31.43 70.75 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.796 0.808 . . . . 0.0 109.469 177.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 35.5 m-70 -103.17 -45.94 4.77 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.26 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.431 ' ND2' ' H ' ' A' ' 42' ' ' ALA . 37.8 t30 -86.91 115.11 24.09 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.87 -175.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -72.7 -29.68 63.58 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.097 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.38 -41.16 93.22 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -173.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.431 ' H ' ' ND2' ' A' ' 39' ' ' ASN . . . -87.35 -21.77 25.48 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.638 177.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.65 -39.59 84.58 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.309 0.576 . . . . 0.0 110.616 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -75.08 -21.38 59.0 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.334 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -69.45 -31.95 70.58 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 176.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.3 t -59.36 -42.73 88.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.38 -35.2 87.02 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.356 178.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.8 t -66.77 -50.07 63.87 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 122.503 0.321 . . . . 0.0 110.66 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.9 p -76.91 -28.12 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.181 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -174.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -98.66 1.89 46.67 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 121.698 -0.627 . . . . 0.0 112.266 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.52 60.22 4.82 Favored Glycine 0 C--N 1.322 -0.233 0 N-CA-C 114.395 0.518 . . . . 0.0 114.395 174.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.07 -46.63 3.43 Favored Glycine 0 C--N 1.31 -0.892 0 C-N-CA 121.769 -0.253 . . . . 0.0 112.615 176.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -77.42 122.34 25.04 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.9 mtm180 -93.75 79.95 4.22 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.774 0.797 . . . . 0.0 112.182 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.7 m -73.17 128.36 35.27 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 173.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.4 t -69.4 -66.71 0.87 Allowed Pre-proline 0 CA--C 1.473 -1.989 0 N-CA-C 114.703 1.372 . . . . 0.0 114.703 -173.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.62 76.77 4.13 Favored 'Trans proline' 0 N--CA 1.4 -3.985 0 CA-C-N 120.381 1.172 . . . . 0.0 112.578 -163.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 91.5 m -107.62 140.27 40.88 Favored 'General case' 0 N--CA 1.388 -3.565 0 CA-C-N 113.486 -1.688 . . . . 0.0 107.571 -176.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.2 p -122.68 132.83 70.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-O 121.318 0.58 . . . . 0.0 111.218 -176.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -110.21 120.31 42.04 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.498 176.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.453 ' CD1' HG12 ' A' ' 82' ' ' ILE . 90.1 m-85 -95.12 171.79 8.52 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.738 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.46 -24.0 61.13 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -173.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -89.87 -7.28 54.62 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 120.708 0.289 . . . . 0.0 111.34 -174.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.54 -5.72 31.41 Favored Glycine 0 N--CA 1.437 -1.237 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.268 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.3 m -75.98 125.91 30.01 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 121.18 0.514 . . . . 0.0 110.17 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.6 p -117.21 138.29 51.79 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.2 mp -130.91 146.31 52.29 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.1 m -116.0 112.64 22.1 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 64.2 t30 47.33 70.88 1.81 Allowed Pre-proline 0 N--CA 1.484 1.274 0 C-N-CA 124.713 1.205 . . . . 0.0 113.835 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -100.01 -175.52 0.15 Allowed 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.013 2.475 . . . . 0.0 111.968 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.6 t -82.31 154.1 25.48 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.48 -34.76 78.47 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 123.713 0.805 . . . . 0.0 109.958 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -63.5 -44.09 95.35 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.881 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.585 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 45.5 mm-40 -57.83 -47.36 82.89 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.392 176.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.6 t -57.73 -44.02 85.01 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.764 0 O-C-N 123.994 0.809 . . . . 0.0 111.502 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 66.1 tttp -62.87 -45.3 93.21 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.23 -21.84 59.61 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.054 0.454 . . . . 0.0 111.568 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.585 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 49.2 mmtm -81.93 -34.49 29.83 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 174.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.0 tp -57.39 -49.04 77.47 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.424 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.8 m -60.59 -33.6 55.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.505 -177.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 15.3 ptmm? -81.69 -38.71 25.41 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.476 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.453 HG12 ' CD1' ' A' ' 61' ' ' PHE . 2.4 pp -77.98 -32.15 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -175.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.852 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.7 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.399 0 CA-C-O 121.497 0.665 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.79 128.75 16.47 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.256 178.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 60' ' ' LYS . 23.4 m -103.07 120.02 39.92 Favored 'General case' 0 C--N 1.277 -2.576 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 176.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.3 mt -109.88 128.44 66.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 CA-C-O 121.06 0.457 . . . . 0.0 109.915 -176.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.463 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 98.3 m-85 -81.05 129.0 34.34 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.636 177.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.8 p -136.83 145.98 45.1 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -174.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 69.4 p -140.22 161.72 36.98 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 172.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.5 p -85.98 -0.39 55.37 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.303 0.573 . . . . 0.0 110.799 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 11.2 m0 -78.91 -30.93 45.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.356 -176.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.8 p -105.65 132.2 52.09 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.265 -175.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.22 -27.99 26.51 Favored Glycine 0 N--CA 1.436 -1.352 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.675 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -65.86 -35.87 81.86 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.592 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 61.1 m -56.5 -46.71 80.37 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.287 176.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.2 tt -66.75 -39.39 87.89 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.751 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.6 mtp180 -58.23 -54.63 44.84 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.484 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 20.7 tp -62.05 -40.13 94.71 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.524 0.678 . . . . 0.0 109.716 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 17' ' ' CYS . 60.5 tttm -57.2 -45.22 83.96 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.664 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.7 m -62.12 -43.59 98.49 Favored 'General case' 0 C--O 1.246 0.884 0 C-N-CA 123.719 0.808 . . . . 0.0 110.665 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.53 -48.21 82.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.04 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 72.4 mt -65.73 -35.64 81.32 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.995 -178.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.8 m -63.6 -45.99 87.83 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.83 -35.63 81.22 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.483 0.659 . . . . 0.0 110.843 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -84.46 21.03 1.54 Allowed 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.492 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 55.7 20.65 4.09 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 126.226 1.81 . . . . 0.0 113.782 175.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 71.4 mt -85.27 115.91 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.94 116.98 23.06 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.264 -177.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -127.75 159.54 34.47 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.215 -177.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -112.27 114.08 26.66 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 175.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -83.17 136.58 34.38 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.1 t -95.15 143.73 11.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 122.909 1.337 . . . . 0.0 113.233 -176.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.57 -0.57 6.92 Favored 'General case' 0 C--N 1.284 -2.283 0 C-N-CA 130.862 3.665 . . . . 0.0 115.118 177.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.471 HD13 HG21 ' A' ' 46' ' ' VAL . 12.7 pt -44.11 -26.42 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.843 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 -171.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -59.0 -36.3 74.68 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.12 0.486 . . . . 0.0 109.815 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 46.7 m-70 -93.15 -34.45 13.62 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.968 -175.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -116.36 113.58 23.12 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -176.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.482 ' HA ' ' HB3' ' A' ' 43' ' ' ALA . 3.8 ptp180 -62.86 -25.58 68.35 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 114.625 -1.171 . . . . 0.0 111.885 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.18 -41.49 71.96 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.238 0.542 . . . . 0.0 111.296 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.451 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -86.96 -30.33 21.37 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.047 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.482 ' HB3' ' HA ' ' A' ' 40' ' ' ARG . . . -65.31 -33.89 77.05 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.996 -178.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -67.53 -34.76 77.75 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.774 -0.194 . . . . 0.0 111.377 178.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -65.25 -37.69 88.0 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.471 HG21 HD13 ' A' ' 36' ' ' ILE . 60.1 t -59.99 -38.06 75.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.091 -0.958 . . . . 0.0 109.877 177.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.66 -49.22 44.82 Favored Glycine 0 N--CA 1.433 -1.55 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.9 m -60.31 -38.13 82.72 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.6 p -79.49 -9.37 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-O 121.531 0.682 . . . . 0.0 111.213 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -104.95 -67.82 0.89 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.145 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 137.67 -112.38 0.9 Allowed Glycine 0 N--CA 1.433 -1.554 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 -175.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.31 -48.33 5.11 Favored Glycine 0 C--N 1.306 -1.127 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.029 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -91.45 116.44 28.85 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -178.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -81.21 83.02 6.94 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.6 m -71.97 125.78 28.09 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.538 ' HB ' ' SG ' ' A' ' 17' ' ' CYS . 3.2 t -76.31 -56.16 1.59 Allowed Pre-proline 0 N--CA 1.435 -1.221 0 CA-C-O 117.323 -1.322 . . . . 0.0 113.55 -175.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.592 ' HD3' ' SG ' ' A' ' 17' ' ' CYS . 64.9 Cg_endo -73.64 44.24 0.89 Allowed 'Trans proline' 0 C--N 1.399 3.227 0 CA-C-N 121.472 1.562 . . . . 0.0 113.691 -170.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 84.1 m -80.57 117.66 21.47 Favored 'General case' 0 N--CA 1.387 -3.599 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.3 p -94.76 129.12 45.39 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.479 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 82.2 tttt -105.03 118.19 35.9 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -87.75 164.21 16.08 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 120.448 -0.501 . . . . 0.0 112.126 -177.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.04 -18.26 45.04 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 124.032 0.933 . . . . 0.0 112.956 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -78.31 -17.29 56.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.863 0.363 . . . . 0.0 110.286 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.02 -21.7 24.5 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 121.245 -0.502 . . . . 0.0 113.193 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.1 m -82.88 159.71 22.3 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.257 0.551 . . . . 0.0 110.522 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.3 p -114.0 171.39 7.62 Favored 'General case' 0 N--CA 1.418 -2.045 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.101 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.8 tp -145.0 109.7 5.0 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 176.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 89.1 m -86.11 122.7 30.49 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.965 -176.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 56.49 64.81 4.53 Favored Pre-proline 0 N--CA 1.482 1.15 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -90.71 -173.61 0.63 Allowed 'Trans proline' 0 N--CA 1.445 -1.38 0 C-N-CA 121.788 1.659 . . . . 0.0 112.653 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.414 ' H ' ' HB2' ' A' ' 74' ' ' GLU . 16.6 m -127.26 165.86 18.86 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 174.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.69 -45.95 67.05 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -64.38 -36.54 84.48 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.431 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.414 ' HB2' ' H ' ' A' ' 71' ' ' SER . 67.0 mm-40 -63.71 -42.51 97.94 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.194 0.521 . . . . 0.0 110.88 177.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.1 t -67.21 -48.8 77.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.192 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -61.57 -31.05 71.08 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.118 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.2 -25.54 63.46 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.431 ' O ' HG13 ' A' ' 82' ' ' ILE . 10.1 mmmm -84.7 -37.22 21.2 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 172.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.8 tp -55.07 -49.63 71.17 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 124.165 0.916 . . . . 0.0 110.171 -177.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.3 m -58.6 -35.53 55.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -178.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.76 -42.53 19.65 Favored 'General case' 0 N--CA 1.427 -1.578 0 C-N-CA 119.071 -1.051 . . . . 0.0 111.804 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.4 pp -76.41 -22.16 15.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -174.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.474 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.985 179.331 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.23 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 62.1 mt -113.97 122.53 47.23 Favored 'General case' 0 CA--C 1.496 -1.101 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.712 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.1 m -103.14 108.54 19.77 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 173.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.476 HG22 HG23 ' A' ' 10' ' ' THR . 55.4 mt -108.42 133.35 53.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-O 121.78 0.8 . . . . 0.0 111.605 -175.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -95.38 107.36 19.49 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.067 -0.969 . . . . 0.0 108.662 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.476 HG23 HG22 ' A' ' 8' ' ' ILE . 4.0 p -135.28 158.96 43.05 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 122.677 0.391 . . . . 0.0 111.897 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.6 p -134.77 174.61 10.39 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 176.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.1 t -86.72 -5.61 59.07 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 19.6 m0 -75.83 -32.61 59.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.093 -175.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.8 p -91.54 165.99 13.07 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 120.738 0.304 . . . . 0.0 111.628 -175.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -113.45 -42.83 0.86 Allowed Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 111.366 -0.693 . . . . 0.0 111.366 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -63.45 -25.77 68.42 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -178.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.493 ' SG ' HD12 ' A' ' 18' ' ' LEU . 1.6 p -56.32 -41.36 75.91 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.677 0.275 . . . . 0.0 111.04 176.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.511 ' HA ' ' HD3' ' A' ' 21' ' ' LYS . 6.3 mp -73.31 -24.96 60.47 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.65 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -71.76 -34.72 69.71 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.8 tp -75.74 -38.36 58.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.084 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.511 ' HD3' ' HA ' ' A' ' 18' ' ' LEU . 27.4 mtpp -55.75 -45.72 77.98 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.706 177.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 p -65.94 -40.2 91.14 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 111.541 0.2 . . . . 0.0 111.541 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.26 -49.53 76.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.674 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.5 mt -64.91 -41.68 95.37 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.754 0.311 . . . . 0.0 111.283 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 68.0 m -67.29 -38.29 84.78 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.198 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.84 -26.37 64.19 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.36 0.6 . . . . 0.0 110.66 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -94.07 10.77 32.33 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.066 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 59.15 30.86 20.73 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.04 1.336 . . . . 0.0 112.719 175.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.6 mt -89.26 123.87 41.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.73 129.93 34.68 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.071 0.463 . . . . 0.0 111.218 -176.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -144.08 157.62 44.21 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.651 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -127.96 124.03 36.28 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 11.7 pt-20 -95.25 146.82 24.07 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.271 0.557 . . . . 0.0 111.764 -175.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -81.07 153.05 4.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.457 -175.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -74.87 0.19 16.42 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 127.903 2.481 . . . . 0.0 114.042 -175.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.7 pt -43.36 -23.71 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.378 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 -172.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -52.85 -39.24 62.39 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.649 0.78 . . . . 0.0 109.709 176.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -119.42 20.28 12.52 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.081 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.413 ' ND2' ' H ' ' A' ' 42' ' ' ALA . 49.5 t30 -139.42 106.89 5.55 Favored 'General case' 0 CA--C 1.492 -1.269 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.26 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -30.59 71.13 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.946 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.43 -38.57 84.76 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -173.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.413 ' H ' ' ND2' ' A' ' 39' ' ' ASN . . . -86.79 -20.73 27.17 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.816 177.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.15 -41.44 86.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.463 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -69.92 -21.91 63.25 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.539 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -68.16 -33.53 74.64 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 175.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.626 ' O ' ' HB2' ' A' ' 50' ' ' ASN . 81.6 t -59.3 -40.22 80.83 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.925 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.631 177.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.92 -32.68 77.82 Favored Glycine 0 C--N 1.332 0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.09 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.0 t -65.8 -29.96 70.53 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 123.147 0.579 . . . . 0.0 110.265 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.4 m -108.1 17.2 6.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 120.887 0.375 . . . . 0.0 110.572 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.626 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 1.7 t-20 -116.49 -174.16 2.51 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -176.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -107.82 75.71 0.22 Allowed Glycine 0 N--CA 1.436 -1.343 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.064 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.01 -93.65 1.31 Allowed Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 -78.62 136.31 37.46 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -64.91 101.4 0.49 Allowed 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -178.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.9 m -83.0 153.35 25.01 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 102.984 -2.969 . . . . 0.0 102.984 169.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 0.442 3.8 t -86.95 -93.75 0.0 OUTLIER Pre-proline 0 CA--C 1.487 -1.472 0 C-N-CA 114.643 -2.823 . . . . 0.0 117.23 -174.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -47.51 93.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.386 2.538 0 N-CA-C 114.551 0.943 . . . . 0.0 114.551 -148.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.31 109.91 21.37 Favored 'General case' 0 N--CA 1.405 -2.705 0 CA-C-N 113.778 -1.555 . . . . 0.0 109.904 -173.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.3 p -102.58 126.46 56.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -104.8 127.41 52.59 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.626 ' HB3' HG21 ' A' ' 82' ' ' ILE . 95.8 m-85 -103.25 170.84 7.71 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.972 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.664 ' HB3' ' HB ' ' A' ' 82' ' ' ILE . . . -65.17 -13.89 59.27 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 -173.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -78.69 -13.09 60.0 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 121.478 0.656 . . . . 0.0 109.627 175.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.54 -1.54 64.15 Favored Glycine 0 N--CA 1.436 -1.319 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -174.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.3 m -67.62 133.5 49.49 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 123.787 0.835 . . . . 0.0 108.96 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.8 m -121.43 137.53 54.67 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 176.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.2 mp -120.06 119.38 33.19 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 120.687 0.28 . . . . 0.0 111.279 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.5 m -92.66 116.55 29.11 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 61.7 69.66 0.97 Allowed Pre-proline 0 CA--C 1.557 1.25 0 C-N-CA 123.643 0.777 . . . . 0.0 111.49 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -94.48 -167.02 0.14 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.444 2.096 . . . . 0.0 112.258 176.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.403 ' O ' HG23 ' A' ' 75' ' ' VAL . 13.5 m -116.08 150.52 37.2 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 176.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.08 -40.43 76.94 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.775 0.43 . . . . 0.0 111.734 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -64.42 -37.76 88.64 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.947 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -62.18 -48.06 81.75 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.906 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 71' ' ' SER . 95.9 t -58.39 -42.3 83.73 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.922 0 O-C-N 124.013 0.821 . . . . 0.0 110.834 -178.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.408 ' O ' ' HD3' ' A' ' 76' ' ' LYS . 2.7 tmtp? -67.76 -40.38 84.09 Favored 'General case' 0 CA--C 1.559 1.315 0 CA-C-O 120.722 0.296 . . . . 0.0 110.52 -178.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.45 -29.84 59.79 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.171 0.51 . . . . 0.0 111.024 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -77.21 -31.09 55.03 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 20.4 tp -58.92 -50.96 72.08 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.984 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 27.5 m -60.57 -39.42 81.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -176.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? -73.31 -32.33 64.54 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.481 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.664 ' HB ' ' HB3' ' A' ' 62' ' ' ALA . 2.0 pp -83.5 -11.91 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-O 121.39 0.614 . . . . 0.0 111.871 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.953 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.529 174.607 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 121.364 0.602 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.2 tp -142.19 114.71 8.45 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -178.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' A' ' 60' ' ' LYS . 40.9 m -107.06 127.74 53.75 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 71.4 mt -118.88 135.79 58.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-O 121.207 0.527 . . . . 0.0 110.389 -177.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.407 ' O ' HG12 ' A' ' 56' ' ' VAL . 92.8 m-85 -88.13 127.8 35.43 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.742 177.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.2 p -134.29 151.82 51.47 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -175.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.0 p -140.15 163.5 32.56 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 175.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.2 m -77.7 -8.21 57.61 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.238 0.542 . . . . 0.0 110.395 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 2.7 m0 -89.8 -25.88 20.86 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.922 0.868 . . . . 0.0 110.246 -176.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.6 t -91.98 118.42 30.75 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.876 -168.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -92.18 -32.54 8.27 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -68.98 -18.25 64.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.058 0.456 . . . . 0.0 112.161 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.632 ' SG ' ' HB ' ' A' ' 56' ' ' VAL . 72.4 m -68.85 -38.67 79.92 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.667 0.746 . . . . 0.0 109.178 174.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.3 tt -68.31 -30.0 68.89 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.775 -178.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -61.65 -41.5 97.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.77 176.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.477 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 17.6 tp -74.51 -39.91 62.12 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.494 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -56.36 -51.61 67.63 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.146 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.4 p -61.08 -42.44 98.51 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.999 0.428 . . . . 0.0 110.84 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.63 -49.54 77.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.993 178.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.484 HD22 HD12 ' A' ' 29' ' ' ILE . 51.8 mt -67.56 -36.77 81.58 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.392 -178.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.7 m -66.91 -41.8 86.5 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 121.207 0.527 . . . . 0.0 110.248 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.0 -7.42 53.61 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.195 0.521 . . . . 0.0 111.889 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -107.75 8.21 28.75 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 123.073 0.549 . . . . 0.0 110.867 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 57.61 62.85 1.99 Allowed 'General case' 0 C--O 1.243 0.724 0 C-N-CA 125.299 1.44 . . . . 0.0 112.219 -177.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.484 HD12 HD22 ' A' ' 24' ' ' LEU . 76.3 mt -121.58 117.41 52.5 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.689 176.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.82 121.88 30.78 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -135.23 156.01 49.7 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.853 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -116.2 132.79 56.56 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 175.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 8.8 pt-20 -96.01 151.05 19.8 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.417 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.6 t -94.76 145.36 8.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.875 0.845 . . . . 0.0 112.921 -173.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.411 ' OD2' ' HB2' ' A' ' 39' ' ' ASN . 28.6 t70 -62.51 -1.49 0.81 Allowed 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 128.352 2.661 . . . . 0.0 114.036 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.423 HG22 ' HB3' ' A' ' 42' ' ' ALA . 26.1 pt -45.2 -21.04 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 N-CA-C 115.759 1.762 . . . . 0.0 115.759 -173.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -56.38 -29.02 60.95 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.003 0.43 . . . . 0.0 110.862 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 46.4 t60 -127.94 -23.7 3.31 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.175 0.512 . . . . 0.0 110.285 173.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.411 ' HB2' ' OD2' ' A' ' 35' ' ' ASP . 8.4 t30 -87.71 87.11 7.28 Favored 'General case' 0 C--O 1.244 0.774 0 O-C-N 121.488 -0.758 . . . . 0.0 109.683 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -67.16 -23.87 65.83 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -174.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.75 -34.78 73.41 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.598 0.713 . . . . 0.0 110.963 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.423 ' HB3' HG22 ' A' ' 36' ' ' ILE . . . -87.09 -20.66 26.8 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.362 0.601 . . . . 0.0 109.871 176.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.01 -34.59 64.21 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.592 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.79 -32.82 74.68 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.52 173.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 94.2 t80 -63.02 -42.46 99.81 Favored 'General case' 0 N--CA 1.461 0.095 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.1 t -57.0 -45.15 83.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.01 177.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 53' ' ' ASN . . . -66.69 -52.39 34.5 Favored Glycine 0 N--CA 1.432 -1.618 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.223 178.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.4 t -59.52 -39.36 83.6 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 123.472 0.709 . . . . 0.0 112.814 -175.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.0 p -70.1 -24.42 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 CA-C-O 121.132 0.492 . . . . 0.0 111.514 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -93.6 -27.58 16.52 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.146 0.498 . . . . 0.0 110.437 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 148.68 -63.1 0.42 Allowed Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 177.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -159.33 -34.19 0.02 OUTLIER Glycine 0 C--N 1.298 -1.565 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.402 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 29.3 p-10 -76.56 145.97 38.66 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.224 0.535 . . . . 0.0 110.748 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -89.66 86.33 6.68 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.659 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.8 m -78.9 117.19 19.75 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 172.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.632 ' HB ' ' SG ' ' A' ' 17' ' ' CYS . 2.3 t -76.01 -60.82 0.94 Allowed Pre-proline 0 C--N 1.308 -1.206 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 -167.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.53 ' HD3' ' SG ' ' A' ' 17' ' ' CYS . 67.8 Cg_endo -73.14 70.67 3.73 Favored 'Trans proline' 0 C--N 1.399 3.219 0 CA-C-N 121.963 1.737 . . . . 0.0 112.952 -171.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 69.2 m -108.29 119.19 38.77 Favored 'General case' 1 N--CA 1.377 -4.096 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.7 p -101.33 139.96 21.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.672 -175.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.417 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 66.2 tttm -108.89 111.79 23.67 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -88.53 177.69 6.72 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.238 -177.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.29 -12.0 59.01 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.44 177.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -65.51 -19.88 66.11 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.953 174.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.18 -12.22 65.1 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -176.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 61.6 p -94.78 166.53 11.94 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.6 p -114.28 140.14 48.85 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.134 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.5 tp -119.25 110.56 17.16 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.8 m -79.16 120.96 24.42 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.044 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 53.89 75.75 0.59 Allowed Pre-proline 0 N--CA 1.481 1.115 0 C-N-CA 124.843 1.257 . . . . 0.0 111.981 176.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -97.88 165.62 0.8 Allowed 'Trans proline' 0 N--CA 1.442 -1.519 0 C-N-CA 122.401 2.068 . . . . 0.0 111.915 178.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.456 ' O ' HG23 ' A' ' 75' ' ' VAL . 13.4 m -84.34 149.82 25.79 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.62 -41.41 94.76 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.07 0.462 . . . . 0.0 111.918 -175.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -63.48 -37.66 88.14 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.723 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -64.92 -42.99 94.25 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.271 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 71' ' ' SER . 63.2 t -62.49 -43.91 98.78 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.75 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.922 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.404 ' O ' HG13 ' A' ' 80' ' ' VAL . 23.2 tptm -62.65 -47.11 85.15 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.551 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.68 -29.09 68.28 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -178.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.496 ' O ' HG13 ' A' ' 82' ' ' ILE . 3.5 tmtp? -82.49 -37.06 25.86 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 19.2 tp -57.69 -49.74 75.52 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.105 0.479 . . . . 0.0 110.068 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 76' ' ' LYS . 33.7 m -61.02 -34.99 62.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.99 -176.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.1 ptpp? -80.55 -32.61 36.64 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.685 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.1 pp -85.29 -12.45 11.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.289 0.566 . . . . 0.0 111.854 -178.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.532 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.236 174.66 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.416 0 CA-C-O 121.363 0.601 . . . . 0.0 109.758 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.1 tp -125.83 137.81 53.78 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -178.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.8 m -122.6 135.71 54.69 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.632 HG22 HG23 ' A' ' 10' ' ' THR . 58.7 mt -126.03 131.33 71.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.264 0.554 . . . . 0.0 109.884 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -91.94 90.29 7.37 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.028 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.632 HG23 HG22 ' A' ' 8' ' ' ILE . 3.7 p -127.62 160.54 31.29 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 123.006 0.523 . . . . 0.0 111.159 -177.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.5 p -115.48 166.63 11.68 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 171.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.8 t -71.87 -13.65 61.72 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-O 121.678 0.751 . . . . 0.0 109.093 172.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 2.2 m0 -90.2 75.74 6.94 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -175.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.2 t -158.52 159.87 36.05 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.675 -178.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.47 -43.9 0.26 Allowed Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -72.24 -26.98 62.23 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 70.0 m -54.88 -32.41 60.84 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 122.652 0.381 . . . . 0.0 111.409 -177.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 38.4 tp -55.02 -33.72 62.88 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.146 0.978 . . . . 0.0 111.943 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -59.72 -42.58 93.4 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.3 0.64 . . . . 0.0 109.442 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.5 tp -84.32 -38.71 20.05 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.437 -178.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -55.44 -48.84 73.84 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.444 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.9 p -68.18 -40.22 82.32 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.876 -178.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.529 ' HB1' ' HB2' ' A' ' 72' ' ' ALA . . . -59.68 -45.83 90.9 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.481 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.0 mt -69.66 -42.67 73.91 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.723 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 59.6 m -64.71 -35.57 81.47 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-O 120.878 0.37 . . . . 0.0 111.175 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.93 -26.56 62.34 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-O 121.463 0.649 . . . . 0.0 110.425 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -91.89 10.64 27.89 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.48 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 65.58 23.87 11.74 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.144 1.377 . . . . 0.0 111.282 175.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 80.0 mt -90.11 130.76 38.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -102.29 150.39 23.37 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -147.86 138.27 22.99 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.3 112.43 22.83 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 176.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -83.38 126.83 33.13 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.4 t -75.51 154.81 6.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-O 121.864 0.84 . . . . 0.0 112.559 -173.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -68.79 -0.52 5.51 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 126.394 1.878 . . . . 0.0 114.418 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.2 pt -44.44 -24.92 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 N-CA-C 117.265 2.32 . . . . 0.0 117.265 -170.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -67.73 -25.77 65.81 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 119.561 -0.855 . . . . 0.0 111.109 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 14.6 t60 -108.93 -43.79 4.13 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 176.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -79.43 102.98 9.03 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.336 -178.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.406 ' HA ' ' HB3' ' A' ' 43' ' ' ALA . 16.9 ptp180 -71.47 -23.41 61.82 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.77 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.39 -38.38 89.82 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.34 -20.99 25.97 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.975 176.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.406 ' HB3' ' HA ' ' A' ' 40' ' ' ARG . . . -66.88 -33.82 76.45 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.402 -178.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -70.81 -30.49 66.94 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.579 176.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -66.73 -32.96 74.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.172 0.51 . . . . 0.0 110.108 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 44.9 t -62.25 -32.51 55.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.392 177.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.55 -43.38 52.98 Favored Glycine 0 N--CA 1.44 -1.079 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 177.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.7 m -58.18 -40.42 81.44 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.497 0.719 . . . . 0.0 112.174 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.3 m -79.72 -7.58 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -107.75 -53.6 2.6 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.856 -0.337 . . . . 0.0 111.619 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 138.52 -87.51 0.21 Allowed Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.193 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -103.14 -42.7 2.02 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.339 -177.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -124.33 149.35 46.68 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.078 0.466 . . . . 0.0 110.72 -177.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.1 mtm180 -80.79 97.44 7.34 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.45 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.7 m -75.8 127.45 33.04 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 175.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 1.564 18.9 m -59.35 -71.02 0.34 Allowed Pre-proline 0 CA--C 1.45 -2.883 1 N-CA-C 124.52 5.007 . . . . 0.0 124.52 -177.329 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.67 79.36 3.38 Favored 'Trans proline' 0 N--CA 1.401 -3.966 0 CA-C-N 122.617 1.97 . . . . 0.0 113.188 -170.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.4 m -108.14 120.97 43.85 Favored 'General case' 0 N--CA 1.417 -2.093 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.155 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.6 p -97.78 143.85 12.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.747 -177.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -121.08 128.17 52.35 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -103.79 149.08 25.36 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.27 -11.91 53.22 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.457 0.646 . . . . 0.0 111.562 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.4 ' HB2' HG22 ' A' ' 82' ' ' ILE . 36.9 t70 -74.92 -14.19 60.62 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 124.104 0.962 . . . . 0.0 110.064 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.03 -21.85 24.22 Favored Glycine 0 CA--C 1.501 -0.812 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.752 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 p -70.36 138.02 51.05 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 123.585 0.754 . . . . 0.0 111.889 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.98 138.09 54.51 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 174.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mp -129.58 119.6 23.9 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 120.87 0.366 . . . . 0.0 110.595 -178.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.9 m -90.3 112.72 24.39 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.732 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 36.4 t30 56.1 74.22 0.73 Allowed Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 177.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -103.59 172.2 0.19 Allowed 'Trans proline' 0 N--CA 1.444 -1.388 0 C-N-CA 122.478 2.119 . . . . 0.0 110.598 172.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.2 t -85.08 165.22 17.67 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 174.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.529 ' HB2' ' HB1' ' A' ' 23' ' ' ALA . . . -60.66 -32.45 71.64 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.958 0.409 . . . . 0.0 111.398 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -56.65 -40.62 75.8 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.598 1.159 . . . . 0.0 109.511 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 11.7 mm-40 -68.96 -53.12 22.48 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.653 -176.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 49.4 t -61.4 -40.84 87.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 114.997 -1.002 . . . . 0.0 111.126 -176.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -64.04 -37.8 88.74 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.572 -177.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.57 -22.58 34.83 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.897 0.38 . . . . 0.0 110.964 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.423 ' O ' HG23 ' A' ' 82' ' ' ILE . 74.8 mmtt -84.56 -35.99 22.42 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.493 177.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.9 tp -55.61 -46.48 77.32 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.467 0.651 . . . . 0.0 109.6 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.7 m -63.42 -40.88 90.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.864 -178.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.12 -24.18 51.73 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.71 -177.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 78' ' ' LYS . 1.9 pp -83.37 -25.45 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 120.004 -0.679 . . . . 0.0 110.426 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.57 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.462 175.991 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.691 0 CA-C-O 121.36 0.6 . . . . 0.0 109.665 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.437 ' CD1' HD13 ' A' ' 79' ' ' LEU . 8.5 mp -93.53 129.42 39.76 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.448 177.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.3 m -118.34 108.31 14.92 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 171.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 57.6 mt -108.5 134.09 51.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-O 121.147 0.498 . . . . 0.0 110.211 -174.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -86.14 123.65 31.66 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.565 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 31.5 p -138.79 -178.91 5.53 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.687 0.755 . . . . 0.0 111.103 -178.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.1 m -139.4 153.25 47.59 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 104.367 -2.457 . . . . 0.0 104.367 174.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.3 p -49.94 -42.6 48.85 Favored 'General case' 0 C--N 1.315 -0.928 0 O-C-N 123.605 0.565 . . . . 0.0 110.99 176.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 35.2 p90 -111.52 129.67 55.98 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 174.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.3 t -164.02 142.13 7.28 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 174.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.47 -49.2 2.04 Favored Glycine 0 N--CA 1.429 -1.792 0 C-N-CA 120.646 -0.787 . . . . 0.0 111.374 178.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -73.42 -34.02 65.26 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 122.548 0.339 . . . . 0.0 111.553 -175.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.414 ' HA ' ' HB3' ' A' ' 57' ' ' PRO . 21.4 m -62.69 -36.96 84.6 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.247 0.546 . . . . 0.0 110.216 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 24.2 tp -65.64 -27.79 68.63 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.831 -174.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.0 ttt180 -54.46 -53.26 56.68 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.865 0.866 . . . . 0.0 110.158 177.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.48 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 23.3 tp -79.99 -37.8 33.48 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.125 -177.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.6 tttm -58.13 -43.56 87.34 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 123.747 0.819 . . . . 0.0 111.069 -175.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.6 m -72.4 -32.06 66.06 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.351 -178.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.97 -46.19 78.95 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.275 0.56 . . . . 0.0 110.042 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 68.9 mt -63.61 -44.46 93.88 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.599 -178.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.5 m -61.57 -37.42 83.78 Favored 'General case' 0 CA--C 1.555 1.167 0 CA-C-O 121.217 0.532 . . . . 0.0 110.68 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.18 -19.82 59.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.107 0.48 . . . . 0.0 111.134 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.422 ' HB3' HG13 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -97.31 10.96 38.18 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.519 -179.284 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 63.99 26.2 14.05 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.792 0.837 . . . . 0.0 111.978 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.422 HG13 ' HB3' ' A' ' 27' ' ' ASN . 77.0 mt -91.52 120.19 40.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.04 146.48 26.08 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -153.01 147.91 26.46 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -176.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -109.46 116.27 31.49 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 177.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.565 ' HB2' ' OG1' ' A' ' 10' ' ' THR . 14.0 pt-20 -87.98 146.91 25.28 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.617 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.7 t -91.07 151.73 3.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -171.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -77.91 1.55 20.23 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 128.724 2.81 . . . . 0.0 113.103 -178.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.1 pt -42.92 -22.48 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.526 3.341 0 N-CA-C 116.978 2.214 . . . . 0.0 116.978 -168.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -74.37 -21.81 59.5 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 119.403 1.001 . . . . 0.0 109.732 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -111.01 -34.86 6.09 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.573 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.524 ' ND2' ' H ' ' A' ' 42' ' ' ALA . 49.6 t30 -90.98 113.46 25.71 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.819 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -72.03 -29.85 64.6 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.625 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.65 -46.94 74.1 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -174.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.524 ' H ' ' ND2' ' A' ' 39' ' ' ASN . . . -76.03 -25.18 55.43 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.522 179.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.48 -42.61 87.2 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.65 -39.55 84.76 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.617 176.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -65.08 -32.85 74.77 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.082 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 42' ' ' ALA . 64.9 t -59.68 -34.47 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 121.195 0.522 . . . . 0.0 109.674 178.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.24 -18.38 65.02 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.834 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.5 t -81.54 -26.85 34.72 Favored 'General case' 0 N--CA 1.433 -1.285 0 O-C-N 122.228 -0.572 . . . . 0.0 110.391 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.4 m -99.42 -23.01 4.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 119.831 -0.748 . . . . 0.0 112.729 -178.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -147.76 154.09 40.07 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 175.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -144.32 170.04 26.18 Favored Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -178.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.51 -82.79 1.66 Allowed Glycine 0 CA--C 1.501 -0.834 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -177.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -104.85 123.59 47.97 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 174.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -67.13 106.25 1.93 Allowed 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.127 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.5 m -78.48 110.72 13.82 Favored 'General case' 0 N--CA 1.409 -2.476 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.4 t -76.89 -57.71 1.15 Allowed Pre-proline 0 N--CA 1.426 -1.632 0 CA-C-O 117.119 -1.42 . . . . 0.0 113.087 -174.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.414 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . 81.1 Cg_endo -73.39 45.49 1.02 Allowed 'Trans proline' 0 C--N 1.402 3.374 0 C-N-CA 121.393 1.395 . . . . 0.0 114.014 -168.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 95.5 m -80.49 138.21 36.53 Favored 'General case' 0 N--CA 1.39 -3.473 0 C-N-CA 126.063 1.745 . . . . 0.0 107.29 177.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.67 136.48 59.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-O 121.13 0.49 . . . . 0.0 110.569 -178.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -114.58 130.59 56.79 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 175.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -100.35 151.99 20.86 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.919 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.4 -10.08 15.29 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 124.234 1.013 . . . . 0.0 113.569 -177.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -89.76 -13.98 35.57 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.181 0.515 . . . . 0.0 109.663 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.72 3.13 30.49 Favored Glycine 0 N--CA 1.436 -1.312 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.6 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.0 m -82.86 131.01 35.21 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.796 177.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.0 p -113.93 137.65 51.4 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 171.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.3 mp -128.08 116.56 20.17 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.9 m -96.91 112.42 24.18 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -178.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 54.08 69.88 1.97 Allowed Pre-proline 0 N--CA 1.488 1.466 0 C-N-CA 124.213 1.005 . . . . 0.0 113.141 -174.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -95.55 172.88 1.16 Allowed 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 122.058 1.839 . . . . 0.0 111.567 175.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.0 t -93.55 161.49 14.34 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 172.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.81 -28.9 67.86 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.16 0.505 . . . . 0.0 110.243 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -56.55 -49.97 73.25 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.191 177.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -65.25 -42.56 93.18 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-N 114.805 -1.088 . . . . 0.0 110.653 -177.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.414 ' CG1' HD21 ' A' ' 6' ' ' LEU . 96.9 t -62.05 -49.38 84.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.29 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -61.36 -43.91 98.06 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.379 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.81 -38.79 87.16 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.575 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.421 ' O ' HG13 ' A' ' 82' ' ' ILE . 18.1 tppt? -66.6 -45.08 80.36 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 177.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.437 HD13 ' CD1' ' A' ' 6' ' ' LEU . 33.9 tp -59.98 -49.45 77.61 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.923 -177.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.8 m -66.61 -30.17 48.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -79.72 -33.44 40.92 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.543 -0.863 . . . . 0.0 111.221 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.5 pp -83.4 -23.8 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.768 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.317 -0.829 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.997 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.386 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.2 tp -110.29 151.55 27.25 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.779 -174.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.2 m -121.44 119.64 32.65 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 176.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 52.3 mt -120.34 131.87 71.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.394 0.616 . . . . 0.0 110.886 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -95.0 127.3 40.96 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 174.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.436 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 7.3 p -151.27 176.54 11.13 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.06 0.457 . . . . 0.0 111.723 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 29.0 m -132.02 149.45 52.42 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 174.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.2 p -68.68 -30.05 68.64 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.957 0.884 . . . . 0.0 108.85 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -84.92 101.78 12.61 Favored 'General case' 0 N--CA 1.412 -2.343 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 171.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.458 ' SG ' HG23 ' A' ' 56' ' ' VAL . 10.0 m -164.22 158.93 19.54 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.954 -1.475 . . . . 0.0 109.471 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -116.75 -62.66 0.33 Allowed Glycine 0 C--N 1.305 -1.193 0 N-CA-C 108.296 -1.921 . . . . 0.0 108.296 167.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.471 ' H ' ' HD1' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -56.62 -30.67 63.52 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 124.696 1.198 . . . . 0.0 113.197 176.842 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.425 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 36.1 m -66.04 -44.63 84.09 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 70.3 mt -62.53 -43.26 99.26 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.196 -176.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -59.01 -39.23 81.24 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.335 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.597 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 25.8 tp -77.7 -45.61 24.33 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.074 0.464 . . . . 0.0 109.826 177.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -56.9 -44.47 82.39 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 123.887 0.875 . . . . 0.0 111.971 -177.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.5 t -71.91 -31.07 66.01 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.47 177.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.64 -45.0 88.68 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 42.5 mt -63.79 -39.98 95.57 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.27 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.0 m -69.09 -33.14 73.04 Favored 'General case' 0 CA--C 1.562 1.426 0 CA-C-O 121.268 0.556 . . . . 0.0 110.504 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.03 -40.47 65.1 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.563 0.697 . . . . 0.0 111.583 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -91.23 18.32 7.14 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 114.959 -1.018 . . . . 0.0 111.902 -174.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 54.66 64.08 1.93 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.612 1.165 . . . . 0.0 113.479 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.489 HD11 ' HB2' ' A' ' 76' ' ' LYS . 89.7 mt -119.68 123.56 71.24 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.706 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 174.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.32 135.19 34.78 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.164 -177.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -155.8 150.7 26.37 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 123.208 0.317 . . . . 0.0 111.564 -176.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -109.44 136.07 49.45 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 172.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 10.0 pt-20 -102.77 142.48 33.85 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.819 178.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -84.07 154.85 3.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-O 121.259 0.552 . . . . 0.0 111.979 -173.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -71.59 -2.21 16.26 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 126.707 2.003 . . . . 0.0 113.245 -174.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.443 HD13 HG21 ' A' ' 46' ' ' VAL . 3.3 pt -44.12 -24.38 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 117.166 2.284 . . . . 0.0 117.166 -167.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -63.52 -41.48 98.5 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.853 0.835 . . . . 0.0 109.058 176.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 56.7 t60 -94.85 -41.76 9.05 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.581 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.502 ' ND2' ' H ' ' A' ' 42' ' ' ALA . 42.1 t30 -85.47 109.94 18.83 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.124 0.487 . . . . 0.0 111.574 -178.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -75.88 -16.68 60.01 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.683 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.11 -43.85 41.34 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -175.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.502 ' H ' ' ND2' ' A' ' 39' ' ' ASN . . . -81.32 -22.79 38.26 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.377 0.608 . . . . 0.0 109.881 177.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.37 -27.13 68.35 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.617 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -64.61 -33.25 75.49 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.942 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -67.54 -36.8 81.67 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.443 HG21 HD13 ' A' ' 36' ' ' ILE . 57.3 t -64.87 -45.68 94.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.999 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.64 -21.02 76.2 Favored Glycine 0 C--O 1.218 -0.881 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.862 178.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.6 t -81.87 -41.62 20.73 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 122.798 0.439 . . . . 0.0 110.798 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.2 p -82.22 -31.43 10.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -96.19 137.02 35.87 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.807 0.337 . . . . 0.0 110.156 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.85 136.14 12.9 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.78 -174.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.32 -88.17 1.58 Allowed Glycine 0 N--CA 1.43 -1.702 0 CA-C-N 115.436 -0.382 . . . . 0.0 112.501 177.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -93.29 162.21 14.09 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -178.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -85.48 83.43 7.93 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 173.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.6 m -60.96 127.76 33.15 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.498 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.458 HG23 ' SG ' ' A' ' 14' ' ' CYS 1.539 12.0 m -68.47 -75.05 0.14 Allowed Pre-proline 0 CA--C 1.433 -3.548 1 N-CA-C 123.902 4.778 . . . . 0.0 123.902 179.509 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.425 ' HD3' ' SG ' ' A' ' 17' ' ' CYS . 98.3 Cg_endo -74.15 89.69 1.03 Allowed 'Trans proline' 0 N--CA 1.403 -3.812 0 CA-C-N 121.218 1.471 . . . . 0.0 112.004 -167.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.7 m -114.42 116.81 29.49 Favored 'General case' 0 N--CA 1.397 -3.1 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 -177.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.13 139.68 23.41 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.137 -176.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -115.2 121.14 42.03 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.454 ' CE2' ' HB3' ' A' ' 78' ' ' LYS . 97.0 m-85 -101.58 155.89 17.81 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.27 -9.87 27.6 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.696 0.76 . . . . 0.0 110.583 176.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -64.92 -18.77 65.51 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.893 1.277 . . . . 0.0 109.906 176.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.43 18.18 36.79 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.501 177.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 27.8 t -133.94 153.73 51.57 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -178.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.2 p -114.33 139.52 49.38 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.578 177.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.9 mp -119.33 123.88 45.26 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 18.2 m -97.67 112.69 24.47 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 54.03 68.81 2.51 Favored Pre-proline 0 N--CA 1.489 1.483 0 C-N-CA 124.437 1.095 . . . . 0.0 112.885 -171.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -85.56 165.26 10.67 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.759 1.639 . . . . 0.0 109.855 172.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.3 m -84.49 159.75 20.68 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 177.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.52 -43.28 79.65 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 122.971 0.508 . . . . 0.0 111.807 -177.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -58.92 -42.37 89.55 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.976 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.494 ' O ' ' HE2' ' A' ' 78' ' ' LYS . 56.2 mm-40 -61.15 -44.39 97.39 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.243 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.8 t -65.83 -48.0 83.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.413 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.489 ' HB2' HD11 ' A' ' 29' ' ' ILE . 57.5 tttp -61.43 -43.81 98.21 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.998 -177.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.1 -35.31 69.15 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.029 0.442 . . . . 0.0 111.369 -178.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.494 ' HE2' ' O ' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -74.22 -31.43 62.61 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 119.994 -0.683 . . . . 0.0 110.13 177.377 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.414 HD22 HG23 ' A' ' 29' ' ' ILE . 16.5 tp -63.21 -48.4 78.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.188 0.518 . . . . 0.0 109.761 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.7 m -65.21 -30.29 49.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.66 -176.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -80.94 -25.81 37.14 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.123 -0.631 . . . . 0.0 111.21 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.4 pp -85.24 -32.03 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.202 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.611 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.709 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.59 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.0 mt -119.28 117.93 29.89 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.675 -1.148 . . . . 0.0 107.933 175.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 60' ' ' LYS . 11.9 m -102.36 108.04 19.25 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 177.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 59.4 mt -108.06 134.49 49.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-O 121.629 0.728 . . . . 0.0 110.26 -176.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -91.19 120.12 31.85 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.031 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.528 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 24.9 p -139.67 162.13 35.85 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.375 0.27 . . . . 0.0 111.193 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.5 p -155.69 -175.1 5.26 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 125.316 1.446 . . . . 0.0 107.684 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.7 t -76.72 -11.03 59.78 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.984 0.421 . . . . 0.0 109.871 172.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 4.1 m0 -83.98 44.96 1.04 Allowed 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 41.3 t -133.97 126.46 30.34 Favored 'General case' 0 N--CA 1.416 -2.143 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -166.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -128.72 -69.91 0.13 Allowed Glycine 0 N--CA 1.437 -1.24 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 170.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -61.66 -18.34 59.13 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.37 -33.98 70.02 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.218 0.532 . . . . 0.0 110.516 177.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 84.1 mt -65.38 -37.28 86.53 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.348 -178.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 -52.58 -48.59 66.13 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 124.274 0.984 . . . . 0.0 110.099 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.4 tp -74.12 -45.8 46.67 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.658 -177.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.7 pttp -70.86 -26.91 63.47 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 119.285 -0.966 . . . . 0.0 112.123 -173.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.9 p -74.98 -28.49 60.57 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.848 -0.532 . . . . 0.0 110.311 175.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.46 -42.06 88.14 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 175.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.1 mt -63.32 -47.54 81.8 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.991 177.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.3 m -57.73 -47.06 83.48 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.811 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.69 -25.61 68.28 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.301 0.572 . . . . 0.0 111.936 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -95.5 6.88 47.82 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.027 -178.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.405 ' HD2' ' HA ' ' A' ' 28' ' ' ARG . 16.3 mmm180 67.53 24.0 8.78 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.78 0.832 . . . . 0.0 112.551 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.438 HG23 HD22 ' A' ' 79' ' ' LEU . 73.2 mt -83.89 120.76 35.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 176.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.52 127.7 34.9 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.4 -176.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -140.27 169.27 18.0 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -136.52 142.52 43.47 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.528 ' HB2' ' OG1' ' A' ' 10' ' ' THR . 10.3 pt-20 -105.32 131.58 52.59 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 123.659 0.599 . . . . 0.0 110.939 -176.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.4 t -78.84 143.61 12.35 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -172.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -59.65 -1.3 0.24 Allowed 'General case' 0 N--CA 1.503 2.215 0 C-N-CA 128.826 2.85 . . . . 0.0 114.878 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.2 pt -44.22 -25.19 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 117.092 2.256 . . . . 0.0 117.092 -168.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -70.91 -25.49 62.79 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 118.967 0.803 . . . . 0.0 109.096 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -97.97 -35.48 10.44 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.257 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . 0.254 0.2 OUTLIER -112.62 118.69 35.77 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.959 0.885 . . . . 0.0 112.667 179.448 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.695 ' H ' ' HD3' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -75.85 -18.9 59.27 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.655 -174.88 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.87 -53.52 56.34 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.789 0.328 . . . . 0.0 111.496 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.417 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -72.82 -21.1 61.02 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.913 177.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.88 -35.46 76.9 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.126 0.489 . . . . 0.0 110.714 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -73.9 -29.28 61.98 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.951 0.405 . . . . 0.0 110.269 177.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -65.21 -29.8 70.64 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.788 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 42' ' ' ALA . 48.0 t -63.03 -30.83 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.834 176.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.75 -43.13 60.27 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 178.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.2 m -65.22 -28.82 69.63 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.222 0.609 . . . . 0.0 112.359 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.8 m -84.61 -5.03 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 O-C-N 121.655 -0.653 . . . . 0.0 111.594 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -104.83 -52.94 2.77 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.638 176.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 143.64 -37.9 1.41 Allowed Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -167.24 -47.73 0.03 OUTLIER Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -88.64 177.31 6.79 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.0 mtm180 -126.19 116.85 21.95 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.529 HG22 ' HD2' ' A' ' 57' ' ' PRO . 16.3 m -98.02 151.16 20.62 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 174.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.44 ' CG1' ' HA ' ' A' ' 10' ' ' THR . 34.5 t -79.38 -69.13 0.21 Allowed Pre-proline 0 CA--C 1.475 -1.926 0 CA-C-O 117.509 -1.234 . . . . 0.0 113.988 -178.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.529 ' HD2' HG22 ' A' ' 55' ' ' THR . 72.8 Cg_endo -76.07 86.68 1.5 Allowed 'Trans proline' 1 N--CA 1.393 -4.387 0 CA-C-N 120.867 1.345 . . . . 0.0 111.797 -163.121 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 64.0 m -121.64 124.88 45.37 Favored 'General case' 1 N--CA 1.373 -4.299 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 -175.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 66' ' ' THR . 4.6 p -115.53 136.1 53.44 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.956 -175.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.413 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 29.7 ttpp -111.74 123.19 49.72 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 174.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.443 ' HB3' HG21 ' A' ' 82' ' ' ILE . 88.2 m-85 -92.03 175.61 6.81 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.015 -178.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.524 ' HB3' ' HB ' ' A' ' 82' ' ' ILE . . . -66.44 -22.84 66.22 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.543 ' OD2' HG22 ' A' ' 82' ' ' ILE . 48.9 m-20 -82.17 0.07 42.65 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.198 0.523 . . . . 0.0 111.046 177.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.57 -0.8 87.02 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.939 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.1 m -68.27 130.45 42.94 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 6.4 p -114.13 137.8 51.27 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 176.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.9 mt -134.61 121.67 21.23 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.926 0.393 . . . . 0.0 110.432 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 91.8 m -90.92 121.83 33.09 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 174.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 58.33 65.64 3.01 Favored Pre-proline 0 N--CA 1.472 0.629 0 C-N-CA 124.284 1.033 . . . . 0.0 113.055 -177.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -84.0 -178.88 3.72 Favored 'Trans proline' 0 C--O 1.25 1.117 0 C-N-CA 121.694 1.596 . . . . 0.0 110.463 171.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.47 ' O ' HG23 ' A' ' 75' ' ' VAL . 3.4 m -112.09 150.83 30.16 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.41 -41.92 66.48 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -174.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -78.27 -34.83 48.71 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.948 0.404 . . . . 0.0 109.953 -178.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -65.06 -37.53 87.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.273 178.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 71' ' ' SER . 91.7 t -61.44 -42.17 92.81 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.626 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -62.52 -41.1 98.63 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.984 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.412 ' O ' HG22 ' A' ' 80' ' ' VAL . . . -69.42 -31.58 70.01 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.504 0.669 . . . . 0.0 111.289 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -78.11 -29.71 49.11 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 176.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.438 HD22 HG23 ' A' ' 29' ' ' ILE . 31.1 tp -65.94 -41.57 91.12 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.445 179.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 77' ' ' ALA . 27.4 m -66.12 -36.19 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -72.99 -34.37 66.37 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.943 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.543 HG22 ' OD2' ' A' ' 63' ' ' ASP . 2.1 pp -77.02 -31.53 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 120.344 -0.543 . . . . 0.0 111.246 -177.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.588 0 CA-C-O 121.062 0.458 . . . . 0.0 110.145 177.596 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.239 0.503 0 CA-C-O 120.891 0.376 . . . . 0.0 111.357 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.84 123.12 41.01 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 121.397 0.618 . . . . 0.0 109.679 175.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.1 m -110.16 112.3 24.2 Favored 'General case' 0 C--N 1.276 -2.605 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 177.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.539 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 57.5 mt -97.88 137.17 26.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.049 -174.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -92.72 117.91 30.5 Favored 'General case' 0 C--N 1.279 -2.459 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.52 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 14.0 p -128.68 155.92 44.29 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 122.511 0.324 . . . . 0.0 110.589 -178.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.573 ' HA ' ' HG2' ' A' ' 37' ' ' GLU . 46.9 p -140.2 175.41 9.62 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.8 m -86.03 -11.41 52.95 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 175.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 8.5 m0 -82.18 -20.23 38.28 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.312 -169.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.492 ' SG ' HG11 ' A' ' 56' ' ' VAL . 9.0 p -109.39 148.33 31.28 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -172.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -101.99 -42.37 2.27 Favored Glycine 0 N--CA 1.432 -1.586 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 172.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -59.75 -24.7 64.25 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -177.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.9 p -68.52 -39.14 81.33 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.448 0.642 . . . . 0.0 109.931 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 37.2 tp -69.29 -28.93 66.72 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.549 -175.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -63.39 -50.82 68.37 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.013 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.448 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 41.4 tp -68.5 -36.84 79.47 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.101 0.477 . . . . 0.0 109.908 178.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -56.56 -37.29 70.34 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.479 177.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.9 m -75.15 -40.11 59.85 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.117 178.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.83 -41.03 94.95 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.818 0.447 . . . . 0.0 111.123 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 81.9 mt -66.13 -33.77 76.53 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.76 178.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.7 m -65.55 -44.25 87.4 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.002 177.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.44 -26.89 65.74 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.561 0.696 . . . . 0.0 110.963 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -84.53 4.35 32.37 Favored 'General case' 0 C--O 1.254 1.3 0 C-N-CA 123.907 0.883 . . . . 0.0 111.858 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 60.3 37.12 20.51 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.931 1.293 . . . . 0.0 110.252 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 85.2 mt -95.61 122.74 47.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.625 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.04 125.2 31.18 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 176.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -135.69 148.67 48.99 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 120.707 0.289 . . . . 0.0 110.671 -178.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -111.04 123.73 50.78 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 174.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 15.7 pt-20 -96.91 151.04 20.08 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.9 t -90.92 143.63 10.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-O 122.163 0.982 . . . . 0.0 113.497 -171.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -63.59 -2.1 1.52 Allowed 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 128.305 2.642 . . . . 0.0 114.822 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.4 pt -45.28 -24.84 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -175.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.573 ' HG2' ' HA ' ' A' ' 11' ' ' THR . 45.3 mt-10 -55.8 -31.7 62.87 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.355 0.662 . . . . 0.0 111.427 178.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -128.08 20.56 6.37 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.22 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.462 ' ND2' ' H ' ' A' ' 42' ' ' ALA . 28.7 t30 -143.52 122.18 12.57 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.957 0.408 . . . . 0.0 111.26 -178.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -77.15 -28.21 54.1 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.421 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.04 -37.48 81.38 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 -172.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.462 ' H ' ' ND2' ' A' ' 39' ' ' ASN . . . -84.19 -24.75 29.98 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 120.113 -0.635 . . . . 0.0 109.466 176.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.79 -30.28 68.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.288 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -64.4 -36.6 84.68 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 114.97 -1.013 . . . . 0.0 108.737 178.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -67.53 -31.78 72.11 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.123 0.487 . . . . 0.0 110.463 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 43.6 t -66.49 -31.42 53.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.33 -23.65 67.68 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.321 176.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 42.3 t -67.94 -43.72 78.47 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 176.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 31.5 m -81.06 -39.52 17.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.923 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' A' ' 53' ' ' ASN . 54.5 m-80 -106.97 109.22 21.06 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 120.862 0.363 . . . . 0.0 110.701 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -81.93 128.17 8.33 Favored Glycine 0 N--CA 1.439 -1.116 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.798 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.31 -84.25 1.37 Allowed Glycine 0 N--CA 1.438 -1.204 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.429 ' O ' ' HB3' ' A' ' 50' ' ' ASN . 93.0 m-20 -88.64 122.61 32.27 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -80.63 94.03 6.24 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.821 177.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.8 m -67.0 123.71 20.99 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 175.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.492 HG11 ' SG ' ' A' ' 14' ' ' CYS . 16.5 t -72.89 -60.56 1.85 Allowed Pre-proline 0 CA--C 1.462 -2.412 0 CA-C-O 117.149 -1.405 . . . . 0.0 114.746 -172.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -77.74 72.17 6.21 Favored 'Trans proline' 1 N--CA 1.394 -4.343 0 CA-C-N 121.185 1.459 . . . . 0.0 112.782 -167.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 88.2 m -106.35 142.12 36.54 Favored 'General case' 0 N--CA 1.38 -3.96 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.6 p -136.81 139.16 45.24 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.862 -174.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -104.54 128.59 52.53 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -112.4 166.43 11.3 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.102 0.477 . . . . 0.0 110.489 177.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.34 -8.84 53.65 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.142 171.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -62.91 -17.07 61.29 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.111 1.764 . . . . 0.0 110.997 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.68 8.67 55.69 Favored Glycine 0 CA--C 1.506 -0.517 0 C-N-CA 120.743 -0.741 . . . . 0.0 113.78 173.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.0 t -150.71 173.75 13.81 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.8 p -114.13 139.68 49.14 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -178.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.403 HD23 ' HB3' ' A' ' 70' ' ' PRO . 9.7 mp -106.09 151.79 24.23 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 177.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 18.2 m -131.48 113.79 14.13 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -177.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.7 m120 61.05 44.96 0.84 Allowed Pre-proline 0 N--CA 1.485 1.322 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -175.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.403 ' HB3' HD23 ' A' ' 67' ' ' LEU . 74.5 Cg_endo -77.28 160.33 32.69 Favored 'Trans proline' 0 C--N 1.366 1.464 0 C-N-CA 121.305 1.337 . . . . 0.0 111.098 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.1 m -84.27 155.25 22.52 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.42 -42.12 70.12 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.717 0.807 . . . . 0.0 112.172 -177.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -61.46 -40.39 94.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.593 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -67.11 -40.81 86.92 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-O 121.075 0.464 . . . . 0.0 110.089 -178.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.3 t -61.22 -43.82 97.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.619 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -68.61 -41.28 79.73 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.452 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.11 -38.88 89.28 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 122.703 0.401 . . . . 0.0 111.033 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.658 ' O ' HG13 ' A' ' 82' ' ' ILE . 28.7 mmtp -69.48 -39.78 77.48 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.366 174.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.9 tp -60.53 -51.07 70.99 Favored 'General case' 0 C--N 1.318 -0.781 0 O-C-N 123.475 0.485 . . . . 0.0 110.729 -178.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.6 m -61.67 -31.41 50.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -177.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.09 -44.32 18.16 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 119.801 -0.76 . . . . 0.0 111.575 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.658 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.2 pp -82.1 -20.37 10.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -175.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.63 0 CA-C-O 121.208 0.527 . . . . 0.0 111.504 -179.006 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.5 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.74 130.71 21.76 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-N 113.561 -1.654 . . . . 0.0 108.922 174.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.5 m -102.94 117.32 34.34 Favored 'General case' 0 C--N 1.274 -2.679 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.504 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 68.9 mt -108.86 133.61 53.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 121.446 0.641 . . . . 0.0 110.93 -175.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -85.12 127.42 34.24 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.598 177.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 39.0 p -133.63 163.17 30.03 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.0 0.429 . . . . 0.0 111.215 -178.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.3 m -147.87 151.6 36.19 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 175.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.4 p -58.41 -42.91 88.27 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 118.534 0.606 . . . . 0.0 109.736 174.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.11 94.36 1.51 Allowed 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 167.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 m -163.82 117.46 1.49 Allowed 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.098 -1.41 . . . . 0.0 111.568 178.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -106.83 -56.93 0.62 Allowed Glycine 0 N--CA 1.428 -1.898 0 N-CA-C 108.681 -1.768 . . . . 0.0 108.681 172.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -69.97 -20.96 63.28 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -179.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.519 ' SG ' ' HB ' ' A' ' 56' ' ' VAL . 3.6 m -72.5 -34.99 68.02 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 177.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 18.3 tp -72.29 -29.39 63.83 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.092 -173.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.419 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 2.2 mmp_? -59.34 -37.59 78.23 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.81 177.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.7 tp -82.58 -41.33 19.69 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.564 178.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -58.61 -45.54 88.96 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.635 -176.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -66.34 -36.73 83.66 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.62 -45.42 86.93 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.947 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.4 mt -67.54 -37.87 83.34 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.359 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.0 m -67.09 -42.72 84.13 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.998 0.428 . . . . 0.0 110.41 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.47 -23.86 65.54 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-O 121.233 0.54 . . . . 0.0 110.801 177.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -93.35 6.63 47.47 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.073 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 64.28 24.21 13.26 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.601 0.76 . . . . 0.0 112.494 176.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 78.1 mt -86.49 120.58 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.4 127.24 33.89 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.634 -178.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -142.47 167.19 22.68 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -129.43 135.59 48.87 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 177.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 17.0 pt-20 -100.44 141.69 32.94 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.079 0.466 . . . . 0.0 111.408 -177.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.4 t -83.57 146.72 6.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -171.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -63.68 -2.36 1.69 Allowed 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 129.187 2.995 . . . . 0.0 115.923 178.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.7 pt -45.7 -24.34 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 -173.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -70.19 -23.56 62.98 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 121.724 0.773 . . . . 0.0 110.327 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 -111.42 -36.62 5.49 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.926 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.426 ' ND2' ' H ' ' A' ' 42' ' ' ALA . 26.5 t30 -100.85 122.43 43.43 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.095 -175.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.426 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 9.7 ptp85 -75.76 -25.6 56.64 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.379 177.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.95 -36.21 79.72 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -172.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.426 ' H ' ' ND2' ' A' ' 39' ' ' ASN . . . -87.0 -22.23 25.64 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.554 175.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.29 -41.25 81.26 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.766 -178.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 40' ' ' ARG . 19.0 mm-40 -70.13 -24.66 63.22 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.787 178.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -67.35 -32.6 73.66 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.71 177.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 38.9 t -65.54 -39.87 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.82 -18.06 78.67 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.956 178.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.8 t -80.54 -42.63 22.07 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 31.7 m -84.07 -32.62 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -103.52 160.0 15.11 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -178.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -128.74 152.12 19.21 Favored Glycine 0 N--CA 1.432 -1.571 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.065 -178.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.63 -111.91 3.62 Favored Glycine 0 N--CA 1.438 -1.189 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -91.62 147.69 22.82 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 175.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -71.49 96.7 1.54 Allowed 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.515 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.8 m -61.98 114.81 3.59 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 174.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.519 ' HB ' ' SG ' ' A' ' 17' ' ' CYS . 5.2 t -75.1 -55.33 2.3 Favored Pre-proline 0 N--CA 1.428 -1.541 0 CA-C-O 117.435 -1.269 . . . . 0.0 113.424 -175.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.55 75.6 3.44 Favored 'Trans proline' 0 N--CA 1.41 -3.42 0 CA-C-N 121.155 1.448 . . . . 0.0 112.706 -170.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 58.5 m -106.5 125.66 51.29 Favored 'General case' 0 N--CA 1.381 -3.909 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.73 121.0 60.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-O 121.505 0.669 . . . . 0.0 110.872 -175.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -105.2 110.11 22.35 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -79.34 159.97 26.94 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.585 -178.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.56 -24.27 31.49 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.239 1.016 . . . . 0.0 113.588 -177.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -80.58 -17.1 52.43 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.014 0.435 . . . . 0.0 110.694 -178.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.2 -8.26 30.99 Favored Glycine 0 C--O 1.246 0.885 0 C-N-CA 121.009 -0.615 . . . . 0.0 113.169 178.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.9 t -79.31 135.87 36.86 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.3 m -116.7 138.6 51.34 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.0 mp -121.83 142.16 50.51 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 120.881 0.372 . . . . 0.0 110.748 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.8 m -98.73 116.32 30.69 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 115.503 -0.772 . . . . 0.0 108.982 -178.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . 0.324 25.9 p-10 34.88 74.66 0.53 Allowed Pre-proline 0 N--CA 1.494 1.755 0 N-CA-C 116.825 2.157 . . . . 0.0 116.825 179.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -92.04 -165.43 0.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.405 2.07 . . . . 0.0 110.248 175.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.4 m -115.02 169.99 8.68 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.73 -41.68 87.01 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -177.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . 0.425 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 5.2 m-20 -64.92 -33.76 76.79 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.691 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -64.21 -51.16 65.07 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.8 t -61.0 -44.76 98.88 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.167 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.779 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . 0.425 ' HE2' ' HA ' ' A' ' 73' ' ' ASP . 37.1 ttpt -58.46 -46.68 86.1 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 123.421 0.688 . . . . 0.0 111.991 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.36 -22.19 61.19 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 120.874 0.369 . . . . 0.0 111.538 -178.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.455 ' O ' HG13 ' A' ' 82' ' ' ILE . 45.3 mmtm -81.55 -40.75 22.63 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 173.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 27.1 tp -55.68 -47.66 76.38 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 123.721 0.808 . . . . 0.0 109.603 -178.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.8 m -60.53 -36.77 72.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.728 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -82.11 -36.35 27.6 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.4 pp -84.6 -29.53 6.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 113.477 0.918 . . . . 0.0 113.477 -176.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.313 -1.0 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.505 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.312 0 CA-C-O 121.103 0.477 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.6 mp -98.52 104.82 16.89 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.163 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.4 m -102.56 107.3 18.19 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 173.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.454 HG22 HG23 ' A' ' 10' ' ' THR . 31.0 mt -106.83 129.85 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 CA-C-O 121.687 0.755 . . . . 0.0 111.555 -173.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -94.09 106.67 18.64 Favored 'General case' 0 N--CA 1.406 -2.654 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.408 176.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.454 HG23 HG22 ' A' ' 8' ' ' ILE . 2.1 p -140.23 142.29 35.82 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.817 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.4 m -84.37 154.41 22.88 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 175.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 p -62.07 -51.98 65.77 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 46.3 p90 -83.28 92.67 7.54 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-O 121.914 0.864 . . . . 0.0 110.917 176.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.4 t -163.84 117.13 1.47 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.483 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.44 -36.13 15.24 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -62.96 -39.18 93.89 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.462 0.648 . . . . 0.0 109.683 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 55.7 m -68.09 -39.21 82.91 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.252 177.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.83 -38.63 82.6 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 123.832 0.853 . . . . 0.0 110.112 -177.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -57.12 -38.78 73.93 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.581 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.453 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 19.5 tp -78.89 -44.08 23.54 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.174 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -54.42 -49.49 69.85 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.908 -178.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.9 p -65.49 -33.68 76.51 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.963 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.21 -42.33 88.9 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.246 178.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 80.3 mt -64.34 -48.52 75.26 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.486 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 87.1 m -54.91 -42.57 72.37 Favored 'General case' 0 CA--C 1.553 1.088 0 CA-C-O 121.058 0.456 . . . . 0.0 110.768 177.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.15 -13.29 60.2 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -177.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -109.4 14.34 23.69 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 65.99 17.33 10.77 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.84 1.256 . . . . 0.0 112.256 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 63.3 mt -87.37 117.32 31.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.99 144.55 28.22 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.4 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -152.3 150.97 30.33 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 120.678 0.275 . . . . 0.0 111.059 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -114.11 113.01 24.13 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 176.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 15.4 pt-20 -91.37 145.02 24.98 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.0 t -90.73 151.8 3.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -171.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.67 -4.23 0.06 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 129.641 3.177 . . . . 0.0 114.91 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.8 pt -49.51 -22.48 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 116.49 2.033 . . . . 0.0 116.49 -168.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -72.73 -13.41 61.33 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 121.458 0.647 . . . . 0.0 111.808 -178.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 34.4 p-80 -128.59 -34.87 1.97 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.615 170.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.48 ' ND2' ' H ' ' A' ' 42' ' ' ALA . 44.3 t30 -80.23 107.23 12.85 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 120.692 0.282 . . . . 0.0 110.77 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -70.77 -23.68 62.45 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.313 -179.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.52 -42.1 71.7 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -176.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.48 ' H ' ' ND2' ' A' ' 39' ' ' ASN . . . -80.02 -23.47 41.45 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.361 177.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.72 -35.42 77.12 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.283 177.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -61.28 -39.66 91.23 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.085 175.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -66.06 -30.96 71.58 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.633 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 88.1 t -64.31 -36.83 78.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.5 -19.01 77.0 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.602 177.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.0 m -76.52 -30.65 57.24 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 177.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.5 m -98.79 -11.38 8.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -125.48 105.13 8.82 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 175.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.99 135.06 23.96 Favored Glycine 0 C--N 1.298 -1.534 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.926 -175.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.25 -59.31 4.99 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.383 -0.409 . . . . 0.0 113.574 176.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -125.75 133.34 52.11 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 -176.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.4 mtm180 -70.63 95.69 1.12 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.307 0.575 . . . . 0.0 110.788 176.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.0 m -77.04 131.02 38.2 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 1.716 15.3 m -58.46 -89.78 0.0 OUTLIER Pre-proline 0 CA--C 1.438 -3.338 1 N-CA-C 123.659 4.689 . . . . 0.0 123.659 -178.891 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -69.9 94.02 0.54 Allowed 'Trans proline' 0 N--CA 1.409 -3.48 0 CA-C-N 120.799 1.321 . . . . 0.0 112.508 -165.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.5 m -119.69 112.42 19.26 Favored 'General case' 0 N--CA 1.407 -2.609 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 -177.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.4 p -103.41 134.85 43.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-O 121.405 0.622 . . . . 0.0 111.211 -176.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -109.03 116.93 32.91 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -100.32 178.81 4.65 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.57 -9.16 24.23 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 122.346 1.07 . . . . 0.0 110.153 174.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -63.01 -19.33 64.25 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.876 1.67 . . . . 0.0 110.152 175.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.51 -22.81 14.63 Favored Glycine 0 C--O 1.238 0.353 0 CA-C-N 116.137 -0.483 . . . . 0.0 113.396 176.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.1 t -100.78 171.57 7.6 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.7 p -113.81 141.13 47.68 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 46.7 tp -115.11 125.25 53.26 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 178.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.9 m -105.24 144.76 31.59 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -175.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.6 p30 50.04 48.41 5.98 Favored Pre-proline 0 N--CA 1.491 1.59 0 C-N-CA 124.78 1.232 . . . . 0.0 113.043 -179.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -80.94 160.66 21.06 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 121.991 1.794 . . . . 0.0 112.703 -174.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.3 m -97.4 153.8 17.86 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 174.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.84 -35.54 73.08 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.044 0.45 . . . . 0.0 111.664 -176.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -62.44 -44.18 97.04 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.218 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -64.38 -41.19 96.82 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.581 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.9 t -57.82 -51.72 66.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.068 178.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -60.96 -44.11 97.77 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.379 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.05 -37.91 84.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.674 -178.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -68.81 -41.24 78.91 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 177.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.17 -49.74 74.62 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 123.796 0.685 . . . . 0.0 110.121 -175.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.5 m -61.88 -35.93 70.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.14 -31.24 34.25 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 119.771 -0.772 . . . . 0.0 111.731 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.4 pp -75.02 -21.52 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.51 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.314 -0.939 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.682 176.42 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.574 0 CA-C-O 121.069 0.462 . . . . 0.0 111.466 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.3 tp -132.68 133.27 43.34 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -178.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.0 m -114.86 124.34 51.47 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.573 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 67.0 mt -119.03 144.94 25.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.436 ' HD1' ' O ' ' A' ' 58' ' ' THR . 92.7 m-85 -98.75 133.01 43.68 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.452 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . 17.1 p -140.49 153.85 46.38 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -176.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.3 p -144.69 164.74 30.07 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 175.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.6 p -86.14 -0.82 56.57 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.34 0.591 . . . . 0.0 111.529 177.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -94.68 27.96 2.84 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -174.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.442 ' HB2' HG21 ' A' ' 56' ' ' VAL . 6.1 t -148.08 151.49 35.76 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -168.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.71 -28.21 0.98 Allowed Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.771 176.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -65.09 -36.46 84.37 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.262 0.553 . . . . 0.0 110.793 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.443 ' HA ' ' HB3' ' A' ' 57' ' ' PRO . 1.7 p -61.0 -32.59 72.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.165 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 81.9 mt -66.73 -28.85 68.75 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.906 -177.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -60.78 -56.08 25.47 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.292 0.568 . . . . 0.0 109.5 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.522 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 16.4 tp -66.79 -39.93 87.97 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.994 -177.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.438 ' HG2' ' OH ' ' A' ' 31' ' ' TYR . 51.1 tttm -58.34 -45.66 87.71 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.847 -177.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.7 p -71.41 -37.47 71.5 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.597 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.47 -42.9 97.18 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 123.066 0.546 . . . . 0.0 110.997 178.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 76.4 mt -69.26 -42.62 75.32 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.01 -178.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.4 m -62.52 -42.13 99.31 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 120.712 0.291 . . . . 0.0 110.273 177.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.79 -19.0 65.04 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.479 0.657 . . . . 0.0 111.196 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -98.25 9.4 43.07 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.932 178.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.475 ' HA ' ' NE ' ' A' ' 28' ' ' ARG . 4.2 mmp_? 65.96 23.14 11.24 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.54 0.736 . . . . 0.0 112.127 177.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.7 mt -87.15 119.95 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.35 127.16 35.78 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.165 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.438 ' OH ' ' HG2' ' A' ' 21' ' ' LYS . 51.6 p90 -136.52 151.92 49.96 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.878 -178.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -111.38 136.25 50.78 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 173.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.573 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 12.8 pt-20 -102.64 146.23 28.49 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.641 -177.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.3 t -96.04 134.69 32.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -173.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -54.57 -0.59 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 129.529 3.132 . . . . 0.0 115.986 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.6 pt -43.85 -25.46 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.514 2.753 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 -168.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -59.63 -45.55 91.63 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -100.54 -31.27 11.35 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.321 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.467 ' ND2' ' H ' ' A' ' 42' ' ' ALA . 50.1 t30 -88.8 104.45 16.93 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -72.86 -17.69 61.51 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.572 -177.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.31 -46.94 53.52 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -176.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.467 ' H ' ' ND2' ' A' ' 39' ' ' ASN . . . -75.29 -25.2 57.74 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.268 0.556 . . . . 0.0 110.001 177.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.16 -32.77 74.1 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.41 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -66.29 -39.89 89.67 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -61.18 -46.17 91.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.796 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 42' ' ' ALA . 80.9 t -57.08 -42.34 79.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.492 178.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.95 -32.95 76.78 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.299 178.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.3 m -81.87 -25.85 34.71 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 120.925 0.393 . . . . 0.0 111.304 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.6 t -79.41 -39.09 20.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.098 0.475 . . . . 0.0 110.516 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -84.97 -174.61 5.37 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.094 -178.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -90.23 -93.14 1.22 Allowed Glycine 0 N--CA 1.438 -1.201 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.181 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.25 -47.15 3.37 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.705 -174.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -126.22 151.82 46.88 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.3 mtm180 -57.88 111.18 1.07 Allowed 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.73 0.776 . . . . 0.0 111.826 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.5 m -87.95 133.82 33.85 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 178.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.452 ' CG1' ' HA ' ' A' ' 10' ' ' THR . 21.9 t -74.77 -64.46 0.64 Allowed Pre-proline 0 CA--C 1.459 -2.528 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -171.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.443 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . 33.0 Cg_endo -79.36 50.48 3.52 Favored 'Trans proline' 0 N--CA 1.415 -3.136 0 CA-C-N 121.092 1.426 . . . . 0.0 113.349 -164.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.436 ' O ' ' HD1' ' A' ' 9' ' ' TYR . 98.8 m -80.02 136.31 36.56 Favored 'General case' 0 N--CA 1.38 -3.938 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 176.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.3 p -125.74 148.69 30.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.325 -174.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -127.22 119.58 26.73 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -87.91 161.13 17.64 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.408 -178.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.56 -10.5 8.2 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.687 0.795 . . . . 0.0 111.735 176.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -77.68 -18.7 56.39 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.845 176.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.44 -13.35 58.31 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.176 -179.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.2 m -82.12 143.88 31.16 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -178.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.8 p -114.35 148.07 38.17 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.346 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.5 mt -130.16 136.3 49.12 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 175.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 82.9 m -100.63 118.03 35.95 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 176.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 58.18 67.44 2.22 Favored Pre-proline 0 N--CA 1.485 1.318 0 C-N-CA 124.395 1.078 . . . . 0.0 112.282 -178.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -88.24 157.54 6.88 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.776 1.651 . . . . 0.0 112.029 176.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 56.5 p -84.79 149.77 25.5 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 175.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.93 -32.83 72.32 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 120.913 0.387 . . . . 0.0 110.318 -178.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -62.11 -49.76 74.6 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.584 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 19.6 mt-10 -64.89 -42.04 95.12 Favored 'General case' 0 C--O 1.203 -1.386 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.573 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.3 t -57.72 -44.64 86.13 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.633 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -65.86 -44.94 83.92 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.21 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.94 -32.13 72.36 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.214 0.531 . . . . 0.0 111.617 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.449 ' O ' HG13 ' A' ' 82' ' ' ILE . 31.4 mmtp -77.15 -38.14 52.51 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 177.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.6 tp -57.59 -48.26 79.87 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 122.734 0.414 . . . . 0.0 110.061 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.6 m -60.62 -35.64 65.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.724 -176.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -81.86 -39.89 23.24 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.2 pp -75.31 -12.44 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -176.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.311 -1.069 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.775 177.105 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.45 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.538 HD21 HD13 ' A' ' 79' ' ' LEU . 1.6 mm? -116.57 115.66 26.16 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 176.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.465 ' HB ' ' HB3' ' A' ' 60' ' ' LYS . 6.2 m -102.26 108.36 19.71 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 177.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 59.3 mt -104.54 132.35 51.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-O 121.285 0.564 . . . . 0.0 110.697 -175.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -93.92 119.96 33.53 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.425 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.8 p -139.06 156.33 47.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.702 -0.226 . . . . 0.0 110.405 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 37.5 p -142.57 -178.21 5.66 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.1 p -74.39 -0.79 18.42 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 121.337 0.589 . . . . 0.0 110.646 173.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 4.2 m0 -93.26 6.42 48.14 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 177.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.9 m -91.41 117.1 29.39 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -176.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -122.51 -56.91 0.2 Allowed Glycine 0 N--CA 1.417 -2.583 0 N-CA-C 107.653 -2.179 . . . . 0.0 107.653 170.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -68.48 -18.76 64.47 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 179.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 28.7 m -64.86 -30.46 71.46 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.182 0.515 . . . . 0.0 109.818 178.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 89.2 mt -68.97 -28.37 66.56 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.579 -173.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -63.85 -32.87 74.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.03 0.443 . . . . 0.0 110.836 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.483 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 13.0 tp -84.19 -43.57 14.81 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.374 177.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -55.9 -54.06 49.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.28 -176.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.3 m -63.72 -30.03 71.18 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-O 121.106 0.479 . . . . 0.0 110.973 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.17 -38.68 82.34 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.047 178.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 70.8 mt -69.94 -39.49 76.07 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.788 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 60.5 m -58.55 -43.26 89.27 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-O 121.329 0.585 . . . . 0.0 110.069 174.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.35 -37.77 83.76 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.05 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -79.32 5.8 11.56 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 123.729 0.812 . . . . 0.0 112.712 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 61.84 26.34 15.95 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.81 0.844 . . . . 0.0 111.344 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 76.9 mt -84.89 125.0 40.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 -178.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.29 115.99 26.19 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.488 -176.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -138.35 164.23 29.83 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.328 0.585 . . . . 0.0 111.266 -174.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -127.92 125.94 40.53 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 8' ' ' ILE 0.254 0.0 OUTLIER -100.01 132.78 45.16 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.506 0.67 . . . . 0.0 111.121 178.45 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.401 ' CG1' HG23 ' A' ' 36' ' ' ILE . 13.0 t -82.7 134.89 25.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -168.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -56.59 -0.69 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 130.544 3.538 . . . . 0.0 114.748 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.401 HG23 ' CG1' ' A' ' 34' ' ' VAL . 31.5 pt -41.98 -27.87 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 N-CA-C 117.862 2.541 . . . . 0.0 117.862 -163.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -67.92 -13.49 62.2 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 119.529 1.059 . . . . 0.0 113.336 -173.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 -116.17 -4.65 11.92 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 119.916 -0.714 . . . . 0.0 110.479 177.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -128.96 108.77 10.68 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -176.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -52.05 -38.25 56.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 113.577 -1.647 . . . . 0.0 113.818 -176.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.34 -52.38 61.76 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -174.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.431 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -87.0 -26.61 23.69 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.876 -177.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' A' ' 36' ' ' ILE . . . -66.09 -38.09 87.38 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.351 0.596 . . . . 0.0 110.639 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -72.66 -29.18 63.22 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.152 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -68.39 -29.4 68.08 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.516 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 42' ' ' ALA . 44.9 t -63.66 -32.04 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 121.463 0.649 . . . . 0.0 109.658 177.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.81 -39.93 46.25 Favored Glycine 0 N--CA 1.439 -1.115 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 177.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.2 m -63.79 -29.67 70.85 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.503 0.721 . . . . 0.0 112.331 -178.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.9 m -91.56 -4.86 10.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -116.03 -32.33 5.43 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.55 65.37 0.53 Allowed Glycine 0 N--CA 1.431 -1.651 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.741 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.33 -46.25 2.81 Favored Glycine 0 C--N 1.316 -0.536 0 C-N-CA 121.287 -0.482 . . . . 0.0 112.846 175.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -90.66 154.21 19.74 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -176.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -105.12 82.74 1.88 Allowed 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.48 0.657 . . . . 0.0 109.301 178.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.1 m -74.98 128.08 34.74 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.727 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 1.704 15.3 m -55.23 -88.0 0.0 OUTLIER Pre-proline 0 CA--C 1.447 -2.989 1 N-CA-C 124.219 4.896 . . . . 0.0 124.219 -176.946 . . . . . . . . 3 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -75.88 77.63 3.36 Favored 'Trans proline' 0 N--CA 1.406 -3.672 0 CA-C-N 121.303 1.501 . . . . 0.0 113.251 -167.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.9 m -103.87 130.68 51.48 Favored 'General case' 0 N--CA 1.399 -2.976 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.1 p -114.74 131.96 65.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-O 121.228 0.537 . . . . 0.0 110.095 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.465 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 26.1 ttpp -104.95 119.97 40.3 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 174.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -89.98 168.06 12.31 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.257 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.46 -10.3 57.45 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.329 175.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -71.06 -19.26 62.5 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.252 178.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.53 -22.21 41.68 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -178.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.2 m -82.09 149.96 27.77 Favored 'General case' 0 C--O 1.255 1.383 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.3 p -114.15 139.32 49.44 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.3 mp -117.67 115.89 25.96 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 51.4 m -87.75 112.01 21.95 Favored 'General case' 0 N--CA 1.411 -2.41 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.207 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 54.89 70.88 1.46 Allowed Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 124.673 1.189 . . . . 0.0 112.548 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -94.21 -175.94 0.46 Allowed 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.501 2.134 . . . . 0.0 110.337 173.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.426 ' O ' HG23 ' A' ' 75' ' ' VAL . 10.3 t -100.16 163.4 12.43 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.31 97.36 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 123.199 0.599 . . . . 0.0 112.125 -175.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -60.82 -37.13 80.96 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.927 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -69.91 -41.11 75.11 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.833 -179.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 71' ' ' SER . 98.0 t -59.54 -42.3 87.59 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.562 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 177.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -61.25 -44.0 97.96 Favored 'General case' 0 CA--C 1.556 1.196 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.922 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.02 -24.28 58.34 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.141 0.496 . . . . 0.0 112.227 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.4 ' O ' ' HG2' ' A' ' 81' ' ' LYS . 74.1 mmtt -84.86 -25.15 28.22 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 174.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.538 HD13 HD21 ' A' ' 6' ' ' LEU . 24.4 tp -68.87 -40.73 79.14 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.3 m -61.78 -32.98 55.58 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.83 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.325 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 14.6 ptmm? -81.04 -30.34 34.87 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.651 -0.82 . . . . 0.0 111.077 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.9 pp -85.46 -32.06 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.204 -175.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.308 -1.229 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.378 178.928 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.371 0 CA-C-O 121.156 0.503 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -131.82 135.48 46.76 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.939 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.7 m -108.27 124.98 51.14 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 177.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 62.0 mt -113.33 134.56 55.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-O 121.348 0.594 . . . . 0.0 110.556 -176.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.449 ' CD1' HG22 ' A' ' 46' ' ' VAL . 97.3 m-85 -85.83 128.07 34.72 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.434 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 13.7 p -139.19 147.94 42.49 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -176.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.418 HG23 ' HG3' ' A' ' 37' ' ' GLU . 50.9 m -148.88 142.84 25.8 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 171.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.7 p -70.81 -4.39 23.85 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -172.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -39.23 94.1 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 122.553 1.168 . . . . 0.0 111.493 178.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.1 t -93.98 132.65 38.23 Favored 'General case' 0 N--CA 1.42 -1.942 0 CA-C-N 113.491 -1.686 . . . . 0.0 112.754 -169.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -92.74 -35.81 6.33 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.041 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -63.18 -36.35 83.33 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.442 0.639 . . . . 0.0 110.833 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.676 ' SG ' ' HB ' ' A' ' 56' ' ' VAL . 62.2 m -57.12 -42.05 80.16 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.257 177.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.3 tt -72.12 -30.21 64.84 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.189 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.3 tpp180 -62.9 -47.27 84.01 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.063 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.439 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 29.7 tp -73.48 -39.04 65.18 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.008 178.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -55.34 -47.45 75.68 Favored 'General case' 0 C--O 1.245 0.861 0 C-N-CA 124.05 0.94 . . . . 0.0 110.639 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 p -69.88 -35.06 74.36 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.573 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.32 -44.94 96.36 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 177.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 87.9 mt -63.71 -39.4 94.21 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.425 178.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.6 m -64.93 -43.55 92.4 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.222 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.2 -22.95 66.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.28 0.562 . . . . 0.0 110.91 178.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -95.34 11.41 32.76 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.34 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 65.97 16.09 10.33 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.834 1.254 . . . . 0.0 111.016 175.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 77.5 mt -78.81 122.64 34.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.654 -0.654 . . . . 0.0 109.262 -179.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.86 129.56 38.74 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.867 -178.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -142.89 161.13 38.91 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.527 -175.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -119.77 124.07 45.27 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 176.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 13.0 pt-20 -91.94 146.08 24.03 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -178.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 t -85.57 156.23 3.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.867 -175.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -83.0 0.3 45.36 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 127.101 2.16 . . . . 0.0 113.683 -176.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.6 pt -42.95 -29.91 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 -168.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.418 ' HG3' HG23 ' A' ' 11' ' ' THR . 40.8 tt0 -61.14 -33.76 73.92 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.509 0.671 . . . . 0.0 110.186 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -123.74 24.0 8.56 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.026 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -148.91 100.88 3.12 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.244 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -67.66 -21.03 65.38 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.73 -43.31 84.57 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -176.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.47 -20.74 31.24 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.932 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.9 -38.16 90.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.175 178.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -58.06 -39.84 79.48 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.364 174.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -68.83 -29.19 67.47 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.027 -175.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.449 HG22 ' CD1' ' A' ' 9' ' ' TYR . 58.2 t -63.2 -43.59 98.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 177.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.97 -18.88 77.99 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.469 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.7 t -82.43 -30.42 30.11 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 120.6 0.238 . . . . 0.0 110.398 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.7 m -81.75 -37.0 14.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.963 178.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -119.17 87.0 2.65 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 122.439 1.114 . . . . 0.0 109.075 172.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -49.51 118.37 5.37 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 113.293 -1.776 . . . . 0.0 115.566 -170.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.4 -20.72 49.34 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 121.366 -0.445 . . . . 0.0 114.117 175.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -126.74 171.44 11.19 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 117.71 0.755 . . . . 0.0 109.344 -177.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -122.32 70.28 0.98 Allowed 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 170.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.1 m -72.08 122.88 21.69 Favored 'General case' 0 C--O 1.248 1.02 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.676 ' HB ' ' SG ' ' A' ' 17' ' ' CYS . 9.4 t -69.36 -65.85 1.11 Allowed Pre-proline 0 CA--C 1.47 -2.126 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -170.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.652 ' HD3' ' SG ' ' A' ' 17' ' ' CYS . 43.9 Cg_endo -77.04 72.31 5.91 Favored 'Trans proline' 0 N--CA 1.403 -3.827 0 CA-C-N 121.755 1.662 . . . . 0.0 112.744 -167.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.424 ' O ' ' HD2' ' A' ' 9' ' ' TYR . 81.6 m -107.72 131.45 54.41 Favored 'General case' 1 N--CA 1.366 -4.637 0 CA-C-N 112.97 -1.923 . . . . 0.0 106.422 179.819 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.2 p -115.43 134.52 58.34 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.366 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.745 -178.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -112.65 119.28 37.56 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 175.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -88.66 159.44 17.84 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.95 -20.5 38.16 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.525 0.679 . . . . 0.0 111.289 177.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -67.68 -18.55 64.97 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.573 1.149 . . . . 0.0 111.22 177.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.95 -9.17 59.82 Favored Glycine 0 CA--C 1.503 -0.695 0 N-CA-C 111.466 -0.653 . . . . 0.0 111.466 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.8 p -81.07 136.03 35.9 Favored 'General case' 0 N--CA 1.412 -2.338 0 CA-C-N 114.948 -0.626 . . . . 0.0 111.088 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.2 p -114.04 137.93 51.06 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 177.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.3 mp -127.43 128.18 45.35 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 61.5 m -105.35 123.88 48.61 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 55.41 54.23 9.43 Favored Pre-proline 0 N--CA 1.477 0.917 0 C-N-CA 124.258 1.023 . . . . 0.0 113.117 -177.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -83.27 166.48 14.23 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.629 1.553 . . . . 0.0 111.235 178.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.4 m -87.38 155.55 19.98 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 175.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.29 -37.01 83.89 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.924 0.392 . . . . 0.0 111.328 -177.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -64.71 -34.88 79.36 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.885 178.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -67.04 -44.37 80.38 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.1 t -61.01 -45.48 98.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.835 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -58.37 -48.87 79.23 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.185 178.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.33 -22.35 62.81 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.89 0.376 . . . . 0.0 111.92 -178.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.486 ' O ' HG13 ' A' ' 82' ' ' ILE . 47.6 mmtm -80.89 -43.31 20.05 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 39.9 tp -54.3 -48.49 71.24 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.82 0.7 . . . . 0.0 110.475 -176.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.0 m -59.4 -41.31 84.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.135 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -81.36 -38.28 26.88 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -176.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 78' ' ' LYS 0.255 2.5 pp -81.44 -37.4 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -176.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.459 ' N ' HD12 ' A' ' 82' ' ' ILE . . . . . . . . 0 C--N 1.321 -0.671 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.892 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 mmt . . . . . 0 N--CA 1.451 -0.399 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.3 p -78.93 100.15 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 122.0 0.905 . . . . 0.0 109.495 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 21.6 m -73.87 105.9 5.35 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.091 -0.958 . . . . 0.0 112.086 -175.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -84.98 99.94 11.32 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.595 177.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.02 -0.87 57.33 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.963 -176.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 49.6 mt -111.54 129.23 56.12 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 116.344 -0.389 . . . . 0.0 109.975 -179.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 26.2 m -103.56 107.95 19.01 Favored 'General case' 0 C--N 1.276 -2.626 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 173.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.53 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 57.8 mt -107.27 133.07 53.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 CA-C-O 121.059 0.457 . . . . 0.0 109.775 -176.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.44 ' HD1' ' O ' ' A' ' 58' ' ' THR . 89.5 m-85 -87.16 128.18 35.13 Favored 'General case' 0 C--N 1.278 -2.509 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.464 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 21.1 p -140.29 163.93 31.45 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.581 0.229 . . . . 0.0 111.329 -178.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.1 p -146.11 166.51 25.94 Favored 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 124.927 1.291 . . . . 0.0 107.795 176.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.0 t -74.78 -21.86 59.08 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 107.581 -1.266 . . . . 0.0 107.581 173.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 1.3 m0 -81.86 80.46 8.15 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 177.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.8 t -132.94 164.7 26.37 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.436 0.636 . . . . 0.0 112.439 -168.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -167.85 -81.34 0.05 OUTLIER Glycine 0 N--CA 1.432 -1.603 0 N-CA-C 108.422 -1.871 . . . . 0.0 108.422 177.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -58.47 -31.75 68.11 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 123.891 0.876 . . . . 0.0 112.551 177.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.447 ' HA ' ' HB3' ' A' ' 57' ' ' PRO . 0.5 OUTLIER -64.49 -36.99 85.99 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.547 178.08 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 32.2 tp -68.04 -31.88 71.85 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.069 -176.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.9 mmp_? -58.28 -56.13 26.09 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.9 tp -65.09 -39.0 92.55 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.425 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -60.98 -35.94 78.13 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.76 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 49.9 m -70.51 -44.6 67.26 Favored 'General case' 0 C--O 1.243 0.731 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 177.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.46 -46.33 89.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.898 -179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.7 mt -68.05 -37.48 81.38 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 111.841 0.311 . . . . 0.0 111.841 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 32.4 m -67.12 -40.85 86.87 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-O 121.007 0.432 . . . . 0.0 110.179 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.65 -25.4 63.9 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.55 0.69 . . . . 0.0 110.94 178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -88.25 6.9 34.69 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.983 178.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 72.9 mtm180 65.34 29.12 11.66 Favored 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 124.475 1.11 . . . . 0.0 111.924 176.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.457 HG23 HD22 ' A' ' 79' ' ' LEU . 80.2 mt -91.69 123.41 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.534 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.707 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.41 126.26 34.77 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.356 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -136.46 156.67 48.28 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.722 -177.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -118.6 114.85 23.42 Favored 'General case' 0 C--N 1.285 -2.226 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 177.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.53 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 16.4 pt-20 -91.12 144.82 25.23 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-O 121.217 0.532 . . . . 0.0 110.796 -177.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.6 t -89.53 152.86 3.27 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.181 0 CA-C-O 122.07 0.938 . . . . 0.0 112.48 -172.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -82.76 2.27 34.75 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 127.944 2.498 . . . . 0.0 114.3 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 39.1 pt -41.56 -26.79 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.835 0 N-CA-C 116.097 1.888 . . . . 0.0 116.097 -167.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -61.83 -41.61 98.0 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.738 0.78 . . . . 0.0 109.131 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -100.66 -36.95 8.96 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-N 114.699 -1.137 . . . . 0.0 109.313 -178.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -90.92 99.85 12.81 Favored 'General case' 0 C--O 1.245 0.842 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.26 -178.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.8 ptp180 -65.04 -38.37 90.64 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 114.352 1.241 . . . . 0.0 114.352 -171.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.56 -29.14 70.44 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.497 0.555 . . . . 0.0 112.497 -174.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.01 -23.42 25.0 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.382 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.67 -39.55 80.57 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.172 0.51 . . . . 0.0 110.117 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.468 ' CD ' HH22 ' A' ' 54' ' ' ARG . 19.2 mm-40 -67.02 -32.26 73.35 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.333 -0.848 . . . . 0.0 110.007 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.4 t80 -67.61 -30.14 69.66 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.756 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.7 t -62.38 -42.93 97.44 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 53' ' ' ASN . . . -60.55 -34.4 85.71 Favored Glycine 0 N--CA 1.442 -0.919 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.337 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.4 m -68.53 -48.13 65.13 Favored 'General case' 0 N--CA 1.435 -1.222 0 C-N-CA 122.872 0.469 . . . . 0.0 111.535 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.2 m -73.99 -27.6 22.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -176.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 53' ' ' ASN . 15.4 m120 -87.95 -28.74 21.28 Favored 'General case' 0 C--N 1.315 -0.925 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.128 177.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.15 65.27 1.07 Allowed Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.364 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 90.79 -12.43 68.81 Favored Glycine 0 C--N 1.315 -0.609 0 C-N-CA 121.234 -0.507 . . . . 0.0 112.485 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.475 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 93.2 m-20 -111.91 161.38 16.47 Favored 'General case' 0 CA--C 1.486 -1.504 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.468 HH22 ' CD ' ' A' ' 44' ' ' GLU . 84.4 mtt180 -127.64 84.09 2.22 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 173.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.4 m -85.64 132.49 34.15 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.451 ' CG1' ' HA ' ' A' ' 10' ' ' THR . 21.3 t -66.42 -67.12 1.02 Allowed Pre-proline 0 CA--C 1.472 -2.057 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -173.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.447 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . 91.7 Cg_endo -81.15 60.47 7.82 Favored 'Trans proline' 1 N--CA 1.399 -4.073 0 CA-C-N 121.115 1.434 . . . . 0.0 112.915 -164.599 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.44 ' O ' ' HD1' ' A' ' 9' ' ' TYR . 53.6 m -91.23 127.08 36.52 Favored 'General case' 1 N--CA 1.377 -4.075 0 C-N-CA 126.363 1.865 . . . . 0.0 106.731 177.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.0 p -115.19 132.73 63.62 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.984 0 CA-C-O 120.916 0.389 . . . . 0.0 110.172 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 5.0 ttpm? -115.01 126.91 55.29 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 174.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -88.94 173.81 8.28 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.389 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.09 -10.17 47.22 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.978 0.894 . . . . 0.0 109.727 174.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -78.63 -18.64 54.17 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.419 -1.264 . . . . 0.0 110.271 177.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.02 -22.12 41.33 Favored Glycine 0 CA--C 1.521 0.457 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.778 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 32.8 t -75.2 149.79 38.84 Favored 'General case' 0 C--O 1.253 1.284 0 CA-C-O 120.868 0.366 . . . . 0.0 110.61 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 14.2 p -114.5 139.73 49.31 Favored 'General case' 0 N--CA 1.425 -1.686 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.069 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 58.1 mt -119.83 113.91 21.31 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 174.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.8 m -87.22 112.83 22.39 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 58.04 65.43 3.26 Favored Pre-proline 0 N--CA 1.487 1.42 0 C-N-CA 123.939 0.896 . . . . 0.0 112.366 -177.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -86.22 172.93 6.99 Favored 'Trans proline' 0 C--O 1.249 1.073 0 C-N-CA 121.955 1.77 . . . . 0.0 112.003 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.3 m -93.78 153.3 18.38 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 174.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.71 -36.23 83.17 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.111 0.481 . . . . 0.0 110.708 -177.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -59.31 -45.72 90.54 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-N 114.955 -1.02 . . . . 0.0 110.974 179.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -60.02 -50.53 73.36 Favored 'General case' 0 CA--C 1.506 -0.748 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.871 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.9 t -58.21 -45.82 88.79 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.519 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.982 -177.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -67.15 -38.13 84.95 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.335 -178.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.55 -31.02 61.96 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-O 121.247 0.546 . . . . 0.0 110.869 -179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -76.59 -37.64 56.14 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.894 175.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.457 HD22 HG23 ' A' ' 29' ' ' ILE . 21.6 tp -58.38 -51.05 71.46 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 34.6 m -60.49 -32.12 50.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.596 -0.729 . . . . 0.0 112.669 -177.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -81.8 -40.8 22.03 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 119.869 -0.732 . . . . 0.0 112.016 177.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.3 pp -76.1 -24.43 16.4 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.426 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -176.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -90.77 -32.73 16.01 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 176.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 70.49 29.35 69.97 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 -178.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.3 tp -146.2 153.65 40.86 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 64.03 21.72 12.69 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-O 122.095 0.95 . . . . 0.0 109.736 -176.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.8 t60 -90.2 -33.03 16.35 Favored 'General case' 0 N--CA 1.434 -1.255 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.343 -174.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 66.9 t60 . . . . . 0 N--CA 1.428 -1.557 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 -177.73 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.8 mmm . . . . . 0 CA--C 1.515 -0.396 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.9 m -74.28 -12.16 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 7.2 m 65.1 44.61 3.3 Favored 'General case' 0 CA--C 1.552 1.038 0 CA-C-O 122.282 1.039 . . . . 0.0 109.475 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -81.39 92.62 6.45 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.774 179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -87.5 1.1 54.46 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.737 -177.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.6 tp -129.51 136.74 50.23 Favored 'General case' 0 N--CA 1.421 -1.904 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 -179.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 89.6 m -123.34 122.16 37.62 Favored 'General case' 0 C--N 1.284 -2.249 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 67.4 mt -111.85 133.49 57.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 CA-C-O 121.298 0.571 . . . . 0.0 110.205 -177.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -87.95 129.39 35.26 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.047 176.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.5 p -134.03 166.04 23.64 Favored 'General case' 0 N--CA 1.432 -1.325 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.607 -178.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 8.3 m -149.84 144.08 25.75 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.56 -1.645 . . . . 0.0 106.56 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.5 m -54.98 -44.42 74.43 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 123.435 0.459 . . . . 0.0 110.887 176.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 36.5 p90 -86.75 89.17 7.86 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 122.09 0.948 . . . . 0.0 109.459 175.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 44.1 t -163.57 154.68 16.47 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.643 -1.162 . . . . 0.0 109.072 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -135.89 -44.73 0.1 OUTLIER Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 177.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -63.6 -33.48 75.71 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.131 0.572 . . . . 0.0 111.38 -176.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.445 ' HA ' ' HB3' ' A' ' 57' ' ' PRO . 10.7 p -65.41 -34.48 78.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.28 -179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 87.9 mt -61.85 -41.94 98.43 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 115.872 -0.603 . . . . 0.0 112.019 -175.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 6.5 tpm_? -59.11 -44.81 92.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.968 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.9 tp -76.37 -38.64 55.51 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.648 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.471 ' HG2' ' OH ' ' A' ' 31' ' ' TYR . 16.4 ttpp -63.14 -43.46 98.29 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.548 -176.277 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.2 t -71.12 -28.18 64.11 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.34 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.35 -41.87 84.42 Favored 'General case' 0 CA--C 1.507 -0.701 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.107 178.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.446 HD22 HD12 ' A' ' 29' ' ' ILE . 92.7 mt -69.6 -35.22 75.11 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.76 178.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.6 m -65.95 -42.93 89.37 Favored 'General case' 0 CA--C 1.548 0.892 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 176.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.0 -31.67 72.39 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-O 121.416 0.626 . . . . 0.0 110.458 176.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -79.42 0.44 29.31 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.274 176.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 30.8 mmt180 69.02 28.26 5.15 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.071 1.349 . . . . 0.0 112.176 174.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.446 HD12 HD22 ' A' ' 24' ' ' LEU . 74.7 mt -87.64 123.05 40.06 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.326 179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -82.92 117.36 22.71 Favored 'General case' 0 CA--C 1.508 -0.65 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.681 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.471 ' OH ' ' HG2' ' A' ' 21' ' ' LYS . 46.4 p90 -136.53 164.0 29.2 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -119.85 138.85 53.14 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 171.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.466 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 6.7 pt-20 -101.7 137.97 39.31 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -177.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -94.43 138.57 20.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 115.265 1.58 . . . . 0.0 115.265 -169.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -60.9 2.13 0.12 Allowed 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 130.186 3.394 . . . . 0.0 116.074 176.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 37.2 pt -41.3 -27.86 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.519 3.001 0 N-CA-C 117.161 2.282 . . . . 0.0 117.161 -162.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -68.97 -24.29 64.22 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 119.552 1.069 . . . . 0.0 110.856 178.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -113.02 8.63 18.49 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -142.85 89.98 2.17 Favored 'General case' 0 C--O 1.25 1.083 0 CA-C-O 121.471 0.653 . . . . 0.0 109.837 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.4 ' HA ' ' HB3' ' A' ' 43' ' ' ALA . 16.3 ptm180 -65.82 -29.23 69.67 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.731 -1.122 . . . . 0.0 113.7 -173.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.81 -37.32 76.12 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.348 0.594 . . . . 0.0 111.303 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.541 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -87.1 -30.38 21.15 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.129 177.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.4 ' HB3' ' HA ' ' A' ' 40' ' ' ARG . . . -64.67 -42.99 94.99 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.108 0.48 . . . . 0.0 111.508 -178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -68.91 -29.34 67.59 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.182 178.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -68.04 -40.64 82.84 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.265 175.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 42' ' ' ALA . 73.8 t -52.85 -51.04 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.568 177.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.47 -32.23 83.46 Favored Glycine 0 N--CA 1.437 -1.288 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.319 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.8 t -65.48 -33.73 76.61 Favored 'General case' 0 C--N 1.313 -0.999 0 C-N-CA 122.272 0.229 . . . . 0.0 110.996 -178.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.3 m -95.1 -10.0 9.2 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -178.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -96.29 -51.35 4.42 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.004 0.431 . . . . 0.0 110.018 177.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 133.13 -138.66 10.3 Favored Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 -176.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -80.99 -21.65 62.73 Favored Glycine 0 C--N 1.306 -1.111 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -101.53 115.07 29.69 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 41.7 ttm180 -71.54 114.75 9.95 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 177.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 39.1 m -99.02 134.5 41.77 Favored 'General case' 0 C--N 1.282 -2.35 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 19.0 t -75.3 -64.52 0.58 Allowed Pre-proline 0 CA--C 1.463 -2.379 0 CA-C-O 117.23 -1.367 . . . . 0.0 113.98 -176.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.445 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . 82.9 Cg_endo -78.78 65.9 8.7 Favored 'Trans proline' 1 N--CA 1.399 -4.076 0 CA-C-N 121.261 1.486 . . . . 0.0 113.029 -167.067 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 96.3 m -92.32 121.37 33.75 Favored 'General case' 1 N--CA 1.376 -4.169 0 CA-C-N 113.146 -1.843 . . . . 0.0 106.051 178.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 66' ' ' THR . 12.7 p -105.61 137.85 33.48 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 C-N-CA 120.505 -0.478 . . . . 0.0 109.998 -178.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -116.44 121.04 40.72 Favored 'General case' 0 C--N 1.291 -1.967 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -85.31 161.64 19.43 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.928 178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -49.69 -32.52 13.56 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 -175.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -90.58 -6.75 54.28 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 120.386 -0.526 . . . . 0.0 111.5 -176.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.6 1.88 30.78 Favored Glycine 0 C--O 1.241 0.551 0 C-N-CA 120.113 -1.041 . . . . 0.0 113.773 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.5 m -73.33 125.49 27.94 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 117.294 0.547 . . . . 0.0 109.651 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 49.5 p -114.2 138.36 50.56 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.9 mp -122.59 118.53 28.42 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.97 -0.382 . . . . 0.0 109.97 178.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 61.2 m -88.05 112.31 22.5 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.11 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 58.86 67.67 1.94 Allowed Pre-proline 0 N--CA 1.482 1.148 0 C-N-CA 124.057 0.943 . . . . 0.0 112.883 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -86.79 -174.73 1.47 Allowed 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.006 1.804 . . . . 0.0 112.227 176.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.424 ' O ' HG23 ' A' ' 75' ' ' VAL . 50.5 m -116.87 150.41 38.47 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 176.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.78 -48.93 72.07 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -174.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -71.9 -24.2 61.61 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 120.639 0.257 . . . . 0.0 111.665 -176.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.56 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 38.1 mm-40 -71.77 -46.6 57.85 Favored 'General case' 0 CA--C 1.491 -1.295 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 173.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 71' ' ' SER . 89.1 t -59.98 -44.12 93.95 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 O-C-N 123.842 0.714 . . . . 0.0 110.113 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.421 ' HB3' ' HE2' ' A' ' 76' ' ' LYS . 33.1 ttpt -62.24 -44.46 96.51 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.652 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.72 -21.17 63.49 Favored 'General case' 0 C--O 1.238 0.487 0 CA-C-O 121.195 0.522 . . . . 0.0 111.538 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.606 ' O ' ' HG3' ' A' ' 81' ' ' LYS . 46.8 mmtm -84.5 -38.92 19.49 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 175.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 18.9 tp -56.9 -49.01 76.86 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.767 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.1 m -61.33 -34.1 59.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.59 -0.732 . . . . 0.0 112.152 -177.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.606 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -81.76 -32.66 31.36 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 120.561 -0.456 . . . . 0.0 111.588 -179.079 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.2 pp -82.21 -12.52 12.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.136 0.493 . . . . 0.0 111.673 -179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -91.57 4.08 53.47 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.394 0.616 . . . . 0.0 110.545 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 85.14 -120.06 5.21 Favored Glycine 0 N--CA 1.431 -1.669 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.565 178.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 24.5 tp -106.03 0.77 25.89 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 121.348 0.594 . . . . 0.0 109.557 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -85.2 94.85 8.99 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.38 0.609 . . . . 0.0 111.05 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -95.55 -29.46 14.34 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.126 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 . . . . . 0 C--N 1.313 -0.979 0 CA-C-O 118.951 -0.547 . . . . 0.0 110.494 -171.517 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mpp? . . . . . 0 CA--C 1.518 -0.255 0 CA-C-O 120.583 0.23 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.2 p -116.51 98.53 6.86 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 CA-C-O 122.166 0.984 . . . . 0.0 111.218 -179.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 12.7 t -109.31 173.66 6.22 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.123 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.51 89.31 2.7 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.567 0.699 . . . . 0.0 110.355 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -96.32 0.68 51.09 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.775 -178.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.9 mt -119.83 137.99 53.65 Favored 'General case' 0 CA--C 1.489 -1.377 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.951 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.4 m -106.91 113.95 27.74 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 107.281 -1.378 . . . . 0.0 107.281 174.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.408 HG22 HG23 ' A' ' 10' ' ' THR . 51.9 mt -112.19 125.97 69.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 CA-C-O 121.473 0.654 . . . . 0.0 110.094 -177.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -80.97 128.14 33.35 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 114.961 -1.018 . . . . 0.0 109.98 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.489 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 7.4 p -140.85 178.16 7.54 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.056 0.543 . . . . 0.0 111.747 -174.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.523 ' HB ' ' O ' ' A' ' 13' ' ' TRP . 27.4 m -156.42 158.81 37.96 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 177.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.7 m -64.8 -51.62 61.22 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 175.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.523 ' O ' ' HB ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -64.62 109.04 1.87 Allowed 'General case' 0 N--CA 1.428 -1.541 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 168.068 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 43.0 t -159.44 130.6 6.04 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.465 -170.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -120.97 -78.56 0.51 Allowed Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 111.385 -0.686 . . . . 0.0 111.385 178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 65.6 t80 -66.71 -33.88 76.63 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-O 120.915 0.388 . . . . 0.0 110.371 -177.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -57.56 -38.57 75.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.984 177.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -67.82 -35.09 77.99 Favored 'General case' 0 C--O 1.245 0.824 0 C-N-CA 123.675 0.79 . . . . 0.0 109.979 -175.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -62.29 -51.69 66.68 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.216 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.459 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 24.8 tp -68.26 -38.78 82.1 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.072 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -59.16 -43.91 92.09 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.616 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 33.2 m -68.7 -37.81 79.81 Favored 'General case' 0 CA--C 1.547 0.857 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.273 178.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.61 -42.17 98.25 Favored 'General case' 0 CA--C 1.511 -0.531 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.875 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 78.6 mt -68.21 -39.53 82.37 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.623 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.5 m -65.35 -35.86 82.27 Favored 'General case' 0 CA--C 1.556 1.195 0 CA-C-O 121.446 0.641 . . . . 0.0 109.987 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.2 -26.03 61.89 Favored 'General case' 0 C--O 1.219 -0.546 0 CA-C-O 121.326 0.584 . . . . 0.0 111.19 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 16.4 m-80 -93.25 11.52 27.76 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.877 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 64.93 25.2 12.75 Favored 'General case' 0 N--CA 1.492 1.65 0 C-N-CA 124.275 1.03 . . . . 0.0 112.394 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 82.0 mt -89.95 116.13 30.74 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.057 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.47 128.82 36.01 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.003 -177.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -137.82 168.96 18.63 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.519 -177.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -119.71 121.54 39.45 Favored 'General case' 0 C--N 1.287 -2.125 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.489 ' HB2' ' OG1' ' A' ' 10' ' ' THR . 12.5 pt-20 -91.81 136.72 32.93 Favored 'General case' 0 C--O 1.245 0.816 0 CA-C-O 121.081 0.467 . . . . 0.0 110.408 -178.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 15.2 t -93.57 156.41 3.08 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.102 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 -168.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -77.09 -0.47 24.9 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 128.201 2.601 . . . . 0.0 113.866 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 13.3 pt -44.68 -21.37 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.466 0 N-CA-C 116.398 1.999 . . . . 0.0 116.398 -171.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -56.97 -52.65 64.38 Favored 'General case' 0 C--O 1.245 0.845 0 CA-C-N 118.834 0.743 . . . . 0.0 109.572 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -97.58 -36.86 10.16 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.136 177.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.452 ' ND2' ' H ' ' A' ' 42' ' ' ALA . 52.2 t30 -71.12 108.15 4.51 Favored 'General case' 0 CA--C 1.513 -0.476 0 CA-C-O 120.727 0.299 . . . . 0.0 111.013 -177.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.64 -22.14 57.07 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.316 -177.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.37 -44.95 67.03 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -177.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.452 ' H ' ' ND2' ' A' ' 39' ' ' ASN . . . -79.87 -24.85 40.94 Favored 'General case' 0 C--N 1.306 -1.299 0 C-N-CA 120.407 -0.517 . . . . 0.0 110.01 177.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.68 -30.2 69.67 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.253 0.549 . . . . 0.0 109.756 177.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 13.8 tp10 -68.77 -33.94 74.73 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.298 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.9 t80 -63.12 -44.1 96.57 Favored 'General case' 0 C--N 1.341 0.233 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.6 t -60.76 -47.52 92.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.759 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.72 -21.61 69.32 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.545 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 50.6 m -83.21 -43.59 15.95 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 176.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.8 p -73.54 -33.14 38.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -176.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -118.63 154.75 32.16 Favored 'General case' 0 C--N 1.316 -0.849 0 O-C-N 121.893 -0.504 . . . . 0.0 109.948 175.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -113.25 156.09 15.85 Favored Glycine 0 N--CA 1.438 -1.212 0 C-N-CA 120.274 -0.965 . . . . 0.0 113.031 -175.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 71.14 -104.4 1.41 Allowed Glycine 0 N--CA 1.44 -1.085 0 O-C-N 123.866 0.392 . . . . 0.0 113.014 177.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 -81.72 119.29 23.66 Favored 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.9 ttp180 -56.91 109.35 0.63 Allowed 'General case' 0 CA--C 1.516 -0.33 0 O-C-N 124.142 0.901 . . . . 0.0 109.348 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.6 m -81.27 123.65 28.67 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 108.226 -1.028 . . . . 0.0 108.226 -179.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.6 t -75.19 -62.32 0.86 Allowed Pre-proline 0 CA--C 1.469 -2.154 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.087 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -79.16 73.41 6.04 Favored 'Trans proline' 1 N--CA 1.397 -4.176 0 CA-C-N 120.604 1.252 . . . . 0.0 112.609 -164.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.5 m -101.92 120.88 41.1 Favored 'General case' 1 N--CA 1.377 -4.116 0 CA-C-N 112.709 -2.041 . . . . 0.0 106.438 -179.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.1 p -113.46 132.61 61.88 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 CA-C-O 120.996 0.427 . . . . 0.0 110.882 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -110.22 126.1 53.78 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 176.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -92.08 174.07 7.51 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.432 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.25 -18.23 63.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.819 179.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -73.57 -18.03 61.12 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.19 0.519 . . . . 0.0 110.152 176.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.34 -12.85 64.95 Favored Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 110.481 -1.048 . . . . 0.0 110.481 -176.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.2 p -75.28 145.71 41.64 Favored 'General case' 0 N--CA 1.421 -1.906 0 C-N-CA 123.211 0.605 . . . . 0.0 111.201 -178.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.6 p -114.1 139.16 49.55 Favored 'General case' 0 N--CA 1.419 -2.002 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.913 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.8 mp -117.05 123.87 47.88 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 176.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.2 m -100.82 112.62 25.08 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.894 -176.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 58.65 60.78 5.29 Favored Pre-proline 0 N--CA 1.492 1.668 0 C-N-CA 124.45 1.1 . . . . 0.0 112.906 -176.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -85.48 177.0 5.27 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.102 1.868 . . . . 0.0 111.696 176.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.402 ' O ' HG23 ' A' ' 75' ' ' VAL . 41.7 m -110.99 151.42 27.98 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 175.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.79 -34.77 63.11 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -174.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -64.01 -37.25 86.73 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 122.287 0.235 . . . . 0.0 111.192 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -73.53 -42.16 62.1 Favored 'General case' 0 CA--C 1.489 -1.38 0 C-N-CA 121.19 -0.204 . . . . 0.0 110.618 175.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 71' ' ' SER . 54.5 t -60.44 -40.8 85.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.807 -176.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -66.48 -45.13 80.67 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.866 0.365 . . . . 0.0 110.789 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.9 -35.82 74.9 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.541 0.686 . . . . 0.0 111.4 -177.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -78.13 -22.39 48.91 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 122.064 -0.397 . . . . 0.0 110.304 177.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.436 ' O ' HG13 ' A' ' 82' ' ' ILE . 26.0 tp -71.66 -46.5 58.74 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.7 m -64.94 -28.78 45.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -75.8 -29.46 58.73 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.869 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.436 HG13 ' O ' ' A' ' 79' ' ' LEU . 2.1 pp -85.69 -16.62 9.88 Favored 'Isoleucine or valine' 0 C--N 1.34 0.173 0 CA-C-O 121.443 0.64 . . . . 0.0 111.382 -176.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.11 -25.02 43.01 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.443 178.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 113.29 -156.92 15.29 Favored Glycine 0 N--CA 1.434 -1.465 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 93.3 mt -94.3 79.37 3.95 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-O 121.648 0.737 . . . . 0.0 110.756 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -102.94 -52.12 3.12 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 177.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 43.2 m-70 -91.66 78.24 5.55 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.446 175.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 19.8 t-80 . . . . . 0 C--N 1.296 -1.737 0 CA-C-O 118.1 -0.952 . . . . 0.0 108.462 -177.626 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.4 mtm . . . . . 0 CA--C 1.509 -0.633 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.7 p -141.82 147.29 21.91 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.5 p -70.05 94.39 0.87 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.263 0.554 . . . . 0.0 110.535 178.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -120.13 124.42 45.73 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.853 -177.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -103.55 1.43 32.2 Favored 'General case' 0 C--N 1.302 -1.5 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.617 -178.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.1 tp -117.94 136.86 53.22 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.309 -176.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.496 ' HB ' ' HB3' ' A' ' 60' ' ' LYS . 22.4 m -110.65 117.82 34.54 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.543 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 53.1 mt -119.98 143.53 31.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -98.64 127.76 44.68 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 177.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.43 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . 25.4 p -137.31 178.52 7.03 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 122.093 0.949 . . . . 0.0 113.459 -174.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.1 m -143.91 147.65 34.3 Favored 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 104.181 -2.526 . . . . 0.0 104.181 173.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.5 m -61.15 -43.2 99.25 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-O 121.352 0.596 . . . . 0.0 109.897 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 40.7 p90 -92.7 93.37 8.43 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-O 121.808 0.813 . . . . 0.0 111.177 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.9 t -163.3 117.31 1.61 Allowed 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.387 176.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.79 -32.16 13.64 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 111.219 -0.753 . . . . 0.0 111.219 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 32.0 t80 -68.96 -27.71 65.98 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.721 0.772 . . . . 0.0 109.666 -178.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.435 ' SG ' ' HB ' ' A' ' 56' ' ' VAL . 70.5 m -71.77 -29.88 64.97 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.118 178.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 82.7 mt -70.43 -30.15 66.94 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.285 -179.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -56.62 -44.16 80.94 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.247 177.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.422 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 28.7 tp -79.33 -41.09 28.71 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.623 179.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -56.76 -45.13 82.24 Favored 'General case' 0 C--O 1.247 0.941 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.6 m -64.04 -38.46 91.15 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.795 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.16 -44.08 80.65 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.421 -179.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 57.3 mt -69.5 -42.31 74.93 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.445 -178.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.8 m -68.92 -23.51 64.18 Favored 'General case' 0 CA--C 1.56 1.352 0 CA-C-O 121.421 0.629 . . . . 0.0 110.651 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -82.87 -12.93 57.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.294 0.569 . . . . 0.0 110.482 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -109.39 14.17 23.78 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.27 -178.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 13.9 ttm180 55.14 62.07 2.65 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.403 1.081 . . . . 0.0 111.079 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.41 ' HB ' ' HB3' ' A' ' 24' ' ' LEU . 75.8 mt -122.78 115.88 47.18 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.028 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.046 178.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.17 111.97 22.21 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -116.38 144.59 44.08 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.577 -177.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -113.74 119.78 38.55 Favored 'General case' 0 C--N 1.29 -2.005 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 177.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.543 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 12.8 pt-20 -95.51 148.13 22.82 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.881 -176.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.434 ' CG1' HG23 ' A' ' 36' ' ' ILE . 25.1 t -96.69 144.88 9.69 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -172.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -58.63 -1.77 0.17 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 128.714 2.806 . . . . 0.0 114.05 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.434 HG23 ' CG1' ' A' ' 34' ' ' VAL . 2.0 pp -45.24 -20.96 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 -172.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -54.41 -48.84 71.16 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.137 0.494 . . . . 0.0 110.039 174.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -111.46 -29.67 7.69 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.795 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -77.67 103.25 7.5 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.55 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 8.7 ptm180 -71.88 -25.78 62.07 Favored 'General case' 0 C--O 1.21 -0.997 0 C-N-CA 119.066 -1.054 . . . . 0.0 110.935 -178.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.56 -42.62 88.36 Favored 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 113.504 0.928 . . . . 0.0 113.504 -176.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.93 -21.0 26.54 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.694 -0.802 . . . . 0.0 109.956 177.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.429 ' HB3' ' HA ' ' A' ' 40' ' ' ARG . . . -68.4 -33.39 74.16 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.214 -178.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.55 ' HG2' ' O ' ' A' ' 40' ' ' ARG . 61.4 mm-40 -61.56 -36.71 81.4 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.034 178.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -66.9 -37.11 83.76 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.119 0.485 . . . . 0.0 109.979 178.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.2 t -64.0 -42.6 96.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.607 0.718 . . . . 0.0 109.129 177.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.51 -18.96 72.33 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.348 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.3 m -81.42 -38.67 26.11 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 110.196 -0.298 . . . . 0.0 110.196 177.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.7 m -80.02 -35.11 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 N-CA-C 111.865 0.32 . . . . 0.0 111.865 -178.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -83.65 137.1 33.95 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 176.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -98.89 139.15 14.29 Favored Glycine 0 C--N 1.301 -1.382 0 C-N-CA 120.399 -0.905 . . . . 0.0 111.128 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 77.53 -87.37 1.03 Allowed Glycine 0 C--N 1.313 -0.731 0 C-N-CA 121.186 -0.53 . . . . 0.0 111.827 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -119.18 145.39 46.05 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 111.707 0.262 . . . . 0.0 111.707 178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -60.95 130.98 49.14 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 123.664 0.603 . . . . 0.0 111.064 -178.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.7 m -108.55 127.68 54.16 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 104.81 -2.293 . . . . 0.0 104.81 177.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.435 ' HB ' ' SG ' ' A' ' 17' ' ' CYS . 8.1 t -73.75 -64.86 0.7 Allowed Pre-proline 0 CA--C 1.468 -2.178 0 CA-C-O 117.091 -1.433 . . . . 0.0 114.245 -171.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -73.75 80.57 2.03 Favored 'Trans proline' 1 N--CA 1.4 -4.018 0 CA-C-N 121.089 1.425 . . . . 0.0 112.65 -168.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 86.8 m -115.02 131.74 56.83 Favored 'General case' 0 N--CA 1.389 -3.503 0 CA-C-N 113.355 -1.748 . . . . 0.0 106.644 -177.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.1 p -117.69 142.91 29.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 CA-C-O 120.844 0.354 . . . . 0.0 110.909 -175.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.496 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 77.5 tttt -116.28 130.7 56.91 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 177.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -104.58 177.86 4.73 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.02 -14.15 52.02 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.471 0.653 . . . . 0.0 110.543 177.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -67.32 -19.39 65.45 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 124.208 1.003 . . . . 0.0 110.33 176.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 92.71 -22.4 33.79 Favored Glycine 0 N--CA 1.442 -0.906 0 CA-C-N 115.9 -0.591 . . . . 0.0 113.061 177.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.4 t -91.57 165.34 13.39 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.1 p -114.52 140.54 48.66 Favored 'General case' 0 N--CA 1.426 -1.672 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.208 -177.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.9 mp -107.97 121.98 45.89 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 174.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 33.8 m -98.48 114.55 26.99 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.226 -178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.3 m120 61.21 61.82 2.83 Favored Pre-proline 0 N--CA 1.481 1.094 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -178.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -91.35 174.04 2.58 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.17 1.913 . . . . 0.0 110.369 176.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.441 ' O ' HG23 ' A' ' 75' ' ' VAL . 6.2 m -89.6 151.29 21.99 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 176.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.63 -37.95 80.01 Favored 'General case' 0 C--N 1.32 -0.682 0 O-C-N 123.186 0.304 . . . . 0.0 110.756 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -57.47 -43.62 84.17 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.108 177.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.53 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 47.3 mt-10 -68.38 -44.76 74.43 Favored 'General case' 0 C--O 1.207 -1.145 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.972 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 71' ' ' SER . 59.5 t -60.16 -43.14 92.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 O-C-N 123.252 0.345 . . . . 0.0 110.531 179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.0 tmtm? -64.21 -44.71 91.09 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.27 -34.99 78.58 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.081 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.53 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 75.5 mmtt -75.07 -36.82 61.74 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 176.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 14.5 tp -61.62 -52.35 64.73 Favored 'General case' 0 C--O 1.214 -0.77 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.545 ' HB ' ' O ' ' A' ' 86' ' ' GLU . 35.5 m -61.93 -35.54 68.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -175.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.7 ptpp? -72.87 -34.1 66.51 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.154 -0.619 . . . . 0.0 111.304 179.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.1 pp -83.89 -29.71 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.056 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.77 -42.76 27.14 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 120.803 0.335 . . . . 0.0 110.591 178.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 88.91 -44.98 3.16 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 114.55 0.58 . . . . 0.0 114.55 175.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.442 ' H ' HD23 ' A' ' 85' ' ' LEU . 2.6 pt? -73.5 -4.13 31.92 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -173.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.545 ' O ' ' HB ' ' A' ' 80' ' ' VAL . 40.4 tt0 -143.07 154.32 43.83 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.45 ' HA ' ' HB ' ' A' ' 80' ' ' VAL . 44.6 t-80 -139.19 -68.91 0.43 Allowed 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 172.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 . . . . . 0 C--O 1.243 0.759 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 176.767 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.7 ttp . . . . . 0 N--CA 1.471 0.607 0 CA-C-O 120.745 0.307 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.6 p -117.02 97.43 5.47 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.229 0 CA-C-O 121.581 0.705 . . . . 0.0 109.543 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 28.8 m 74.07 -35.78 0.32 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.569 1.147 . . . . 0.0 111.683 -177.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.32 133.76 38.69 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 176.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.09 -18.78 63.27 Favored 'General case' 0 C--O 1.246 0.87 0 C-N-CA 123.212 0.605 . . . . 0.0 112.109 -176.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.537 HD11 HD21 ' A' ' 79' ' ' LEU . 8.6 mp -109.48 141.23 42.2 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-O 121.558 0.694 . . . . 0.0 111.901 -177.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.4 ' HB ' ' HB3' ' A' ' 60' ' ' LYS . 28.7 m -125.82 108.32 11.36 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 105.707 -1.961 . . . . 0.0 105.707 171.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.559 HG22 HG23 ' A' ' 10' ' ' THR . 62.4 mt -108.89 135.23 48.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.704 0 CA-C-O 121.943 0.878 . . . . 0.0 111.445 -173.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.43 ' CD1' HG22 ' A' ' 46' ' ' VAL . 98.9 m-85 -90.22 111.32 22.45 Favored 'General case' 0 C--N 1.28 -2.431 0 CA-C-N 114.258 -1.337 . . . . 0.0 108.453 178.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.559 HG23 HG22 ' A' ' 8' ' ' ILE . 6.9 p -137.31 144.33 42.56 Favored 'General case' 0 C--O 1.24 0.563 0 CA-C-O 121.169 0.509 . . . . 0.0 112.215 -178.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.6 p -130.79 165.38 23.08 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 107.189 -1.412 . . . . 0.0 107.189 174.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.9 p -86.73 0.23 55.08 Favored 'General case' 0 C--N 1.296 -1.742 0 CA-C-O 121.373 0.606 . . . . 0.0 110.723 176.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 10.6 m0 -83.0 12.84 4.47 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.518 -173.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.583 ' SG ' HG21 ' A' ' 56' ' ' VAL . 6.7 p -146.26 171.8 14.43 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 122.05 -0.406 . . . . 0.0 111.402 -177.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -116.39 -36.63 1.08 Allowed Glycine 0 N--CA 1.436 -1.328 0 N-CA-C 111.554 -0.618 . . . . 0.0 111.554 176.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -64.69 -23.4 67.24 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 121.207 0.527 . . . . 0.0 112.068 -177.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 1.9 p -70.48 -43.1 70.45 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.154 178.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 11.1 mp -64.61 -31.43 72.64 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.924 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 34.8 mmt180 -61.06 -52.07 66.5 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 123.485 0.491 . . . . 0.0 110.673 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.4 tp -68.35 -41.92 80.01 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.987 179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -56.78 -50.04 73.49 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 115.199 -0.91 . . . . 0.0 110.691 -177.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.5 p -68.1 -34.2 75.95 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.54 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.9 -48.77 78.99 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.215 178.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.6 mt -63.89 -37.0 85.77 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.325 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 58.0 m -59.53 -48.81 80.2 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.813 177.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.84 -34.66 77.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.883 -178.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -81.93 5.15 19.96 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -177.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 78.2 mtp180 70.07 24.55 4.99 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 124.046 0.938 . . . . 0.0 113.121 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.7 mt -93.94 115.49 32.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -77.68 144.87 37.0 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.95 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -159.71 145.09 15.54 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.837 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 53.8 m-20 -102.39 133.4 47.39 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 175.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.429 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 12.7 pt-20 -94.13 142.37 27.48 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.415 HG21 ' CE1' ' A' ' 9' ' ' TYR . 13.6 t -87.83 144.69 8.7 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 CA-C-O 121.717 0.77 . . . . 0.0 112.181 -175.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -65.17 -1.84 2.51 Favored 'General case' 0 CA--C 1.56 1.357 0 C-N-CA 127.76 2.424 . . . . 0.0 113.91 -176.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.2 pt -44.3 -23.78 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.51 2.564 0 N-CA-C 116.334 1.975 . . . . 0.0 116.334 -172.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -65.51 -25.43 67.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.573 0.701 . . . . 0.0 109.262 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 43.4 m-70 -112.32 -46.74 3.15 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.199 -0.909 . . . . 0.0 108.906 175.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.538 ' ND2' ' H ' ' A' ' 42' ' ' ALA . 56.9 t30 -70.18 111.11 5.58 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.948 -176.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 21.1 ptp180 -73.53 -24.83 60.19 Favored 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.063 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -69.41 -54.6 13.56 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -175.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.538 ' H ' ' ND2' ' A' ' 39' ' ' ASN . . . -72.75 -20.97 61.09 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 120.525 -0.47 . . . . 0.0 110.647 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.03 93.45 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 121.182 0.515 . . . . 0.0 110.925 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -72.95 -29.97 63.49 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.162 0.506 . . . . 0.0 110.414 177.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -68.1 -33.07 73.83 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.752 177.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 42' ' ' ALA . 76.7 t -55.49 -56.2 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.463 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.498 175.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.41 -33.99 78.76 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.088 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 31.3 m -65.82 -42.83 90.09 Favored 'General case' 0 C--N 1.315 -0.894 0 C-N-CA 122.862 0.465 . . . . 0.0 112.087 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.8 m -80.92 -19.54 11.59 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.873 -178.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -77.82 -50.17 12.83 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 175.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 149.55 -104.91 0.28 Allowed Glycine 0 N--CA 1.431 -1.652 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -103.74 -37.02 3.09 Favored Glycine 0 C--N 1.307 -1.057 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -104.98 148.13 27.05 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -78.92 135.98 37.13 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 175.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.2 m -118.33 153.79 33.41 Favored 'General case' 0 C--N 1.268 -2.957 0 N-CA-C 103.73 -2.693 . . . . 0.0 103.73 174.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.583 HG21 ' SG ' ' A' ' 14' ' ' CYS 0.267 21.9 t -86.86 -72.35 0.07 OUTLIER Pre-proline 0 CA--C 1.456 -2.642 0 C-N-CA 116.136 -2.226 . . . . 0.0 114.506 -178.59 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.96 88.73 1.21 Allowed 'Trans proline' 1 N--CA 1.39 -4.575 0 CA-C-N 120.577 1.242 . . . . 0.0 112.498 -162.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 32.4 m -119.98 130.74 54.9 Favored 'General case' 0 N--CA 1.385 -3.698 0 CA-C-N 113.27 -1.786 . . . . 0.0 106.841 -174.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.1 p -116.45 132.67 65.38 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.099 0 CA-C-O 121.15 0.5 . . . . 0.0 110.856 -176.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.4 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 62.9 tttm -107.04 116.79 32.55 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 174.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -87.66 155.18 20.06 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.189 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.16 -21.37 61.57 Favored 'General case' 0 C--O 1.22 -0.494 0 C-N-CA 123.481 0.712 . . . . 0.0 111.57 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -72.71 -14.33 61.54 Favored 'General case' 0 CA--C 1.543 0.674 0 CA-C-O 121.507 0.67 . . . . 0.0 110.145 178.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.81 -20.43 26.88 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.901 177.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 9.8 m -71.36 140.1 50.07 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 122.687 0.395 . . . . 0.0 111.661 -177.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.9 p -114.21 137.79 51.3 Favored 'General case' 0 N--CA 1.427 -1.616 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 173.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mp -128.43 123.21 33.17 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-O 120.76 0.314 . . . . 0.0 110.4 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 87.6 m -97.15 119.14 35.1 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.231 178.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 57.77 67.78 2.2 Favored Pre-proline 0 N--CA 1.484 1.237 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -96.56 169.52 1.03 Allowed 'Trans proline' 0 CA--C 1.546 1.124 0 C-N-CA 122.324 2.016 . . . . 0.0 111.148 171.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.0 m -93.29 155.38 17.45 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 173.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.29 -36.43 71.04 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 122.91 0.484 . . . . 0.0 111.704 -178.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -69.18 -35.7 76.57 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.502 0.668 . . . . 0.0 110.839 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -67.03 -36.56 82.36 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.268 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.9 t -66.26 -46.75 86.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.038 177.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 47.2 tttm -53.72 -42.33 67.95 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.22 0.608 . . . . 0.0 112.027 178.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.34 -20.3 65.57 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.131 0.491 . . . . 0.0 111.394 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.597 ' O ' HG13 ' A' ' 82' ' ' ILE . 34.4 mmtp -84.59 -39.49 18.65 Favored 'General case' 0 N--CA 1.436 -1.168 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.116 175.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.537 HD21 HD11 ' A' ' 6' ' ' LEU . 4.5 mm? -56.82 -41.19 77.37 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 111.944 0.35 . . . . 0.0 111.944 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 30.5 m -63.38 -40.5 89.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.304 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.497 ' HA ' ' HB3' ' A' ' 87' ' ' HIS . 22.2 ptmt -83.03 -54.6 4.94 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.597 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.1 pp -68.52 -17.12 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -170.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -80.37 -11.64 59.68 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.145 177.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 62.79 57.43 16.14 Favored Glycine 0 CA--C 1.494 -1.26 0 N-CA-C 110.061 -1.216 . . . . 0.0 110.061 -177.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -134.5 -70.08 0.51 Allowed 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -176.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -90.44 4.63 50.44 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 122.362 1.077 . . . . 0.0 109.911 -174.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.497 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 58.6 t-80 -167.93 131.52 1.65 Allowed 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 175.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 80.3 m-70 . . . . . 0 C--N 1.292 -1.934 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.577 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.9 mmt . . . . . 0 CA--C 1.502 -0.871 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 47.8 t -75.83 84.1 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-O 121.768 0.795 . . . . 0.0 110.428 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.5 t -109.88 6.48 23.35 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 114.901 -1.045 . . . . 0.0 109.07 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -133.7 141.39 47.54 Favored 'General case' 0 N--CA 1.423 -1.79 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.005 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.61 -12.26 51.92 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 123.752 0.657 . . . . 0.0 111.457 -177.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.444 ' HB2' ' CG2' ' A' ' 59' ' ' VAL . 0.5 OUTLIER -130.56 123.96 30.75 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.542 0.687 . . . . 0.0 111.372 178.693 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.3 m -103.2 114.18 28.25 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 178.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.576 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 55.7 mt -103.58 136.98 33.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 -177.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -91.5 118.21 30.38 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 176.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.556 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 29.3 p -128.19 -172.08 2.61 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-O 121.343 0.592 . . . . 0.0 111.894 -177.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.474 ' HB ' ' O ' ' A' ' 13' ' ' TRP . 38.7 m -155.81 146.12 21.72 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 177.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.1 m -56.36 -47.84 78.05 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 176.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.474 ' O ' ' HB ' ' A' ' 11' ' ' THR . 0.0 OUTLIER -65.94 111.78 3.48 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 105.891 -1.892 . . . . 0.0 105.891 164.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 11' ' ' THR . 42.8 t -150.71 120.14 6.89 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.788 -174.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -113.99 -70.24 0.52 Allowed Glycine 0 N--CA 1.427 -1.9 0 C-N-CA 120.499 -0.858 . . . . 0.0 111.236 179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -73.91 -30.23 62.47 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 123.029 0.531 . . . . 0.0 111.083 -176.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -63.34 -27.78 69.55 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -63.08 -35.66 80.99 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 123.458 0.703 . . . . 0.0 109.678 -177.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -51.87 -45.47 64.11 Favored 'General case' 0 C--O 1.245 0.819 0 C-N-CA 124.774 1.23 . . . . 0.0 111.301 -179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.428 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 12.4 tp -84.19 -42.37 16.03 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.86 -177.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -52.84 -48.91 66.68 Favored 'General case' 0 C--O 1.246 0.916 0 C-N-CA 124.397 1.079 . . . . 0.0 112.522 -176.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.9 t -74.15 -28.48 61.33 Favored 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 120.152 -0.619 . . . . 0.0 111.515 -178.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -67.16 -42.49 84.21 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 116.488 -0.324 . . . . 0.0 110.325 -179.176 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 59.7 mt -65.26 -44.04 89.38 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.403 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 44.3 m -59.88 -43.59 94.65 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.963 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -74.12 -10.37 59.55 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.948 0.404 . . . . 0.0 111.928 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -109.31 16.03 22.68 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.964 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 71.5 mtm180 67.77 17.39 9.77 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 124.27 1.028 . . . . 0.0 112.624 177.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.6 mt -91.06 118.15 35.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.737 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -95.59 138.14 33.68 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -136.3 171.01 15.11 Favored 'General case' 0 C--N 1.286 -2.194 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.044 -177.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -128.45 117.89 22.15 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 175.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.576 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 13.8 pt-20 -95.03 135.2 36.86 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-O 120.866 0.365 . . . . 0.0 110.841 -178.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.7 t -85.05 140.09 16.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -171.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.418 ' OD2' ' HB2' ' A' ' 38' ' ' HIS . 14.5 t70 -58.67 0.39 0.08 Allowed 'General case' 0 CA--C 1.567 1.624 0 C-N-CA 129.508 3.123 . . . . 0.0 114.751 178.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.8 pt -43.59 -20.82 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.519 3.006 0 N-CA-C 116.971 2.212 . . . . 0.0 116.971 -168.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.42 ' HG3' ' CD2' ' A' ' 38' ' ' HIS . 13.2 pt-20 -73.18 -23.61 60.44 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 119.176 0.898 . . . . 0.0 110.276 178.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . 0.42 ' CD2' ' HG3' ' A' ' 37' ' ' GLU . 67.2 m-70 -105.39 -47.32 3.98 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 174.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -78.19 99.64 6.31 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.734 -177.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -67.26 -30.21 70.04 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.553 -179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.9 -44.89 82.81 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 113.194 0.813 . . . . 0.0 113.194 -177.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.43 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -85.96 -23.34 26.96 Favored 'General case' 0 C--N 1.311 -1.086 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.419 178.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.36 -40.42 93.54 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.197 0.522 . . . . 0.0 110.222 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -65.46 -24.3 67.13 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.117 177.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -74.68 -38.16 62.48 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 176.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 42' ' ' ALA . 40.3 t -65.71 -41.88 91.37 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.447 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.826 178.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.78 -22.58 75.55 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.029 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -81.85 -41.86 20.43 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 14.6 p -76.55 -37.56 30.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 O-C-N 122.045 -0.409 . . . . 0.0 110.593 -179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 -105.19 92.07 4.06 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 176.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -80.86 143.18 24.08 Favored Glycine 0 C--N 1.306 -1.12 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.494 -176.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.56 -62.88 2.68 Favored Glycine 0 N--CA 1.437 -1.29 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -126.11 145.92 50.15 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 42.6 ttp85 -88.31 89.06 7.84 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 177.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.0 m -65.58 133.46 51.23 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 176.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 25.4 t -77.01 -69.43 0.23 Allowed Pre-proline 0 CA--C 1.468 -2.187 0 C-N-CA 118.174 -1.411 . . . . 0.0 114.061 -176.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -74.51 82.67 1.85 Allowed 'Trans proline' 0 N--CA 1.4 -3.992 0 CA-C-N 120.637 1.263 . . . . 0.0 112.969 -163.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 51.9 m -115.36 125.3 53.04 Favored 'General case' 0 N--CA 1.388 -3.53 0 CA-C-N 113.299 -1.773 . . . . 0.0 106.509 -176.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.444 ' CG2' ' HB2' ' A' ' 6' ' ' LEU . 7.2 p -118.3 137.17 53.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.865 0 CA-C-O 121.007 0.432 . . . . 0.0 111.181 -177.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -111.36 119.57 39.28 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 176.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -94.99 168.57 10.69 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.46 -10.98 20.0 Favored 'General case' 0 C--O 1.218 -0.57 0 O-C-N 123.738 0.649 . . . . 0.0 111.329 177.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -73.59 -18.31 61.07 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.794 0.807 . . . . 0.0 109.87 177.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.43 -15.12 63.88 Favored Glycine 0 CA--C 1.499 -0.917 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.236 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.5 m -83.41 151.69 25.37 Favored 'General case' 0 N--CA 1.42 -1.949 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.4 p -113.6 139.31 49.12 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 177.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.6 tp -121.93 119.91 32.92 Favored 'General case' 0 C--N 1.289 -2.029 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -177.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 7.0 m -107.94 126.25 52.46 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 110.413 -0.217 . . . . 0.0 110.413 -174.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 54.03 60.04 11.48 Favored Pre-proline 0 N--CA 1.482 1.126 0 O-C-N 123.941 0.776 . . . . 0.0 112.315 -179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -90.08 178.44 2.23 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 121.856 1.704 . . . . 0.0 113.242 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.4 m -96.42 164.46 12.62 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 174.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.57 -39.34 94.14 Favored 'General case' 0 C--O 1.24 0.562 0 CA-C-O 120.958 0.409 . . . . 0.0 110.99 -178.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -64.42 -33.27 75.49 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.512 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -68.33 -39.09 82.05 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.048 0.451 . . . . 0.0 110.35 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 87.4 t -66.42 -44.91 90.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.899 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -60.49 -43.31 97.13 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.507 178.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.89 -36.8 84.4 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.714 0.293 . . . . 0.0 111.32 179.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.487 ' O ' HG13 ' A' ' 82' ' ' ILE . 14.4 mptt -70.96 -37.13 72.79 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.941 175.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 30.1 tp -62.06 -47.04 86.49 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.412 -178.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.8 m -66.07 -32.69 59.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -177.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.484 ' HA ' ' HB3' ' A' ' 87' ' ' HIS . 19.6 ptmt -77.29 -41.02 42.41 Favored 'General case' 0 CA--C 1.513 -0.473 0 C-N-CA 120.144 -0.622 . . . . 0.0 111.684 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.487 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.2 pp -74.41 -14.28 15.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 C-N-CA 120.454 -0.498 . . . . 0.0 112.074 -177.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.81 -26.18 59.54 Favored 'General case' 0 N--CA 1.441 -0.881 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.66 176.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 58.46 49.0 80.88 Favored Glycine 0 C--N 1.344 0.973 0 N-CA-C 110.68 -0.968 . . . . 0.0 110.68 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 62.2 tp -154.08 -49.2 0.09 Allowed 'General case' 0 C--N 1.307 -1.254 0 CA-C-O 121.324 0.583 . . . . 0.0 110.044 -174.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -94.79 -7.24 40.97 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 122.009 0.909 . . . . 0.0 110.077 -177.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.484 ' HB3' ' HA ' ' A' ' 81' ' ' LYS . 55.5 t-80 -167.59 143.63 4.1 Favored 'General case' 0 N--CA 1.427 -1.607 0 N-CA-C 104.918 -2.253 . . . . 0.0 104.918 176.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 . . . . . 0 C--N 1.292 -1.916 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 177.586 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.451 ' SD ' ' HE3' ' A' ' 60' ' ' LYS . 83.1 mtp . . . . . 0 N--CA 1.475 0.78 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.489 HG23 ' H ' ' A' ' 3' ' ' THR . 5.1 m -111.98 -100.51 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 O-C-N 121.739 -0.601 . . . . 0.0 112.425 176.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.489 ' H ' HG23 ' A' ' 2' ' ' VAL . 14.0 p -80.63 -34.99 34.6 Favored 'General case' 0 C--N 1.312 -1.039 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 173.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.18 102.1 14.39 Favored 'General case' 0 N--CA 1.414 -2.231 0 N-CA-C 105.577 -2.008 . . . . 0.0 105.577 169.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -68.92 -58.51 4.03 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.386 -175.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.635 HD23 ' H ' ' A' ' 6' ' ' LEU . 0.7 OUTLIER -68.58 120.65 14.95 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-O 121.849 0.833 . . . . 0.0 111.013 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.3 m -103.64 111.75 24.37 Favored 'General case' 0 C--N 1.28 -2.415 0 CA-C-N 114.399 -1.273 . . . . 0.0 107.851 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 63.4 mt -102.79 139.04 24.81 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 CA-C-O 121.303 0.573 . . . . 0.0 110.703 -174.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -92.04 122.8 34.88 Favored 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 177.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.523 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 27.3 p -138.57 177.22 8.04 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.533 0.682 . . . . 0.0 111.817 -177.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.5 m -148.08 156.16 42.29 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 104.466 -2.42 . . . . 0.0 104.466 174.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.5 m -69.22 -45.34 70.1 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 49.5 p90 -87.38 96.28 10.31 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-O 122.126 0.965 . . . . 0.0 109.906 175.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 32.7 t -163.56 152.17 13.84 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.799 -1.091 . . . . 0.0 108.415 -177.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -119.93 -55.84 0.25 Allowed Glycine 0 N--CA 1.429 -1.831 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.226 178.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -68.39 -16.3 63.87 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -173.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.6 p -78.49 -24.88 45.68 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-O 121.211 0.529 . . . . 0.0 109.963 177.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 21' ' ' LYS . 28.7 tp -69.01 -21.75 64.12 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.991 -175.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.4 tmm_? -60.18 -60.71 3.39 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.165 178.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 14.1 tp -66.3 -42.74 87.86 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.492 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.423 ' HB3' ' HA ' ' A' ' 18' ' ' LEU . 63.8 tttp -54.72 -47.23 74.01 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.35 -178.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.5 p -71.12 -34.7 71.31 Favored 'General case' 0 C--O 1.244 0.778 0 C-N-CA 120.584 -0.446 . . . . 0.0 111.654 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.38 -46.93 86.4 Favored 'General case' 0 CA--C 1.508 -0.657 0 C-N-CA 123.387 0.675 . . . . 0.0 110.66 178.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.9 mt -65.79 -37.88 87.49 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.902 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 29.3 m -65.24 -38.52 90.62 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.74 -26.94 62.67 Favored 'General case' 0 C--O 1.219 -0.501 0 CA-C-O 121.519 0.676 . . . . 0.0 111.02 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.17 2.8 48.81 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.308 178.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 61.67 30.52 18.55 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.54 1.136 . . . . 0.0 110.441 178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 74.1 mt -86.86 115.41 27.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.666 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -73.48 100.65 3.31 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.509 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -113.61 163.94 14.31 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.412 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -130.5 130.1 43.74 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 175.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.523 ' HB2' ' OG1' ' A' ' 10' ' ' THR . 11.6 pt-20 -99.79 140.92 33.29 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 121.025 0.441 . . . . 0.0 111.14 -178.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.2 t -78.07 146.79 7.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 CA-C-O 121.86 0.838 . . . . 0.0 113.1 -172.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -66.85 -0.82 3.29 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 127.718 2.407 . . . . 0.0 114.371 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 36.5 pt -44.17 -22.58 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.514 2.737 0 N-CA-C 116.473 2.027 . . . . 0.0 116.473 -169.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -68.42 -31.43 70.75 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.796 0.808 . . . . 0.0 109.469 177.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 35.5 m-70 -103.17 -45.94 4.77 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.017 -0.992 . . . . 0.0 109.26 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.431 ' ND2' ' H ' ' A' ' 42' ' ' ALA . 37.8 t30 -86.91 115.11 24.09 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.87 -175.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -72.7 -29.68 63.58 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 120.532 -0.467 . . . . 0.0 111.097 178.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.38 -41.16 93.22 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -173.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.431 ' H ' ' ND2' ' A' ' 39' ' ' ASN . . . -87.35 -21.77 25.48 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 120.175 -0.61 . . . . 0.0 110.638 177.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.65 -39.59 84.58 Favored 'General case' 0 CA--C 1.507 -0.679 0 CA-C-O 121.309 0.576 . . . . 0.0 110.616 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -75.08 -21.38 59.0 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.334 178.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -69.45 -31.95 70.58 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 176.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.3 t -59.36 -42.73 88.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 177.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.38 -35.2 87.02 Favored Glycine 0 N--CA 1.442 -0.933 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.356 178.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.8 t -66.77 -50.07 63.87 Favored 'General case' 0 C--N 1.308 -1.212 0 C-N-CA 122.503 0.321 . . . . 0.0 110.66 179.293 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.9 p -76.91 -28.12 16.86 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.181 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -174.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -98.66 1.89 46.67 Favored 'General case' 0 N--CA 1.477 0.92 0 O-C-N 121.698 -0.627 . . . . 0.0 112.266 178.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 70.52 60.22 4.82 Favored Glycine 0 C--N 1.322 -0.233 0 N-CA-C 114.395 0.518 . . . . 0.0 114.395 174.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 88.07 -46.63 3.43 Favored Glycine 0 C--N 1.31 -0.892 0 C-N-CA 121.769 -0.253 . . . . 0.0 112.615 176.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.5 m-80 -77.42 122.34 25.04 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -178.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 69.9 mtm180 -93.75 79.95 4.22 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 121.774 0.797 . . . . 0.0 112.182 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.7 m -73.17 128.36 35.27 Favored 'General case' 0 N--CA 1.423 -1.815 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 173.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.4 t -69.4 -66.71 0.87 Allowed Pre-proline 0 CA--C 1.473 -1.989 0 N-CA-C 114.703 1.372 . . . . 0.0 114.703 -173.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.62 76.77 4.13 Favored 'Trans proline' 0 N--CA 1.4 -3.985 0 CA-C-N 120.381 1.172 . . . . 0.0 112.578 -163.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 91.5 m -107.62 140.27 40.88 Favored 'General case' 0 N--CA 1.388 -3.565 0 CA-C-N 113.486 -1.688 . . . . 0.0 107.571 -176.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 8.2 p -122.68 132.83 70.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-O 121.318 0.58 . . . . 0.0 111.218 -176.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.451 ' HE3' ' SD ' ' A' ' 1' ' ' MET . 63.5 tttp -110.21 120.31 42.04 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-N 114.916 -1.038 . . . . 0.0 108.498 176.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.453 ' CD1' HG12 ' A' ' 82' ' ' ILE . 90.1 m-85 -95.12 171.79 8.52 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.738 178.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -72.46 -24.0 61.13 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -173.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -89.87 -7.28 54.62 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 120.708 0.289 . . . . 0.0 111.34 -174.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.54 -5.72 31.41 Favored Glycine 0 N--CA 1.437 -1.237 0 C-N-CA 120.456 -0.878 . . . . 0.0 112.268 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.3 m -75.98 125.91 30.01 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-O 121.18 0.514 . . . . 0.0 110.17 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.6 p -117.21 138.29 51.79 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.2 mp -130.91 146.31 52.29 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -178.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.1 m -116.0 112.64 22.1 Favored 'General case' 0 C--N 1.287 -2.129 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 64.2 t30 47.33 70.88 1.81 Allowed Pre-proline 0 N--CA 1.484 1.274 0 C-N-CA 124.713 1.205 . . . . 0.0 113.835 178.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -100.01 -175.52 0.15 Allowed 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.013 2.475 . . . . 0.0 111.968 177.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.6 t -82.31 154.1 25.48 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.144 -0.687 . . . . 0.0 109.144 176.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.48 -34.76 78.47 Favored 'General case' 0 C--N 1.313 -0.995 0 C-N-CA 123.713 0.805 . . . . 0.0 109.958 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -63.5 -44.09 95.35 Favored 'General case' 0 CA--C 1.511 -0.555 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.881 178.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.585 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 45.5 mm-40 -57.83 -47.36 82.89 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.392 176.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.6 t -57.73 -44.02 85.01 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.764 0 O-C-N 123.994 0.809 . . . . 0.0 111.502 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 66.1 tttp -62.87 -45.3 93.21 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.366 0.506 . . . . 0.0 112.366 -178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.23 -21.84 59.61 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.054 0.454 . . . . 0.0 111.568 -178.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.585 ' HG2' ' O ' ' A' ' 74' ' ' GLU . 49.2 mmtm -81.93 -34.49 29.83 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 174.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 63.0 tp -57.39 -49.04 77.47 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.424 179.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.8 m -60.59 -33.6 55.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.712 -0.676 . . . . 0.0 112.505 -177.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 15.3 ptmm? -81.69 -38.71 25.41 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 120.415 -0.514 . . . . 0.0 111.476 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.453 HG12 ' CD1' ' A' ' 61' ' ' PHE . 2.4 pp -77.98 -32.15 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -175.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.44 -42.31 59.35 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 82.82 -49.68 4.25 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.399 177.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 2.5 pp -84.47 167.12 16.69 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -179.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 61.37 32.48 19.09 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 126.179 1.792 . . . . 0.0 112.717 174.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 46.1 t60 -107.42 78.39 1.21 Allowed 'General case' 0 N--CA 1.423 -1.779 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 174.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 34.7 m80 . . . . . 0 C--O 1.262 1.749 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.918 -176.186 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.8 ptp . . . . . 0 CA--C 1.513 -0.462 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 27.1 m -128.37 143.28 41.5 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 171.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.2 t -130.95 114.29 15.05 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-O 122.05 0.929 . . . . 0.0 110.993 -177.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -113.37 113.47 25.27 Favored 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 177.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -86.94 1.16 53.57 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.497 0.665 . . . . 0.0 110.334 -178.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -145.79 128.75 16.47 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.256 178.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 60' ' ' LYS . 23.4 m -103.07 120.02 39.92 Favored 'General case' 0 C--N 1.277 -2.576 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 176.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.3 mt -109.88 128.44 66.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 CA-C-O 121.06 0.457 . . . . 0.0 109.915 -176.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.463 ' HB2' ' O ' ' A' ' 56' ' ' VAL . 98.3 m-85 -81.05 129.0 34.34 Favored 'General case' 0 N--CA 1.413 -2.293 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.636 177.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.8 p -136.83 145.98 45.1 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -174.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 69.4 p -140.22 161.72 36.98 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 105.743 -1.947 . . . . 0.0 105.743 172.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 38.5 p -85.98 -0.39 55.37 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 121.303 0.573 . . . . 0.0 110.799 178.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 11.2 m0 -78.91 -30.93 45.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.356 -176.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.8 p -105.65 132.2 52.09 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.265 -175.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.22 -27.99 26.51 Favored Glycine 0 N--CA 1.436 -1.352 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.675 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -65.86 -35.87 81.86 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.592 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 61.1 m -56.5 -46.71 80.37 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.287 176.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.2 tt -66.75 -39.39 87.89 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.074 -0.966 . . . . 0.0 110.751 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 35.6 mtp180 -58.23 -54.63 44.84 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 112.064 0.394 . . . . 0.0 112.064 179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.484 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 20.7 tp -62.05 -40.13 94.71 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.524 0.678 . . . . 0.0 109.716 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 17' ' ' CYS . 60.5 tttm -57.2 -45.22 83.96 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.664 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 91.7 m -62.12 -43.59 98.49 Favored 'General case' 0 C--O 1.246 0.884 0 C-N-CA 123.719 0.808 . . . . 0.0 110.665 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.53 -48.21 82.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.04 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 72.4 mt -65.73 -35.64 81.32 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.995 -178.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.8 m -63.6 -45.99 87.83 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.83 -35.63 81.22 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.483 0.659 . . . . 0.0 110.843 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.7 m-80 -84.46 21.03 1.54 Allowed 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.18 -0.918 . . . . 0.0 112.492 -178.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 55.7 20.65 4.09 Favored 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 126.226 1.81 . . . . 0.0 113.782 175.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 71.4 mt -85.27 115.91 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 -179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.94 116.98 23.06 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.264 -177.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 40.8 p90 -127.75 159.54 34.47 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.215 -177.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -112.27 114.08 26.66 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 175.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -83.17 136.58 34.38 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 5.1 t -95.15 143.73 11.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 122.909 1.337 . . . . 0.0 113.233 -176.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.57 -0.57 6.92 Favored 'General case' 0 C--N 1.284 -2.283 0 C-N-CA 130.862 3.665 . . . . 0.0 115.118 177.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.471 HD13 HG21 ' A' ' 46' ' ' VAL . 12.7 pt -44.11 -26.42 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.516 2.843 0 N-CA-C 115.257 1.577 . . . . 0.0 115.257 -171.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -59.0 -36.3 74.68 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.12 0.486 . . . . 0.0 109.815 -179.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 46.7 m-70 -93.15 -34.45 13.62 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.968 -175.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -116.36 113.58 23.12 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -176.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.482 ' HA ' ' HB3' ' A' ' 43' ' ' ALA . 3.8 ptp180 -62.86 -25.58 68.35 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 114.625 -1.171 . . . . 0.0 111.885 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.18 -41.49 71.96 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.238 0.542 . . . . 0.0 111.296 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.451 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -86.96 -30.33 21.37 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.047 178.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.482 ' HB3' ' HA ' ' A' ' 40' ' ' ARG . . . -65.31 -33.89 77.05 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.996 -178.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.1 mm-40 -67.53 -34.76 77.75 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.774 -0.194 . . . . 0.0 111.377 178.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -65.25 -37.69 88.0 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.471 HG21 HD13 ' A' ' 36' ' ' ILE . 60.1 t -59.99 -38.06 75.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.091 -0.958 . . . . 0.0 109.877 177.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.66 -49.22 44.82 Favored Glycine 0 N--CA 1.433 -1.55 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 177.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.9 m -60.31 -38.13 82.72 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.6 p -79.49 -9.37 12.15 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.927 0 CA-C-O 121.531 0.682 . . . . 0.0 111.213 -177.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -104.95 -67.82 0.89 Allowed 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.145 177.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 137.67 -112.38 0.9 Allowed Glycine 0 N--CA 1.433 -1.554 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 -175.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -84.31 -48.33 5.11 Favored Glycine 0 C--N 1.306 -1.127 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.029 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -91.45 116.44 28.85 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -178.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -81.21 83.02 6.94 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.6 m -71.97 125.78 28.09 Favored 'General case' 0 N--CA 1.432 -1.335 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.538 ' HB ' ' SG ' ' A' ' 17' ' ' CYS . 3.2 t -76.31 -56.16 1.59 Allowed Pre-proline 0 N--CA 1.435 -1.221 0 CA-C-O 117.323 -1.322 . . . . 0.0 113.55 -175.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.592 ' HD3' ' SG ' ' A' ' 17' ' ' CYS . 64.9 Cg_endo -73.64 44.24 0.89 Allowed 'Trans proline' 0 C--N 1.399 3.227 0 CA-C-N 121.472 1.562 . . . . 0.0 113.691 -170.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 84.1 m -80.57 117.66 21.47 Favored 'General case' 0 N--CA 1.387 -3.599 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.3 p -94.76 129.12 45.39 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.479 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 82.2 tttt -105.03 118.19 35.9 Favored 'General case' 0 C--N 1.286 -2.193 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 178.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 78.6 m-85 -87.75 164.21 16.08 Favored 'General case' 0 C--N 1.296 -1.731 0 C-N-CA 120.448 -0.501 . . . . 0.0 112.126 -177.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.04 -18.26 45.04 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 124.032 0.933 . . . . 0.0 112.956 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -78.31 -17.29 56.79 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.863 0.363 . . . . 0.0 110.286 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.02 -21.7 24.5 Favored Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 121.245 -0.502 . . . . 0.0 113.193 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 13.1 m -82.88 159.71 22.3 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.257 0.551 . . . . 0.0 110.522 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.3 p -114.0 171.39 7.62 Favored 'General case' 0 N--CA 1.418 -2.045 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.101 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.8 tp -145.0 109.7 5.0 Favored 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 176.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 89.1 m -86.11 122.7 30.49 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.619 -0.718 . . . . 0.0 110.965 -176.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 56.49 64.81 4.53 Favored Pre-proline 0 N--CA 1.482 1.15 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -179.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -90.71 -173.61 0.63 Allowed 'Trans proline' 0 N--CA 1.445 -1.38 0 C-N-CA 121.788 1.659 . . . . 0.0 112.653 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.414 ' H ' ' HB2' ' A' ' 74' ' ' GLU . 16.6 m -127.26 165.86 18.86 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 174.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.69 -45.95 67.05 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -177.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -64.38 -36.54 84.48 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.431 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.414 ' HB2' ' H ' ' A' ' 71' ' ' SER . 67.0 mm-40 -63.71 -42.51 97.94 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 121.194 0.521 . . . . 0.0 110.88 177.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.1 t -67.21 -48.8 77.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.192 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -61.57 -31.05 71.08 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.118 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.2 -25.54 63.46 Favored 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.431 ' O ' HG13 ' A' ' 82' ' ' ILE . 10.1 mmmm -84.7 -37.22 21.2 Favored 'General case' 0 CA--C 1.497 -1.063 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 172.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 21.8 tp -55.07 -49.63 71.17 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 124.165 0.916 . . . . 0.0 110.171 -177.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.3 m -58.6 -35.53 55.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -178.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.76 -42.53 19.65 Favored 'General case' 0 N--CA 1.427 -1.578 0 C-N-CA 119.071 -1.051 . . . . 0.0 111.804 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.431 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.4 pp -76.41 -22.16 15.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 112.537 0.569 . . . . 0.0 112.537 -174.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -87.35 4.42 43.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.985 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.39 -102.89 1.65 Allowed Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 116.259 -0.428 . . . . 0.0 112.13 177.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.421 ' H ' HD23 ' A' ' 85' ' ' LEU . 2.1 pt? -127.56 0.69 6.2 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.152 0.501 . . . . 0.0 110.504 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.9 88.62 5.8 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 35.3 p80 -163.58 174.83 11.29 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -177.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 . . . . . 0 C--N 1.305 -1.33 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 176.776 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 tmt? . . . . . 0 N--CA 1.473 0.676 0 N-CA-C 110.818 -0.068 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 65.5 t -65.2 113.83 2.3 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.463 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 175.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.6 m -76.91 94.08 3.87 Favored 'General case' 0 N--CA 1.422 -1.868 0 CA-C-O 121.805 0.812 . . . . 0.0 111.703 -172.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.74 173.82 9.22 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.486 175.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -68.58 -22.85 64.44 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 112.022 0.378 . . . . 0.0 112.022 -178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 62.1 mt -113.97 122.53 47.23 Favored 'General case' 0 CA--C 1.496 -1.101 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.712 -178.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.1 m -103.14 108.54 19.77 Favored 'General case' 0 C--N 1.287 -2.143 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 173.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.476 HG22 HG23 ' A' ' 10' ' ' THR . 55.4 mt -108.42 133.35 53.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-O 121.78 0.8 . . . . 0.0 111.605 -175.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -95.38 107.36 19.49 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 115.067 -0.969 . . . . 0.0 108.662 178.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.476 HG23 HG22 ' A' ' 8' ' ' ILE . 4.0 p -135.28 158.96 43.05 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 122.677 0.391 . . . . 0.0 111.897 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 36.6 p -134.77 174.61 10.39 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 176.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 36.1 t -86.72 -5.61 59.07 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 19.6 m0 -75.83 -32.61 59.87 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.093 -175.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.8 p -91.54 165.99 13.07 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 120.738 0.304 . . . . 0.0 111.628 -175.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -113.45 -42.83 0.86 Allowed Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 111.366 -0.693 . . . . 0.0 111.366 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -63.45 -25.77 68.42 Favored 'General case' 0 C--O 1.236 0.35 0 N-CA-C 112.041 0.385 . . . . 0.0 112.041 -178.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.493 ' SG ' HD12 ' A' ' 18' ' ' LEU . 1.6 p -56.32 -41.36 75.91 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.677 0.275 . . . . 0.0 111.04 176.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.511 ' HA ' ' HD3' ' A' ' 21' ' ' LYS . 6.3 mp -73.31 -24.96 60.47 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.65 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -71.76 -34.72 69.71 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.596 -0.891 . . . . 0.0 108.596 179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.8 tp -75.74 -38.36 58.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.084 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.511 ' HD3' ' HA ' ' A' ' 18' ' ' LEU . 27.4 mtpp -55.75 -45.72 77.98 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 115.569 -0.741 . . . . 0.0 111.706 177.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 p -65.94 -40.2 91.14 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 111.541 0.2 . . . . 0.0 111.541 179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.26 -49.53 76.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.674 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.5 mt -64.91 -41.68 95.37 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.754 0.311 . . . . 0.0 111.283 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 68.0 m -67.29 -38.29 84.78 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.198 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.84 -26.37 64.19 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 121.36 0.6 . . . . 0.0 110.66 178.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -94.07 10.77 32.33 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.066 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 59.15 30.86 20.73 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.04 1.336 . . . . 0.0 112.719 175.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.6 mt -89.26 123.87 41.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.73 129.93 34.68 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.071 0.463 . . . . 0.0 111.218 -176.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -144.08 157.62 44.21 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.651 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -127.96 124.03 36.28 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 11.7 pt-20 -95.25 146.82 24.07 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-O 121.271 0.557 . . . . 0.0 111.764 -175.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -81.07 153.05 4.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.457 -175.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -74.87 0.19 16.42 Favored 'General case' 0 C--N 1.307 -1.252 0 C-N-CA 127.903 2.481 . . . . 0.0 114.042 -175.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.7 pt -43.36 -23.71 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.378 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 -172.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.5 tp10 -52.85 -39.24 62.39 Favored 'General case' 0 C--O 1.24 0.557 0 C-N-CA 123.649 0.78 . . . . 0.0 109.709 176.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -119.42 20.28 12.52 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.081 -179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.413 ' ND2' ' H ' ' A' ' 42' ' ' ALA . 49.5 t30 -139.42 106.89 5.55 Favored 'General case' 0 CA--C 1.492 -1.269 0 C-N-CA 120.764 -0.374 . . . . 0.0 111.26 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -30.59 71.13 Favored 'General case' 0 C--N 1.303 -1.453 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.946 179.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.43 -38.57 84.76 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -173.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.413 ' H ' ' ND2' ' A' ' 39' ' ' ASN . . . -86.79 -20.73 27.17 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.816 177.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.15 -41.44 86.03 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.463 179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -69.92 -21.91 63.25 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.539 178.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -68.16 -33.53 74.64 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 175.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.626 ' O ' ' HB2' ' A' ' 50' ' ' ASN . 81.6 t -59.3 -40.22 80.83 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.925 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.631 177.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.92 -32.68 77.82 Favored Glycine 0 C--N 1.332 0.328 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.09 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 30.0 t -65.8 -29.96 70.53 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 123.147 0.579 . . . . 0.0 110.265 -179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 28.4 m -108.1 17.2 6.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-O 120.887 0.375 . . . . 0.0 110.572 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.626 ' HB2' ' O ' ' A' ' 46' ' ' VAL . 1.7 t-20 -116.49 -174.16 2.51 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 -176.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -107.82 75.71 0.22 Allowed Glycine 0 N--CA 1.436 -1.343 0 C-N-CA 121.219 -0.515 . . . . 0.0 112.064 -179.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 79.01 -93.65 1.31 Allowed Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 50.3 m-80 -78.62 136.31 37.46 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -64.91 101.4 0.49 Allowed 'General case' 0 C--N 1.312 -1.029 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -178.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.9 m -83.0 153.35 25.01 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 102.984 -2.969 . . . . 0.0 102.984 169.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 0.442 3.8 t -86.95 -93.75 0.0 OUTLIER Pre-proline 0 CA--C 1.487 -1.472 0 C-N-CA 114.643 -2.823 . . . . 0.0 117.23 -174.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -47.51 93.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.386 2.538 0 N-CA-C 114.551 0.943 . . . . 0.0 114.551 -148.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.31 109.91 21.37 Favored 'General case' 0 N--CA 1.405 -2.705 0 CA-C-N 113.778 -1.555 . . . . 0.0 109.904 -173.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.3 p -102.58 126.46 56.74 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.995 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.9 tttm -104.8 127.41 52.59 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.626 ' HB3' HG21 ' A' ' 82' ' ' ILE . 95.8 m-85 -103.25 170.84 7.71 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.972 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.664 ' HB3' ' HB ' ' A' ' 82' ' ' ILE . . . -65.17 -13.89 59.27 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 115.142 1.534 . . . . 0.0 115.142 -173.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -78.69 -13.09 60.0 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 121.478 0.656 . . . . 0.0 109.627 175.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 95.54 -1.54 64.15 Favored Glycine 0 N--CA 1.436 -1.319 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -174.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 6.3 m -67.62 133.5 49.49 Favored 'General case' 0 N--CA 1.434 -1.233 0 C-N-CA 123.787 0.835 . . . . 0.0 108.96 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.8 m -121.43 137.53 54.67 Favored 'General case' 0 N--CA 1.421 -1.914 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 176.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.2 mp -120.06 119.38 33.19 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-O 120.687 0.28 . . . . 0.0 111.279 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.5 m -92.66 116.55 29.11 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 61.7 69.66 0.97 Allowed Pre-proline 0 CA--C 1.557 1.25 0 C-N-CA 123.643 0.777 . . . . 0.0 111.49 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -94.48 -167.02 0.14 Allowed 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.444 2.096 . . . . 0.0 112.258 176.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.403 ' O ' HG23 ' A' ' 75' ' ' VAL . 13.5 m -116.08 150.52 37.2 Favored 'General case' 0 N--CA 1.431 -1.377 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 176.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.08 -40.43 76.94 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.775 0.43 . . . . 0.0 111.734 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -64.42 -37.76 88.64 Favored 'General case' 0 C--O 1.244 0.771 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.947 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 67.0 mm-40 -62.18 -48.06 81.75 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.906 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 71' ' ' SER . 95.9 t -58.39 -42.3 83.73 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.922 0 O-C-N 124.013 0.821 . . . . 0.0 110.834 -178.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.408 ' O ' ' HD3' ' A' ' 76' ' ' LYS . 2.7 tmtp? -67.76 -40.38 84.09 Favored 'General case' 0 CA--C 1.559 1.315 0 CA-C-O 120.722 0.296 . . . . 0.0 110.52 -178.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.45 -29.84 59.79 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.171 0.51 . . . . 0.0 111.024 -179.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 48.1 mmtm -77.21 -31.09 55.03 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 20.4 tp -58.92 -50.96 72.08 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.984 178.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 86' ' ' GLU . 27.5 m -60.57 -39.42 81.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -176.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? -73.31 -32.33 64.54 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.481 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.664 ' HB ' ' HB3' ' A' ' 62' ' ' ALA . 2.0 pp -83.5 -11.91 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.566 0 CA-C-O 121.39 0.614 . . . . 0.0 111.871 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.85 -7.2 57.68 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.529 174.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 81.17 -71.83 2.84 Favored Glycine 0 N--CA 1.44 -1.045 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.896 177.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 80.5 mt -92.69 15.0 15.44 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 123.158 0.583 . . . . 0.0 110.376 -177.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.566 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 41.8 mt-10 61.1 -84.66 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 125.634 1.574 . . . . 0.0 113.621 177.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 162.06 -24.03 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 103.364 -2.828 . . . . 0.0 103.364 -171.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 34.8 m80 . . . . . 0 C--O 1.245 0.836 0 CA-C-N 113.558 -1.656 . . . . 0.0 108.447 176.705 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.43 ' HG2' HG23 ' A' ' 2' ' ' VAL . 27.5 ttt . . . . . 0 CA--C 1.517 -0.297 0 N-CA-C 110.613 -0.143 . . . . 0.0 110.613 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.43 HG23 ' HG2' ' A' ' 1' ' ' MET . 53.0 t 65.04 92.19 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.08 0.952 . . . . 0.0 110.588 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 35.5 m -136.61 123.56 21.44 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.847 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -127.51 173.3 9.96 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.28 1.1 57.36 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.364 0.602 . . . . 0.0 109.61 177.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.2 tp -142.19 114.71 8.45 Favored 'General case' 0 N--CA 1.422 -1.854 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -178.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.417 ' HB ' ' HB3' ' A' ' 60' ' ' LYS . 40.9 m -107.06 127.74 53.75 Favored 'General case' 0 C--N 1.286 -2.186 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 179.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.517 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 71.4 mt -118.88 135.79 58.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-O 121.207 0.527 . . . . 0.0 110.389 -177.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.407 ' O ' HG12 ' A' ' 56' ' ' VAL . 92.8 m-85 -88.13 127.8 35.43 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.742 177.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 19.2 p -134.29 151.82 51.47 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -175.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 11.0 p -140.15 163.5 32.56 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 175.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.2 m -77.7 -8.21 57.61 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.238 0.542 . . . . 0.0 110.395 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 2.7 m0 -89.8 -25.88 20.86 Favored 'General case' 0 CA--C 1.515 -0.401 0 CA-C-O 121.922 0.868 . . . . 0.0 110.246 -176.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.6 t -91.98 118.42 30.75 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.876 -168.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -92.18 -32.54 8.27 Favored Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 13.7 p90 -68.98 -18.25 64.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.058 0.456 . . . . 0.0 112.161 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.632 ' SG ' ' HB ' ' A' ' 56' ' ' VAL . 72.4 m -68.85 -38.67 79.92 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.667 0.746 . . . . 0.0 109.178 174.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.3 tt -68.31 -30.0 68.89 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.775 -178.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -61.65 -41.5 97.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.77 176.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.477 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 17.6 tp -74.51 -39.91 62.12 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.494 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -56.36 -51.61 67.63 Favored 'General case' 0 C--O 1.239 0.542 0 CA-C-N 116.071 -0.513 . . . . 0.0 112.146 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.4 p -61.08 -42.44 98.51 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.999 0.428 . . . . 0.0 110.84 -179.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -59.63 -49.54 77.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.993 178.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.484 HD22 HD12 ' A' ' 29' ' ' ILE . 51.8 mt -67.56 -36.77 81.58 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.392 -178.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.7 m -66.91 -41.8 86.5 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-O 121.207 0.527 . . . . 0.0 110.248 179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.0 -7.42 53.61 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.195 0.521 . . . . 0.0 111.889 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -107.75 8.21 28.75 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 123.073 0.549 . . . . 0.0 110.867 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 60.6 ttt180 57.61 62.85 1.99 Allowed 'General case' 0 C--O 1.243 0.724 0 C-N-CA 125.299 1.44 . . . . 0.0 112.219 -177.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.484 HD12 HD22 ' A' ' 24' ' ' LEU . 76.3 mt -121.58 117.41 52.5 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.206 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.689 176.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.82 121.88 30.78 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -135.23 156.01 49.7 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.853 -177.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -116.2 132.79 56.56 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 175.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 8.8 pt-20 -96.01 151.05 19.8 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.417 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 16.6 t -94.76 145.36 8.19 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.875 0.845 . . . . 0.0 112.921 -173.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.411 ' OD2' ' HB2' ' A' ' 39' ' ' ASN . 28.6 t70 -62.51 -1.49 0.81 Allowed 'General case' 0 CA--C 1.564 1.498 0 C-N-CA 128.352 2.661 . . . . 0.0 114.036 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.423 HG22 ' HB3' ' A' ' 42' ' ' ALA . 26.1 pt -45.2 -21.04 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.452 0 N-CA-C 115.759 1.762 . . . . 0.0 115.759 -173.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -56.38 -29.02 60.95 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.003 0.43 . . . . 0.0 110.862 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 46.4 t60 -127.94 -23.7 3.31 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-O 121.175 0.512 . . . . 0.0 110.285 173.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.411 ' HB2' ' OD2' ' A' ' 35' ' ' ASP . 8.4 t30 -87.71 87.11 7.28 Favored 'General case' 0 C--O 1.244 0.774 0 O-C-N 121.488 -0.758 . . . . 0.0 109.683 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -67.16 -23.87 65.83 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -174.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.75 -34.78 73.41 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.598 0.713 . . . . 0.0 110.963 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.423 ' HB3' HG22 ' A' ' 36' ' ' ILE . . . -87.09 -20.66 26.8 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 121.362 0.601 . . . . 0.0 109.871 176.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.01 -34.59 64.21 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.592 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.79 -32.82 74.68 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.52 173.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 94.2 t80 -63.02 -42.46 99.81 Favored 'General case' 0 N--CA 1.461 0.095 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 176.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.1 t -57.0 -45.15 83.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.01 177.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 53' ' ' ASN . . . -66.69 -52.39 34.5 Favored Glycine 0 N--CA 1.432 -1.618 0 CA-C-N 115.263 -0.88 . . . . 0.0 111.223 178.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.4 t -59.52 -39.36 83.6 Favored 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 123.472 0.709 . . . . 0.0 112.814 -175.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 9.0 p -70.1 -24.42 26.2 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.944 0 CA-C-O 121.132 0.492 . . . . 0.0 111.514 -177.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -93.6 -27.58 16.52 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.146 0.498 . . . . 0.0 110.437 177.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 148.68 -63.1 0.42 Allowed Glycine 0 N--CA 1.436 -1.352 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 177.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -159.33 -34.19 0.02 OUTLIER Glycine 0 C--N 1.298 -1.565 0 N-CA-C 110.389 -1.084 . . . . 0.0 110.389 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.402 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 29.3 p-10 -76.56 145.97 38.66 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.224 0.535 . . . . 0.0 110.748 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -89.66 86.33 6.68 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.659 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.8 m -78.9 117.19 19.75 Favored 'General case' 0 C--N 1.312 -1.058 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 172.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.632 ' HB ' ' SG ' ' A' ' 17' ' ' CYS . 2.3 t -76.01 -60.82 0.94 Allowed Pre-proline 0 C--N 1.308 -1.206 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 -167.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.53 ' HD3' ' SG ' ' A' ' 17' ' ' CYS . 67.8 Cg_endo -73.14 70.67 3.73 Favored 'Trans proline' 0 C--N 1.399 3.219 0 CA-C-N 121.963 1.737 . . . . 0.0 112.952 -171.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 69.2 m -108.29 119.19 38.77 Favored 'General case' 1 N--CA 1.377 -4.096 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 -179.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.7 p -101.33 139.96 21.25 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.672 -175.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.417 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 66.2 tttm -108.89 111.79 23.67 Favored 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -88.53 177.69 6.72 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.238 -177.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.29 -12.0 59.01 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.44 177.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -65.51 -19.88 66.11 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.953 174.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 88.18 -12.22 65.1 Favored Glycine 0 N--CA 1.435 -1.397 0 N-CA-C 111.089 -0.804 . . . . 0.0 111.089 -176.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 61.6 p -94.78 166.53 11.94 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.6 p -114.28 140.14 48.85 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.134 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.5 tp -119.25 110.56 17.16 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.8 m -79.16 120.96 24.42 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.044 -177.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 50.4 t-20 53.89 75.75 0.59 Allowed Pre-proline 0 N--CA 1.481 1.115 0 C-N-CA 124.843 1.257 . . . . 0.0 111.981 176.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -97.88 165.62 0.8 Allowed 'Trans proline' 0 N--CA 1.442 -1.519 0 C-N-CA 122.401 2.068 . . . . 0.0 111.915 178.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.456 ' O ' HG23 ' A' ' 75' ' ' VAL . 13.4 m -84.34 149.82 25.79 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.62 -41.41 94.76 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.07 0.462 . . . . 0.0 111.918 -175.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -63.48 -37.66 88.14 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.723 178.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.8 mm-40 -64.92 -42.99 94.25 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.271 177.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 71' ' ' SER . 63.2 t -62.49 -43.91 98.78 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.75 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.922 178.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.404 ' O ' HG13 ' A' ' 80' ' ' VAL . 23.2 tptm -62.65 -47.11 85.15 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.551 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.68 -29.09 68.28 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 111.961 0.356 . . . . 0.0 111.961 -178.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.496 ' O ' HG13 ' A' ' 82' ' ' ILE . 3.5 tmtp? -82.49 -37.06 25.86 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 177.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 19.2 tp -57.69 -49.74 75.52 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.105 0.479 . . . . 0.0 110.068 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 76' ' ' LYS . 33.7 m -61.02 -34.99 62.21 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.326 -0.852 . . . . 0.0 112.99 -176.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.1 ptpp? -80.55 -32.61 36.64 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 120.427 -0.509 . . . . 0.0 111.685 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.1 pp -85.29 -12.45 11.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.289 0.566 . . . . 0.0 111.854 -178.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -86.14 -6.83 58.93 Favored 'General case' 0 C--O 1.239 0.532 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.236 174.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.21 -128.15 9.19 Favored Glycine 0 N--CA 1.421 -2.327 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.963 177.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 42.5 tp -97.82 -9.01 27.2 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 120.98 0.419 . . . . 0.0 109.947 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -72.66 90.93 1.41 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.505 -177.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -129.86 -7.03 4.5 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.485 0.659 . . . . 0.0 110.071 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 65.2 m80 . . . . . 0 C--N 1.312 -1.045 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 -176.076 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ptm . . . . . 0 CA--C 1.539 0.543 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.3 p -105.33 -53.73 6.74 Favored 'Isoleucine or valine' 0 C--N 1.345 0.376 0 C-N-CA 118.625 -1.23 . . . . 0.0 111.707 -178.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.8 p -133.98 -19.61 2.0 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.155 0.502 . . . . 0.0 111.505 177.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -101.0 158.37 16.06 Favored 'General case' 0 N--CA 1.419 -2.0 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 177.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -88.16 -2.19 58.46 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-O 121.363 0.601 . . . . 0.0 109.758 178.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.1 tp -125.83 137.81 53.78 Favored 'General case' 0 N--CA 1.424 -1.746 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 -178.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 70.8 m -122.6 135.71 54.69 Favored 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.632 HG22 HG23 ' A' ' 10' ' ' THR . 58.7 mt -126.03 131.33 71.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 CA-C-O 121.264 0.554 . . . . 0.0 109.884 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -91.94 90.29 7.37 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.028 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.632 HG23 HG22 ' A' ' 8' ' ' ILE . 3.7 p -127.62 160.54 31.29 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 123.006 0.523 . . . . 0.0 111.159 -177.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 41.5 p -115.48 166.63 11.68 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 106.119 -1.808 . . . . 0.0 106.119 171.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.8 t -71.87 -13.65 61.72 Favored 'General case' 0 CA--C 1.552 1.02 0 CA-C-O 121.678 0.751 . . . . 0.0 109.093 172.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 2.2 m0 -90.2 75.74 6.94 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -175.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.2 t -158.52 159.87 36.05 Favored 'General case' 0 C--N 1.296 -1.743 0 C-N-CA 120.211 -0.596 . . . . 0.0 109.675 -178.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.47 -43.9 0.26 Allowed Glycine 0 N--CA 1.43 -1.761 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 178.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -72.24 -26.98 62.23 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 70.0 m -54.88 -32.41 60.84 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 122.652 0.381 . . . . 0.0 111.409 -177.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 38.4 tp -55.02 -33.72 62.88 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.146 0.978 . . . . 0.0 111.943 178.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -59.72 -42.58 93.4 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.3 0.64 . . . . 0.0 109.442 -179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.5 tp -84.32 -38.71 20.05 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.437 -178.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -55.44 -48.84 73.84 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.749 -0.66 . . . . 0.0 112.444 -178.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.9 p -68.18 -40.22 82.32 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.876 -178.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.529 ' HB1' ' HB2' ' A' ' 72' ' ' ALA . . . -59.68 -45.83 90.9 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.481 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.0 mt -69.66 -42.67 73.91 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.723 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 59.6 m -64.71 -35.57 81.47 Favored 'General case' 0 CA--C 1.556 1.18 0 CA-C-O 120.878 0.37 . . . . 0.0 111.175 -179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.93 -26.56 62.34 Favored 'General case' 0 C--O 1.218 -0.572 0 CA-C-O 121.463 0.649 . . . . 0.0 110.425 177.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -91.89 10.64 27.89 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.48 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 29.0 mmt180 65.58 23.87 11.74 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 125.144 1.377 . . . . 0.0 111.282 175.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 80.0 mt -90.11 130.76 38.86 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -102.29 150.39 23.37 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.6 p90 -147.86 138.27 22.99 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 111.915 0.339 . . . . 0.0 111.915 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.3 112.43 22.83 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 106.291 -1.744 . . . . 0.0 106.291 176.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -83.38 126.83 33.13 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 17.4 t -75.51 154.81 6.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 CA-C-O 121.864 0.84 . . . . 0.0 112.559 -173.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -68.79 -0.52 5.51 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 126.394 1.878 . . . . 0.0 114.418 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 40.2 pt -44.44 -24.92 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.331 0 N-CA-C 117.265 2.32 . . . . 0.0 117.265 -170.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -67.73 -25.77 65.81 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 119.561 -0.855 . . . . 0.0 111.109 179.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 14.6 t60 -108.93 -43.79 4.13 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 176.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -79.43 102.98 9.03 Favored 'General case' 0 CA--C 1.501 -0.905 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.336 -178.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.406 ' HA ' ' HB3' ' A' ' 43' ' ' ALA . 16.9 ptp180 -71.47 -23.41 61.82 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.77 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -65.39 -38.38 89.82 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.34 -20.99 25.97 Favored 'General case' 0 C--N 1.31 -1.133 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.975 176.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.406 ' HB3' ' HA ' ' A' ' 40' ' ' ARG . . . -66.88 -33.82 76.45 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.402 -178.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -70.81 -30.49 66.94 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.579 176.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -66.73 -32.96 74.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.172 0.51 . . . . 0.0 110.108 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 44.9 t -62.25 -32.51 55.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.392 177.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.55 -43.38 52.98 Favored Glycine 0 N--CA 1.44 -1.079 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 177.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 19.7 m -58.18 -40.42 81.44 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.497 0.719 . . . . 0.0 112.174 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.3 m -79.72 -7.58 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -178.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 37.5 m-80 -107.75 -53.6 2.6 Favored 'General case' 0 C--N 1.315 -0.897 0 C-N-CA 120.856 -0.337 . . . . 0.0 111.619 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 138.52 -87.51 0.21 Allowed Glycine 0 N--CA 1.435 -1.369 0 C-N-CA 120.537 -0.839 . . . . 0.0 112.193 179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -103.14 -42.7 2.02 Favored Glycine 0 N--CA 1.432 -1.631 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.339 -177.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -124.33 149.35 46.68 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.078 0.466 . . . . 0.0 110.72 -177.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.1 mtm180 -80.79 97.44 7.34 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.45 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 2.7 m -75.8 127.45 33.04 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.41 -1.33 . . . . 0.0 107.41 175.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 1.564 18.9 m -59.35 -71.02 0.34 Allowed Pre-proline 0 CA--C 1.45 -2.883 1 N-CA-C 124.52 5.007 . . . . 0.0 124.52 -177.329 . . . . . . . . 3 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -79.67 79.36 3.38 Favored 'Trans proline' 0 N--CA 1.401 -3.966 0 CA-C-N 122.617 1.97 . . . . 0.0 113.188 -170.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 29.4 m -108.14 120.97 43.85 Favored 'General case' 0 N--CA 1.417 -2.093 0 CA-C-N 114.858 -1.065 . . . . 0.0 108.155 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.6 p -97.78 143.85 12.08 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.747 -177.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -121.08 128.17 52.35 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -103.79 149.08 25.36 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.27 -11.91 53.22 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.457 0.646 . . . . 0.0 111.562 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.4 ' HB2' HG22 ' A' ' 82' ' ' ILE . 36.9 t70 -74.92 -14.19 60.62 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 124.104 0.962 . . . . 0.0 110.064 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.03 -21.85 24.22 Favored Glycine 0 CA--C 1.501 -0.812 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.752 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 3.8 p -70.36 138.02 51.05 Favored 'General case' 0 C--N 1.292 -1.933 0 C-N-CA 123.585 0.754 . . . . 0.0 111.889 -178.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.98 138.09 54.51 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 106.015 -1.846 . . . . 0.0 106.015 174.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.6 mp -129.58 119.6 23.9 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-O 120.87 0.366 . . . . 0.0 110.595 -178.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 35.9 m -90.3 112.72 24.39 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 116.115 -0.493 . . . . 0.0 109.732 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 36.4 t30 56.1 74.22 0.73 Allowed Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 177.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -103.59 172.2 0.19 Allowed 'Trans proline' 0 N--CA 1.444 -1.388 0 C-N-CA 122.478 2.119 . . . . 0.0 110.598 172.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.2 t -85.08 165.22 17.67 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 174.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.529 ' HB2' ' HB1' ' A' ' 23' ' ' ALA . . . -60.66 -32.45 71.64 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.958 0.409 . . . . 0.0 111.398 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -56.65 -40.62 75.8 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.598 1.159 . . . . 0.0 109.511 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.403 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 11.7 mm-40 -68.96 -53.12 22.48 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.399 -1.273 . . . . 0.0 109.653 -176.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 49.4 t -61.4 -40.84 87.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.156 0 CA-C-N 114.997 -1.002 . . . . 0.0 111.126 -176.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -64.04 -37.8 88.74 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.572 -177.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -82.57 -22.58 34.83 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.897 0.38 . . . . 0.0 110.964 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.423 ' O ' HG23 ' A' ' 82' ' ' ILE . 74.8 mmtt -84.56 -35.99 22.42 Favored 'General case' 0 C--N 1.309 -1.176 0 C-N-CA 120.003 -0.679 . . . . 0.0 110.493 177.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 32.9 tp -55.61 -46.48 77.32 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.467 0.651 . . . . 0.0 109.6 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 29.7 m -63.42 -40.88 90.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.864 -178.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.12 -24.18 51.73 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.582 -0.447 . . . . 0.0 111.71 -177.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.423 HG23 ' O ' ' A' ' 78' ' ' LYS . 1.9 pp -83.37 -25.45 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 C-N-CA 120.004 -0.679 . . . . 0.0 110.426 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -75.5 -28.37 59.13 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.462 175.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 143.57 -122.5 1.87 Allowed Glycine 0 N--CA 1.428 -1.842 0 N-CA-C 111.375 -0.69 . . . . 0.0 111.375 178.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 94.6 mt -127.81 30.01 5.36 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 106.648 -1.612 . . . . 0.0 106.648 -178.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.423 ' HB3' ' CE1' ' A' ' 88' ' ' HIS . 4.5 mm-40 -78.9 -57.15 3.9 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 112.987 -1.915 . . . . 0.0 109.735 -172.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.0 t60 58.09 80.17 0.18 Allowed 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.798 1.239 . . . . 0.0 111.53 -178.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.423 ' CE1' ' HB3' ' A' ' 86' ' ' GLU . 37.0 m80 . . . . . 0 C--N 1.308 -1.213 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 177.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.504 -0.814 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 46.8 t 68.15 -70.55 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.921 0 C-N-CA 124.227 1.011 . . . . 0.0 109.891 -174.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 29.4 m 71.59 -47.79 0.67 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.602 1.561 . . . . 0.0 113.996 174.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -99.46 146.51 26.28 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 121.93 -0.481 . . . . 0.0 110.726 -178.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.13 -22.78 20.51 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 121.36 0.6 . . . . 0.0 109.665 177.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.437 ' CD1' HD13 ' A' ' 79' ' ' LEU . 8.5 mp -93.53 129.42 39.76 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.448 177.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.3 m -118.34 108.31 14.92 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 171.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.538 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 57.6 mt -108.5 134.09 51.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-O 121.147 0.498 . . . . 0.0 110.211 -174.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -86.14 123.65 31.66 Favored 'General case' 0 C--N 1.281 -2.404 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.565 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 31.5 p -138.79 -178.91 5.53 Favored 'General case' 0 C--O 1.242 0.691 0 CA-C-O 121.687 0.755 . . . . 0.0 111.103 -178.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 24.1 m -139.4 153.25 47.59 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 104.367 -2.457 . . . . 0.0 104.367 174.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.3 p -49.94 -42.6 48.85 Favored 'General case' 0 C--N 1.315 -0.928 0 O-C-N 123.605 0.565 . . . . 0.0 110.99 176.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 35.2 p90 -111.52 129.67 55.98 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 174.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.3 t -164.02 142.13 7.28 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 174.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.47 -49.2 2.04 Favored Glycine 0 N--CA 1.429 -1.792 0 C-N-CA 120.646 -0.787 . . . . 0.0 111.374 178.272 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -73.42 -34.02 65.26 Favored 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 122.548 0.339 . . . . 0.0 111.553 -175.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.414 ' HA ' ' HB3' ' A' ' 57' ' ' PRO . 21.4 m -62.69 -36.96 84.6 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.247 0.546 . . . . 0.0 110.216 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 24.2 tp -65.64 -27.79 68.63 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.831 -174.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.0 ttt180 -54.46 -53.26 56.68 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.865 0.866 . . . . 0.0 110.158 177.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.48 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 23.3 tp -79.99 -37.8 33.48 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.125 -177.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.6 tttm -58.13 -43.56 87.34 Favored 'General case' 0 C--N 1.32 -0.689 0 C-N-CA 123.747 0.819 . . . . 0.0 111.069 -175.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 17.6 m -72.4 -32.06 66.06 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.351 -178.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -65.97 -46.19 78.95 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.275 0.56 . . . . 0.0 110.042 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 68.9 mt -63.61 -44.46 93.88 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.599 -178.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 30.5 m -61.57 -37.42 83.78 Favored 'General case' 0 CA--C 1.555 1.167 0 CA-C-O 121.217 0.532 . . . . 0.0 110.68 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.18 -19.82 59.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.107 0.48 . . . . 0.0 111.134 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.422 ' HB3' HG13 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -97.31 10.96 38.18 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.519 -179.284 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 96.4 mtt180 63.99 26.2 14.05 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.792 0.837 . . . . 0.0 111.978 -179.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.422 HG13 ' HB3' ' A' ' 27' ' ' ASN . 77.0 mt -91.52 120.19 40.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.276 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -87.04 146.48 26.08 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -153.01 147.91 26.46 Favored 'General case' 0 C--N 1.299 -1.612 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -176.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -109.46 116.27 31.49 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 177.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.565 ' HB2' ' OG1' ' A' ' 10' ' ' THR . 14.0 pt-20 -87.98 146.91 25.28 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.617 -178.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 6.7 t -91.07 151.73 3.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 -171.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -77.91 1.55 20.23 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 128.724 2.81 . . . . 0.0 113.103 -178.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 21.1 pt -42.92 -22.48 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.526 3.341 0 N-CA-C 116.978 2.214 . . . . 0.0 116.978 -168.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -74.37 -21.81 59.5 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 119.403 1.001 . . . . 0.0 109.732 179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 27.3 t-80 -111.01 -34.86 6.09 Favored 'General case' 0 N--CA 1.43 -1.433 0 CA-C-N 114.566 -1.197 . . . . 0.0 109.573 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.524 ' ND2' ' H ' ' A' ' 42' ' ' ALA . 49.6 t30 -90.98 113.46 25.71 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.628 -0.26 . . . . 0.0 110.819 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.3 ptm180 -72.03 -29.85 64.6 Favored 'General case' 0 C--N 1.32 -0.713 0 C-N-CA 120.858 -0.337 . . . . 0.0 111.625 -178.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.65 -46.94 74.1 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -174.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.524 ' H ' ' ND2' ' A' ' 39' ' ' ASN . . . -76.03 -25.18 55.43 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.522 179.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.48 -42.61 87.2 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 177.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.65 -39.55 84.76 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.617 176.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -65.08 -32.85 74.77 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-N 115.142 -0.935 . . . . 0.0 111.082 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 42' ' ' ALA . 64.9 t -59.68 -34.47 55.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-O 121.195 0.522 . . . . 0.0 109.674 178.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.24 -18.38 65.02 Favored Glycine 0 N--CA 1.448 -0.527 0 CA-C-N 115.249 -0.887 . . . . 0.0 112.834 178.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.5 t -81.54 -26.85 34.72 Favored 'General case' 0 N--CA 1.433 -1.285 0 O-C-N 122.228 -0.572 . . . . 0.0 110.391 179.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 27.4 m -99.42 -23.01 4.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 119.831 -0.748 . . . . 0.0 112.729 -178.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -147.76 154.09 40.07 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 175.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -144.32 170.04 26.18 Favored Glycine 0 N--CA 1.439 -1.156 0 N-CA-C 111.172 -0.771 . . . . 0.0 111.172 -178.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 84.51 -82.79 1.66 Allowed Glycine 0 CA--C 1.501 -0.834 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -177.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 16.1 m120 -104.85 123.59 47.97 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 106.771 -1.566 . . . . 0.0 106.771 174.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 55.8 ttp180 -67.13 106.25 1.93 Allowed 'General case' 0 N--CA 1.437 -1.113 0 C-N-CA 119.997 -0.681 . . . . 0.0 110.127 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.5 m -78.48 110.72 13.82 Favored 'General case' 0 N--CA 1.409 -2.476 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 5.4 t -76.89 -57.71 1.15 Allowed Pre-proline 0 N--CA 1.426 -1.632 0 CA-C-O 117.119 -1.42 . . . . 0.0 113.087 -174.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.414 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . 81.1 Cg_endo -73.39 45.49 1.02 Allowed 'Trans proline' 0 C--N 1.402 3.374 0 C-N-CA 121.393 1.395 . . . . 0.0 114.014 -168.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 95.5 m -80.49 138.21 36.53 Favored 'General case' 0 N--CA 1.39 -3.473 0 C-N-CA 126.063 1.745 . . . . 0.0 107.29 177.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.6 p -122.67 136.48 59.36 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 CA-C-O 121.13 0.49 . . . . 0.0 110.569 -178.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -114.58 130.59 56.79 Favored 'General case' 0 N--CA 1.423 -1.812 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 175.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -100.35 151.99 20.86 Favored 'General case' 0 C--N 1.291 -1.945 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.919 179.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.4 -10.08 15.29 Favored 'General case' 0 C--N 1.316 -0.865 0 C-N-CA 124.234 1.013 . . . . 0.0 113.569 -177.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -89.76 -13.98 35.57 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.181 0.515 . . . . 0.0 109.663 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 109.72 3.13 30.49 Favored Glycine 0 N--CA 1.436 -1.312 0 C-N-CA 121.074 -0.584 . . . . 0.0 112.6 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 69.0 m -82.86 131.01 35.21 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.796 177.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.0 p -113.93 137.65 51.4 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 171.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.3 mp -128.08 116.56 20.17 Favored 'General case' 0 C--N 1.293 -1.872 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 14.9 m -96.91 112.42 24.18 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -178.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 54.08 69.88 1.97 Allowed Pre-proline 0 N--CA 1.488 1.466 0 C-N-CA 124.213 1.005 . . . . 0.0 113.141 -174.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -95.55 172.88 1.16 Allowed 'Trans proline' 0 N--CA 1.448 -1.176 0 C-N-CA 122.058 1.839 . . . . 0.0 111.567 175.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 30.0 t -93.55 161.49 14.34 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 172.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.81 -28.9 67.86 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.16 0.505 . . . . 0.0 110.243 178.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -56.55 -49.97 73.25 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 114.917 -1.038 . . . . 0.0 110.191 177.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -65.25 -42.56 93.18 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-N 114.805 -1.088 . . . . 0.0 110.653 -177.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.414 ' CG1' HD21 ' A' ' 6' ' ' LEU . 96.9 t -62.05 -49.38 84.34 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.29 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 53.3 tttp -61.36 -43.91 98.06 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.379 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.81 -38.79 87.16 Favored 'General case' 0 C--O 1.242 0.672 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.575 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.421 ' O ' HG13 ' A' ' 82' ' ' ILE . 18.1 tppt? -66.6 -45.08 80.36 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 177.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.437 HD13 ' CD1' ' A' ' 6' ' ' LEU . 33.9 tp -59.98 -49.45 77.61 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.923 -177.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.8 m -66.61 -30.17 48.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -79.72 -33.44 40.92 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 119.543 -0.863 . . . . 0.0 111.221 -178.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.5 pp -83.4 -23.8 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 120.157 -0.617 . . . . 0.0 111.768 -179.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -84.81 -31.91 23.61 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 175.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.27 -60.88 4.79 Favored Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 179.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 97.2 mt -134.48 -152.6 0.48 Allowed 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 69.63 -74.48 0.08 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.818 1.247 . . . . 0.0 111.257 177.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -80.08 -26.07 39.77 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 13.7 t-80 . . . . . 0 N--CA 1.427 -1.58 0 CA-C-N 113.804 -1.544 . . . . 0.0 107.199 177.349 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.6 ' HG3' ' H ' ' A' ' 2' ' ' VAL . 17.8 ptm . . . . . 0 N--CA 1.466 0.34 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.6 ' H ' ' HG3' ' A' ' 1' ' ' MET . 67.7 t -125.67 -43.39 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.503 -0.842 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -177.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.91 -42.46 76.07 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-N 114.55 -1.205 . . . . 0.0 109.994 177.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -122.9 148.1 45.84 Favored 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 167.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.14 -20.91 65.81 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -174.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.2 tp -110.29 151.55 27.25 Favored 'General case' 0 C--N 1.313 -1.005 0 C-N-CA 120.681 -0.408 . . . . 0.0 111.779 -174.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 77.2 m -121.44 119.64 32.65 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 176.023 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 52.3 mt -120.34 131.87 71.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.394 0.616 . . . . 0.0 110.886 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -95.0 127.3 40.96 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 174.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.436 ' HA ' ' HB ' ' A' ' 56' ' ' VAL . 7.3 p -151.27 176.54 11.13 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.06 0.457 . . . . 0.0 111.723 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 29.0 m -132.02 149.45 52.42 Favored 'General case' 0 N--CA 1.429 -1.512 0 N-CA-C 105.687 -1.968 . . . . 0.0 105.687 174.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 78.2 p -68.68 -30.05 68.64 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.957 0.884 . . . . 0.0 108.85 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -84.92 101.78 12.61 Favored 'General case' 0 N--CA 1.412 -2.343 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 171.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.458 ' SG ' HG23 ' A' ' 56' ' ' VAL . 10.0 m -164.22 158.93 19.54 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 113.954 -1.475 . . . . 0.0 109.471 179.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -116.75 -62.66 0.33 Allowed Glycine 0 C--N 1.305 -1.193 0 N-CA-C 108.296 -1.921 . . . . 0.0 108.296 167.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.471 ' H ' ' HD1' ' A' ' 16' ' ' TYR . 0.1 OUTLIER -56.62 -30.67 63.52 Favored 'General case' 0 C--N 1.309 -1.16 0 C-N-CA 124.696 1.198 . . . . 0.0 113.197 176.842 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.425 ' SG ' ' HD3' ' A' ' 57' ' ' PRO . 36.1 m -66.04 -44.63 84.09 Favored 'General case' 0 C--O 1.217 -0.637 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 70.3 mt -62.53 -43.26 99.26 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.196 -176.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -59.01 -39.23 81.24 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.335 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.597 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 25.8 tp -77.7 -45.61 24.33 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.074 0.464 . . . . 0.0 109.826 177.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -56.9 -44.47 82.39 Favored 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 123.887 0.875 . . . . 0.0 111.971 -177.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 13.5 t -71.91 -31.07 66.01 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.47 177.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.64 -45.0 88.68 Favored 'General case' 0 CA--C 1.505 -0.776 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 178.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.597 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 42.5 mt -63.79 -39.98 95.57 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.27 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.0 m -69.09 -33.14 73.04 Favored 'General case' 0 CA--C 1.562 1.426 0 CA-C-O 121.268 0.556 . . . . 0.0 110.504 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -73.03 -40.47 65.1 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.563 0.697 . . . . 0.0 111.583 179.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -91.23 18.32 7.14 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 114.959 -1.018 . . . . 0.0 111.902 -174.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.535 ' NH1' ' HA ' ' A' ' 88' ' ' HIS . 35.5 ttt180 54.66 64.08 1.93 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 124.612 1.165 . . . . 0.0 113.479 179.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.489 HD11 ' HB2' ' A' ' 76' ' ' LYS . 89.7 mt -119.68 123.56 71.24 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.706 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 174.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -93.32 135.19 34.78 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.164 -177.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 46.8 p90 -155.8 150.7 26.37 Favored 'General case' 0 C--N 1.315 -0.897 0 O-C-N 123.208 0.317 . . . . 0.0 111.564 -176.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -109.44 136.07 49.45 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 172.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.45 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 10.0 pt-20 -102.77 142.48 33.85 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.819 178.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -84.07 154.85 3.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 CA-C-O 121.259 0.552 . . . . 0.0 111.979 -173.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -71.59 -2.21 16.26 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 126.707 2.003 . . . . 0.0 113.245 -174.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.443 HD13 HG21 ' A' ' 46' ' ' VAL . 3.3 pt -44.12 -24.38 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 117.166 2.284 . . . . 0.0 117.166 -167.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -63.52 -41.48 98.5 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.853 0.835 . . . . 0.0 109.058 176.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 56.7 t60 -94.85 -41.76 9.05 Favored 'General case' 0 N--CA 1.434 -1.275 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.581 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.502 ' ND2' ' H ' ' A' ' 42' ' ' ALA . 42.1 t30 -85.47 109.94 18.83 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.124 0.487 . . . . 0.0 111.574 -178.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -75.88 -16.68 60.01 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.683 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -76.11 -43.85 41.34 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -175.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.502 ' H ' ' ND2' ' A' ' 39' ' ' ASN . . . -81.32 -22.79 38.26 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.377 0.608 . . . . 0.0 109.881 177.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.37 -27.13 68.35 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.617 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -64.61 -33.25 75.49 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.942 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -67.54 -36.8 81.67 Favored 'General case' 0 C--O 1.223 -0.296 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.443 HG21 HD13 ' A' ' 36' ' ' ILE . 57.3 t -64.87 -45.68 94.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.999 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -69.64 -21.02 76.2 Favored Glycine 0 C--O 1.218 -0.881 0 C-N-CA 120.885 -0.674 . . . . 0.0 111.862 178.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 39.6 t -81.87 -41.62 20.73 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 122.798 0.439 . . . . 0.0 110.798 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.2 p -82.22 -31.43 10.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.618 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -176.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -96.19 137.02 35.87 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 120.807 0.337 . . . . 0.0 110.156 179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -93.85 136.14 12.9 Favored Glycine 0 N--CA 1.436 -1.328 0 C-N-CA 121.006 -0.616 . . . . 0.0 113.78 -174.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.32 -88.17 1.58 Allowed Glycine 0 N--CA 1.43 -1.702 0 CA-C-N 115.436 -0.382 . . . . 0.0 112.501 177.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -93.29 162.21 14.09 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -178.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 54.1 ttp180 -85.48 83.43 7.93 Favored 'General case' 0 N--CA 1.43 -1.444 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 173.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.6 m -60.96 127.76 33.15 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 115.078 -0.964 . . . . 0.0 109.498 179.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.458 HG23 ' SG ' ' A' ' 14' ' ' CYS 1.539 12.0 m -68.47 -75.05 0.14 Allowed Pre-proline 0 CA--C 1.433 -3.548 1 N-CA-C 123.902 4.778 . . . . 0.0 123.902 179.509 . . . . . . . . 4 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.425 ' HD3' ' SG ' ' A' ' 17' ' ' CYS . 98.3 Cg_endo -74.15 89.69 1.03 Allowed 'Trans proline' 0 N--CA 1.403 -3.812 0 CA-C-N 121.218 1.471 . . . . 0.0 112.004 -167.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 4.7 m -114.42 116.81 29.49 Favored 'General case' 0 N--CA 1.397 -3.1 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 -177.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.2 p -103.13 139.68 23.41 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.391 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.137 -176.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -115.2 121.14 42.03 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -178.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.454 ' CE2' ' HB3' ' A' ' 78' ' ' LYS . 97.0 m-85 -101.58 155.89 17.81 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.27 -9.87 27.6 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-O 121.696 0.76 . . . . 0.0 110.583 176.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -64.92 -18.77 65.51 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.893 1.277 . . . . 0.0 109.906 176.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 94.43 18.18 36.79 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.501 177.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 27.8 t -133.94 153.73 51.57 Favored 'General case' 0 N--CA 1.428 -1.563 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 -178.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.2 p -114.33 139.52 49.38 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.578 177.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.9 mp -119.33 123.88 45.26 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 18.2 m -97.67 112.69 24.47 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 54.03 68.81 2.51 Favored Pre-proline 0 N--CA 1.489 1.483 0 C-N-CA 124.437 1.095 . . . . 0.0 112.885 -171.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -85.56 165.26 10.67 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 121.759 1.639 . . . . 0.0 109.855 172.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.3 m -84.49 159.75 20.68 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 177.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.52 -43.28 79.65 Favored 'General case' 0 C--O 1.241 0.648 0 C-N-CA 122.971 0.508 . . . . 0.0 111.807 -177.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -58.92 -42.37 89.55 Favored 'General case' 0 CA--C 1.5 -0.977 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.976 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.494 ' O ' ' HE2' ' A' ' 78' ' ' LYS . 56.2 mm-40 -61.15 -44.39 97.39 Favored 'General case' 0 CA--C 1.509 -0.621 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.243 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 50.8 t -65.83 -48.0 83.66 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.413 -178.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.489 ' HB2' HD11 ' A' ' 29' ' ' ILE . 57.5 tttp -61.43 -43.81 98.21 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.998 -177.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.1 -35.31 69.15 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.029 0.442 . . . . 0.0 111.369 -178.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.494 ' HE2' ' O ' ' A' ' 74' ' ' GLU . 0.3 OUTLIER -74.22 -31.43 62.61 Favored 'General case' 0 C--N 1.315 -0.926 0 C-N-CA 119.994 -0.683 . . . . 0.0 110.13 177.377 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.414 HD22 HG23 ' A' ' 29' ' ' ILE . 16.5 tp -63.21 -48.4 78.46 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.188 0.518 . . . . 0.0 109.761 179.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.7 m -65.21 -30.29 49.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.66 -176.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' A' ' 78' ' ' LYS . 0.0 OUTLIER -80.94 -25.81 37.14 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.123 -0.631 . . . . 0.0 111.21 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.4 pp -85.24 -32.03 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.202 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -79.23 -62.06 1.81 Allowed 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 119.78 -109.37 1.63 Allowed Glycine 0 N--CA 1.429 -1.784 0 C-N-CA 120.475 -0.869 . . . . 0.0 113.001 177.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -67.62 -44.53 77.81 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 123.069 0.548 . . . . 0.0 110.342 -176.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -76.6 98.1 4.59 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.661 0.743 . . . . 0.0 111.516 178.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 21.6 p-80 -97.31 128.83 44.49 Favored 'General case' 0 N--CA 1.423 -1.794 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.802 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.535 ' HA ' ' NH1' ' A' ' 28' ' ' ARG . 82.3 m-70 . . . . . 0 C--N 1.293 -1.881 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 178.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtm . . . . . 0 CA--C 1.509 -0.617 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.5 p -98.7 -11.83 8.5 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 174.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.5 p -70.08 123.79 22.46 Favored 'General case' 0 N--CA 1.422 -1.841 0 CA-C-N 114.487 -1.233 . . . . 0.0 110.343 178.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.401 ' HB2' ' HB3' ' A' ' 32' ' ' ASP . . . -82.37 117.18 22.24 Favored 'General case' 0 N--CA 1.422 -1.842 0 CA-C-N 115.247 -0.888 . . . . 0.0 111.337 -177.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.72 -33.63 62.42 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 172.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 60.0 mt -119.28 117.93 29.89 Favored 'General case' 0 N--CA 1.435 -1.194 0 CA-C-N 114.675 -1.148 . . . . 0.0 107.933 175.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.413 ' HB ' ' HB3' ' A' ' 60' ' ' LYS . 11.9 m -102.36 108.04 19.25 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 177.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 59.4 mt -108.06 134.49 49.73 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 CA-C-O 121.629 0.728 . . . . 0.0 110.26 -176.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -91.19 120.12 31.85 Favored 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 115.116 -0.947 . . . . 0.0 109.031 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.528 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 24.9 p -139.67 162.13 35.85 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 122.375 0.27 . . . . 0.0 111.193 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 16.5 p -155.69 -175.1 5.26 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 125.316 1.446 . . . . 0.0 107.684 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.7 t -76.72 -11.03 59.78 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-O 120.984 0.421 . . . . 0.0 109.871 172.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 4.1 m0 -83.98 44.96 1.04 Allowed 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 41.3 t -133.97 126.46 30.34 Favored 'General case' 0 N--CA 1.416 -2.143 0 N-CA-C 113.299 0.851 . . . . 0.0 113.299 -166.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -128.72 -69.91 0.13 Allowed Glycine 0 N--CA 1.437 -1.24 0 N-CA-C 110.123 -1.191 . . . . 0.0 110.123 170.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -61.66 -18.34 59.13 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -71.37 -33.98 70.02 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.218 0.532 . . . . 0.0 110.516 177.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 84.1 mt -65.38 -37.28 86.53 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.348 -178.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 48.7 ttp180 -52.58 -48.59 66.13 Favored 'General case' 0 C--O 1.235 0.316 0 O-C-N 124.274 0.984 . . . . 0.0 110.099 177.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.4 tp -74.12 -45.8 46.67 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.178 -0.919 . . . . 0.0 111.658 -177.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 10.7 pttp -70.86 -26.91 63.47 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 119.285 -0.966 . . . . 0.0 112.123 -173.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.9 p -74.98 -28.49 60.57 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 121.848 -0.532 . . . . 0.0 110.311 175.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.46 -42.06 88.14 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 175.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.1 mt -63.32 -47.54 81.8 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.991 177.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 33.3 m -57.73 -47.06 83.48 Favored 'General case' 0 CA--C 1.552 1.051 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.811 179.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.69 -25.61 68.28 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-O 121.301 0.572 . . . . 0.0 111.936 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -95.5 6.88 47.82 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.027 -178.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.405 ' HD2' ' HA ' ' A' ' 28' ' ' ARG . 16.3 mmm180 67.53 24.0 8.78 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.78 0.832 . . . . 0.0 112.551 -179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.438 HG23 HD22 ' A' ' 79' ' ' LEU . 73.2 mt -83.89 120.76 35.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.742 0 N-CA-C 107.875 -1.158 . . . . 0.0 107.875 176.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -86.52 127.7 34.9 Favored 'General case' 0 C--N 1.308 -1.221 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.4 -176.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -140.27 169.27 18.0 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.401 ' HB3' ' HB2' ' A' ' 4' ' ' ALA . 21.7 t0 -136.52 142.52 43.47 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 175.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.528 ' HB2' ' OG1' ' A' ' 10' ' ' THR . 10.3 pt-20 -105.32 131.58 52.59 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 123.659 0.599 . . . . 0.0 110.939 -176.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 18.4 t -78.84 143.61 12.35 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.953 0 N-CA-C 113.846 1.054 . . . . 0.0 113.846 -172.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -59.65 -1.3 0.24 Allowed 'General case' 0 N--CA 1.503 2.215 0 C-N-CA 128.826 2.85 . . . . 0.0 114.878 -179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 42.2 pt -44.22 -25.19 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.122 0 N-CA-C 117.092 2.256 . . . . 0.0 117.092 -168.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -70.91 -25.49 62.79 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 118.967 0.803 . . . . 0.0 109.096 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 62.8 m-70 -97.97 -35.48 10.44 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.257 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . 0.254 0.2 OUTLIER -112.62 118.69 35.77 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.959 0.885 . . . . 0.0 112.667 179.448 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.695 ' H ' ' HD3' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -75.85 -18.9 59.27 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.655 -174.88 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.87 -53.52 56.34 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.789 0.328 . . . . 0.0 111.496 -179.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.417 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -72.82 -21.1 61.02 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 120.679 -0.408 . . . . 0.0 110.913 177.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.88 -35.46 76.9 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.126 0.489 . . . . 0.0 110.714 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -73.9 -29.28 61.98 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.951 0.405 . . . . 0.0 110.269 177.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -65.21 -29.8 70.64 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.788 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 42' ' ' ALA . 48.0 t -63.03 -30.83 50.61 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.834 176.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -70.75 -43.13 60.27 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 178.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 18.2 m -65.22 -28.82 69.63 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 123.222 0.609 . . . . 0.0 112.359 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 32.8 m -84.61 -5.03 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 O-C-N 121.655 -0.653 . . . . 0.0 111.594 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 27.0 m-80 -104.83 -52.94 2.77 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.638 176.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 143.64 -37.9 1.41 Allowed Glycine 0 N--CA 1.437 -1.248 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -167.24 -47.73 0.03 OUTLIER Glycine 0 N--CA 1.435 -1.38 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -88.64 177.31 6.79 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 37.0 mtm180 -126.19 116.85 21.95 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 178.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.529 HG22 ' HD2' ' A' ' 57' ' ' PRO . 16.3 m -98.02 151.16 20.62 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 106.696 -1.594 . . . . 0.0 106.696 174.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.44 ' CG1' ' HA ' ' A' ' 10' ' ' THR . 34.5 t -79.38 -69.13 0.21 Allowed Pre-proline 0 CA--C 1.475 -1.926 0 CA-C-O 117.509 -1.234 . . . . 0.0 113.988 -178.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.529 ' HD2' HG22 ' A' ' 55' ' ' THR . 72.8 Cg_endo -76.07 86.68 1.5 Allowed 'Trans proline' 1 N--CA 1.393 -4.387 0 CA-C-N 120.867 1.345 . . . . 0.0 111.797 -163.121 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 64.0 m -121.64 124.88 45.37 Favored 'General case' 1 N--CA 1.373 -4.299 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 -175.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 66' ' ' THR . 4.6 p -115.53 136.1 53.44 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.963 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.956 -175.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.413 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 29.7 ttpp -111.74 123.19 49.72 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 174.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.443 ' HB3' HG21 ' A' ' 82' ' ' ILE . 88.2 m-85 -92.03 175.61 6.81 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.015 -178.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.524 ' HB3' ' HB ' ' A' ' 82' ' ' ILE . . . -66.44 -22.84 66.22 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -178.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.543 ' OD2' HG22 ' A' ' 82' ' ' ILE . 48.9 m-20 -82.17 0.07 42.65 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.198 0.523 . . . . 0.0 111.046 177.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 86.57 -0.8 87.02 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.939 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.1 m -68.27 130.45 42.94 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.431 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 6.4 p -114.13 137.8 51.27 Favored 'General case' 0 N--CA 1.428 -1.558 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 176.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 74.9 mt -134.61 121.67 21.23 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 120.926 0.393 . . . . 0.0 110.432 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 91.8 m -90.92 121.83 33.09 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 174.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 58.33 65.64 3.01 Favored Pre-proline 0 N--CA 1.472 0.629 0 C-N-CA 124.284 1.033 . . . . 0.0 113.055 -177.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -84.0 -178.88 3.72 Favored 'Trans proline' 0 C--O 1.25 1.117 0 C-N-CA 121.694 1.596 . . . . 0.0 110.463 171.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.47 ' O ' HG23 ' A' ' 75' ' ' VAL . 3.4 m -112.09 150.83 30.16 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.41 -41.92 66.48 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -174.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -78.27 -34.83 48.71 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 120.948 0.404 . . . . 0.0 109.953 -178.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -65.06 -37.53 87.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.273 178.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 71' ' ' SER . 91.7 t -61.44 -42.17 92.81 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.626 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -62.52 -41.1 98.63 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.984 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.412 ' O ' HG22 ' A' ' 80' ' ' VAL . . . -69.42 -31.58 70.01 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.504 0.669 . . . . 0.0 111.289 179.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm -78.11 -29.71 49.11 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 176.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.438 HD22 HG23 ' A' ' 29' ' ' ILE . 31.1 tp -65.94 -41.57 91.12 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.445 179.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 77' ' ' ALA . 27.4 m -66.12 -36.19 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -178.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -72.99 -34.37 66.37 Favored 'General case' 0 CA--C 1.51 -0.578 0 C-N-CA 119.856 -0.738 . . . . 0.0 110.943 -179.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.543 HG22 ' OD2' ' A' ' 63' ' ' ASP . 2.1 pp -77.02 -31.53 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 C-N-CA 120.344 -0.543 . . . . 0.0 111.246 -177.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -78.63 -46.92 18.14 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.062 0.458 . . . . 0.0 110.145 177.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 82.48 -65.28 4.13 Favored Glycine 0 N--CA 1.447 -0.586 0 N-CA-C 111.654 -0.578 . . . . 0.0 111.654 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 88.6 mt -99.65 -178.28 3.83 Favored 'General case' 0 C--N 1.308 -1.219 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 74.24 -53.77 0.68 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.078 1.351 . . . . 0.0 112.202 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 50.1 m-70 -72.02 -23.86 61.46 Favored 'General case' 0 CA--C 1.506 -0.749 0 CA-C-O 121.522 0.677 . . . . 0.0 110.09 176.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.411 ' NE2' ' HB ' ' A' ' 80' ' ' VAL . 92.0 m-70 . . . . . 0 N--CA 1.421 -1.909 0 N-CA-C 105.76 -1.941 . . . . 0.0 105.76 177.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.3 mmt . . . . . 0 CA--C 1.506 -0.719 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 97.6 t -80.93 -32.58 12.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 -178.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 82.3 p 63.92 142.08 0.02 OUTLIER 'General case' 0 C--O 1.239 0.507 0 C-N-CA 126.445 1.898 . . . . 0.0 112.066 -174.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -78.3 150.64 33.28 Favored 'General case' 0 C--N 1.293 -1.857 0 CA-C-O 120.902 0.382 . . . . 0.0 110.066 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -76.88 -5.27 47.77 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.357 -178.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.84 123.12 41.01 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 121.397 0.618 . . . . 0.0 109.679 175.13 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 25.1 m -110.16 112.3 24.2 Favored 'General case' 0 C--N 1.276 -2.605 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 177.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.539 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 57.5 mt -97.88 137.17 26.22 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.279 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.049 -174.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -92.72 117.91 30.5 Favored 'General case' 0 C--N 1.279 -2.459 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.52 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 14.0 p -128.68 155.92 44.29 Favored 'General case' 0 C--N 1.318 -0.786 0 C-N-CA 122.511 0.324 . . . . 0.0 110.589 -178.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.573 ' HA ' ' HG2' ' A' ' 37' ' ' GLU . 46.9 p -140.2 175.41 9.62 Favored 'General case' 0 N--CA 1.434 -1.23 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 176.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.8 m -86.03 -11.41 52.95 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 175.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 8.5 m0 -82.18 -20.23 38.28 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 114.952 -1.022 . . . . 0.0 112.312 -169.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.492 ' SG ' HG11 ' A' ' 56' ' ' VAL . 9.0 p -109.39 148.33 31.28 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -172.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -101.99 -42.37 2.27 Favored Glycine 0 N--CA 1.432 -1.586 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 172.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -59.75 -24.7 64.25 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -177.545 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.9 p -68.52 -39.14 81.33 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.448 0.642 . . . . 0.0 109.931 178.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 37.2 tp -69.29 -28.93 66.72 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 114.99 -1.004 . . . . 0.0 111.549 -175.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 7.4 mpt_? -63.39 -50.82 68.37 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.013 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.448 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 41.4 tp -68.5 -36.84 79.47 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.101 0.477 . . . . 0.0 109.908 178.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -56.56 -37.29 70.34 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.479 177.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.9 m -75.15 -40.11 59.85 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.117 178.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.83 -41.03 94.95 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 122.818 0.447 . . . . 0.0 111.123 178.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 81.9 mt -66.13 -33.77 76.53 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.76 178.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.7 m -65.55 -44.25 87.4 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.002 177.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.44 -26.89 65.74 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 121.561 0.696 . . . . 0.0 110.963 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -84.53 4.35 32.37 Favored 'General case' 0 C--O 1.254 1.3 0 C-N-CA 123.907 0.883 . . . . 0.0 111.858 179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 48.4 ttt180 60.3 37.12 20.51 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.931 1.293 . . . . 0.0 110.252 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 85.2 mt -95.61 122.74 47.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.916 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.625 179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -83.04 125.2 31.18 Favored 'General case' 0 N--CA 1.434 -1.271 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 176.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -135.69 148.67 48.99 Favored 'General case' 0 C--N 1.298 -1.635 0 CA-C-O 120.707 0.289 . . . . 0.0 110.671 -178.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -111.04 123.73 50.78 Favored 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 174.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.539 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 15.7 pt-20 -96.91 151.04 20.08 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.9 t -90.92 143.63 10.82 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-O 122.163 0.982 . . . . 0.0 113.497 -171.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -63.59 -2.1 1.52 Allowed 'General case' 0 C--N 1.311 -1.094 0 C-N-CA 128.305 2.642 . . . . 0.0 114.822 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 46.4 pt -45.28 -24.84 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.102 0 N-CA-C 114.314 1.227 . . . . 0.0 114.314 -175.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.573 ' HG2' ' HA ' ' A' ' 11' ' ' THR . 45.3 mt-10 -55.8 -31.7 62.87 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.355 0.662 . . . . 0.0 111.427 178.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 15.6 p-80 -128.08 20.56 6.37 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.22 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.462 ' ND2' ' H ' ' A' ' 42' ' ' ALA . 28.7 t30 -143.52 122.18 12.57 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 120.957 0.408 . . . . 0.0 111.26 -178.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 15.0 ptp180 -77.15 -28.21 54.1 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.421 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -68.04 -37.48 81.38 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 -172.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.462 ' H ' ' ND2' ' A' ' 39' ' ' ASN . . . -84.19 -24.75 29.98 Favored 'General case' 0 C--N 1.307 -1.279 0 C-N-CA 120.113 -0.635 . . . . 0.0 109.466 176.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.79 -30.28 68.83 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.288 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -64.4 -36.6 84.68 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 114.97 -1.013 . . . . 0.0 108.737 178.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -67.53 -31.78 72.11 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.123 0.487 . . . . 0.0 110.463 177.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 43.6 t -66.49 -31.42 53.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 177.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.33 -23.65 67.68 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.321 176.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 42.3 t -67.94 -43.72 78.47 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 176.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 31.5 m -81.06 -39.52 17.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 C-N-CA 120.586 -0.446 . . . . 0.0 111.923 179.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.429 ' HB3' ' O ' ' A' ' 53' ' ' ASN . 54.5 m-80 -106.97 109.22 21.06 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 120.862 0.363 . . . . 0.0 110.701 179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -81.93 128.17 8.33 Favored Glycine 0 N--CA 1.439 -1.116 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.798 -179.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 80.31 -84.25 1.37 Allowed Glycine 0 N--CA 1.438 -1.204 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.429 ' O ' ' HB3' ' A' ' 50' ' ' ASN . 93.0 m-20 -88.64 122.61 32.27 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -80.63 94.03 6.24 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-N 116.123 -0.49 . . . . 0.0 109.821 177.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 9.8 m -67.0 123.71 20.99 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 175.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.492 HG11 ' SG ' ' A' ' 14' ' ' CYS . 16.5 t -72.89 -60.56 1.85 Allowed Pre-proline 0 CA--C 1.462 -2.412 0 CA-C-O 117.149 -1.405 . . . . 0.0 114.746 -172.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -77.74 72.17 6.21 Favored 'Trans proline' 1 N--CA 1.394 -4.343 0 CA-C-N 121.185 1.459 . . . . 0.0 112.782 -167.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 88.2 m -106.35 142.12 36.54 Favored 'General case' 0 N--CA 1.38 -3.96 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.6 p -136.81 139.16 45.24 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.862 -174.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -104.54 128.59 52.53 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 177.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -112.4 166.43 11.3 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-O 121.102 0.477 . . . . 0.0 110.489 177.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.34 -8.84 53.65 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 114.654 -1.157 . . . . 0.0 109.142 171.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -62.91 -17.07 61.29 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.111 1.764 . . . . 0.0 110.997 178.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 97.68 8.67 55.69 Favored Glycine 0 CA--C 1.506 -0.517 0 C-N-CA 120.743 -0.741 . . . . 0.0 113.78 173.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.0 t -150.71 173.75 13.81 Favored 'General case' 0 N--CA 1.426 -1.644 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.8 p -114.13 139.68 49.14 Favored 'General case' 0 N--CA 1.427 -1.583 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -178.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.403 HD23 ' HB3' ' A' ' 70' ' ' PRO . 9.7 mp -106.09 151.79 24.23 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 177.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 18.2 m -131.48 113.79 14.13 Favored 'General case' 0 C--N 1.289 -2.053 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -177.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 16.7 m120 61.05 44.96 0.84 Allowed Pre-proline 0 N--CA 1.485 1.322 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -175.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.403 ' HB3' HD23 ' A' ' 67' ' ' LEU . 74.5 Cg_endo -77.28 160.33 32.69 Favored 'Trans proline' 0 C--N 1.366 1.464 0 C-N-CA 121.305 1.337 . . . . 0.0 111.098 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.1 m -84.27 155.25 22.52 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.42 -42.12 70.12 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 123.717 0.807 . . . . 0.0 112.172 -177.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -61.46 -40.39 94.33 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.593 179.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -67.11 -40.81 86.92 Favored 'General case' 0 CA--C 1.505 -0.77 0 CA-C-O 121.075 0.464 . . . . 0.0 110.089 -178.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 92.3 t -61.22 -43.82 97.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.619 177.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.8 tptm -68.61 -41.28 79.73 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.452 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.11 -38.88 89.28 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 122.703 0.401 . . . . 0.0 111.033 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.658 ' O ' HG13 ' A' ' 82' ' ' ILE . 28.7 mmtp -69.48 -39.78 77.48 Favored 'General case' 0 CA--C 1.5 -0.975 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.366 174.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 33.9 tp -60.53 -51.07 70.99 Favored 'General case' 0 C--N 1.318 -0.781 0 O-C-N 123.475 0.485 . . . . 0.0 110.729 -178.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 33.6 m -61.67 -31.41 50.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -177.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -81.09 -44.32 18.16 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 119.801 -0.76 . . . . 0.0 111.575 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.658 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.2 pp -82.1 -20.37 10.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -175.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -100.38 4.14 43.7 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.208 0.527 . . . . 0.0 111.504 -179.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.14 179.1 51.71 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.875 -0.679 . . . . 0.0 114.511 173.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.6 tp -63.4 -26.79 68.9 Favored 'General case' 0 C--O 1.244 0.79 0 C-N-CA 124.609 1.164 . . . . 0.0 110.8 -177.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -66.71 -26.35 66.97 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.651 -1.159 . . . . 0.0 112.013 -175.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -101.3 112.82 25.44 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 121.634 0.73 . . . . 0.0 111.161 -177.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 7.0 p80 . . . . . 0 C--N 1.306 -1.308 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -176.902 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.1 mtp . . . . . 0 CA--C 1.497 -1.058 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 45.3 t -76.76 96.72 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.14 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 29.0 m -83.08 -47.59 11.5 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.28 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -97.87 76.57 2.45 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-O 121.381 0.61 . . . . 0.0 111.518 -177.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -82.6 -24.52 33.85 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 173.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.74 130.71 21.76 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-N 113.561 -1.654 . . . . 0.0 108.922 174.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 28.5 m -102.94 117.32 34.34 Favored 'General case' 0 C--N 1.274 -2.679 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.504 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 68.9 mt -108.86 133.61 53.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 121.446 0.641 . . . . 0.0 110.93 -175.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -85.12 127.42 34.24 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.598 177.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 39.0 p -133.63 163.17 30.03 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.0 0.429 . . . . 0.0 111.215 -178.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 30.3 m -147.87 151.6 36.19 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 175.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.4 p -58.41 -42.91 88.27 Favored 'General case' 0 C--O 1.24 0.592 0 CA-C-N 118.534 0.606 . . . . 0.0 109.736 174.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -72.11 94.36 1.51 Allowed 'General case' 0 N--CA 1.419 -2.001 0 N-CA-C 106.819 -1.548 . . . . 0.0 106.819 167.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 m -163.82 117.46 1.49 Allowed 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.098 -1.41 . . . . 0.0 111.568 178.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -106.83 -56.93 0.62 Allowed Glycine 0 N--CA 1.428 -1.898 0 N-CA-C 108.681 -1.768 . . . . 0.0 108.681 172.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -69.97 -20.96 63.28 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -179.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.519 ' SG ' ' HB ' ' A' ' 56' ' ' VAL . 3.6 m -72.5 -34.99 68.02 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 177.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 18.3 tp -72.29 -29.39 63.83 Favored 'General case' 0 N--CA 1.437 -1.102 0 CA-C-N 114.97 -1.014 . . . . 0.0 110.092 -173.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.419 ' HA ' ' NE ' ' A' ' 19' ' ' ARG . 2.2 mmp_? -59.34 -37.59 78.23 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.81 177.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.7 tp -82.58 -41.33 19.69 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.564 178.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -58.61 -45.54 88.96 Favored 'General case' 0 C--O 1.247 0.951 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.635 -176.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -66.34 -36.73 83.66 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 178.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.62 -45.42 86.93 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.947 -178.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.4 mt -67.54 -37.87 83.34 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.359 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 28.0 m -67.09 -42.72 84.13 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 120.998 0.428 . . . . 0.0 110.41 179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.47 -23.86 65.54 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-O 121.233 0.54 . . . . 0.0 110.801 177.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 19.5 m-80 -93.35 6.63 47.47 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.073 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 64.28 24.21 13.26 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.601 0.76 . . . . 0.0 112.494 176.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 78.1 mt -86.49 120.58 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.4 127.24 33.89 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.634 -178.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 47.3 p90 -142.47 167.19 22.68 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 -178.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -129.43 135.59 48.87 Favored 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 177.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 17.0 pt-20 -100.44 141.69 32.94 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.079 0.466 . . . . 0.0 111.408 -177.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 11.4 t -83.57 146.72 6.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 -171.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -63.68 -2.36 1.69 Allowed 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 129.187 2.995 . . . . 0.0 115.923 178.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 30.7 pt -45.7 -24.34 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 -173.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -70.19 -23.56 62.98 Favored 'General case' 0 CA--C 1.548 0.902 0 CA-C-O 121.724 0.773 . . . . 0.0 110.327 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 26.7 m-70 -111.42 -36.62 5.49 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.926 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.426 ' ND2' ' H ' ' A' ' 42' ' ' ALA . 26.5 t30 -100.85 122.43 43.43 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 114.895 -1.048 . . . . 0.0 112.095 -175.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.426 ' O ' ' HG2' ' A' ' 44' ' ' GLU . 9.7 ptp85 -75.76 -25.6 56.64 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.379 177.498 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -67.95 -36.21 79.72 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -172.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.426 ' H ' ' ND2' ' A' ' 39' ' ' ASN . . . -87.0 -22.23 25.64 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.554 175.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.29 -41.25 81.26 Favored 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.766 -178.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 40' ' ' ARG . 19.0 mm-40 -70.13 -24.66 63.22 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.787 178.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -67.35 -32.6 73.66 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.71 177.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 38.9 t -65.54 -39.87 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 176.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.82 -18.06 78.67 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.956 178.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 32.8 t -80.54 -42.63 22.07 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 178.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 31.7 m -84.07 -32.62 8.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -103.52 160.0 15.11 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -178.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -128.74 152.12 19.21 Favored Glycine 0 N--CA 1.432 -1.571 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.065 -178.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 85.63 -111.91 3.62 Favored Glycine 0 N--CA 1.438 -1.189 0 N-CA-C 110.2 -1.16 . . . . 0.0 110.2 -178.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -91.62 147.69 22.82 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 175.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -71.49 96.7 1.54 Allowed 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.515 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 3.8 m -61.98 114.81 3.59 Favored 'General case' 0 N--CA 1.422 -1.866 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 174.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.519 ' HB ' ' SG ' ' A' ' 17' ' ' CYS . 5.2 t -75.1 -55.33 2.3 Favored Pre-proline 0 N--CA 1.428 -1.541 0 CA-C-O 117.435 -1.269 . . . . 0.0 113.424 -175.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.55 75.6 3.44 Favored 'Trans proline' 0 N--CA 1.41 -3.42 0 CA-C-N 121.155 1.448 . . . . 0.0 112.706 -170.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 58.5 m -106.5 125.66 51.29 Favored 'General case' 0 N--CA 1.381 -3.909 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.3 p -107.73 121.0 60.06 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 CA-C-O 121.505 0.669 . . . . 0.0 110.872 -175.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -105.2 110.11 22.35 Favored 'General case' 0 C--N 1.282 -2.327 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -79.34 159.97 26.94 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.585 -178.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -55.56 -24.27 31.49 Favored 'General case' 0 C--O 1.24 0.601 0 C-N-CA 124.239 1.016 . . . . 0.0 113.588 -177.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -80.58 -17.1 52.43 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.014 0.435 . . . . 0.0 110.694 -178.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 110.2 -8.26 30.99 Favored Glycine 0 C--O 1.246 0.885 0 C-N-CA 121.009 -0.615 . . . . 0.0 113.169 178.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 22.9 t -79.31 135.87 36.86 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.3 m -116.7 138.6 51.34 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -178.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.0 mp -121.83 142.16 50.51 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 120.881 0.372 . . . . 0.0 110.748 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 9.8 m -98.73 116.32 30.69 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-N 115.503 -0.772 . . . . 0.0 108.982 -178.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . 0.324 25.9 p-10 34.88 74.66 0.53 Allowed Pre-proline 0 N--CA 1.494 1.755 0 N-CA-C 116.825 2.157 . . . . 0.0 116.825 179.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -92.04 -165.43 0.15 Allowed 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 122.405 2.07 . . . . 0.0 110.248 175.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.4 m -115.02 169.99 8.68 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 177.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.73 -41.68 87.01 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -177.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . 0.425 ' HA ' ' HE2' ' A' ' 76' ' ' LYS . 5.2 m-20 -64.92 -33.76 76.79 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.691 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -64.21 -51.16 65.07 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 177.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.8 t -61.0 -44.76 98.88 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.167 0 CA-C-N 114.771 -1.104 . . . . 0.0 110.779 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . 0.425 ' HE2' ' HA ' ' A' ' 73' ' ' ASP . 37.1 ttpt -58.46 -46.68 86.1 Favored 'General case' 0 C--N 1.31 -1.119 0 C-N-CA 123.421 0.688 . . . . 0.0 111.991 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.36 -22.19 61.19 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 120.874 0.369 . . . . 0.0 111.538 -178.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.455 ' O ' HG13 ' A' ' 82' ' ' ILE . 45.3 mmtm -81.55 -40.75 22.63 Favored 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 173.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 27.1 tp -55.68 -47.66 76.38 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 123.721 0.808 . . . . 0.0 109.603 -178.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 22.8 m -60.53 -36.77 72.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.732 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.728 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -82.11 -36.35 27.6 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.4 pp -84.6 -29.53 6.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 113.477 0.918 . . . . 0.0 113.477 -176.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -92.22 -30.83 15.7 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 97.31 -144.39 17.3 Favored Glycine 0 N--CA 1.427 -1.955 0 N-CA-C 110.975 -0.85 . . . . 0.0 110.975 179.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -70.27 -30.82 67.94 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 120.661 0.267 . . . . 0.0 110.772 -178.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -98.14 93.91 6.52 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-O 121.31 0.576 . . . . 0.0 109.915 178.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 12.6 p-80 -118.62 -0.92 11.24 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.597 177.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 . . . . . 0 C--O 1.251 1.178 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 172.806 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 ptp . . . . . 0 CA--C 1.507 -0.681 0 N-CA-C 110.499 -0.186 . . . . 0.0 110.499 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.9 m -96.1 177.16 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -172.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 61.0 m -146.32 116.64 7.46 Favored 'General case' 0 N--CA 1.427 -1.61 0 N-CA-C 105.159 -2.164 . . . . 0.0 105.159 173.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -130.35 173.65 10.61 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.174 -0.61 . . . . 0.0 112.36 -177.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.58 1.0 27.63 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.866 178.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.6 mp -98.52 104.82 16.89 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.163 178.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.4 m -102.56 107.3 18.19 Favored 'General case' 0 C--N 1.28 -2.416 0 N-CA-C 105.335 -2.098 . . . . 0.0 105.335 173.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.454 HG22 HG23 ' A' ' 10' ' ' THR . 31.0 mt -106.83 129.85 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.592 0 CA-C-O 121.687 0.755 . . . . 0.0 111.555 -173.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -94.09 106.67 18.64 Favored 'General case' 0 N--CA 1.406 -2.654 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.408 176.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.454 HG23 HG22 ' A' ' 8' ' ' ILE . 2.1 p -140.23 142.29 35.82 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.817 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.4 m -84.37 154.41 22.88 Favored 'General case' 0 N--CA 1.43 -1.47 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 175.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.9 p -62.07 -51.98 65.77 Favored 'General case' 0 N--CA 1.436 -1.174 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 46.3 p90 -83.28 92.67 7.54 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-O 121.914 0.864 . . . . 0.0 110.917 176.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.4 t -163.84 117.13 1.47 Allowed 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.483 177.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.44 -36.13 15.24 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 111.211 -0.756 . . . . 0.0 111.211 -179.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -62.96 -39.18 93.89 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.462 0.648 . . . . 0.0 109.683 179.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 55.7 m -68.09 -39.21 82.91 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.252 177.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.83 -38.63 82.6 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 123.832 0.853 . . . . 0.0 110.112 -177.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 82.5 mtp180 -57.12 -38.78 73.93 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.581 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.453 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 19.5 tp -78.89 -44.08 23.54 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.174 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.5 mtpt -54.42 -49.49 69.85 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.908 -178.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.9 p -65.49 -33.68 76.51 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.963 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.21 -42.33 88.9 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.246 178.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 80.3 mt -64.34 -48.52 75.26 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.486 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 87.1 m -54.91 -42.57 72.37 Favored 'General case' 0 CA--C 1.553 1.088 0 CA-C-O 121.058 0.456 . . . . 0.0 110.768 177.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.15 -13.29 60.2 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -177.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 30.7 m-80 -109.4 14.34 23.69 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 39.9 mtm180 65.99 17.33 10.77 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 124.84 1.256 . . . . 0.0 112.256 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 63.3 mt -87.37 117.32 31.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -178.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -84.99 144.55 28.22 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.4 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -152.3 150.97 30.33 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 120.678 0.275 . . . . 0.0 111.059 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -114.11 113.01 24.13 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 176.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 15.4 pt-20 -91.37 145.02 24.98 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 179.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.0 t -90.73 151.8 3.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 -171.076 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -54.67 -4.23 0.06 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 129.641 3.177 . . . . 0.0 114.91 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 31.8 pt -49.51 -22.48 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 N-CA-C 116.49 2.033 . . . . 0.0 116.49 -168.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? -72.73 -13.41 61.33 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-O 121.458 0.647 . . . . 0.0 111.808 -178.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 34.4 p-80 -128.59 -34.87 1.97 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.615 170.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.48 ' ND2' ' H ' ' A' ' 42' ' ' ALA . 44.3 t30 -80.23 107.23 12.85 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 120.692 0.282 . . . . 0.0 110.77 -179.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -70.77 -23.68 62.45 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.313 -179.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -70.52 -42.1 71.7 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -176.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.48 ' H ' ' ND2' ' A' ' 39' ' ' ASN . . . -80.02 -23.47 41.45 Favored 'General case' 0 C--N 1.31 -1.137 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.361 177.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -68.72 -35.42 77.12 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.283 177.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -61.28 -39.66 91.23 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.072 -0.967 . . . . 0.0 109.085 175.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.4 t80 -66.06 -30.96 71.58 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.633 178.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 88.1 t -64.31 -36.83 78.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 177.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.5 -19.01 77.0 Favored Glycine 0 N--CA 1.444 -0.828 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.602 177.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.0 m -76.52 -30.65 57.24 Favored 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 177.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.5 m -98.79 -11.38 8.61 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -125.48 105.13 8.82 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 175.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -70.99 135.06 23.96 Favored Glycine 0 C--N 1.298 -1.534 0 CA-C-N 115.823 -0.626 . . . . 0.0 113.926 -175.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 83.25 -59.31 4.99 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.383 -0.409 . . . . 0.0 113.574 176.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -125.75 133.34 52.11 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 110.266 -0.272 . . . . 0.0 110.266 -176.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 53.4 mtm180 -70.63 95.69 1.12 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.307 0.575 . . . . 0.0 110.788 176.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.0 m -77.04 131.02 38.2 Favored 'General case' 0 N--CA 1.423 -1.787 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 1.716 15.3 m -58.46 -89.78 0.0 OUTLIER Pre-proline 0 CA--C 1.438 -3.338 1 N-CA-C 123.659 4.689 . . . . 0.0 123.659 -178.891 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -69.9 94.02 0.54 Allowed 'Trans proline' 0 N--CA 1.409 -3.48 0 CA-C-N 120.799 1.321 . . . . 0.0 112.508 -165.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.5 m -119.69 112.42 19.26 Favored 'General case' 0 N--CA 1.407 -2.609 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 -177.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.4 p -103.41 134.85 43.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 CA-C-O 121.405 0.622 . . . . 0.0 111.211 -176.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -109.03 116.93 32.91 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 177.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -100.32 178.81 4.65 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 178.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.57 -9.16 24.23 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 122.346 1.07 . . . . 0.0 110.153 174.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -63.01 -19.33 64.25 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 125.876 1.67 . . . . 0.0 110.152 175.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 87.51 -22.81 14.63 Favored Glycine 0 C--O 1.238 0.353 0 CA-C-N 116.137 -0.483 . . . . 0.0 113.396 176.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.1 t -100.78 171.57 7.6 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 178.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.7 p -113.81 141.13 47.68 Favored 'General case' 0 C--N 1.287 -2.144 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 46.7 tp -115.11 125.25 53.26 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 107.821 -1.178 . . . . 0.0 107.821 178.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.9 m -105.24 144.76 31.59 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -175.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 9.6 p30 50.04 48.41 5.98 Favored Pre-proline 0 N--CA 1.491 1.59 0 C-N-CA 124.78 1.232 . . . . 0.0 113.043 -179.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -80.94 160.66 21.06 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 121.991 1.794 . . . . 0.0 112.703 -174.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.3 m -97.4 153.8 17.86 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 174.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.84 -35.54 73.08 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.044 0.45 . . . . 0.0 111.664 -176.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -62.44 -44.18 97.04 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.218 178.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -64.38 -41.19 96.82 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.581 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 95.9 t -57.82 -51.72 66.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.068 178.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -60.96 -44.11 97.77 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.379 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.05 -37.91 84.9 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.674 -178.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -68.81 -41.24 78.91 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 177.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.17 -49.74 74.62 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 123.796 0.685 . . . . 0.0 110.121 -175.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 26.5 m -61.88 -35.93 70.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -178.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.14 -31.24 34.25 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 119.771 -0.772 . . . . 0.0 111.731 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.4 pp -75.02 -21.52 16.69 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.51 179.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -85.87 4.75 35.91 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.682 176.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 96.46 -105.56 3.24 Favored Glycine 0 N--CA 1.424 -2.161 0 N-CA-C 109.265 -1.534 . . . . 0.0 109.265 -179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.1 mt -138.85 19.57 2.66 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 173.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -97.78 142.75 29.17 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 15.7 m170 75.69 9.71 3.49 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 124.125 0.97 . . . . 0.0 110.739 -172.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 . . . . . 0 N--CA 1.426 -1.63 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 177.4 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.355 0 CA-C-O 120.269 0.08 . . . . 0.0 111.182 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.7 t -80.55 72.47 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 CA-C-O 121.839 0.828 . . . . 0.0 108.999 -178.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.7 m -83.87 -21.74 31.87 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.99 -178.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -134.88 163.14 30.5 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.329 -178.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -95.89 1.18 52.83 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.069 0.462 . . . . 0.0 111.466 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.3 tp -132.68 133.27 43.34 Favored 'General case' 0 N--CA 1.434 -1.252 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -178.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 63.0 m -114.86 124.34 51.47 Favored 'General case' 0 C--N 1.292 -1.926 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 177.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.573 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 67.0 mt -119.03 144.94 25.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -178.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.436 ' HD1' ' O ' ' A' ' 58' ' ' THR . 92.7 m-85 -98.75 133.01 43.68 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.452 ' HA ' ' CG1' ' A' ' 56' ' ' VAL . 17.1 p -140.49 153.85 46.38 Favored 'General case' 0 C--O 1.242 0.689 0 N-CA-C 112.531 0.567 . . . . 0.0 112.531 -176.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 32.3 p -144.69 164.74 30.07 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 106.663 -1.606 . . . . 0.0 106.663 175.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 41.6 p -86.14 -0.82 56.57 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 121.34 0.591 . . . . 0.0 111.529 177.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 2.8 m0 -94.68 27.96 2.84 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -174.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.442 ' HB2' HG21 ' A' ' 56' ' ' VAL . 6.1 t -148.08 151.49 35.76 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -168.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -126.71 -28.21 0.98 Allowed Glycine 0 N--CA 1.441 -1.025 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.771 176.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -65.09 -36.46 84.37 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.262 0.553 . . . . 0.0 110.793 -178.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.443 ' HA ' ' HB3' ' A' ' 57' ' ' PRO . 1.7 p -61.0 -32.59 72.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.165 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 81.9 mt -66.73 -28.85 68.75 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.906 -177.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -60.78 -56.08 25.47 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 121.292 0.568 . . . . 0.0 109.5 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.522 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 16.4 tp -66.79 -39.93 87.97 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.994 -177.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.438 ' HG2' ' OH ' ' A' ' 31' ' ' TYR . 51.1 tttm -58.34 -45.66 87.71 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.847 -177.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.7 p -71.41 -37.47 71.5 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.597 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.47 -42.9 97.18 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 123.066 0.546 . . . . 0.0 110.997 178.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 76.4 mt -69.26 -42.62 75.32 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.01 -178.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.4 m -62.52 -42.13 99.31 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 120.712 0.291 . . . . 0.0 110.273 177.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.79 -19.0 65.04 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 121.479 0.657 . . . . 0.0 111.196 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -98.25 9.4 43.07 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.932 178.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.475 ' HA ' ' NE ' ' A' ' 28' ' ' ARG . 4.2 mmp_? 65.96 23.14 11.24 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.54 0.736 . . . . 0.0 112.127 177.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.7 mt -87.15 119.95 35.7 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.467 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -89.35 127.16 35.78 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.165 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.438 ' OH ' ' HG2' ' A' ' 21' ' ' LYS . 51.6 p90 -136.52 151.92 49.96 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.878 -178.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -111.38 136.25 50.78 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 173.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.573 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 12.8 pt-20 -102.64 146.23 28.49 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.641 -177.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.3 t -96.04 134.69 32.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 -173.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -54.57 -0.59 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 129.529 3.132 . . . . 0.0 115.986 179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 10.6 pt -43.85 -25.46 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.514 2.753 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 -168.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -59.63 -45.55 91.63 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 20.3 t-80 -100.54 -31.27 11.35 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.321 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.467 ' ND2' ' H ' ' A' ' 42' ' ' ALA . 50.1 t30 -88.8 104.45 16.93 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -72.86 -17.69 61.51 Favored 'General case' 0 C--N 1.308 -1.215 0 C-N-CA 120.82 -0.352 . . . . 0.0 111.572 -177.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -72.31 -46.94 53.52 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 112.823 0.675 . . . . 0.0 112.823 -176.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.467 ' H ' ' ND2' ' A' ' 39' ' ' ASN . . . -75.29 -25.2 57.74 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 121.268 0.556 . . . . 0.0 110.001 177.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -67.16 -32.77 74.1 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.41 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -66.29 -39.89 89.67 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.7 t80 -61.18 -46.17 91.61 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.796 177.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 42' ' ' ALA . 80.9 t -57.08 -42.34 79.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.492 178.222 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -59.95 -32.95 76.78 Favored Glycine 0 CA--C 1.527 0.793 0 CA-C-N 115.937 -0.574 . . . . 0.0 112.299 178.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.3 m -81.87 -25.85 34.71 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 120.925 0.393 . . . . 0.0 111.304 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 86.6 t -79.41 -39.09 20.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.098 0.475 . . . . 0.0 110.516 179.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -84.97 -174.61 5.37 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.094 -178.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -90.23 -93.14 1.22 Allowed Glycine 0 N--CA 1.438 -1.201 0 C-N-CA 121.072 -0.585 . . . . 0.0 113.181 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -92.25 -47.15 3.37 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.705 -174.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -126.22 151.82 46.88 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 62.3 mtm180 -57.88 111.18 1.07 Allowed 'General case' 0 C--O 1.24 0.567 0 CA-C-O 121.73 0.776 . . . . 0.0 111.826 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 24.5 m -87.95 133.82 33.85 Favored 'General case' 0 C--N 1.297 -1.688 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 178.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.452 ' CG1' ' HA ' ' A' ' 10' ' ' THR . 21.9 t -74.77 -64.46 0.64 Allowed Pre-proline 0 CA--C 1.459 -2.528 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -171.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.443 ' HB3' ' HA ' ' A' ' 17' ' ' CYS . 33.0 Cg_endo -79.36 50.48 3.52 Favored 'Trans proline' 0 N--CA 1.415 -3.136 0 CA-C-N 121.092 1.426 . . . . 0.0 113.349 -164.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.436 ' O ' ' HD1' ' A' ' 9' ' ' TYR . 98.8 m -80.02 136.31 36.56 Favored 'General case' 0 N--CA 1.38 -3.938 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 176.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 14.3 p -125.74 148.69 30.3 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.325 -174.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -127.22 119.58 26.73 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 177.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -87.91 161.13 17.64 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.408 -178.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.56 -10.5 8.2 Favored 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 123.687 0.795 . . . . 0.0 111.735 176.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -77.68 -18.7 56.39 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.845 176.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 101.44 -13.35 58.31 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.176 -179.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.2 m -82.12 143.88 31.16 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -178.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.8 p -114.35 148.07 38.17 Favored 'General case' 0 N--CA 1.438 -1.059 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.346 179.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 63.5 mt -130.16 136.3 49.12 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 175.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 82.9 m -100.63 118.03 35.95 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 176.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 58.18 67.44 2.22 Favored Pre-proline 0 N--CA 1.485 1.318 0 C-N-CA 124.395 1.078 . . . . 0.0 112.282 -178.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -88.24 157.54 6.88 Favored 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 121.776 1.651 . . . . 0.0 112.029 176.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 56.5 p -84.79 149.77 25.5 Favored 'General case' 0 N--CA 1.419 -1.992 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 175.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.93 -32.83 72.32 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 120.913 0.387 . . . . 0.0 110.318 -178.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -62.11 -49.76 74.6 Favored 'General case' 0 CA--C 1.506 -0.747 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.584 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 19.6 mt-10 -64.89 -42.04 95.12 Favored 'General case' 0 C--O 1.203 -1.386 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.573 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.3 t -57.72 -44.64 86.13 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.433 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.633 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -65.86 -44.94 83.92 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.21 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -67.94 -32.13 72.36 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-O 121.214 0.531 . . . . 0.0 111.617 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.449 ' O ' HG13 ' A' ' 82' ' ' ILE . 31.4 mmtp -77.15 -38.14 52.51 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 177.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 15.6 tp -57.59 -48.26 79.87 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 122.734 0.414 . . . . 0.0 110.061 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.469 ' HA ' ' CE1' ' A' ' 87' ' ' HIS . 34.6 m -60.62 -35.64 65.04 Favored 'Isoleucine or valine' 0 C--O 1.239 0.528 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.724 -176.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 21.7 ptmt -81.86 -39.89 23.24 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 78' ' ' LYS . 2.2 pp -75.31 -12.44 14.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.657 0 N-CA-C 112.84 0.682 . . . . 0.0 112.84 -176.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -83.22 3.98 28.77 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.775 177.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 79.39 -146.22 28.7 Favored Glycine 0 CA--C 1.496 -1.14 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 178.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 6.2 tt -94.63 103.99 15.92 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 176.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -150.75 -49.58 0.12 Allowed 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.569 0.7 . . . . 0.0 110.115 -175.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . 0.469 ' CE1' ' HA ' ' A' ' 80' ' ' VAL . 65.3 m80 -78.89 -48.66 14.22 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.838 -178.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 33.8 t60 . . . . . 0 C--N 1.299 -1.62 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -178.911 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 CA--C 1.513 -0.472 0 CA-C-O 120.866 0.365 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.6 m -99.66 -176.48 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -174.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 8.0 m -54.29 134.81 45.15 Favored 'General case' 0 C--O 1.248 1.0 0 O-C-N 123.957 0.786 . . . . 0.0 110.342 178.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -68.5 89.14 0.35 Allowed 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.118 -0.492 . . . . 0.0 112.052 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.25 -31.52 67.63 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 175.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.538 HD21 HD13 ' A' ' 79' ' ' LEU . 1.6 mm? -116.57 115.66 26.16 Favored 'General case' 0 N--CA 1.43 -1.435 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 176.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.465 ' HB ' ' HB3' ' A' ' 60' ' ' LYS . 6.2 m -102.26 108.36 19.71 Favored 'General case' 0 C--N 1.286 -2.157 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 177.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 59.3 mt -104.54 132.35 51.38 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 CA-C-O 121.285 0.564 . . . . 0.0 110.697 -175.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -93.92 119.96 33.53 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.425 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.8 p -139.06 156.33 47.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.702 -0.226 . . . . 0.0 110.405 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 37.5 p -142.57 -178.21 5.66 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.1 p -74.39 -0.79 18.42 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-O 121.337 0.589 . . . . 0.0 110.646 173.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 4.2 m0 -93.26 6.42 48.14 Favored 'General case' 0 C--O 1.237 0.446 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 177.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.9 m -91.41 117.1 29.39 Favored 'General case' 0 N--CA 1.426 -1.638 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -176.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -122.51 -56.91 0.2 Allowed Glycine 0 N--CA 1.417 -2.583 0 N-CA-C 107.653 -2.179 . . . . 0.0 107.653 170.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -68.48 -18.76 64.47 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 179.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 28.7 m -64.86 -30.46 71.46 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.182 0.515 . . . . 0.0 109.818 178.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 89.2 mt -68.97 -28.37 66.56 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.579 -173.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 28.8 mmm180 -63.85 -32.87 74.53 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.03 0.443 . . . . 0.0 110.836 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.483 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 13.0 tp -84.19 -43.57 14.81 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.374 177.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -55.9 -54.06 49.3 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.28 -176.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.3 m -63.72 -30.03 71.18 Favored 'General case' 0 CA--C 1.552 1.023 0 CA-C-O 121.106 0.479 . . . . 0.0 110.973 -179.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -68.17 -38.68 82.34 Favored 'General case' 0 CA--C 1.507 -0.691 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.047 178.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 70.8 mt -69.94 -39.49 76.07 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.788 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 60.5 m -58.55 -43.26 89.27 Favored 'General case' 0 CA--C 1.553 1.075 0 CA-C-O 121.329 0.585 . . . . 0.0 110.069 174.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.35 -37.77 83.76 Favored 'General case' 0 C--O 1.216 -0.707 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.05 178.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -79.32 5.8 11.56 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 123.729 0.812 . . . . 0.0 112.712 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 61.84 26.34 15.95 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.81 0.844 . . . . 0.0 111.344 179.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 76.9 mt -84.89 125.0 40.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 -178.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -88.29 115.99 26.19 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.488 -176.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -138.35 164.23 29.83 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.328 0.585 . . . . 0.0 111.266 -174.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -127.92 125.94 40.53 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 177.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.444 ' HA ' ' O ' ' A' ' 8' ' ' ILE 0.254 0.0 OUTLIER -100.01 132.78 45.16 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.506 0.67 . . . . 0.0 111.121 178.45 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.401 ' CG1' HG23 ' A' ' 36' ' ' ILE . 13.0 t -82.7 134.89 25.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -168.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -56.59 -0.69 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 C-N-CA 130.544 3.538 . . . . 0.0 114.748 178.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.401 HG23 ' CG1' ' A' ' 34' ' ' VAL . 31.5 pt -41.98 -27.87 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 N-CA-C 117.862 2.541 . . . . 0.0 117.862 -163.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -67.92 -13.49 62.2 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 119.529 1.059 . . . . 0.0 113.336 -173.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 -116.17 -4.65 11.92 Favored 'General case' 0 C--N 1.311 -1.07 0 C-N-CA 119.916 -0.714 . . . . 0.0 110.479 177.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -128.96 108.77 10.68 Favored 'General case' 0 C--O 1.244 0.791 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -176.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -52.05 -38.25 56.4 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 113.577 -1.647 . . . . 0.0 113.818 -176.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -54.34 -52.38 61.76 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.707 0.632 . . . . 0.0 112.707 -174.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.431 ' O ' HG23 ' A' ' 46' ' ' VAL . . . -87.0 -26.61 23.69 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.876 -177.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.401 ' HB2' ' O ' ' A' ' 36' ' ' ILE . . . -66.09 -38.09 87.38 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-O 121.351 0.596 . . . . 0.0 110.639 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -72.66 -29.18 63.22 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.152 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -68.39 -29.4 68.08 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.516 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.431 HG23 ' O ' ' A' ' 42' ' ' ALA . 44.9 t -63.66 -32.04 55.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 CA-C-O 121.463 0.649 . . . . 0.0 109.658 177.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -73.81 -39.93 46.25 Favored Glycine 0 N--CA 1.439 -1.115 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 177.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.2 m -63.79 -29.67 70.85 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 123.503 0.721 . . . . 0.0 112.331 -178.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 26.9 m -91.56 -4.86 10.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -179.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -116.03 -32.33 5.43 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.55 65.37 0.53 Allowed Glycine 0 N--CA 1.431 -1.651 0 C-N-CA 120.286 -0.959 . . . . 0.0 111.741 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 91.33 -46.25 2.81 Favored Glycine 0 C--N 1.316 -0.536 0 C-N-CA 121.287 -0.482 . . . . 0.0 112.846 175.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -90.66 154.21 19.74 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -176.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -105.12 82.74 1.88 Allowed 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.48 0.657 . . . . 0.0 109.301 178.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 8.1 m -74.98 128.08 34.74 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 114.856 -1.065 . . . . 0.0 108.727 178.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . 1.704 15.3 m -55.23 -88.0 0.0 OUTLIER Pre-proline 0 CA--C 1.447 -2.989 1 N-CA-C 124.219 4.896 . . . . 0.0 124.219 -176.946 . . . . . . . . 3 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -75.88 77.63 3.36 Favored 'Trans proline' 0 N--CA 1.406 -3.672 0 CA-C-N 121.303 1.501 . . . . 0.0 113.251 -167.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.9 m -103.87 130.68 51.48 Favored 'General case' 0 N--CA 1.399 -2.976 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.1 p -114.74 131.96 65.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-O 121.228 0.537 . . . . 0.0 110.095 -179.502 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.465 ' HB3' ' HB ' ' A' ' 7' ' ' THR . 26.1 ttpp -104.95 119.97 40.3 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 174.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 68.1 m-85 -89.98 168.06 12.31 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.257 -179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -69.46 -10.3 57.45 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.329 175.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -71.06 -19.26 62.5 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.252 178.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.53 -22.21 41.68 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 -178.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 19.2 m -82.09 149.96 27.77 Favored 'General case' 0 C--O 1.255 1.383 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.3 p -114.15 139.32 49.44 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.3 mp -117.67 115.89 25.96 Favored 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 177.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 51.4 m -87.75 112.01 21.95 Favored 'General case' 0 N--CA 1.411 -2.41 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.207 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 49.9 t-20 54.89 70.88 1.46 Allowed Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 124.673 1.189 . . . . 0.0 112.548 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -94.21 -175.94 0.46 Allowed 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.501 2.134 . . . . 0.0 110.337 173.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.426 ' O ' HG23 ' A' ' 75' ' ' VAL . 10.3 t -100.16 163.4 12.43 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.94 -42.31 97.36 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 123.199 0.599 . . . . 0.0 112.125 -175.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -60.82 -37.13 80.96 Favored 'General case' 0 C--O 1.242 0.667 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.927 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -69.91 -41.11 75.11 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.043 -0.98 . . . . 0.0 109.833 -179.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 71' ' ' SER . 98.0 t -59.54 -42.3 87.59 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.562 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 177.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -61.25 -44.0 97.96 Favored 'General case' 0 CA--C 1.556 1.196 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.922 177.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.02 -24.28 58.34 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 121.141 0.496 . . . . 0.0 112.227 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.4 ' O ' ' HG2' ' A' ' 81' ' ' LYS . 74.1 mmtt -84.86 -25.15 28.22 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 174.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.538 HD13 HD21 ' A' ' 6' ' ' LEU . 24.4 tp -68.87 -40.73 79.14 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 32.3 m -61.78 -32.98 55.58 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.83 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.325 -178.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 78' ' ' LYS . 14.6 ptmm? -81.04 -30.34 34.87 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 119.651 -0.82 . . . . 0.0 111.077 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.9 pp -85.46 -32.06 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 119.975 -0.69 . . . . 0.0 112.204 -175.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -101.21 -61.86 1.32 Allowed 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.378 178.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 83.06 21.5 58.97 Favored Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 111.246 -0.742 . . . . 0.0 111.246 -176.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 32.6 tp -99.99 -46.33 5.38 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 122.348 -0.501 . . . . 0.0 110.616 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -70.77 -43.66 68.32 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.7 m170 -167.23 178.95 5.32 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 126.362 1.865 . . . . 0.0 106.175 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 15.1 p80 . . . . . 0 C--N 1.302 -1.493 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 174.616 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.8 ttm . . . . . 0 N--CA 1.467 0.423 0 CA-C-O 121.248 0.546 . . . . 0.0 110.075 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.3 m -120.62 171.85 8.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 26.2 m -82.31 75.77 9.21 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.865 0.841 . . . . 0.0 110.536 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.54 86.56 5.25 Favored 'General case' 0 N--CA 1.429 -1.489 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 177.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -91.89 1.19 57.34 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.848 -177.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -131.82 135.48 46.76 Favored 'General case' 0 N--CA 1.432 -1.357 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.939 179.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 22.7 m -108.27 124.98 51.14 Favored 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 177.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 33' ' ' GLU . 62.0 mt -113.33 134.56 55.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 CA-C-O 121.348 0.594 . . . . 0.0 110.556 -176.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.449 ' CD1' HG22 ' A' ' 46' ' ' VAL . 97.3 m-85 -85.83 128.07 34.72 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.434 ' OG1' ' HB2' ' A' ' 33' ' ' GLU . 13.7 p -139.19 147.94 42.49 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -176.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.418 HG23 ' HG3' ' A' ' 37' ' ' GLU . 50.9 m -148.88 142.84 25.8 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 105.657 -1.979 . . . . 0.0 105.657 171.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 49.7 p -70.81 -4.39 23.85 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 -172.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -39.23 94.1 Favored 'General case' 0 CA--C 1.501 -0.932 0 CA-C-O 122.553 1.168 . . . . 0.0 111.493 178.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.1 t -93.98 132.65 38.23 Favored 'General case' 0 N--CA 1.42 -1.942 0 CA-C-N 113.491 -1.686 . . . . 0.0 112.754 -169.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -92.74 -35.81 6.33 Favored Glycine 0 N--CA 1.444 -0.8 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.041 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -63.18 -36.35 83.33 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 121.442 0.639 . . . . 0.0 110.833 -179.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.676 ' SG ' ' HB ' ' A' ' 56' ' ' VAL . 62.2 m -57.12 -42.05 80.16 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.257 177.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 9.3 tt -72.12 -30.21 64.84 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 115.185 -0.916 . . . . 0.0 110.189 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 4.3 tpp180 -62.9 -47.27 84.01 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.063 -179.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.439 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 29.7 tp -73.48 -39.04 65.18 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.008 178.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -55.34 -47.45 75.68 Favored 'General case' 0 C--O 1.245 0.861 0 C-N-CA 124.05 0.94 . . . . 0.0 110.639 -179.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 14.7 p -69.88 -35.06 74.36 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.573 179.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.32 -44.94 96.36 Favored 'General case' 0 CA--C 1.509 -0.605 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 177.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 20' ' ' LEU . 87.9 mt -63.71 -39.4 94.21 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.425 178.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 31.6 m -64.93 -43.55 92.4 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.222 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.2 -22.95 66.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.28 0.562 . . . . 0.0 110.91 178.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 23.0 m-80 -95.34 11.41 32.76 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.34 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 65.97 16.09 10.33 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 124.834 1.254 . . . . 0.0 111.016 175.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 77.5 mt -78.81 122.64 34.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.654 -0.654 . . . . 0.0 109.262 -179.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -92.86 129.56 38.74 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.836 -0.62 . . . . 0.0 109.867 -178.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -142.89 161.13 38.91 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-N 115.807 -0.633 . . . . 0.0 109.527 -175.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -119.77 124.07 45.27 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 176.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 8' ' ' ILE . 13.0 pt-20 -91.94 146.08 24.03 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 -178.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 7.1 t -85.57 156.23 3.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.867 -175.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -83.0 0.3 45.36 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 127.101 2.16 . . . . 0.0 113.683 -176.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 43.6 pt -42.95 -29.91 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 -168.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.418 ' HG3' HG23 ' A' ' 11' ' ' THR . 40.8 tt0 -61.14 -33.76 73.92 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.509 0.671 . . . . 0.0 110.186 -179.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -123.74 24.0 8.56 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.026 -179.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -148.91 100.88 3.12 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.244 178.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.9 ptm180 -67.66 -21.03 65.38 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 112.57 0.582 . . . . 0.0 112.57 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -66.73 -43.31 84.57 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -176.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -84.47 -20.74 31.24 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 120.487 -0.485 . . . . 0.0 109.932 177.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.9 -38.16 90.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.175 178.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -58.06 -39.84 79.48 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.364 174.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -68.83 -29.19 67.47 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.027 -175.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.449 HG22 ' CD1' ' A' ' 9' ' ' TYR . 58.2 t -63.2 -43.59 98.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 109.149 -0.685 . . . . 0.0 109.149 177.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.97 -18.88 77.99 Favored Glycine 0 N--CA 1.443 -0.882 0 CA-C-N 115.254 -0.884 . . . . 0.0 111.469 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.7 t -82.43 -30.42 30.11 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-O 120.6 0.238 . . . . 0.0 110.398 179.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 35.7 m -81.75 -37.0 14.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.963 178.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -119.17 87.0 2.65 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-O 122.439 1.114 . . . . 0.0 109.075 172.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -49.51 118.37 5.37 Favored Glycine 0 N--CA 1.45 -0.409 0 CA-C-N 113.293 -1.776 . . . . 0.0 115.566 -170.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.4 -20.72 49.34 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 121.366 -0.445 . . . . 0.0 114.117 175.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -126.74 171.44 11.19 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 117.71 0.755 . . . . 0.0 109.344 -177.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 87.0 mtm180 -122.32 70.28 0.98 Allowed 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 170.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.1 m -72.08 122.88 21.69 Favored 'General case' 0 C--O 1.248 1.02 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 178.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.676 ' HB ' ' SG ' ' A' ' 17' ' ' CYS . 9.4 t -69.36 -65.85 1.11 Allowed Pre-proline 0 CA--C 1.47 -2.126 0 N-CA-C 115.418 1.636 . . . . 0.0 115.418 -170.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.652 ' HD3' ' SG ' ' A' ' 17' ' ' CYS . 43.9 Cg_endo -77.04 72.31 5.91 Favored 'Trans proline' 0 N--CA 1.403 -3.827 0 CA-C-N 121.755 1.662 . . . . 0.0 112.744 -167.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.424 ' O ' ' HD2' ' A' ' 9' ' ' TYR . 81.6 m -107.72 131.45 54.41 Favored 'General case' 1 N--CA 1.366 -4.637 0 CA-C-N 112.97 -1.923 . . . . 0.0 106.422 179.819 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.2 p -115.43 134.52 58.34 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.366 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.745 -178.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 38.3 ttpt -112.65 119.28 37.56 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 175.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -88.66 159.44 17.84 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.95 -20.5 38.16 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.525 0.679 . . . . 0.0 111.289 177.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -67.68 -18.55 64.97 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 124.573 1.149 . . . . 0.0 111.22 177.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 99.95 -9.17 59.82 Favored Glycine 0 CA--C 1.503 -0.695 0 N-CA-C 111.466 -0.653 . . . . 0.0 111.466 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 2.8 p -81.07 136.03 35.9 Favored 'General case' 0 N--CA 1.412 -2.338 0 CA-C-N 114.948 -0.626 . . . . 0.0 111.088 -179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 34.2 p -114.04 137.93 51.06 Favored 'General case' 0 N--CA 1.421 -1.889 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 177.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.3 mp -127.43 128.18 45.35 Favored 'General case' 0 C--N 1.297 -1.711 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 61.5 m -105.35 123.88 48.61 Favored 'General case' 0 C--N 1.288 -2.079 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 55.41 54.23 9.43 Favored Pre-proline 0 N--CA 1.477 0.917 0 C-N-CA 124.258 1.023 . . . . 0.0 113.117 -177.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -83.27 166.48 14.23 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.629 1.553 . . . . 0.0 111.235 178.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.4 m -87.38 155.55 19.98 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 175.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.29 -37.01 83.89 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.924 0.392 . . . . 0.0 111.328 -177.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -64.71 -34.88 79.36 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.885 178.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -67.04 -44.37 80.38 Favored 'General case' 0 CA--C 1.503 -0.83 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 91.1 t -61.01 -45.48 98.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.835 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -58.37 -48.87 79.23 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.185 178.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.33 -22.35 62.81 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-O 120.89 0.376 . . . . 0.0 111.92 -178.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.486 ' O ' HG13 ' A' ' 82' ' ' ILE . 47.6 mmtm -80.89 -43.31 20.05 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 174.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 39.9 tp -54.3 -48.49 71.24 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 123.82 0.7 . . . . 0.0 110.475 -176.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.0 m -59.4 -41.31 84.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.417 -0.81 . . . . 0.0 112.135 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -81.36 -38.28 26.88 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 112.681 0.622 . . . . 0.0 112.681 -176.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.486 HG13 ' O ' ' A' ' 78' ' ' LYS 0.255 2.5 pp -81.44 -37.4 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -176.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.459 ' N ' HD12 ' A' ' 82' ' ' ILE . . . -83.81 -31.17 26.0 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.504 -0.478 . . . . 0.0 109.892 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.2 -50.38 3.96 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 116.287 -0.415 . . . . 0.0 113.929 174.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 85' ' ' LEU . 35.6 tp -84.73 27.32 0.75 Allowed 'General case' 0 C--N 1.312 -1.031 0 CA-C-O 121.452 0.644 . . . . 0.0 111.848 -175.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -110.79 98.84 7.88 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 175.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 51.7 t-80 55.88 71.17 0.57 Allowed 'General case' 0 C--O 1.239 0.537 0 O-C-N 124.423 1.077 . . . . 0.0 108.806 -175.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 29.9 t60 . . . . . 0 C--N 1.305 -1.339 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.539 -173.438 . . . . . . . . 0 0 . 1 stop_ save_